,CUI1,CUI2,label
0,Singular,Refractory Bladder Carcinoma,0
1,Most,Maxillary Sinus Adenoid Cystic Carcinoma,0
2,Known,Benign neoplasm of thorax,0
3,Age of Onset,Intraepithelial Melanocytic Hyperplasia,0
4,Sex Behavior,Breast Ductal Adenoma,0
5,Immature,Benign Anal Granular Cell Tumor,0
6,International Classification of Diseases,Thyroid Hurthle Cell Carcinoma,0
7,Common (qualifier value),Basal Cell Ameloblastoma,0
8,7.2,Breast Apocrine Adenoma,0
9,Pharyngeal structure,Secondary malignant neoplasm of lymph node,0
10,point - UnitsOfMeasure,Cervical Adenomyoma,0
11,Qualitative form,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12,Linear,Recurrent Primary Lymphoma of Bone,0
13,Characterization,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14,Call (Instruction),Thyroid Hurthle Cell Carcinoma,0
15,Array Feature,Carcinoma of submandibular gland,0
16,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17,What subject filter - Result,Choroid Epithelioid Cell Melanoma,0
18,Negation,Nasal cavity carcinoma,0
19,Condition:Find:Pt:^Patient:Nom,Splenic Manifestation of Hairy Cell Leukemia,0
20,Feel Tired question,Human Papillomavirus-Related Carcinoma,0
21,PREVENT (product),FIGO Stage IVA Ovarian Cancer,0
22,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
23,High Risk Acute Leukemia,Vaginal Adenoma,0
24,Personal appearance,Benign Anal Granular Cell Tumor,0
25,Usually,Liver Lymphangioma,0
26,Mechanism (attribute),Activated B-cell type diffuse large B-cell lymphoma,0
27,Large,Advanced Lung Carcinoma,0
28,Condition,Granular Cell Leiomyosarcoma,0
29,Medical Devices,Non-Metastatic Gestational Trophoblastic Tumor,0
30,Most,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
31,Neoplasms,Clonal Hematopoiesis of Indeterminate Potential,0
32,lymph nodes,Stage I Colon Neuroendocrine Tumor AJCC v8,0
33,1980s,Benign squamous cell tumor,0
34,<90,Kaposi's sarcoma of skin,0
35,To,Peripheral primitive neuroectodermal tumor of soft tissue,0
36,Blood Vessel,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
37,Togo,Benign Anal Granular Cell Tumor,0
38,Immature,Anterior Urethral Malignant Neoplasm,0
39,Affect (mental function),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
40,Adverse Event Associated with Vascular,Stage 0 Lip Carcinoma,0
41,To,Low Grade Squamous Intraepithelial Neoplasia,0
42,Future,Thymoma malignant recurrent,0
43,Valid,Leiomyoma of Gallbladder,0
44,T-Cell Receptor,Locally Advanced Epithelioid Hemangioendothelioma,0
45,Tumor type,squamous cell carcinoma of the thyroid gland,0
46,Minor (value),FIGO Stage II Ovarian Cancer,0
47,Feelings,Anterior Urethral Malignant Neoplasm,0
48,Including (qualifier),Endometrial Small Cell Carcinoma,0
49,Released (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
50,Tumor Suppression,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
51,Woman,ROSE Cluster 3,0
52,Chemotherapy Regimen,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
53,Plasma Cells,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
54,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
55,Duct (organ) structure,Rhabdomyosarcoma with ganglionic differentiation,0
56,Function (attribute),Benign Apocrine Neoplasm,0
57,depend,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
58,Glioblastoma,Brain Tumor,0
59,Skin Specimen,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
60,Shortness of breath:-:Point in time:^Patient:-,Clinical Stage I Cutaneous Melanoma AJCC v8,0
61,Malignant tumor of colon,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
62,Antibodies,Nasal cavity carcinoma,0
63,Fibrous connective tissue,Splenic Manifestation of Hairy Cell Leukemia,0
64,combination - answer to question,Stage III Cutaneous Melanoma AJCC v6,0
65,Beginning,Adrenal Rest Tumor,0
66,Chemotherapy,Intraepithelial Melanocytic Hyperplasia,0
67,Estrogens,Recurrent Testicular Lymphoma,0
68,Paraganglioma,Adenocarcinoma of duodenum,0
69,Screening procedure,Atypical Mesothelial Hyperplasia,0
70,Good,High Grade Glandular Intraepithelial Neoplasia,0
71,Enlargement procedure,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
72,Term (temporal),Xeroderma pigmentosum,0
73,Tree Node,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
74,PSA Level Greater than Fifty,Xeroderma pigmentosum,0
75,Left sided,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
76,CYREN gene,Ovarian Dermoid Cyst with Secondary Carcinoma,0
77,Characterization,Undifferentiated Neuroblastoma,0
78,Carcinoma of bladder,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
79,Frequently,de novo Myelodysplastic Syndrome,0
80,Science of Etiology,Stage IB Pancreatic Cancer AJCC v8,0
81,Concept model domain,Cervical Adenomyoma,0
82,Microscopic description,Spongiotic dermatitis,0
83,Interventional procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
84,Current (present time),Botryoid-Type Embryonal Rhabdomyosarcoma,0
85,CD69 wt Allele,sarcoma of spinal cord,0
86,shared attribute,Ovarian germ cell choriocarcinoma stage IV,0
87,Cerebral Cavernous Hemangioma,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
88,Cutaneous Melanoma,Cerebral Primitive Neuroectodermal Tumor,0
89,Closed,Xeroderma pigmentosum,0
90,Table Cell Horizontal Align - left,Giant cell angiofibroma,0
91,Elevated alpha-fetoprotein,Childhood Cerebellar Neoplasm,0
92,Vomiting,Carcinoma ex pleomorphic adenoma of parotid gland,0
93,Financial Account,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
94,Delta (difference),Clinical Stage I Cutaneous Melanoma AJCC v8,0
95,Occurrence,Diffuse malignant mesothelioma,0
96,Treated with,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
97,Including (qualifier),Vaginal Adenoma,0
98,Histological Techniques,Stage IB Pancreatic Cancer AJCC v8,0
99,Adult,Metastatic Ductal Breast Carcinoma,0
100,unknown vaccine or immune globulin,Stage I Adult Non-Hodgkin Lymphoma,0
101,Occurrence Indicator,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
102,Specimen Source Codes - Serum,Localized Ewing Sarcoma,0
103,Usual Severity Shortness of Breath,Carcinoma,0
104,Relationship by association,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
105,90 - 100%,Melanomatosis,0
106,Medications,Adenocarcinoma,0
107,Respiration,Refractory Ependymoma,0
108,High risk of,gliosarcoma,0
109,Spreading (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
110,Administration procedure,Malignant neoplasm of thalamus,0
111,Cartilage,Stage III Cutaneous Melanoma AJCC v6,0
112,ADCY10 gene,Thymic Atypical Carcinoid Tumor,0
113,Cell Device,Metastatic Malignant Neoplasm in the Sellar Region,0
114,Primary malignant neoplasm,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
115,Positioning Attribute,Mastocytosis,0
116,Togo,Carcinoma of urinary bladder,0
117,Conditional,Endometrial Small Cell Carcinoma,0
118,Location of Oral Residue Following Swallowing,Grade 3a Malignant Neoplasm,0
119,Adult human body,Adult Anaplastic Oligodendroglioma,0
120,Public Domain,Angiosarcoma of liver,0
121,Chemotherapy Regimen,Platinum-Resistant Lung Small Cell Carcinoma,0
122,Confirmed by,Cervical Fibroepithelial Polyp,0
123,Bone Marrow,Primary Cutaneous Plasmablastic Lymphoma,0
124,Measurement,Medulloblastoma,0
125,Kidney Tubules,Uterine Cancer,0
126,Cause of Death,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
127,Body tissue,Unresectable Rhabdomyosarcoma,0
128,Therapeutic procedure,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
129,Category Type,Ectomesenchymal Chondromyxoid Tumor,0
130,Biomaterial Treatment,Recurrent Testicular Lymphoma,0
131,Frequently,Malignant melanoma of eyelid,0
132,Bone Growth,Toxic Epidermal Necrolysis,0
133,Study Variable,Airway Hemangioma,0
134,Sound - physical agent,Undifferentiated Neuroblastoma,0
135,melanocyte,Childhood Central Nervous System Immature Teratoma,0
136,Acetic Acid,non-Hodgkin's lymphoma of spleen,0
137,Average of Value Derivation Technique,Adult Brain Stem Mixed Glioma,0
138,Poor - grade value,Multiple Skull Base Meningiomas,0
139,Both ovaries,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
140,Rare,Human Papillomavirus-Related Carcinoma,0
141,diagnosis aspect,Leiomyoma of Gallbladder,0
142,Symptoms,Refractory Ependymoma,0
143,As Much as Desired,Blepharal carcinoma,0
144,Endogenous,Adult Acute Eosinophilic Leukemia,0
145,risk factors,embryonal rhabdomyosarcoma of prostate,0
146,Referring,Bladder Neuroendocrine Neoplasm,0
147,Subject Risk,Tonsillar Carcinoma,0
148,Abnormal Cell Count,Nasal cavity carcinoma,0
149,Chemotherapy,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
150,Birth,Stage 0 Penile Cancer AJCC v8,0
151,Act Relationship Subset - previous,Mucosal Melanoma,0
152,Leads (device),GIANT PIGMENTED HAIRY NEVUS,0
153,Numbers,Malignant neoplasm of olfactory nerve,0
154,Simple,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
155,Array Feature,Non-Metastatic Gestational Trophoblastic Tumor,0
156,Pharmacotherapy,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
157,Type - attribute,Small cell neuroendocrine carcinoma of bladder,0
158,List,Clonal Hematopoiesis of Indeterminate Potential,0
159,Treatment Epoch,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
160,Functional disorder,Malignant melanoma of eyelid,0
161,Experimental Result,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
162,Often - answer to question,Angiosarcoma of liver,0
163,Mixed Tumor,adenoid cystic carcinoma of lung,0
164,various antiseptic throat preparations,Platinum-Resistant Lung Small Cell Carcinoma,0
165,medication - HL7 publishing domain,Digestive System Hodgkin Lymphoma,0
166,Junction Device,Cartilaginous exostosis,0
167,Complication Aspects,Vaginal Adenoid Cystic Carcinoma,0
168,Including (qualifier),Low Grade Squamous Intraepithelial Neoplasia,0
169,Occurrence Indicator,Stage IB Lung Cancer AJCC v7,0
170,Age,Thyroid Hurthle Cell Carcinoma,0
171,Class (taxonomic),Carcinoma of urinary bladder,0
172,Rapid,Gallbladder adenoma,0
173,Have Itch,Stage III Cutaneous Melanoma AJCC v6,0
174,MS gene,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
175,T-Cell Receptor,Metastatic Carcinoma in the Lung,0
176,Body Site Modifier - Lower,Maxillary Sinus Adenocarcinoma,0
177,Qualitative form,Stage I Colon Neuroendocrine Tumor AJCC v8,0
178,Item Collection,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
179,Usual Severity Cough,Basal Cell Ameloblastoma,0
180,risk factors,Acantholytic squamous cell carcinoma,0
181,End,clear cell adenocarcinoma of gallbladder,0
182,Immunoproliferative Disorders,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
183,Type - attribute,Ovarian germ cell choriocarcinoma stage IV,0
184,Tryptophanase,Localized Ewing Sarcoma,0
185,Cells,clear cell adenocarcinoma of gallbladder,0
186,Symptoms,Papillary squamous cell carcinoma,0
187,Aspects of signs,Lung Inflammatory Myofibroblastic Tumor,0
188,What subject filter - Result,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
189,Surgery specialty,Ovarian Dermoid Cyst with Secondary Carcinoma,0
190,Occurrence Indicator,Adult Alveolar Soft Part Sarcoma,0
191,Neoplasms,Uterine Cancer,0
192,Used by,embryonal rhabdomyosarcoma of prostate,0
193,Guide device,squamous cell carcinoma of the thyroid gland,0
194,Equine laminitis,Bladder Neuroendocrine Neoplasm,0
195,Often - answer to question,Locally Advanced Carcinoma,0
196,Responsible to,Adult Fibrolamellar Carcinoma,0
197,Cell Differentiation process,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
198,Set (Psychology),Stage III Cutaneous Melanoma AJCC v6,0
199,Useful,Xeroderma pigmentosum,0
200,Immunoglobulin Heavy Chain Variable Domain,Acantholytic squamous cell carcinoma,0
201,Nucleated Thrombocyte Count,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
202,Rating (action),squamous cell carcinoma of the thyroid gland,0
203,Take,Benign neoplasm of thorax,0
204,Nasopharynx,Bladder adenocarcinoma stage IV,0
205,Specific qualifier value,Female Breast Carcinoma,0
206,NCI CTEP SDC Osteosarcoma Sub-Category Terminology,Pilocytic astrocytoma of cerebellum,0
207,40%,adenosquamous carcinoma of breast,0
208,Preventive monitoring,Cerebral Primitive Neuroectodermal Tumor,0
209,United States Military Commissioned Officer O4,Transitional cell carcinoma,0
210,<3 (qualifier value),FIGO Stage IVA Ovarian Cancer,0
211,Slow Growing,Ovarian Dermoid Cyst with Secondary Carcinoma,0
212,60%,Non-Metastatic Gestational Trophoblastic Tumor,0
213,Breast,Kaposi's sarcoma of skin,0
214,Organ,Brain Tumor,0
215,burrow wound,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
216,Ephrin Type-B Receptor 1,Astrocytoma of brain,0
217,Mathematical Operator,Refractory Bladder Carcinoma,0
218,Process,Low Grade Squamous Intraepithelial Neoplasia,0
219,Fibrous layer,Testicular cancer metastatic,0
220,Related personal status,Thymic Clear Cell Carcinoma,0
221,radiotherapeutic,Blepharal carcinoma,0
222,Treatment Epoch,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
223,Surgery specialty,mucinous adenocarcinoma of gallbladder,0
224,Ability,Benign tumor of eyelid,0
225,Esophageal,Stage II Hepatocellular Carcinoma AJCC v8,0
226,Stop brand of fluoride,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
227,shared attribute,Intraepithelial Melanocytic Hyperplasia,0
228,Skin Specimen,Benign tumor of eyelid,0
229,Neoplasms,Intestinal Metaplasia of Bladder Urothelium,0
230,Line Specimen,Intestinal Metaplasia of Bladder Urothelium,0
231,Infrequent,Recurrent Primary Lymphoma of Bone,0
232,To,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
233,pharmacotherapeutic,Adult Acute Eosinophilic Leukemia,0
234,status - In progress,Cartilaginous exostosis,0
235,low exposure,Prostate Lymphoma,0
236,lymph nodes,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
237,Young,Benign squamous cell tumor,0
238,Case unit dose,non-Hodgkin's lymphoma of spleen,0
239,Childhood Ganglioneuroblastoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
240,Veins,Stage IB Lung Cancer AJCC v7,0
241,Chemotherapy Regimen,Heavy Chain Deposition Disease,0
242,Benign Neoplasm,Digestive System Hodgkin Lymphoma,0
243,On (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
244,Elective procedure,Tonsillar Carcinoma,0
245,Carcinoma,Liver Lymphangioma,0
246,Unknown GENC,Stage IB Lung Cancer AJCC v7,0
247,Surgical aspects,Recurrent Testicular Lymphoma,0
248,Computed Tomography Study File,Kaposi's sarcoma of extrahepatic bile duct,0
249,Marketing basis - Transitional,Leiomyoma of Gallbladder,0
250,Risk,Benign squamous cell tumor,0
251,Pressure - action,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
252,Classification,Refractory Bladder Carcinoma,0
253,Hemorrhage,Cervical Fibroepithelial Polyp,0
254,Maturity of Progression,Malignant melanoma of eyelid,0
255,Treatment Epoch,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
256,Account number:Identifier:Point in time:^Patient:Nominal,Clinical Stage I Cutaneous Melanoma AJCC v8,0
257,seconds,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
258,Genital system,Basal Cell Ameloblastoma,0
259,Persons,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
260,Large,Pleomorphic adenoma of parotid gland,0
261,Referring,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
262,Linear,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
263,Mirror,Testicular cancer metastatic,0
264,IPSS Risk Category High,Diffuse malignant mesothelioma,0
265,Primary,Bladder Neuroendocrine Neoplasm,0
266,Age,Intraepithelial Melanocytic Hyperplasia,0
267,Cause of death:Find:Pt:^Patient:Nom,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
268,Leading,Lipoma of small intestine,0
269,Five,Medulloblastoma,0
270,Rare,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
271,Time (foundation metadata concept),Medulloblastoma,0
272,Aggressive Non-Hodgkin Lymphoma,Transitional cell carcinoma,0
273,Primary,Maxillary Sinus Adenocarcinoma,0
274,Infective cystitis,Human Papillomavirus-Related Carcinoma,0
275,Human body structure,mucinous adenocarcinoma of gallbladder,0
276,Extension,Chronic Myelomonocytic Leukemia-2,0
277,pregnancy related,Human Papillomavirus-Related Carcinoma,0
278,Post,Localized Askin Tumor,0
279,Same,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
280,Chemical Association,Adenocarcinoma,0
281,Therapeutic procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
282,Include (action),clear cell adenocarcinoma of gallbladder,0
283,Etiology,Blepharal carcinoma,0
284,Site of,Blepharal carcinoma,0
285,Adenocarcinoma of pancreas,Malignant neoplasm of olfactory nerve,0
286,Different,Non-Metastatic Gestational Trophoblastic Tumor,0
287,Hemorrhage,BRCA2 Syndrome,0
288,Young,Neonatal leukemia,0
289,Antibiotics,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
290,Shiny,Astrocytoma of brain,0
291,Occurrence,Peripheral primitive neuroectodermal tumor of soft tissue,0
292,Cosmetic procedure,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
293,Line Specimen,Cerebral hemangioma,0
294,90%,Childhood Lymphoma,0
295,Cell (compartment),Malignant Neoplasm with Regional Lymph Node Involvement,0
296,Melanoma Pathway,Clinical Stage I Cutaneous Melanoma AJCC v8,0
297,Malignant Neoplasms,adenoid cystic carcinoma of lung,0
298,biomedical tube device,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
299,Activities,Ovarian Carcinoid Tumor,0
300,Imaging Techniques,Cerebral Primitive Neuroectodermal Tumor,0
301,High risk,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
302,Primary malignant neoplasm,BRCA2 Syndrome,0
303,Cell Device,Extra-abdominal fibromatosis,0
304,Ductal Carcinoma,Endometrial Small Cell Carcinoma,0
305,Fast Growing,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
306,Contraceptives,Malignant melanoma of eyelid,0
307,Leads (device),embryonal rhabdomyosarcoma of prostate,0
308,Complete,embryonal rhabdomyosarcoma of prostate,0
309,10%,Testicular cancer metastatic,0
310,Diagnosis,Benign tumor of eyelid,0
311,Morning,Undifferentiated Endocervical Sarcoma,0
312,Account number:Identifier:Point in time:^Patient:Nominal,Stage III Cutaneous Melanoma AJCC v6,0
313,Malignant Female Reproductive System Neoplasm,Benign squamous cell tumor,0
314,biopsy characteristics,Tonsillar Carcinoma,0
315,Pancreatic Intraductal Papillary Mucinous Neoplasm,FIGO Stage IVA Ovarian Cancer,0
316,Factor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
317,Sarcoma of soft tissue,Liver Lymphangioma,0
318,Before values,Clinical Stage I Cutaneous Melanoma AJCC v8,0
319,Acute monocytic leukemia,Kaposi's sarcoma of skin,0
320,god,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
321,Dysplasia,Cystadenocarcinoma,0
322,Type - attribute,Thyroid Hurthle Cell Carcinoma,0
323,Specimen Source Codes - Macrophages,Undifferentiated Endocervical Sarcoma,0
324,Prognosis:Find:Pt:^Patient:Nom,FIGO Stage II Ovarian Cancer,0
325,High Level,Collecting Duct Carcinoma of the Kidney,0
326,During,Ovarian germ cell choriocarcinoma stage IV,0
327,treatment - ActInformationManagementReason,Stage 0 Lip Carcinoma,0
328,N+ (tumor staging),Benign tumor of eyelid,0
329,Location of Oral Residue Following Swallowing,Central Nervous System Anaplastic Large Cell Lymphoma,0
330,described,adenoid cystic carcinoma of lung,0
331,Australia,Unresectable Rhabdomyosarcoma,0
332,International Classification of Diseases for Oncology,Neonatal leukemia,0
333,Vaginal Sarcoma,Periosteal Osteosarcoma,0
334,Five-year Survival Rate,Mixed astrocytoma-ependymoma,0
335,Flank (surface region),Mucinous cystadenofibroma,0
336,Feel Tired question,Bladder adenocarcinoma stage IV,0
337,Affecting,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
338,Vaginal intraepithelial neoplasia,embryonal rhabdomyosarcoma of prostate,0
339,Known,Pilocytic astrocytoma of cerebellum,0
340,Different,Female Breast Carcinoma,0
341,Injury due to exposure to external cause,Diffuse malignant mesothelioma,0
342,Red Blood Cell Count measurement,Bladder adenocarcinoma stage IV,0
343,low exposure,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
344,Malignant neoplasm of skin,Neonatal leukemia,0
345,IPSS Risk Category High,Type II Endometrial Adenocarcinoma,0
346,high - ActExposureLevelCode,Bladder squamous cell carcinoma stage I,0
347,Lacking,Botryoid-Type Embryonal Rhabdomyosarcoma,0
348,pharmacotherapeutic,Type II Endometrial Adenocarcinoma,0
349,Circulating blood,Small cell neuroendocrine carcinoma of bladder,0
350,Adipocytes,Blood Vessel Tumors,0
351,Others - Allergy,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
352,Smaller,Benign Apocrine Neoplasm,0
353,Human Papillomavirus Positive,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
354,Numbers,Melanomatosis,0
355,Young Adult,Locally Advanced Epithelioid Hemangioendothelioma,0
356,Complication,Stage II Carcinoma of Penis,0
357,Childhood Lymphoma,Acantholytic squamous cell carcinoma,0
358,Abnormally high,Intraepithelial Melanocytic Hyperplasia,0
359,Examination of pharynx,Vaginal Adenoid Cystic Carcinoma,0
360,Pain,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
361,Sequence Data Type,Digestive System Hodgkin Lymphoma,0
362,Neoplasm Metastasis,Endometrial Small Cell Carcinoma,0
363,Spreading (qualifier value),Papillary squamous cell carcinoma,0
364,Immunoproliferative Disorders,Endometrial Small Cell Carcinoma,0
365,Stem of plant,Non-Metastatic Gestational Trophoblastic Tumor,0
366,Feelings,Lipoma of small intestine,0
367,Adolescent (age group),Transitional cell carcinoma,0
368,Disease,Kaposi's sarcoma of extrahepatic bile duct,0
369,List,Malignant neoplasm of olfactory nerve,0
370,International Classification of Diseases for Oncology,Benign squamous cell tumor,0
371,disease transmission qualifier,Cancer of Urinary Tract,0
372,Stem cell transplant,Childhood Lymphoma,0
373,Tumor Mass,Kaposi's sarcoma of skin,0
374,Certain (qualifier value),Fourth Ventricle and Brain Stem Ependymal Tumor,0
375,Virus,Anaplastic large cell lymphoma,0
376,Evidence,Refractory Ependymoma,0
377,Primary malignant neoplasm,sarcoma of spinal cord,0
378,Progress,Human Papillomavirus-Related Carcinoma,0
379,Average of Value Derivation Technique,Ichthyosis,0
380,Name Given at Birth,Peripheral primitive neuroectodermal tumor of soft tissue,0
381,Firstly,Leiomyoma of Gallbladder,0
382,Cells,Giant cell angiofibroma,0
383,+2,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
384,Percent normal,mucinous adenocarcinoma of gallbladder,0
385,Occur (action),Intraepithelial Melanocytic Hyperplasia,0
386,Feelings,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
387,Vomiting,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
388,Cystic teratoma,Mucinous cystadenofibroma,0
389,Include (action),Blepharal carcinoma,0
390,*Type - Kind of quantity,Splenic Manifestation of Hairy Cell Leukemia,0
391,Pathogenic organism,embryonal rhabdomyosarcoma of prostate,0
392,Operation excision,Kaposi's sarcoma of extrahepatic bile duct,0
393,Aspects of signs,Astrocytoma of brain,0
394,Fever,Placental aromatase deficiency,0
395,How Often Weight Loss,Cancer of Urinary Tract,0
396,Surface of cervix,Undifferentiated Neuroblastoma,0
397,Referring,Noninfiltrating Intraductal Carcinoma,0
398,Biopsy,Endometrial Small Cell Carcinoma,0
399,Either,Mucinous adenocarcinoma gastric,0
400,Type - attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
401,Frequently,Choroid Necrotic Melanoma,0
402,Biological Response Modifiers,Neoplasms,0
403,Poor - qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
404,How Much Distress Weight Loss,Maxillary Sinus Adenocarcinoma,0
405,Stage,Brain Ependymoma,0
406,Similarity,Unicystic ameloblastoma,0
407,Pharmacotherapy,Locally Advanced Soft Tissue Sarcoma,0
408,Neoplastic disease,Congenital hamartoma,0
409,Symptoms aspect,Testicular cancer metastatic,0
410,Sensation quality,Low Grade Squamous Intraepithelial Neoplasia,0
411,shared attribute,Localized Malignant Neoplasm,0
412,SLC5A5 gene,Refractory Ependymoma,0
413,SERPINA3 protein,Werner Syndrome,0
414,Body tissue,Benign Apocrine Neoplasm,0
415,Immune system,Malignant Testicular Sertoli Cell Tumor,0
416,Breast,Choroid Necrotic Melanoma,0
417,Treatment intent,Metastatic Lung Small Cell Carcinoma,0
418,Classification of information,Childhood Fibrillary Astrocytoma,0
419,Extent of disease,FIGO Stage IVA Ovarian Cancer,0
420,Q13,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
421,Cell (compartment),Intraepithelial Melanocytic Hyperplasia,0
422,Aggressive behavior,Engraftment syndrome,0
423,Therapeutic radiology procedure,Malignant neoplasm of choroid,0
424,Neoplastic Glandular Cell,Melanomatosis,0
425,Only - dosing instruction fragment,Undifferentiated Neuroblastoma,0
426,65,Stage I Adult Non-Hodgkin Lymphoma,0
427,Diagnosis,BRCA2 Syndrome,0
428,oncology field,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
429,New Zealand Rabbits,Colorectal cancer,0
430,Occur (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
431,Supratentorial Embryonal Tumor,Diffuse malignant mesothelioma,0
432,Event Seriousness - Significant,clear cell adenocarcinoma of gallbladder,0
433,66,Non-Metastatic Gestational Trophoblastic Tumor,0
434,Occurrence Indicator,Endometrial Small Cell Carcinoma,0
435,Early,Transitional cell carcinoma,0
436,Case (situation),Stage IV Childhood Non-Hodgkin Lymphoma,0
437,Malignant Neoplasms,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
438,Stage Grouping,Giant cell angiofibroma,0
439,site-specific telomere resolvase activity,clear cell adenocarcinoma of gallbladder,0
440,Free (available (qualifier)),Locally Advanced Squamous Cell Carcinoma,0
441,Fallopian Tubes,Malignant neoplasm of thalamus,0
442,Prolonged,Low Grade Squamous Intraepithelial Neoplasia,0
443,white blood cell type,Leptomeningeal sarcoma,0
444,Tissue Specimen Code,Choroid Necrotic Melanoma,0
445,2+ Score,Peripheral primitive neuroectodermal tumor of soft tissue,0
446,Death (finding),Kaposi's sarcoma of extrahepatic bile duct,0
447,Time,Malignant Testicular Sertoli Cell Tumor,0
448,Occurrence Indicator,Localized Malignant Neoplasm,0
449,Homo sapiens,Neonatal leukemia,0
450,Symptoms,Peripheral primitive neuroectodermal tumor of soft tissue,0
451,Beginning,Chronic Myelomonocytic Leukemia-2,0
452,Measured,Trichilemmocarcinoma,0
453,Simpson Grade 3,Type II Endometrial Adenocarcinoma,0
454,Body structure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
455,Clear,Bladder squamous cell carcinoma stage I,0
456,Term (lexical),ROSE Cluster 3,0
457,Tissue Specimen Code,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
458,Systemic disease,benign mature teratoma of pancreas,0
459,risk factors,Maxillary Sinus Adenoid Cystic Carcinoma,0
460,Squamous cell carcinoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
461,Location of Pharyngeal Residue Following Swallowing,Malignant neoplasm of gallbladder,0
462,Never (frequency),Kaposi's sarcoma of extrahepatic bile duct,0
463,66,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
464,Specific qualifier value,Adult Brain Stem Mixed Glioma,0
465,Coating (film),Human Papillomavirus-Related Carcinoma,0
466,Together,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
467,Gastrointestinal tract structure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
468,Cell Count,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
469,Melanocytic nevus of skin,Human Papillomavirus-Related Carcinoma,0
470,Australia,Maxillary Sinus Adenoid Cystic Carcinoma,0
471,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
472,Nearly,Digestive System Hodgkin Lymphoma,0
473,Mild (qualifier value),Unicystic ameloblastoma,0
474,Fasting,Familial Adenomatous Polyposis Associated Medulloblastoma,0
475,ethnic european,Cervical Fibroepithelial Polyp,0
476,Function Axis,Ovarian Dermoid Cyst with Secondary Carcinoma,0
477,Therapeutic tactile stimulation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
478,Polypeptide Hormones,Squamous cell carcinoma of lip,0
479,Tubal Ligation,Undifferentiated Endocervical Sarcoma,0
480,Increase,Undifferentiated Neuroblastoma,0
481,shared attribute,Undifferentiated Neuroblastoma,0
482,Survival Rate,Brain Tumor,0
483,Love,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
484,Presentation,Childhood Anaplastic Large Cell Lymphoma,0
485,Relationships,Recurrent Testicular Lymphoma,0
486,Etiology aspects,Benign neoplasm of thorax,0
487,Application Context,Metastatic Malignant Neoplasm in the Sellar Region,0
488,Body part,Refractory Bladder Carcinoma,0
489,Anatomic Site,Mucinous neoplasm,0
490,Childhood Diffuse Large B-Cell Lymphoma,Recurrent Testicular Lymphoma,0
491,Sequence Arm,Mucosal Melanoma,0
492,dendritic spine neck,Clonal Hematopoiesis of Indeterminate Potential,0
493,Tooth structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
494,Severe (severity modifier),Neoplasms,0
495,Result,Placental aromatase deficiency,0
496,Development,FIGO Stage IVA Ovarian Cancer,0
497,Possible diagnosis,Clinical Stage I Cutaneous Melanoma AJCC v8,0
498,Areas <moth>,Metastatic Lung Neuroendocrine Neoplasm,0
499,Mass of body structure,Medulloblastoma,0
500,Characterization,Stage III Adult Immunoblastic Lymphoma,0
501,Death NOS,Angiosarcoma of liver,0
502,Formation,Female Breast Carcinoma,0
503,DOCK1 gene,embryonal rhabdomyosarcoma of prostate,0
504,include - SetOperator,Endometrial Small Cell Carcinoma,0
505,Geographic Locations,Cartilaginous exostosis,0
506,Usual,Testicular cancer metastatic,0
507,Latin America,Maxillary Sinus Adenocarcinoma,0
508,1+,Mucinous adenocarcinoma gastric,0
509,Renal Cell Carcinoma Pathway,Pancreatic Endocrine Carcinoma,0
510,Diagnosis,Small intestine carcinoma,0
511,Exclusion,embryonal rhabdomyosarcoma of prostate,0
512,enzyme activity,Childhood Fibrillary Astrocytoma,0
513,Light Emitting Diode Device,Localized Ewing Sarcoma,0
514,Dependent for dressing,Vaginal Adenoid Cystic Carcinoma,0
515,Divide,Childhood Central Nervous System Ganglioneuroblastoma,0
516,Spreading (qualifier value),FIGO Stage IVA Ovarian Cancer,0
517,Vision,Refractory Barrett Esophagus,0
518,Cystoscopy,Acantholytic squamous cell carcinoma,0
519,Speaking (activity),Refractory Glioma,0
520,Group A (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
521,Nausea,Colorectal cancer,0
522,gene therapy,Stage II Fallopian Tube Cancer,0
523,vulvovaginal,Hodgkin lymphoma,0
524,Occur (action),Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
525,pharmacotherapeutic,Digestive System Hodgkin Lymphoma,0
526,Liver,Colorectal cancer,0
527,Decision,Recurrent Primary Lymphoma of Bone,0
528,Progress,Benign neoplasm of thorax,0
529,Formation,Transitional cell carcinoma,0
530,Old,Intracortical osteosarcoma,0
531,Surgical aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
532,Workers,Intracortical osteosarcoma,0
533,Occurrence,Localized Ewing Sarcoma,0
534,84,Blood Vessel Tumors,0
535,Structure of great blood vessel (organ),Carcinoma of submandibular gland,0
536,Togo,Astrocytoma of brain,0
537,Limited stage (cancer stage),sarcoma of spinal cord,0
538,Occur (action),Stage IB Lung Cancer AJCC v7,0
539,Leading,Adenocarcinoma of duodenum,0
540,Most,Occult Lung Adenosquamous Carcinoma,0
541,Vaginal (intended site),Squamous cell carcinoma of lip,0
542,Number of birth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
543,Usual Severity Weight Loss,Localized Malignant Neoplasm,0
544,Body Fluids,Blepharal carcinoma,0
545,Derived value,ALK positive large B-cell lymphoma,0
546,biopsy characteristics,Benign neoplasm of thorax,0
547,Areas <moth>,Chest Wall Fibromatosis,0
548,Free of (attribute),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
549,Person 1,Benign Carotid Body Paraganglioma,0
550,Unexplained weight loss,Small cell neuroendocrine carcinoma of bladder,0
551,Tryptophanase,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
552,Multiple Myeloma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
553,Positive Selection,Childhood Anaplastic Large Cell Lymphoma,0
554,Dyspnea,Mucinous cystadenofibroma,0
555,Recurrence,Testicular cancer metastatic,0
556,Umbilical stump observable,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
557,white blood cell type,Squamous cell carcinoma of lip,0
558,Overall Well Being,Type II Endometrial Adenocarcinoma,0
559,Case unit dose,Undifferentiated Neuroblastoma,0
560,How Much Distress Weight Loss,Carcinoma of urinary bladder,0
561,1960s,Localized Askin Tumor,0
562,Malignant neoplasm of large intestine,Testicular cancer metastatic,0
563,Negation,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
564,Include (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
565,<50,Breast Apocrine Adenoma,0
566,Natures,FIGO Stage IVA Ovarian Cancer,0
567,Following,Intraepithelial Melanocytic Hyperplasia,0
568,Present,Brain Tumor,0
569,Have Diarrhea,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
570,Younger child,Stage IB Pancreatic Cancer AJCC v8,0
571,Protection,Fourth Ventricle and Brain Stem Ependymal Tumor,0
572,Approximate,Malignant neoplasm of olfactory nerve,0
573,therapeutic aspects,Cervical Fibroepithelial Polyp,0
574,Hematopoietic Neoplasms,Congenital hamartoma,0
575,Trial Screening,Intracortical osteosarcoma,0
576,Tryptophanase,Endometrial Small Cell Carcinoma,0
577,Term Birth,Clinical Stage I Cutaneous Melanoma AJCC v8,0
578,Europe,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
579,Asia,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
580,Include (action),BRCA2 Syndrome,0
581,Far East,Angiosarcoma of liver,0
582,What subject filter - Result,Cerebral Primitive Neuroectodermal Tumor,0
583,Average of Value Derivation Technique,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
584,Over (spatial),adenoid cystic carcinoma of lung,0
585,High risk,Recurrent Rhabdomyosarcoma,0
586,Melanocytic nevus,Deep Leiomyoma,0
587,risk factors,Recurrent Uveal Melanoma,0
588,research subject screening,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
589,therapeutic aspects,Testicular cancer metastatic,0
590,Artificial Airways,Splenic Manifestation of Hairy Cell Leukemia,0
591,Space - property,Type II Endometrial Adenocarcinoma,0
592,Vaginal intraepithelial neoplasia,Malignant melanoma of eyelid,0
593,biopsy characteristics,Granular Cell Leiomyosarcoma,0
594,Proliferation (morphologic abnormality),Hodgkin Disease,0
595,betel quid,Peripheral primitive neuroectodermal tumor of soft tissue,0
596,Organ,Stage II Fallopian Tube Cancer,0
597,Status post,Female Breast Carcinoma,0
598,combination - answer to question,Pancreatic carcinoma,0
599,Treating,Mucinous adenocarcinoma gastric,0
600,Talpidae,Heavy Chain Deposition Disease,0
601,Endocrine Cells,Recurrent Testicular Lymphoma,0
602,Appearance,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
603,Third revision,Splenic Manifestation of Hairy Cell Leukemia,0
604,Beginning,Stage IV Penile Cancer AJCC v7,0
605,Age at menopause:Time:Point in time:^Patient:Quantitative,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
606,seconds,Refractory Bladder Carcinoma,0
607,World,Cartilaginous exostosis,0
608,Often - answer to question,Intestinal Metaplasia of Bladder Urothelium,0
609,United States,Localized Askin Tumor,0
610,Treatment Epoch,Malignant neoplasm of thalamus,0
611,With shape,Cerebral Primitive Neuroectodermal Tumor,0
612,Malignant Neoplasms,Refractory Ependymoma,0
613,Digestive Enzymes,Trichilemmocarcinoma,0
614,Time,Stage I Adult Non-Hodgkin Lymphoma,0
615,Disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
616,Cystic,Unresectable Rhabdomyosarcoma,0
617,Pesticides,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
618,Neoplasms,Recurrent Uveal Melanoma,0
619,Malignant Neoplasms,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
620,Cell Lineage,FIGO Stage IVA Ovarian Cancer,0
621,Sore Throat,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
622,<90,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
623,include - SetOperator,Diffuse malignant mesothelioma,0
624,Occurrence Indicator,Breast Ductal Adenoma,0
625,Boat dock,Methotrexate-Associated Hodgkin Lymphoma,0
626,Linear,Metastatic Lung Small Cell Carcinoma,0
627,Most,Bladder adenocarcinoma stage IV,0
628,Unconscious State,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
629,Worse,Digestive System Hodgkin Lymphoma,0
630,Symptoms aspect,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
631,Childhood Medulloblastoma,Ectomesenchymal Chondromyxoid Tumor,0
632,Condition:Find:Pt:^Patient:Nom,Endometrial Small Cell Carcinoma,0
633,Short,Intraepithelial Melanocytic Hyperplasia,0
634,Binding action,Extra-abdominal fibromatosis,0
635,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
636,To,Engraftment syndrome,0
637,Include (action),Cancer of Urinary Tract,0
638,Cancer Genus,Rhabdomyosarcoma with ganglionic differentiation,0
639,First (number),Tonsillar Carcinoma,0
640,Usual Severity Itching,Bladder adenocarcinoma stage IV,0
641,Including (qualifier),Carcinomatosis of peritoneal cavity,0
642,Prevalence aspects,Non-Metastatic Gestational Trophoblastic Tumor,0
643,Medical Device Emits Smoke,Cerebral Primitive Neuroectodermal Tumor,0
644,site-specific telomere resolvase activity,Blood Vessel Tumors,0
645,Treated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
646,Associated topography,Childhood Fibrillary Astrocytoma,0
647,Asians,adenoid cystic carcinoma of lung,0
648,NCI CTEP SDC Melanoma Sub-Category Terminology,Mixed parotid tumor,0
649,Pharmacotherapy,Malignant melanoma of eyelid,0
650,Bone Marrow,Maxillary Sinus Adenocarcinoma,0
651,Retinoic Acid Response Element,Malignant Neoplasm of Lung - Multiple Primary Sites,0
652,Malignant neoplasm of thyroid,Cervical Squamous Intraepithelial Neoplasia,0
653,Occurrence,Astrocytoma of brain,0
654,Stem of plant,Lipoma of small intestine,0
655,Diagnosis,Secondary malignant neoplasm of lymph node,0
656,Retinoic Acid Response Element,Stage IB Pancreatic Cancer AJCC v8,0
657,Common Specifications in HL7 V3 Publishing,Granular Cell Leiomyosarcoma,0
658,Primary malignant neoplasm of lung,Localized Askin Tumor,0
659,Representation (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
660,CEL gene,Basal Cell Ameloblastoma,0
661,Functional Relationship,Adenocarcinoma,0
662,Minor (value),Primary Cutaneous Plasmablastic Lymphoma,0
663,Hemangioma,Stage II Fallopian Tube Cancer,0
664,Tumor Mass,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
665,Previous,Small Intestinal Villous Adenoma,0
666,Numbers,Carcinomatosis of peritoneal cavity,0
667,Togo,Recurrent Uveal Melanoma,0
668,Triggered by,Low Grade Squamous Intraepithelial Neoplasia,0
669,Problems - What subject filter,Female Breast Carcinoma,0
670,Data Transformation,Atypical Lobular Breast Hyperplasia,0
671,Physical Medical Procedure,Advanced Uterine Corpus Carcinosarcoma,0
672,LYMPHOID Cancers,Giant cell angiofibroma,0
673,intent,Mucinous cystadenofibroma,0
674,Surgical reduction,Colorectal Neuroendocrine Tumor G2,0
675,Platelet Glycoprotein 4,Liver Lymphangioma,0
676,Blood Platelets,Stage II Hepatocellular Carcinoma AJCC v8,0
677,Togo,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
678,Net (qualifier),Ovarian Dermoid Cyst with Secondary Carcinoma,0
679,Empty (qualifier),Carcinoma of urinary bladder,0
680,Concept model domain,Diffuse malignant mesothelioma,0
681,Soft Tissue Route of Drug Administration,Intraepithelial Melanocytic Hyperplasia,0
682,Provide (product),Benign Anal Granular Cell Tumor,0
683,consider,Cancer of Urinary Tract,0
684,Squamous cell carcinoma,Metastatic Lung Small Cell Carcinoma,0
685,100%,Plexosarcoma,0
686,Therapeutic radiology procedure,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
687,Usually Need Help from Another Person for Reach,Precursor B-lymphoblastic lymphoma stage II,0
688,Absence (morphologic abnormality),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
689,Extrinsic,Intracortical osteosarcoma,0
690,Usual,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
691,Pale feces (finding),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
692,Body structure,Nasal cavity carcinoma,0
693,Include (action),Human Papillomavirus-Related Carcinoma,0
694,consider,Breast Ductal Adenoma,0
695,Plaque (lesion),Gallbladder adenoma,0
696,primary tumor,Brain Tumor,0
697,Body part,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
698,shared attribute,Carcinomatosis of peritoneal cavity,0
699,Adult,Heavy Chain Deposition Disease,0
700,Breast Cancer Type 1 Susceptibility Protein Measurement,Intestinal Metaplasia of Bladder Urothelium,0
701,Beginning,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
702,Precision - characteristic,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
703,Immature Lymphocytes Measurement,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
704,Diagnostic Imaging,Tonsillar Carcinoma,0
705,Up,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
706,Blood Vessel,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
707,Characteristics,Breast Ductal Adenoma,0
708,Surgical service,Undifferentiated Endocervical Sarcoma,0
709,ALLERGENS IDENTIFIED:PRESENCE OR IDENTITY:POINT IN TIME:SERUM:NOMINAL,BRCA2 Syndrome,0
710,LYMPHOID Cancers,Malignant melanoma of eyelid,0
711,Xeroderma Pigmentosum,Undifferentiated Endocervical Sarcoma,0
712,To,Maxillary Sinus Adenoid Cystic Carcinoma,0
713,Continuance of life,Mixed astrocytoma-ependymoma,0
714,Organ,Blepharal carcinoma,0
715,Fluid behavior,Adult Acute Eosinophilic Leukemia,0
716,Early Therapy,Prostate Lymphoma,0
717,Diagnosis,Cerebral Primitive Neuroectodermal Tumor,0
718,10%,Maxillary Sinus Adenoid Cystic Carcinoma,0
719,Upper,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
720,peripheral blood,Refractory Ependymoma,0
721,Growth,Medulloblastoma,0
722,Head,Precursor B-lymphoblastic lymphoma stage II,0
723,Three,Refractory Ependymoma,0
724,Abdomen distended,Leiomyoma of Gallbladder,0
725,Neoplasm Metastasis,Airway Hemangioma,0
726,Abnormal cell,Malignant melanoma of eyelid,0
727,More,Kaposi's sarcoma of extrahepatic bile duct,0
728,peripheral blood,Gastric Diffuse Large B-Cell Lymphoma,0
729,Aerosols,Benign Ovarian Thecoma,0
730,Process (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
731,Subject Risk,Lipoma of small intestine,0
732,Thyroid Neoplasm,Engraftment syndrome,0
733,ancestors,Basal Cell Ameloblastoma,0
734,To,Cervical Adenomyoma,0
735,Tumor cells,Astrocytoma of brain,0
736,Communicable Diseases,Diffuse malignant mesothelioma,0
737,Mobility aid,Female Breast Carcinoma,0
738,Drinking Water,clear cell adenocarcinoma of gallbladder,0
739,Coloring Excipient,Bladder squamous cell carcinoma stage I,0
740,Alcohol consumption,Thyroid Hurthle Cell Carcinoma,0
741,Comparison,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
742,True Control Status,Carcinoma of urinary bladder,0
743,Usual Severity Pain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
744,Common Specifications in HL7 V3 Publishing,Botryoid-Type Embryonal Rhabdomyosarcoma,0
745,House (environment),Intestinal Metaplasia of Bladder Urothelium,0
746,diagnostic image,Benign neoplasm of thorax,0
747,Diagnosis Study,Fibroadenoma of breast,0
748,Tumor site,Malignant neoplasm of choroid,0
749,Thyroid carcinoma,Liver Lymphangioma,0
750,Childhood Lymphoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
751,Combined Modality Therapy,Thymic Clear Cell Carcinoma,0
752,Specific qualifier value,Benign Carotid Body Paraganglioma,0
753,Malignant neoplasm of pancreas,Leptomeningeal sarcoma,0
754,Icterus,FIGO Stage II Ovarian Cancer,0
755,Case (situation),Ovarian Carcinoid Tumor,0
756,*Type - Kind of quantity,Bladder adenocarcinoma stage IV,0
757,Chest,Cartilaginous exostosis,0
758,Cell of Claudius,Bladder squamous cell carcinoma stage I,0
759,Well,Mucinous adenocarcinoma gastric,0
760,Cord - Body Parts,Diffuse malignant mesothelioma,0
761,Malignant - descriptor,Childhood Fibrillary Astrocytoma,0
762,Iodides,Ovarian germ cell choriocarcinoma stage IV,0
763,Surrounding (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
764,Abdomen+,Metastatic Neoplasm to the Gallbladder,0
765,Benign,Childhood Lymphoma,0
766,Proteins,Benign Carotid Body Paraganglioma,0
767,What subject filter - Result,Occult Lung Adenosquamous Carcinoma,0
768,Connecticut,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
769,Have Pain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
770,Person Observer,Heavy Chain Deposition Disease,0
771,Muscle (organ),Locally Advanced Soft Tissue Sarcoma,0
772,Case (situation),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
773,Together,Vaginal Adenoid Cystic Carcinoma,0
774,Population Group,Familial Adenomatous Polyposis Associated Medulloblastoma,0
775,Progress,Mixed astrocytoma-ependymoma,0
776,More,Benign squamous cell tumor,0
777,Benign melanocytic nevus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
778,Physical shape,Mixed astrocytoma-ependymoma,0
779,International Aspects,Squamous cell carcinoma of lip,0
780,Occur (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
781,Respiration,Locally Advanced Epithelioid Hemangioendothelioma,0
782,Neoplasms,Extra-Adrenal Paraganglioma,0
783,Increase,papillary carcinoma of penis,0
784,Cancer Other,Hodgkin lymphoma,0
785,Representation (action),Werner Syndrome,0
786,Treating,Tonsillar Carcinoma,0
787,Medial,sarcoma of spinal cord,0
788,Decision,Airway Hemangioma,0
789,Primary malignant neoplasm,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
790,Organ,Kaposi's sarcoma of extrahepatic bile duct,0
791,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
792,What subject filter - Result,Kaposi's sarcoma of skin,0
793,Antibiotic throat preparations,Female Breast Carcinoma,0
794,Arranged (transportation),Malignant Neoplasm with Regional Lymph Node Involvement,0
795,Early disease stage,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
796,Unintentional,Recurrent Primary Lymphoma of Bone,0
797,Show,Astrocytoma of brain,0
798,Surgical service,Unresectable Rhabdomyosarcoma,0
799,First (number),Human Papillomavirus-Related Carcinoma,0
800,Tonsillar Carcinoma,Testicular cancer metastatic,0
801,Population Group,Pilocytic astrocytoma of cerebellum,0
802,75,Multiple Skull Base Meningiomas,0
803,Changed status,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
804,Abnormal Cell Count,Maxillary Sinus Adenoid Cystic Carcinoma,0
805,Fever symptoms (finding),Malignant melanoma of eyelid,0
806,Dana-Farber/Harvard Cancer Center,Mastocytosis,0
807,Type A,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
808,Decreasing,Vaginal Adenoid Cystic Carcinoma,0
809,Common (qualifier value),Cherubism,0
810,Usually,Advanced Lung Carcinoma,0
811,Occur (action),Acute Undifferentiated Leukemia,0
812,Malignant Neoplasms,Cancer of Urinary Tract,0
813,Digestion,Childhood Central Nervous System Ganglioneuroblastoma,0
814,Carcinoma,Gallbladder Adenocarcinoma,0
815,Range,Intraepithelial Melanocytic Hyperplasia,0
816,Mutation Abnormality,FIGO Stage IVA Ovarian Cancer,0
817,Malignant Neoplasms,Non-Hodgkin Lymphoma During Pregnancy,0
818,Therapy Object (animal model),FIGO Stage IVA Ovarian Cancer,0
819,Infrequent,Primary Cutaneous Plasmablastic Lymphoma,0
820,Common (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
821,20%,Pancreatic carcinoma,0
822,Poor function,clear cell adenocarcinoma of gallbladder,0
823,described,clear cell adenocarcinoma of gallbladder,0
824,Include (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
825,80%,Epithelioid Sarcoma NCI Grade 3,0
826,Entity Name Part Qualifier - birth,Endometrial Small Cell Carcinoma,0
827,Designated Blood Product Donation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
828,Flat shape,Secondary malignant neoplasm of lymph node,0
829,Nervous system structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
830,Tired,Anterior Urethral Malignant Neoplasm,0
831,Down Syndrome,Liver Lymphangioma,0
832,Effectiveness,Lipoma of small intestine,0
833,Persons,Lipoma of small intestine,0
834,Financial Account,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
835,Percent (qualifier value),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
836,Acetic Acids,Ovarian germ cell choriocarcinoma stage IV,0
837,Severe (severity modifier),Spermatocytic seminoma,0
838,Biomaterial Treatment,Adenocarcinoma,0
839,Science of Etiology,Trabecular adenocarcinoma,0
840,Pitcairn Island,Hodgkin Disease,0
841,Chest Pain,benign mature teratoma of pancreas,0
842,VARIOUS DRUG CLASSES IN ATC,Brain Ependymoma,0
843,Does stand alone,mucinous adenocarcinoma of gallbladder,0
844,Weight decreased,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
845,Africa,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
846,Squamous cell carcinoma - category,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
847,Treatment intent,Ichthyosis,0
848,T-Lymphocytopenia,Hereditary Diffuse Gastric Adenocarcinoma,0
849,New bone formation (morphologic abnormality),Atypical Mesothelial Hyperplasia,0
850,Mixed Cell Morphology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
851,Preventive intent,Tongue Alveolar Soft Part Sarcoma,0
852,Hereditary Diseases,Hereditary Diffuse Gastric Adenocarcinoma,0
853,Result,clear cell adenocarcinoma of gallbladder,0
854,Disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
855,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,de novo Myelodysplastic Syndrome,0
856,Esophageal Stricture,Nasal cavity carcinoma,0
857,Tumor Mass,Tonsillar Carcinoma,0
858,Characterization,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
859,Obesity,clear cell adenocarcinoma of gallbladder,0
860,Neurofibromatosis 2,Squamous cell carcinoma of lip,0
861,Diffuse Large B-Cell Lymphoma,Testicular cancer metastatic,0
862,Median (qualifier value),Cervical Squamous Intraepithelial Neoplasia,0
863,Chromosomes,Endometrial Small Cell Carcinoma,0
864,Science of Statistics,Uterine Cancer,0
865,Linear,Stage IB Pancreatic Cancer AJCC v8,0
866,Symptoms aspect,clear cell adenocarcinoma of gallbladder,0
867,Bacteria,Human Papillomavirus-Related Carcinoma,0
868,How Often Itching,Clinical Stage I Cutaneous Melanoma AJCC v8,0
869,Subgroup,Childhood Fibrillary Astrocytoma,0
870,Patient observation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
871,Occurrence,Maxillary Sinus Adenoid Cystic Carcinoma,0
872,Daily Living,Acantholytic squamous cell carcinoma,0
873,diagnosis aspect,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
874,history (of) disease family,Microcystic meningioma,0
875,Never (frequency),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
876,Subtype (attribute),Ovarian Dermoid Cyst with Secondary Carcinoma,0
877,Lymphoma,Mixed parotid tumor,0
878,Brain Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
879,Malignant tumor of cervix,FIGO Stage IVA Ovarian Cancer,0
880,Common (qualifier value),Fibroadenoma of breast,0
881,Age - 16,Recurrent Testicular Lymphoma,0
882,Often - answer to question,Chest Wall Fibromatosis,0
883,Flank Pain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
884,Symptoms,Pancreatic Intraepithelial Neoplasia-3,0
885,Astrocytoma,Bladder adenocarcinoma stage IV,0
886,ASIP wt Allele,Carcinoma of urinary bladder,0
887,Therapeutic radiology procedure,Refractory Ependymoma,0
888,Vaginal (intended site),Microcystic meningioma,0
889,Antigens,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
890,Continuance of life,Refractory Ependymoma,0
891,Etiology,Epithelioid Sarcoma NCI Grade 3,0
892,Condition,Cancer of Urinary Tract,0
893,Five-year Survival Rate,Serous cystadenocarcinoma ovary,0
894,Visual Impairment,Multiple Endocrine Neoplasia,0
895,body system,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
896,Spreading (qualifier value),Metastatic Neoplasm to the Gallbladder,0
897,Manufactured form,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
898,Nodule,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
899,Known,Diffuse malignant mesothelioma,0
900,Shortness of Breath Visual Analogue Scale,Plexosarcoma,0
901,Cause of death.underlying,Carcinoma of urinary bladder,0
902,treatment - ActInformationManagementReason,Giant cell angiofibroma,0
903,Term (temporal),Squamous cell carcinoma of lip,0
904,>90,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
905,Percent of Abnormal Cells,Malignant Neoplasm of Lung - Multiple Primary Sites,0
906,Lymphocyte component of blood,Diffuse malignant mesothelioma,0
907,To,Childhood Lung Non-Small Cell Carcinoma,0
908,Histology aspects,Parathyroid Gland Adenocarcinoma,0
909,Aggressive behavior,Human Papillomavirus-Related Carcinoma,0
910,Optic Nerve Glioma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
911,Occurrence Indicator,Cancer of Urinary Tract,0
912,Human Cells,Melanomatosis,0
913,Network,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
914,Entity Determiner - specific,ROSE Cluster 3,0
915,How Much Distress Sweats,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
916,Cessation of life,Childhood Anaplastic Large Cell Lymphoma,0
917,Eye lid,FIGO Stage IVA Ovarian Cancer,0
918,*Type - Kind of quantity,Uterine Cancer,0
919,Eye,Stage II Carcinoma of Penis,0
920,Occurrence Indicator,Breast Apocrine Adenoma,0
921,Used by,Clonal Hematopoiesis of Indeterminate Potential,0
922,General surgery specialty,Childhood Central Nervous System Ganglioneuroblastoma,0
923,Exist,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
924,Cancer Genus,Ectomesenchymal Chondromyxoid Tumor,0
925,Abdominal Cavity,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
926,Human Papilloma Virus Vaccine,Gallbladder Adenocarcinoma,0
927,1000000,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
928,Persons,Stage III Cutaneous Melanoma AJCC v6,0
929,Picture,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
930,Weight measurement scales,Childhood Fibrillary Astrocytoma,0
931,Object Class,Cerebral Primitive Neuroectodermal Tumor,0
932,Treatment Effectiveness,Pleomorphic adenoma of parotid gland,0
933,Relationships,Cerebral hemangioma,0
934,Retinoic Acid Response Element,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
935,classical example,Refractory Barrett Esophagus,0
936,Infrequent,Refractory Bladder Carcinoma,0
937,Treating,Peripheral primitive neuroectodermal tumor of soft tissue,0
938,NCI CTEP SDC Thyroid Cancer Sub-Category Terminology,Refractory Bladder Carcinoma,0
939,Exposure to radiation,FIGO Stage II Ovarian Cancer,0
940,Including (qualifier),Melanomatosis,0
941,Disks (device),Locally Advanced Epithelioid Hemangioendothelioma,0
942,Delayed Puberty,Stage II Hepatocellular Carcinoma AJCC v8,0
943,What subject filter - Result,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
944,Tryptophanase,Chest Wall Fibromatosis,0
945,Qualitative form,Unicystic ameloblastoma,0
946,Upper,Benign squamous cell tumor,0
947,Frequently,Stage IV Penile Cancer AJCC v7,0
948,Gastrectomy,Metastatic Neoplasm to the Gallbladder,0
949,Cerebrospinal Fluid,Familial Adenomatous Polyposis Associated Medulloblastoma,0
950,Contribution,gliosarcoma,0
951,Abnormally high,Childhood Fibrillary Astrocytoma,0
952,god,FIGO Stage IVA Ovarian Cancer,0
953,Persons,Occult Lung Adenosquamous Carcinoma,0
954,Increased,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
955,Decision,Benign Apocrine Neoplasm,0
956,Science of Etiology,Brain Tumor,0
957,1000000,FIGO Stage IVA Ovarian Cancer,0
958,Hydrocephalus,Recurrent Rhabdomyosarcoma,0
959,Death (finding),Unresectable Rhabdomyosarcoma,0
960,Common Specifications in HL7 V3 Publishing,Splenic Manifestation of Hairy Cell Leukemia,0
961,Usually,Acute Undifferentiated Leukemia,0
962,Count of entities,Mixed astrocytoma-ependymoma,0
963,Experimental Result,Metaplastic carcinoma of breast,0
964,Adult Diffuse Large B-Cell Lymphoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
965,Rectal examination,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
966,shared attribute,Adult Alveolar Soft Part Sarcoma,0
967,per second,Metastatic Malignant Neoplasm in the Sellar Region,0
968,Development,Microcystic meningioma,0
969,Childhood Non-Hodgkin Lymphoma,Carcinoma,0
970,Classification,Unfavorable Non-Hodgkin Lymphoma,0
971,Levels (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
972,Bone Marrow,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
973,Primary malignant neoplasm,adenosquamous carcinoma of breast,0
974,Secondary Neoplasm,Localized Ewing Sarcoma,0
975,Ewings sarcoma,Cervical Squamous Intraepithelial Neoplasia,0
976,Paired box protein Pax-3,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
977,Different,Recurrent Testicular Lymphoma,0
978,Component object,Benign Anal Granular Cell Tumor,0
979,Blood Cells,Benign Anal Granular Cell Tumor,0
980,Radiology Specialty,Fibroadenoma of breast,0
981,Document Body,Kaposi's sarcoma of skin,0
982,Dosing Days to Detection,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
983,Providing presence (regime/therapy),Adult Acute Eosinophilic Leukemia,0
984,Cancer Genus,Cerebral Primitive Neuroectodermal Tumor,0
985,seen,Funisitis (disorder),0
986,Earache,Recurrent Rhabdomyosarcoma,0
987,morphological,Sarcomatoid Renal Cell Carcinoma,0
988,Cell Count,Brain Tumor,0
989,Carcinoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
990,Malignant Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
991,low exposure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
992,One,Intraepithelial Melanocytic Hyperplasia,0
993,Body tissue patch material,Lipoma of small intestine,0
994,Exist,Ichthyosis,0
995,VARIOUS DRUG CLASSES IN ATC,Adult Alveolar Soft Part Sarcoma,0
996,anaphylaxis,Malignant neoplasm of subglottis,0
997,65+,FIGO Stage II Ovarian Cancer,0
998,per year,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
999,Aim,Adult Acute Eosinophilic Leukemia,0
1000,Various patch test substance,Endometrial Small Cell Carcinoma,0
1001,Most,Childhood Lymphoma,0
1002,bony process,Adenocarcinoma,0
1003,Disease,Multiple Skull Base Meningiomas,0
1004,Stomach structure,Unfavorable Non-Hodgkin Lymphoma,0
1005,Ovarian Germ Cell Tumor,Mucinous adenocarcinoma gastric,0
1006,Type - attribute,Stage IV Penile Cancer AJCC v7,0
1007,Category Type,Malignant neoplasm of gallbladder,0
1008,Gonadal Dysgenesis,Benign tumor of eyelid,0
1009,Apocrine Glands,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
1010,Time (foundation metadata concept),Ovarian Dermoid Cyst with Secondary Carcinoma,0
1011,Affect (mental function),Metaplastic carcinoma of breast,0
1012,Pancreas part,Larynx carcinoma recurrent,0
1013,Rare,Maxillary Sinus Adenoid Cystic Carcinoma,0
1014,Usually,Testicular cancer metastatic,0
1015,Contain (action),Malignant melanoma of eyelid,0
1016,Containing (qualifier),Trichilemmocarcinoma,0
1017,potential,Uterine Cancer,0
1018,Rating (action),Colorectal cancer,0
1019,Reported Term,Peripheral primitive neuroectodermal tumor of soft tissue,0
1020,Excision,Malignant melanoma of eyelid,0
1021,Organ,Liver Lymphangioma,0
1022,Males,Female Breast Carcinoma,0
1023,World Health Organization,Stage II Hepatocellular Carcinoma AJCC v8,0
1024,Tumor cells,Trabecular adenocarcinoma,0
1025,Dorsal,Neonatal leukemia,0
1026,Therapeutic radiology procedure,Metaplastic carcinoma of breast,0
1027,Symptoms aspect,Childhood Fibrillary Astrocytoma,0
1028,Stage Grouping,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1029,Usually Need Help from Another Person for Reach,Recurrent Uveal Melanoma,0
1030,Death (finding),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1031,Skin,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
1032,Togo,Localized Malignant Neoplasm,0
1033,various other nasal preparations in ATC,sarcoma of spinal cord,0
1034,Hematopoiesis,benign mature teratoma of pancreas,0
1035,Involvement with,Heavy Chain Deposition Disease,0
1036,Infrequent,Lipoma of small intestine,0
1037,Pruritus,Cervical Squamous Intraepithelial Neoplasia,0
1038,Palmitic Acid,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1039,High Risk Acute Leukemia,Xeroderma pigmentosum,0
1040,Increase,sarcoma of spinal cord,0
1041,Dorsal,Neonatal leukemia,0
1042,Nevus,benign mature teratoma of pancreas,0
1043,Often - answer to question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1044,Basis - conceptual entity,Intraepithelial Melanocytic Hyperplasia,0
1045,Usually Need Help from Another Person for Reach,Unresectable Rhabdomyosarcoma,0
1046,Life Expectancy Less than Ten Years,Uterine Cancer,0
1047,Physical findings,Digestive System Hodgkin Lymphoma,0
1048,Including (qualifier),Recurrent Primary Lymphoma of Bone,0
1049,Malignant Head and Neck Neoplasm,Unfavorable Non-Hodgkin Lymphoma,0
1050,Drop (unit of presentation),Stage III Cutaneous Melanoma AJCC v6,0
1051,Approximate,Endometrial Small Cell Carcinoma,0
1052,Estrogen [EPC],Stage III Adult Immunoblastic Lymphoma,0
1053,Children only,Stage III Adult Immunoblastic Lymphoma,0
1054,Proprietary Name,Vaginal Adenoma,0
1055,Disease Screening,Malignant neoplasm of subglottis,0
1056,Linear,Platinum-Resistant Lung Small Cell Carcinoma,0
1057,Age,Benign Carotid Body Paraganglioma,0
1058,Manufactured form,embryonal rhabdomyosarcoma of prostate,0
1059,Difficult (qualifier value),Hemangioma,0
1060,Including (qualifier),Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
1061,Known,Stage III Cutaneous Melanoma AJCC v6,0
1062,Adult,Testicular cancer metastatic,0
1063,Pain,Pleomorphic adenoma of parotid gland,0
1064,peripheral blood,Cancer of Urinary Tract,0
1065,Molecular Mass,Gallbladder Adenocarcinoma,0
1066,Persons,Refractory Ependymoma,0
1067,Different,Larynx carcinoma recurrent,0
1068,Involvement with,Methotrexate-Associated Hodgkin Lymphoma,0
1069,Result,Primary Cutaneous Plasmablastic Lymphoma,0
1070,Taxonomic,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1071,Manufactured sign,Bladder adenocarcinoma stage IV,0
1072,Advanced phase,Chondrosarcoma,0
1073,Associated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1074,Bladder Neoplasm,mucinous adenocarcinoma of gallbladder,0
1075,International Statistical Classification of Diseases and Related Health Problems,Refractory Ependymoma,0
1076,Progestins,Breast Ductal Adenoma,0
1077,Young Adult,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1078,Used by,Type II Endometrial Adenocarcinoma,0
1079,Representation (action),Stage III Adult Immunoblastic Lymphoma,0
1080,Contents,Xeroderma pigmentosum,0
1081,Empty (qualifier),Keratoderma,0
1082,Form:Finding:Point in time:{Setting}:Document:{Role},Botryoid-Type Embryonal Rhabdomyosarcoma,0
1083,Disease Management,Benign Anal Granular Cell Tumor,0
1084,Endocrine Cells,Acantholytic squamous cell carcinoma,0
1085,Soft Tissue Route of Drug Administration,squamous cell carcinoma of the thyroid gland,0
1086,Separate,Splenic Manifestation of Hairy Cell Leukemia,0
1087,Hodgkin Disease,Stage 0 Penile Cancer AJCC v8,0
1088,Singular,Carcinoma of urinary bladder,0
1089,Often - answer to question,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1090,Adult Pilocytic Astrocytoma,Ovarian germ cell choriocarcinoma stage IV,0
1091,Atypical ductal hyperplasia (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1092,Metastatic Disease Clinical Trial Setting,Liver Cavernous Hemangioma,0
1093,Symptoms,Ampulla of Vater Tubular Adenoma,0
1094,Lower - spatial qualifier,Stage II Carcinoma of Penis,0
1095,76,Mucinous adenocarcinoma gastric,0
1096,Medical Device Emits Smoke,Intracortical osteosarcoma,0
1097,Present,Lipoma of small intestine,0
1098,Bayer Visual Acuity Changes Grade 3,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1099,Body part,Stage IB Pancreatic Cancer AJCC v8,0
1100,Physical findings,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1101,Body tissue,Colorectal High Grade B-Cell Lymphoma,0
1102,Five-year Survival Rate,Localized Malignant Neoplasm,0
1103,Metastatic to,Kaposi's sarcoma of skin,0
1104,SLC6A2 protein,Liver Lymphangioma,0
1105,Esthesia,Malignant melanoma of eyelid,0
1106,Solid organ transplant,Vaginal Adenoid Cystic Carcinoma,0
1107,Approximate,Placental aromatase deficiency,0
1108,Rare,BRCA2 Syndrome,0
1109,Togo,Stage I Adult Non-Hodgkin Lymphoma,0
1110,More,FIGO Stage II Ovarian Cancer,0
1111,Cancer Genus,Engraftment syndrome,0
1112,Has focus,Breast Ductal Adenoma,0
1113,SLC6A2 protein,FIGO Stage II Ovarian Cancer,0
1114,Excision,Secondary malignant neoplasm of lymph node,0
1115,Slow Growing,Gallbladder Adenocarcinoma,0
1116,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1117,Brain,Acute Undifferentiated Leukemia,0
1118,Tired,Bladder Neuroendocrine Neoplasm,0
1119,Premalignant,Choroid Epithelioid Cell Melanoma,0
1120,Relationships,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1121,Malignant Neoplasms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1122,Metastatic Disease Clinical Trial Setting,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1123,Heterogeneity,Contact dermatitis due to alkali,0
1124,Case (situation),Endometrial Small Cell Carcinoma,0
1125,Adult Hodgkin Lymphoma,Localized Ewing Sarcoma,0
1126,Metastasis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1127,Gait normal,Low Grade Squamous Intraepithelial Neoplasia,0
1128,classical example,Pilocytic astrocytoma of cerebellum,0
1129,MNX1 gene,Metastatic Ductal Breast Carcinoma,0
1130,Tumor cells,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
1131,Heart,Ichthyosis,0
1132,Nicotiana tabacum,Benign neoplasm of eye,0
1133,Line Specimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1134,Therapeutic radiology procedure,Mucinous neoplasm,0
1135,Response to treatment,Carcinoma,0
1136,How Much Distress Weight Loss,Stage IV Childhood Non-Hodgkin Lymphoma,0
1137,Case unit dose,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1138,Imaging Techniques,Childhood Extragonadal Malignant Germ Cell Tumor,0
1139,Occurrence,Funisitis (disorder),0
1140,Cell division,Keratoderma,0
1141,At risk of infection,Small intestine carcinoma,0
1142,Painless,Hemangioma,0
1143,Tired,Mucinous neoplasm,0
1144,Family history,Metaplastic carcinoma of breast,0
1145,Presentation,Leptomeningeal sarcoma,0
1146,Package Type Not Applicable,Choroid Necrotic Melanoma,0
1147,Head,Childhood Anaplastic Large Cell Lymphoma,0
1148,Sufficient,Uterine Cancer,0
1149,Adult Non-Hodgkin Lymphoma,Platinum-Resistant Lung Small Cell Carcinoma,0
1150,Smear test,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1151,Ability,Malignant neoplasm of choroid,0
1152,3+ Score,Localized Ewing Sarcoma,0
1153,Cancer Genus,Human Papillomavirus-Related Carcinoma,0
1154,Australia,Adenocarcinoma of the prostate metastatic,0
1155,Base - General Qualifier,Malignant melanoma of eyelid,0
1156,Eye,Localized Askin Tumor,0
1157,Blood Vessel,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
1158,Frequencies (time pattern),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1159,Intestines,Brain Ependymoma,0
1160,Index,Lipoma of small intestine,0
1161,Woman,gliosarcoma,0
1162,Long-term,Refractory Glioma,0
1163,Data operation - complete,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1164,Mutation,Pancreatic Endocrine Carcinoma,0
1165,Neoplasms,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
1166,Hematuria,Carcinoma ex pleomorphic adenoma of parotid gland,0
1167,high-risk group,Leiomyoma of Gallbladder,0
1168,Embryo,Digestive System Hodgkin Lymphoma,0
1169,Skin tanning,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1170,section sample,Mucinous adenocarcinoma gastric,0
1171,Include (action),Pancreatic carcinoma,0
1172,Old,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
1173,Sweat gland cyst,Stage III Cutaneous Melanoma AJCC v6,0
1174,PSA Level Less than Five,Clonal Hematopoiesis of Indeterminate Potential,0
1175,Lymphocyte,Astrocytoma of brain,0
1176,Descending,Metastatic Kidney Carcinoma,0
1177,Feature,Mixed astrocytoma-ependymoma,0
1178,Primary malignant neoplasm,Vaginal Adenoma,0
1179,Occur (action),Adult Hepatocellular Carcinoma,0
1180,Area,Cancer of Urinary Tract,0
1181,Left sided,Childhood Central Nervous System Ganglioneuroblastoma,0
1182,Carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1183,Absence of Signs or Symptoms,Intracortical osteosarcoma,0
1184,Thyroid Gland,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1185,Cancer Genus,Malignant Neoplasm with Regional Lymph Node Involvement,0
1186,Reported Term,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1187,Changing,Adenocarcinoma of the prostate metastatic,0
1188,use of ultrasonography,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1189,Infertility risk,Xeroderma pigmentosum,0
1190,Lymphocyte,Digestive System Hodgkin Lymphoma,0
1191,Vision:-:Point in time:^Patient:-,Kaposi's sarcoma of skin,0
1192,Infrequent,Diffuse malignant mesothelioma,0
1193,New Zealand Rabbits,Stage IV Childhood Non-Hodgkin Lymphoma,0
1194,Chemotherapy Regimen,Stage IB Pancreatic Cancer AJCC v8,0
1195,Followed by,Tonsillar Carcinoma,0
1196,Anterior chest wall structure,Localized Malignant Neoplasm,0
1197,Second edition,Keratoderma,0
1198,Section - Geographic Area,Benign Anal Granular Cell Tumor,0
1199,Parenchyma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1200,Main,Basal Cell Ameloblastoma,0
1201,Imaging Techniques,gliosarcoma,0
1202,Second edition,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1203,Immunotherapy for cancer,Diffuse malignant mesothelioma,0
1204,include - SetOperator,Recurrent Testicular Lymphoma,0
1205,Sometimes,Malignant neoplasm of gallbladder,0
1206,Operative Surgical Procedures,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1207,Mutation,Blepharal carcinoma,0
1208,Diagnosis Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1209,PSA Level Less than Two,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1210,6/3,Collecting Duct Carcinoma of the Kidney,0
1211,Human body structure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1212,Nursing interventions,Medulloblastoma,0
1213,Main,Kaposi's sarcoma of skin,0
1214,Blood,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1215,Mammal liver preparation,Anterior Urethral Malignant Neoplasm,0
1216,Plant nodule,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1217,include - SetOperator,Locally Advanced Soft Tissue Sarcoma,0
1218,Often - answer to question,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1219,Cancer/Testis Antigen,Clonal Hematopoiesis of Indeterminate Potential,0
1220,Shortness of breath:-:Point in time:^Patient:-,Clonal Hematopoiesis of Indeterminate Potential,0
1221,therapeutic aspects,benign mature teratoma of pancreas,0
1222,Persons,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1223,Non-invasive,Platinum-Resistant Lung Small Cell Carcinoma,0
1224,Entity Determiner - specific,Recurrent Testicular Lymphoma,0
1225,Blood group A (finding),Grade 1 Clear Cell Renal Cell Carcinoma,0
1226,Metastatic Neoplasm,Brain Tumor,0
1227,Abnormal,Brain Tumor,0
1228,Lung,Malignant melanoma of eyelid,0
1229,Affecting,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1230,Painless,adenoid cystic carcinoma of lung,0
1231,Drop - Unit of Volume,FIGO Stage IVA Ovarian Cancer,0
1232,Grade,Bladder squamous cell carcinoma stage I,0
1233,Injury due to exposure to external cause,Xeroderma pigmentosum,0
1234,Cornea,Benign Anal Granular Cell Tumor,0
1235,Subtype (attribute),Carcinomatosis of peritoneal cavity,0
1236,Benign melanocytic nevus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1237,Tryptophanase,Kaposi's sarcoma of extrahepatic bile duct,0
1238,Uterine Cancer,Carcinomatosis of peritoneal cavity,0
1239,Buildup,Stage IV Colorectal Cancer AJCC v8,0
1240,Common (qualifier value),Metastatic Neoplasm to the Gallbladder,0
1241,Present,FIGO Stage IVA Ovarian Cancer,0
1242,High risk,Acantholytic squamous cell carcinoma,0
1243,As Much as Desired,Localized Ewing Sarcoma,0
1244,Abnormal Cell Count,Childhood Choriocarcinoma,0
1245,TableCellVerticalAlign - bottom,Gallbladder Adenocarcinoma,0
1246,Chemotherapy,Benign Anal Granular Cell Tumor,0
1247,Tumor cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1248,Tissue Growth,Type II Endometrial Adenocarcinoma,0
1249,Usual,Hodgkin lymphoma,0
1250,Abnormal cell,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1251,Tests (qualifier value),non-Hodgkin's lymphoma of spleen,0
1252,Microplate Well,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1253,Death Related to Adverse Event,Breast Ductal Adenoma,0
1254,Benign,Stage II Carcinoma of Penis,0
1255,diagnosis aspect,Malignant Neoplasm with Regional Lymph Node Involvement,0
1256,North America,Basal Cell Ameloblastoma,0
1257,Primary malignant neoplasm,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1258,Cell Lineage,Malignant neoplasm of thalamus,0
1259,Low probability,Epithelioid Sarcoma NCI Grade 3,0
1260,Case unit dose,Adult Alveolar Soft Part Sarcoma,0
1261,Bodily secretions,Gallbladder Adenocarcinoma,0
1262,More Often than Once a Day,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1263,risk factors,Intraepithelial Melanocytic Hyperplasia,0
1264,Calcium Channel Antagonists [MoA],Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1265,intent,mucinous adenocarcinoma of gallbladder,0
1266,Occurrence,Testicular cancer metastatic,0
1267,Grade,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
1268,Carcinoma of bladder,Chest Wall Fibromatosis,0
1269,Childhood Non-Hodgkin Lymphoma,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1270,Negation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1271,Excision,Ovarian Carcinoid Tumor,0
1272,Aspects of signs,Malignant neoplasm of subglottis,0
1273,Recipient,Recurrent Uveal Melanoma,0
1274,International Classification of Disease for Oncology,Cervical Fibroepithelial Polyp,0
1275,Classical (qualifier value),Mucinous adenocarcinoma gastric,0
1276,95,Chronic Myelomonocytic Leukemia-2,0
1277,include - SetOperator,Digestive System Hodgkin Lymphoma,0
1278,Case unit dose,Localized Ewing Sarcoma,0
1279,Special,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1280,therapeutic aspects,Cerebral Primitive Neuroectodermal Tumor,0
1281,10%,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1282,Genetic,Sarcomatoid Renal Cell Carcinoma,0
1283,Burkina Faso,Childhood Central Nervous System Ganglioneuroblastoma,0
1284,Aspects of signs,Liver Lymphangioma,0
1285,68,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1286,Europe,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1287,Definition,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1288,Involvement with,Fibroadenoma of breast,0
1289,CDISC SEND Tumor Findings Results Terminology,Childhood Fibrillary Astrocytoma,0
1290,Greater,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
1291,Common Specifications in HL7 V3 Publishing,ROSE Cluster 3,0
1292,Malignant Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1293,Walls of a building,Thyroid Hurthle Cell Carcinoma,0
1294,Lymphatic vessel,Transitional cell carcinoma,0
1295,To,Stage III Cutaneous Melanoma AJCC v6,0
1296,Sarcoma - category (morphologic abnormality),Vaginal Adenoma,0
1297,How Often Weight Loss,Metaplastic carcinoma of breast,0
1298,Nicotiana tabacum,Refractory Barrett Esophagus,0
1299,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
1300,Tryptophanase,Hereditary Diffuse Gastric Adenocarcinoma,0
1301,Dependent for dressing,Stage IV Childhood Non-Hodgkin Lymphoma,0
1302,Rating (action),Necrotizing Funisitis,0
1303,Acute Myeloid Leukemia Pathway,Childhood Lymphoma,0
1304,% of total,Advanced Lung Carcinoma,0
1305,Juvenile Myelomonocytic Leukemia,Benign squamous cell tumor,0
1306,Occurrence Indicator,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1307,Aim,Occult Lung Adenosquamous Carcinoma,0
1308,Child,Hemangioma,0
1309,Term (lexical),Cancer of Urinary Tract,0
1310,Togo,Acute Undifferentiated Leukemia,0
1311,Infratentorial,Benign squamous cell tumor,0
1312,Fatigue,Splenic Manifestation of Hairy Cell Leukemia,0
1313,% index,Extracranial Neuroblastoma,0
1314,Malignant Neoplasms,Acantholytic squamous cell carcinoma,0
1315,Often - answer to question,Stage III Cutaneous Melanoma AJCC v6,0
1316,risk factors - observation list,Refractory Ependymoma,0
1317,Primary malignant neoplasm,Metastatic Carcinoma in the Lung,0
1318,various antiseptic throat preparations,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1319,Monocyte count procedure,Lung squamous cell carcinoma stage I,0
1320,Negation,Carcinoma of urinary bladder,0
1321,Monoclonal Antibodies,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1322,Oral,Benign squamous cell tumor,0
1323,Malignant - descriptor,Melanomatosis,0
1324,High Mitosis-Karyorrhexis Index,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1325,Muscle Tissue,Metastatic Lung Small Cell Carcinoma,0
1326,Block (unit of measure),Metastatic Kidney Carcinoma,0
1327,Cold Temperature,Hereditary corneal dystrophy,0
1328,Premalignant Cell,Neoplasms,0
1329,abnormal growth by tissue,Localized Askin Tumor,0
1330,Physical shape,Anterior Urethral Malignant Neoplasm,0
1331,Squamous cell carcinoma,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1332,Adult Classical Hodgkin Lymphoma,Mucinous neoplasm,0
1333,Foot British,FIGO Stage II Ovarian Cancer,0
1334,use of ultrasonography,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1335,Section - Geographic Area,Kaposi's sarcoma of skin,0
1336,Cover - action,High Grade Glandular Intraepithelial Neoplasia,0
1337,Person Observer,Platinum-Resistant Lung Small Cell Carcinoma,0
1338,Etiology aspects,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1339,Deep Resection Margin,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1340,various other intestinal adsorbents in ATC,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1341,Human body,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1342,Ursidae Family,Extra-Adrenal Paraganglioma,0
1343,Skin,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1344,Consistency,ICHTHYOSIS,0
1345,Eye protection,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1346,2+ Score,Leptomeningeal sarcoma,0
1347,Widening,Stage IV Childhood Non-Hodgkin Lymphoma,0
1348,Persons,benign mature teratoma of pancreas,0
1349,Usual,Childhood Central Nervous System Ganglioneuroblastoma,0
1350,shared attribute,Digestive System Hodgkin Lymphoma,0
1351,Skin,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1352,Tumor Mass,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1353,Type - attribute,Localized Ewing Sarcoma,0
1354,Poor - qualifier,Localized Ewing Sarcoma,0
1355,Reactive fibrous tissue proliferation,Intracortical osteosarcoma,0
1356,diagnosis aspect,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1357,Rest,Unicystic ameloblastoma,0
1358,ERBB2 gene,Malignant neoplasm of olfactory nerve,0
1359,Togo,Malignant Testicular Sertoli Cell Tumor,0
1360,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Mixed astrocytoma-ependymoma,0
1361,physiological aspects,Endometrial Small Cell Carcinoma,0
1362,Cardiac Lead Procedure,Cerebral hemangioma,0
1363,Singular,Localized Malignant Neoplasm,0
1364,Abnormal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
1365,various other agents for local oral treatment in ATC,Kaposi's sarcoma of skin,0
1366,Virus Diseases,Adenocarcinoma,0
1367,Metastasis,Nasal cavity carcinoma,0
1368,Good,Recurrent Testicular Lymphoma,0
1369,Generalization (Psychology),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1370,Increase,Digestive System Hodgkin Lymphoma,0
1371,Spreading (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
1372,Cause of death.underlying,Hyperplasia of pituitary gland,0
1373,Stromal Cells,Thymic Atypical Carcinoid Tumor,0
1374,Rating (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1375,Include (action),Testicular cancer metastatic,0
1376,Respiratory organs,Adenocarcinoma,0
1377,Affecting,Anterior Urethral Malignant Neoplasm,0
1378,Occurrence,Uterine Cancer,0
1379,Type - attribute,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1380,Gram per Deciliter,Mucinous neoplasm,0
1381,Pancreas,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1382,Elbow joint structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1383,<50,Bladder adenocarcinoma stage IV,0
1384,Together,Adult Hepatocellular Carcinoma,0
1385,Manufactured sign,FIGO Stage IVA Ovarian Cancer,0
1386,Affecting,Medulloblastoma,0
1387,Qualitative form,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1388,Mode of inheritance,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1389,Occurrence,Peripheral primitive neuroectodermal tumor of soft tissue,0
1390,radiotherapeutic,Stage II Carcinoma of Penis,0
1391,Bilateral complete salpingectomy,Unicystic ameloblastoma,0
1392,Body tissue,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1393,Atypical Teratoid Rhabdoid Tumor,Medulloblastoma,0
1394,Personal appearance,Hodgkin lymphoma,0
1395,Multiple malignancy,Kaposi's sarcoma of extrahepatic bile duct,0
1396,Aluminum measurement,Small Intestinal Villous Adenoma,0
1397,Life threatening - Event Consequence,Diffuse malignant mesothelioma,0
1398,Topical Corticosteroid Therapy,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1399,Logical Condition,Astrocytoma of brain,0
1400,Term (lexical),Melanomatosis,0
1401,treatment - ActInformationManagementReason,Primary Cutaneous Plasmablastic Lymphoma,0
1402,Abnormal increase in number,Extracranial Neuroblastoma,0
1403,Spreading (qualifier value),Extra-abdominal fibromatosis,0
1404,Presentation,Adult Hepatocellular Carcinoma,0
1405,Symptoms aspect,embryonal rhabdomyosarcoma of prostate,0
1406,Skin Pigmentation,Cervical Squamous Intraepithelial Neoplasia,0
1407,winter,Primary Cutaneous Plasmablastic Lymphoma,0
1408,Scar Tissue,Low Grade Squamous Intraepithelial Neoplasia,0
1409,Time (foundation metadata concept),Anterior Urethral Malignant Neoplasm,0
1410,removal technique,Human Papillomavirus-Related Carcinoma,0
1411,Singular,Adenocarcinoma,0
1412,Variety (taxon),Giant cell angiofibroma,0
1413,Malignant Neoplasms,BRCA2 Syndrome,0
1414,Cancer Genus,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1415,Basis - conceptual entity,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
1416,Precursor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1417,2+ Score,Pleomorphic adenoma of parotid gland,0
1418,Actual Aspiration,Diffuse malignant mesothelioma,0
1419,Qualitative form,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1420,Dimple,Childhood Fibrillary Astrocytoma,0
1421,Increased,Testicular cancer metastatic,0
1422,*Type - Kind of quantity,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
1423,Greeks,Colorectal Neuroendocrine Tumor G2,0
1424,Logical Condition,Acute lymphadenitis,0
1425,10%,Recurrent Uveal Melanoma,0
1426,N not otherwise specified Antibody,Astrocytoma of brain,0
1427,Dermatologist,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1428,Manufactured form,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1429,Medical History,Malignant neoplasm of choroid,0
1430,Science of Etiology,Mucinous neoplasm,0
1431,Third,Congenital hamartoma,0
1432,Togo,Recurrent Testicular Lymphoma,0
1433,Blood Cell Count,Advanced Lung Carcinoma,0
1434,Vulva,Unresectable Rhabdomyosarcoma,0
1435,Cardiac Lead Procedure,Benign Apocrine Neoplasm,0
1436,Concept model range (foundation metadata concept),Maxillary Sinus Adenocarcinoma,0
1437,Symptoms,Platinum-Resistant Lung Small Cell Carcinoma,0
1438,Main,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1439,Back structure,Intraepithelial Melanocytic Hyperplasia,0
1440,Grouped (foundation metadata concept),Cerebral hemangioma,0
1441,Infection,Bladder squamous cell carcinoma stage I,0
1442,2+ Score,Localized Ewing Sarcoma,0
1443,Condition:Find:Pt:^Patient:Nom,Pancreatic carcinoma,0
1444,Pharmaceutical Preparations,Localized Askin Tumor,0
1445,Etiology aspects,Undifferentiated Neuroblastoma,0
1446,Physical Examination,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1447,Physical Inactivity,Grade 3a Malignant Neoplasm,0
1448,Include (action),Recurrent Uveal Melanoma,0
1449,Aggressive Non-Hodgkin Lymphoma,Melanomatosis,0
1450,>5,Heavy Chain Deposition Disease,0
1451,Curative - procedure intent,Metastatic Carcinoma in the Lung,0
1452,Ten,Chest Wall Fibromatosis,0
1453,Neoplasms,Funisitis (disorder),0
1454,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1455,Have Constipation,Adenocarcinoma,0
1456,Squamous cell carcinoma,Lung squamous cell carcinoma stage I,0
1457,Progress,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
1458,Radiology studies,Blood Vessel Tumors,0
1459,Fine needle aspiration biopsy,Cancer of Urinary Tract,0
1460,Percent Activity,Hereditary Diffuse Gastric Adenocarcinoma,0
1461,Pharmacotherapy,Uterine Cancer,0
1462,Anorexia,Granular Cell Leiomyosarcoma,0
1463,Vertebrates,Refractory Ependymoma,0
1464,Chemotherapy,Diffuse malignant mesothelioma,0
1465,Precaution Code - Confused,Clinical Stage I Cutaneous Melanoma AJCC v8,0
1466,Current (present time),Spermatocytic seminoma,0
1467,Ovary,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1468,Contrast Media,Adenocarcinoma,0
1469,Name,Ovarian germ cell choriocarcinoma stage IV,0
1470,Cardiac Lead Procedure,Central Nervous System Anaplastic Large Cell Lymphoma,0
1471,10%,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1472,Subgroup,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1473,To,Mucinous adenocarcinoma gastric,0
1474,Basis - conceptual entity,Cancer of Urinary Tract,0
1475,rituximab,Anterior Urethral Malignant Neoplasm,0
1476,One,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1477,Taxonomic,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1478,ovarian neoplasm,Extra-abdominal fibromatosis,0
1479,T-Cell Development,Localized Askin Tumor,0
1480,Reaching,Mucinous neoplasm,0
1481,therapeutic aspects,Human Papillomavirus-Related Carcinoma,0
1482,Agreement,Hereditary Diffuse Gastric Adenocarcinoma,0
1483,Minor (value),Clinical Stage I Cutaneous Melanoma AJCC v8,0
1484,Most,Choroid Necrotic Melanoma,0
1485,GCFC2 gene,Ectomesenchymal Chondromyxoid Tumor,0
1486,Form:Finding:Point in time:{Setting}:Document:{Role},Hereditary Diffuse Gastric Adenocarcinoma,0
1487,Age of onset of symptoms:Time:Pt:^Patient:Qn,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1488,Benzene,Chondrosarcoma,0
1489,Reaching,embryonal rhabdomyosarcoma of prostate,0
1490,Night time,Recurrent Uveal Melanoma,0
1491,Weight Loss,Recurrent Testicular Lymphoma,0
1492,Administration occupational activities,Vaginal Adenoid Cystic Carcinoma,0
1493,Involvement with,Unfavorable Non-Hodgkin Lymphoma,0
1494,Dietary Lead,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1495,Abnormal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1496,Papillomaviridae,Acantholytic squamous cell carcinoma,0
1497,Thickened,Granular Cell Leiomyosarcoma,0
1498,Ultrasonics (sound),Clinical Stage I Cutaneous Melanoma AJCC v8,0
1499,Removed,Clonal Hematopoiesis of Indeterminate Potential,0
1500,Papanicolaou Test,Stage IV Penile Cancer AJCC v7,0
1501,Papanicolaou Test,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1502,Cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
1503,Five-year Survival Rate,Locally Advanced Carcinoma,0
1504,N+ (tumor staging),Kaposi's sarcoma of skin,0
1505,A Codes,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
1506,Before,Anterior Urethral Malignant Neoplasm,0
1507,Males,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
1508,Present,Angiosarcoma of liver,0
1509,Condylomata Acuminata,Medulloblastoma,0
1510,Klinefelter's syndrome - male with more than two X chromosomes,Nasal cavity carcinoma,0
1511,Predisposition -- attribute,Benign Anal Granular Cell Tumor,0
1512,Medical Imaging,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1513,production,Ovarian germ cell choriocarcinoma stage IV,0
1514,Grade three rank,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
1515,seen,Metaplastic carcinoma of breast,0
1516,Genitalia,Testicular cancer metastatic,0
1517,isolation aspects,Recurrent Uveal Melanoma,0
1518,Diagnosis,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
1519,Function (attribute),High Grade Salivary Gland Mucoepidermoid Carcinoma,0
1520,Tissue Specimen Code,Cervical Adenomyoma,0
1521,Human body,Squamous cell carcinoma of lip,0
1522,Containing (qualifier),Blood Vessel Tumors,0
1523,Tobacco smoking behavior,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1524,Primary malignant neoplasm,Parathyroid Gland Adenocarcinoma,0
1525,Person Name,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1526,Metastasis,Unresectable Rhabdomyosarcoma,0
1527,Primary malignant neoplasm,Airway Hemangioma,0
1528,Effect,Malignant melanoma of eyelid,0
1529,Including (qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1530,Item Collection,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1531,renaissance,Kaposi's sarcoma of skin,0
1532,Replacement - supply,Anterior Urethral Malignant Neoplasm,0
1533,Precursor,Malignant Neoplasm of Lung - Multiple Primary Sites,0
1534,Continuous,Metastatic Neoplasm to the Gallbladder,0
1535,Major,Localized Ewing Sarcoma,0
1536,Biological Processes,Benign neoplasm of eye,0
1537,Mesothelioma,Giant cell angiofibroma,0
1538,Case (situation),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1539,To,Heavy Chain Deposition Disease,0
1540,65+,ROSE Cluster 3,0
1541,>65 years,Mucinous adenocarcinoma gastric,0
1542,Abnormally high,Pancreatic Intraepithelial Neoplasia-3,0
1543,Type - attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1544,N+ (tumor staging),High Grade Glandular Intraepithelial Neoplasia,0
1545,Retinoic Acid Response Element,Type II Endometrial Adenocarcinoma,0
1546,chronic,Unicystic ameloblastoma,0
1547,Old age,Endometrial Small Cell Carcinoma,0
1548,Decrease,Benign Apocrine Neoplasm,0
1549,More,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
1550,lymph nodes,Anaplastic large cell lymphoma,0
1551,animal allergen extracts,Benign squamous cell tumor,0
1552,3+ Score,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1553,Protein Digestion (research activity),Female Breast Carcinoma,0
1554,Manufactured form,Type II Endometrial Adenocarcinoma,0
1555,Administration occupational activities,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1556,risk factors - observation list,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1557,Cryptorchidism,Epithelioid Sarcoma NCI Grade 3,0
1558,Urinary Tract Infection,Type II Endometrial Adenocarcinoma,0
1559,Pale color,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1560,Prior Medication Usage,Refractory Ependymoma,0
1561,Estrogen (disposition),Familial Adenomatous Polyposis Associated Medulloblastoma,0
1562,Ectoderm,Atypical Lobular Breast Hyperplasia,0
1563,Used by,Multiple Skull Base Meningiomas,0
1564,Different,Vaginal Adenoma,0
1565,White Blood Cell Count procedure,Angiosarcoma of liver,0
1566,Malignant tumor of cervix,Locally Advanced Soft Tissue Sarcoma,0
1567,include - SetOperator,Splenic Manifestation of Hairy Cell Leukemia,0
1568,Containing (qualifier),Xeroderma pigmentosum,0
1569,Coding,malignant lymphoma of pancreatic lymph nodes,0
1570,Tumor cells,Vaginal Adenoma,0
1571,Occur (action),non-Hodgkin's lymphoma of spleen,0
1572,Classification,Anterior Urethral Malignant Neoplasm,0
1573,<3 (qualifier value),Maxillary Sinus Adenocarcinoma,0
1574,PSA Level Less than Two,Basal Cell Ameloblastoma,0
1575,Social Role,Intestinal Metaplasia of Bladder Urothelium,0
1576,Pediculus humanus capitis (eukaryote),Ovarian Dermoid Cyst with Secondary Carcinoma,0
1577,Two,Grade 3a Malignant Neoplasm,0
1578,Platelets,Kaposi's sarcoma of extrahepatic bile duct,0
1579,Thickened,squamous cell carcinoma of the thyroid gland,0
1580,Heterogeneity,sarcoma of spinal cord,0
1581,Result,Basal Cell Ameloblastoma,0
1582,Ulceration,Stage IB Lung Cancer AJCC v7,0
1583,suggestion,Metastatic Kidney Carcinoma,0
1584,Tissue Specimen Code,ROSE Cluster 3,0
1585,Primary,Benign tumor of eyelid,0
1586,Hyperlink,Breast Ductal Adenoma,0
1587,Common (qualifier value),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
1588,VIPR1 wt Allele,Trabecular adenocarcinoma,0
1589,findings aspects,Refractory Bladder Carcinoma,0
1590,Name,Blepharal carcinoma,0
1591,Strawberry nevus of skin,Cervical Squamous Intraepithelial Neoplasia,0
1592,Preventive intent,Pancreatic Endocrine Carcinoma,0
1593,Disease,Splenic Manifestation of Hairy Cell Leukemia,0
1594,Colon <insect>,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1595,Providing presence (regime/therapy),Unicystic ameloblastoma,0
1596,Primary malignant neoplasm,Refractory Ependymoma,0
1597,SPINK5 gene,Basal Cell Ameloblastoma,0
1598,Vagina Carcinoma,Low Grade Squamous Intraepithelial Neoplasia,0
1599,Increase,Thyroid Hurthle Cell Carcinoma,0
1600,Weight decreased,Recurrent Rhabdomyosarcoma,0
1601,Abnormally high,Gallbladder Adenocarcinoma,0
1602,Rapid,Noninfiltrating Intraductal Carcinoma,0
1603,include - SetOperator,Benign Apocrine Neoplasm,0
1604,98,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1605,Tumor cells,Cerebral Primitive Neuroectodermal Tumor,0
1606,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1607,Medical Devices,Nasal cavity carcinoma,0
1608,Brain Neoplasms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1609,Result,BRCA2 Syndrome,0
1610,Desmoplastic fibroblastoma,Non-Metastatic Gestational Trophoblastic Tumor,0
1611,Case (situation),Localized Ewing Sarcoma,0
1612,Stem of plant,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1613,Etiology aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1614,Better than Others,Neonatal leukemia,0
1615,Seventh,Trichilemmocarcinoma,0
1616,Patient Reported Outcome Stem,Ovarian germ cell choriocarcinoma stage IV,0
1617,Lymphoma cells,Breast Ductal Adenoma,0
1618,Birth,Recurrent Testicular Lymphoma,0
1619,Cosmetics,malignant lymphoma of pancreatic lymph nodes,0
1620,Devices,Refractory Bladder Carcinoma,0
1621,Usual,Secondary malignant neoplasm of lymph node,0
1622,PSA Level Greater than Fifty,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1623,Cancer Genus,Thymic Clear Cell Carcinoma,0
1624,shared attribute,Werner Syndrome,0
1625,Host (organism),Epithelioid Sarcoma NCI Grade 3,0
1626,System (unit of presentation),Atypical Lobular Breast Hyperplasia,0
1627,Poverty,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1628,In Blood,Xeroderma pigmentosum,0
1629,Various patch test substance,Mucinous adenocarcinoma gastric,0
1630,Chemotherapy,Childhood Fibrillary Astrocytoma,0
1631,Secondary to,Transitional cell carcinoma,0
1632,PSA Level Less than Two,Mucinous adenocarcinoma gastric,0
1633,Acute Myeloid Leukemia Pathway,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1634,Qualitative form,Hereditary corneal dystrophy,0
1635,Importance Rating Score 0,Astrocytoma of brain,0
1636,Intravascular line,Hereditary Diffuse Gastric Adenocarcinoma,0
1637,Etiology aspects,ROSE Cluster 3,0
1638,Manufactured sign,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
1639,Barrett Esophagus,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
1640,mouth swelling,Hemangioma,0
1641,Melanins,Childhood Anaplastic Large Cell Lymphoma,0
1642,Redness,Extra-Adrenal Paraganglioma,0
1643,Involvement with,Intraepithelial Melanocytic Hyperplasia,0
1644,Cell Device,Stage I Colon Neuroendocrine Tumor AJCC v8,0
1645,Five,Angiosarcoma of liver,0
1646,status - In progress,Pleomorphic adenoma of parotid gland,0
1647,Special,FIGO Stage IVA Ovarian Cancer,0
1648,Divide,Trabecular adenocarcinoma,0
1649,Basis - conceptual entity,Thyroid Hurthle Cell Carcinoma,0
1650,Effect,Lung Mucinous Cystadenoma,0
1651,Noma,Pancreatic carcinoma,0
1652,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
1653,Body tissue,Malignant Testicular Sertoli Cell Tumor,0
1654,Hematopoiesis,Endometrial Small Cell Carcinoma,0
1655,Specialized,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1656,Common (qualifier value),Childhood Lung Non-Small Cell Carcinoma,0
1657,Metastasis,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
1658,Left sided,BRCA2 Syndrome,0
1659,Sweating,Clonal Hematopoiesis of Indeterminate Potential,0
1660,N not otherwise specified Antibody,Angiosarcoma of liver,0
1661,high - ActExposureLevelCode,Kaposi's sarcoma of skin,0
1662,Accurate (qualifier),Adult Anaplastic Oligodendroglioma,0
1663,Cancer Genus,Ichthyoses,0
1664,Count of entities,Astrocytoma of brain,0
1665,Cohort Studies,Pancreatic Intraepithelial Neoplasia-3,0
1666,acinar cell adenocarcinoma of the pancreas,Uterine Cancer,0
1667,Known,Extracranial Neuroblastoma,0
1668,Platelets,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1669,Symptoms,Stage IV Penile Cancer AJCC v7,0
1670,Blood,Basal Cell Ameloblastoma,0
1671,Carrying,Mucinous neoplasm,0
1672,Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1673,Carcinoid Tumor,Locally Advanced Carcinoma,0
1674,False Discovery Rate,Female Breast Carcinoma,0
1675,Spherical shape,malignant lymphoma of pancreatic lymph nodes,0
1676,Talpidae,Advanced Lung Carcinoma,0
1677,Togo,Recurrent Testicular Lymphoma,0
1678,Symptoms aspect,Kaposi's sarcoma of skin,0
1679,Night sweats,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1680,Hemopoietic tissue,Stage 0 Penile Cancer AJCC v8,0
1681,Increased,Childhood Central Nervous System Ganglioneuroblastoma,0
1682,Adoptive Immunotherapy,High Grade Glandular Intraepithelial Neoplasia,0
1683,various other agents for local oral treatment in ATC,Recurrent Uveal Melanoma,0
1684,Mammal liver preparation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
1685,Mesothelial cell,Cervical Squamous Intraepithelial Neoplasia,0
1686,posterior fossa,Stage II Carcinoma of Penis,0
1687,Western Europe,embryonal rhabdomyosarcoma of prostate,0
1688,Females,Human Papillomavirus-Related Carcinoma,0
1689,Dependent for dressing,Thymic Clear Cell Carcinoma,0
1690,pharmacotherapeutic,Acantholytic squamous cell carcinoma,0
1691,HLA Class II Histocompatibility Antigen Gamma Chain,Uterine Cancer,0
1692,Human body,Refractory Barrett Esophagus,0
1693,Pigment cell,Breast Ductal Adenoma,0
1694,Multiply - dosing instruction fragment,Heavy Chain Deposition Disease,0
1695,Evidence,Hair nevus,0
1696,Diagnosis Study,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1697,Negative Surgical Margin,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1698,Include (action),Intestinal Metaplasia of Bladder Urothelium,0
1699,PREVENT (product),Malignant neoplasm of thalamus,0
1700,Established,Clonal Hematopoiesis of Indeterminate Potential,0
1701,parent,Tubal Hyperplasia,0
1702,Occurrence,Extra-abdominal fibromatosis,0
1703,Person Name,Kaposi's sarcoma of extrahepatic bile duct,0
1704,Tactile,Thymic Clear Cell Carcinoma,0
1705,Angioma,Melanomatosis,0
1706,Histology aspects,Tumorlet,0
1707,Mutation Abnormality,Cerebral hemangioma,0
1708,Three,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1709,*Type - Kind of quantity,Acantholytic squamous cell carcinoma,0
1710,Part of,Stage IV Penile Cancer AJCC v7,0
1711,Providing presence (regime/therapy),Stage IV Penile Cancer AJCC v7,0
1712,various antiinfectives and antiseptics for local oral treatment,Malignant melanoma of eyelid,0
1713,Percent normal,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1714,Combined,Childhood Anaplastic Large Cell Lymphoma,0
1715,Mass of body region,Recurrent Uveal Melanoma,0
1716,Exhibits as Topic,Blepharal carcinoma,0
1717,Pelvic Pain,Precursor B-lymphoblastic lymphoma stage II,0
1718,Occurrence,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1719,Mass of body structure,Splenic Manifestation of Hairy Cell Leukemia,0
1720,Notable,FIGO Stage II Ovarian Cancer,0
1721,Part of,BRCA2 Syndrome,0
1722,Affecting,Stage III Adult Immunoblastic Lymphoma,0
1723,Financial Account,Metastatic Malignant Neoplasm in the Sellar Region,0
1724,year,Splenic Manifestation of Hairy Cell Leukemia,0
1725,Occurrence Indicator,Extra-abdominal fibromatosis,0
1726,Upper jaw region,Cerebral Primitive Neuroectodermal Tumor,0
1727,described,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
1728,Congenital Abnormality,Multiple Skull Base Meningiomas,0
1729,Chemotherapy,Malignant neoplasm of olfactory nerve,0
1730,Rare,Locally Advanced Carcinoma,0
1731,Tumor Mass,Refractory Bladder Carcinoma,0
1732,Diagnosis,Testicular cancer metastatic,0
1733,chapter,embryonal rhabdomyosarcoma of prostate,0
1734,Remaining,Stage 0 Lip Carcinoma,0
1735,Treating,Liver Cavernous Hemangioma,0
1736,+2,Clonal Hematopoiesis of Indeterminate Potential,0
1737,Back Pain,Chest Wall Fibromatosis,0
1738,Image Feature,Type II Endometrial Adenocarcinoma,0
1739,Geographic state,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1740,Show,Locally Advanced Squamous Cell Carcinoma,0
1741,Immune System Finding,Hair nevus,0
1742,Dermatologic disorders,Astrocytoma of brain,0
1743,Rest,Multiple Skull Base Meningiomas,0
1744,Floor (anatomic),Microcystic meningioma,0
1745,Negative Surgical Margin,Neonatal leukemia,0
1746,Symptoms,Low Grade Squamous Intraepithelial Neoplasia,0
1747,Home environment,Carcinoma of submandibular gland,0
1748,Five-year Survival Rate,Kaposi's sarcoma of extrahepatic bile duct,0
1749,Definitely Related to Intervention,Kaposi's sarcoma of skin,0
1750,thiocolchicoside,Type II Endometrial Adenocarcinoma,0
1751,Painless,Heavy Chain Deposition Disease,0
1752,Plasma,Intestinal Metaplasia of Bladder Urothelium,0
1753,Therapeutic radiology procedure,Gallbladder adenoma,0
1754,Togo,Peripheral primitive neuroectodermal tumor of soft tissue,0
1755,Experimental Result,Digestive System Hodgkin Lymphoma,0
1756,Vision,adenoid cystic carcinoma of lung,0
1757,Enlargement procedure,Bladder squamous cell carcinoma stage I,0
1758,Frequently,Cancer of Urinary Tract,0
1759,Plasmacytoma,Plexosarcoma,0
1760,Malignant Head and Neck Neoplasm,Stage III Cutaneous Melanoma AJCC v6,0
1761,Affect (mental function),Malignant Neoplasm with Regional Lymph Node Involvement,0
1762,Therapy Object (animal model),Neonatal leukemia,0
1763,Body part,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
1764,research subject screening,Plexosarcoma,0
1765,Magnetic Resonance Imaging Study File,Leiomyoma of Gallbladder,0
1766,Fever,Stage IV Childhood Non-Hodgkin Lymphoma,0
1767,Time (foundation metadata concept),Central Nervous System Yolk Sac Tumor,0
1768,Time (foundation metadata concept),Malignant melanoma of eyelid,0
1769,Urine looks dark,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
1770,Northern Europe,Vaginal Adenoma,0
1771,Cancer Genus,Intraepithelial Melanocytic Hyperplasia,0
1772,Blood,Benign squamous cell tumor,0
1773,How Often Vomiting,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1774,Usual Severity Weight Loss,Primary Cutaneous Plasmablastic Lymphoma,0
1775,Type - attribute,Leptomeningeal sarcoma,0
1776,East,Acute Undifferentiated Leukemia,0
1777,Formation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
1778,Penis carcinoma,Colorectal High Grade B-Cell Lymphoma,0
1779,GORAB gene,Bladder Neuroendocrine Neoplasm,0
1780,Symptoms,Adult Alveolar Soft Part Sarcoma,0
1781,Tryptophanase,Metastatic Kidney Carcinoma,0
1782,Very,Congenital hamartoma,0
1783,Ultraviolet Light Sterilization,Hodgkin lymphoma,0
1784,Tumor type,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1785,Chest,Recurrent Testicular Lymphoma,0
1786,diagnosis aspect,Endometrial Small Cell Carcinoma,0
1787,peripheral blood,Mixed astrocytoma-ependymoma,0
1788,Term (lexical),Heavy Chain Deposition Disease,0
1789,Decrease,Maxillary Sinus Adenocarcinoma,0
1790,Derived value,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1791,Estrogen [EPC],Pancreatic carcinoma,0
1792,Manufactured form,Fibroadenoma of breast,0
1793,risk factors - observation list,Carcinomatosis of peritoneal cavity,0
1794,Meningitis,GIANT PIGMENTED HAIRY NEVUS,0
1795,Abnormal cell,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
1796,Evidence,Intestinal Neuroendocrine Carcinoma,0
1797,Bothered by Night Sweats,Liver Cavernous Hemangioma,0
1798,Anterior thoracic region,Cerebral Primitive Neuroectodermal Tumor,0
1799,Benign Ovarian Neoplasm,Acantholytic squamous cell carcinoma,0
1800,Proliferation (morphologic abnormality),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1801,Including (qualifier),Stage III Cutaneous Melanoma AJCC v6,0
1802,Tryptophanase,Mucinous neoplasm,0
1803,Social Networks,Breast Ductal Adenoma,0
1804,How Often Weight Loss,Locally Advanced Squamous Cell Carcinoma,0
1805,Salivary Gland Tissue,Locally Advanced Carcinoma,0
1806,Occur (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
1807,depend,Recurrent Testicular Lymphoma,0
1808,Malignant - descriptor,Stage I Colon Neuroendocrine Tumor AJCC v8,0
1809,Affecting,Mastocytosis,0
1810,Persons,Acantholytic squamous cell carcinoma,0
1811,Universal HL7CMETAttribution,clear cell adenocarcinoma of gallbladder,0
1812,Ductal,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1813,Sex Cord-Stromal Tumor,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
1814,development aspects,Mixed astrocytoma-ependymoma,0
1815,NCI CTEP SDC Endocrine Neoplasm Category Terminology,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
1816,Polyvinyl Chloride,Bladder adenocarcinoma stage IV,0
1817,Capsule Shape,Type II Endometrial Adenocarcinoma,0
1818,Usual,Anaplastic large cell lymphoma,0
1819,Manufactured form,malignant lymphoma of pancreatic lymph nodes,0
1820,Necrosis,Peripheral primitive neuroectodermal tumor of soft tissue,0
1821,Life,Microcystic meningioma,0
1822,Personal appearance,FIGO Stage II Ovarian Cancer,0
1823,Buccal smear procedure,Blood Vessel Tumors,0
1824,Excision,Maxillary Sinus Adenoid Cystic Carcinoma,0
1825,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
1826,Reaching,Carcinoma of urinary bladder,0
1827,Subject Risk,Medulloblastoma,0
1828,Well Differentiated,Benign squamous cell tumor,0
1829,UV Radiation,Metastatic Neoplasm to the Gallbladder,0
1830,3+ Answer to Question,Small intestine carcinoma,0
1831,Ninein,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
1832,Aspartic Acid Measurement,Liver Cavernous Hemangioma,0
1833,breast.duct,Central Nervous System Anaplastic Large Cell Lymphoma,0
1834,Histology,High Grade Glandular Intraepithelial Neoplasia,0
1835,Left sided,Rhabdomyosarcoma with ganglionic differentiation,0
1836,Human body structure,Tubal Hyperplasia,0
1837,Oral region,Giant cell angiofibroma,0
1838,Crowding,ROSE Cluster 3,0
1839,Derived value,Peripheral primitive neuroectodermal tumor of soft tissue,0
1840,Unspecified,Xeroderma pigmentosum,0
1841,Stem of Organ,Metaplastic carcinoma of breast,0
1842,United States Military Commissioned Officer O4,Rhabdomyosarcoma with ganglionic differentiation,0
1843,Tubular adenoma,Keratoderma,0
1844,Surgical reduction,Squamous cell carcinoma of lip,0
1845,Chromosomal deoxyribonucleic acid,Locally Advanced Squamous Cell Carcinoma,0
1846,Cessation of life,Human Papillomavirus-Related Carcinoma,0
1847,Group A (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
1848,Smoking,Basal Cell Ameloblastoma,0
1849,Ultrasonography,BRCA2 Syndrome,0
1850,Transitional cell morphology,Recurrent Testicular Lymphoma,0
1851,Human papillomavirus typing (procedure),Childhood Anaplastic Large Cell Lymphoma,0
1852,Biomaterial Treatment,Nasal cavity carcinoma,0
1853,Lesion,Stage 0 Penile Cancer AJCC v8,0
1854,Singular,malignant lymphoma of pancreatic lymph nodes,0
1855,Tryptophanase,Human Papillomavirus-Related Carcinoma,0
1856,Has focus,Giant cell angiofibroma,0
1857,Specific qualifier value,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1858,Common Specifications in HL7 V3 Publishing,Pancreatic Intraepithelial Neoplasia-3,0
1859,>5,Breast Ductal Adenoma,0
1860,Malignant - descriptor,Maxillary Sinus Adenocarcinoma,0
1861,Disease Response,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
1862,SHORT STATURE,Recurrent Rhabdomyosarcoma,0
1863,Substance amount,Metastatic Kidney Carcinoma,0
1864,Myeloid neoplasm,Secondary malignant neoplasm of lymph node,0
1865,artesunate,Recurrent Primary Lymphoma of Bone,0
1866,other medicated shampoos in ATC,Refractory Ependymoma,0
1867,Classification,Secondary malignant neoplasm of lymph node,0
1868,Observation of color of skin,Pancreatic Intraepithelial Neoplasia-3,0
1869,Treating,Acinar cell carcinoma of pancreas,0
1870,Symptoms aspect,Secondary malignant neoplasm of lymph node,0
1871,Abnormally high,Papillary squamous cell carcinoma,0
1872,Irritant (disposition),Female Breast Carcinoma,0
1873,Mean Percent of Normal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
1874,shared attribute,clear cell adenocarcinoma of gallbladder,0
1875,Usually,Malignant neoplasm of thalamus,0
1876,Painful intercourse female,Kaposi's sarcoma of extrahepatic bile duct,0
1877,Cancer Genus,Adrenal Rest Tumor,0
1878,treatment - ActInformationManagementReason,Bladder squamous cell carcinoma stage I,0
1879,Nutrients,Metaplastic carcinoma of breast,0
1880,Diabetes Mellitus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1881,Delta (difference),Intestinal Metaplasia of Bladder Urothelium,0
1882,Then,Endometrial Small Cell Carcinoma,0
1883,Volume (publication),Ovarian germ cell choriocarcinoma stage IV,0
1884,Affecting,Anterior Urethral Malignant Neoplasm,0
1885,Cystoscopy,Stage I Adult Non-Hodgkin Lymphoma,0
1886,Recurrent Malignant Neoplasm,Benign neoplasm of thorax,0
1887,Created By,Kaposi's sarcoma of skin,0
1888,Categories,Intraepithelial Melanocytic Hyperplasia,0
1889,Affecting,Liver Lymphangioma,0
1890,Diagnosis,Nasal cavity carcinoma,0
1891,Clinical Study Follow-up,Human Papillomavirus-Related Carcinoma,0
1892,Immunization Domain,Benign Anal Granular Cell Tumor,0
1893,Americas Ethnicity,Chronic Myelomonocytic Leukemia-2,0
1894,treatment - ActInformationManagementReason,Multiple Skull Base Meningiomas,0
1895,Including (qualifier),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
1896,Therapeutic radiology procedure,Acantholytic squamous cell carcinoma,0
1897,Room of building - Study,Undifferentiated Endocervical Sarcoma,0
1898,Support,FIGO Stage IVA Ovarian Cancer,0
1899,Function (attribute),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1900,March (month),Vaginal Adenoid Cystic Carcinoma,0
1901,Age of onset of symptoms:Time:Pt:^Patient:Qn,Cervical Squamous Intraepithelial Neoplasia,0
1902,Several,Airway Hemangioma,0
1903,Molecule,mucinous adenocarcinoma of gallbladder,0
1904,Reduced,Hereditary Diffuse Gastric Adenocarcinoma,0
1905,Including (qualifier),Diffuse malignant mesothelioma,0
1906,Classification,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
1907,Pregnancy,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
1908,Adult human body,Thymic Clear Cell Carcinoma,0
1909,How Much Distress Itching,Childhood Cerebellar Neoplasm,0
1910,Specimen Source Codes - Respiratory,Mucinous adenocarcinoma gastric,0
1911,Sarcoma - category (morphologic abnormality),Refractory Bladder Carcinoma,0
1912,Most,Localized Ewing Sarcoma,0
1913,Specimen Source Codes - tumor,Granular Cell Leiomyosarcoma,0
1914,Worsening pattern,Localized Askin Tumor,0
1915,Medical Imaging,Neoplasms,0
1916,MYELODYSPLASTIC SYNDROME,Parathyroid Gland Adenocarcinoma,0
1917,Menopause present (finding),Heavy Chain Deposition Disease,0
1918,Lung,Kaposi's sarcoma of extrahepatic bile duct,0
1919,Organ,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
1920,Science of Etiology,Type II Endometrial Adenocarcinoma,0
1921,Regular,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1922,Screening,Blood Vessel Tumors,0
1923,Present,Type II Endometrial Adenocarcinoma,0
1924,Part,Childhood Thyroid Gland Follicular Carcinoma,0
1925,Possibly Related to Intervention,Cancer of Urinary Tract,0
1926,Granulocytes Product,Splenic Manifestation of Hairy Cell Leukemia,0
1927,Unexplained weight loss,Atypical Mesothelial Hyperplasia,0
1928,Both kidneys,Thymic Clear Cell Carcinoma,0
1929,Series,FIGO Stage II Ovarian Cancer,0
1930,How Often Weight Loss,FIGO Stage II Ovarian Cancer,0
1931,shared attribute,Kaposi's sarcoma of extrahepatic bile duct,0
1932,Case unit dose,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
1933,B-Cell Receptor Complex,Childhood Lung Non-Small Cell Carcinoma,0
1934,Malignant Neoplasms,Acantholytic squamous cell carcinoma,0
1935,Usual,Neonatal leukemia,0
1936,Cervix Uteri,Ovarian Dermoid Cyst with Secondary Carcinoma,0
1937,pharmacotherapeutic,gliosarcoma,0
1938,Name (property) (qualifier value),Noninfiltrating Intraductal Carcinoma,0
1939,Symptoms,Mixed astrocytoma-ependymoma,0
1940,Obsolete - EditStatus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1941,How Often Sweats,Chronic Myelomonocytic Leukemia-2,0
1942,Including (qualifier),Epithelioid Sarcoma NCI Grade 3,0
1943,Part,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
1944,Drop (unit of presentation),Ovarian germ cell choriocarcinoma stage IV,0
1945,Body tissue,Bladder squamous cell carcinoma stage I,0
1946,Case (situation),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1947,Occipital,Stage 0 Lip Carcinoma,0
1948,Therapeutic radiology procedure,Necrotizing Funisitis,0
1949,Tumor Mass,Thymic Clear Cell Carcinoma,0
1950,Lamina Propria,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
1951,Secondary to,Multiple Endocrine Neoplasia,0
1952,Population Group,Liver Lymphangioma,0
1953,include - SetOperator,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
1954,Different,Cervical Squamous Intraepithelial Neoplasia,0
1955,Excision,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1956,analysis aspect,Cervical Fibroepithelial Polyp,0
1957,N+ (tumor staging),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
1958,Metastatic Neoplasm,Medulloblastoma,0
1959,Group A (qualifier value),Extra-Adrenal Paraganglioma,0
1960,Woman,Acinar cell carcinoma of pancreas,0
1961,Purple,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
1962,Purpose,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
1963,Adverse effects,Giant cell angiofibroma,0
1964,Risk,Stage IV Childhood Non-Hodgkin Lymphoma,0
1965,Damage,Adult Alveolar Soft Part Sarcoma,0
1966,Slightly Able,Leptomeningeal sarcoma,0
1967,Science of Etiology,Malignant Testicular Sertoli Cell Tumor,0
1968,Clear,Giant cell angiofibroma,0
1969,Surgery specialty,Endometrial Small Cell Carcinoma,0
1970,Basis - conceptual entity,Benign Anal Granular Cell Tumor,0
1971,Subject Risk,Cystadenocarcinoma,0
1972,Term (lexical),Central Nervous System Yolk Sac Tumor,0
1973,Vasculature,Cerebral Primitive Neuroectodermal Tumor,0
1974,2+,Botryoid-Type Embryonal Rhabdomyosarcoma,0
1975,Breathing Distress Question,Small intestine carcinoma,0
1976,Neoplasms,Neonatal leukemia,0
1977,Genitalia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
1978,Sexual Partners,Pancreatic Intraepithelial Neoplasia-3,0
1979,Adult Rhabdomyosarcoma,Adult Hepatocellular Carcinoma,0
1980,Endometrial scraping,Bladder adenocarcinoma stage IV,0
1981,Common Specifications in HL7 V3 Publishing,Carcinoma of urinary bladder,0
1982,THPO wt Allele,Thyroid Hurthle Cell Carcinoma,0
1983,Nephron brand of racepinephrine hydrochloride,Human Papillomavirus-Related Carcinoma,0
1984,Image Feature,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
1985,What subject filter - Result,Endometrial Small Cell Carcinoma,0
1986,Subject Risk,Xeroderma pigmentosum,0
1987,Lesion,Mucinous cystadenofibroma,0
1988,Five-year Survival Rate,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
1989,Rate,Transitional cell carcinoma,0
1990,Vertebrates,Anterior Urethral Malignant Neoplasm,0
1991,Cultured Cell Line,Spongiotic dermatitis,0
1992,Benign neurologic neoplasms,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
1993,Grouped (foundation metadata concept),Vaginal Adenoma,0
1994,Residential flat,Endometrial Small Cell Carcinoma,0
1995,Needs,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
1996,Supportive assistance,Digestive System Hodgkin Lymphoma,0
1997,Include (action),Chest Wall Fibromatosis,0
1998,Either,Melanomatosis,0
1999,Carcinoma of bladder,Granular Cell Leiomyosarcoma,0
2000,Carcinoid Tumor,Atypical Lobular Breast Hyperplasia,0
2001,Usual,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2002,Malignant neoplasm of stomach,Vaginal Adenoma,0
2003,Common Specifications in HL7 V3 Publishing,Choroid Necrotic Melanoma,0
2004,Type A,Stage IV Childhood Non-Hodgkin Lymphoma,0
2005,Usually Need Help from Another Person for Arising,Lung squamous cell carcinoma stage I,0
2006,Total,Type II Endometrial Adenocarcinoma,0
2007,Base - General Qualifier,Stage 0 Lip Carcinoma,0
2008,Therapeutic procedure,Stage IB Lung Cancer AJCC v7,0
2009,Prevalence aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2010,Excision,clear cell adenocarcinoma of gallbladder,0
2011,Measures,Childhood Fibrillary Astrocytoma,0
2012,Purpose,Recurrent Primary Lymphoma of Bone,0
2013,Fever,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2014,Continuance of life,Thymic Atypical Carcinoid Tumor,0
2015,Better,Diffuse malignant mesothelioma,0
2016,Use of,Malignant melanoma of eyelid,0
2017,Malignant Neoplasms,Giant cell angiofibroma,0
2018,Target Awareness - partial,Kaposi's sarcoma of extrahepatic bile duct,0
2019,Case unit dose,BRCA2 Syndrome,0
2020,Midline (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2021,Frequently,Malignant Testicular Sertoli Cell Tumor,0
2022,1+ Score,Engraftment syndrome,0
2023,Weight decreased,Melanomatosis,0
2024,Major,Toxic Epidermal Necrolysis,0
2025,Placental Steroid Sulfatase Deficiency,Low Grade Squamous Intraepithelial Neoplasia,0
2026,Biopsy,FIGO Stage IVA Ovarian Cancer,0
2027,Hollow shape,Carcinomatosis of peritoneal cavity,0
2028,Blast Cell,Localized Askin Tumor,0
2029,Visual Accommodation,Cerebral Primitive Neuroectodermal Tumor,0
2030,Occur (action),Melanomatosis,0
2031,Increasing,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2032,Occur (action),Thymic Clear Cell Carcinoma,0
2033,Swollen Lymph Node,ROSE Cluster 3,0
2034,Factor,BRCA2 Syndrome,0
2035,In Blood,Intestinal Neuroendocrine Carcinoma,0
2036,Acquired Immunodeficiency Syndrome,Peripheral primitive neuroectodermal tumor of soft tissue,0
2037,Due to,Ovarian germ cell choriocarcinoma stage IV,0
2038,Very Much,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2039,physiological aspects,Intestinal Metaplasia of Bladder Urothelium,0
2040,Medical service,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2041,Etiology aspects,Stage III Cutaneous Melanoma AJCC v6,0
2042,Gait normal,Benign tumor of eyelid,0
2043,inferiority,ROSE Cluster 3,0
2044,Supportive assistance,Chronic Myelomonocytic Leukemia-2,0
2045,Ingestible alcohol,Cancer of Urinary Tract,0
2046,Immune,Carcinoma of urinary bladder,0
2047,morphological,Parathyroid Gland Adenocarcinoma,0
2048,Tumor Mass,Squamous cell carcinoma of lip,0
2049,Eye,Carcinoma of urinary bladder,0
2050,Funisitis (disorder),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2051,Chest,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2052,How Often Vomiting,Low Grade Squamous Intraepithelial Neoplasia,0
2053,Usually,Occult Lung Adenosquamous Carcinoma,0
2054,Reported Term,Primary Cutaneous Plasmablastic Lymphoma,0
2055,Type A,Low Grade Squamous Intraepithelial Neoplasia,0
2056,Effusion of blood,Vaginal Adenoid Cystic Carcinoma,0
2057,Feature,Recurrent Testicular Lymphoma,0
2058,Surgical aspects,Female Breast Carcinoma,0
2059,Monitoring - action,Pancreatic carcinoma,0
2060,Slow,Intraepithelial Melanocytic Hyperplasia,0
2061,Qualitative form,Adult Hepatocellular Carcinoma,0
2062,Relationships,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2063,Medical,Carcinoma of urinary bladder,0
2064,Child,Hodgkin Disease,0
2065,Sufficiently defined concept definition status (core metadata concept),Botryoid-Type Embryonal Rhabdomyosarcoma,0
2066,Cancer Genus,Cervical Squamous Intraepithelial Neoplasia,0
2067,Togo,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2068,Alternative,Pancreatic Endocrine Carcinoma,0
2069,1980s,Tonsillar Carcinoma,0
2070,control aspects,Diffuse malignant mesothelioma,0
2071,Horse Melanoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2072,Fasting Status Indicator,Pancreatic carcinoma,0
2073,Apocrine Cell,Thyroid Hurthle Cell Carcinoma,0
2074,To,ROSE Cluster 3,0
2075,ISOLATE COMPOUND,Gallbladder Adenocarcinoma,0
2076,combination of objects,High Grade Glandular Intraepithelial Neoplasia,0
2077,Treatment intent,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2078,human MUC1 protein,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2079,Common (qualifier value),Anterior Urethral Malignant Neoplasm,0
2080,Age,Colorectal High Grade B-Cell Lymphoma,0
2081,1930s,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2082,Tumor cells,Refractory Barrett Esophagus,0
2083,Togo,Cervical Adenomyoma,0
2084,Infant,Hyperplasia of pituitary gland,0
2085,site-specific telomere resolvase activity,Mucinous adenocarcinoma gastric,0
2086,Tryptophanase,Stage III Adult Immunoblastic Lymphoma,0
2087,Certain (qualifier value),FIGO Stage II Ovarian Cancer,0
2088,Present,Recurrent Uveal Melanoma,0
2089,Term (lexical),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2090,Treated with,Recurrent Uveal Melanoma,0
2091,Name,Locally Advanced Epithelioid Hemangioendothelioma,0
2092,various antiseptic throat preparations,Mucinous cystadenofibroma,0
2093,United States Military Commissioned Officer O4,Malignant Testicular Sertoli Cell Tumor,0
2094,Frequently,Benign Anal Granular Cell Tumor,0
2095,How Often Weight Loss,Lipoma of small intestine,0
2096,Operative Surgical Procedures,Hodgkin Disease,0
2097,Certain (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2098,Resulting in,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
2099,Rate,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2100,What subject filter - Result,Recurrent Testicular Lymphoma,0
2101,Then,Cervical Squamous Intraepithelial Neoplasia,0
2102,Headache,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2103,Diagnosis,Cerebral hemangioma,0
2104,bony process,Carcinoma of urinary bladder,0
2105,Term Birth,FIGO Stage II Ovarian Cancer,0
2106,Characterization,papillary carcinoma of penis,0
2107,Bladder Infection,Childhood Central Nervous System Ganglioneuroblastoma,0
2108,Brain,Malignant melanoma of eyelid,0
2109,Levels (qualifier value),Refractory Bladder Carcinoma,0
2110,Proteins,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2111,Abnormal,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2112,Larynx,Unfavorable Non-Hodgkin Lymphoma,0
2113,Abdomen,Benign neoplasm of thorax,0
2114,French language,Pancreatic carcinoma,0
2115,Feel Tired question,Precursor B-lymphoblastic lymphoma stage II,0
2116,Cytologic,Cervical Fibroepithelial Polyp,0
2117,Cell (compartment),Recurrent Uveal Melanoma,0
2118,Class (taxonomic),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
2119,One,gliosarcoma,0
2120,Therapeutic radiology procedure,FIGO Stage II Ovarian Cancer,0
2121,Mass of body structure,Neoplasms,0
2122,Ability,Stage IB Pancreatic Cancer AJCC v8,0
2123,Thinking,Hodgkin Disease,0
2124,Oral cavity,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
2125,Cartilage,Liver Cavernous Hemangioma,0
2126,ACACA wt Allele,FIGO Stage II Ovarian Cancer,0
2127,Biopsy,Occult Lung Adenosquamous Carcinoma,0
2128,Body tissue,Undifferentiated Neuroblastoma,0
2129,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2130,Empty (qualifier),Leptomeningeal sarcoma,0
2131,Antibodies,FIGO Stage IVA Ovarian Cancer,0
2132,Major,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2133,Ability,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
2134,Disease,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
2135,Management procedure,FIGO Stage IVA Ovarian Cancer,0
2136,Malignant neoplasm of lung,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2137,Fever symptoms (finding),Choroid Epithelioid Cell Melanoma,0
2138,Clinical Item,Gallbladder Adenocarcinoma,0
2139,Cessation of life,Refractory Ependymoma,0
2140,Thyroid cancer,Adult Alveolar Soft Part Sarcoma,0
2141,Make - Instruction Imperative,Acute Undifferentiated Leukemia,0
2142,Disease Outcome,Hodgkin lymphoma,0
2143,Occurrence Indicator,Locally Advanced Carcinoma,0
2144,Possible,Maxillary Sinus Adenocarcinoma,0
2145,Cell (compartment),Neoplasms,0
2146,Response Likelihood,Metastatic Carcinoma in the Lung,0
2147,70%,Vaginal Adenoid Cystic Carcinoma,0
2148,*Type - Kind of quantity,Mixed astrocytoma-ependymoma,0
2149,Rate,Malignant melanoma of eyelid,0
2150,More than 5 years,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2151,Negation,embryonal rhabdomyosarcoma of prostate,0
2152,Time,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2153,Sequence Data Type,Hemangioma,0
2154,3+ Answer to Question,Benign neoplasm of thorax,0
2155,Overall,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2156,Call (Instruction),Familial Adenomatous Polyposis Associated Medulloblastoma,0
2157,Headache,Placental aromatase deficiency,0
2158,Abnormal cell,Childhood Lymphoma,0
2159,Childhood Diffuse Large B-Cell Lymphoma,Childhood Anaplastic Large Cell Lymphoma,0
2160,One,Cystadenocarcinoma,0
2161,Tryptophanase,Locally Advanced Squamous Cell Carcinoma,0
2162,Biomaterial Treatment,Metaplastic carcinoma of breast,0
2163,Mutation,Refractory Barrett Esophagus,0
2164,Central,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2165,Tryptophanase,Microcystic meningioma,0
2166,Negation,Malignant melanoma of eyelid,0
2167,Brain,sarcoma of spinal cord,0
2168,90%,Anterior Urethral Malignant Neoplasm,0
2169,Physical Activity Measurement,Female Breast Carcinoma,0
2170,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2171,Section (object),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2172,Itchiness,Collecting Duct Carcinoma of the Kidney,0
2173,Malignant neoplasm of mouth,Nasal cavity carcinoma,0
2174,Aspects of signs,ROSE Cluster 3,0
2175,50%,Clonal Hematopoiesis of Indeterminate Potential,0
2176,Major <insect>,Malignant neoplasm of gallbladder,0
2177,Autoimmune Diseases,Thyroid Hurthle Cell Carcinoma,0
2178,Exposure to,Thymoma malignant recurrent,0
2179,growth aspects,Carcinoma,0
2180,Occurrence,Intestinal Neuroendocrine Carcinoma,0
2181,regional,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2182,Therapeutic procedure,Ectomesenchymal Chondromyxoid Tumor,0
2183,Clinical trial protocol document,Digestive System Hodgkin Lymphoma,0
2184,year,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
2185,M+ (tumor staging),Botryoid-Type Embryonal Rhabdomyosarcoma,0
2186,therapeutic aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
2187,Pleural effusion disorder,Lung squamous cell carcinoma stage I,0
2188,pharmacotherapeutic,Locally Advanced Carcinoma,0
2189,Occurrence Indicator,Intestinal Neuroendocrine Carcinoma,0
2190,Main,adenosquamous carcinoma of breast,0
2191,High Risk Acute Leukemia,Unresectable Rhabdomyosarcoma,0
2192,Historical aspects qualifier,Extra-Adrenal Paraganglioma,0
2193,Formation,Engraftment syndrome,0
2194,Vocal articulation,Pancreatic Intraepithelial Neoplasia-3,0
2195,Specific qualifier value,Adenocarcinoma,0
2196,Health,Pilocytic astrocytoma of cerebellum,0
2197,Packaging Case,Acute Undifferentiated Leukemia,0
2198,Patch - Extended Release Film,Lipoma of small intestine,0
2199,Smoking,Kaposi's sarcoma of extrahepatic bile duct,0
2200,Aspects of disease screening,Benign tumor of eyelid,0
2201,include - SetOperator,Epithelioid Sarcoma NCI Grade 3,0
2202,Cells,embryonal rhabdomyosarcoma of prostate,0
2203,Enneking Low Surgical Grade,Malignant melanoma of eyelid,0
2204,Cisplatin,Stage III Cutaneous Melanoma AJCC v6,0
2205,gastrointestinal gas,Clonal Hematopoiesis of Indeterminate Potential,0
2206,90%,Astrocytoma of brain,0
2207,survival aspects,Cervical Squamous Intraepithelial Neoplasia,0
2208,Fertility Agents,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2209,Gender,Thyroid Hurthle Cell Carcinoma,0
2210,Surgical Replantation,Anterior Urethral Malignant Neoplasm,0
2211,day,Type II Endometrial Adenocarcinoma,0
2212,Episode of,Spindle Cell Melanoma,0
2213,Skin,Chronic Myelomonocytic Leukemia-2,0
2214,Pediatric Neoplasm,Mastocytosis,0
2215,Occurrence Indicator,Urethral Carcinoma,0
2216,Function Axis,Blepharal carcinoma,0
2217,Taxonomic,Periosteal Osteosarcoma,0
2218,Cells,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2219,Mucous body substance,Medulloblastoma,0
2220,Stem of Organ,Hemangioma,0
2221,Uncomplicated,FIGO Stage IVA Ovarian Cancer,0
2222,Ectomesenchymal Chondromyxoid Tumor,mucinous adenocarcinoma of gallbladder,0
2223,European Viper,Cervical Fibroepithelial Polyp,0
2224,Pilocytic Astrocytoma,Thyroid carcinoma,0
2225,Communicable Diseases,Malignant Testicular Sertoli Cell Tumor,0
2226,Mass,Clonal Hematopoiesis of Indeterminate Potential,0
2227,Relationships,Pilocytic astrocytoma of cerebellum,0
2228,Hematologic Tests,Intraepithelial Melanocytic Hyperplasia,0
2229,Include (action),Neonatal leukemia,0
2230,Malignant neoplasm of larynx,Tonsillar Carcinoma,0
2231,Causing,Recurrent Primary Lymphoma of Bone,0
2232,row - Table,Extracranial Neuroblastoma,0
2233,Focal,Trichilemmocarcinoma,0
2234,Western World,Diffuse malignant mesothelioma,0
2235,High,Recurrent Uveal Melanoma,0
2236,Involvement with,Hereditary Diffuse Gastric Adenocarcinoma,0
2237,Molecular,Metaplastic carcinoma of breast,0
2238,Escherichia coli,Adult Hepatocellular Carcinoma,0
2239,Decision,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2240,Symptoms,Advanced Uterine Corpus Carcinosarcoma,0
2241,Site of,sarcoma of spinal cord,0
2242,Physical assessment findings,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2243,Obese build,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2244,Basis,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
2245,To,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2246,Early stage,FIGO Stage IVA Ovarian Cancer,0
2247,Lymphoma,Mucosal Melanoma,0
2248,Mechanism (attribute),Stage IV Childhood Non-Hodgkin Lymphoma,0
2249,Skin cell,Liver Lymphangioma,0
2250,Eye lid,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2251,Unusual,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2252,Ovary,embryonal rhabdomyosarcoma of prostate,0
2253,PSA Level Less than Two,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2254,Noninvasive,Localized Askin Tumor,0
2255,Meningocele,Placental aromatase deficiency,0
2256,National Cancer Institute,Human Papillomavirus-Related Carcinoma,0
2257,Radiation Oncologists,Angiosarcoma of liver,0
2258,unknown vaccine or immune globulin,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2259,Etiology aspects,Unfavorable Non-Hodgkin Lymphoma,0
2260,Thorotrast,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2261,Term (lexical),Pancreatic Intraepithelial Neoplasia-3,0
2262,Used by,Grade 3a Malignant Neoplasm,0
2263,Spreading (qualifier value),Pancreatic carcinoma,0
2264,Hydrocephalus,FIGO Stage IVA Ovarian Cancer,0
2265,M Protein,Undifferentiated Endocervical Sarcoma,0
2266,Common (qualifier value),Papillary squamous cell carcinoma,0
2267,Ability,Granular Cell Leiomyosarcoma,0
2268,Treating,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2269,Death NOS,Locally Advanced Squamous Cell Carcinoma,0
2270,Interventional procedure,Acute Undifferentiated Leukemia,0
2271,Mean Percent of Normal,Uterine Cancer,0
2272,In Blood,Atypical Mesothelial Hyperplasia,0
2273,Childhood Lymphoma,mucinous adenocarcinoma of gallbladder,0
2274,Act Class - investigation,Precursor B-lymphoblastic lymphoma stage II,0
2275,Lymphocyte component of blood,Metastatic Lung Neuroendocrine Neoplasm,0
2276,Human papilloma virus infection,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2277,Lead,Stage II Hepatocellular Carcinoma AJCC v8,0
2278,Retinal pigment epithelial cell,Recurrent Uveal Melanoma,0
2279,Removed,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2280,Tissue Specimen Code,Ovarian germ cell choriocarcinoma stage IV,0
2281,Leads (device),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2282,Associated topography,Stage I Adult Non-Hodgkin Lymphoma,0
2283,Within,Blood Vessel Tumors,0
2284,+5,Cerebral hemangioma,0
2285,Cessation of life,Squamous cell carcinoma of lip,0
2286,Usual Severity Vomiting,Maxillary Sinus Adenocarcinoma,0
2287,Uterus,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2288,Evidence,Benign tumor of eyelid,0
2289,Germ Cells,Stage III Cutaneous Melanoma AJCC v6,0
2290,Fetal Ultrasonography,Gastric Diffuse Large B-Cell Lymphoma,0
2291,Science of Etiology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2292,Vaginal clear cell adenocarcinoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2293,How Much Distress Weight Loss,Choroid Necrotic Melanoma,0
2294,Symptoms aspect,Breast Apocrine Adenoma,0
2295,Case (situation),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2296,Severe (severity modifier),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
2297,Squamous cell carcinoma,Engraftment syndrome,0
2298,Subject Risk,Intestinal Neuroendocrine Carcinoma,0
2299,Case (situation),Clonal Hematopoiesis of Indeterminate Potential,0
2300,year,Giant cell angiofibroma,0
2301,Feel Tired question,Stage III Cutaneous Melanoma AJCC v6,0
2302,Fish (substance),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2303,cell growth,Recurrent Testicular Lymphoma,0
2304,Malignant melanoma of vulva,Granular Cell Leiomyosarcoma,0
2305,Front of neck,Female Breast Carcinoma,0
2306,Occurrence,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2307,Childhood Diffuse Large B-Cell Lymphoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2308,Diagnosis Study,Clonal Hematopoiesis of Indeterminate Potential,0
2309,Including (qualifier),Atypical Mesothelial Hyperplasia,0
2310,Substance,Hereditary Diffuse Gastric Adenocarcinoma,0
2311,Brain Neoplasms,Malignant Testicular Sertoli Cell Tumor,0
2312,Group A (blood group),Adult Acute Eosinophilic Leukemia,0
2313,Childbirth,Unfavorable Non-Hodgkin Lymphoma,0
2314,Infrequent,Nasal cavity carcinoma,0
2315,immune system development,Locally Advanced Squamous Cell Carcinoma,0
2316,Benign,ROSE Cluster 3,0
2317,59,ICHTHYOSIS,0
2318,Dental White Spot,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2319,Lip structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2320,Introduction procedure,Benign Apocrine Neoplasm,0
2321,Valid,ROSE Cluster 3,0
2322,Cancer Genus,Liver Cavernous Hemangioma,0
2323,Unknown GENC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2324,PSA Level Greater than Fifty,Carcinomatosis of peritoneal cavity,0
2325,75,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2326,Humor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2327,Soft,Benign Carotid Body Paraganglioma,0
2328,United States,Cartilaginous exostosis,0
2329,Subject Risk,Benign squamous cell tumor,0
2330,Tumor cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2331,Ability,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2332,Malignant Neoplasms,Female Breast Carcinoma,0
2333,Absent,Funisitis (disorder),0
2334,Percent normal,Malignant neoplasm of subglottis,0
2335,Cure (remedy),Carcinoma of urinary bladder,0
2336,Vaginal,Type II Endometrial Adenocarcinoma,0
2337,Child,Choroid Necrotic Melanoma,0
2338,Melanoma Pathway,Benign Anal Granular Cell Tumor,0
2339,Breast Carcinoma,Cancer of Urinary Tract,0
2340,Esthesia,Acute lymphadenitis,0
2341,Cell Count,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2342,Lesion,Human Papillomavirus-Related Carcinoma,0
2343,Result,Squamous cell carcinoma of lip,0
2344,Orbital region,Endometrial Small Cell Carcinoma,0
2345,Tumor Mass,Benign Carotid Body Paraganglioma,0
2346,Reduced,Adult Alveolar Soft Part Sarcoma,0
2347,Germinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2348,Fertility Agents,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2349,high - ActExposureLevelCode,FIGO Stage IVA Ovarian Cancer,0
2350,Topical surface,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2351,To,Acute lymphadenitis,0
2352,Combined,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
2353,Intention - mental process,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2354,Therapeutic procedure,Leptomeningeal sarcoma,0
2355,Surgical aspects,Cerebral Primitive Neuroectodermal Tumor,0
2356,Smaller,Transitional cell carcinoma,0
2357,Image Feature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2358,low,Serous cystadenocarcinoma ovary,0
2359,Fatigue,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2360,Molecular Mass,Stage III Cutaneous Melanoma AJCC v6,0
2361,Main,Childhood Cerebellar Neoplasm,0
2362,1000000,Chronic Myelomonocytic Leukemia-2,0
2363,pharmacotherapeutic,Secondary malignant neoplasm of lymph node,0
2364,Upper arm,Kaposi's sarcoma of skin,0
2365,Caucasoid Race,Benign squamous cell tumor,0
2366,Small,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2367,65+,Non-Metastatic Gestational Trophoblastic Tumor,0
2368,Usually,Intracortical osteosarcoma,0
2369,Feel Tired question,Hemangioma,0
2370,Squamous cell carcinoma of skin,Xeroderma pigmentosum,0
2371,900,Thymic Clear Cell Carcinoma,0
2372,Skin,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2373,Interstitial Cells of Cajal,Thymic Clear Cell Carcinoma,0
2374,Therapeutic procedure,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2375,Cells,Non-Metastatic Gestational Trophoblastic Tumor,0
2376,Chemotherapy,Bladder squamous cell carcinoma stage I,0
2377,Disease,Kaposi's sarcoma of extrahepatic bile duct,0
2378,Pancreas,Malignant neoplasm of choroid,0
2379,High risk of,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
2380,Lymphocyte component of blood,BRCA2 Syndrome,0
2381,Hemorrhage,Lung squamous cell carcinoma stage I,0
2382,50%,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
2383,Right,Clonal Hematopoiesis of Indeterminate Potential,0
2384,Endometrium,Papillary squamous cell carcinoma,0
2385,Disease,non-Hodgkin's lymphoma of spleen,0
2386,Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2387,Central Minus,Acantholytic squamous cell carcinoma,0
2388,Neoplasms,Heavy Chain Deposition Disease,0
2389,Involvement with,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2390,How Much Distress Weight Loss,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2391,Abnormal number of nucleoli,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2392,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2393,Drain device,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2394,Affecting,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2395,Sample Median,Human Papillomavirus-Related Carcinoma,0
2396,Swab specimen,Thymic Clear Cell Carcinoma,0
2397,Precaution Code - Confused,Intestinal Metaplasia of Bladder Urothelium,0
2398,Primary lymphoid organ,Pancreatic Endocrine Carcinoma,0
2399,Over (spatial),Adult Acute Eosinophilic Leukemia,0
2400,low exposure,Digestive System Hodgkin Lymphoma,0
2401,Usual Severity Sweats,Bladder squamous cell carcinoma stage I,0
2402,Congenital Abnormality,Advanced Uterine Corpus Carcinosarcoma,0
2403,high - ActExposureLevelCode,Chronic Myelomonocytic Leukemia-2,0
2404,Numerous,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2405,Present,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2406,Slightly Agree,Thymic Atypical Carcinoid Tumor,0
2407,Benign Neoplasm,Locally Advanced Soft Tissue Sarcoma,0
2408,Fever,Astrocytoma of brain,0
2409,Cardiovascular system,Stage I Colon Neuroendocrine Tumor AJCC v8,0
2410,Dry,Mucinous adenocarcinoma gastric,0
2411,Urinary Bladder,Type II Endometrial Adenocarcinoma,0
2412,pharmacotherapeutic,FIGO Stage IVA Ovarian Cancer,0
2413,Biopsy,Advanced Lung Carcinoma,0
2414,Concept model domain,Acinar cell carcinoma of pancreas,0
2415,Adenium obesum,Choroid Necrotic Melanoma,0
2416,Central neuroblastoma,Adult Acute Eosinophilic Leukemia,0
2417,Status post,Acute lymphadenitis,0
2418,Base - General Qualifier,Female Breast Carcinoma,0
2419,Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2420,Accessory,Gallbladder Adenocarcinoma,0
2421,Progress,Methotrexate-Associated Hodgkin Lymphoma,0
2422,Minor salivary gland structure,Vaginal Adenoid Cystic Carcinoma,0
2423,Reported Term,Mucinous adenocarcinoma,0
2424,Presence (property),Primary Cutaneous Plasmablastic Lymphoma,0
2425,Pathology report,Locally Advanced Soft Tissue Sarcoma,0
2426,Unit - NCI Thesaurus Property,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2427,PREVENT (product),FIGO Stage II Ovarian Cancer,0
2428,Exogenous Factors,GIANT PIGMENTED HAIRY NEVUS,0
2429,HLA Class II Histocompatibility Antigen Gamma Chain,Metastatic Carcinoma in the Lung,0
2430,Known,Spongiotic dermatitis,0
2431,Cell (compartment),Malignant neoplasm of choroid,0
2432,Procedure (set of actions),Cancer of Urinary Tract,0
2433,Acute Undifferentiated Leukemia,Keratoderma,0
2434,Death (finding),Stage IV Childhood Non-Hodgkin Lymphoma,0
2435,Metastatic Neoplasm,Pancreatic carcinoma,0
2436,Prophylactic behavior,Bladder squamous cell carcinoma stage I,0
2437,GDF15 protein,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2438,Etiology aspects,Ovarian germ cell choriocarcinoma stage IV,0
2439,Common (qualifier value),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
2440,Adult Cholangiocarcinoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2441,Large,Ovarian germ cell choriocarcinoma stage IV,0
2442,To,Pancreatic Intraepithelial Neoplasia-3,0
2443,Europe,Congenital hamartoma,0
2444,Brain,Testicular cancer metastatic,0
2445,melanocyte,Ichthyosis,0
2446,Including (qualifier),BRCA2 Syndrome,0
2447,Type - attribute,Undifferentiated Endocervical Sarcoma,0
2448,Orbit (brand of fungicide),Locally Advanced Soft Tissue Sarcoma,0
2449,Primary operation,Airway Hemangioma,0
2450,Separate,Cancer of Urinary Tract,0
2451,Object Class,Blood Vessel Tumors,0
2452,Confirmed by,Xeroderma pigmentosum,0
2453,Approximate,Placental aromatase deficiency,0
2454,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2455,Gene Cluster Text Format,clear cell adenocarcinoma of gallbladder,0
2456,Therapeutic procedure,Hereditary Diffuse Gastric Adenocarcinoma,0
2457,United States Military Commissioned Officer O4,Familial Adenomatous Polyposis Associated Medulloblastoma,0
2458,Subependymal Giant Cell Astrocytoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2459,consider,Ichthyosis,0
2460,Surface of brain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2461,Occur (action),Nasal cavity carcinoma,0
2462,Have Weight Loss,Giant cell angiofibroma,0
2463,Cell Invasion,Hereditary Diffuse Gastric Adenocarcinoma,0
2464,Abnormal cell,Advanced Uterine Corpus Carcinosarcoma,0
2465,Fifth,Stage 0 Penile Cancer AJCC v8,0
2466,Swallowing painful,Recurrent Uveal Melanoma,0
2467,Basis - conceptual entity,Liver Lymphangioma,0
2468,ocular sphere,Liver Cavernous Hemangioma,0
2469,Cow's milk,Extracranial Neuroblastoma,0
2470,Adverse Event Associated with Vascular,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
2471,Arm of chromosome,Adult Alveolar Soft Part Sarcoma,0
2472,What subject filter - Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2473,Cancer Genus,Childhood Fibrillary Astrocytoma,0
2474,Japan,Malignant melanoma of eyelid,0
2475,Left,Small Intestinal Villous Adenoma,0
2476,Sharing (Social Behavior),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
2477,Complete Agreement,Refractory Barrett Esophagus,0
2478,Type A,carcinoma of middle ear,0
2479,75,Squamous cell carcinoma of lip,0
2480,Neurons,Precursor B-lymphoblastic lymphoma stage II,0
2481,risk factors,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2482,Malignant Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2483,Abdominal hysterectomy,Extracranial Neuroblastoma,0
2484,BRCA2 gene,Hodgkin Disease,0
2485,International Classification of Diseases for Oncology,Uterine Cancer,0
2486,Occur (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2487,All,Splenic Manifestation of Hairy Cell Leukemia,0
2488,include - SetOperator,Gallbladder adenoma,0
2489,Neoplasms by Site,Refractory Barrett Esophagus,0
2490,include - SetOperator,Malignant neoplasm of thalamus,0
2491,Cell (compartment),Cancer of Urinary Tract,0
2492,Science of Etiology,Blood Vessel Tumors,0
2493,How Often Weight Loss,Benign Anal Granular Cell Tumor,0
2494,Occurrence Indicator,Diffuse malignant mesothelioma,0
2495,Chemotherapy,Chronic Myelomonocytic Leukemia-2,0
2496,Anaplasia,Cerebral Primitive Neuroectodermal Tumor,0
2497,Skeletal bone,Basal Cell Ameloblastoma,0
2498,Benign tumor of salivary gland,Childhood Lymphoma,0
2499,Surgery specialty,Mucinous neoplasm,0
2500,To,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2501,derivation calculation,clear cell adenocarcinoma of gallbladder,0
2502,Palatine Tonsil,Malignant neoplasm of gallbladder,0
2503,Death (finding),Uterine Cancer,0
2504,Etiology aspects,Childhood Central Nervous System Ganglioneuroblastoma,0
2505,Metastatic Neoplasm,Spongiotic dermatitis,0
2506,Occurrence,Acute lymphadenitis,0
2507,Doubling Time,Platinum-Resistant Lung Small Cell Carcinoma,0
2508,shared attribute,Unresectable Rhabdomyosarcoma,0
2509,Acute lymphocytic leukemia,Human Papillomavirus-Related Carcinoma,0
2510,Manipulation procedure,Chest Wall Fibromatosis,0
2511,Usual,Stage III Cutaneous Melanoma AJCC v6,0
2512,Case unit dose,Melanomatosis,0
2513,Melanocytic nevus,Adult Hepatocellular Carcinoma,0
2514,Cough,Malignant neoplasm of thalamus,0
2515,Feelings,Spongiotic dermatitis,0
2516,General Health:Find:Pt:^Patient:Ord,Spongiotic dermatitis,0
2517,Result,Chest Wall Fibromatosis,0
2518,Long Variable,Mucinous cystadenofibroma,0
2519,Occurrence Indicator,Maxillary Sinus Adenocarcinoma,0
2520,Hyperestrogenism,Undifferentiated Endocervical Sarcoma,0
2521,Data,Testicular cancer metastatic,0
2522,Feel Tired question,Kaposi's sarcoma of extrahepatic bile duct,0
2523,Nuclear hyperchromasia,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2524,59,Human Papillomavirus-Related Carcinoma,0
2525,Tissue Specimen Code,Diffuse malignant mesothelioma,0
2526,seen,Mixed astrocytoma-ependymoma,0
2527,Body site,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
2528,Sensitive,Human Papillomavirus-Related Carcinoma,0
2529,development aspects,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
2530,Decision,Locally Advanced Soft Tissue Sarcoma,0
2531,Borg Category-Ratio 10 Perceived Exertion Score 5,Neoplasms,0
2532,member,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2533,Removed,Low Grade Squamous Intraepithelial Neoplasia,0
2534,How Often Difficulty Swallowing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2535,Basis - conceptual entity,Cervical Fibroepithelial Polyp,0
2536,4+ Answer to question,Digestive System Hodgkin Lymphoma,0
2537,Very high,Thymoma malignant recurrent,0
2538,Liver carcinoma,Vaginal Adenoma,0
2539,Name (property) (qualifier value),Vaginal Adenoma,0
2540,Pieris rapae,Chest Wall Fibromatosis,0
2541,Cornea,Adult Alveolar Soft Part Sarcoma,0
2542,Pelvic Pain,Small cell neuroendocrine carcinoma of bladder,0
2543,*Type - Kind of quantity,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
2544,potential,Benign Ovarian Thecoma,0
2545,Testis,benign mature teratoma of pancreas,0
2546,regional,Metastatic Lung Small Cell Carcinoma,0
2547,Feel Tired question,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2548,Rosa,Malignant neoplasm of choroid,0
2549,Leads (device),Recurrent Testicular Lymphoma,0
2550,Communicable Diseases,Stage III Cutaneous Melanoma AJCC v6,0
2551,Chronic myeloproliferative disorder,Congenital hamartoma,0
2552,Neoplasm Metastasis,Type II Endometrial Adenocarcinoma,0
2553,Study Control,Extra-abdominal fibromatosis,0
2554,Most,Benign tumor of eyelid,0
2555,+2,Gallbladder Adenocarcinoma,0
2556,Representation (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2557,Before values,Carcinoma ex pleomorphic adenoma of parotid gland,0
2558,Etiology aspects,Kaposi's sarcoma of skin,0
2559,Associated with,Acute Undifferentiated Leukemia,0
2560,Mass of body structure,Platinum-Resistant Lung Small Cell Carcinoma,0
2561,Testis present,adenosquamous carcinoma of breast,0
2562,Benign Neoplasm,Neonatal leukemia,0
2563,Disease remission,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2564,Involvement with,Malignant Testicular Sertoli Cell Tumor,0
2565,Lymphoma,Pancreatic Intraepithelial Neoplasia-3,0
2566,Early,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2567,Proliferation,Engraftment syndrome,0
2568,diagnosis aspect,Benign squamous cell tumor,0
2569,Common Specifications in HL7 V3 Publishing,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2570,Ultra-violet,non-Hodgkin's lymphoma of spleen,0
2571,Group A (blood group),Acantholytic squamous cell carcinoma,0
2572,Beginning,Liver Lymphangioma,0
2573,Stellate,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
2574,Together,Intestinal Metaplasia of Bladder Urothelium,0
2575,Administration procedure,BRCA2 Syndrome,0
2576,Tissue Specimen Code,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2577,Age-Years,Papillary squamous cell carcinoma,0
2578,described,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2579,Neoadjuvant Therapy,Unresectable Rhabdomyosarcoma,0
2580,Human papillomavirus types,Breast Apocrine Adenoma,0
2581,CDISC SEND Tumor Findings Results Terminology,Metastatic Carcinoma in the Lung,0
2582,Early disease stage,Refractory Barrett Esophagus,0
2583,Tumor cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2584,TP53 gene,Malignant Neoplasm of Lung - Multiple Primary Sites,0
2585,Malignant neoplasm of breast,Uterine Cancer,0
2586,Blood group A (finding),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2587,What subject filter - Result,Kaposi's sarcoma of extrahepatic bile duct,0
2588,Cause of Death,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2589,Human Cells,Placental aromatase deficiency,0
2590,Acute leukemia,Acute Undifferentiated Leukemia,0
2591,<50,Basal Cell Ameloblastoma,0
2592,Cancer Genus,Deep Leiomyoma,0
2593,How Much Distress Shortness of Breath,Chronic Myelomonocytic Leukemia-2,0
2594,Sharing (Social Behavior),Cherubism,0
2595,Call (Instruction),Extracranial Neuroblastoma,0
2596,Administration procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2597,Mediator brand of benfluorex hydrochloride,Peripheral primitive neuroectodermal tumor of soft tissue,0
2598,Remetinostat,sarcoma of spinal cord,0
2599,Distant,Recurrent Uveal Melanoma,0
2600,Peripheral,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2601,Tumor type,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2602,Disruptive,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2603,Hemorrhage,Cancer of Urinary Tract,0
2604,Upper arm,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2605,Disease Management,Primary Cutaneous Plasmablastic Lymphoma,0
2606,primary tumor,Digestive System Hodgkin Lymphoma,0
2607,Antibodies,Non-Metastatic Gestational Trophoblastic Tumor,0
2608,Frequently,Nasal cavity carcinoma,0
2609,Performed,Uterine Cancer,0
2610,Occurrence Indicator,Human Papillomavirus-Related Carcinoma,0
2611,Tumor Mass,Adult Acute Eosinophilic Leukemia,0
2612,Two,Squamous cell carcinoma of lip,0
2613,Prior Medication Usage,Vaginal Adenoid Cystic Carcinoma,0
2614,Adjacent,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2615,Changing,Stage IB Pancreatic Cancer AJCC v8,0
2616,Include (action),clear cell adenocarcinoma of gallbladder,0
2617,Money or percentage indicator - Percentage,Transitional cell carcinoma,0
2618,Tanning of leather,Hodgkin lymphoma,0
2619,10%,Acantholytic squamous cell carcinoma,0
2620,Type - attribute,Small Intestinal Villous Adenoma,0
2621,Rare,Type II Endometrial Adenocarcinoma,0
2622,Immunoproliferative Disorders,Stage I Adult Non-Hodgkin Lymphoma,0
2623,Togo,Metastatic Malignant Neoplasm in the Sellar Region,0
2624,Make - Instruction Imperative,Nasal cavity carcinoma,0
2625,Iodides,Metaplastic carcinoma of breast,0
2626,Malignant neoplasm of lung,Thymic Clear Cell Carcinoma,0
2627,Tumor cells,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
2628,Tissue damage,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2629,Offspring,Xeroderma pigmentosum,0
2630,Diagnostic Neoplasm Staging,Lung squamous cell carcinoma stage I,0
2631,Person 1,Multiple Skull Base Meningiomas,0
2632,Undifferentiated,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2633,Nausea Visual Analogue Scale,Chronic Myelomonocytic Leukemia-2,0
2634,Loss of Appetite question,Stage IB Pancreatic Cancer AJCC v8,0
2635,Small cell carcinoma of lung,Pancreatic carcinoma,0
2636,Histology,Lipoma of small intestine,0
2637,Critical,Placental aromatase deficiency,0
2638,thymocyte,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2639,Frequently,Endometrial Small Cell Carcinoma,0
2640,Inheritance,High Grade Glandular Intraepithelial Neoplasia,0
2641,Intestines,Stage III Cutaneous Melanoma AJCC v6,0
2642,Bronchoconstriction,Neoplasms,0
2643,Singular,Low Grade Squamous Intraepithelial Neoplasia,0
2644,Abnormal,Melanomatosis,0
2645,Incidence,Metastatic Neoplasm to the Gallbladder,0
2646,Numerous,Endometrial Small Cell Carcinoma,0
2647,TP53 gene,Mixed astrocytoma-ependymoma,0
2648,Lower - spatial qualifier,Bladder squamous cell carcinoma stage I,0
2649,Upper arm,squamous cell carcinoma of the thyroid gland,0
2650,Lung Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2651,Canada,de novo Myelodysplastic Syndrome,0
2652,Asia,Heavy Chain Deposition Disease,0
2653,Surgery specialty,Acute Undifferentiated Leukemia,0
2654,Wound Healing,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
2655,medication - HL7 publishing domain,Blood Vessel Tumors,0
2656,Neoplasms,Localized Askin Tumor,0
2657,Major salivary gland structure,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
2658,Often - answer to question,Refractory Glioma,0
2659,Aspects of signs,Benign tumor of eyelid,0
2660,Circulatory Process,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2661,Eyelid structure,Fourth Ventricle and Brain Stem Ependymal Tumor,0
2662,Tryptophanase,Intraepithelial Melanocytic Hyperplasia,0
2663,Compleat Liquid Nutrition,Deep Leiomyoma,0
2664,Mammals,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2665,Entity,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2666,Post,ROSE Cluster 3,0
2667,Bone Marrow Transplantation,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
2668,Specimen Source Codes - tumor,Acantholytic squamous cell carcinoma,0
2669,Indication of (contextual qualifier),Ovarian Dermoid Cyst with Secondary Carcinoma,0
2670,Range,Intestinal Metaplasia of Bladder Urothelium,0
2671,Benign Smooth Muscle Neoplasm,Childhood Central Nervous System Ganglioneuroblastoma,0
2672,Tryptophanase,Type II Endometrial Adenocarcinoma,0
2673,Tryptophanase,Stage III Cutaneous Melanoma AJCC v6,0
2674,Tissue Specimen Code,Carcinomatosis of peritoneal cavity,0
2675,subapical complex location,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2676,Walls of a building,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
2677,Abnormality of the face,Carcinoma,0
2678,Screening procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
2679,Expanding,Stage 0 Lip Carcinoma,0
2680,Loss of appetite (finding),Adult Acute Eosinophilic Leukemia,0
2681,Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
2682,health and disease,Mastocytosis,0
2683,Administration procedure,Unresectable Rhabdomyosarcoma,0
2684,Vision,Acute lymphadenitis,0
2685,Prognosis:Find:Pt:^Patient:Nom,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2686,Type - attribute,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
2687,At risk of infection,Thyroid Hurthle Cell Carcinoma,0
2688,Benign disorder,Extra-abdominal fibromatosis,0
2689,Skin Erosion,Mucinous adenocarcinoma gastric,0
2690,More,Cerebral Primitive Neuroectodermal Tumor,0
2691,Areas <moth>,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2692,Mean Percent of Normal,Human Papillomavirus-Related Carcinoma,0
2693,CDISC SEND Body System Terminology,Diffuse malignant mesothelioma,0
2694,Persons,Human Papillomavirus-Related Carcinoma,0
2695,Renal Cell Carcinoma Pathway,Ichthyosis,0
2696,Pineal germinoma,Refractory Ependymoma,0
2697,Tryptophanase,Precursor B-lymphoblastic lymphoma stage II,0
2698,Papillomavirus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2699,bony process,Cervical Adenomyoma,0
2700,biopsy characteristics,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2701,Obese build,Childhood Thyroid Gland Follicular Carcinoma,0
2702,Rare,Refractory Barrett Esophagus,0
2703,Morphology,Benign tumor of eyelid,0
2704,Malignant Neoplasms,FIGO Stage IVA Ovarian Cancer,0
2705,Neoplasms by Site,Collecting Duct Carcinoma of the Kidney,0
2706,Vaginal neoplasia,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2707,depend,Squamous cell carcinoma of lip,0
2708,English race,BRCA2 Syndrome,0
2709,Specimen Source Codes - Genital,High Grade Glandular Intraepithelial Neoplasia,0
2710,Congestive heart failure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2711,disease transmission,Hereditary corneal dystrophy,0
2712,Reaching,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
2713,Tissue specific,Intraepithelial Melanocytic Hyperplasia,0
2714,Exertion,Gallbladder Adenocarcinoma,0
2715,Form:Finding:Point in time:{Setting}:Document:{Role},Urethral Carcinoma,0
2716,Li-Fraumeni Syndrome,Spongiotic dermatitis,0
2717,Kind of quantity - Frequency,Cerebral Primitive Neuroectodermal Tumor,0
2718,Smaller,Stage III Adult Immunoblastic Lymphoma,0
2719,Two,Uterine Cancer,0
2720,Usual Severity Nausea,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
2721,Histocompatibility Testing,Carcinoma of submandibular gland,0
2722,Form:Finding:Point in time:{Setting}:Document:{Role},Benign tumor of eyelid,0
2723,Time,Recurrent Testicular Lymphoma,0
2724,Secondary malignant neoplasm of lung,Heavy Chain Deposition Disease,0
2725,Science of Etiology,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2726,Class (taxonomic),Benign squamous cell tumor,0
2727,Night sweats,Human Papillomavirus-Related Carcinoma,0
2728,Part of,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2729,Musculature of limb,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2730,second (number),Stage III Cutaneous Melanoma AJCC v6,0
2731,Immune system,Localized Ewing Sarcoma,0
2732,Certain (qualifier value),Diffuse malignant mesothelioma,0
2733,shared attribute,Malignant melanoma of eyelid,0
2734,Human papilloma virus infection,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2735,Therapeutic radiology procedure,Astrocytoma of brain,0
2736,Therapeutic radiology procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2737,Lymphoid Tissue,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2738,Biological Response Modifier Therapy,Liver Lymphangioma,0
2739,English [International Organization for Standardization 639-1 code en] language reference set,Chronic Myelomonocytic Leukemia-2,0
2740,Preventing (action),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2741,Pharmacotherapy,Cherubism,0
2742,bony process,Benign squamous cell tumor,0
2743,Has difficulty doing (qualifier value),malignant lymphoma of pancreatic lymph nodes,0
2744,Development,Small intestine carcinoma,0
2745,Surgical extraction,Keratoderma,0
2746,Numerous,Stage IB Pancreatic Cancer AJCC v8,0
2747,Time (foundation metadata concept),Hemangioma,0
2748,% live,Acute Undifferentiated Leukemia,0
2749,Cervix carcinoma,Colorectal Neuroendocrine Tumor G2,0
2750,Use of,Squamous cell carcinoma of lip,0
2751,Human Chorionic Gonadotropin,Tubal Hyperplasia,0
2752,Liver Flavor,Childhood Central Nervous System Ganglioneuroblastoma,0
2753,Age,Recurrent Uveal Melanoma,0
2754,bony process,Angiosarcoma of liver,0
2755,Data Transformation,Acute lymphadenitis,0
2756,Various patch test substance,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2757,Term (lexical),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2758,morphological,Malignant neoplasm of olfactory nerve,0
2759,Urinary tract,Endometrial Small Cell Carcinoma,0
2760,Levels (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
2761,Trial Screening,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2762,Science of Etiology,Benign Apocrine Neoplasm,0
2763,Diagnostic radiologic examination,Bladder squamous cell carcinoma stage I,0
2764,Female,Congenital hamartoma,0
2765,Usual Severity Weight Loss,Mucinous adenocarcinoma gastric,0
2766,Skin Pigmentation,Chronic Myelomonocytic Leukemia-2,0
2767,SPINK5 gene,Clonal Hematopoiesis of Indeterminate Potential,0
2768,Polyglandular Type I Autoimmune Syndrome,Xeroderma pigmentosum,0
2769,Bathing,Bladder squamous cell carcinoma stage I,0
2770,Uterine Cancer,Small cell neuroendocrine carcinoma of bladder,0
2771,Injury due to exposure to external cause,Multiple Endocrine Neoplasia,0
2772,Abnormal Reference Range,Breast Apocrine Adenoma,0
2773,Digital Content Category,Stage III Adult Immunoblastic Lymphoma,0
2774,Biopsy,Trabecular adenocarcinoma,0
2775,Life Threatening or Disabling Adverse Event,Botryoid-Type Embryonal Rhabdomyosarcoma,0
2776,Either,Recurrent Uveal Melanoma,0
2777,Chewing,sarcoma of spinal cord,0
2778,pump (device),Tongue Alveolar Soft Part Sarcoma,0
2779,Symptoms aspect,Engraftment syndrome,0
2780,Recurrent infections,Stage 0 Penile Cancer AJCC v8,0
2781,Stomach,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2782,Beginning,Metastatic Lung Neuroendocrine Neoplasm,0
2783,+5,Astrocytoma of brain,0
2784,Severe atopic dermatitis,Clonal Hematopoiesis of Indeterminate Potential,0
2785,Chemotherapy Regimen,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
2786,Observation in research,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
2787,Important,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2788,Both kidneys,Astrocytoma of brain,0
2789,Recurrence,Neonatal leukemia,0
2790,Usual Severity Weight Loss,Gallbladder Adenocarcinoma,0
2791,Disruptive,Benign neoplasm of eye,0
2792,Characterization,Localized Askin Tumor,0
2793,Name (property) (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2794,Skin,Metastatic Lung Neuroendocrine Neoplasm,0
2795,Melanocytic nevus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2796,Physical findings,Rhabdomyosarcoma with ganglionic differentiation,0
2797,Sarcoma,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
2798,shared attribute,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2799,Laboratory Procedures,Fourth Ventricle and Brain Stem Ependymal Tumor,0
2800,Neoadjuvant Therapy Clinical Trial Setting,Anterior Urethral Malignant Neoplasm,0
2801,Cancer Biology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
2802,How Much Distress Weight Loss,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2803,Ewings sarcoma,Cancer of Urinary Tract,0
2804,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Malignant Neoplasm with Regional Lymph Node Involvement,0
2805,point - UnitsOfMeasure,Neonatal leukemia,0
2806,Basis - conceptual entity,Metastatic Lung Small Cell Carcinoma,0
2807,Hormone Therapy,Unfavorable Non-Hodgkin Lymphoma,0
2808,Subtype (attribute),Maxillary Sinus Adenoid Cystic Carcinoma,0
2809,Primary,Carcinomatosis of peritoneal cavity,0
2810,various antiseptic throat preparations,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2811,diagnosis aspect,Stage IV Childhood Non-Hodgkin Lymphoma,0
2812,Binding Sites,Pancreatic Intraepithelial Neoplasia-3,0
2813,genetic aspects,Multiple Skull Base Meningiomas,0
2814,Cervix Uteri,Kaposi's sarcoma of extrahepatic bile duct,0
2815,*Type - Kind of quantity,Kaposi's sarcoma of skin,0
2816,therapeutic aspects,Methotrexate-Associated Hodgkin Lymphoma,0
2817,Appearance,Stage II Carcinoma of Penis,0
2818,Overall Publication Type,Locally Advanced Squamous Cell Carcinoma,0
2819,Over (spatial),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2820,Ephrin Type-B Receptor 1,Brain Ependymoma,0
2821,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2822,Term (lexical),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2823,Pediculus (eukaryote),Recurrent Testicular Lymphoma,0
2824,Definition,Acute Undifferentiated Leukemia,0
2825,20%,Ichthyoses,0
2826,Lingual tonsil,Rhabdomyosarcoma with ganglionic differentiation,0
2827,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
2828,Intellectual scale,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2829,Type - attribute,Tongue Alveolar Soft Part Sarcoma,0
2830,Age,Unfavorable Non-Hodgkin Lymphoma,0
2831,Abdomen distended,Locally Advanced Epithelioid Hemangioendothelioma,0
2832,Effective,Mixed parotid tumor,0
2833,Does carry,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
2834,Benign neoplasm of paraganglion,Extra-Adrenal Paraganglioma,0
2835,insensitivity,Recurrent Testicular Lymphoma,0
2836,Wound Healing,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
2837,Pressure - action,Acute Undifferentiated Leukemia,0
2838,Disease,Undifferentiated Neuroblastoma,0
2839,Uncontrolled,Childhood Thyroid Gland Follicular Carcinoma,0
2840,International Classification of Disease,Pleomorphic adenoma of parotid gland,0
2841,10%,Anaplastic large cell lymphoma,0
2842,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2843,Administration procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
2844,2+ Score,Colorectal High Grade B-Cell Lymphoma,0
2845,Percent (qualifier value),Breast Ductal Adenoma,0
2846,International Classification of Diseases for Oncology,Digestive System Hodgkin Lymphoma,0
2847,Percent inhibition,gliosarcoma,0
2848,year,Unresectable Rhabdomyosarcoma,0
2849,To,Malignant neoplasm of thalamus,0
2850,Myasthenia Gravis,Childhood Lung Non-Small Cell Carcinoma,0
2851,Life threatening - Event Consequence,Squamous cell carcinoma of lip,0
2852,Packaging Case,Splenic Manifestation of Hairy Cell Leukemia,0
2853,30%,Neoplasms,0
2854,Ureter,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
2855,Side,gliosarcoma,0
2856,Result,Anaplastic large cell lymphoma,0
2857,Recurrence,Neoplasms,0
2858,Infection,Localized Askin Tumor,0
2859,Observation - diagnostic procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2860,System - kit,embryonal rhabdomyosarcoma of prostate,0
2861,Biopsy,Trichilemmocarcinoma,0
2862,Abnormal Reference Range,Kaposi's sarcoma of skin,0
2863,Basis,Multiple Endocrine Neoplasia,0
2864,Lymphoma,Maxillary Sinus Adenoid Cystic Carcinoma,0
2865,Diagnosis Study,Choroid Epithelioid Cell Melanoma,0
2866,Most,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
2867,Medical,Locally Advanced Carcinoma,0
2868,Numbers,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
2869,Cell (compartment),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2870,Extrinsic,Primary Cutaneous Plasmablastic Lymphoma,0
2871,Protein Turn,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
2872,Translucent,Engraftment syndrome,0
2873,Immune System Processes,Recurrent Rhabdomyosarcoma,0
2874,Loss of appetite (finding),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
2875,year,Childhood Fibrillary Astrocytoma,0
2876,Cover (physical object),Acute lymphadenitis,0
2877,Type A,Thymic Atypical Carcinoid Tumor,0
2878,Disease,Cystadenocarcinoma,0
2879,prior radiation therapy,Tonsillar Carcinoma,0
2880,Manufactured form,Xeroderma pigmentosum,0
2881,Thymoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
2882,bony process,Endometrial Small Cell Carcinoma,0
2883,Recommendation,Lipoma of small intestine,0
2884,Term (temporal),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2885,Worse,Lipoma of small intestine,0
2886,Vulva,Benign Anal Granular Cell Tumor,0
2887,Severe Extremity Pain,gliosarcoma,0
2888,Rapid,Astrocytoma of brain,0
2889,Dorsal funiculus,Benign Anal Granular Cell Tumor,0
2890,week,Chondrosarcoma,0
2891,Proliferation,Intracortical osteosarcoma,0
2892,Base - General Qualifier,Ovarian Dermoid Cyst with Secondary Carcinoma,0
2893,Lead,Refractory Bladder Carcinoma,0
2894,Dyspnea,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
2895,Ability,Glomeruloid hemangioma,0
2896,Three,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2897,Present,Lipoma of small intestine,0
2898,Sunlight,Hereditary Diffuse Gastric Adenocarcinoma,0
2899,Neuron spine,Hodgkin Disease,0
2900,Epithelium,FIGO Stage IVA Ovarian Cancer,0
2901,Oral cavity,Primary Cutaneous Plasmablastic Lymphoma,0
2902,Tumor type,Mucinous adenocarcinoma gastric,0
2903,patient condition,Locally Advanced Soft Tissue Sarcoma,0
2904,Cell Count,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2905,Gram per Deciliter,Carcinomatosis of peritoneal cavity,0
2906,Neoplasms,Benign Anal Granular Cell Tumor,0
2907,Skin,Benign Anal Granular Cell Tumor,0
2908,Coughing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2909,Osteoporosis,Adrenal Rest Tumor,0
2910,Rare,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
2911,Due to,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
2912,radiotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2913,Gait normal,Recurrent Testicular Lymphoma,0
2914,Postmenopausal state,Melanomatosis,0
2915,vowels,Acute Undifferentiated Leukemia,0
2916,Count of entities,Kaposi's sarcoma of skin,0
2917,include - SetOperator,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
2918,Cluster,Mucinous adenocarcinoma gastric,0
2919,white blood cell type,Pancreatic carcinoma,0
2920,IPSS Risk Category High,Undifferentiated Endocervical Sarcoma,0
2921,United States,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
2922,seconds,Cerebral Primitive Neuroectodermal Tumor,0
2923,pharmacotherapeutic,Childhood Lung Non-Small Cell Carcinoma,0
2924,Chemotherapy Regimen,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2925,Affect (mental function),Tonsillar Carcinoma,0
2926,Mammal liver preparation,Liver Lymphangioma,0
2927,Monitor,Fibroadenoma of breast,0
2928,described,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
2929,Woman,Pancreatic carcinoma,0
2930,Family history,Childhood Anaplastic Large Cell Lymphoma,0
2931,Large,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
2932,Analysis of substances,Stage IV Colorectal Cancer AJCC v8,0
2933,Infective cystitis,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
2934,Activities,Benign Apocrine Neoplasm,0
2935,Occurrence Indicator,Mixed astrocytoma-ependymoma,0
2936,Formation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
2937,Treating,Childhood Lung Non-Small Cell Carcinoma,0
2938,Lymphoplasmacytoid Cell,Vaginal Adenoid Cystic Carcinoma,0
2939,30%,Nasal cavity carcinoma,0
2940,Type A,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
2941,radiotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2942,Pain,Recurrent Uveal Melanoma,0
2943,Chemotherapy Regimen,Refractory Bladder Carcinoma,0
2944,Generic Role,Adult Hepatocellular Carcinoma,0
2945,Present,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
2946,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,FIGO Stage IVA Ovarian Cancer,0
2947,shared attribute,Benign tumor of eyelid,0
2948,respiratory,Breast Ductal Adenoma,0
2949,A Codes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2950,risk factors - observation list,Basal Cell Ameloblastoma,0
2951,Glandular,Stage III Cutaneous Melanoma AJCC v6,0
2952,How Much Distress Vomiting,Intracortical osteosarcoma,0
2953,Aspects of signs,Methotrexate-Associated Hodgkin Lymphoma,0
2954,Usual,Malignant melanoma of eyelid,0
2955,Disease,Stage IB Lung Cancer AJCC v7,0
2956,Cell (compartment),Primary Cutaneous Plasmablastic Lymphoma,0
2957,Family history,Multiple Endocrine Neoplasia,0
2958,Gland,Extracranial Neuroblastoma,0
2959,Spreading (qualifier value),Diffuse malignant mesothelioma,0
2960,radiotherapeutic,Malignant melanoma of eyelid,0
2961,Abnormal cellular component of blood,Precursor B-lymphoblastic lymphoma stage II,0
2962,geographic population,Diffuse malignant mesothelioma,0
2963,Term (temporal),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2964,Benign,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
2965,Spreading (qualifier value),Xeroderma pigmentosum,0
2966,Skeletal bone,Cervical Fibroepithelial Polyp,0
2967,Infection,Adenocarcinoma of duodenum,0
2968,Frequently,Gallbladder Adenocarcinoma,0
2969,Negation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2970,Poor - grade value,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
2971,Overall,Adrenal Rest Tumor,0
2972,Abnormal,Childhood Lymphoma,0
2973,Carcinoma of lung,Kaposi's sarcoma of extrahepatic bile duct,0
2974,Females,Undifferentiated Endocervical Sarcoma,0
2975,Natural History,Mucinous cystadenofibroma,0
2976,Group Object,Splenic Manifestation of Hairy Cell Leukemia,0
2977,Rating (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
2978,Malignant neoplasm of salivary gland,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
2979,Percent (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
2980,Jaw,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
2981,Osteogenesis,Malignant melanoma of eyelid,0
2982,Adenomatous Polyposis Coli,Ichthyosis,0
2983,Discover,Mucinous neoplasm,0
2984,Official,Thyroid Hurthle Cell Carcinoma,0
2985,SERPINA3 protein,Childhood Lymphoma,0
2986,Fish Flavor,Kaposi's sarcoma of skin,0
2987,Balanced - adjective,Type II Endometrial Adenocarcinoma,0
2988,*Type - Kind of quantity,Carcinoma,0
2989,FAT1 wt Allele,Mucinous adenocarcinoma gastric,0
2990,Small,Hair nevus,0
2991,*Type - Kind of quantity,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
2992,Pressure- physical agent,Benign Anal Granular Cell Tumor,0
2993,Malignant Neoplasms,Engraftment syndrome,0
2994,Fetus,Cervical Squamous Intraepithelial Neoplasia,0
2995,Condition,Chest Wall Fibromatosis,0
2996,Human body structure,Contact dermatitis due to alkali,0
2997,35,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
2998,Similarity,Hodgkin lymphoma,0
2999,Inguinal region,Acute Undifferentiated Leukemia,0
3000,Known,Pancreatic Intraepithelial Neoplasia-3,0
3001,Experimental Result,Pancreatic carcinoma,0
3002,Decrease,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3003,Known,Mucinous adenocarcinoma gastric,0
3004,Tissue Specimen Code,Hereditary Diffuse Gastric Adenocarcinoma,0
3005,Diagnosis,Digestive System Hodgkin Lymphoma,0
3006,Usual,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3007,68,Nasal cavity carcinoma,0
3008,Probable diagnosis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3009,Immunotherapy,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3010,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Cancer of Urinary Tract,0
3011,Tumor Mass,Liver Cavernous Hemangioma,0
3012,Worse,Intraepithelial Melanocytic Hyperplasia,0
3013,GDF15 protein,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3014,Pharmacotherapy,Malignant melanoma of eyelid,0
3015,Two,Cerebral hemangioma,0
3016,Screening Study,Kaposi's sarcoma of skin,0
3017,High Mitosis-Karyorrhexis Index,non-Hodgkin's lymphoma of spleen,0
3018,Fragments,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3019,Act Class - investigation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3020,Nutrients,Thymic Clear Cell Carcinoma,0
3021,Account number:Identifier:Point in time:^Patient:Nominal,Hodgkin Disease,0
3022,Distant,Adult Acute Eosinophilic Leukemia,0
3023,Completely Able,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3024,Malignant neoplasm of urinary bladder,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3025,Tired,Mucinous adenocarcinoma gastric,0
3026,Historical aspects qualifier,Medulloblastoma,0
3027,Intention - mental process,Peripheral primitive neuroectodermal tumor of soft tissue,0
3028,Occurrence Indicator,Digestive System Hodgkin Lymphoma,0
3029,Similarity,Refractory Barrett Esophagus,0
3030,Lung,Undifferentiated Neuroblastoma,0
3031,CEL gene,Stage IB Pancreatic Cancer AJCC v8,0
3032,Logical Condition,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3033,How Often Weight Loss,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3034,Body part,Pilocytic astrocytoma of cerebellum,0
3035,centimeter,Kaposi's sarcoma of extrahepatic bile duct,0
3036,Icterus,Engraftment syndrome,0
3037,Growth,Xeroderma pigmentosum,0
3038,Shortened,Kaposi's sarcoma of extrahepatic bile duct,0
3039,Human body structure,Transitional cell carcinoma,0
3040,Neoplasms,Childhood Fibrillary Astrocytoma,0
3041,diagnosis aspect,FIGO Stage II Ovarian Cancer,0
3042,Different,Familial Hemophagocytic Lymphocytosis,0
3043,Financial Account,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3044,Spreading (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3045,Surface Antigens,Chronic Myelomonocytic Leukemia-2,0
3046,Surgical aspects,Uterine Cancer,0
3047,Weight Loss,Ichthyoses,0
3048,Plumbum metallicum,Mucinous adenocarcinoma gastric,0
3049,Unknown GENC,Type II Endometrial Adenocarcinoma,0
3050,Good,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3051,Cells,Breast Ductal Adenoma,0
3052,Glomeruloid hemangioma,Tonsillar Carcinoma,0
3053,Inhibition,Granular Cell Leiomyosarcoma,0
3054,Tumor Mass,Nasal cavity carcinoma,0
3055,Location,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3056,Third grade in elementary school,Peripheral primitive neuroectodermal tumor of soft tissue,0
3057,NCI CTEP SDC Melanoma Sub-Category Terminology,Childhood Choriocarcinoma,0
3058,Linear,adenosquamous carcinoma of breast,0
3059,Swelling,Recurrent Uveal Melanoma,0
3060,Biological Response Modifiers,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3061,ethnic european,Benign tumor of eyelid,0
3062,Slow,Benign Anal Granular Cell Tumor,0
3063,Often - answer to question,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3064,Common Specifications in HL7 V3 Publishing,Mucosal Melanoma,0
3065,CD5L wt Allele,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3066,Stop (qualifier value),Gallbladder Adenocarcinoma,0
3067,DNA,Refractory Ependymoma,0
3068,Term (lexical),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3069,X-linked inheritance,Bladder adenocarcinoma stage IV,0
3070,Maxilla,Vaginal Adenoid Cystic Carcinoma,0
3071,Frequently,Gallbladder Adenocarcinoma,0
3072,1+ Score,High Grade Glandular Intraepithelial Neoplasia,0
3073,Symptoms,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3074,% Ercs,Plexosarcoma,0
3075,Prognosis:Find:Pt:^Patient:Nom,Stage 0 Penile Cancer AJCC v8,0
3076,Estimated,Basal Cell Ameloblastoma,0
3077,include - SetOperator,Stage III Adult Immunoblastic Lymphoma,0
3078,include - SetOperator,Neoplasms,0
3079,Smear - instruction imperative,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3080,Inguinal region,Carcinomatosis of peritoneal cavity,0
3081,Infected,Childhood Thyroid Gland Follicular Carcinoma,0
3082,Person 1,Colorectal High Grade B-Cell Lymphoma,0
3083,Count of entities,Parathyroid Gland Adenocarcinoma,0
3084,Well,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3085,Squamous cell carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3086,Pharmacotherapy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3087,Residue on Aryepiglottic Folds Following Swallowing,Undifferentiated Endocervical Sarcoma,0
3088,Study,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3089,Name (property) (qualifier value),Recurrent Uveal Melanoma,0
3090,Neck,FIGO Stage IVA Ovarian Cancer,0
3091,peripheral blood,embryonal rhabdomyosarcoma of prostate,0
3092,Klinefelter Syndrome,Primary Cutaneous Plasmablastic Lymphoma,0
3093,Abnormally high,Occult Lung Adenosquamous Carcinoma,0
3094,PSA Level Greater than Fifty,Uterine Cancer,0
3095,Version,Digestive System Hodgkin Lymphoma,0
3096,Lip structure,Refractory Ependymoma,0
3097,Pain Distress Question,Hodgkin lymphoma,0
3098,Hospital specialist,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3099,Intraepithelial Neoplasia,Benign Apocrine Neoplasm,0
3100,Possible,Ovarian germ cell choriocarcinoma stage IV,0
3101,Togo,gliosarcoma,0
3102,Percent of Abnormal Cells,Unfavorable Non-Hodgkin Lymphoma,0
3103,Often - answer to question,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3104,Bloating,Anterior Urethral Malignant Neoplasm,0
3105,1+ Score,Anterior Urethral Malignant Neoplasm,0
3106,Pages,Platinum-Resistant Lung Small Cell Carcinoma,0
3107,Skin Pigmentation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3108,Limited stage (cancer stage),Malignant neoplasm of subglottis,0
3109,Age,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3110,Small,Kaposi's sarcoma of extrahepatic bile duct,0
3111,Offspring,non-Hodgkin's lymphoma of spleen,0
3112,Statistical Significance,Squamous cell carcinoma of lip,0
3113,Reporting,Malignant melanoma of eyelid,0
3114,Hormone replacement therapy,Lipoma of small intestine,0
3115,Time (foundation metadata concept),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3116,Manufactured form,Adult Hepatocellular Carcinoma,0
3117,Knee,Sarcomatoid Renal Cell Carcinoma,0
3118,Central Nervous System Neoplasms,Pancreatic Intraepithelial Neoplasia-3,0
3119,Hemorrhage,Carcinoma of urinary bladder,0
3120,Childhood Hodgkin Lymphoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3121,Malignant neoplasm of large intestine,Nasal cavity carcinoma,0
3122,Ethanol,Medulloblastoma,0
3123,Financial Account,Mixed astrocytoma-ependymoma,0
3124,Trial Subject Replacement,Kaposi's sarcoma of extrahepatic bile duct,0
3125,Structure of germinal center of lymph node,Malignant neoplasm of subglottis,0
3126,Ultraviolet Rays,Spindle Cell Melanoma,0
3127,Respiratory System Finding,Granular Cell Leiomyosarcoma,0
3128,Non-Metastatic Childhood Soft Tissue Sarcoma,Colorectal cancer,0
3129,X-Ray Computed Tomography,Undifferentiated Endocervical Sarcoma,0
3130,Tissue Growth,Stage II Carcinoma of Penis,0
3131,Adenocarcinoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3132,90 - 100%,Diffuse malignant mesothelioma,0
3133,64,Acute Undifferentiated Leukemia,0
3134,Immature,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3135,% bound (qualifier value),Stage 0 Penile Cancer AJCC v8,0
3136,CD69 protein,Heavy Chain Deposition Disease,0
3137,Known,Endometrial Small Cell Carcinoma,0
3138,High Level,Unicystic ameloblastoma,0
3139,10%,Clonal Hematopoiesis of Indeterminate Potential,0
3140,Normal function,Occult Lung Adenosquamous Carcinoma,0
3141,Biomaterial Treatment,Adult Anaplastic Oligodendroglioma,0
3142,Primary,embryonal rhabdomyosarcoma of prostate,0
3143,North America,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3144,Physical findings,Malignant melanoma of eyelid,0
3145,Age of Onset,Mucinous adenocarcinoma,0
3146,2+ Score,Malignant Testicular Sertoli Cell Tumor,0
3147,Cancer Genus,Clonal Hematopoiesis of Indeterminate Potential,0
3148,Abdominal Pain,Brain Ependymoma,0
3149,Adult Non-Hodgkin Lymphoma,Stage IB Lung Cancer AJCC v7,0
3150,Second Look Surgery,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3151,Uveal melanoma,Primary Cutaneous Plasmablastic Lymphoma,0
3152,Targeted Therapy,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
3153,Sensory (qualifier value),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
3154,capsule (pharmacologic),Mixed astrocytoma-ependymoma,0
3155,Bile Duct Diseases,Endometrial Small Cell Carcinoma,0
3156,Diagnostic Neoplasm Staging,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3157,Human body,Adult Acute Eosinophilic Leukemia,0
3158,pharmacotherapeutic,Splenic Manifestation of Hairy Cell Leukemia,0
3159,Omphalitis,Female Breast Carcinoma,0
3160,Stomach structure,Mixed astrocytoma-ependymoma,0
3161,Smear - instruction imperative,High Grade Glandular Intraepithelial Neoplasia,0
3162,Version,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3163,Squamous,Spongiotic dermatitis,0
3164,Eyelid structure,Multiple Skull Base Meningiomas,0
3165,Esophageal manometry,Digestive System Hodgkin Lymphoma,0
3166,Function (attribute),mucinous adenocarcinoma of gallbladder,0
3167,Most,Benign neoplasm of eye,0
3168,Diagnosis,malignant lymphoma of pancreatic lymph nodes,0
3169,Comparison,Malignant melanoma of eyelid,0
3170,protein body,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3171,Primary malignant neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3172,Survival Rate,Neoplasms,0
3173,Skin,Kaposi's sarcoma of skin,0
3174,Before values,Human Papillomavirus-Related Carcinoma,0
3175,Snake Bites,Locally Advanced Epithelioid Hemangioendothelioma,0
3176,Occur (action),Unicystic ameloblastoma,0
3177,Minor salivary gland structure,Uterine Cancer,0
3178,Childhood Non-Hodgkin Lymphoma,Recurrent Testicular Lymphoma,0
3179,Lymphoid,Extra-Adrenal Paraganglioma,0
3180,Body site,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
3181,Tissue Growth,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3182,Oral (intended site),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3183,Location,Liver Lymphangioma,0
3184,Death (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3185,Name,Neonatal leukemia,0
3186,United States,Benign Carotid Body Paraganglioma,0
3187,Indication of (contextual qualifier),Intestinal Metaplasia of Bladder Urothelium,0
3188,How Much Distress Weight Loss,Vaginal Adenoid Cystic Carcinoma,0
3189,Symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3190,interstitial,FIGO Stage IVA Ovarian Cancer,0
3191,Involvement with,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3192,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Tongue Alveolar Soft Part Sarcoma,0
3193,Geographic Locations,Metastatic Carcinoma in the Lung,0
3194,Malignant Head and Neck Neoplasm,Benign Anal Granular Cell Tumor,0
3195,Myeloid Leukemia,Endometrial Small Cell Carcinoma,0
3196,Formation,Secondary malignant neoplasm of lymph node,0
3197,Make - Instruction Imperative,Toxic Epidermal Necrolysis,0
3198,Morphology,clear cell adenocarcinoma of gallbladder,0
3199,Smear - instruction imperative,Liver Lymphangioma,0
3200,Distant,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3201,20%,Cartilaginous exostosis,0
3202,Medical Drop,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3203,Ulceration,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
3204,Line Specimen,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
3205,Abnormal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3206,Early,Hereditary Diffuse Gastric Adenocarcinoma,0
3207,Web Site,Malignant neoplasm of thalamus,0
3208,Belgium,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
3209,Goes <invertebrate>,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
3210,Further,Benign tumor of eyelid,0
3211,Publications,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3212,Case (situation),Gallbladder Adenocarcinoma,0
3213,Ultraviolet Light Sterilization,Mixed astrocytoma-ependymoma,0
3214,What subject filter - Result,Methotrexate-Associated Hodgkin Lymphoma,0
3215,Neck of organ,Stage IV Childhood Non-Hodgkin Lymphoma,0
3216,Healthy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
3217,Fever symptoms (finding),Fibroadenoma of breast,0
3218,Skin Specimen,Anterior Urethral Malignant Neoplasm,0
3219,Specimen Source Codes - Serum,Pancreatic Intraepithelial Neoplasia-3,0
3220,Stage Grouping,Cervical Fibroepithelial Polyp,0
3221,Manufactured sign,Low Grade Squamous Intraepithelial Neoplasia,0
3222,Human papillomavirus 11,Intraepithelial Melanocytic Hyperplasia,0
3223,Tumor Mass,Gallbladder Adenocarcinoma,0
3224,Chemotherapy,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3225,Local disease,Ichthyosis,0
3226,<3 (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3227,Study Site,Acute Undifferentiated Leukemia,0
3228,Overall Publication Type,High Grade Glandular Intraepithelial Neoplasia,0
3229,Urinary Bladder,Hyperplasia of pituitary gland,0
3230,Floor - story of building,Leiomyoma of Gallbladder,0
3231,Result,Non-Metastatic Gestational Trophoblastic Tumor,0
3232,dendritic spine neck,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
3233,Lymphoid Tissue,Anaplastic large cell lymphoma,0
3234,Symptoms,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3235,Name (property) (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
3236,Tests (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3237,Antibiotics,Stage IV Penile Cancer AJCC v7,0
3238,Macrophage Activation Syndrome,Spongiotic dermatitis,0
3239,Vasopressins,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3240,ovarian neoplasm,Stage IV Penile Cancer AJCC v7,0
3241,Surgical aspects,Testicular cancer metastatic,0
3242,Mutation,Unresectable Rhabdomyosarcoma,0
3243,Condition:Find:Pt:^Patient:Nom,Intestinal Neuroendocrine Carcinoma,0
3244,Better than Others,Malignant melanoma of eyelid,0
3245,Death NOS,Malignant Neoplasm with Regional Lymph Node Involvement,0
3246,Neonatal (qualifier value),Localized Askin Tumor,0
3247,Morphology,Rhabdomyosarcoma with ganglionic differentiation,0
3248,Metabolic Inhibition,Granular Cell Leiomyosarcoma,0
3249,Weight decreased,Extracranial Neuroblastoma,0
3250,Dependent for Toilet Use,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3251,Persons,mucinous adenocarcinoma of gallbladder,0
3252,Specimen Source Codes - tumor,Nasal cavity carcinoma,0
3253,Form:Finding:Point in time:{Setting}:Document:{Role},Epithelioid Sarcoma NCI Grade 3,0
3254,Initially,Fibroadenoma of breast,0
3255,Usually,Occult Lung Adenosquamous Carcinoma,0
3256,Adult human body,Adult Fibrolamellar Carcinoma,0
3257,Basis - conceptual entity,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
3258,Persons,Adenocarcinoma of the prostate metastatic,0
3259,Severe (severity modifier),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3260,Series - set of composite instances,Mixed astrocytoma-ependymoma,0
3261,Comparison,Childhood Thyroid Gland Follicular Carcinoma,0
3262,Patterns,Cancer of Urinary Tract,0
3263,Extravasation,Childhood Central Nervous System Ganglioneuroblastoma,0
3264,Loss,Malignant neoplasm of olfactory nerve,0
3265,Known,BRCA2 Syndrome,0
3266,Uterine Fibroids,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3267,Abnormal,Tubal Hyperplasia,0
3268,Transitional epithelium,Chronic Myelomonocytic Leukemia-2,0
3269,Poor function,Anterior Urethral Malignant Neoplasm,0
3270,Subtype (attribute),gliosarcoma,0
3271,Report (document),Mucinous adenocarcinoma gastric,0
3272,Then,Chest Wall Fibromatosis,0
3273,Neoplasm Metastasis,Platinum-Resistant Lung Small Cell Carcinoma,0
3274,Recommendation,Engraftment syndrome,0
3275,Screening procedure,Bladder squamous cell carcinoma stage I,0
3276,Aspects of signs,Digestive System Hodgkin Lymphoma,0
3277,Function (attribute),Refractory Glioma,0
3278,Imaging Techniques,Diffuse malignant mesothelioma,0
3279,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Astrocytoma of brain,0
3280,Condyloma,Peripheral primitive neuroectodermal tumor of soft tissue,0
3281,Confirmed by,Malignant neoplasm of subglottis,0
3282,Urothelium,Vaginal Adenoid Cystic Carcinoma,0
3283,Act Mood - intent,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3284,Ethanol,Thyroid Hurthle Cell Carcinoma,0
3285,800,Adult Alveolar Soft Part Sarcoma,0
3286,Symptoms aspect,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3287,Epithelial cell count (procedure),Metastatic Lung Small Cell Carcinoma,0
3288,Cerebral Cavernous Hemangioma,Malignant Neoplasm of Lung - Multiple Primary Sites,0
3289,Containing (qualifier),embryonal rhabdomyosarcoma of prostate,0
3290,To,Acute Undifferentiated Leukemia,0
3291,Histopathology,Metastatic Neoplasm to the Gallbladder,0
3292,Live - Specimen Condition,Stage III Cutaneous Melanoma AJCC v6,0
3293,Two,Localized Malignant Neoplasm,0
3294,Distant,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3295,Degree or extent,Splenic Manifestation of Hairy Cell Leukemia,0
3296,PREVENT (product),Intraepithelial Melanocytic Hyperplasia,0
3297,Effectiveness,Cervical Squamous Intraepithelial Neoplasia,0
3298,Microplate Well,Diffuse malignant mesothelioma,0
3299,Include (action),Microcystic meningioma,0
3300,Late,Stage 0 Lip Carcinoma,0
3301,Supportive assistance,Primary Cutaneous Plasmablastic Lymphoma,0
3302,Occurrence Indicator,Mucinous adenocarcinoma gastric,0
3303,Cancer Genus,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
3304,Decision,Digestive System Hodgkin Lymphoma,0
3305,treatment - ActInformationManagementReason,Ovarian germ cell choriocarcinoma stage IV,0
3306,Body part,Thymic Clear Cell Carcinoma,0
3307,Mature Teratoma,Bladder adenocarcinoma stage IV,0
3308,Africa,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3309,2000,Tonsillar Carcinoma,0
3310,Present,Non-Metastatic Gestational Trophoblastic Tumor,0
3311,Usual,Neonatal leukemia,0
3312,20%,Chest Wall Fibromatosis,0
3313,Continuance of life,Chest Wall Fibromatosis,0
3314,Retinoic Acid Response Element,Clonal Hematopoiesis of Indeterminate Potential,0
3315,Back,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
3316,Skin cell,Mucinous adenocarcinoma gastric,0
3317,DNA,Papillary squamous cell carcinoma,0
3318,Pale color,Ovarian Carcinoid Tumor,0
3319,Previously Treated Childhood Rhabdomyosarcoma,Methotrexate-Associated Hodgkin Lymphoma,0
3320,Example,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3321,Milk Specimen,squamous cell carcinoma of the thyroid gland,0
3322,Frequently,Vaginal Adenoid Cystic Carcinoma,0
3323,Usually Need Help from Another Person for Reach,Cartilaginous exostosis,0
3324,Smoking,Stage III Cutaneous Melanoma AJCC v6,0
3325,Tissue of urinary bladder,Neonatal leukemia,0
3326,Covers (device),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3327,CDH1 protein,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3328,Compleat Liquid Nutrition,Cerebral hemangioma,0
3329,Alcohol intake above recommended sensible limits,Melanomatosis,0
3330,Exposure to,Refractory Barrett Esophagus,0
3331,Child,Hemangioma,0
3332,Treatment Epoch,Endometrial Small Cell Carcinoma,0
3333,320,Xeroderma pigmentosum,0
3334,Testing,Malignant melanoma of eyelid,0
3335,SLC35G1 gene,Ovarian germ cell choriocarcinoma stage IV,0
3336,Receptors,Stage IB Pancreatic Cancer AJCC v8,0
3337,Lacrimal duct,Stage IB Pancreatic Cancer AJCC v8,0
3338,How Often Itching,Childhood Central Nervous System Ganglioneuroblastoma,0
3339,Deep Resection Margin,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3340,intramanchette transport,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3341,Affecting,adenoid cystic carcinoma of lung,0
3342,Usual,Benign Carotid Body Paraganglioma,0
3343,CEL gene,Kaposi's sarcoma of extrahepatic bile duct,0
3344,Females,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3345,Behaviorial Habits,Germinoma,0
3346,+5,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3347,ovarian neoplasm,Serous cystadenocarcinoma ovary,0
3348,Malignant neoplasm of pancreas,Thyroid Hurthle Cell Carcinoma,0
3349,Associated topography,Hyperplasia of pituitary gland,0
3350,Two,Squamous cell carcinoma of lip,0
3351,Cancer Genus,Benign Anal Granular Cell Tumor,0
3352,Include (action),Gallbladder Adenocarcinoma,0
3353,Skin,Stage 0 Penile Cancer AJCC v8,0
3354,Skin tanning,Stage IB Pancreatic Cancer AJCC v8,0
3355,Process of secretion,Malignant neoplasm of subglottis,0
3356,Decrease,High Grade Glandular Intraepithelial Neoplasia,0
3357,Account number:Identifier:Point in time:^Patient:Nominal,Primary Cutaneous Plasmablastic Lymphoma,0
3358,Area,Cervical Squamous Intraepithelial Neoplasia,0
3359,Chamber (physical object),Cancer of Urinary Tract,0
3360,Procedures involving the use of pharmaceuticals,Ichthyosis,0
3361,Parenchyma,High Grade Glandular Intraepithelial Neoplasia,0
3362,shared attribute,Endometrial Small Cell Carcinoma,0
3363,Receptors,Stage II Carcinoma of Penis,0
3364,Patient Condition Code - Stable,Kaposi's sarcoma of extrahepatic bile duct,0
3365,Palmitic Acid,Human Papillomavirus-Related Carcinoma,0
3366,Established,Cerebral Primitive Neuroectodermal Tumor,0
3367,Class (taxonomic),Cerebral Primitive Neuroectodermal Tumor,0
3368,Skin Specimen,Carcinoma ex pleomorphic adenoma of parotid gland,0
3369,ETS Translocation Variant 5,sarcoma of spinal cord,0
3370,Breast Carcinoma,Pancreatic carcinoma,0
3371,Uveal melanoma,Diffuse malignant mesothelioma,0
3372,Vaginal (intended site),Chondrosarcoma,0
3373,Have Pain,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3374,Local-Regional anatomy,Human Papillomavirus-Related Carcinoma,0
3375,Dangerousness,Pancreatic Intraepithelial Neoplasia-3,0
3376,contents - HtmlLinkType,FIGO Stage II Ovarian Cancer,0
3377,Including (qualifier),Primary Cutaneous Plasmablastic Lymphoma,0
3378,Age of onset of symptoms:Time:Pt:^Patient:Qn,Recurrent Testicular Lymphoma,0
3379,*Type - Kind of quantity,Familial Adenomatous Polyposis Associated Medulloblastoma,0
3380,Relative Survival,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3381,General surgery specialty,Malignant Testicular Sertoli Cell Tumor,0
3382,Most Recent,Malignant neoplasm of subglottis,0
3383,Genetic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3384,Human body structure,Malignant Testicular Sertoli Cell Tumor,0
3385,Hodgkin Disease,mucinous adenocarcinoma of gallbladder,0
3386,Present,Small cell neuroendocrine carcinoma of bladder,0
3387,Preventing (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
3388,Tired,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3389,Body part,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
3390,Sometimes,Low Grade Squamous Intraepithelial Neoplasia,0
3391,Area,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3392,Biomaterial Treatment,Recurrent Testicular Lymphoma,0
3393,Bands,Familial Hemophagocytic Lymphocytosis,0
3394,Platelet Glycoprotein 4,Mixed parotid tumor,0
3395,Manufactured form,Type II Endometrial Adenocarcinoma,0
3396,How Much Distress Vomiting,FIGO Stage IVA Ovarian Cancer,0
3397,Main,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3398,Lesion,Blood Vessel Tumors,0
3399,98,Lipoma of small intestine,0
3400,Bone Pain,Malignant Testicular Sertoli Cell Tumor,0
3401,Old,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3402,Large,Unicystic ameloblastoma,0
3403,Standard (qualifier),Undifferentiated Endocervical Sarcoma,0
3404,Acquired (qualifier value),Malignant Neoplasm of Lung - Multiple Primary Sites,0
3405,Occur (action),Engraftment syndrome,0
3406,Descent,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3407,2+,Mucosal Melanoma,0
3408,Progress,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3409,Known,FIGO Stage II Ovarian Cancer,0
3410,Vertebral column,Pilocytic astrocytoma of cerebellum,0
3411,Usually Need Help from Another Person for Eating,Angiosarcoma of liver,0
3412,Blood capillaries,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
3413,Local disease,Endometrial Small Cell Carcinoma,0
3414,Lichenification,Metastatic Neoplasm to the Gallbladder,0
3415,Cover - action,non-Hodgkin's lymphoma of spleen,0
3416,include - SetOperator,Chest Wall Fibromatosis,0
3417,2+ Score,Neoplasms,0
3418,anatomical layer,Stage 0 Penile Cancer AJCC v8,0
3419,Medical Device Emits Smoke,Nasal cavity carcinoma,0
3420,Disease Management,Giant cell angiofibroma,0
3421,Rare,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3422,Cardiac Lead Procedure,Stage IB Pancreatic Cancer AJCC v8,0
3423,Decision,Platinum-Resistant Lung Small Cell Carcinoma,0
3424,Headache,Xeroderma pigmentosum,0
3425,Lesion,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3426,Carcinogenesis,Benign Anal Granular Cell Tumor,0
3427,Occur (action),Secondary malignant neoplasm of lymph node,0
3428,Most,Pancreatic Intraepithelial Neoplasia-3,0
3429,Malignant neoplasm of soft tissue,Metastatic Malignant Neoplasm in the Sellar Region,0
3430,High Level,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3431,T prime,Intestinal Metaplasia of Bladder Urothelium,0
3432,Cell Count,Intestinal Metaplasia of Bladder Urothelium,0
3433,Pelvis+,Malignant melanoma of eyelid,0
3434,Standard (document),Cervical Squamous Intraepithelial Neoplasia,0
3435,Formation,Angiosarcoma of liver,0
3436,Positive,BRCA2 Syndrome,0
3437,CDISC SEND Tumor Findings Results Terminology,Epithelioid Sarcoma NCI Grade 3,0
3438,low confidentiality,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3439,Sharing (Social Behavior),FIGO Stage IVA Ovarian Cancer,0
3440,Specimen Source Codes - tumor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3441,Biopsy,Cervical Squamous Intraepithelial Neoplasia,0
3442,Publications,Hodgkin lymphoma,0
3443,Decision,Acute Undifferentiated Leukemia,0
3444,biopsy characteristics,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3445,Biomaterial Treatment,mucinous adenocarcinoma of gallbladder,0
3446,Negation,Angiosarcoma of liver,0
3447,Intermediate Mitosis-Karyorrhexis Index,Splenic Manifestation of Hairy Cell Leukemia,0
3448,Decision,Cartilaginous exostosis,0
3449,Five,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3450,High Grade Cervical Squamous Intraepithelial Neoplasia,Platinum-Resistant Lung Small Cell Carcinoma,0
3451,United States,Cystadenocarcinoma,0
3452,Root Mean Square,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3453,day,Spindle Cell Melanoma,0
3454,Formation,Extracranial Neuroblastoma,0
3455,Infrequent,Angiosarcoma of liver,0
3456,World Health Organization,Diffuse malignant mesothelioma,0
3457,Togo,Locally Advanced Epithelioid Hemangioendothelioma,0
3458,Five,Primary Cutaneous Plasmablastic Lymphoma,0
3459,Experimental Result,Breast Ductal Adenoma,0
3460,Dilate procedure,Acute Undifferentiated Leukemia,0
3461,Primary operation,Engraftment syndrome,0
3462,Overall Survival,Neonatal leukemia,0
3463,analysis aspect,FIGO Stage II Ovarian Cancer,0
3464,Abdominal bloating,Peripheral primitive neuroectodermal tumor of soft tissue,0
3465,low,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3466,Overall,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3467,3+ Score,Bladder adenocarcinoma stage IV,0
3468,Type A,Kaposi's sarcoma of extrahepatic bile duct,0
3469,Immune System Finding,Cerebral Primitive Neuroectodermal Tumor,0
3470,Line Specimen,Methotrexate-Associated Hodgkin Lymphoma,0
3471,Investigative Subject,Cancer of Urinary Tract,0
3472,Coding,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3473,Cells,adenoid cystic carcinoma of lung,0
3474,Screening Study,Chondrosarcoma,0
3475,Common (qualifier value),Angiosarcoma of liver,0
3476,Carcinoma of lung,mucinous adenocarcinoma of gallbladder,0
3477,Sexually Transmitted Diseases,Papillary squamous cell carcinoma,0
3478,eTMF Content Model Code,Cerebral hemangioma,0
3479,How Much Distress Weight Loss,Stage IV Colorectal Cancer AJCC v8,0
3480,Biomaterial Treatment,embryonal rhabdomyosarcoma of prostate,0
3481,Individual,Fibroadenoma of breast,0
3482,Effectiveness,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3483,Hepatitis B,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3484,Stop (qualifier value),Metastatic Malignant Neoplasm in the Sellar Region,0
3485,Biopsy,Chronic Myelomonocytic Leukemia-2,0
3486,Smaller,Hemangioma,0
3487,Ovary,FIGO Stage II Ovarian Cancer,0
3488,Muscle of orbit,Grade 3a Malignant Neoplasm,0
3489,Tumor Mass,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3490,Analysis of substances,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3491,Common (qualifier value),Mucinous adenocarcinoma gastric,0
3492,Male population group,Hodgkin Disease,0
3493,Deglutition Disorders,Stage III Cutaneous Melanoma AJCC v6,0
3494,Keloid,Tubal Hyperplasia,0
3495,include - SetOperator,Cervical Fibroepithelial Polyp,0
3496,Lymphoid leukemia,Liver Cavernous Hemangioma,0
3497,Known,Malignant neoplasm of gallbladder,0
3498,Unknown GENC,Acantholytic squamous cell carcinoma,0
3499,Location of Pharyngeal Residue Following Swallowing,Bladder adenocarcinoma stage IV,0
3500,Symptoms aspect,Carcinoma ex pleomorphic adenoma of parotid gland,0
3501,Intervention regimes,Acantholytic squamous cell carcinoma,0
3502,Relationships,Giant cell angiofibroma,0
3503,Along edge (qualifier value),Heavy Chain Deposition Disease,0
3504,Type - attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3505,Subject Risk,Childhood Thyroid Gland Follicular Carcinoma,0
3506,Most,Maxillary Sinus Adenocarcinoma,0
3507,Pain,Liver Lymphangioma,0
3508,Four,Gallbladder Adenocarcinoma,0
3509,Primary,Low Grade Squamous Intraepithelial Neoplasia,0
3510,Value Above Reference Range,Engraftment syndrome,0
3511,Liver,Angiosarcoma of liver,0
3512,Presentation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3513,Premalignant,Benign neoplasm of eye,0
3514,Anterior nares,Stage II Carcinoma of Penis,0
3515,metaplastic cell transformation,FIGO Stage IVA Ovarian Cancer,0
3516,Use - dosing instruction imperative,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3517,3+ Score,Acantholytic squamous cell carcinoma,0
3518,Reduction procedure,Carcinoma of urinary bladder,0
3519,Classification,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
3520,Name,Refractory Ependymoma,0
3521,American College of Cardiology/American Heart Association Lesion Complexity Score C,Benign Anal Granular Cell Tumor,0
3522,Sweat,Colorectal cancer,0
3523,Greater,sarcoma of spinal cord,0
3524,Always (frequency),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3525,Show,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3526,Digestive Enzymes,Giant cell angiofibroma,0
3527,Human Cells,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3528,Prostate,Larynx carcinoma recurrent,0
3529,Refractory Cytopenia of Childhood,Chondrosarcoma,0
3530,Specific qualifier value,Kaposi's sarcoma of extrahepatic bile duct,0
3531,Skin,Chronic Myelomonocytic Leukemia-2,0
3532,Gastrointestinal tract structure,Adult Alveolar Soft Part Sarcoma,0
3533,How Often Vomiting,Diffuse malignant mesothelioma,0
3534,Node - plant part,Acute lymphadenitis,0
3535,Malignant - descriptor,Microcystic meningioma,0
3536,Chemotherapy,Cerebral Primitive Neuroectodermal Tumor,0
3537,Body surface,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3538,Formations,malignant lymphoma of pancreatic lymph nodes,0
3539,Universal,Diffuse malignant mesothelioma,0
3540,Associated with,Carcinoma of urinary bladder,0
3541,THM gene,Melanomatosis,0
3542,Embryonic Development,Benign Anal Granular Cell Tumor,0
3543,Cancer Registry,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3544,Progress,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3545,Repeat Surgery,Thymic Clear Cell Carcinoma,0
3546,Bayer Visual Acuity Changes Grade 3,Mucinous adenocarcinoma gastric,0
3547,Division (action),Anterior Urethral Malignant Neoplasm,0
3548,First (number),Refractory Barrett Esophagus,0
3549,High,Heavy Chain Deposition Disease,0
3550,Pediatric Neoplasm,Stage IB Pancreatic Cancer AJCC v8,0
3551,Erythropoiesis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3552,Endocrine Gland Neoplasms,Malignant neoplasm of thalamus,0
3553,Neoplasms,Adult Acute Eosinophilic Leukemia,0
3554,Response (statement),Botryoid-Type Embryonal Rhabdomyosarcoma,0
3555,Diagnosis Study,Childhood Lymphoma,0
3556,shared attribute,FIGO Stage IVA Ovarian Cancer,0
3557,seen,Primary Cutaneous Plasmablastic Lymphoma,0
3558,Brain Neoplasms,Neonatal leukemia,0
3559,preference,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3560,Tissue Donors,Maxillary Sinus Adenocarcinoma,0
3561,Beginning,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
3562,Supratentorial Embryonal Tumor,Heavy Chain Deposition Disease,0
3563,Participation Type - origin,Vaginal Adenoma,0
3564,What subject filter - Result,Mucinous adenocarcinoma,0
3565,Source,Stage IB Pancreatic Cancer AJCC v8,0
3566,pharmacotherapeutic,Adenocarcinoma,0
3567,Large,Squamous cell carcinoma of lip,0
3568,Frequently,Malignant Neoplasm with Regional Lymph Node Involvement,0
3569,Determined by,Placental aromatase deficiency,0
3570,Occur (action),Mucinous adenocarcinoma gastric,0
3571,Infrequent,clear cell adenocarcinoma of gallbladder,0
3572,Genetic syndrome,Unfavorable Non-Hodgkin Lymphoma,0
3573,Brain Neoplasms,Unresectable Rhabdomyosarcoma,0
3574,Chemotherapy Regimen,Intestinal Metaplasia of Bladder Urothelium,0
3575,Adjacent,Astrocytoma of brain,0
3576,Occurrence Indicator,Diffuse malignant mesothelioma,0
3577,Neoadjuvant Therapy,Benign tumor of eyelid,0
3578,Several,Benign squamous cell tumor,0
3579,Term Birth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3580,Specimen Source Codes - Tube,Squamous cell carcinoma of lip,0
3581,Tryptophanase,Mucinous adenocarcinoma gastric,0
3582,Cessation of life,Recurrent Rhabdomyosarcoma,0
3583,Capsule Dosing Unit,squamous cell carcinoma of the thyroid gland,0
3584,Manufactured sign,Testicular cancer metastatic,0
3585,Used by,Stage III Cutaneous Melanoma AJCC v6,0
3586,Malignant neoplasm of salivary gland,Acantholytic squamous cell carcinoma,0
3587,Occurrence,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
3588,United States Food and Drug Administration,Astrocytoma of brain,0
3589,Aim (idea),Primary Cutaneous Plasmablastic Lymphoma,0
3590,Mass,Benign Anal Granular Cell Tumor,0
3591,Occurrence Indicator,Benign Anal Granular Cell Tumor,0
3592,Tumor cells,Childhood Central Nervous System Ganglioneuroblastoma,0
3593,Patient need for (contextual qualifier),Adenocarcinoma,0
3594,Three,Chronic Myelomonocytic Leukemia-2,0
3595,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3596,Usual Severity Vomiting,Diffuse malignant mesothelioma,0
3597,Blood Cells,Metaplastic carcinoma of breast,0
3598,Occurrence,Colorectal Neuroendocrine Tumor G2,0
3599,Spreading (qualifier value),Adenocarcinoma,0
3600,Blood Vessel,Multiple Skull Base Meningiomas,0
3601,Beginning,Intestinal Neuroendocrine Carcinoma,0
3602,Qualitative form,Adenocarcinoma of duodenum,0
3603,Thyroid Gland Tissue,Primary Cutaneous Plasmablastic Lymphoma,0
3604,Females,Malignant melanoma of eyelid,0
3605,Function (attribute),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
3606,Filters,Recurrent Uveal Melanoma,0
3607,Science of Etiology,Ovarian germ cell choriocarcinoma stage IV,0
3608,Result,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3609,Persistent,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3610,Open,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3611,week,Extra-abdominal fibromatosis,0
3612,Circulatory System Process,Splenic Manifestation of Hairy Cell Leukemia,0
3613,Entity Determiner - specific,Benign neoplasm of thorax,0
3614,Malignant Head and Neck Neoplasm,Noninfiltrating Intraductal Carcinoma,0
3615,Surgical service,Nasal cavity carcinoma,0
3616,therapeutic aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3617,Risk,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3618,Categories,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3619,Including (qualifier),Vaginal Adenoma,0
3620,Pancreas,Tonsillar Carcinoma,0
3621,Abdominal mass,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
3622,United States,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3623,Name (property) (qualifier value),Endometrial Small Cell Carcinoma,0
3624,Formation,Malignant neoplasm of subglottis,0
3625,Sounds device,Epithelioid Sarcoma NCI Grade 3,0
3626,Superkingdom (taxonomic category),Stage III Cutaneous Melanoma AJCC v6,0
3627,Main,Childhood Central Nervous System Ganglioneuroblastoma,0
3628,+5,Childhood Lung Non-Small Cell Carcinoma,0
3629,Tissue Specimen Code,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
3630,pemetrexed,FIGO Stage II Ovarian Cancer,0
3631,Possibly Related to Intervention,Childhood Extragonadal Malignant Germ Cell Tumor,0
3632,Malignant neoplasm of skin,Mixed astrocytoma-ependymoma,0
3633,Childhood Non-Hodgkin Lymphoma,Stage I Colon Neuroendocrine Tumor AJCC v8,0
3634,Metastatic Neoplasm,Kaposi's sarcoma of skin,0
3635,Formation,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
3636,Occurrence Indicator,Stage IB Pancreatic Cancer AJCC v8,0
3637,Usual,Kaposi's sarcoma of skin,0
3638,Mathematical Factor,mucinous adenocarcinoma of gallbladder,0
3639,Two,Kaposi's sarcoma of skin,0
3640,Autosomal Recessive Disorder,Breast Ductal Adenoma,0
3641,Expression procedure,Neonatal leukemia,0
3642,65+,Unicystic ameloblastoma,0
3643,Neoplasm Metastasis,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3644,Biological Markers,Benign tumor of eyelid,0
3645,Urinary Diversion,Malignant neoplasm of olfactory nerve,0
3646,How Often Itching,Lung Mucinous Cystadenoma,0
3647,Term (lexical),Fibroadenoma of breast,0
3648,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Refractory Bladder Carcinoma,0
3649,Five-year Survival Rate,Locally Advanced Soft Tissue Sarcoma,0
3650,Patient Visit,Recurrent Rhabdomyosarcoma,0
3651,Flushing,Acute Undifferentiated Leukemia,0
3652,Sweating,ROSE Cluster 3,0
3653,Diagnosis,Stage III Adult Immunoblastic Lymphoma,0
3654,Non-Metastatic Childhood Soft Tissue Sarcoma,Stage IB Pancreatic Cancer AJCC v8,0
3655,History of present illness,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3656,Cancer Genus,Digestive System Hodgkin Lymphoma,0
3657,Disease,Adenocarcinoma of the prostate metastatic,0
3658,Color change,Type II Endometrial Adenocarcinoma,0
3659,chance,Carcinomatosis of peritoneal cavity,0
3660,Frequently,Breast Ductal Adenoma,0
3661,Natural History,Squamous cell carcinoma of lip,0
3662,pharmacotherapeutic,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3663,Surface of cervix,Engraftment syndrome,0
3664,Post,Vaginal Adenoid Cystic Carcinoma,0
3665,Root Mean Square,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3666,Japanese race,Cerebral Primitive Neuroectodermal Tumor,0
3667,Appearance,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
3668,filter information process,Parathyroid Gland Adenocarcinoma,0
3669,Does move,Astrocytoma of brain,0
3670,Hodgkin Disease,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3671,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3672,Tryptophanase,adenoid cystic carcinoma of lung,0
3673,Synonym,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3674,Upper,Human Papillomavirus-Related Carcinoma,0
3675,majority,Adenocarcinoma of the prostate metastatic,0
3676,Juvenile,Pancreatic carcinoma,0
3677,Half,Mucinous adenocarcinoma gastric,0
3678,Have Weight Loss,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
3679,Risk,Transitional cell carcinoma,0
3680,cell growth,Unresectable Rhabdomyosarcoma,0
3681,General surgery specialty,Cervical Fibroepithelial Polyp,0
3682,Lymphoma,Childhood Thyroid Gland Follicular Carcinoma,0
3683,Receive,FIGO Stage II Ovarian Cancer,0
3684,Regulatory Application,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
3685,Occurrence,Melanomatosis,0
3686,Aplasia Cutis Congenita,Vaginal Adenoid Cystic Carcinoma,0
3687,Present,Squamous cell carcinoma of lip,0
3688,Therapeutic radiology procedure,Childhood Extragonadal Malignant Germ Cell Tumor,0
3689,High,Childhood Anaplastic Large Cell Lymphoma,0
3690,Return to (contextual qualifier) (qualifier value),Platinum-Resistant Lung Small Cell Carcinoma,0
3691,Shapes,Benign squamous cell tumor,0
3692,Following,Localized Askin Tumor,0
3693,Treatment Epoch,Carcinoma of urinary bladder,0
3694,Reflex action,Papillary squamous cell carcinoma,0
3695,Did not receive therapy or drug for,Mucinous adenocarcinoma,0
3696,Symptoms,Adult Alveolar Soft Part Sarcoma,0
3697,New,Stage III Cutaneous Melanoma AJCC v6,0
3698,SPINK5 gene,Malignant melanoma of eyelid,0
3699,Occurrence Indicator,Cervical Fibroepithelial Polyp,0
3700,Neurilemmoma,Extracranial Neuroblastoma,0
3701,Sunscreening Agents,Stage III Adult Immunoblastic Lymphoma,0
3702,Nevus,Malignant neoplasm of subglottis,0
3703,rapid diagnosis,Small cell neuroendocrine carcinoma of bladder,0
3704,+2,Carcinoma ex pleomorphic adenoma of parotid gland,0
3705,+2,Acantholytic squamous cell carcinoma,0
3706,Oral,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
3707,More,Malignant neoplasm of subglottis,0
3708,Study Variable,Mucosal Melanoma,0
3709,biopsy characteristics,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
3710,Lung,Metastatic Lung Small Cell Carcinoma,0
3711,Disease,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3712,What subject filter - Result,embryonal rhabdomyosarcoma of prostate,0
3713,Testis,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
3714,Common Specifications in HL7 V3 Publishing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3715,Significant,Nasal cavity carcinoma,0
3716,Supportive assistance,sarcoma of spinal cord,0
3717,Including (qualifier),Blepharal carcinoma,0
3718,Swallowing G-code,Lipoma of small intestine,0
3719,Circular,FIGO Stage II Ovarian Cancer,0
3720,Often - answer to question,Mastocytosis,0
3721,Aspects of congenital malformations,Localized Malignant Neoplasm,0
3722,Fall,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3723,Appearance,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3724,Compression,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
3725,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,Neoplasms,0
3726,cell type,Maxillary Sinus Adenoid Cystic Carcinoma,0
3727,Established,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3728,medication - HL7 publishing domain,Gallbladder adenoma,0
3729,Epithelial Cells,Pancreatic Intraepithelial Neoplasia-3,0
3730,Throat,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
3731,stage,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
3732,Varies,Intraepithelial Melanocytic Hyperplasia,0
3733,include - SetOperator,Primary Cutaneous Plasmablastic Lymphoma,0
3734,Decision,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
3735,photoreactivating enzyme activity,Metastatic Kidney Carcinoma,0
3736,Death (finding),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3737,Negation,Adult Hepatocellular Carcinoma,0
3738,Sequence Data Type,Pancreatic carcinoma,0
3739,Body part,Precursor B-lymphoblastic lymphoma stage II,0
3740,Most,Vaginal Adenoma,0
3741,Type - attribute,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3742,Neoplasms,Liver Lymphangioma,0
3743,Singular,Carcinomatosis of peritoneal cavity,0
3744,Times,Cervical Squamous Intraepithelial Neoplasia,0
3745,Physical findings,Kaposi's sarcoma of extrahepatic bile duct,0
3746,Sample Mean,Recurrent Rhabdomyosarcoma,0
3747,<90,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3748,Contrast,Papillary cystic tumor,0
3749,risk factors,Splenic Manifestation of Hairy Cell Leukemia,0
3750,Singular,Microcystic meningioma,0
3751,Show,Digestive System Hodgkin Lymphoma,0
3752,Lung,Engraftment syndrome,0
3753,shared attribute,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3754,International Classification of Disease for Oncology,Extracranial Neuroblastoma,0
3755,health and disease,papillary carcinoma of penis,0
3756,Metastatic Disease Clinical Trial Setting,Localized Malignant Neoplasm,0
3757,Filters,Thyroid Hurthle Cell Carcinoma,0
3758,NCI CTEP SDC Myeloma Sub-Category Terminology,Stage IB Pancreatic Cancer AJCC v8,0
3759,Subject Risk,Locally Advanced Carcinoma,0
3760,Category Type,Low Grade Squamous Intraepithelial Neoplasia,0
3761,Nuclear (incident type),Recurrent Uveal Melanoma,0
3762,Two,Thyroid Hurthle Cell Carcinoma,0
3763,Tissue Growth,Melanomatosis,0
3764,control substance,High Grade Glandular Intraepithelial Neoplasia,0
3765,<50,Ampulla of Vater Tubular Adenoma,0
3766,Stem of plant,Heavy Chain Deposition Disease,0
3767,Grade IV Childhood Astrocytic Neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3768,Aspects of signs,embryonal rhabdomyosarcoma of prostate,0
3769,Solid,Pancreatic carcinoma,0
3770,*Type - Kind of quantity,Refractory Ependymoma,0
3771,Fallopian Tubes,Anaplastic large cell lymphoma,0
3772,Carcinoma of lung,Spongiotic dermatitis,0
3773,Lung,Trichilemmocarcinoma,0
3774,Make - Instruction Imperative,Locally Advanced Squamous Cell Carcinoma,0
3775,Factor,Pancreatic carcinoma,0
3776,Characteristics,Cervical Fibroepithelial Polyp,0
3777,therapeutic aspects,Adult Hepatocellular Carcinoma,0
3778,How Often Sweats,embryonal rhabdomyosarcoma of prostate,0
3779,Encounter due to family history of leukemia,Granular Cell Leiomyosarcoma,0
3780,Observation in research,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3781,alone - group size,Splenic Manifestation of Hairy Cell Leukemia,0
3782,Removed,Congenital hamartoma,0
3783,kill - ActRelationshipJoin,Benign Anal Granular Cell Tumor,0
3784,Term Birth,papillary carcinoma of penis,0
3785,Pallor,Melanomatosis,0
3786,Body structure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3787,Human body,Carcinoma of urinary bladder,0
3788,Communicable Diseases,Hereditary Diffuse Gastric Adenocarcinoma,0
3789,Type A,Placental aromatase deficiency,0
3790,Obesity,benign mature teratoma of pancreas,0
3791,depend,Locally Advanced Soft Tissue Sarcoma,0
3792,Asia,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
3793,year,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
3794,Pelvic Pain,Carcinomatosis of peritoneal cavity,0
3795,Therapeutic procedure,BRCA2 Syndrome,0
3796,PROC wt Allele,Intraepithelial Melanocytic Hyperplasia,0
3797,Abdomen+,Kaposi's sarcoma of extrahepatic bile duct,0
3798,Often - answer to question,BRCA2 Syndrome,0
3799,100%,Human Papillomavirus-Related Carcinoma,0
3800,Surgery specialty,Refractory Barrett Esophagus,0
3801,Malignant neoplasm of soft tissue,Unresectable Rhabdomyosarcoma,0
3802,risk factors - observation list,Adult Hepatocellular Carcinoma,0
3803,year,Childhood Central Nervous System Ganglioneuroblastoma,0
3804,Rate,Stage IB Pancreatic Cancer AJCC v8,0
3805,vinyl chloride,Precursor B-lymphoblastic lymphoma stage II,0
3806,Togo,Epithelioid Sarcoma NCI Grade 3,0
3807,95,Endometrial Small Cell Carcinoma,0
3808,Pharmacotherapy,Malignant neoplasm of gallbladder,0
3809,Genes,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3810,Structure of venule,Recurrent Testicular Lymphoma,0
3811,pharmacotherapeutic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3812,Common (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
3813,Cachexia,Adult Hepatocellular Carcinoma,0
3814,Before,Unicystic ameloblastoma,0
3815,Adult Lymphoma,Kaposi's sarcoma of extrahepatic bile duct,0
3816,negative regulation of biological process,Diffuse malignant mesothelioma,0
3817,0%,Papillary squamous cell carcinoma,0
3818,World Health Organization,Chronic Myelomonocytic Leukemia-2,0
3819,Age at diagnosis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3820,Brain,Endometrial Small Cell Carcinoma,0
3821,Behavior,Malignant Testicular Sertoli Cell Tumor,0
3822,Reported Term,Metastatic Malignant Neoplasm in the Sellar Region,0
3823,Target Lesion Identification,Heavy Chain Deposition Disease,0
3824,Death (finding),Vaginal Adenoma,0
3825,Glandular Pattern,Adult Alveolar Soft Part Sarcoma,0
3826,Fish (substance),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3827,Occur (action),Metastatic Carcinoma in the Lung,0
3828,Medical Device Emits Smoke,Hodgkin Disease,0
3829,Dry skin,Childhood Lung Non-Small Cell Carcinoma,0
3830,Scaly skin,Carcinoma of urinary bladder,0
3831,In Blood,Splenic Manifestation of Hairy Cell Leukemia,0
3832,Medications,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3833,Occur (action),Small Intestinal Villous Adenoma,0
3834,Pharmacotherapy,mucinous adenocarcinoma of gallbladder,0
3835,Time,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
3836,combination - answer to question,Leiomyoma of Gallbladder,0
3837,Contiguous gene syndrome,Unfavorable Non-Hodgkin Lymphoma,0
3838,Diagnosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3839,Bodily secretions,Choroid Necrotic Melanoma,0
3840,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
3841,50%,Squamous cell carcinoma of lip,0
3842,Gene Mutation,Blepharal carcinoma,0
3843,Abnormally high,Testicular cancer metastatic,0
3844,Common Specifications in HL7 V3 Publishing,Localized Askin Tumor,0
3845,Microscopic,Cancer of Urinary Tract,0
3846,Classification,Benign neoplasm of thorax,0
3847,Surgical reduction,Ovarian Dermoid Cyst with Secondary Carcinoma,0
3848,Stem cell transplant,Mucinous adenocarcinoma gastric,0
3849,Intravascular line,Mixed astrocytoma-ependymoma,0
3850,Hematopoietic stem cells,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3851,risk factors,Refractory Ependymoma,0
3852,Lymphatic duct,Female Breast Carcinoma,0
3853,Symptoms aspect,Localized Ewing Sarcoma,0
3854,Etiology,Childhood Fibrillary Astrocytoma,0
3855,Cartilage,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
3856,Immune System Finding,Vaginal Adenoid Cystic Carcinoma,0
3857,MOSTLY,Metaplastic carcinoma of breast,0
3858,1960s,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3859,Manufactured form,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3860,Statistical Frequency,Angiosarcoma of liver,0
3861,Hypertensive disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3862,Biomaterial Treatment,Low Grade Squamous Intraepithelial Neoplasia,0
3863,Pharmacologic Substance,Microcystic meningioma,0
3864,Vision,Undifferentiated Endocervical Sarcoma,0
3865,Morphology,mucinous adenocarcinoma of gallbladder,0
3866,Cancer Genus,Melanomatosis,0
3867,Genetic Marker Expression,Mixed astrocytoma-ependymoma,0
3868,Adult Children,Malignant melanoma of eyelid,0
3869,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
3870,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Pancreatic carcinoma,0
3871,Participation Type - origin,Grade 3a Malignant Neoplasm,0
3872,Americas Ethnicity,Adult Hepatocellular Carcinoma,0
3873,Offspring,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
3874,Poor function,Recurrent Uveal Melanoma,0
3875,World Health Organization,Leiomyoma of Gallbladder,0
3876,One,FIGO Stage II Ovarian Cancer,0
3877,Persons,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3878,Risk,Lung squamous cell carcinoma stage I,0
3879,Interleukins,Mucinous neoplasm,0
3880,Colorectal Cancer,Xeroderma pigmentosum,0
3881,depend,Mucinous adenocarcinoma gastric,0
3882,Immunocompromised Host,Stage IB Pancreatic Cancer AJCC v8,0
3883,Hyperplastic Polyp,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
3884,Additional,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
3885,Specialized cell structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
3886,Derived value,Mucinous adenocarcinoma gastric,0
3887,various other agents for local oral treatment in ATC,Recurrent Testicular Lymphoma,0
3888,Formation,Cervical Squamous Intraepithelial Neoplasia,0
3889,Ulcer,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3890,Time,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3891,CDISC SDTM Disease Outcome Terminology,Placental aromatase deficiency,0
3892,cancer-predisposing genes,Advanced Lung Carcinoma,0
3893,Scientific Publication,Localized Askin Tumor,0
3894,Pruritus,Small Intestinal Villous Adenoma,0
3895,Cause of death.underlying,Maxillary Sinus Adenocarcinoma,0
3896,Aspects of signs,Thymic Atypical Carcinoid Tumor,0
3897,Antibiotics,Stage IV Colorectal Cancer AJCC v8,0
3898,The Sun,Low Grade Squamous Intraepithelial Neoplasia,0
3899,Smoking,Acute lymphadenitis,0
3900,WHO Central Nervous System Grade II,Giant cell angiofibroma,0
3901,polyps,Diffuse malignant mesothelioma,0
3902,Occurrence,Stage IV Childhood Non-Hodgkin Lymphoma,0
3903,Hormone replacement therapy,Stage III Cutaneous Melanoma AJCC v6,0
3904,Group A (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
3905,Term (lexical),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
3906,Body structure,Atypical Lobular Breast Hyperplasia,0
3907,Cystitis,Carcinomatosis of peritoneal cavity,0
3908,Ultraviolet Light Sterilization,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3909,chronic,Thyroid Hurthle Cell Carcinoma,0
3910,65+,FIGO Stage II Ovarian Cancer,0
3911,Immunotherapy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3912,photoreactivating enzyme activity,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3913,Surgery specialty,Squamous cell carcinoma of lip,0
3914,Referring,adenoid cystic carcinoma of lung,0
3915,Male population group,mucinous adenocarcinoma of gallbladder,0
3916,Treating,Pleomorphic adenoma of parotid gland,0
3917,More,Acute Undifferentiated Leukemia,0
3918,Slow,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
3919,Html Link Type - index,Stage IB Pancreatic Cancer AJCC v8,0
3920,Often - answer to question,Vaginal Adenoma,0
3921,3+ Score,Kaposi's sarcoma of skin,0
3922,Type - attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3923,Blue - answer to question,Cerebral Primitive Neuroectodermal Tumor,0
3924,Neoplasms,Splenic Manifestation of Hairy Cell Leukemia,0
3925,Highest,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
3926,Fever,Childhood Fibrillary Astrocytoma,0
3927,>5,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
3928,Feel Tired question,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3929,Togo,Xeroderma pigmentosum,0
3930,Metastatic Disease Clinical Trial Setting,Squamous cell carcinoma of lip,0
3931,The Sun,Acute Undifferentiated Leukemia,0
3932,Very Much,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
3933,prior radiation therapy,BRCA2 Syndrome,0
3934,Methods aspects,Glomeruloid hemangioma,0
3935,Surgical aspects,Malignant Testicular Sertoli Cell Tumor,0
3936,Diagnosis Study,Precursor B-lymphoblastic lymphoma stage II,0
3937,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Locally Advanced Squamous Cell Carcinoma,0
3938,Neoplasms,Brain Tumor,0
3939,Diagnosis Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
3940,Thin (qualifier value),Malignant melanoma of eyelid,0
3941,Term (lexical),Localized Askin Tumor,0
3942,>90,Intraepithelial Melanocytic Hyperplasia,0
3943,Call (Instruction),Localized Ewing Sarcoma,0
3944,Sequence Data Type,Bladder adenocarcinoma stage IV,0
3945,Spreading (qualifier value),Kaposi's sarcoma of skin,0
3946,Cessation of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
3947,Known,Basal Cell Ameloblastoma,0
3948,lymph nodes,Thymic Clear Cell Carcinoma,0
3949,Tryptophanase,Acantholytic squamous cell carcinoma,0
3950,seen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
3951,Malignant neoplasm of lung,malignant lymphoma of pancreatic lymph nodes,0
3952,Ability,Acantholytic squamous cell carcinoma,0
3953,Unification process,Benign Anal Granular Cell Tumor,0
3954,Cancer Registry,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
3955,Response (communication),Benign Anal Granular Cell Tumor,0
3956,French Catheter Gauge,Advanced Uterine Corpus Carcinosarcoma,0
3957,Subtype (attribute),Primary Cutaneous Plasmablastic Lymphoma,0
3958,size,Non-Hodgkin Lymphoma During Pregnancy,0
3959,Excision,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
3960,Fecal Impaction,Intestinal Metaplasia of Bladder Urothelium,0
3961,What subject filter - Result,Benign Anal Granular Cell Tumor,0
3962,Catch - Finding of sensory dimension of pain,Diffuse malignant mesothelioma,0
3963,Same,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
3964,Breaking down,FIGO Stage IVA Ovarian Cancer,0
3965,Structure of parenchyma of lung,Hair nevus,0
3966,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Activated B-cell type diffuse large B-cell lymphoma,0
3967,Location,Clinical Stage I Cutaneous Melanoma AJCC v8,0
3968,Negation,Female Breast Carcinoma,0
3969,Time (foundation metadata concept),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
3970,Testis,Liver Cavernous Hemangioma,0
3971,Connective Tissue,Occult Lung Adenosquamous Carcinoma,0
3972,Medical service,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
3973,bony process,Locally Advanced Epithelioid Hemangioendothelioma,0
3974,Problems - What subject filter,Malignant melanoma of eyelid,0
3975,Skin,Stage 0 Penile Cancer AJCC v8,0
3976,Spreading (qualifier value),Undifferentiated Endocervical Sarcoma,0
3977,Mass of body region,Papillary squamous cell carcinoma,0
3978,Cell (compartment),Clonal Hematopoiesis of Indeterminate Potential,0
3979,Pharmacotherapy,Mucinous adenocarcinoma gastric,0
3980,Symptoms,papillary carcinoma of penis,0
3981,Tracheal aspiration,Granular Cell Leiomyosarcoma,0
3982,Coding,mucinous adenocarcinoma of gallbladder,0
3983,Cancer Genus,Malignant Testicular Sertoli Cell Tumor,0
3984,Mature,Engraftment syndrome,0
3985,lymph nodes,Secondary malignant neoplasm of lymph node,0
3986,Human body,Nasal cavity carcinoma,0
3987,Medullary carcinoma of thyroid,Melanomatosis,0
3988,Smear - instruction imperative,Malignant neoplasm of choroid,0
3989,Greater,Spermatocytic seminoma,0
3990,teratologic,Carcinoma of urinary bladder,0
3991,Nasal sinus,Metastatic Malignant Neoplasm in the Sellar Region,0
3992,shared attribute,FIGO Stage II Ovarian Cancer,0
3993,Randomization,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
3994,Base - General Qualifier,Pancreatic carcinoma,0
3995,Wounds and Injuries,Vaginal Adenoma,0
3996,Cancer Genus,Primary Cutaneous Plasmablastic Lymphoma,0
3997,Left sided,Childhood Lymphoma,0
3998,Fever symptoms (finding),Human Papillomavirus-Related Carcinoma,0
3999,Term Birth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4000,Thin (qualifier value),Basal Cell Ameloblastoma,0
4001,Pleomorphic Xanthoastrocytoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4002,Cell Differentiation process,Engraftment syndrome,0
4003,Personal appearance,FIGO Stage IVA Ovarian Cancer,0
4004,risk factors,Digestive System Hodgkin Lymphoma,0
4005,Primary,Low Grade Squamous Intraepithelial Neoplasia,0
4006,Specific qualifier value,Hereditary Diffuse Gastric Adenocarcinoma,0
4007,Occurrence Indicator,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4008,Abdomen,Adult Hepatocellular Carcinoma,0
4009,Noninvasive,Ovarian germ cell choriocarcinoma stage IV,0
4010,peripheral blood,BRCA2 Syndrome,0
4011,Manufactured form,Malignant neoplasm of thalamus,0
4012,Common (qualifier value),Stage III Adult Immunoblastic Lymphoma,0
4013,Growth,Benign squamous cell tumor,0
4014,Base - General Qualifier,Mucinous adenocarcinoma,0
4015,Lymphocyte,Refractory Bladder Carcinoma,0
4016,One,Human Papillomavirus-Related Carcinoma,0
4017,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
4018,Sequence of Planned Assessment Schedule,embryonal rhabdomyosarcoma of prostate,0
4019,Feature,Extracranial Neuroblastoma,0
4020,Squamous cell carcinoma,Giant cell angiofibroma,0
4021,In Blood,Melanomatosis,0
4022,Surgical aspects,Hyperplasia of pituitary gland,0
4023,Central nervous system tract structure,Recurrent Testicular Lymphoma,0
4024,Term Birth,Hodgkin Disease,0
4025,Mutation,Liver Lymphangioma,0
4026,Anatomic Site,Mucinous adenocarcinoma gastric,0
4027,+2,Epithelioid Sarcoma NCI Grade 3,0
4028,Germ cell tumor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4029,Orbital region,Hyperplasia of pituitary gland,0
4030,blood neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4031,Coding,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4032,Tumor Mass,Splenic Manifestation of Hairy Cell Leukemia,0
4033,Common (qualifier value),Benign neoplasm of eye,0
4034,Skin,Breast Ductal Adenoma,0
4035,Numerous,Cancer of Urinary Tract,0
4036,Type - attribute,Deep Leiomyoma,0
4037,physiological aspects,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4038,Alternating,Recurrent Uveal Melanoma,0
4039,leukemia,Multiple Endocrine Neoplasia,0
4040,Name Given at Birth,Heavy Chain Deposition Disease,0
4041,Common (qualifier value),Carcinoma of urinary bladder,0
4042,Pharyngitis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4043,Options,High Grade Glandular Intraepithelial Neoplasia,0
4044,Cancer Registry,Intraepithelial Melanocytic Hyperplasia,0
4045,Cause of death:Find:Pt:^Patient:Nom,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4046,Hereditary Diseases,Bladder adenocarcinoma stage IV,0
4047,Vaginal Neoplasms,Atypical Mesothelial Hyperplasia,0
4048,Acute Undifferentiated Leukemia,Bladder squamous cell carcinoma stage I,0
4049,Cell Proliferation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
4050,Set scale,Adult Hepatocellular Carcinoma,0
4051,Osteophyte,Stage III Adult Immunoblastic Lymphoma,0
4052,Diagnosis Study,papillary carcinoma of penis,0
4053,Mucins,Papillary squamous cell carcinoma,0
4054,Percent of Bacteria,Giant cell angiofibroma,0
4055,Limited stage (cancer stage),Grade 3a Malignant Neoplasm,0
4056,Cataract,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4057,How Often Vomiting,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4058,Basis - conceptual entity,Acantholytic squamous cell carcinoma,0
4059,Mucosa-Associated Lymphoid Tissue Lymphoma,Stage 0 Penile Cancer AJCC v8,0
4060,solid substance,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4061,Dermoid Cyst,Mixed astrocytoma-ependymoma,0
4062,Tumor Progression,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4063,99,Squamous cell carcinoma of lip,0
4064,South Korea,Cystadenocarcinoma,0
4065,low exposure,Refractory Ependymoma,0
4066,Sore Throat,Tongue Alveolar Soft Part Sarcoma,0
4067,Fluid behavior,Malignant neoplasm of subglottis,0
4068,Reduction (chemical),squamous cell carcinoma of the thyroid gland,0
4069,Manual pelvic examination (procedure),Bladder squamous cell carcinoma stage I,0
4070,2+ Score,Childhood Fibrillary Astrocytoma,0
4071,Fever,Stage III Adult Immunoblastic Lymphoma,0
4072,Alveolar Soft Part Sarcoma,Squamous cell carcinoma of lip,0
4073,Device Cord,Melanomatosis,0
4074,Dangerousness,Adenocarcinoma,0
4075,potential,Peripheral primitive neuroectodermal tumor of soft tissue,0
4076,aggressive cancer,Metaplastic carcinoma of breast,0
4077,Infiltration,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4078,Country,Squamous cell carcinoma of lip,0
4079,Used by,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4080,Common (qualifier value),Gallbladder Adenocarcinoma,0
4081,Age at diagnosis:Time:Pt:^Patient:Qn,Metastatic Carcinoma in the Lung,0
4082,Logical Condition,Primary Cutaneous Plasmablastic Lymphoma,0
4083,classic behavior,Kaposi's sarcoma of skin,0
4084,Granulocyte count,Pilocytic astrocytoma of cerebellum,0
4085,Qualitative form,Localized Malignant Neoplasm,0
4086,1+,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4087,Symptoms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4088,treatment - ActInformationManagementReason,Brain Tumor,0
4089,Rare,Basal Cell Ameloblastoma,0
4090,Tobacco smoking behavior,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4091,Fluid Balance,Maxillary Sinus Adenoid Cystic Carcinoma,0
4092,Eccrine Glands,ROSE Cluster 3,0
4093,Categories,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4094,Histopathologic Grade differentiation,Stage IV Colorectal Cancer AJCC v8,0
4095,Bound (value),Peripheral primitive neuroectodermal tumor of soft tissue,0
4096,Americas Ethnicity,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4097,Classification,ROSE Cluster 3,0
4098,Often - answer to question,Brain Ependymoma,0
4099,Diagnosis,Malignant neoplasm of choroid,0
4100,Meningioma,Primary Cutaneous Plasmablastic Lymphoma,0
4101,failed,Neonatal leukemia,0
4102,United States Military Commissioned Officer O4,Chondrosarcoma,0
4103,Adult human body,Unresectable Rhabdomyosarcoma,0
4104,dendritic spine neck,Breast Apocrine Adenoma,0
4105,Usually,Peripheral primitive neuroectodermal tumor of soft tissue,0
4106,Woman,papillary carcinoma of penis,0
4107,Smudge cell,Basal Cell Ameloblastoma,0
4108,Generation (action),adenosquamous carcinoma of breast,0
4109,Biological Response Modifiers,Melanomatosis,0
4110,Flat shape,Airway Hemangioma,0
4111,Blood Vessel,Extra-Adrenal Paraganglioma,0
4112,How Much Distress Weight Loss,Chronic Myelomonocytic Leukemia-2,0
4113,Immune System Finding,Refractory Bladder Carcinoma,0
4114,Digestive Enzymes,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4115,shared attribute,Stage I Adult Non-Hodgkin Lymphoma,0
4116,Low Level,Acute lymphadenitis,0
4117,Feelings,Medulloblastoma,0
4118,Singular,Angiosarcoma of liver,0
4119,Common Specifications in HL7 V3 Publishing,Benign Anal Granular Cell Tumor,0
4120,Often - answer to question,Diffuse malignant mesothelioma,0
4121,Sometimes,Kaposi's sarcoma of extrahepatic bile duct,0
4122,Frequently,Engraftment syndrome,0
4123,Does stand alone,Clonal Hematopoiesis of Indeterminate Potential,0
4124,Drainage procedure,Stage II Carcinoma of Penis,0
4125,Most,Benign Apocrine Neoplasm,0
4126,treatment - ActInformationManagementReason,Central Nervous System Anaplastic Large Cell Lymphoma,0
4127,Possible diagnosis,Ovarian Carcinoid Tumor,0
4128,Togo,Refractory Bladder Carcinoma,0
4129,Bone Marrow Examination,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
4130,shared attribute,Adult Alveolar Soft Part Sarcoma,0
4131,How Often Diarrhea,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4132,Neuron spine,Squamous cell carcinoma of lip,0
4133,Specific qualifier value,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4134,Worse,Engraftment syndrome,0
4135,SLC6A2 protein,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4136,seen,Malignant melanoma of eyelid,0
4137,90%,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4138,Sustain,Non-Hodgkin Lymphoma During Pregnancy,0
4139,Certainties,Acantholytic squamous cell carcinoma,0
4140,Benign neoplasm of sweat gland,clear cell adenocarcinoma of gallbladder,0
4141,90%,Squamous cell carcinoma of lip,0
4142,Population Mean,BRCA2 Syndrome,0
4143,Occur (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4144,THM gene,Recurrent Uveal Melanoma,0
4145,Very high,High Grade Glandular Intraepithelial Neoplasia,0
4146,Square Mile,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4147,Medical Device Emits Smoke,Fourth Ventricle and Brain Stem Ependymal Tumor,0
4148,Cold Temperature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4149,Polypeptide Hormones,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4150,Manufactured sign,Bladder squamous cell carcinoma stage I,0
4151,Tumor type,Basal Cell Ameloblastoma,0
4152,Phimosis,Pancreatic carcinoma,0
4153,Urine,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4154,Surveys,Liver Lymphangioma,0
4155,1960s,Refractory Bladder Carcinoma,0
4156,Cancer Genus,Colorectal High Grade B-Cell Lymphoma,0
4157,radiotherapeutic,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4158,Rare Diseases,Primary Cutaneous Plasmablastic Lymphoma,0
4159,Adult Rhabdomyosarcoma,Mucinous adenocarcinoma gastric,0
4160,Status post,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4161,Main,Acinar cell carcinoma of pancreas,0
4162,metastatic qualifier,Malignant neoplasm of olfactory nerve,0
4163,Physical shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4164,Cells,Colorectal Neuroendocrine Tumor G2,0
4165,To,Spongiotic dermatitis,0
4166,Two,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4167,Triggered by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4168,3+ Score,papillary carcinoma of penis,0
4169,Alveolus,Cartilaginous exostosis,0
4170,Sore sensation,Acute Undifferentiated Leukemia,0
4171,Ovarian Carcinoma,Recurrent Uveal Melanoma,0
4172,Adult Diffuse Large B-Cell Lymphoma,Xeroderma pigmentosum,0
4173,Solid,Childhood Choriocarcinoma,0
4174,Secondary to,Hodgkin lymphoma,0
4175,Occurrence Indicator,Adult Hepatocellular Carcinoma,0
4176,0%,Fourth Ventricle and Brain Stem Ependymal Tumor,0
4177,diagnosis aspect,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4178,Mast Cell Count,Malignant Neoplasm of Lung - Multiple Primary Sites,0
4179,Cancer Registry,Clonal Hematopoiesis of Indeterminate Potential,0
4180,potential,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
4181,Distal (qualifier value),Cartilaginous exostosis,0
4182,Rare,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4183,Glioblastoma Multiforme,Liver Lymphangioma,0
4184,Most,Childhood Anaplastic Large Cell Lymphoma,0
4185,Indication of (contextual qualifier),Acute Undifferentiated Leukemia,0
4186,Genes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4187,Pacemaker Procedure,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4188,Blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4189,Make - Instruction Imperative,clear cell adenocarcinoma of gallbladder,0
4190,Gonadal Dysgenesis,Hereditary Diffuse Gastric Adenocarcinoma,0
4191,Body structure,Pancreatic carcinoma,0
4192,utilization qualifier,Malignant neoplasm of gallbladder,0
4193,Hepatitis C virus,Testicular cancer metastatic,0
4194,Active License,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4195,Type - attribute,Plexosarcoma,0
4196,Term Birth,Acantholytic squamous cell carcinoma,0
4197,Progress,Undifferentiated Endocervical Sarcoma,0
4198,Morbidity - disease rate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4199,Adult,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
4200,Fourth (suffix),malignant lymphoma of pancreatic lymph nodes,0
4201,Dorsal,Localized Malignant Neoplasm,0
4202,Circulating Neoplastic Cells,Small Intestinal Villous Adenoma,0
4203,Obesity,Malignant neoplasm of thalamus,0
4204,pharmacotherapeutic,Refractory Bladder Carcinoma,0
4205,Retinoic Acid Response Element,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4206,Old,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4207,Case (situation),Airway Hemangioma,0
4208,Imaging Techniques,Cervical Adenomyoma,0
4209,Did not receive therapy or drug for,Vaginal Adenoid Cystic Carcinoma,0
4210,incidence of cases,Unfavorable Non-Hodgkin Lymphoma,0
4211,Primary operation,Multiple Endocrine Neoplasia,0
4212,General surgery specialty,Squamous cell carcinoma of lip,0
4213,Long,Female Breast Carcinoma,0
4214,300,Acantholytic squamous cell carcinoma,0
4215,Shortness of breath:-:Point in time:^Patient:-,FIGO Stage II Ovarian Cancer,0
4216,development aspects,Mucinous adenocarcinoma gastric,0
4217,Medical Device Material Separation,Adult Alveolar Soft Part Sarcoma,0
4218,Last,Choroid Epithelioid Cell Melanoma,0
4219,Most,Metaplastic carcinoma of breast,0
4220,Back Pain,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4221,Scientific Publication,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4222,Symptoms,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4223,Chemotherapy Regimen,Giant cell angiofibroma,0
4224,Characteristics,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4225,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Pancreatic Endocrine Carcinoma,0
4226,Glycation End Products,Pancreatic carcinoma,0
4227,Pediatric,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4228,Appearance of breast,FIGO Stage IVA Ovarian Cancer,0
4229,Trial Screening,Airway Hemangioma,0
4230,Site of,Carcinoma of urinary bladder,0
4231,ovarian neoplasm,Type II Endometrial Adenocarcinoma,0
4232,Destruction (action),clear cell adenocarcinoma of gallbladder,0
4233,Manufactured form,Benign Anal Granular Cell Tumor,0
4234,Adult,Cartilaginous exostosis,0
4235,aggressive cancer,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
4236,Discover,Liver Lymphangioma,0
4237,Uterine Corpus Sarcoma,Squamous cell carcinoma of lip,0
4238,Yellow complexion,Cerebral Primitive Neuroectodermal Tumor,0
4239,System,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4240,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Choroid Necrotic Melanoma,0
4241,Usual,Childhood Central Nervous System Immature Teratoma,0
4242,Induce (action),Acute Undifferentiated Leukemia,0
4243,Cancer/Testis Antigen,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4244,Histocompatibility Testing,Lipoma of small intestine,0
4245,Moist,Low Grade Squamous Intraepithelial Neoplasia,0
4246,Definitely Related to Intervention,Benign Anal Granular Cell Tumor,0
4247,Tobacco,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4248,Skin Specimen,Primary Cutaneous Plasmablastic Lymphoma,0
4249,Patient need for (contextual qualifier),Refractory Ependymoma,0
4250,Entity Determiner - specific,Stage III Adult Immunoblastic Lymphoma,0
4251,Manufactured form,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4252,Used by,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4253,radiotherapeutic,Childhood Fibrillary Astrocytoma,0
4254,Usual,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4255,Case (situation),Diffuse malignant mesothelioma,0
4256,Symptoms,Localized Askin Tumor,0
4257,Five-year Survival Rate,Metastatic Lung Neuroendocrine Neoplasm,0
4258,Bothered by Night Sweats,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4259,Have Shortness of Breath question,Benign Anal Granular Cell Tumor,0
4260,Certainties,Extra-Adrenal Paraganglioma,0
4261,Male Gender,Digestive System Hodgkin Lymphoma,0
4262,Including (qualifier),Cartilaginous exostosis,0
4263,Sarcoma - category (morphologic abnormality),Botryoid-Type Embryonal Rhabdomyosarcoma,0
4264,Cells,Trichilemmocarcinoma,0
4265,Known,Heavy Chain Deposition Disease,0
4266,Hemopoietic tissue,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
4267,peripheral blood,Nasal cavity carcinoma,0
4268,Symptoms aspect,Metastatic Kidney Carcinoma,0
4269,year,Tongue Alveolar Soft Part Sarcoma,0
4270,Personal appearance,Acute lymphadenitis,0
4271,Malignant Neoplasms,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4272,IPSS Risk Category Low,Neoplasms,0
4273,Include (action),embryonal rhabdomyosarcoma of prostate,0
4274,Treated with,Papillary squamous cell carcinoma,0
4275,Melanoma Pathway,Stage III Cutaneous Melanoma AJCC v6,0
4276,Smaller,Stage IB Pancreatic Cancer AJCC v8,0
4277,Early stage,Metastatic Ductal Breast Carcinoma,0
4278,Volume,Metaplastic carcinoma of breast,0
4279,Case unit dose,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4280,Approximate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4281,Pallor of skin,Adult Alveolar Soft Part Sarcoma,0
4282,What subject filter - Result,Kaposi's sarcoma of extrahepatic bile duct,0
4283,size,Thymic Clear Cell Carcinoma,0
4284,To,Spongiotic dermatitis,0
4285,Absent,Maxillary Sinus Adenocarcinoma,0
4286,Diagnosis Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4287,Retraction (finding),Carcinoma of urinary bladder,0
4288,Old,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4289,Have Itch,Human Papillomavirus-Related Carcinoma,0
4290,Visual Analog Pain Scale,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4291,Hepatobiliary System,Cervical Fibroepithelial Polyp,0
4292,Shapes,Ichthyosis,0
4293,Average of Value Derivation Technique,Collecting Duct Carcinoma of the Kidney,0
4294,Fatal,Mixed astrocytoma-ependymoma,0
4295,Aim,Thyroid Hurthle Cell Carcinoma,0
4296,Negation,FIGO Stage IVA Ovarian Cancer,0
4297,MOSTLY,Extra-Adrenal Paraganglioma,0
4298,Then,Chondrosarcoma,0
4299,Ovarian Carcinoma,Ichthyoses,0
4300,Tissue damage,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4301,Uterine Fibroids,Endometrial Small Cell Carcinoma,0
4302,Critical,Cartilaginous exostosis,0
4303,Neoplasms,Acute Undifferentiated Leukemia,0
4304,More,Familial Hemophagocytic Lymphocytosis,0
4305,Food,Anterior Urethral Malignant Neoplasm,0
4306,Similarity,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4307,Cervical lymph node group,FIGO Stage IVA Ovarian Cancer,0
4308,Grouped (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4309,Does turn (finding),Localized Askin Tumor,0
4310,Uncontrolled,Adult Acute Eosinophilic Leukemia,0
4311,To,Giant cell angiofibroma,0
4312,Weight decreased,Trabecular adenocarcinoma,0
4313,year,Cartilaginous exostosis,0
4314,Lasers,Thyroid Hurthle Cell Carcinoma,0
4315,Cell Count,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4316,Feel Tired question,Cancer of Urinary Tract,0
4317,Tumor cells,Kaposi's sarcoma of skin,0
4318,Ivory Coast,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4319,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4320,Known,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4321,Tumor Mass,Intraepithelial Melanocytic Hyperplasia,0
4322,Immature cells,Squamous cell carcinoma of lip,0
4323,parent,Locally Advanced Soft Tissue Sarcoma,0
4324,Most,Female Breast Carcinoma,0
4325,Reduced,Benign neoplasm of thorax,0
4326,Mixed Cell Morphology,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4327,Dysuria,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4328,abnormal growth by tissue,Undifferentiated Endocervical Sarcoma,0
4329,Ependymoma,Uterine Cancer,0
4330,Tissue Specimen Code,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4331,Numerous,Recurrent Testicular Lymphoma,0
4332,CEL gene,Kaposi's sarcoma of extrahepatic bile duct,0
4333,Include (action),Methotrexate-Associated Hodgkin Lymphoma,0
4334,Study Site,Mucinous neoplasm,0
4335,Three,Localized Ewing Sarcoma,0
4336,Pleural effusion fluid,Xeroderma pigmentosum,0
4337,Limb structure,Mucinous adenocarcinoma gastric,0
4338,Including (qualifier),embryonal rhabdomyosarcoma of prostate,0
4339,Generation (action),Primary Cutaneous Plasmablastic Lymphoma,0
4340,Adenocarcinoma,Benign neoplasm of eye,0
4341,English Language,Splenic Manifestation of Hairy Cell Leukemia,0
4342,Malignant Neoplasms,Thyroid carcinoma,0
4343,Rare,Pancreatic Intraepithelial Neoplasia-3,0
4344,include - SetOperator,Maxillary Sinus Adenocarcinoma,0
4345,Special,Vaginal Adenoid Cystic Carcinoma,0
4346,Phimosis,Recurrent Testicular Lymphoma,0
4347,Complication,Hodgkin Disease,0
4348,Disruption,embryonal rhabdomyosarcoma of prostate,0
4349,Blood Circulation,Breast Ductal Adenoma,0
4350,Presentation,Precursor B-lymphoblastic lymphoma stage II,0
4351,See,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4352,Growth action,Locally Advanced Soft Tissue Sarcoma,0
4353,melanoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4354,Evaluation,Gallbladder Adenocarcinoma,0
4355,Social Role,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4356,b cell differentiation,FIGO Stage II Ovarian Cancer,0
4357,Cancer Registry,Benign neoplasm of thorax,0
4358,Primary malignant neoplasm,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4359,Beginning,Localized Askin Tumor,0
4360,Togo,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
4361,Spreading (qualifier value),Cancer of Urinary Tract,0
4362,Needs,Bladder Neuroendocrine Neoplasm,0
4363,Forecast of outcome,Digestive System Hodgkin Lymphoma,0
4364,Did not receive therapy or drug for,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
4365,Area,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4366,Infant,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4367,Involvement with,adenosquamous carcinoma of breast,0
4368,Lower (action),Astrocytoma of brain,0
4369,Involvement with,Precursor B-lymphoblastic lymphoma stage II,0
4370,One,mucinous adenocarcinoma of gallbladder,0
4371,Multiple Myeloma,Childhood Fibrillary Astrocytoma,0
4372,Lymphocyte component of blood,non-Hodgkin's lymphoma of spleen,0
4373,Peas - dietary,Refractory Barrett Esophagus,0
4374,ETV5 wt Allele,Uterine Cancer,0
4375,Specimen Source Codes - tumor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4376,Known,Human Papillomavirus-Related Carcinoma,0
4377,Stem cells,Small Intestinal Villous Adenoma,0
4378,Abdomen,Stage IB Lung Cancer AJCC v7,0
4379,Including (qualifier),Periosteal Osteosarcoma,0
4380,Entity,Bladder squamous cell carcinoma stage I,0
4381,Both ovaries,Chronic Myelomonocytic Leukemia-2,0
4382,protein complex location,Gallbladder Adenocarcinoma,0
4383,Biomaterial Treatment,Bladder Neuroendocrine Neoplasm,0
4384,Skeletal bone,Stage IV Colorectal Cancer AJCC v8,0
4385,Most,Pancreatic Intraepithelial Neoplasia-3,0
4386,Cancer Genus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4387,chronic,Prostate Lymphoma,0
4388,2+ Score,Acute lymphadenitis,0
4389,Time,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4390,Epithelioma,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4391,PSA Level Less than Five,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4392,Dorsal,Unfavorable Non-Hodgkin Lymphoma,0
4393,Menopause,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4394,Brain,Carcinomatosis of peritoneal cavity,0
4395,Smear - instruction imperative,Acantholytic squamous cell carcinoma,0
4396,Means,Secondary malignant neoplasm of lymph node,0
4397,include - SetOperator,Undifferentiated Endocervical Sarcoma,0
4398,Formation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4399,Disease,Granular Cell Leiomyosarcoma,0
4400,Exocrine Glands,Splenic Manifestation of Hairy Cell Leukemia,0
4401,Metastatic to,Anaplastic large cell lymphoma,0
4402,Endometrial Carcinoma,Extra-Adrenal Paraganglioma,0
4403,Calcarea sulphurica,Basal Cell Ameloblastoma,0
4404,Southern Europe,Lipoma of small intestine,0
4405,Negation,Larynx carcinoma recurrent,0
4406,Monitoring Device,Non-Metastatic Gestational Trophoblastic Tumor,0
4407,Often - answer to question,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4408,potential,Acute lymphadenitis,0
4409,Usually,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4410,Metaplastic carcinoma,Mixed astrocytoma-ependymoma,0
4411,Malignant neoplasm of lung,Acantholytic squamous cell carcinoma,0
4412,Aggressive behavior,Hyperplasia of pituitary gland,0
4413,Rating (action),Cervical Squamous Intraepithelial Neoplasia,0
4414,Symptoms,Anterior Urethral Malignant Neoplasm,0
4415,Very,Malignant neoplasm of subglottis,0
4416,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4417,Cardiovascular system,Type II Endometrial Adenocarcinoma,0
4418,Medical Device Emits Smoke,Chest Wall Fibromatosis,0
4419,Percent (qualifier value),Adult Anaplastic Oligodendroglioma,0
4420,Give - dosing instruction imperative,carcinoma of middle ear,0
4421,Face (spatial concept),Cancer of Urinary Tract,0
4422,risk factors,Small cell neuroendocrine carcinoma of bladder,0
4423,lymph nodes,Splenic Manifestation of Hairy Cell Leukemia,0
4424,Body structure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4425,Exposure to,Cervical Fibroepithelial Polyp,0
4426,Expiration,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
4427,Common Specifications in HL7 V3 Publishing,Gallbladder Adenocarcinoma,0
4428,Characterization,Engraftment syndrome,0
4429,Caucasoid Race,Localized Askin Tumor,0
4430,Operative Surgical Procedures,Benign neoplasm of thorax,0
4431,Weight decreased,Recurrent Uveal Melanoma,0
4432,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4433,Stomach Carcinoma,Microcystic meningioma,0
4434,Hematologic Tests,Malignant melanoma of eyelid,0
4435,Benign neoplasm of brain,Extracranial Neuroblastoma,0
4436,family of origin,Ovarian germ cell choriocarcinoma stage IV,0
4437,Symptoms,Testicular cancer metastatic,0
4438,Include (action),Werner Syndrome,0
4439,white blood cell type,Lipoma of small intestine,0
4440,Less Than,Blood Vessel Tumors,0
4441,Hormones,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4442,Weight Loss,Human Papillomavirus-Related Carcinoma,0
4443,High Level,Uterine Cancer,0
4444,Screening Study,FIGO Stage II Ovarian Cancer,0
4445,Categories,Splenic Manifestation of Hairy Cell Leukemia,0
4446,Percent (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
4447,United States Military Commissioned Officer O4,Liver Lymphangioma,0
4448,diagnosis aspect,Splenic Manifestation of Hairy Cell Leukemia,0
4449,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4450,N not otherwise specified Antibody,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4451,Tumor Mass,Chronic Myelomonocytic Leukemia-2,0
4452,Location of Oral Residue Following Swallowing,Mucinous adenocarcinoma,0
4453,Smear - instruction imperative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4454,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
4455,66,Kaposi's sarcoma of skin,0
4456,risk factors - observation list,Malignant neoplasm of subglottis,0
4457,Southern Europe,Extra-Adrenal Paraganglioma,0
4458,Stat (do immediately),Malignant neoplasm of gallbladder,0
4459,Males,Melanomatosis,0
4460,Tobacco smoking behavior,Cerebral Primitive Neuroectodermal Tumor,0
4461,bony process,Intraepithelial Melanocytic Hyperplasia,0
4462,Congenital Abnormality,Stage I Colon Neuroendocrine Tumor AJCC v8,0
4463,General surgery specialty,High Grade Glandular Intraepithelial Neoplasia,0
4464,Singular,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
4465,Identifier,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4466,Phase,Necrotizing Funisitis,0
4467,Unknown,Extra-Adrenal Paraganglioma,0
4468,Sunlight,Intestinal Metaplasia of Bladder Urothelium,0
4469,Chemotherapy,Basal Cell Ameloblastoma,0
4470,Pathogenesis,Malignant neoplasm of olfactory nerve,0
4471,Mutation Abnormality,Carcinoma,0
4472,Body tissue,Spongiotic dermatitis,0
4473,Glioblastoma,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4474,Neoplastic disease,Intraepithelial Melanocytic Hyperplasia,0
4475,Characteristics,Lung Mucinous Cystadenoma,0
4476,Dermis,Plexosarcoma,0
4477,Column (anatomic),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
4478,>90,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4479,Anorexia,Type II Endometrial Adenocarcinoma,0
4480,Human body structure,Benign Anal Granular Cell Tumor,0
4481,Collecting system,Xeroderma pigmentosum,0
4482,Common Specifications in HL7 V3 Publishing,Malignant melanoma of eyelid,0
4483,Blood Cells,Non-Metastatic Gestational Trophoblastic Tumor,0
4484,Primitive,Benign Anal Granular Cell Tumor,0
4485,FAT1 wt Allele,Locally Advanced Soft Tissue Sarcoma,0
4486,Before,Mucinous adenocarcinoma gastric,0
4487,Common (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
4488,Frequently,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4489,risk factors,Adult Hepatocellular Carcinoma,0
4490,Metaplasia,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4491,Experimental Result,Mixed astrocytoma-ependymoma,0
4492,Arteries,clear cell adenocarcinoma of gallbladder,0
4493,How Much Distress Weight Loss,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4494,Africa South of the Sahara,Blepharal carcinoma,0
4495,Pancreatic Cancer Pathway,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4496,Case unit dose,Gallbladder Adenocarcinoma,0
4497,Childhood Atypical Teratoid/Rhabdoid Tumor,Ichthyosis,0
4498,Nervous system structure,BRCA2 Syndrome,0
4499,Structure of thyroid follicle,Peripheral primitive neuroectodermal tumor of soft tissue,0
4500,Connective Tissue,Airway Hemangioma,0
4501,Neoplasms,Acantholytic squamous cell carcinoma,0
4502,Diabetes,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4503,Renal carcinoma,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4504,Form:Finding:Point in time:{Setting}:Document:{Role},Benign Ovarian Thecoma,0
4505,Responsible to,Bladder squamous cell carcinoma stage I,0
4506,Drainage procedure,Malignant Testicular Sertoli Cell Tumor,0
4507,Symptoms,Carcinoma of submandibular gland,0
4508,Grade two rank,Stage II Hepatocellular Carcinoma AJCC v8,0
4509,NCI CTEP SDC Melanoma Sub-Category Terminology,Mucinous adenocarcinoma gastric,0
4510,Secondary hypercalcemia,Precursor B-lymphoblastic lymphoma stage II,0
4511,Fibroadenoma,Cancer of Urinary Tract,0
4512,Mechanism (attribute),Thymic Clear Cell Carcinoma,0
4513,Unknown GENC,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4514,Primary,Atypical Lobular Breast Hyperplasia,0
4515,Over (spatial),Serous cystadenocarcinoma ovary,0
4516,Critical,Chronic Myelomonocytic Leukemia-2,0
4517,Complete Trisomy 21 Syndrome,Bladder squamous cell carcinoma stage I,0
4518,Mixed Neoplasm,Locally Advanced Epithelioid Hemangioendothelioma,0
4519,Difficult (qualifier value),Astrocytoma of brain,0
4520,Main,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4521,Therapeutic procedure,Diffuse malignant mesothelioma,0
4522,Symptoms aspect,non-Hodgkin's lymphoma of spleen,0
4523,Symptoms,FIGO Stage IVA Ovarian Cancer,0
4524,Use of,Stage IV Penile Cancer AJCC v7,0
4525,Blast (physical force),Botryoid-Type Embryonal Rhabdomyosarcoma,0
4526,various other nasal preparations in ATC,Low Grade Squamous Intraepithelial Neoplasia,0
4527,Tissue Specimen Code,Leptomeningeal sarcoma,0
4528,Very,Fibroadenoma of breast,0
4529,General surgery specialty,Refractory Ependymoma,0
4530,Science of Etiology,Bladder squamous cell carcinoma stage I,0
4531,Medical pathologist,Locally Advanced Carcinoma,0
4532,granulocyte,Advanced Lung Carcinoma,0
4533,Term (lexical),Diffuse malignant mesothelioma,0
4534,Including (qualifier),Childhood Central Nervous System Ganglioneuroblastoma,0
4535,Male population group,Chest Wall Fibromatosis,0
4536,Devices,Testicular cancer metastatic,0
4537,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
4538,Functional,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
4539,Kissing,Low Grade Squamous Intraepithelial Neoplasia,0
4540,Immune System Processes,Stage III Cutaneous Melanoma AJCC v6,0
4541,Stable status,Low Grade Squamous Intraepithelial Neoplasia,0
4542,Occurrence,Refractory Ependymoma,0
4543,Common Specifications in HL7 V3 Publishing,Atypical Mesothelial Hyperplasia,0
4544,Group A (qualifier value),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
4545,Pharmacologic Substance,Stage IV Colorectal Cancer AJCC v8,0
4546,Sufficiently defined concept definition status (core metadata concept),Advanced Lung Carcinoma,0
4547,Rapid,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4548,Type - attribute,Benign squamous cell tumor,0
4549,Pain,Stage III Cutaneous Melanoma AJCC v6,0
4550,Sometimes,Medulloblastoma,0
4551,Tumor Mass,Recurrent Testicular Lymphoma,0
4552,Body tissue,Breast Ductal Adenoma,0
4553,How Often Shortness of Breath,Metastatic Lung Small Cell Carcinoma,0
4554,Set (Psychology),Prostate Lymphoma,0
4555,Fever symptoms (finding),Blood Vessel Tumors,0
4556,<3 (qualifier value),Breast Ductal Adenoma,0
4557,Growth abnormality,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4558,Unconscious State,Primary Cutaneous Plasmablastic Lymphoma,0
4559,Area,Refractory Barrett Esophagus,0
4560,Trauma,Bladder adenocarcinoma stage IV,0
4561,Normal,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
4562,Case (situation),Bladder squamous cell carcinoma stage I,0
4563,Benign,FIGO Stage II Ovarian Cancer,0
4564,Term (lexical),Acantholytic squamous cell carcinoma,0
4565,Compressed structure,Mucinous adenocarcinoma gastric,0
4566,Granulocyte component of blood,ROSE Cluster 3,0
4567,Phenazopyridine,Hodgkin Disease,0
4568,FAT1 wt Allele,Periosteal Osteosarcoma,0
4569,Surface of skin,Anaplastic large cell lymphoma,0
4570,melanoma,ROSE Cluster 3,0
4571,KIT gene,Colorectal High Grade B-Cell Lymphoma,0
4572,Academic degree,Adenocarcinoma,0
4573,Overall Publication Type,Childhood Choriocarcinoma,0
4574,seconds,Stage III Adult Immunoblastic Lymphoma,0
4575,Include (action),Spongiotic dermatitis,0
4576,Biological Response Modifier Therapy,Pancreatic carcinoma,0
4577,diagnosis aspect,Recurrent Uveal Melanoma,0
4578,omit,Hereditary corneal dystrophy,0
4579,Extrinsic,Acantholytic squamous cell carcinoma,0
4580,occurrence characteristics,Vaginal Adenoma,0
4581,immunologist,embryonal rhabdomyosarcoma of prostate,0
4582,How Often Felt Normal question,Undifferentiated Endocervical Sarcoma,0
4583,Tonsil,Maxillary Sinus Adenoid Cystic Carcinoma,0
4584,Chemicals,malignant lymphoma of pancreatic lymph nodes,0
4585,Skin,Metaplastic carcinoma of breast,0
4586,Body structure,Cancer of Urinary Tract,0
4587,Negation,Fourth Ventricle and Brain Stem Ependymal Tumor,0
4588,Inspiration function,Chronic Myelomonocytic Leukemia-2,0
4589,Person Name,Tonsillar Carcinoma,0
4590,Representation (action),Adult Fibrolamellar Carcinoma,0
4591,Domain (area of knowledge),Low Grade Squamous Intraepithelial Neoplasia,0
4592,Vasculature,Trabecular adenocarcinoma,0
4593,Cancer Genus,Carcinoma of urinary bladder,0
4594,status - In progress,Intracortical osteosarcoma,0
4595,Linear,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4596,Immature cells,Breast Ductal Adenoma,0
4597,List,FIGO Stage II Ovarian Cancer,0
4598,Togo,Carcinoma of urinary bladder,0
4599,90%,Cervical Fibroepithelial Polyp,0
4600,Diagnosis Study,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4601,Ability,Choroid Epithelioid Cell Melanoma,0
4602,Secretory Vesicles,Splenic Manifestation of Hairy Cell Leukemia,0
4603,Contrast Media,Anterior Urethral Malignant Neoplasm,0
4604,Diagnosis Study,Medulloblastoma,0
4605,Deletion 1p36,Leiomyoma of Gallbladder,0
4606,Epoetin Alfa,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
4607,Wound Healing,Atypical Lobular Breast Hyperplasia,0
4608,Skin Lymphangiosarcoma,Gallbladder Adenocarcinoma,0
4609,Clone,Epithelioid Sarcoma NCI Grade 3,0
4610,Hospitals,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4611,Tired,Xeroderma pigmentosum,0
4612,Couple (action),Malignant Testicular Sertoli Cell Tumor,0
4613,Chemotherapy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4614,Functional,Secondary malignant neoplasm of lymph node,0
4615,aspects of adverse effects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4616,Homo sapiens,Multiple Skull Base Meningiomas,0
4617,Groups,Cancer of Urinary Tract,0
4618,described,Childhood Extragonadal Malignant Germ Cell Tumor,0
4619,Renal carcinoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4620,Family,Human Papillomavirus-Related Carcinoma,0
4621,Qualitative form,Malignant neoplasm of subglottis,0
4622,diagnosis aspect,Stage IB Pancreatic Cancer AJCC v8,0
4623,Stroma,Malignant neoplasm of gallbladder,0
4624,Night sweats,Liver Cavernous Hemangioma,0
4625,Linear,Neonatal leukemia,0
4626,Female,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4627,Decision,Acantholytic squamous cell carcinoma,0
4628,Meaning,Neonatal leukemia,0
4629,Approximate,Rhabdomyosarcoma with ganglionic differentiation,0
4630,Usage,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4631,74,Intraepithelial Melanocytic Hyperplasia,0
4632,Arising,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
4633,Gene Mutant,FIGO Stage II Ovarian Cancer,0
4634,Radiation Ionizing Radiotherapy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4635,Less Than,Unfavorable Non-Hodgkin Lymphoma,0
4636,Hemangioma,Cervical Adenomyoma,0
4637,Weight decreased,Colorectal cancer,0
4638,High Mitosis-Karyorrhexis Index,Intestinal Neuroendocrine Carcinoma,0
4639,Distant,Cartilaginous exostosis,0
4640,fluid - substance,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4641,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Primary Cutaneous Plasmablastic Lymphoma,0
4642,Hormone Therapy,Gallbladder Adenocarcinoma,0
4643,Concept model domain,Vaginal Adenoma,0
4644,Histopathologic Grade,Metastatic Ductal Breast Carcinoma,0
4645,melanocyte,Refractory Barrett Esophagus,0
4646,One,Non-Metastatic Gestational Trophoblastic Tumor,0
4647,84,Multiple Skull Base Meningiomas,0
4648,New Zealand,Refractory Barrett Esophagus,0
4649,cell type,Childhood Cerebellar Neoplasm,0
4650,To,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4651,Organ,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4652,Follicular,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4653,combination of objects,Giant cell angiofibroma,0
4654,Free (available (qualifier)),Anaplastic large cell lymphoma,0
4655,Persons,Placental aromatase deficiency,0
4656,Code,Tongue Alveolar Soft Part Sarcoma,0
4657,consider,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
4658,classical example,Splenic Manifestation of Hairy Cell Leukemia,0
4659,Back,Human Papillomavirus-Related Carcinoma,0
4660,Dysuria,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4661,Homo sapiens,Recurrent Uveal Melanoma,0
4662,Diffuse Large B-Cell Lymphoma,Prostate Lymphoma,0
4663,combination - answer to question,Recurrent Testicular Lymphoma,0
4664,style,Intraepithelial Melanocytic Hyperplasia,0
4665,Beginning,Childhood Choriocarcinoma,0
4666,100%,Malignant melanoma of eyelid,0
4667,Skin,Childhood Central Nervous System Ganglioneuroblastoma,0
4668,Rapid,Mixed astrocytoma-ependymoma,0
4669,Value Above Reference Range,Methotrexate-Associated Hodgkin Lymphoma,0
4670,Primary operation,Atypical Lobular Breast Hyperplasia,0
4671,Lymphocyte,Female Breast Carcinoma,0
4672,<3 (qualifier value),Localized Malignant Neoplasm,0
4673,Symptoms aspect,Metastatic Malignant Neoplasm in the Sellar Region,0
4674,Macrophage Activation Syndrome,Female Breast Carcinoma,0
4675,With shape,Diffuse malignant mesothelioma,0
4676,Appearance Distress Question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4677,Tryptophanase,Kaposi's sarcoma of skin,0
4678,Characteristics,Thymic Clear Cell Carcinoma,0
4679,Rapid,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4680,55,Undifferentiated Neuroblastoma,0
4681,Medical,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
4682,Financial Account,Precursor B-lymphoblastic lymphoma stage II,0
4683,Hospitalization,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4684,Central neuroblastoma,Recurrent Testicular Lymphoma,0
4685,Neoplasms,Recurrent Testicular Lymphoma,0
4686,Type - attribute,Angiosarcoma of liver,0
4687,Tissue Specimen Code,Non-Metastatic Gestational Trophoblastic Tumor,0
4688,National origin,Human Papillomavirus-Related Carcinoma,0
4689,Hyperestrogenism,Adult Anaplastic Oligodendroglioma,0
4690,aggressive cancer,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
4691,Appearance Distress Question,Noninfiltrating Intraductal Carcinoma,0
4692,Six,Undifferentiated Endocervical Sarcoma,0
4693,lymph nodes,Brain Ependymoma,0
4694,Child,Congenital hamartoma,0
4695,peripheral blood,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4696,cell growth,Refractory Bladder Carcinoma,0
4697,Severe (severity modifier),Localized Ewing Sarcoma,0
4698,Animals,Childhood Extragonadal Malignant Germ Cell Tumor,0
4699,Body part,FIGO Stage IVA Ovarian Cancer,0
4700,Oral cavity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4701,Chemotherapy Regimen,Liver Cavernous Hemangioma,0
4702,Usually,Carcinomatosis of peritoneal cavity,0
4703,risk factors,Grade 1 Clear Cell Renal Cell Carcinoma,0
4704,Combined,Localized Malignant Neoplasm,0
4705,Malignant Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4706,Qualitative form,Splenic Manifestation of Hairy Cell Leukemia,0
4707,Skin Pigmentation,Cancer of Urinary Tract,0
4708,cell transformation,Serous cystadenocarcinoma ovary,0
4709,hiv-infection/aids,Angiosarcoma of liver,0
4710,Fertility Agents,Recurrent Testicular Lymphoma,0
4711,Presence (property),Familial Adenomatous Polyposis Associated Medulloblastoma,0
4712,Elements,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4713,Type A,Engraftment syndrome,0
4714,Benign,Adrenal Rest Tumor,0
4715,Logical Condition,Intraepithelial Melanocytic Hyperplasia,0
4716,Intimate (qualifier value),Atypical Mesothelial Hyperplasia,0
4717,How Often Sweats,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4718,Malignant neoplasm of gastrointestinal tract,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
4719,Breast,Botryoid-Type Embryonal Rhabdomyosarcoma,0
4720,Major <insect>,Squamous cell carcinoma of lip,0
4721,Neoplasms,FIGO Stage IVA Ovarian Cancer,0
4722,Procedure Domain,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
4723,Make - Instruction Imperative,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4724,Sacrococcygeal,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4725,Dietary Lead,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4726,Stem cell transplant,Cancer of Urinary Tract,0
4727,Including (qualifier),Uterine Cancer,0
4728,Occurrence,Endometrial Small Cell Carcinoma,0
4729,Chemotherapy Regimen,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4730,Affect (mental function),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4731,Exposure to,Splenic Manifestation of Hairy Cell Leukemia,0
4732,New,Chondrosarcoma,0
4733,Benign neoplasm of uterus,Epithelioid Sarcoma NCI Grade 3,0
4734,Mismatch Repair,Clinical Stage I Cutaneous Melanoma AJCC v8,0
4735,Used by,mucinous adenocarcinoma of gallbladder,0
4736,Due to,Basal Cell Ameloblastoma,0
4737,Asia,Nasal cavity carcinoma,0
4738,All extremities,Malignant Neoplasm with Regional Lymph Node Involvement,0
4739,Bristol Stool Type 3,Granular Cell Leiomyosarcoma,0
4740,various other intestinal adsorbents in ATC,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4741,Rare,Kaposi's sarcoma of skin,0
4742,Lower - spatial qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
4743,Including (qualifier),BRCA2 Syndrome,0
4744,Skin,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
4745,include - SetOperator,Liver Lymphangioma,0
4746,Disease,Metaplastic carcinoma of breast,0
4747,Leg,Toxic Epidermal Necrolysis,0
4748,Skin,Small cell neuroendocrine carcinoma of bladder,0
4749,Tobacco smoking behavior,Carcinoma ex pleomorphic adenoma of parotid gland,0
4750,Known,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4751,Large,Metastatic Lung Neuroendocrine Neoplasm,0
4752,Make - Instruction Imperative,Acute Undifferentiated Leukemia,0
4753,1000000,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4754,risk factors,Adrenal Rest Tumor,0
4755,clinical aspects,Ovarian germ cell choriocarcinoma stage IV,0
4756,Distal (qualifier value),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4757,Meaning,Recurrent Testicular Lymphoma,0
4758,Age,Hereditary Diffuse Gastric Adenocarcinoma,0
4759,Hair,Refractory Barrett Esophagus,0
4760,Negative Finding,Acute Undifferentiated Leukemia,0
4761,Linear,non-Hodgkin's lymphoma of spleen,0
4762,Diagnostic tests,clear cell adenocarcinoma of gallbladder,0
4763,Divide,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4764,Sore Throat,Gallbladder Adenocarcinoma,0
4765,Symptoms aspect,Childhood Central Nervous System Ganglioneuroblastoma,0
4766,Disorder of cellular component of blood,Stage IV Penile Cancer AJCC v7,0
4767,Chemotherapy Regimen,Thyroid Hurthle Cell Carcinoma,0
4768,Time,Familial Adenomatous Polyposis Associated Medulloblastoma,0
4769,Target Awareness - partial,Tongue Alveolar Soft Part Sarcoma,0
4770,Ovary,Metaplastic carcinoma of breast,0
4771,various allergen extracts,Tonsillar Carcinoma,0
4772,PSA Level Less than Two,Maxillary Sinus Adenoid Cystic Carcinoma,0
4773,skin color,Carcinoma ex pleomorphic adenoma of parotid gland,0
4774,Etiology aspects,Childhood Central Nervous System Ganglioneuroblastoma,0
4775,Night time,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4776,Cancer Other,Extra-Adrenal Paraganglioma,0
4777,therapeutic aspects,Occult Lung Adenosquamous Carcinoma,0
4778,Pancreatic Cancer Pathway,Kaposi's sarcoma of skin,0
4779,Targeted Therapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4780,Architecture,ROSE Cluster 3,0
4781,Specimen Source Codes - tumor,Tongue Alveolar Soft Part Sarcoma,0
4782,Have Been Vomiting,Recurrent Testicular Lymphoma,0
4783,metaplastic cell transformation,Pancreatic carcinoma,0
4784,PSA Level Less than Two,Stage I Colon Neuroendocrine Tumor AJCC v8,0
4785,Current (present time),Cervical Squamous Intraepithelial Neoplasia,0
4786,warming process,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4787,High Mitosis-Karyorrhexis Index,Cartilaginous exostosis,0
4788,Entity,Childhood Choriocarcinoma,0
4789,Hereditary,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4790,Childhood Myelodysplastic Syndrome,Spongiotic dermatitis,0
4791,Frequently,Benign Carotid Body Paraganglioma,0
4792,Tryptophanase,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4793,Focal,Anterior Urethral Malignant Neoplasm,0
4794,removal technique,Childhood Fibrillary Astrocytoma,0
4795,Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
4796,*Type - Kind of quantity,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
4797,Reported Term,Extra-Adrenal Paraganglioma,0
4798,Childhood Grade III Meningioma,Childhood Fibrillary Astrocytoma,0
4799,CDISC SEND Tumor Findings Results Terminology,Mixed parotid tumor,0
4800,Forecast of outcome,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
4801,Benign,embryonal rhabdomyosarcoma of prostate,0
4802,Vaginal,Malignant melanoma of eyelid,0
4803,oncology field,Pilocytic astrocytoma of cerebellum,0
4804,Specimen Source Codes - Lesion,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4805,Nodule,Kaposi's sarcoma of skin,0
4806,Form:Finding:Point in time:{Setting}:Document:{Role},Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4807,Divide,Basal Cell Ameloblastoma,0
4808,Beginning,Metaplastic carcinoma of breast,0
4809,prior radiation therapy,Recurrent Testicular Lymphoma,0
4810,Money or percentage indicator - Percentage,mucinous adenocarcinoma of gallbladder,0
4811,Involvement with,Mixed astrocytoma-ependymoma,0
4812,Present,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
4813,Malignant Childhood Neoplasm,Refractory Bladder Carcinoma,0
4814,Targeted Therapy,Splenic Manifestation of Hairy Cell Leukemia,0
4815,Body tissue,Stage IV Colorectal Cancer AJCC v8,0
4816,High,Cervical Fibroepithelial Polyp,0
4817,+2,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
4818,Therapeutic radiology procedure,Uterine Cancer,0
4819,Body tissue,Human Papillomavirus-Related Carcinoma,0
4820,Nodule,Granular Cell Leiomyosarcoma,0
4821,Date in time,embryonal rhabdomyosarcoma of prostate,0
4822,85,Benign squamous cell tumor,0
4823,Melanoma Pathway,Locally Advanced Carcinoma,0
4824,Chemicals,Undifferentiated Endocervical Sarcoma,0
4825,Derived value,FIGO Stage II Ovarian Cancer,0
4826,Medulla Oblongata,Pancreatic carcinoma,0
4827,Basis - conceptual entity,Endometrial Small Cell Carcinoma,0
4828,Multiply - dosing instruction fragment,Stage IB Lung Cancer AJCC v7,0
4829,Adult Diffuse Large B-Cell Lymphoma,Undifferentiated Neuroblastoma,0
4830,Covers (device),Medulloblastoma,0
4831,+2,Angiosarcoma of liver,0
4832,Benign neoplasm of breast,BRCA2 Syndrome,0
4833,Frequently,Nasal cavity carcinoma,0
4834,Main,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
4835,Chemotherapy Regimen,Testicular cancer metastatic,0
4836,dendritic spine neck,Squamous cell carcinoma of lip,0
4837,CD5L wt Allele,Stage 0 Penile Cancer AJCC v8,0
4838,Contain (action),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
4839,Blood,Stage III Cutaneous Melanoma AJCC v6,0
4840,Inactive - answer to question,Hereditary Diffuse Gastric Adenocarcinoma,0
4841,Plumbum metallicum,Primary Cutaneous Plasmablastic Lymphoma,0
4842,Childhood Teratoma,Intraepithelial Melanocytic Hyperplasia,0
4843,Cause of death:Find:Pt:^Patient:Nom,Malignant Testicular Sertoli Cell Tumor,0
4844,Surgical service,Heavy Chain Deposition Disease,0
4845,Hereditary,Malignant neoplasm of thalamus,0
4846,Times,Peripheral primitive neuroectodermal tumor of soft tissue,0
4847,Array Feature,Thymic Clear Cell Carcinoma,0
4848,Neoplasms,Gallbladder Adenocarcinoma,0
4849,Vaginal,Hodgkin lymphoma,0
4850,Intestinal metaplasia,Recurrent Uveal Melanoma,0
4851,Often - answer to question,Intestinal Metaplasia of Bladder Urothelium,0
4852,60%,Melanomatosis,0
4853,Result,Liver Cavernous Hemangioma,0
4854,Seizures,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
4855,Platelets,Benign Anal Granular Cell Tumor,0
4856,Tumor Mass,Localized Askin Tumor,0
4857,Skin cell,Malignant neoplasm of subglottis,0
4858,Near,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4859,Plumbum metallicum,Gallbladder Adenocarcinoma,0
4860,Personal appearance,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4861,Type A,Peripheral primitive neuroectodermal tumor of soft tissue,0
4862,Negation,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
4863,Involvement with,Splenic Manifestation of Hairy Cell Leukemia,0
4864,Finding,Liver Cavernous Hemangioma,0
4865,Increase,Engraftment syndrome,0
4866,Five-year Survival Rate,Carcinomatosis of peritoneal cavity,0
4867,Stenting,Malignant neoplasm of subglottis,0
4868,shared attribute,Cancer of Urinary Tract,0
4869,Known,Endometrial Small Cell Carcinoma,0
4870,Lymphoma,BRCA2 Syndrome,0
4871,Two,Leptomeningeal sarcoma,0
4872,Dermatitis,Giant cell angiofibroma,0
4873,Code,Chest Wall Fibromatosis,0
4874,Exposure to,adenoid cystic carcinoma of lung,0
4875,Revealed,Female Breast Carcinoma,0
4876,Leads (device),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4877,unknown vaccine or immune globulin,Type II Endometrial Adenocarcinoma,0
4878,Tissue specific,FIGO Stage II Ovarian Cancer,0
4879,Arising in,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4880,Crystal deposition,Peripheral primitive neuroectodermal tumor of soft tissue,0
4881,Age-Years,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
4882,Beginning,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
4883,Biopsy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
4884,Type - attribute,Malignant neoplasm of thalamus,0
4885,Chemotherapy,Gallbladder Adenocarcinoma,0
4886,Togo,Cerebral hemangioma,0
4887,Include (action),Blood Vessel Tumors,0
4888,Referring,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
4889,common types,Malignant neoplasm of gallbladder,0
4890,Smear - instruction imperative,Mastocytosis,0
4891,Death (finding),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
4892,Subject Risk,Malignant Neoplasm with Regional Lymph Node Involvement,0
4893,Site of,Stage III Adult Immunoblastic Lymphoma,0
4894,Fever symptoms (finding),Congenital hamartoma,0
4895,High risk,Carcinoma,0
4896,Widening,Clonal Hematopoiesis of Indeterminate Potential,0
4897,Hereditary,Bladder Neuroendocrine Neoplasm,0
4898,Five,Extra-abdominal fibromatosis,0
4899,Primary,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4900,Thyroid Hormones,Refractory Barrett Esophagus,0
4901,Residue on Tongue,Intestinal Metaplasia of Bladder Urothelium,0
4902,Greater,Benign Carotid Body Paraganglioma,0
4903,Examination,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
4904,Family history,Mucinous adenocarcinoma gastric,0
4905,Common (qualifier value),Xeroderma pigmentosum,0
4906,Neoplasms,Pilocytic astrocytoma of cerebellum,0
4907,Etiology aspects,Bladder squamous cell carcinoma stage I,0
4908,Inguinal region,Vaginal Adenoid Cystic Carcinoma,0
4909,Compression,Neoplasms,0
4910,Have Been Vomiting,Intestinal Metaplasia of Bladder Urothelium,0
4911,Onset of (contextual qualifier),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
4912,depend,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
4913,Tissue of urinary bladder,Human Papillomavirus-Related Carcinoma,0
4914,Characteristics,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
4915,Granulocyte count,Mastocytosis,0
4916,Often - answer to question,Squamous cell carcinoma of lip,0
4917,Type A,FIGO Stage II Ovarian Cancer,0
4918,Several,Astrocytoma of brain,0
4919,Views survey,Ichthyoses,0
4920,Component object,FIGO Stage II Ovarian Cancer,0
4921,Science of Etiology,Malignant Testicular Sertoli Cell Tumor,0
4922,Painless,Bladder adenocarcinoma stage IV,0
4923,Science of Etiology,Bladder Neuroendocrine Neoplasm,0
4924,Transection (procedure),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4925,Delta (difference),Uterine Cancer,0
4926,Skin,Mixed parotid tumor,0
4927,Atypical proliferation,BRCA2 Syndrome,0
4928,Result,Multiple Skull Base Meningiomas,0
4929,Object Relationship,Refractory Ependymoma,0
4930,Primary malignant neoplasm,Nasal cavity carcinoma,0
4931,Cells,Mucinous adenocarcinoma gastric,0
4932,Risk,Recurrent Testicular Lymphoma,0
4933,CYREN gene,Mucinous adenocarcinoma gastric,0
4934,Chemotherapy,Mucinous adenocarcinoma gastric,0
4935,Enzymes,clear cell adenocarcinoma of gallbladder,0
4936,Colon structure (body structure),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
4937,Cell Count,Childhood Fibrillary Astrocytoma,0
4938,Unintentional,Adult Anaplastic Oligodendroglioma,0
4939,Immune,Lung squamous cell carcinoma stage I,0
4940,Excision,Neonatal leukemia,0
4941,Myeloid Progenitor Cells,Carcinoma of urinary bladder,0
4942,Medical History,Ichthyosis,0
4943,Age-Years,Nasal cavity carcinoma,0
4944,Squamous cell carcinoma - category,Colorectal cancer,0
4945,Hereditary,Refractory Ependymoma,0
4946,Classification,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4947,Cultured Cell Line,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
4948,Canada,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
4949,Present,Locally Advanced Soft Tissue Sarcoma,0
4950,Spreading (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
4951,Vitamin B 12 Deficiency,Mucosal Melanoma,0
4952,Genes,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4953,research subject screening,Recurrent Primary Lymphoma of Bone,0
4954,Hormonal Contraception,Acantholytic squamous cell carcinoma,0
4955,Cessation of life,Cerebral Primitive Neuroectodermal Tumor,0
4956,Apply,mucinous adenocarcinoma of gallbladder,0
4957,Sibling,Multiple Endocrine Neoplasia,0
4958,Adenocarcinoma of large intestine,Gallbladder Adenocarcinoma,0
4959,Medical,clear cell adenocarcinoma of gallbladder,0
4960,Left,Bladder squamous cell carcinoma stage I,0
4961,Treating,Childhood Fibrillary Astrocytoma,0
4962,Bladder Cancer Pathway,Cervical Squamous Intraepithelial Neoplasia,0
4963,Greater than one,Hodgkin Disease,0
4964,Analysis of substances,High Grade Glandular Intraepithelial Neoplasia,0
4965,Cells,Digestive System Hodgkin Lymphoma,0
4966,Skin Specimen,Undifferentiated Endocervical Sarcoma,0
4967,Sometimes,Malignant melanoma of eyelid,0
4968,Two,Advanced Uterine Corpus Carcinosarcoma,0
4969,Diet Code Specification Type - Preference,Thymic Clear Cell Carcinoma,0
4970,True,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
4971,Usual,Human Papillomavirus-Related Carcinoma,0
4972,Spreading (qualifier value),adenoid cystic carcinoma of lung,0
4973,Negation,Grade 3a Malignant Neoplasm,0
4974,Neoplastic disease,Methotrexate-Associated Hodgkin Lymphoma,0
4975,Death (finding),Digestive System Hodgkin Lymphoma,0
4976,Dietary Lead,Stage III Cutaneous Melanoma AJCC v6,0
4977,Involvement with,Vaginal Adenoid Cystic Carcinoma,0
4978,Witnesses,Ovarian Dermoid Cyst with Secondary Carcinoma,0
4979,Glycation End Products,Tonsillar Carcinoma,0
4980,Malignant - descriptor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4981,Formation,Plexosarcoma,0
4982,Reduced,Adult Anaplastic Oligodendroglioma,0
4983,Term (temporal),Stage III Cutaneous Melanoma AJCC v6,0
4984,Lymphoma,FIGO Stage IVA Ovarian Cancer,0
4985,Occurrence,Bladder adenocarcinoma stage IV,0
4986,Uncontrolled,Carcinomatosis of peritoneal cavity,0
4987,Characteristics,Extracranial Neuroblastoma,0
4988,Plasma Product,Recurrent Testicular Lymphoma,0
4989,Negation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
4990,65+,Melanomatosis,0
4991,Sarcoma,Undifferentiated Endocervical Sarcoma,0
4992,Then,Adult Alveolar Soft Part Sarcoma,0
4993,Respiratory System Agents,non-Hodgkin's lymphoma of spleen,0
4994,Acquired Name,Cervical Fibroepithelial Polyp,0
4995,Right lymphatic duct,Undifferentiated Endocervical Sarcoma,0
4996,Case (situation),Human Papillomavirus-Related Carcinoma,0
4997,Animals,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
4998,Overall,Adult Anaplastic Oligodendroglioma,0
4999,Imaging Techniques,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5000,device aspects,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5001,Tissue membrane,Choroid Necrotic Melanoma,0
5002,Biomaterial Treatment,Grade 3a Malignant Neoplasm,0
5003,Usual Severity Weight Loss,papillary carcinoma of penis,0
5004,Abdomen+,Airway Hemangioma,0
5005,Benign,Benign squamous cell tumor,0
5006,In Blood,Stage IV Penile Cancer AJCC v7,0
5007,common types,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5008,Dorsal,ROSE Cluster 3,0
5009,Aim (idea),Anaplastic large cell lymphoma,0
5010,Adenoid Cystic Carcinoma,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
5011,*Type - Kind of quantity,Cerebral Primitive Neuroectodermal Tumor,0
5012,Pharyngeal structure,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5013,Constant (qualifier),Childhood Central Nervous System Immature Teratoma,0
5014,Brain Neoplasms,Hereditary Diffuse Gastric Adenocarcinoma,0
5015,Anorexia,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5016,Condition,Chronic Myelomonocytic Leukemia-2,0
5017,Weighing patient,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5018,Cutaneous,Advanced Lung Carcinoma,0
5019,Primary malignant neoplasm,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5020,Make - Instruction Imperative,Adenocarcinoma of duodenum,0
5021,NCI CTEP SDC Melanoma Sub-Category Terminology,Cartilaginous exostosis,0
5022,Combined,Childhood Fibrillary Astrocytoma,0
5023,Females,Hyperplasia of pituitary gland,0
5024,ACTG2 wt Allele,Childhood Central Nervous System Immature Teratoma,0
5025,Frequently,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
5026,treatment - ActInformationManagementReason,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5027,To,Acantholytic squamous cell carcinoma,0
5028,Common Specifications in HL7 V3 Publishing,Unicystic ameloblastoma,0
5029,animal allergen extracts,Gallbladder Adenocarcinoma,0
5030,Have Weight Loss,Anterior Urethral Malignant Neoplasm,0
5031,Carcinoma,Stage III Cutaneous Melanoma AJCC v6,0
5032,Malignant neoplasm of stomach,Urethral Carcinoma,0
5033,Low Mitosis-Karyorrhexis Index,Endometrial Small Cell Carcinoma,0
5034,Physicians,Diffuse malignant mesothelioma,0
5035,shared attribute,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5036,Surgical aspects,Platinum-Resistant Lung Small Cell Carcinoma,0
5037,Cell (compartment),Vaginal Adenoid Cystic Carcinoma,0
5038,cancer risk,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5039,2+ Score,Metastatic Kidney Carcinoma,0
5040,treatment - ActInformationManagementReason,Adult Alveolar Soft Part Sarcoma,0
5041,include - SetOperator,sarcoma of spinal cord,0
5042,Togo,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5043,Radiological Exposure Device,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5044,Feel Pain,de novo Myelodysplastic Syndrome,0
5045,Occurrence Indicator,Anterior Urethral Malignant Neoplasm,0
5046,veterans alcoholism screening test (VAST),Mucinous neoplasm,0
5047,Childhood Lymphoma,Metaplastic carcinoma of breast,0
5048,seconds,Nasal cavity carcinoma,0
5049,Pancreatic carcinoma,Adenocarcinoma,0
5050,Two,Endometrial Small Cell Carcinoma,0
5051,Feel Pain,Digestive System Hodgkin Lymphoma,0
5052,Metastatic Neoplasm,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
5053,Patterns,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5054,include - SetOperator,Hereditary Diffuse Gastric Adenocarcinoma,0
5055,Lymphocyte,Malignant melanoma of eyelid,0
5056,Female,benign mature teratoma of pancreas,0
5057,Show,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5058,Contain (action),Plexosarcoma,0
5059,pharmacotherapeutic,Epithelioid Sarcoma NCI Grade 3,0
5060,CD69 wt Allele,High Grade Glandular Intraepithelial Neoplasia,0
5061,Frequency of Pain Question,Astrocytoma of brain,0
5062,7.2,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5063,Therapeutic procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5064,Entity Determiner - specific,clear cell adenocarcinoma of gallbladder,0
5065,Firstly,Benign tumor of eyelid,0
5066,Milk (body substance),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5067,Egg of order Phthiraptera,Pancreatic Intraepithelial Neoplasia-3,0
5068,Following,Colorectal High Grade B-Cell Lymphoma,0
5069,Process (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
5070,Shell (rigid covering),Mucosal Melanoma,0
5071,Benign Neoplasm,Carcinoma of submandibular gland,0
5072,Neoplasms by Site,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5073,Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5074,Shortened,Placental aromatase deficiency,0
5075,Abnormally high,Metastatic Malignant Neoplasm in the Sellar Region,0
5076,Epidermal cells,Brain Ependymoma,0
5077,> 2 years,Atypical Lobular Breast Hyperplasia,0
5078,Moist,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5079,Nose,Splenic Manifestation of Hairy Cell Leukemia,0
5080,Moved to,Cerebral Primitive Neuroectodermal Tumor,0
5081,Specimen Source Codes - tumor,Engraftment syndrome,0
5082,Pain,FIGO Stage IVA Ovarian Cancer,0
5083,Retinoic Acid Response Element,Mastocytosis,0
5084,*Type - Kind of quantity,Liver Cavernous Hemangioma,0
5085,Epithelial Cells,Female Breast Carcinoma,0
5086,High,Maxillary Sinus Adenocarcinoma,0
5087,Representation (action),Nasal cavity carcinoma,0
5088,Term (temporal),Diffuse malignant mesothelioma,0
5089,Mesothelial cell count,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5090,Congenital qualifier,Locally Advanced Epithelioid Hemangioendothelioma,0
5091,Thyroid carcinoma,Fibroadenoma of breast,0
5092,Egg of order Phthiraptera,Bladder adenocarcinoma stage IV,0
5093,To,Stage II Carcinoma of Penis,0
5094,Screening Study,Squamous cell carcinoma of lip,0
5095,Diagnosis,Maxillary Sinus Adenoid Cystic Carcinoma,0
5096,pathologic fistula,Locally Advanced Carcinoma,0
5097,Third,Extra-abdominal fibromatosis,0
5098,Following,mucinous adenocarcinoma of gallbladder,0
5099,Personal appearance,Acute lymphadenitis,0
5100,Categories,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
5101,Deoxyribonucleic Acid Measurement,Locally Advanced Squamous Cell Carcinoma,0
5102,Malignant neoplasm of ovary,Transitional cell carcinoma,0
5103,Including (qualifier),Intraepithelial Melanocytic Hyperplasia,0
5104,Life Threatening or Disabling Adverse Event,Ovarian germ cell choriocarcinoma stage IV,0
5105,Including (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5106,Physical shape,Basal Cell Ameloblastoma,0
5107,Diagnostic Imaging,Malignant neoplasm of gallbladder,0
5108,Agenesis of corpus callosum,Microcystic meningioma,0
5109,Sample Median,Acantholytic squamous cell carcinoma,0
5110,Include (action),Trabecular adenocarcinoma,0
5111,Cells,Cervical Squamous Intraepithelial Neoplasia,0
5112,Occurrence,Melanomatosis,0
5113,Contain (action),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
5114,Primary malignant neoplasm,Intraepithelial Melanocytic Hyperplasia,0
5115,Involvement with,Extracranial Neuroblastoma,0
5116,Symptoms,Intraepithelial Melanocytic Hyperplasia,0
5117,Form:Finding:Point in time:{Setting}:Document:{Role},Secondary malignant neoplasm of lymph node,0
5118,Hyperplasia,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5119,Tumor Mass,Vaginal Adenoma,0
5120,Cancer Genus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5121,Beginning,Squamous cell carcinoma of lip,0
5122,production,Cerebral Primitive Neuroectodermal Tumor,0
5123,Localized,Neoplasms,0
5124,diagnosis aspect,Stage III Cutaneous Melanoma AJCC v6,0
5125,Body structure,ICHTHYOSIS,0
5126,Group A (qualifier value),Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
5127,Vagina,mucinous adenocarcinoma of gallbladder,0
5128,Cancer Genus,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
5129,Concentration measurement,Cervical Fibroepithelial Polyp,0
5130,Administration procedure,Refractory Ependymoma,0
5131,Personal appearance,Intracortical osteosarcoma,0
5132,Location of Pharyngeal Residue Following Swallowing,Undifferentiated Endocervical Sarcoma,0
5133,campbell,Localized Askin Tumor,0
5134,Poverty,Carcinoma of urinary bladder,0
5135,Iodides,Necrotizing Funisitis,0
5136,Most,Bladder adenocarcinoma stage IV,0
5137,Involvement with,Diffuse malignant mesothelioma,0
5138,Rest,Melanomatosis,0
5139,Very,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5140,Night time,Refractory Bladder Carcinoma,0
5141,Does run (finding),Pancreatic carcinoma,0
5142,diagnostic accuracy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5143,Tryptophanase,embryonal rhabdomyosarcoma of prostate,0
5144,Group A (qualifier value),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
5145,Used by,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
5146,DNA,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5147,Include (action),Locally Advanced Epithelioid Hemangioendothelioma,0
5148,Therapeutic radiology procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5149,various allergen extracts,Childhood Fibrillary Astrocytoma,0
5150,Embryonic tissue,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5151,High Level,Malignant neoplasm of gallbladder,0
5152,Include (action),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5153,Platelets,Malignant melanoma of eyelid,0
5154,Body tissue,Unresectable Rhabdomyosarcoma,0
5155,Repaired,Recurrent Uveal Melanoma,0
5156,majority,Benign neoplasm of eye,0
5157,History,Engraftment syndrome,0
5158,Affecting,Recurrent Uveal Melanoma,0
5159,Family history,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5160,Poor - qualifier,Familial Hemophagocytic Lymphocytosis,0
5161,Recurrent infections,Thymic Clear Cell Carcinoma,0
5162,Root body part,Malignant neoplasm of thalamus,0
5163,Reported,Cervical Fibroepithelial Polyp,0
5164,Symptoms aspect,Clonal Hematopoiesis of Indeterminate Potential,0
5165,Including (qualifier),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5166,Surface,Intraepithelial Melanocytic Hyperplasia,0
5167,Type - attribute,Mucinous adenocarcinoma gastric,0
5168,Present,Hereditary corneal dystrophy,0
5169,To,Splenic Manifestation of Hairy Cell Leukemia,0
5170,Endometrial biopsy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5171,Organ,Chronic Myelomonocytic Leukemia-2,0
5172,Referring,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
5173,Image Feature,Choroid Necrotic Melanoma,0
5174,2+ Score,Stage III Cutaneous Melanoma AJCC v6,0
5175,Diagnosis Study,Stage IB Pancreatic Cancer AJCC v8,0
5176,Primary lymphoid organ,Kaposi's sarcoma of extrahepatic bile duct,0
5177,Manufactured sign,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5178,survival aspects,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5179,Classification,sarcoma of spinal cord,0
5180,BRCA2 protein,Platinum-Resistant Lung Small Cell Carcinoma,0
5181,High Mitosis-Karyorrhexis Index,Methotrexate-Associated Hodgkin Lymphoma,0
5182,Age,Localized Malignant Neoplasm,0
5183,Participation Type - origin,Thymic Clear Cell Carcinoma,0
5184,What subject filter - Result,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5185,Pressure (property),Precursor B-lymphoblastic lymphoma stage II,0
5186,Sweat,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5187,Structure of lymphatic trunk,Malignant melanoma of eyelid,0
5188,Neoplasms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5189,Screening,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5190,Cause of death.underlying,Grade 3a Malignant Neoplasm,0
5191,Germ cell tumor,Malignant Testicular Sertoli Cell Tumor,0
5192,United States,Kaposi's sarcoma of skin,0
5193,Pesticides,Cancer of Urinary Tract,0
5194,peripheral blood,Adult Brain Stem Mixed Glioma,0
5195,Canada,Malignant neoplasm of choroid,0
5196,Result,Adult Hepatocellular Carcinoma,0
5197,Contain (action),Microcystic meningioma,0
5198,Definition,Unicystic ameloblastoma,0
5199,Aspects of disease screening,Ovarian Carcinoid Tumor,0
5200,shared attribute,Malignant Testicular Sertoli Cell Tumor,0
5201,other medicated shampoos in ATC,Endometrial Small Cell Carcinoma,0
5202,Breast,Female Breast Carcinoma,0
5203,Appearance,Recurrent Uveal Melanoma,0
5204,N not otherwise specified Antibody,Splenic Manifestation of Hairy Cell Leukemia,0
5205,filtration,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5206,Morbidity - disease rate,Stage IV Colorectal Cancer AJCC v8,0
5207,Body tissue,Childhood Thyroid Gland Follicular Carcinoma,0
5208,Breast Carcinoma,Stage IV Childhood Non-Hodgkin Lymphoma,0
5209,Capsule Shape,FIGO Stage IVA Ovarian Cancer,0
5210,Arising in,Benign neoplasm of thorax,0
5211,Negation,Metastatic Malignant Neoplasm in the Sellar Region,0
5212,Human body structure,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5213,Polyp of large intestine,Refractory Barrett Esophagus,0
5214,Blastoma,Adult Fibrolamellar Carcinoma,0
5215,Carcinoid Tumor,Recurrent Primary Lymphoma of Bone,0
5216,Location,Cervical Fibroepithelial Polyp,0
5217,Cell (compartment),Mucinous adenocarcinoma gastric,0
5218,Follow-Up Report,clear cell adenocarcinoma of gallbladder,0
5219,Most,Gallbladder Adenocarcinoma,0
5220,True,Recurrent Uveal Melanoma,0
5221,First (number),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
5222,Act Class - investigation,Pilocytic astrocytoma of cerebellum,0
5223,Affecting,Nasal cavity carcinoma,0
5224,Transitional cell morphology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5225,Vaginal Sarcoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5226,Retinoic Acid Response Element,Basal Cell Ameloblastoma,0
5227,Include (action),Recurrent Testicular Lymphoma,0
5228,Smear - instruction imperative,Larynx carcinoma recurrent,0
5229,melanocyte,Mucinous adenocarcinoma,0
5230,Screening - general (procedure),Stage I Adult Non-Hodgkin Lymphoma,0
5231,Etiology aspects,Acantholytic squamous cell carcinoma,0
5232,Neoplasms,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
5233,Immune system,Locally Advanced Soft Tissue Sarcoma,0
5234,Infected,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5235,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5236,Males,Adrenal Rest Tumor,0
5237,Increase,Fibroadenoma of breast,0
5238,Symptoms,Mucinous adenocarcinoma gastric,0
5239,Swallowing painful,Cerebral Primitive Neuroectodermal Tumor,0
5240,treatment - ActInformationManagementReason,Kaposi's sarcoma of skin,0
5241,Able (finding),Botryoid-Type Embryonal Rhabdomyosarcoma,0
5242,Specimen Source Codes - tumor,Type II Endometrial Adenocarcinoma,0
5243,Round shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5244,Hearing examination finding,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5245,Occurrence Indicator,Mucinous adenocarcinoma gastric,0
5246,Increased,Mixed astrocytoma-ependymoma,0
5247,Precision - characteristic,Acute Undifferentiated Leukemia,0
5248,Large,Mucinous adenocarcinoma gastric,0
5249,Interferes with,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5250,Secondary Neoplasm,Vaginal Adenoid Cystic Carcinoma,0
5251,Vomiting,Testicular cancer metastatic,0
5252,Rare,Recurrent Primary Lymphoma of Bone,0
5253,Body tissue,Breast Ductal Adenoma,0
5254,Common (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5255,Usual Severity Weight Loss,Tonsillar Carcinoma,0
5256,Malignant Neoplasms,Heavy Chain Deposition Disease,0
5257,3+ Answer to Question,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5258,What subject filter - Result,Stage II Carcinoma of Penis,0
5259,1960s,Cancer of Urinary Tract,0
5260,Occurrence Indicator,Lipoma of small intestine,0
5261,Person 1,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5262,various allergen extracts,Benign squamous cell tumor,0
5263,Palpebronasal fold,Adult Anaplastic Oligodendroglioma,0
5264,low,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5265,Patients,Acute Undifferentiated Leukemia,0
5266,Autoimmune Diseases,embryonal rhabdomyosarcoma of prostate,0
5267,Continuance of life,Blood Vessel Tumors,0
5268,Primary Malignant Liver Neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5269,Cessation of life,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5270,Neuroblastoma,Trichilemmocarcinoma,0
5271,Incidence,Melanomatosis,0
5272,More,Uterine Cancer,0
5273,Qualitative form,Digestive System Hodgkin Lymphoma,0
5274,year,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5275,Left sided,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5276,Usual Severity Weight Loss,Malignant neoplasm of thalamus,0
5277,Severe (severity modifier),Digestive System Hodgkin Lymphoma,0
5278,Availability of,Noninfiltrating Intraductal Carcinoma,0
5279,Malignant neoplasm of skin,Liver Lymphangioma,0
5280,Containing (qualifier),Unresectable Rhabdomyosarcoma,0
5281,diagnosis aspect,Childhood Fibrillary Astrocytoma,0
5282,*Type - Kind of quantity,Mucosal Melanoma,0
5283,Linear,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5284,Active License,Astrocytoma of brain,0
5285,Anterior,Adult Hepatocellular Carcinoma,0
5286,Arising,Carcinoma of submandibular gland,0
5287,Squamous,Adult Alveolar Soft Part Sarcoma,0
5288,Sore skin,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5289,Linear,Benign tumor of eyelid,0
5290,Togo,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5291,Contain (action),Pancreatic carcinoma,0
5292,Urinary tract,Transitional cell carcinoma,0
5293,Malignant Neoplasms,Testicular cancer metastatic,0
5294,Malignant neoplasm of kidney,mucinous adenocarcinoma of gallbladder,0
5295,SPINK5 gene,Central Nervous System Yolk Sac Tumor,0
5296,User Group,Benign Apocrine Neoplasm,0
5297,Term Birth,Benign Carotid Body Paraganglioma,0
5298,Tired,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5299,Pharmacotherapy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5300,Image Feature,Advanced Uterine Corpus Carcinosarcoma,0
5301,Tumor site,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5302,Tissue Specimen Code,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5303,Rare,Pleomorphic adenoma of parotid gland,0
5304,Ephrin Type-B Receptor 1,Mucinous neoplasm,0
5305,Distant,Recurrent Testicular Lymphoma,0
5306,Effective,Colorectal Neuroendocrine Tumor G2,0
5307,Generalized,Anaplastic large cell lymphoma,0
5308,Specimen Source Codes - tumor,Metaplastic carcinoma of breast,0
5309,Lifetime,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5310,Molecular Mass,Benign Anal Granular Cell Tumor,0
5311,Castor bean poisoning,Cervical Fibroepithelial Polyp,0
5312,Treating,Recurrent Uveal Melanoma,0
5313,Disorder of cellular component of blood,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5314,Development,Atypical Lobular Breast Hyperplasia,0
5315,lead increased,Recurrent Testicular Lymphoma,0
5316,Form:Finding:Point in time:{Setting}:Document:{Role},Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5317,Chromosome Aberrations,Gallbladder Adenocarcinoma,0
5318,Inferior Colliculus,Human Papillomavirus-Related Carcinoma,0
5319,various other intestinal adsorbents in ATC,BRCA2 Syndrome,0
5320,ovarian,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5321,Entity Determiner - specific,Nasal cavity carcinoma,0
5322,Removal of bladder,benign mature teratoma of pancreas,0
5323,Human body structure,BRCA2 Syndrome,0
5324,Out (direction),Occult Lung Adenosquamous Carcinoma,0
5325,Medications:-:Point in time:^Patient:-,Cerebral Primitive Neuroectodermal Tumor,0
5326,Tumor Mass,Stage III Cutaneous Melanoma AJCC v6,0
5327,Pediatric Neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5328,Negative,Colorectal cancer,0
5329,Flat shape,Mixed astrocytoma-ependymoma,0
5330,Hormonal,Squamous cell carcinoma of lip,0
5331,Research Activities,Advanced Uterine Corpus Carcinosarcoma,0
5332,Vaginal,Malignant melanoma of eyelid,0
5333,Including (qualifier),Bladder squamous cell carcinoma stage I,0
5334,Aggressive behavior,Malignant melanoma of eyelid,0
5335,Areas <moth>,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
5336,Usually,Medulloblastoma,0
5337,International Statistical Classification of Diseases and Related Health Problems,Gallbladder Adenocarcinoma,0
5338,Drop - Unit of Volume,Intraepithelial Melanocytic Hyperplasia,0
5339,depend,Adenocarcinoma,0
5340,Give - dosing instruction imperative,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5341,Application Dosing Unit,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5342,option - ActMoodPredicate,Stage III Cutaneous Melanoma AJCC v6,0
5343,DNA,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5344,P-Glycoproteins,Airway Hemangioma,0
5345,Including (qualifier),Tongue Alveolar Soft Part Sarcoma,0
5346,Post Device,Larynx carcinoma recurrent,0
5347,Biopsy,Lipoma of small intestine,0
5348,Treating,Bladder squamous cell carcinoma stage I,0
5349,theca cell,Benign squamous cell tumor,0
5350,Endocrine,Colorectal cancer,0
5351,Fine needle aspiration biopsy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5352,Icterus,Familial Hemophagocytic Lymphocytosis,0
5353,Version,Mucosal Melanoma,0
5354,Variable (uniformity),Metastatic Lung Small Cell Carcinoma,0
5355,diagnosis aspect,Hodgkin Disease,0
5356,Lung,Cystadenocarcinoma,0
5357,active (HL7 RoleLink),Thymic Atypical Carcinoid Tumor,0
5358,Fix,Benign Anal Granular Cell Tumor,0
5359,Cellular infiltrate,Malignant neoplasm of subglottis,0
5360,Intervention regimes,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5361,More,Methotrexate-Associated Hodgkin Lymphoma,0
5362,Glycation End Products,Childhood Central Nervous System Ganglioneuroblastoma,0
5363,More,Platinum-Resistant Lung Small Cell Carcinoma,0
5364,Numerous,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5365,Type of reconstruction,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5366,Infective cystitis,Chronic Myelomonocytic Leukemia-2,0
5367,Occur (action),Type II Endometrial Adenocarcinoma,0
5368,therapeutic aspects,Unfavorable Non-Hodgkin Lymphoma,0
5369,84,Vaginal Adenoma,0
5370,Childhood Leukemia,Endometrial Small Cell Carcinoma,0
5371,Very,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5372,Term (temporal),Benign Carotid Body Paraganglioma,0
5373,Common (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
5374,Include (action),Undifferentiated Endocervical Sarcoma,0
5375,various other intestinal adsorbents in ATC,Metastatic Ductal Breast Carcinoma,0
5376,3+ Score,Human Papillomavirus-Related Carcinoma,0
5377,17th century,Human Papillomavirus-Related Carcinoma,0
5378,Original Regulatory Submission,Stage III Cutaneous Melanoma AJCC v6,0
5379,Leakage,Endometrial Small Cell Carcinoma,0
5380,Supportive assistance,Childhood Choriocarcinoma,0
5381,Etiology aspects,Locally Advanced Carcinoma,0
5382,Usual Severity Difficulty Swallowing,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5383,All extremities,Epithelioid Sarcoma NCI Grade 3,0
5384,Metastatic to,Vaginal Adenoma,0
5385,Impaired skin integrity,Werner Syndrome,0
5386,65,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5387,80%,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5388,Natures,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5389,Administration type,Cancer of Urinary Tract,0
5390,risk factors - observation list,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5391,Line Unit of Length,Human Papillomavirus-Related Carcinoma,0
5392,Mass of body structure,Childhood Central Nervous System Ganglioneuroblastoma,0
5393,Anemia,Cerebral Primitive Neuroectodermal Tumor,0
5394,Primitive Mesenchymal Cell,Malignant Testicular Sertoli Cell Tumor,0
5395,Five,Hodgkin lymphoma,0
5396,Time (foundation metadata concept),Acute Undifferentiated Leukemia,0
5397,Tumor cells,Cerebral Primitive Neuroectodermal Tumor,0
5398,Neoplasm Metastasis,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
5399,Rest,Non-Metastatic Gestational Trophoblastic Tumor,0
5400,Coding,Tonsillar Carcinoma,0
5401,What subject filter - Result,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5402,Second Suffix,Extra-Adrenal Paraganglioma,0
5403,Mechanism (attribute),Vaginal Adenoma,0
5404,Negation,Multiple Skull Base Meningiomas,0
5405,Account number:Identifier:Point in time:^Patient:Nominal,Airway Hemangioma,0
5406,Loss of appetite (finding),Childhood Central Nervous System Ganglioneuroblastoma,0
5407,Screening procedure,Mucinous adenocarcinoma,0
5408,68,Thyroid Hurthle Cell Carcinoma,0
5409,Age of Onset,Pancreatic Intraepithelial Neoplasia-3,0
5410,PREVENT (product),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
5411,Similarity,Unresectable Rhabdomyosarcoma,0
5412,year,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5413,Usually,Stage IV Childhood Non-Hodgkin Lymphoma,0
5414,Cause of Death,Adult Alveolar Soft Part Sarcoma,0
5415,seen,Occult Lung Adenosquamous Carcinoma,0
5416,Followed by,Cancer of Urinary Tract,0
5417,Multiple Sclerosis,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5418,Common (qualifier value),Recurrent Testicular Lymphoma,0
5419,Physical findings,Clonal Hematopoiesis of Indeterminate Potential,0
5420,Sternum,Recurrent Testicular Lymphoma,0
5421,Eye,Intraepithelial Melanocytic Hyperplasia,0
5422,Nicotiana,Benign neoplasm of eye,0
5423,Lock Device,Melanomatosis,0
5424,Arising in,Papillary squamous cell carcinoma,0
5425,Malignant Neoplasms,Undifferentiated Neuroblastoma,0
5426,Treated with,Benign tumor of eyelid,0
5427,Affecting,Chest Wall Fibromatosis,0
5428,Togo,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5429,Mutation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5430,Usual Severity Weight Loss,Kaposi's sarcoma of extrahepatic bile duct,0
5431,Malignancy,Metastatic Neoplasm to the Gallbladder,0
5432,Main,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5433,Simpson Grade 2,Benign tumor of eyelid,0
5434,Type - attribute,Vaginal Adenoma,0
5435,Blood Platelets,Lipoma of small intestine,0
5436,Person Name,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5437,Previous,Diffuse malignant mesothelioma,0
5438,Neoplasms,BRCA2 Syndrome,0
5439,Crystal Device,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5440,History of previous events,Testicular cancer metastatic,0
5441,American College of Cardiology/American Heart Association Lesion Complexity Score C,Extra-Adrenal Paraganglioma,0
5442,Alveolar rhabdomyosarcoma,Malignant melanoma of eyelid,0
5443,Initially,Anterior Urethral Malignant Neoplasm,0
5444,Early,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5445,Warts,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5446,Abdominal hysterectomy,Acute lymphadenitis,0
5447,Infrequent,Serous cystadenocarcinoma ovary,0
5448,Estrogen (disposition),Kaposi's sarcoma of skin,0
5449,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
5450,Pharmacotherapy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5451,Electrical Current,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
5452,Base - General Qualifier,Hodgkin Disease,0
5453,Growth action,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
5454,Tissue Specimen Code,Colorectal Neuroendocrine Tumor G2,0
5455,Antibody Formation,sarcoma of spinal cord,0
5456,Type - attribute,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5457,Adult Gliosarcoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5458,Encounter due to being a donor,Mucinous adenocarcinoma,0
5459,Cancer Genus,Type II Endometrial Adenocarcinoma,0
5460,cervical cancer,Anaplastic large cell lymphoma,0
5461,Include (action),Pleomorphic adenoma of parotid gland,0
5462,Presence (property),Unicystic ameloblastoma,0
5463,Synonym (core metadata concept),Clinical Stage I Cutaneous Melanoma AJCC v8,0
5464,Malignant Neoplasms,Grade 3a Malignant Neoplasm,0
5465,Vaginal Melanoma,Benign Anal Granular Cell Tumor,0
5466,Stem of Organ,BRCA2 Syndrome,0
5467,Operative Surgical Procedures,Tonsillar Carcinoma,0
5468,Characterization,Recurrent Uveal Melanoma,0
5469,Leg,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5470,Proliferation (morphologic abnormality),Benign Ovarian Thecoma,0
5471,Psyche structure,ROSE Cluster 3,0
5472,Cell (compartment),Endometrial Small Cell Carcinoma,0
5473,Operative Surgical Procedures,Anaplastic large cell lymphoma,0
5474,Country,Trichilemmocarcinoma,0
5475,Sequence Data Type,Intestinal Metaplasia of Bladder Urothelium,0
5476,Axillary Lymph Node Involvement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5477,First (number),Stage III Cutaneous Melanoma AJCC v6,0
5478,Genetic Inheritance,FIGO Stage IVA Ovarian Cancer,0
5479,Heart Failure,Childhood Anaplastic Large Cell Lymphoma,0
5480,Exposure to Agent Orange,BRCA2 Syndrome,0
5481,*Type - Kind of quantity,Maxillary Sinus Adenoid Cystic Carcinoma,0
5482,Immunocompromised Host,Noninfiltrating Intraductal Carcinoma,0
5483,Neurofibromatosis 1,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5484,Absence (morphologic abnormality),Ovarian germ cell choriocarcinoma stage IV,0
5485,Tissue Specimen Code,Intestinal Metaplasia of Bladder Urothelium,0
5486,Contain (action),Refractory Bladder Carcinoma,0
5487,Pilocytic Astrocytoma,Spermatocytic seminoma,0
5488,various other nasal preparations in ATC,Splenic Manifestation of Hairy Cell Leukemia,0
5489,Abnormal Cell Count,Splenic Manifestation of Hairy Cell Leukemia,0
5490,Diet,Colorectal Neuroendocrine Tumor G2,0
5491,In situ,FIGO Stage IVA Ovarian Cancer,0
5492,Infective cystitis,Thyroid carcinoma,0
5493,Cervical lymph node group,Hyperplasia of pituitary gland,0
5494,Adult Myelodysplastic Syndrome,Engraftment syndrome,0
5495,Now (temporal qualifier),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5496,radiotherapeutic,Anterior Urethral Malignant Neoplasm,0
5497,Widening,High Grade Glandular Intraepithelial Neoplasia,0
5498,Timepoint,Intestinal Metaplasia of Bladder Urothelium,0
5499,900,Ichthyosis,0
5500,Name (property) (qualifier value),Benign neoplasm of thorax,0
5501,Abnormal result,Mastocytosis,0
5502,To,Platinum-Resistant Lung Small Cell Carcinoma,0
5503,Sunlight,Advanced Uterine Corpus Carcinosarcoma,0
5504,include - SetOperator,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5505,Source of radiation (attribute),Intestinal Neuroendocrine Carcinoma,0
5506,Slightly Able,Colorectal High Grade B-Cell Lymphoma,0
5507,Exertion,Unicystic ameloblastoma,0
5508,Endometrial Carcinoma,Localized Ewing Sarcoma,0
5509,Tissue Specimen Code,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5510,Inguinal region,Basal Cell Ameloblastoma,0
5511,African American,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5512,Poor - qualifier,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5513,Persons,Astrocytoma of brain,0
5514,Kidney,Rhabdomyosarcoma with ganglionic differentiation,0
5515,New,Localized Ewing Sarcoma,0
5516,Assisted (qualifier value),Xeroderma pigmentosum,0
5517,Portion of urine,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
5518,>5,Peripheral primitive neuroectodermal tumor of soft tissue,0
5519,Linear,Childhood Fibrillary Astrocytoma,0
5520,Unknown GENC,Refractory Ependymoma,0
5521,Common (qualifier value),Gallbladder Adenocarcinoma,0
5522,Rating (action),Cervical Fibroepithelial Polyp,0
5523,Muscle Pain,Colorectal cancer,0
5524,WHO Central Nervous System Grade IV,Brain Tumor,0
5525,Isolated,Cancer of Urinary Tract,0
5526,Fever,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5527,Escape (mental process),Carcinomatosis of peritoneal cavity,0
5528,Squamous cell carcinoma - category,Carcinoma of urinary bladder,0
5529,Common (qualifier value),Bladder squamous cell carcinoma stage I,0
5530,Neoadjuvant Therapy,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
5531,Tryptophanase,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5532,Australia,Localized Askin Tumor,0
5533,PSA Level Less than Two,Rhabdomyosarcoma with ganglionic differentiation,0
5534,Occurrence,Gallbladder Adenocarcinoma,0
5535,In situ,Type II Endometrial Adenocarcinoma,0
5536,Malignant neoplasm of lung,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
5537,Acetaminophen,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5538,Smear - instruction imperative,Localized Askin Tumor,0
5539,survival aspects,Stage III Cutaneous Melanoma AJCC v6,0
5540,Evidence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5541,Stains,Benign neoplasm of eye,0
5542,Fasting,Tongue Alveolar Soft Part Sarcoma,0
5543,Result,Carcinoma of submandibular gland,0
5544,Correct (qualifier),Thymic Clear Cell Carcinoma,0
5545,Spreading (qualifier value),Childhood Lymphoma,0
5546,Medical History,FIGO Stage II Ovarian Cancer,0
5547,Tissue Specimen Code,Metaplastic carcinoma of breast,0
5548,Corner Plus,Mucinous adenocarcinoma gastric,0
5549,Lesion,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5550,Tumor Mass,Metastatic Lung Small Cell Carcinoma,0
5551,English race,Adult Acute Eosinophilic Leukemia,0
5552,Sore sensation,Pancreatic carcinoma,0
5553,World Health Organization,Squamous cell carcinoma of lip,0
5554,Classification of information,ICHTHYOSIS,0
5555,Malignant - descriptor,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5556,Gastrointestinal tract structure,Spindle Cell Melanoma,0
5557,Rating (action),Multiple Skull Base Meningiomas,0
5558,Pancreatic Hormones,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5559,Childhood Diffuse Large B-Cell Lymphoma,Digestive System Hodgkin Lymphoma,0
5560,Loss of Appetite question,Adult Fibrolamellar Carcinoma,0
5561,Eighth,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5562,Malignant - descriptor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5563,Age at diagnosis,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5564,Organ,Benign neoplasm of eye,0
5565,risk factors - observation list,Stage II Carcinoma of Penis,0
5566,To,Stage III Adult Immunoblastic Lymphoma,0
5567,Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5568,Abnormally high,Recurrent Diffuse Intrinsic Pontine Glioma,0
5569,C3 gene,Benign squamous cell tumor,0
5570,Diagnosis,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5571,Regurgitation - mechanism,Malignant melanoma of eyelid,0
5572,Complete Agreement,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5573,Continuance of life,Locally Advanced Squamous Cell Carcinoma,0
5574,Togo,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5575,Separate,Localized Ewing Sarcoma,0
5576,Behavior,Metastatic Neoplasm to the Gallbladder,0
5577,Cause of Death,Maxillary Sinus Adenocarcinoma,0
5578,Body structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
5579,Name (property) (qualifier value),Childhood Anaplastic Large Cell Lymphoma,0
5580,Leading,Acantholytic squamous cell carcinoma,0
5581,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Undifferentiated Leukemia,0
5582,Rest,Adult Acute Eosinophilic Leukemia,0
5583,Site,Mixed parotid tumor,0
5584,Renal carcinoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5585,Type A,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
5586,depend,Breast Ductal Adenoma,0
5587,Age,Human Papillomavirus-Related Carcinoma,0
5588,Body Fluid Discharge,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5589,Affecting,Bladder adenocarcinoma stage IV,0
5590,Leading,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5591,Salivary Glands,Microcystic meningioma,0
5592,Lymphoma,FIGO Stage II Ovarian Cancer,0
5593,child survival,Central Nervous System Yolk Sac Tumor,0
5594,Involvement with,Medulloblastoma,0
5595,Excision,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5596,Surgical aspects,Uterine Cancer,0
5597,Five-year Survival Rate,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5598,International Foot,Squamous cell carcinoma of lip,0
5599,Make - Instruction Imperative,Localized Askin Tumor,0
5600,Hypothalamic structure,Stage IB Lung Cancer AJCC v7,0
5601,Glycation End Products,Endometrial Small Cell Carcinoma,0
5602,Case (situation),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5603,More,Cartilaginous exostosis,0
5604,Thyroid carcinoma,Stage III Cutaneous Melanoma AJCC v6,0
5605,Human body structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5606,Death (finding),Primary Cutaneous Plasmablastic Lymphoma,0
5607,Death (finding),Localized Malignant Neoplasm,0
5608,Disease remission,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
5609,Tumor cells,Splenic Manifestation of Hairy Cell Leukemia,0
5610,Relationships,Bladder Neuroendocrine Neoplasm,0
5611,Tissue Specimen Code,Peripheral primitive neuroectodermal tumor of soft tissue,0
5612,Antacids,Localized Askin Tumor,0
5613,Palatine Tonsil,Refractory Glioma,0
5614,Human body,mucinous adenocarcinoma of gallbladder,0
5615,Bulbomembranous Urethra,Tonsillar Carcinoma,0
5616,Breast Carcinoma,Advanced Lung Carcinoma,0
5617,Due to,papillary carcinoma of penis,0
5618,What subject filter - Result,Anterior Urethral Malignant Neoplasm,0
5619,Base of the Brain,Spermatocytic seminoma,0
5620,Freckles,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
5621,Vertebrates,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5622,Inguinal region,Squamous cell carcinoma of lip,0
5623,Negative Selection,Testicular cancer metastatic,0
5624,High Mitosis-Karyorrhexis Index,Carcinomatosis of peritoneal cavity,0
5625,Pleomorphism,Precursor B-lymphoblastic lymphoma stage II,0
5626,Meaning,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5627,Pericardial sac structure,Neoplasms,0
5628,Tissue Specimen Code,Liver Lymphangioma,0
5629,Throat,Low Grade Squamous Intraepithelial Neoplasia,0
5630,70%,Locally Advanced Squamous Cell Carcinoma,0
5631,Carcinoma with osteoclast-like giant cells,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5632,Early,Anterior Urethral Malignant Neoplasm,0
5633,Cancer Genus,Localized Ewing Sarcoma,0
5634,Location,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5635,Involvement with,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5636,Occur (action),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5637,Therapeutic radiology procedure,Bladder adenocarcinoma stage IV,0
5638,various antiseptic throat preparations,Non-Metastatic Gestational Trophoblastic Tumor,0
5639,Type - attribute,BRCA2 Syndrome,0
5640,Skin lesion,adenoid cystic carcinoma of lung,0
5641,Result,Cervical Squamous Intraepithelial Neoplasia,0
5642,Set of regional lymph nodes,Carcinomatosis of peritoneal cavity,0
5643,Coding Subtest (WAIS-IV),Adult Acute Eosinophilic Leukemia,0
5644,Suspected diagnosis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5645,Current (present time),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5646,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5647,Class,Neonatal leukemia,0
5648,70%,Tubal Hyperplasia,0
5649,Location,Recurrent Primary Lymphoma of Bone,0
5650,Cervix carcinoma,Maxillary Sinus Adenocarcinoma,0
5651,Exposure to,Spermatocytic seminoma,0
5652,nonspecific,clear cell adenocarcinoma of gallbladder,0
5653,Thyroid Gland,Cartilaginous exostosis,0
5654,40%,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5655,Diagnosis Study,Stage IB Lung Cancer AJCC v7,0
5656,African American,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5657,Support,Colorectal cancer,0
5658,Sweat,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5659,Blood Products Laboratory Testing,Cancer of Urinary Tract,0
5660,Immune,Benign neoplasm of thorax,0
5661,Primary malignant neoplasm,Lipoma of small intestine,0
5662,Name (property) (qualifier value),Mucinous cystadenofibroma,0
5663,Blood group antibody I,Transitional cell carcinoma,0
5664,Several,Heavy Chain Deposition Disease,0
5665,Requirement,FIGO Stage IVA Ovarian Cancer,0
5666,Tract,Metaplastic carcinoma of breast,0
5667,Complete,malignant lymphoma of pancreatic lymph nodes,0
5668,IPSS Risk Category High,Acinar cell carcinoma of pancreas,0
5669,American College of Cardiology/American Heart Association Lesion Complexity Score C,Stage IB Pancreatic Cancer AJCC v8,0
5670,Pelvic pain female,Recurrent Testicular Lymphoma,0
5671,adjectives,Bladder squamous cell carcinoma stage I,0
5672,Human body,Vaginal Adenoid Cystic Carcinoma,0
5673,Usually Need Help from Another Person for Reach,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
5674,Name,embryonal rhabdomyosarcoma of prostate,0
5675,Body tissue,Extracranial Neuroblastoma,0
5676,History of - blood transfusion,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5677,FDA Establishment Activity Terminology,Locally Advanced Squamous Cell Carcinoma,0
5678,Limited stage (cancer stage),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5679,Mass of body structure,Cancer of Urinary Tract,0
5680,Known,Grade 1 Clear Cell Renal Cell Carcinoma,0
5681,Common Specifications in HL7 V3 Publishing,Chronic Myelomonocytic Leukemia-2,0
5682,Screening,Refractory Ependymoma,0
5683,Occur (action),Hodgkin Disease,0
5684,Structure of minor calyx,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5685,To,Benign tumor of eyelid,0
5686,Advanced phase,Plexosarcoma,0
5687,>5,Digestive System Hodgkin Lymphoma,0
5688,Papillary thyroid carcinoma,Locally Advanced Squamous Cell Carcinoma,0
5689,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Childhood Central Nervous System Ganglioneuroblastoma,0
5690,Common (qualifier value),Benign Apocrine Neoplasm,0
5691,Tentorium <eukaryote>,Acantholytic squamous cell carcinoma,0
5692,Operative Surgical Procedures,Mucinous neoplasm,0
5693,To,Basal Cell Ameloblastoma,0
5694,Nasal cavity,Cartilaginous exostosis,0
5695,Concept model domain,FIGO Stage II Ovarian Cancer,0
5696,Cerebral hemisphere structure (body structure),Ovarian Dermoid Cyst with Secondary Carcinoma,0
5697,How Often Felt Normal question,Childhood Central Nervous System Ganglioneuroblastoma,0
5698,filtration,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5699,Usually,malignant lymphoma of pancreatic lymph nodes,0
5700,abnormal growth by tissue,Squamous cell carcinoma of lip,0
5701,Use of,Benign squamous cell tumor,0
5702,Common (qualifier value),Glomeruloid hemangioma,0
5703,Often - answer to question,adenoid cystic carcinoma of lung,0
5704,member,Gallbladder Adenocarcinoma,0
5705,Presentation,Intraepithelial Melanocytic Hyperplasia,0
5706,diagnosis aspect,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
5707,Base Pairing,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5708,leukemia,Adult Acute Eosinophilic Leukemia,0
5709,Death (finding),Acute Undifferentiated Leukemia,0
5710,Feel Tired question,Diffuse malignant mesothelioma,0
5711,Lower lip structure,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
5712,Referring,Liver Lymphangioma,0
5713,Blood Cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5714,Ultraviolet Rays,Squamous cell carcinoma of lip,0
5715,Obesity,Ichthyosis,0
5716,Cells,Engraftment syndrome,0
5717,Woman,embryonal rhabdomyosarcoma of prostate,0
5718,Patient Reported Outcome,Larynx carcinoma recurrent,0
5719,Medicine,Engraftment syndrome,0
5720,Normal,Rhabdomyosarcoma with ganglionic differentiation,0
5721,Chemotherapy,Occult Lung Adenosquamous Carcinoma,0
5722,Frequently,Refractory Bladder Carcinoma,0
5723,Cover - action,Digestive System Hodgkin Lymphoma,0
5724,Definitely Related to Intervention,mucinous adenocarcinoma of gallbladder,0
5725,1+ Score,Cerebral Primitive Neuroectodermal Tumor,0
5726,Coding,Stage III Cutaneous Melanoma AJCC v6,0
5727,Hodgkin Disease,Contact dermatitis due to alkali,0
5728,Cessation of life,Engraftment syndrome,0
5729,Often - answer to question,Squamous cell carcinoma of lip,0
5730,PREVENT (product),mucinous adenocarcinoma of gallbladder,0
5731,Negation,Type II Endometrial Adenocarcinoma,0
5732,Tissue Growth,Cancer of Urinary Tract,0
5733,Carcinoma,Recurrent Testicular Lymphoma,0
5734,Canada,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5735,Usual Severity Weight Loss,Pilocytic astrocytoma of cerebellum,0
5736,50%,Human Papillomavirus-Related Carcinoma,0
5737,Patient observation,Pancreatic carcinoma,0
5738,Include (action),Thyroid Hurthle Cell Carcinoma,0
5739,What subject filter - Result,Vaginal Adenoma,0
5740,Neoplasms,Endometrial Small Cell Carcinoma,0
5741,Gonadal structure,Bladder squamous cell carcinoma stage I,0
5742,Arising in,Pancreatic carcinoma,0
5743,include - SetOperator,Undifferentiated Endocervical Sarcoma,0
5744,Benign Vascular Neoplasm,Ichthyosis,0
5745,Biomaterial Treatment,Medulloblastoma,0
5746,Occur (action),Carcinoma,0
5747,Tumor cells,Neoplasms,0
5748,Formed,FIGO Stage IVA Ovarian Cancer,0
5749,Genus equus,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
5750,Malignant Neoplasms,Periosteal Osteosarcoma,0
5751,Sufficiently defined concept definition status (core metadata concept),Locally Advanced Epithelioid Hemangioendothelioma,0
5752,Pure Spanish horse breed (organism),Acantholytic squamous cell carcinoma,0
5753,PSA Level Less than Two,Giant cell angiofibroma,0
5754,<90,Malignant melanoma of eyelid,0
5755,Chemotherapy Regimen,Platinum-Resistant Lung Small Cell Carcinoma,0
5756,To,Non-Metastatic Gestational Trophoblastic Tumor,0
5757,Abdomen distended,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5758,abnormal growth by tissue,Ovarian Dermoid Cyst with Secondary Carcinoma,0
5759,Common (qualifier value),embryonal rhabdomyosarcoma of prostate,0
5760,Areas <moth>,Cervical Squamous Intraepithelial Neoplasia,0
5761,Wild flowers,Unresectable Rhabdomyosarcoma,0
5762,radiotherapeutic,Refractory Barrett Esophagus,0
5763,10%,Methotrexate-Associated Hodgkin Lymphoma,0
5764,Variable (uniformity),Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
5765,Approximate,Uterine Cancer,0
5766,Brain part,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5767,Malignant Neoplasms,Refractory Barrett Esophagus,0
5768,Diagnosis,Kaposi's sarcoma of extrahepatic bile duct,0
5769,Illness: Cannot describe symptoms,Cartilaginous exostosis,0
5770,Tissue Specimen Code,Endometrial Small Cell Carcinoma,0
5771,Most,Intraepithelial Melanocytic Hyperplasia,0
5772,Dryness (characteristic),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5773,2+,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
5774,Usually Need Help from Another Person for Arising,Carcinoma of urinary bladder,0
5775,Time (foundation metadata concept),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
5776,Divide,Metastatic Neoplasm to the Gallbladder,0
5777,Secondary Neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5778,Wounds and Injuries,Platinum-Resistant Lung Small Cell Carcinoma,0
5779,Coding,Maxillary Sinus Adenoid Cystic Carcinoma,0
5780,Disease,Chest Wall Fibromatosis,0
5781,Abdominal Cavity,Cancer of Urinary Tract,0
5782,Example,Digestive System Hodgkin Lymphoma,0
5783,Contain (action),Bladder adenocarcinoma stage IV,0
5784,Component object,Multiple Skull Base Meningiomas,0
5785,Complete Pharyngeal Contraction,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5786,Benign melanocytic nevus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5787,<3 (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5788,Age at diagnosis:Time:Pt:^Patient:Qn,High Grade Glandular Intraepithelial Neoplasia,0
5789,Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5790,Result,Metastatic Ductal Breast Carcinoma,0
5791,Tissue Specimen Code,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5792,Meibomian Cyst,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5793,Publishing,Childhood Fibrillary Astrocytoma,0
5794,To,Pancreatic carcinoma,0
5795,Only - dosing instruction fragment,Hodgkin lymphoma,0
5796,Human Cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5797,Tickling sensation quality,Childhood Central Nervous System Ganglioneuroblastoma,0
5798,Togo,Pancreatic carcinoma,0
5799,Malignant Neoplasms,Cervical Fibroepithelial Polyp,0
5800,Screening - general NOS (finding),Acute Undifferentiated Leukemia,0
5801,Childhood Lymphoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
5802,Arising,Giant cell angiofibroma,0
5803,Type - attribute,embryonal rhabdomyosarcoma of prostate,0
5804,Pediculus (eukaryote),Hodgkin lymphoma,0
5805,Numerous,Cartilaginous exostosis,0
5806,Feelings,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
5807,Pituitary Gland,Angiosarcoma of liver,0
5808,Malignant neoplasm of skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
5809,Tryptophanase,Adenocarcinoma of the prostate metastatic,0
5810,Esophageal,Recurrent Testicular Lymphoma,0
5811,Human Papillomavirus,Digestive System Hodgkin Lymphoma,0
5812,Tumor Cell Invasion,Mixed astrocytoma-ependymoma,0
5813,Cancer Genus,de novo Myelodysplastic Syndrome,0
5814,Aspects of disease screening,Recurrent Diffuse Intrinsic Pontine Glioma,0
5815,Secretory Vesicles,Refractory Barrett Esophagus,0
5816,Function Axis,Airway Hemangioma,0
5817,Type A,Benign Anal Granular Cell Tumor,0
5818,Small cell carcinoma of lung,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5819,Togo,Peripheral primitive neuroectodermal tumor of soft tissue,0
5820,Regulatory Application,Tonsillar Carcinoma,0
5821,Cells,Chronic Myelomonocytic Leukemia-2,0
5822,Vertebral column,BRCA2 Syndrome,0
5823,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5824,Observation of color of skin,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5825,Done (qualifier value),Pancreatic Intraepithelial Neoplasia-3,0
5826,Often - answer to question,Tonsillar Carcinoma,0
5827,Site of origin,mucinous adenocarcinoma of gallbladder,0
5828,Suspected diagnosis,Occult Lung Adenosquamous Carcinoma,0
5829,Adenocarcinoma of anal sac,Low Grade Squamous Intraepithelial Neoplasia,0
5830,N+ (tumor staging),Nasal cavity carcinoma,0
5831,3+ Score,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
5832,Name,Thyroid Hurthle Cell Carcinoma,0
5833,Double eyelid,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5834,Concept model range (foundation metadata concept),Childhood Fibrillary Astrocytoma,0
5835,RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Metastatic Lung Neuroendocrine Neoplasm,0
5836,Contain (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5837,Neoplasms,Intestinal Metaplasia of Bladder Urothelium,0
5838,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5839,Probably,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
5840,Manufactured sign,Vaginal Adenoma,0
5841,Number of birth,Gallbladder Adenocarcinoma,0
5842,VARIOUS DRUG CLASSES IN ATC,Recurrent Uveal Melanoma,0
5843,Surgical aspects,Liver Lymphangioma,0
5844,Ultraviolet Rays,Stage I Adult Non-Hodgkin Lymphoma,0
5845,exception - ResponseLevel,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5846,Histopathologic Grade,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5847,Injury wounds,Lung squamous cell carcinoma stage I,0
5848,Biomaterial Treatment,Trabecular adenocarcinoma,0
5849,Usual,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5850,Blood capillaries,Breast Ductal Adenoma,0
5851,Subject Risk,Adult Alveolar Soft Part Sarcoma,0
5852,Most,Small cell neuroendocrine carcinoma of bladder,0
5853,Talpidae,Malignant neoplasm of olfactory nerve,0
5854,To,Squamous cell carcinoma of lip,0
5855,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Primary Cutaneous Plasmablastic Lymphoma,0
5856,Cell Count,Hyperplasia of pituitary gland,0
5857,Treatment Epoch,Gallbladder adenoma,0
5858,Different,Metaplastic carcinoma of breast,0
5859,Negation,adenosquamous carcinoma of breast,0
5860,Inguinal part of abdomen,Stage III Cutaneous Melanoma AJCC v6,0
5861,Pass (indicator),Mucinous neoplasm,0
5862,pharmacotherapeutic,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5863,Lymphoid organ structure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5864,Present,Tubal Hyperplasia,0
5865,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
5866,Rare,Airway Hemangioma,0
5867,Mixed Neoplasm,Lung Mucinous Cystadenoma,0
5868,Possible,Medulloblastoma,0
5869,Large,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5870,Out (direction),Adult Alveolar Soft Part Sarcoma,0
5871,International Aspects,malignant lymphoma of pancreatic lymph nodes,0
5872,Persons,embryonal rhabdomyosarcoma of prostate,0
5873,Providing presence (regime/therapy),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5874,Diagnosis,Bladder squamous cell carcinoma stage I,0
5875,Have Weight Loss,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
5876,1+,Refractory Bladder Carcinoma,0
5877,Screening procedure,Cancer of Urinary Tract,0
5878,Combined,Pancreatic Intraepithelial Neoplasia-3,0
5879,85,Hodgkin lymphoma,0
5880,Include (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5881,Catch - Finding of sensory dimension of pain,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5882,Smear - instruction imperative,Childhood Anaplastic Large Cell Lymphoma,0
5883,LYMPHOID Cancers,Childhood Thyroid Gland Follicular Carcinoma,0
5884,Distal (qualifier value),Benign squamous cell tumor,0
5885,Sunscreening Agents,FIGO Stage IVA Ovarian Cancer,0
5886,Ancestry-Informative Marker,Nasal cavity carcinoma,0
5887,Metastatic Neoplasm,Spongiotic dermatitis,0
5888,Tryptophanase,Choroid Necrotic Melanoma,0
5889,penis,Malignant melanoma of eyelid,0
5890,Sequence Arm,adenosquamous carcinoma of breast,0
5891,Further,Engraftment syndrome,0
5892,Germ Layers,Trabecular adenocarcinoma,0
5893,Abnormal,Thymic Clear Cell Carcinoma,0
5894,Body structure,Thyroid Hurthle Cell Carcinoma,0
5895,English Language,Low Grade Squamous Intraepithelial Neoplasia,0
5896,Administration procedure,Stage IB Pancreatic Cancer AJCC v8,0
5897,Name (property) (qualifier value),Undifferentiated Endocervical Sarcoma,0
5898,Sore to touch,Metastatic Lung Neuroendocrine Neoplasm,0
5899,Survey Foot,Thymic Clear Cell Carcinoma,0
5900,Oligodendroglia,Benign tumor of eyelid,0
5901,Neoplasms,Metastatic Neoplasm to the Gallbladder,0
5902,Tissue Growth,Airway Hemangioma,0
5903,risk factors,Testicular cancer metastatic,0
5904,Diagnostic Imaging,ROSE Cluster 3,0
5905,Oral (intended site),Spongiotic dermatitis,0
5906,metaplastic cell transformation,Platinum-Resistant Lung Small Cell Carcinoma,0
5907,Diagnosis Study,adenoid cystic carcinoma of lung,0
5908,More,Mucinous adenocarcinoma gastric,0
5909,Non-Small Cell Lung Carcinoma,Deep Leiomyoma,0
5910,Malignant Neoplasms,Lipoma of small intestine,0
5911,European race,Hereditary Diffuse Gastric Adenocarcinoma,0
5912,Plumbum metallicum,Carcinoma of urinary bladder,0
5913,Vaginal,Benign tumor of eyelid,0
5914,Uveal melanoma,benign mature teratoma of pancreas,0
5915,Controlled by,Human Papillomavirus-Related Carcinoma,0
5916,potential,Basal Cell Ameloblastoma,0
5917,Skin Specimen,Stage IB Lung Cancer AJCC v7,0
5918,Term (temporal),Human Papillomavirus-Related Carcinoma,0
5919,Primary malignant neoplasm,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5920,Fibroid Tumor,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5921,Surgical aspects,Plexosarcoma,0
5922,Feature,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
5923,OTULIN gene,Colorectal High Grade B-Cell Lymphoma,0
5924,Unmarried,Thyroid carcinoma,0
5925,Term (temporal),adenosquamous carcinoma of breast,0
5926,Specific qualifier value,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
5927,Adult Lymphoma,Colorectal Neuroendocrine Tumor G2,0
5928,Sepsis (Invertebrate),Adult Alveolar Soft Part Sarcoma,0
5929,diagnosis aspect,Refractory Bladder Carcinoma,0
5930,per year,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
5931,Confirmation,Keratoderma,0
5932,Hepatoblastoma,Cystadenocarcinoma,0
5933,Negation,Tonsillar Carcinoma,0
5934,Most,Malignant melanoma of eyelid,0
5935,Control function,de novo Myelodysplastic Syndrome,0
5936,Morphology,Metastatic Malignant Neoplasm in the Sellar Region,0
5937,Sometimes,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
5938,65,Pancreatic Intraepithelial Neoplasia-3,0
5939,Cervix Uteri,Recurrent Primary Lymphoma of Bone,0
5940,Problems - What subject filter,Squamous cell carcinoma of lip,0
5941,Further,adenoid cystic carcinoma of lung,0
5942,Breathing Distress Question,Benign Carotid Body Paraganglioma,0
5943,Human Cells,Botryoid-Type Embryonal Rhabdomyosarcoma,0
5944,Most,Testicular cancer metastatic,0
5945,Classification,Stage III Adult Immunoblastic Lymphoma,0
5946,Data Type - Point In Time,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5947,Initially,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
5948,Pelvic Pain,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
5949,Supportive assistance,Medulloblastoma,0
5950,Negation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
5951,Occurrence Indicator,Tonsillar Carcinoma,0
5952,REMS Protocol,Diffuse malignant mesothelioma,0
5953,Weight Loss,Ovarian germ cell choriocarcinoma stage IV,0
5954,Surrounding (qualifier value),Type II Endometrial Adenocarcinoma,0
5955,Retinoic Acid Response Element,Splenic Manifestation of Hairy Cell Leukemia,0
5956,Biomaterial Treatment,Breast Ductal Adenoma,0
5957,radiotherapeutic,Heavy Chain Deposition Disease,0
5958,Anaplastic thyroid carcinoma,Extra-Adrenal Paraganglioma,0
5959,Primary malignant neoplasm,Xeroderma pigmentosum,0
5960,To,Metastatic Neoplasm to the Gallbladder,0
5961,Hematologic Tests,Heavy Chain Deposition Disease,0
5962,North America,Heavy Chain Deposition Disease,0
5963,Biomaterial Treatment,Testicular cancer metastatic,0
5964,Used by,Clinical Stage I Cutaneous Melanoma AJCC v8,0
5965,Condition:Find:Pt:^Patient:Nom,Stage I Adult Non-Hodgkin Lymphoma,0
5966,High Grade Cervical Squamous Intraepithelial Neoplasia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
5967,Part of,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
5968,Splenomegaly,Malignant melanoma of eyelid,0
5969,Case unit dose,Refractory Bladder Carcinoma,0
5970,IPSS Risk Category High,Low Grade Squamous Intraepithelial Neoplasia,0
5971,intended - ParticipationSignature,FIGO Stage II Ovarian Cancer,0
5972,Lymphoid,Neonatal leukemia,0
5973,Measures,Heavy Chain Deposition Disease,0
5974,Term Birth,Cancer of Urinary Tract,0
5975,Average,Choroid Necrotic Melanoma,0
5976,Component object,Undifferentiated Endocervical Sarcoma,0
5977,Gait normal,Primary Cutaneous Plasmablastic Lymphoma,0
5978,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
5979,pharmacotherapeutic,Familial Hemophagocytic Lymphocytosis,0
5980,shared attribute,Tonsillar Carcinoma,0
5981,Cells,Mucinous cystadenofibroma,0
5982,React,Spongiotic dermatitis,0
5983,Comparison,Ovarian germ cell choriocarcinoma stage IV,0
5984,Age at menopause:Time:Point in time:^Patient:Quantitative,Benign Ovarian Thecoma,0
5985,United States Military Commissioned Officer O4,Lung squamous cell carcinoma stage I,0
5986,Enhance (action),papillary carcinoma of penis,0
5987,Symptoms aspect,Digestive System Hodgkin Lymphoma,0
5988,Rapid,Metastatic Lung Neuroendocrine Neoplasm,0
5989,occurrence characteristics,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
5990,<90,Intraepithelial Melanocytic Hyperplasia,0
5991,Degree Unit of Plane Angle,Acute Undifferentiated Leukemia,0
5992,<3 (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
5993,Anterior portion of neck,Heavy Chain Deposition Disease,0
5994,Striated muscle cell,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
5995,Group Object,Localized Askin Tumor,0
5996,With shape,Bladder squamous cell carcinoma stage I,0
5997,BRCA2 gene,Blood Vessel Tumors,0
5998,Hormonal,Leptomeningeal sarcoma,0
5999,Colon <insect>,Xeroderma pigmentosum,0
6000,Lead,Mucosal Melanoma,0
6001,Physical shape,Carcinoma of submandibular gland,0
6002,Type - attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
6003,Ovary,Acantholytic squamous cell carcinoma,0
6004,Either,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6005,Orbital region,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6006,Intrinsic origin,Brain Tumor,0
6007,Exchange (clinical),Stage 0 Penile Cancer AJCC v8,0
6008,Eyelid structure,FIGO Stage II Ovarian Cancer,0
6009,Food Consumption,Clonal Hematopoiesis of Indeterminate Potential,0
6010,Line Unit of Length,Refractory Ependymoma,0
6011,Symptoms,Thymic Clear Cell Carcinoma,0
6012,biopsy characteristics,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6013,Non-Neoplastic Disorder,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
6014,Pharmacotherapy,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6015,Multiple Myeloma,Childhood Central Nervous System Ganglioneuroblastoma,0
6016,Groups,Xeroderma pigmentosum,0
6017,Usually,Xeroderma pigmentosum,0
6018,Application Context,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6019,Body Site Modifier - Lower,Metastatic Lung Neuroendocrine Neoplasm,0
6020,Feel Nausea,Medulloblastoma,0
6021,Primary malignant neoplasm,Mixed astrocytoma-ependymoma,0
6022,Stem of plant,Thyroid Hurthle Cell Carcinoma,0
6023,Common (qualifier value),mucinous adenocarcinoma of gallbladder,0
6024,Body tissue,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6025,Regurgitates after swallowing,Type II Endometrial Adenocarcinoma,0
6026,Skin tanning,Adenocarcinoma,0
6027,Bladder Continence Question,Peripheral primitive neuroectodermal tumor of soft tissue,0
6028,bony process,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6029,Type A,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6030,Blood flow,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6031,Ability,clear cell adenocarcinoma of gallbladder,0
6032,Approximate,clear cell adenocarcinoma of gallbladder,0
6033,Carcinoma,Intraepithelial Melanocytic Hyperplasia,0
6034,Membrane Device,Lipoma of small intestine,0
6035,Adenoidal structure,Stage III Cutaneous Melanoma AJCC v6,0
6036,>5,Necrotizing Funisitis,0
6037,Medical Device Emits Smoke,Intestinal Neuroendocrine Carcinoma,0
6038,Malignant - descriptor,Intraepithelial Melanocytic Hyperplasia,0
6039,Skin,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6040,SLC6A2 protein,Benign Anal Granular Cell Tumor,0
6041,Metaplasia,Intraepithelial Melanocytic Hyperplasia,0
6042,Time,Refractory Bladder Carcinoma,0
6043,shared attribute,Extracranial Neuroblastoma,0
6044,Telling untruths,Childhood Fibrillary Astrocytoma,0
6045,Spectrum,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6046,Occur (action),Stage III Cutaneous Melanoma AJCC v6,0
6047,Accurate (qualifier),Carcinoma of submandibular gland,0
6048,Division (surgical procedure),Familial Adenomatous Polyposis Associated Medulloblastoma,0
6049,Growth action,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6050,Lymphoma,Ovarian germ cell choriocarcinoma stage IV,0
6051,Death (finding),Intracortical osteosarcoma,0
6052,ovarian neoplasm,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6053,Pale color saturation,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
6054,NCI Thesaurus Qualifier,Xeroderma pigmentosum,0
6055,Hematologic Neoplasms,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
6056,Tissue Specimen Code,Colorectal Neuroendocrine Tumor G2,0
6057,Malignant neoplasm of breast,Colorectal cancer,0
6058,Second edition,Metastatic Neoplasm to the Gallbladder,0
6059,Contain (action),mucinous adenocarcinoma of gallbladder,0
6060,peripheral blood,High Grade Glandular Intraepithelial Neoplasia,0
6061,Malignant neoplasm of breast,Unresectable Rhabdomyosarcoma,0
6062,Recent,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6063,Gastrointestinal tract structure,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
6064,Pancreatic Cancer Pathway,Childhood Central Nervous System Ganglioneuroblastoma,0
6065,Singular,Intraepithelial Melanocytic Hyperplasia,0
6066,Anabolism,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6067,Probably,Undifferentiated Endocervical Sarcoma,0
6068,Symptoms,Choroid Necrotic Melanoma,0
6069,Malignant Neoplasms,Transitional cell carcinoma,0
6070,Disease,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6071,Less Than,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6072,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6073,2+,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6074,Test Result,Chondrosarcoma,0
6075,Cystic,malignant lymphoma of pancreatic lymph nodes,0
6076,Fluid behavior,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6077,Early,Engraftment syndrome,0
6078,Pediculus (eukaryote),Fourth Ventricle and Brain Stem Ependymal Tumor,0
6079,Primary,Occult Lung Adenosquamous Carcinoma,0
6080,Greater,Adult Fibrolamellar Carcinoma,0
6081,Cells,BRCA2 Syndrome,0
6082,Cells,Mucinous adenocarcinoma gastric,0
6083,Subject Risk,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6084,Use of,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6085,Radioactive Seed Implant Dosing Unit,Human Papillomavirus-Related Carcinoma,0
6086,Cancer Genus,Advanced Lung Carcinoma,0
6087,Walled,Choroid Epithelioid Cell Melanoma,0
6088,Myoepithelioma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6089,Plasma,Contact dermatitis due to alkali,0
6090,Malignant neoplasm of liver,Benign neoplasm of thorax,0
6091,Pure Spanish horse breed (organism),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6092,Upper arm,Epithelioid Sarcoma NCI Grade 3,0
6093,Malignant tumor of exocrine pancreas,Localized Malignant Neoplasm,0
6094,Occur (action),Female Breast Carcinoma,0
6095,BEP protocol,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6096,Person Name,Kaposi's sarcoma of extrahepatic bile duct,0
6097,unknown vaccine or immune globulin,Gallbladder Adenocarcinoma,0
6098,Malignant neoplasm of ovary,Small cell neuroendocrine carcinoma of bladder,0
6099,To,Childhood Fibrillary Astrocytoma,0
6100,Molecular Mass,Trichilemmocarcinoma,0
6101,Biogenic Amines,Pancreatic Intraepithelial Neoplasia-3,0
6102,Manufactured sign,Funisitis (disorder),0
6103,Xeroderma Pigmentosum,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6104,Communicable Diseases,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6105,Pallor,Engraftment syndrome,0
6106,Contraceptives,Kaposi's sarcoma of extrahepatic bile duct,0
6107,control substance,Familial Adenomatous Polyposis Associated Medulloblastoma,0
6108,Metastatic to,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6109,Determined by,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6110,growth aspects,Human Papillomavirus-Related Carcinoma,0
6111,Woman,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6112,Biological Response Modifier Therapy,Mucinous adenocarcinoma gastric,0
6113,Smooth muscle (tissue),Brain Ependymoma,0
6114,Small cell carcinoma of lung,Malignant melanoma of eyelid,0
6115,Primary,Astrocytoma of brain,0
6116,International Unit,Stage III Cutaneous Melanoma AJCC v6,0
6117,Benign Neoplasm,Thymic Atypical Carcinoid Tumor,0
6118,Site of,Cervical Squamous Intraepithelial Neoplasia,0
6119,risk factors,Unicystic ameloblastoma,0
6120,Value Above Reference Range,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6121,The Sun,Atypical Lobular Breast Hyperplasia,0
6122,Lymphadenopathy,papillary carcinoma of penis,0
6123,Myeloid,Astrocytoma of brain,0
6124,PSA Level Less than Five,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6125,Manufactured sign,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6126,CT of systems,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6127,Illness: Cannot describe symptoms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6128,Unmarried,Stage III Adult Immunoblastic Lymphoma,0
6129,Germ cell tumor,clear cell adenocarcinoma of gallbladder,0
6130,List,High Grade Glandular Intraepithelial Neoplasia,0
6131,Africa,Localized Malignant Neoplasm,0
6132,Adult Lymphoma,Astrocytoma of brain,0
6133,NCI CTEP SDC Mesothelioma Sub-Category Terminology,Atypical Mesothelial Hyperplasia,0
6134,combination of objects,Vaginal Adenoma,0
6135,Malignant - descriptor,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6136,Fusion-Negative Rhabdomyosarcoma,Malignant Testicular Sertoli Cell Tumor,0
6137,*Type - Kind of quantity,Periosteal Osteosarcoma,0
6138,Tired,Basal Cell Ameloblastoma,0
6139,Carcinoid Tumor,mucinous adenocarcinoma of gallbladder,0
6140,B-Cell Lymphomas,Cervical Squamous Intraepithelial Neoplasia,0
6141,Childhood Hodgkin Lymphoma,Acantholytic squamous cell carcinoma,0
6142,>90,Advanced Uterine Corpus Carcinosarcoma,0
6143,Entire elbow region,Type II Endometrial Adenocarcinoma,0
6144,Provide (product),Hereditary Diffuse Gastric Adenocarcinoma,0
6145,Beginning,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6146,Sometimes,Melanomatosis,0
6147,mole changes,Carcinoma of urinary bladder,0
6148,peripheral blood,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6149,Lifestyle changes,Gallbladder Adenocarcinoma,0
6150,Make - Instruction Imperative,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6151,Form of joint,Stage IV Childhood Non-Hodgkin Lymphoma,0
6152,SPINK5 gene,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6153,Only - dosing instruction fragment,Transitional cell carcinoma,0
6154,Beginning,Cerebral Primitive Neuroectodermal Tumor,0
6155,year,Adult Acute Eosinophilic Leukemia,0
6156,week,Cerebral Primitive Neuroectodermal Tumor,0
6157,Microscopes,Cancer of Urinary Tract,0
6158,More,Childhood Anaplastic Large Cell Lymphoma,0
6159,Feelings,Thyroid Hurthle Cell Carcinoma,0
6160,Type A,Endometrial Small Cell Carcinoma,0
6161,Unmarried,Uterine Cancer,0
6162,Taxonomic,Clonal Hematopoiesis of Indeterminate Potential,0
6163,risk factors - observation list,Benign Ovarian Thecoma,0
6164,Scab,Breast Ductal Adenoma,0
6165,Enhance (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
6166,Orbital region,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6167,Secondary Neoplasm,Female Breast Carcinoma,0
6168,Tumor Mass,Stage III Adult Immunoblastic Lymphoma,0
6169,Person Name,Locally Advanced Squamous Cell Carcinoma,0
6170,Unexplained weight loss,High Grade Glandular Intraepithelial Neoplasia,0
6171,Referral placed,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6172,Same,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6173,Primary malignant neoplasm,Localized Askin Tumor,0
6174,Upper arm,Gallbladder Adenocarcinoma,0
6175,1000000,clear cell adenocarcinoma of gallbladder,0
6176,Child,Pancreatic carcinoma,0
6177,Management Occupations,Benign tumor of eyelid,0
6178,Statistical Significance,Refractory Ependymoma,0
6179,Resulting in,Cervical Fibroepithelial Polyp,0
6180,Swelling,Childhood Central Nervous System Ganglioneuroblastoma,0
6181,Descending,Angiosarcoma of liver,0
6182,Metaplasia,Endometrial Small Cell Carcinoma,0
6183,Overweight,Granular Cell Leiomyosarcoma,0
6184,factor A,Metaplastic carcinoma of breast,0
6185,Early,Malignant neoplasm of thalamus,0
6186,South East Asian,Intestinal Metaplasia of Bladder Urothelium,0
6187,Symptoms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6188,Lymphoid Tissue,Locally Advanced Squamous Cell Carcinoma,0
6189,United States,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6190,Have Weight Loss,Heavy Chain Deposition Disease,0
6191,Body tissue,Pancreatic Intraepithelial Neoplasia-3,0
6192,Small cell carcinoma of lung,Recurrent Uveal Melanoma,0
6193,Egg of order Phthiraptera,Kaposi's sarcoma of extrahepatic bile duct,0
6194,IPSS Risk Category Low,Kaposi's sarcoma of skin,0
6195,How Often,embryonal rhabdomyosarcoma of prostate,0
6196,Include (action),Cervical Squamous Intraepithelial Neoplasia,0
6197,Vaginal Hemorrhage,BRCA2 Syndrome,0
6198,Hematopoietic Neoplasms,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6199,Tests (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
6200,Hormone (disposition),Unicystic ameloblastoma,0
6201,Germ cell tumor,Unicystic ameloblastoma,0
6202,Part of,Recurrent Primary Lymphoma of Bone,0
6203,Latin America,Stage IB Pancreatic Cancer AJCC v8,0
6204,Cell Device,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6205,Mechanism Component of Device,FIGO Stage IVA Ovarian Cancer,0
6206,Occurrence,Human Papillomavirus-Related Carcinoma,0
6207,True,Bladder Neuroendocrine Neoplasm,0
6208,Usual,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6209,Treatment Epoch,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6210,Poor - qualifier,Tubal Hyperplasia,0
6211,Swallowing:-:Point in time:^Patient:-,gliosarcoma,0
6212,Body tissue,Intestinal Metaplasia of Bladder Urothelium,0
6213,Neoplasm Metastasis,Stage I Adult Non-Hodgkin Lymphoma,0
6214,Result,Localized Ewing Sarcoma,0
6215,Biopsy,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6216,Patient need for (contextual qualifier),Type II Endometrial Adenocarcinoma,0
6217,Childhood Gliosarcoma,Acantholytic squamous cell carcinoma,0
6218,Base - General Qualifier,Anaplastic large cell lymphoma,0
6219,Eighth,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6220,MOSTLY,Medulloblastoma,0
6221,Bile duct structure,ICHTHYOSIS,0
6222,Bone Marrow,Neoplasms,0
6223,Rare,clear cell adenocarcinoma of gallbladder,0
6224,Smoking,Nasal cavity carcinoma,0
6225,Abdomen+,Cervical Fibroepithelial Polyp,0
6226,rituximab,Stage IV Penile Cancer AJCC v7,0
6227,Mammary Gland Parenchyma,Human Papillomavirus-Related Carcinoma,0
6228,Class,Non-Metastatic Gestational Trophoblastic Tumor,0
6229,Percent (qualifier value),Clonal Hematopoiesis of Indeterminate Potential,0
6230,Rest,Metastatic Ductal Breast Carcinoma,0
6231,Subtype (attribute),Malignant Neoplasm with Regional Lymph Node Involvement,0
6232,Epithelium,Unfavorable Non-Hodgkin Lymphoma,0
6233,Affecting,Malignant melanoma of eyelid,0
6234,Very Much,Glomeruloid hemangioma,0
6235,3+ Score,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6236,Normal,malignant lymphoma of pancreatic lymph nodes,0
6237,Widening,Ovarian Carcinoid Tumor,0
6238,PSA Level Greater than Fifty,Medulloblastoma,0
6239,30%,Childhood Fibrillary Astrocytoma,0
6240,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Airway Hemangioma,0
6241,Immunotherapy,Tonsillar Carcinoma,0
6242,Linear,Localized Askin Tumor,0
6243,Salts,Chronic Myelomonocytic Leukemia-2,0
6244,Physical findings,Intraepithelial Melanocytic Hyperplasia,0
6245,Spreading (qualifier value),Testicular cancer metastatic,0
6246,Feel Tired question,Non-Metastatic Gestational Trophoblastic Tumor,0
6247,Pseudomyxoma Peritonei,Thyroid Hurthle Cell Carcinoma,0
6248,95,Cervical Squamous Intraepithelial Neoplasia,0
6249,Common (qualifier value),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
6250,breast.duct,Adult Alveolar Soft Part Sarcoma,0
6251,Treatment Effectiveness,Stage III Cutaneous Melanoma AJCC v6,0
6252,Life,Ovarian germ cell choriocarcinoma stage IV,0
6253,Scientific Study,Metaplastic carcinoma of breast,0
6254,Abdomen distended,Carcinomatosis of peritoneal cavity,0
6255,Characteristics,Recurrent Diffuse Intrinsic Pontine Glioma,0
6256,Have Itch,Unresectable Rhabdomyosarcoma,0
6257,90%,Ovarian germ cell choriocarcinoma stage IV,0
6258,PAGR1 wt Allele,Benign Anal Granular Cell Tumor,0
6259,interstitial,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6260,Common Specifications in HL7 V3 Publishing,Trichilemmocarcinoma,0
6261,Cell Count,Xeroderma pigmentosum,0
6262,Numerous,Hodgkin lymphoma,0
6263,Common Specifications in HL7 V3 Publishing,Malignant Neoplasm with Regional Lymph Node Involvement,0
6264,Have Weight Loss,Thyroid Hurthle Cell Carcinoma,0
6265,To,Noninfiltrating Intraductal Carcinoma,0
6266,Lung,non-Hodgkin's lymphoma of spleen,0
6267,Include (action),Hodgkin Disease,0
6268,Nobel Prize,Tonsillar Carcinoma,0
6269,Greeks,embryonal rhabdomyosarcoma of prostate,0
6270,regional,Malignant melanoma of eyelid,0
6271,Tryptophanase,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
6272,Ultrasonic,Granular Cell Leiomyosarcoma,0
6273,size,BRCA2 Syndrome,0
6274,More Often than Once a Day,gliosarcoma,0
6275,Female Phenotype,Testicular cancer metastatic,0
6276,Removal of bladder,Cystadenocarcinoma,0
6277,Screening Study,Refractory Glioma,0
6278,Storage Unit,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
6279,Symptoms,Low Grade Squamous Intraepithelial Neoplasia,0
6280,Probably,Unicystic ameloblastoma,0
6281,Job Status - Temporary,Adult Hepatocellular Carcinoma,0
6282,Hematologic Neoplasms,Rhabdomyosarcoma with ganglionic differentiation,0
6283,include - SetOperator,Malignant Testicular Sertoli Cell Tumor,0
6284,Smaller,Cervical Squamous Intraepithelial Neoplasia,0
6285,Colon <insect>,Bladder squamous cell carcinoma stage I,0
6286,Disease,Locally Advanced Soft Tissue Sarcoma,0
6287,Carrying,Extracranial Neuroblastoma,0
6288,Secondary to,Malignant neoplasm of thalamus,0
6289,Tanning of leather,malignant lymphoma of pancreatic lymph nodes,0
6290,Physical findings,squamous cell carcinoma of the thyroid gland,0
6291,80%,Mucinous neoplasm,0
6292,Chemotherapy,Contact dermatitis due to alkali,0
6293,How Much Distress Weight Loss,Noninfiltrating Intraductal Carcinoma,0
6294,Deoxyribonucleic Acid Measurement,Refractory Bladder Carcinoma,0
6295,Environmental risk factor,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6296,General surgery specialty,Recurrent Uveal Melanoma,0
6297,Increase in size since previous mammogram,Necrotizing Funisitis,0
6298,1000000,Squamous cell carcinoma of lip,0
6299,per year,Female Breast Carcinoma,0
6300,Sufficiently defined concept definition status (core metadata concept),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6301,Itchiness,Stage IV Colorectal Cancer AJCC v8,0
6302,Subject Risk,clear cell adenocarcinoma of gallbladder,0
6303,How Much Distress Itching,Primary Cutaneous Plasmablastic Lymphoma,0
6304,Etiology aspects,FIGO Stage IVA Ovarian Cancer,0
6305,Median (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
6306,majority,Undifferentiated Endocervical Sarcoma,0
6307,Tissue Specimen Code,Malignant neoplasm of choroid,0
6308,Location of Oral Residue Following Swallowing,Metastatic Ductal Breast Carcinoma,0
6309,Specimen Source Codes - Mucus,Extracranial Neuroblastoma,0
6310,Occur (action),Microcystic meningioma,0
6311,Occur (action),Stage IV Penile Cancer AJCC v7,0
6312,Thyroid carcinoma,Parathyroid Gland Adenocarcinoma,0
6313,Lymphohistiocytosis,Neoplasms,0
6314,Trauma,Leptomeningeal sarcoma,0
6315,Firstly,Refractory Barrett Esophagus,0
6316,Morphology,FIGO Stage IVA Ovarian Cancer,0
6317,Tobacco smoking behavior,Metastatic Neoplasm to the Gallbladder,0
6318,various allergen extracts,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6319,Air,Medulloblastoma,0
6320,Transurethral Resection,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6321,Specific qualifier value,Diffuse malignant mesothelioma,0
6322,PCYT1A wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6323,Process (qualifier value),mucinous adenocarcinoma of gallbladder,0
6324,Rate,Acute Undifferentiated Leukemia,0
6325,Glandular,Breast Ductal Adenoma,0
6326,Primary malignant neoplasm,Malignant melanoma of eyelid,0
6327,Treatment Epoch,Stage I Colon Neuroendocrine Tumor AJCC v8,0
6328,Nausea,Melanomatosis,0
6329,Then,Extracranial Neuroblastoma,0
6330,Malignant Neoplasms,Childhood Lung Non-Small Cell Carcinoma,0
6331,Prostate,Metastatic Malignant Neoplasm in the Sellar Region,0
6332,CEL gene,Larynx carcinoma recurrent,0
6333,Code,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6334,Tryptophanase,Benign Apocrine Neoplasm,0
6335,Patterns,Advanced Lung Carcinoma,0
6336,Specimen Source Codes - tumor,Stage III Cutaneous Melanoma AJCC v6,0
6337,Mass of body structure,Prostate Lymphoma,0
6338,Milliampere second,Cerebral Primitive Neuroectodermal Tumor,0
6339,Greece,Childhood Central Nervous System Ganglioneuroblastoma,0
6340,Science of Morphology,Medulloblastoma,0
6341,Rating (action),Small intestine carcinoma,0
6342,Involvement with,Thyroid carcinoma,0
6343,Abnormal Reference Range,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6344,Parenchyma,Rhabdomyosarcoma with ganglionic differentiation,0
6345,Immature Lymphocytes Measurement,Kaposi's sarcoma of extrahepatic bile duct,0
6346,Form:Finding:Point in time:{Setting}:Document:{Role},Extracranial Neuroblastoma,0
6347,Time,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6348,Group Object,Extra-Adrenal Paraganglioma,0
6349,Hepatitis Viruses,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6350,Pickled food,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6351,Infrequent,Liver Lymphangioma,0
6352,Inspiration function,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
6353,Call (Instruction),Kaposi's sarcoma of skin,0
6354,Lung,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
6355,Sole of Foot,ROSE Cluster 3,0
6356,CD5 Positive,Splenic Manifestation of Hairy Cell Leukemia,0
6357,Prognosis good,Stage 0 Penile Cancer AJCC v8,0
6358,Short Value,Mixed astrocytoma-ependymoma,0
6359,Follicle,Basal Cell Ameloblastoma,0
6360,Liver,Breast Ductal Adenoma,0
6361,Introduces,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6362,Limb structure,Bladder squamous cell carcinoma stage I,0
6363,Limited stage (cancer stage),Malignant Neoplasm with Regional Lymph Node Involvement,0
6364,Adenocarcinoma of large intestine,Noninfiltrating Intraductal Carcinoma,0
6365,Taking of swab,Pancreatic carcinoma,0
6366,Dysgerminoma,Bladder squamous cell carcinoma stage I,0
6367,CHURC1 gene,Colorectal cancer,0
6368,Neuroendocrine Tumors,Undifferentiated Endocervical Sarcoma,0
6369,Xeroderma Pigmentosum,BRCA2 Syndrome,0
6370,Nicotiana,Localized Askin Tumor,0
6371,Edema,Recurrent Testicular Lymphoma,0
6372,Undifferentiated,Stage III Cutaneous Melanoma AJCC v6,0
6373,best (quality),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6374,risk factors,Childhood Choriocarcinoma,0
6375,Insecticides,Mucinous adenocarcinoma gastric,0
6376,Food,Unresectable Rhabdomyosarcoma,0
6377,Left,Gallbladder Adenocarcinoma,0
6378,Mean Percent of Normal,Adult Brain Stem Mixed Glioma,0
6379,Occur (action),Squamous cell carcinoma of lip,0
6380,Combined,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6381,Treating,Squamous cell carcinoma of lip,0
6382,True primary (qualifier value),ICHTHYOSIS,0
6383,Blood,Undifferentiated Endocervical Sarcoma,0
6384,control substance,Localized Malignant Neoplasm,0
6385,Entity Name Part Qualifier - birth,clear cell adenocarcinoma of gallbladder,0
6386,biopsy characteristics,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6387,Often - answer to question,Vaginal Adenoid Cystic Carcinoma,0
6388,Patient Outcome,Kaposi's sarcoma of extrahepatic bile duct,0
6389,Abnormal cell,Endometrial Small Cell Carcinoma,0
6390,white blood cell type,Medulloblastoma,0
6391,Type - attribute,Microcystic meningioma,0
6392,Dietary Lead,Thymic Clear Cell Carcinoma,0
6393,Assortment,Mixed astrocytoma-ependymoma,0
6394,Possible diagnosis,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6395,Before,Mucinous cystadenofibroma,0
6396,Pancreas part,Spongiotic dermatitis,0
6397,Specimen Source Codes - tumor,Clonal Hematopoiesis of Indeterminate Potential,0
6398,Primary malignant neoplasm,Undifferentiated Endocervical Sarcoma,0
6399,combination of objects,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6400,Mechanism (attribute),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6401,Glioma,Astrocytoma of brain,0
6402,Adverse Event Associated with Vascular,Endometrial Small Cell Carcinoma,0
6403,Mathematical Operator,Thymic Clear Cell Carcinoma,0
6404,Squamous Epithelial Cells,Stage I Colon Neuroendocrine Tumor AJCC v8,0
6405,Adult human body,FIGO Stage II Ovarian Cancer,0
6406,Sometimes,Intraepithelial Melanocytic Hyperplasia,0
6407,Skin Specimen,Metastatic Malignant Neoplasm in the Sellar Region,0
6408,Slow Growing Mass,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6409,Unmarried person,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6410,Exposure to radiation,High Grade Glandular Intraepithelial Neoplasia,0
6411,Play,Benign Apocrine Neoplasm,0
6412,National origin,Anterior Urethral Malignant Neoplasm,0
6413,Abnormal,Squamous cell carcinoma of lip,0
6414,Proliferation,High Grade Glandular Intraepithelial Neoplasia,0
6415,Ocular orbit,Adult Alveolar Soft Part Sarcoma,0
6416,Chromosomal translocation,Colorectal Neuroendocrine Tumor G2,0
6417,Pharmacotherapy,Mixed astrocytoma-ependymoma,0
6418,Transmitted by,Localized Malignant Neoplasm,0
6419,Skin,Stage 0 Lip Carcinoma,0
6420,Grade three rank,Spermatocytic seminoma,0
6421,Area,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6422,Lymphoid Tissue,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6423,Togo,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6424,Type - attribute,Thyroid Hurthle Cell Carcinoma,0
6425,Part of,Basal Cell Ameloblastoma,0
6426,Common (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
6427,Sex Behavior,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6428,Pharmacotherapy,Precursor B-lymphoblastic lymphoma stage II,0
6429,SELL protein,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
6430,Microscopes,Colorectal Neuroendocrine Tumor G2,0
6431,Light Microscopy,Diffuse malignant mesothelioma,0
6432,Lymphoma,Mucinous adenocarcinoma gastric,0
6433,Conditional,Digestive System Hodgkin Lymphoma,0
6434,Medical Imaging,Ectomesenchymal Chondromyxoid Tumor,0
6435,Long-term,Mucinous adenocarcinoma gastric,0
6436,High Risk Acute Leukemia,Ichthyosis,0
6437,melanoma,Activated B-cell type diffuse large B-cell lymphoma,0
6438,Dyspareunia,Adenocarcinoma,0
6439,Immunoglobulins,Noninfiltrating Intraductal Carcinoma,0
6440,NCI CTEP SDC Thyroid Cancer Sub-Category Terminology,Microcystic meningioma,0
6441,Abundance,Cervical Squamous Intraepithelial Neoplasia,0
6442,Thyroid hormone (disposition),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
6443,High Level,squamous cell carcinoma of the thyroid gland,0
6444,Negation,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6445,Fungi,Carcinomatosis of peritoneal cavity,0
6446,False Discovery Rate,Locally Advanced Soft Tissue Sarcoma,0
6447,MALIGNANT benign,Undifferentiated Endocervical Sarcoma,0
6448,Ocular orbit,Childhood Anaplastic Large Cell Lymphoma,0
6449,Weight Loss,Acantholytic squamous cell carcinoma,0
6450,How Much Distress Shortness of Breath,Spongiotic dermatitis,0
6451,risk factors - observation list,FIGO Stage IVA Ovarian Cancer,0
6452,Large,Squamous cell carcinoma of lip,0
6453,Life Threatening,Type II Endometrial Adenocarcinoma,0
6454,Hemangioma,Carcinomatosis of peritoneal cavity,0
6455,Abdomen+,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6456,Back Pain,Chest Wall Fibromatosis,0
6457,Body part,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6458,Decision,Cervical Adenomyoma,0
6459,Long-term Follow-up,Stage I Adult Non-Hodgkin Lymphoma,0
6460,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6461,Call (Instruction),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6462,Common (qualifier value),Unresectable Rhabdomyosarcoma,0
6463,Area,Angiosarcoma of liver,0
6464,status - In progress,Epithelioid Sarcoma NCI Grade 3,0
6465,Immunotherapy,Precursor B-lymphoblastic lymphoma stage II,0
6466,Incidence,Pilocytic astrocytoma of cerebellum,0
6467,Result,BRCA2 Syndrome,0
6468,Frequently,papillary carcinoma of penis,0
6469,Mass of body structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6470,Complex,Pancreatic Endocrine Carcinoma,0
6471,Lacking,Unfavorable Non-Hodgkin Lymphoma,0
6472,Scar Tissue,Localized Ewing Sarcoma,0
6473,Rarely malignant,Unresectable Rhabdomyosarcoma,0
6474,Decision,Kaposi's sarcoma of extrahepatic bile duct,0
6475,Inhaled air,Refractory Ependymoma,0
6476,United States,Cancer of Urinary Tract,0
6477,Targeted Therapy,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6478,Subtype (attribute),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6479,Volume,Endometrial Small Cell Carcinoma,0
6480,Experimental Result,Adult Hepatocellular Carcinoma,0
6481,cancer risk,Intestinal Metaplasia of Bladder Urothelium,0
6482,Gestational Trophoblastic Neoplasms,Cancer of Urinary Tract,0
6483,Fatigue,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
6484,Type - attribute,Unresectable Rhabdomyosarcoma,0
6485,Gestational trophoblastic disease,FIGO Stage II Ovarian Cancer,0
6486,Base - General Qualifier,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6487,Larynx,Acantholytic squamous cell carcinoma,0
6488,Often - answer to question,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6489,Individual,Refractory Bladder Carcinoma,0
6490,Surface of skin,Pilocytic astrocytoma of cerebellum,0
6491,Term Birth,Digestive System Hodgkin Lymphoma,0
6492,Childhood Extracranial Germ Cell Tumor,Angiosarcoma of liver,0
6493,Experimental Result,Mastocytosis,0
6494,Primary malignant neoplasm,Human Papillomavirus-Related Carcinoma,0
6495,New,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6496,Call (Instruction),Cancer of Urinary Tract,0
6497,Electromagnetic Spectrum,Clonal Hematopoiesis of Indeterminate Potential,0
6498,Malignant Vaginal Neoplasm,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6499,High expression,Breast Ductal Adenoma,0
6500,Stem of plant,Acute Undifferentiated Leukemia,0
6501,Cell (compartment),Squamous cell carcinoma of lip,0
6502,Form:Finding:Point in time:{Setting}:Document:{Role},embryonal rhabdomyosarcoma of prostate,0
6503,AIDS defining illness,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
6504,Disease susceptibility,Vaginal Adenoid Cystic Carcinoma,0
6505,Cell Count,Maxillary Sinus Adenocarcinoma,0
6506,Qualifier (concept),Astrocytoma of brain,0
6507,Free (available (qualifier)),Benign Anal Granular Cell Tumor,0
6508,Entity Determiner - specific,Lipoma of small intestine,0
6509,Growth,FIGO Stage II Ovarian Cancer,0
6510,Collection (action),Childhood Lymphoma,0
6511,Areas <moth>,Kaposi's sarcoma of extrahepatic bile duct,0
6512,Negation,Kaposi's sarcoma of skin,0
6513,Adult human body,Nasal cavity carcinoma,0
6514,Most,Malignant neoplasm of thalamus,0
6515,Surgery specialty,Cartilaginous exostosis,0
6516,Palpebral margin,Microcystic meningioma,0
6517,mole changes,Ichthyoses,0
6518,Low Back Pain,Non-Metastatic Gestational Trophoblastic Tumor,0
6519,Two,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6520,shared attribute,Colorectal Neuroendocrine Tumor G2,0
6521,Has difficulty doing (qualifier value),Cancer of Urinary Tract,0
6522,Including (qualifier),Stage IB Pancreatic Cancer AJCC v8,0
6523,10%,Stage IV Colorectal Cancer AJCC v8,0
6524,Lung,Metastatic Lung Neuroendocrine Neoplasm,0
6525,Old,Kaposi's sarcoma of skin,0
6526,Usually,Thymic Clear Cell Carcinoma,0
6527,Count of entities,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6528,Possible diagnosis,Human Papillomavirus-Related Carcinoma,0
6529,Ambient,embryonal rhabdomyosarcoma of prostate,0
6530,Childhood Non-Hodgkin Lymphoma,Papillary squamous cell carcinoma,0
6531,House mice,Digestive System Hodgkin Lymphoma,0
6532,1000000,Recurrent Uveal Melanoma,0
6533,Large,Acute Undifferentiated Leukemia,0
6534,Sequence Data Type,Prostate Lymphoma,0
6535,Study Site,Female Breast Carcinoma,0
6536,Pharyngitis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6537,Characteristics,Blepharal carcinoma,0
6538,Neoplastic Cell Transformation,Chronic Myelomonocytic Leukemia-2,0
6539,Negation,Adrenal Rest Tumor,0
6540,Blood Platelets,Refractory Bladder Carcinoma,0
6541,Mutation Abnormality,Hodgkin lymphoma,0
6542,Participation Type - origin,Human Papillomavirus-Related Carcinoma,0
6543,Decision,Undifferentiated Endocervical Sarcoma,0
6544,Type - attribute,Pilocytic astrocytoma of cerebellum,0
6545,Severe (severity modifier),Recurrent Rhabdomyosarcoma,0
6546,Count of entities,Splenic Manifestation of Hairy Cell Leukemia,0
6547,Skin,Stage IB Lung Cancer AJCC v7,0
6548,Status post,Atypical Mesothelial Hyperplasia,0
6549,Note (document),Undifferentiated Neuroblastoma,0
6550,Affecting,Human Papillomavirus-Related Carcinoma,0
6551,Primary malignant neoplasm,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
6552,Appearance,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6553,Urine,Kaposi's sarcoma of extrahepatic bile duct,0
6554,Common Specifications in HL7 V3 Publishing,Clonal Hematopoiesis of Indeterminate Potential,0
6555,Blood group antibody I,Blood Vessel Tumors,0
6556,Ninth,Liver Cavernous Hemangioma,0
6557,Fever,Adult Alveolar Soft Part Sarcoma,0
6558,Genus Homo,Locally Advanced Squamous Cell Carcinoma,0
6559,World,Pancreatic Intraepithelial Neoplasia-3,0
6560,include - SetOperator,Thyroid carcinoma,0
6561,Lip structure,Extracranial Neuroblastoma,0
6562,Out (direction),Benign neoplasm of thorax,0
6563,Management procedure,Cerebral Primitive Neuroectodermal Tumor,0
6564,Adverse Event Associated with Syndromes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6565,risk factors,embryonal rhabdomyosarcoma of prostate,0
6566,Ancestry-Informative Marker,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6567,Poor - grade value,Granular Cell Leiomyosarcoma,0
6568,Age,Stage II Carcinoma of Penis,0
6569,Pith - plant part,Mucinous adenocarcinoma gastric,0
6570,Primary malignant neoplasm,Papillary squamous cell carcinoma,0
6571,Testicular Neoplasms,Adult Acute Eosinophilic Leukemia,0
6572,Estrogens,Childhood Anaplastic Large Cell Lymphoma,0
6573,Mean Percent of Normal,Pancreatic Intraepithelial Neoplasia-3,0
6574,Cancer Genus,embryonal rhabdomyosarcoma of prostate,0
6575,Carcinoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6576,Usual Severity Pain,Carcinoma of urinary bladder,0
6577,Animals,Cerebral Primitive Neuroectodermal Tumor,0
6578,Stomach,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6579,bacteria aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6580,Distal (qualifier value),Bladder squamous cell carcinoma stage I,0
6581,Reinfection,clear cell adenocarcinoma of gallbladder,0
6582,Play,Bladder squamous cell carcinoma stage I,0
6583,Financial Account,FIGO Stage II Ovarian Cancer,0
6584,Imaging Techniques,Pancreatic Intraepithelial Neoplasia-3,0
6585,IPSS Risk Category High,squamous cell carcinoma of the thyroid gland,0
6586,Surgical aspects,Mucinous adenocarcinoma gastric,0
6587,Injury cause,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6588,Metastatic to,Localized Malignant Neoplasm,0
6589,Presentation,Diffuse malignant mesothelioma,0
6590,risk factors,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6591,Retinoic Acid Response Element,Refractory Bladder Carcinoma,0
6592,Dermatitis,Multiple Skull Base Meningiomas,0
6593,Primary operation,BRCA2 Syndrome,0
6594,Characteristics,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6595,Participation Type - origin,Childhood Central Nervous System Ganglioneuroblastoma,0
6596,BBS9 wt Allele,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6597,include - SetOperator,Mucosal Melanoma,0
6598,CEL gene,Methotrexate-Associated Hodgkin Lymphoma,0
6599,Base - General Qualifier,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6600,90%,Trichilemmocarcinoma,0
6601,Prophylactic behavior,Cerebral Primitive Neuroectodermal Tumor,0
6602,Gastroenterologist,Mucinous neoplasm,0
6603,Tactile,adenosquamous carcinoma of breast,0
6604,Crystal Structure,Nasal cavity carcinoma,0
6605,Adult Germ Cell Tumor,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6606,A Codes,Benign tumor of eyelid,0
6607,Rapid,Placental aromatase deficiency,0
6608,Symptoms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6609,Source,Werner Syndrome,0
6610,Tissue Specimen Code,Cancer of Urinary Tract,0
6611,Decision,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6612,melanoma,Human Papillomavirus-Related Carcinoma,0
6613,Pitch (deviation),Atypical Lobular Breast Hyperplasia,0
6614,FAT1 wt Allele,Peripheral primitive neuroectodermal tumor of soft tissue,0
6615,Including (qualifier),Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
6616,Empty (qualifier),Lipoma of small intestine,0
6617,Known,FIGO Stage II Ovarian Cancer,0
6618,treatment options,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6619,Cervical Intraepithelial Neoplasia,Intraepithelial Melanocytic Hyperplasia,0
6620,Neoplasms,Vaginal Adenoid Cystic Carcinoma,0
6621,Adult,Type II Endometrial Adenocarcinoma,0
6622,trauma qualifier,Thymoma malignant recurrent,0
6623,cell-cell adhesion,Stage II Carcinoma of Penis,0
6624,Linear,Chest Wall Fibromatosis,0
6625,Lung,Stage IB Pancreatic Cancer AJCC v8,0
6626,Childhood Rhabdomyosarcoma,Gastric Diffuse Large B-Cell Lymphoma,0
6627,Young,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6628,Reported,Diffuse malignant mesothelioma,0
6629,Primary malignant neoplasm,Refractory Ependymoma,0
6630,Malignant neoplasm of thyroid,FIGO Stage II Ovarian Cancer,0
6631,other medicated shampoos in ATC,Metaplastic carcinoma of breast,0
6632,Frequently,Childhood Thyroid Gland Follicular Carcinoma,0
6633,Publications,Cerebral Primitive Neuroectodermal Tumor,0
6634,United States Military Commissioned Officer O4,Giant cell angiofibroma,0
6635,High,Keratoderma,0
6636,Unspecified,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6637,Retinoic Acid Response Element,Adult Anaplastic Oligodendroglioma,0
6638,What subject filter - Result,Stage IV Childhood Non-Hodgkin Lymphoma,0
6639,Intention - mental process,Tubal Hyperplasia,0
6640,Lifetime,papillary carcinoma of penis,0
6641,Class,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6642,Abnormal Cell Count,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6643,Dryness (characteristic),Grade 3a Malignant Neoplasm,0
6644,Anorexia,Childhood Fibrillary Astrocytoma,0
6645,Entity Determiner - specific,Intestinal Metaplasia of Bladder Urothelium,0
6646,35,Diffuse malignant mesothelioma,0
6647,Diffuse malignant lymphoma - centroblastic-centrocytic,Nasal cavity carcinoma,0
6648,Radiographic imaging procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6649,Eczema,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6650,cell type,Pancreatic Intraepithelial Neoplasia-3,0
6651,Primary malignant neoplasm of endometrium,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6652,Occur (action),Mucinous adenocarcinoma gastric,0
6653,Lymphoma,Ovarian germ cell choriocarcinoma stage IV,0
6654,Known,Airway Hemangioma,0
6655,Symptoms,Mucosal Melanoma,0
6656,Pelvic Pain,Rhabdomyosarcoma with ganglionic differentiation,0
6657,spring (season),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6658,Common Specifications in HL7 V3 Publishing,Carcinomatosis of peritoneal cavity,0
6659,Compartment syndromes,Intestinal Neuroendocrine Carcinoma,0
6660,Vision,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6661,Treatment Epoch,Cerebral hemangioma,0
6662,Males,Diffuse malignant mesothelioma,0
6663,To,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6664,Dry,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6665,Fill,Peripheral primitive neuroectodermal tumor of soft tissue,0
6666,Occurrence,Splenic Manifestation of Hairy Cell Leukemia,0
6667,Medical Imaging,Malignant melanoma of eyelid,0
6668,common types,Intraepithelial Melanocytic Hyperplasia,0
6669,Diagnosis,Childhood Lung Non-Small Cell Carcinoma,0
6670,Plumbum metallicum,Nasal cavity carcinoma,0
6671,Immature Cell Count (laboratory procedure),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6672,Urine,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6673,TONICS,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6674,Recommendation,Melanomatosis,0
6675,regional,Small cell neuroendocrine carcinoma of bladder,0
6676,Record - QueryRequestLimit,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6677,BLNK gene,Diffuse malignant mesothelioma,0
6678,Structure of thyroid parafollicular cell,Type II Endometrial Adenocarcinoma,0
6679,Skin,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6680,Skeletal bone,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6681,per year,Congenital hamartoma,0
6682,Teens,Undifferentiated Endocervical Sarcoma,0
6683,Linear,Human Papillomavirus-Related Carcinoma,0
6684,member,Hereditary Diffuse Gastric Adenocarcinoma,0
6685,Pain in scrotum,Leiomyoma of Gallbladder,0
6686,Part of,Advanced Lung Carcinoma,0
6687,Present,Stage III Cutaneous Melanoma AJCC v6,0
6688,Degree or extent,Digestive System Hodgkin Lymphoma,0
6689,Specific qualifier value,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6690,Pelvic cavity structure,Kaposi's sarcoma of extrahepatic bile duct,0
6691,Colorectal Cancer,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6692,Abdominal Cavity,Localized Ewing Sarcoma,0
6693,Variant,Granular Cell Leiomyosarcoma,0
6694,Primary malignant neoplasm,Metastatic Neoplasm to the Gallbladder,0
6695,Acquired phimosis,Benign Ovarian Thecoma,0
6696,Group A (blood group),Mucinous adenocarcinoma gastric,0
6697,Astrocytes,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6698,Destruction (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6699,1000000,Pancreatic carcinoma,0
6700,Biological Response Modifiers,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6701,Reported Term,Benign tumor of eyelid,0
6702,Scaling,Fourth Ventricle and Brain Stem Ependymal Tumor,0
6703,eTMF Content Model Code,Intraepithelial Melanocytic Hyperplasia,0
6704,Contain (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
6705,Analysis,Uterine Cancer,0
6706,Administration procedure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6707,Common (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6708,Specific qualifier value,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6709,Salivary Glands,Unicystic ameloblastoma,0
6710,Gonadal structure,Thymic Clear Cell Carcinoma,0
6711,Record - QueryRequestLimit,Recurrent Testicular Lymphoma,0
6712,Reaching,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6713,Local disease,Engraftment syndrome,0
6714,Lower (action),Recurrent Uveal Melanoma,0
6715,Surgical service,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6716,Family history,Mucinous cystadenofibroma,0
6717,Guide device,Low Grade Squamous Intraepithelial Neoplasia,0
6718,Myoepithelial,de novo Myelodysplastic Syndrome,0
6719,To,Unfavorable Non-Hodgkin Lymphoma,0
6720,Have Sweats,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
6721,Sequence Arm,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6722,Woman,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6723,Response process,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6724,Homo sapiens,Benign Anal Granular Cell Tumor,0
6725,Certain (qualifier value),ROSE Cluster 3,0
6726,Division (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6727,Dark brown,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6728,Undifferentiated Sex,Recurrent Testicular Lymphoma,0
6729,Permanent,Malignant Neoplasm of Lung - Multiple Primary Sites,0
6730,Experimental Result,Recurrent Testicular Lymphoma,0
6731,Context,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
6732,Formation,Grade 1 Clear Cell Renal Cell Carcinoma,0
6733,Biologic Development,Kaposi's sarcoma of skin,0
6734,Surgery specialty,Pancreatic Endocrine Carcinoma,0
6735,Geographic Locations,Recurrent Uveal Melanoma,0
6736,Symptoms,Endometrial Small Cell Carcinoma,0
6737,Methods,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6738,Gender Status - Intact,Mucinous adenocarcinoma gastric,0
6739,Malignant - descriptor,Refractory Ependymoma,0
6740,Human body,Testicular cancer metastatic,0
6741,Most,Mucinous adenocarcinoma,0
6742,include - SetOperator,Multiple Skull Base Meningiomas,0
6743,Sore skin,Chondrosarcoma,0
6744,Less Than,Intestinal Neuroendocrine Carcinoma,0
6745,Negative Charge,Refractory Bladder Carcinoma,0
6746,Set scale,Multiple Skull Base Meningiomas,0
6747,Order (record artifact),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6748,Medical service,Localized Askin Tumor,0
6749,Etiology aspects,Metastatic Neoplasm to the Gallbladder,0
6750,Group A (blood group),Chondrosarcoma,0
6751,Latin America,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6752,Thymus <angiosperm>,Cervical Squamous Intraepithelial Neoplasia,0
6753,Australia,Cartilaginous exostosis,0
6754,Use of,Larynx carcinoma recurrent,0
6755,Qualitative form,Stage II Carcinoma of Penis,0
6756,Therapeutic procedure,Malignant Neoplasm with Regional Lymph Node Involvement,0
6757,metastatic qualifier,Blepharal carcinoma,0
6758,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
6759,Better,Microcystic meningioma,0
6760,Predisposition -- attribute,Tongue Alveolar Soft Part Sarcoma,0
6761,Tumor stage,Low Grade Squamous Intraepithelial Neoplasia,0
6762,lymph nodes,Uterine Cancer,0
6763,Symptoms aspect,Hodgkin Disease,0
6764,Malignant Neoplasms,Stage III Cutaneous Melanoma AJCC v6,0
6765,Transitional cell morphology,Cancer of Urinary Tract,0
6766,Sound - physical agent,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6767,Patterns,Childhood Central Nervous System Ganglioneuroblastoma,0
6768,*Type - Kind of quantity,Multiple Skull Base Meningiomas,0
6769,Blood,Basal Cell Ameloblastoma,0
6770,World Health Organization,Acute Undifferentiated Leukemia,0
6771,Occur (action),Benign tumor of eyelid,0
6772,Tissue Specimen Code,Metastatic Malignant Neoplasm in the Sellar Region,0
6773,True primary (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6774,Foot,Refractory Ependymoma,0
6775,shared attribute,High Grade Glandular Intraepithelial Neoplasia,0
6776,Solid Dose Form,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
6777,Smear - instruction imperative,clear cell adenocarcinoma of gallbladder,0
6778,Occurrence Indicator,Xeroderma pigmentosum,0
6779,Stains,Undifferentiated Endocervical Sarcoma,0
6780,Involvement with,Peripheral primitive neuroectodermal tumor of soft tissue,0
6781,Secondary tumor site,Chest Wall Fibromatosis,0
6782,Uterine Corpus Sarcoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6783,Biogenic Amines,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
6784,BRCA1 protein,Extracranial Neuroblastoma,0
6785,ovarian,Benign tumor of eyelid,0
6786,Rate,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6787,Reported Term,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6788,PERMANENT DEAFNESS,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6789,Estrogen (disposition),Hodgkin Disease,0
6790,Adult,Spongiotic dermatitis,0
6791,Units Of Measure - lumen,Localized Askin Tumor,0
6792,Identity,Cervical Squamous Intraepithelial Neoplasia,0
6793,Tumor cells,non-Hodgkin's lymphoma of spleen,0
6794,Presacral,Colorectal High Grade B-Cell Lymphoma,0
6795,To,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6796,Post Device,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6797,status - In progress,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
6798,Hyalinizing trabecular adenoma,ROSE Cluster 3,0
6799,/40,Mucinous cystadenofibroma,0
6800,Lymphocyte component of blood,Contact dermatitis due to alkali,0
6801,>90,Hodgkin lymphoma,0
6802,Financial Account,Undifferentiated Endocervical Sarcoma,0
6803,Classification of information,Mucinous adenocarcinoma,0
6804,Abnormally high,Adult Alveolar Soft Part Sarcoma,0
6805,Coughing,Funisitis (disorder),0
6806,Abnormal Cell Count,Atypical Lobular Breast Hyperplasia,0
6807,Occurrence,sarcoma of spinal cord,0
6808,Transurethral Resection,Astrocytoma of brain,0
6809,First (number),Gallbladder Adenocarcinoma,0
6810,United States,Squamous cell carcinoma of lip,0
6811,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Extracranial Neuroblastoma,0
6812,Cerebellum,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
6813,Group A (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6814,Interventional procedure,Squamous cell carcinoma of lip,0
6815,Breeding,Digestive System Hodgkin Lymphoma,0
6816,Extreme,Human Papillomavirus-Related Carcinoma,0
6817,Neuron spine,Melanomatosis,0
6818,Treatment Epoch,Adult Anaplastic Oligodendroglioma,0
6819,Benign condition,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6820,Site,FIGO Stage IVA Ovarian Cancer,0
6821,Age,Cervical Squamous Intraepithelial Neoplasia,0
6822,Waste Products,Hyperplasia of pituitary gland,0
6823,brain cell,Liver Lymphangioma,0
6824,Occur (action),Childhood Central Nervous System Immature Teratoma,0
6825,Childhood Lymphoma,Angiosarcoma of liver,0
6826,Life Expectancy Less than Five Years,Localized Askin Tumor,0
6827,System,Plexosarcoma,0
6828,Coding,Carcinoma ex pleomorphic adenoma of parotid gland,0
6829,Worker,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6830,Improved - answer to question,Mucinous adenocarcinoma gastric,0
6831,PSA Level Greater than Fifty,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6832,Scientific Publication,Benign Anal Granular Cell Tumor,0
6833,Cancer Genus,Kaposi's sarcoma of skin,0
6834,Nausea,Spermatocytic seminoma,0
6835,Promotional Kit,Bladder adenocarcinoma stage IV,0
6836,Usually,Benign squamous cell tumor,0
6837,Mixed Cell Morphology,Mucinous adenocarcinoma gastric,0
6838,Back structure,Malignant Testicular Sertoli Cell Tumor,0
6839,Symptoms,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6840,Percent of Abnormal Cells,papillary carcinoma of penis,0
6841,Very Much,Familial Hemophagocytic Lymphocytosis,0
6842,Changing,Carcinoma ex pleomorphic adenoma of parotid gland,0
6843,General surgery specialty,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6844,Young Adult,Tongue Alveolar Soft Part Sarcoma,0
6845,Differentiation,Multiple Skull Base Meningiomas,0
6846,Oral (intended site),Collecting Duct Carcinoma of the Kidney,0
6847,Epithelial ovarian cancer,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6848,Form:Finding:Point in time:{Setting}:Document:{Role},Botryoid-Type Embryonal Rhabdomyosarcoma,0
6849,Adult,Acute Undifferentiated Leukemia,0
6850,Adult Lymphoma,FIGO Stage II Ovarian Cancer,0
6851,To,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
6852,Menstruation,Thyroid Hurthle Cell Carcinoma,0
6853,Long-term Follow-up,Gallbladder adenoma,0
6854,Severe Extremity Pain,Type II Endometrial Adenocarcinoma,0
6855,Mass of body region,Nasal cavity carcinoma,0
6856,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6857,Abnormal,Sarcomatoid Renal Cell Carcinoma,0
6858,intent,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
6859,Entire ear,Unicystic ameloblastoma,0
6860,Associated with,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
6861,lymph nodes,Stage II Carcinoma of Penis,0
6862,Growth,Pancreatic carcinoma,0
6863,Fish Flavor,Neonatal leukemia,0
6864,Biological Response Modifier Therapy,Benign Anal Granular Cell Tumor,0
6865,Include (action),benign mature teratoma of pancreas,0
6866,Involvement with,Mixed astrocytoma-ependymoma,0
6867,Childhood Lymphoma,Colorectal High Grade B-Cell Lymphoma,0
6868,Fever,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6869,Overall Publication Type,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
6870,Disease Progression,Acantholytic squamous cell carcinoma,0
6871,N+ (tumor staging),Congenital hamartoma,0
6872,Headache,clear cell adenocarcinoma of gallbladder,0
6873,Operative Surgical Procedures,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6874,Include (action),Melanomatosis,0
6875,Malignant - descriptor,Papillary squamous cell carcinoma,0
6876,Pancreas,Toxic Epidermal Necrolysis,0
6877,Administration procedure,Benign Anal Granular Cell Tumor,0
6878,Cover (physical object),Clinical Stage I Cutaneous Melanoma AJCC v8,0
6879,Asymptomatic,Undifferentiated Endocervical Sarcoma,0
6880,Carcinoma,Advanced Uterine Corpus Carcinosarcoma,0
6881,Molecular Mass,Melanomatosis,0
6882,metaplastic cell transformation,Non-Hodgkin Lymphoma During Pregnancy,0
6883,Call (Instruction),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6884,spells (neurological symptom),Cartilaginous exostosis,0
6885,Most,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6886,Diagnosis,Ovarian Dermoid Cyst with Secondary Carcinoma,0
6887,System,Hemangioma,0
6888,Measures,Carcinoma of urinary bladder,0
6889,various allergen extracts,Cervical Fibroepithelial Polyp,0
6890,Laboratory Procedures,Colorectal Neuroendocrine Tumor G2,0
6891,Known,Bladder squamous cell carcinoma stage I,0
6892,Benign,Malignant neoplasm of choroid,0
6893,Present,Multiple Endocrine Neoplasia,0
6894,cancer genetics,FIGO Stage IVA Ovarian Cancer,0
6895,Data operation - complete,Airway Hemangioma,0
6896,Respiration,Childhood Central Nervous System Ganglioneuroblastoma,0
6897,Five,Metastatic Carcinoma in the Lung,0
6898,Only - dosing instruction fragment,Brain Tumor,0
6899,Therapeutic procedure,Stage III Cutaneous Melanoma AJCC v6,0
6900,Diagnosis Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
6901,Usually,Cancer of Urinary Tract,0
6902,Hemorrhage,Acantholytic squamous cell carcinoma,0
6903,Clinical,Thymic Clear Cell Carcinoma,0
6904,Deterioration of status,Cervical Squamous Intraepithelial Neoplasia,0
6905,Small cell carcinoma of lung,Intestinal Neuroendocrine Carcinoma,0
6906,Person Observer,Childhood Central Nervous System Ganglioneuroblastoma,0
6907,Iodides,Methotrexate-Associated Hodgkin Lymphoma,0
6908,Cells panel,Benign tumor of eyelid,0
6909,Symptoms aspect,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
6910,low exposure,Malignant melanoma of eyelid,0
6911,Maybe,Childhood Fibrillary Astrocytoma,0
6912,Caucasoid Race,Carcinoma of urinary bladder,0
6913,Adult Classical Hodgkin Lymphoma,Benign Anal Granular Cell Tumor,0
6914,Most,Clonal Hematopoiesis of Indeterminate Potential,0
6915,Protection,Angiosarcoma of liver,0
6916,Ephrin Type-B Receptor 1,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
6917,Form:Finding:Point in time:{Setting}:Document:{Role},squamous cell carcinoma of the thyroid gland,0
6918,Numerous,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
6919,How Often Felt Normal question,Astrocytoma of brain,0
6920,Presentation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6921,Usually,Benign Anal Granular Cell Tumor,0
6922,Nicotiana tabacum,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
6923,Most,Testicular cancer metastatic,0
6924,Head - Component of Device,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
6925,Histopathologic Grade,Stage III Cutaneous Melanoma AJCC v6,0
6926,Glioblastoma Multiforme Pathway,Low Grade Squamous Intraepithelial Neoplasia,0
6927,Common Specifications in HL7 V3 Publishing,Childhood Thyroid Gland Follicular Carcinoma,0
6928,Hodgkin Disease,Small cell neuroendocrine carcinoma of bladder,0
6929,Painless,Vaginal Adenoma,0
6930,Cancer Other,Recurrent Primary Lymphoma of Bone,0
6931,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
6932,User Group,Carcinoma of submandibular gland,0
6933,Affecting,adenosquamous carcinoma of breast,0
6934,Growth,Choroid Necrotic Melanoma,0
6935,combination of objects,Intracortical osteosarcoma,0
6936,Case (situation),Kaposi's sarcoma of extrahepatic bile duct,0
6937,Bothered by Vomiting,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
6938,Subtype (attribute),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
6939,Neoadjuvant Therapy,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
6940,Have Nausea,Clinical Stage I Cutaneous Melanoma AJCC v8,0
6941,Manufactured sign,Engraftment syndrome,0
6942,Post Device,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
6943,2+ Score,Malignant Neoplasm with Regional Lymph Node Involvement,0
6944,Interventional procedure,Digestive System Hodgkin Lymphoma,0
6945,Periungual fibroma,Childhood Fibrillary Astrocytoma,0
6946,Genetic,Adult Alveolar Soft Part Sarcoma,0
6947,Occur (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
6948,Four,Ovarian germ cell choriocarcinoma stage IV,0
6949,Value Above Reference Range,Benign neoplasm of eye,0
6950,Interstitial Fluid,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
6951,System One,Botryoid-Type Embryonal Rhabdomyosarcoma,0
6952,Skin,Gallbladder Adenocarcinoma,0
6953,Edema,Benign Anal Granular Cell Tumor,0
6954,Derivation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6955,Iris <mantid>,Type II Endometrial Adenocarcinoma,0
6956,Population Group,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
6957,Smear test,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
6958,Intestines,Squamous cell carcinoma of lip,0
6959,Weight decreased,Low Grade Squamous Intraepithelial Neoplasia,0
6960,Medical Devices,Unresectable Rhabdomyosarcoma,0
6961,Females,High Grade Glandular Intraepithelial Neoplasia,0
6962,Experimental Result,adenoid cystic carcinoma of lung,0
6963,Current (present time),Bladder adenocarcinoma stage IV,0
6964,Section (object),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
6965,Formation,FIGO Stage IVA Ovarian Cancer,0
6966,Dark color,Stage II Hepatocellular Carcinoma AJCC v8,0
6967,How Much Distress Vomiting,Refractory Ependymoma,0
6968,The Sun,Clonal Hematopoiesis of Indeterminate Potential,0
6969,Bothered by Night Sweats,Malignant neoplasm of gallbladder,0
6970,Genus Homo,FIGO Stage II Ovarian Cancer,0
6971,Vasculature,Ovarian germ cell choriocarcinoma stage IV,0
6972,Beginning,Atypical Lobular Breast Hyperplasia,0
6973,Related personal status,Thyroid Hurthle Cell Carcinoma,0
6974,per year,Spongiotic dermatitis,0
6975,Abdomen distended,Melanomatosis,0
6976,Hospital specialist,Unicystic ameloblastoma,0
6977,Respiratory System,malignant lymphoma of pancreatic lymph nodes,0
6978,CD244 protein,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
6979,biopsy characteristics,Cervical Squamous Intraepithelial Neoplasia,0
6980,Web Site,Acute Undifferentiated Leukemia,0
6981,Often - answer to question,Stage III Cutaneous Melanoma AJCC v6,0
6982,Leakage,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
6983,Definitely Related to Intervention,Basal Cell Ameloblastoma,0
6984,National origin,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
6985,Oral region,Adult Alveolar Soft Part Sarcoma,0
6986,Science of Etiology,Anterior Urethral Malignant Neoplasm,0
6987,Frequently,Type II Endometrial Adenocarcinoma,0
6988,Greater,Childhood Extragonadal Malignant Germ Cell Tumor,0
6989,Review [Publication Type],Peripheral primitive neuroectodermal tumor of soft tissue,0
6990,Present,FIGO Stage II Ovarian Cancer,0
6991,Immune,Recurrent Testicular Lymphoma,0
6992,Abnormally high,Acute lymphadenitis,0
6993,Natures,Chondrosarcoma,0
6994,Arising in,sarcoma of spinal cord,0
6995,Laparoscopy,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
6996,Contain (action),Acantholytic squamous cell carcinoma,0
6997,Experimental Result,embryonal rhabdomyosarcoma of prostate,0
6998,Survival Rate,Grade 3a Malignant Neoplasm,0
6999,Image Feature,Pancreatic carcinoma,0
7000,Treating,Stage III Cutaneous Melanoma AJCC v6,0
7001,Term (temporal),Human Papillomavirus-Related Carcinoma,0
7002,Neck,Grade 1 Clear Cell Renal Cell Carcinoma,0
7003,Malignant Neoplasms,FIGO Stage II Ovarian Cancer,0
7004,Inguinal region,Breast Ductal Adenoma,0
7005,Experimental Result,gliosarcoma,0
7006,Molecular Mass,Intestinal Metaplasia of Bladder Urothelium,0
7007,Abdomen,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7008,Formation,Colorectal High Grade B-Cell Lymphoma,0
7009,How Much Distress Weight Loss,Brain Ependymoma,0
7010,Antibody studies (procedure),Vaginal Adenoid Cystic Carcinoma,0
7011,Ability to Drive,Ovarian germ cell choriocarcinoma stage IV,0
7012,Room of building - Study,Clonal Hematopoiesis of Indeterminate Potential,0
7013,Basis - conceptual entity,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7014,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Hodgkin lymphoma,0
7015,Including (qualifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
7016,Does carry,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7017,Endocrine system,Microcystic meningioma,0
7018,Consistency,Clonal Hematopoiesis of Indeterminate Potential,0
7019,Hardness,Plexosarcoma,0
7020,Malignant Neoplasms,Malignant neoplasm of gallbladder,0
7021,Crowding,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7022,vascular inflammations,Thymic Clear Cell Carcinoma,0
7023,Old,Vaginal Adenoid Cystic Carcinoma,0
7024,Call (Instruction),Bladder adenocarcinoma stage IV,0
7025,Skin cell,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7026,Cancer Genus,Transitional cell carcinoma,0
7027,Feelings,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7028,Valid,ICHTHYOSIS,0
7029,Early Therapy,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7030,Data,Digestive System Hodgkin Lymphoma,0
7031,Antibiotic throat preparations,Chronic Myelomonocytic Leukemia-2,0
7032,Anatomic Structure,Unicystic ameloblastoma,0
7033,Include (action),Liver Cavernous Hemangioma,0
7034,Toxic Epidermal Necrolysis,Pancreatic carcinoma,0
7035,Papillary thyroid carcinoma,Basal Cell Ameloblastoma,0
7036,Unit of radiation dose,Bladder adenocarcinoma stage IV,0
7037,lymph nodes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7038,International Classification of Diseases,Female Breast Carcinoma,0
7039,Latin America,Adult Alveolar Soft Part Sarcoma,0
7040,Etiology,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7041,High Level,Mucinous adenocarcinoma gastric,0
7042,Myeloid Leukemia,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7043,Skin,Clonal Hematopoiesis of Indeterminate Potential,0
7044,Previous,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
7045,Infant,FIGO Stage II Ovarian Cancer,0
7046,Relationships,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
7047,Outlines (document),Stage II Hepatocellular Carcinoma AJCC v8,0
7048,System,Mucinous adenocarcinoma gastric,0
7049,Five,Malignant melanoma of eyelid,0
7050,Treating,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7051,Cessation of life,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7052,Page (document),Maxillary Sinus Adenoid Cystic Carcinoma,0
7053,Occur (action),Childhood Thyroid Gland Follicular Carcinoma,0
7054,Treating,Advanced Uterine Corpus Carcinosarcoma,0
7055,common types,Advanced Uterine Corpus Carcinosarcoma,0
7056,Pharmacotherapy,Stage IB Pancreatic Cancer AJCC v8,0
7057,Therapeutic procedure,Liver Lymphangioma,0
7058,Disease,Uterine Cancer,0
7059,Characterization,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7060,Immune,Vaginal Adenoid Cystic Carcinoma,0
7061,Examined,Lung squamous cell carcinoma stage I,0
7062,Manufactured form,Choroid Necrotic Melanoma,0
7063,therapeutic aspects,Stage IB Pancreatic Cancer AJCC v8,0
7064,Set (Psychology),Recurrent Testicular Lymphoma,0
7065,Image Feature,Stage II Carcinoma of Penis,0
7066,Type - attribute,Stage III Cutaneous Melanoma AJCC v6,0
7067,Adult Liposarcoma,Lipoma of small intestine,0
7068,Mutation,Small cell neuroendocrine carcinoma of bladder,0
7069,Frequently,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7070,Adult Classical Hodgkin Lymphoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7071,Specific qualifier value,Anterior Urethral Malignant Neoplasm,0
7072,Primary malignant neoplasm,Mixed parotid tumor,0
7073,Negative Charge,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7074,Ovarian mucinous tumor,Thymic Clear Cell Carcinoma,0
7075,Include (action),Mixed astrocytoma-ependymoma,0
7076,Known,Stage II Carcinoma of Penis,0
7077,Malignant Neoplasms,Low Grade Squamous Intraepithelial Neoplasia,0
7078,Psychotherapy,Mucinous adenocarcinoma,0
7079,Heightened,Digestive System Hodgkin Lymphoma,0
7080,Brain,Low Grade Squamous Intraepithelial Neoplasia,0
7081,Severe (severity modifier),Intracortical osteosarcoma,0
7082,Malignant tumor of colon,Breast Apocrine Adenoma,0
7083,Sometimes,Low Grade Squamous Intraepithelial Neoplasia,0
7084,Hydranencephaly with Renal Aplasia-Dysplasia,Carcinoma of urinary bladder,0
7085,3+ Score,Chondrosarcoma,0
7086,Average of Value Derivation Technique,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7087,Specimen Source Codes - Pacemaker,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7088,Very,Acute Undifferentiated Leukemia,0
7089,Malignant - descriptor,Locally Advanced Epithelioid Hemangioendothelioma,0
7090,Formation,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7091,Ultrasonic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7092,Survival Rate,FIGO Stage II Ovarian Cancer,0
7093,Medical service,Intracortical osteosarcoma,0
7094,Frequently,Ichthyosis,0
7095,Hormonal,Hyperplasia of pituitary gland,0
7096,Gland,Blepharal carcinoma,0
7097,Specimen Type - Genital,Adult Alveolar Soft Part Sarcoma,0
7098,0%,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
7099,Lymphadenopathy,Benign tumor of eyelid,0
7100,Malignant Neoplasms,Stage III Cutaneous Melanoma AJCC v6,0
7101,Common (qualifier value),Atypical Mesothelial Hyperplasia,0
7102,Hypesthesia,Vaginal Adenoid Cystic Carcinoma,0
7103,Diagnosis,Malignant melanoma of eyelid,0
7104,AKR1A1 wt Allele,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7105,How Much Distress Cough,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7106,Mobility as a finding,Pancreatic carcinoma,0
7107,Cancer Registry,Ovarian Carcinoid Tumor,0
7108,Body part,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7109,Condition,Nasal cavity carcinoma,0
7110,Lymphoid Cell Count,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7111,Electromagnetic Spectrum,Neonatal leukemia,0
7112,Usually Need Help from Another Person for Arising,Unicystic ameloblastoma,0
7113,Metastasis,Nasal cavity carcinoma,0
7114,Several,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7115,Usually,FIGO Stage II Ovarian Cancer,0
7116,Body structure,Angiosarcoma of liver,0
7117,Literature,Refractory Ependymoma,0
7118,cervical cancer,Rhabdomyosarcoma with ganglionic differentiation,0
7119,Usual,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7120,In Urine,Digestive System Hodgkin Lymphoma,0
7121,Before values,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7122,Rare,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7123,Adult Hodgkin Lymphoma,Locally Advanced Carcinoma,0
7124,Household composition,Xeroderma pigmentosum,0
7125,Trial Screening,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7126,risk factors,Recurrent Uveal Melanoma,0
7127,Retinoic Acid Response Element,Recurrent Uveal Melanoma,0
7128,Detection,Precursor B-lymphoblastic lymphoma stage II,0
7129,Inguinal part of abdomen,Xeroderma pigmentosum,0
7130,Advance,squamous cell carcinoma of the thyroid gland,0
7131,Cells,Squamous cell carcinoma of lip,0
7132,Call (Instruction),Hyperplasia of pituitary gland,0
7133,depend,Ovarian germ cell choriocarcinoma stage IV,0
7134,Removed,adenosquamous carcinoma of breast,0
7135,Cancer Genus,Mixed astrocytoma-ependymoma,0
7136,Adult Lymphoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7137,Persons,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7138,Cancer Genus,Diffuse malignant mesothelioma,0
7139,Glioma,Secondary malignant neoplasm of lymph node,0
7140,Palpebronasal fold,Kaposi's sarcoma of extrahepatic bile duct,0
7141,Neuroendocrine Tumors,Adult Acute Eosinophilic Leukemia,0
7142,Experimental Finding,Benign Carotid Body Paraganglioma,0
7143,Known,Pilocytic astrocytoma of cerebellum,0
7144,Possibly Related to Intervention,Human Papillomavirus-Related Carcinoma,0
7145,Descending,Childhood Lymphoma,0
7146,Poverty,Congenital hamartoma,0
7147,Surgical aspects,Contact dermatitis due to alkali,0
7148,All of the Time,Stage III Cutaneous Melanoma AJCC v6,0
7149,Combined,Localized Askin Tumor,0
7150,shared attribute,Carcinoma of submandibular gland,0
7151,System (unit of presentation),Locally Advanced Soft Tissue Sarcoma,0
7152,Country,Primary Cutaneous Plasmablastic Lymphoma,0
7153,Process (qualifier value),Xeroderma pigmentosum,0
7154,70%,FIGO Stage IVA Ovarian Cancer,0
7155,shared attribute,Kaposi's sarcoma of skin,0
7156,Negation,Acantholytic squamous cell carcinoma,0
7157,described,Adenocarcinoma of the prostate metastatic,0
7158,Present,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7159,Act Relationship Type - occurrence,Bladder squamous cell carcinoma stage I,0
7160,Internal,Mucinous adenocarcinoma gastric,0
7161,Shock,Tongue Alveolar Soft Part Sarcoma,0
7162,Varies,FIGO Stage II Ovarian Cancer,0
7163,Object Class,Liver Cavernous Hemangioma,0
7164,Speaking (activity),Thymoma malignant recurrent,0
7165,Unmarried person,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7166,Science of Morphology,Female Breast Carcinoma,0
7167,Blood Vessel,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7168,Tumor Mass,Astrocytoma of brain,0
7169,Entity Determiner - specific,mucinous adenocarcinoma of gallbladder,0
7170,<3 (qualifier value),Benign Apocrine Neoplasm,0
7171,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7172,Liquid substance,Hemangioma,0
7173,List,Childhood Anaplastic Large Cell Lymphoma,0
7174,Fallopian Tubes,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7175,Classification of information,Malignant melanoma of eyelid,0
7176,Negation,Splenic Manifestation of Hairy Cell Leukemia,0
7177,Pancreas,Hodgkin lymphoma,0
7178,Malignant tumor of cervix,ROSE Cluster 3,0
7179,Supportive assistance,Basal Cell Ameloblastoma,0
7180,Tobacco,Hereditary Diffuse Gastric Adenocarcinoma,0
7181,Brain part,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
7182,800,Benign tumor of eyelid,0
7183,Common Specifications in HL7 V3 Publishing,Splenic Manifestation of Hairy Cell Leukemia,0
7184,status - In progress,Benign Anal Granular Cell Tumor,0
7185,Work,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7186,Operative Surgical Procedures,Colorectal High Grade B-Cell Lymphoma,0
7187,CDISC SEND Tumor Findings Results Terminology,clear cell adenocarcinoma of gallbladder,0
7188,Jumping,Endometrial Small Cell Carcinoma,0
7189,Case (situation),Type II Endometrial Adenocarcinoma,0
7190,Area,Mixed astrocytoma-ependymoma,0
7191,Surgery specialty,Anaplastic large cell lymphoma,0
7192,Intermediate,Carcinoma of urinary bladder,0
7193,Abdomen,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7194,Formation,High Grade Glandular Intraepithelial Neoplasia,0
7195,Appearance,Stage IB Pancreatic Cancer AJCC v8,0
7196,Palmitic Acid,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7197,Occur (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7198,59,Malignant neoplasm of olfactory nerve,0
7199,Nasal sinus,ICHTHYOSIS,0
7200,CDISC SEND Body System Terminology,Vaginal Adenoid Cystic Carcinoma,0
7201,Females,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7202,Including (qualifier),Acute Undifferentiated Leukemia,0
7203,Factor,Occult Lung Adenosquamous Carcinoma,0
7204,Weight Loss,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7205,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
7206,Recurrent urinary tract infection,Cerebral Primitive Neuroectodermal Tumor,0
7207,Medical,Digestive System Hodgkin Lymphoma,0
7208,eTMF Content Model Code,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
7209,year,Bladder adenocarcinoma stage IV,0
7210,Widening,Pancreatic Intraepithelial Neoplasia-3,0
7211,Skin,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7212,Times,Basal Cell Ameloblastoma,0
7213,Illness: Cannot describe symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7214,+5,Werner Syndrome,0
7215,Part of,Adult Acute Eosinophilic Leukemia,0
7216,Form:Finding:Point in time:{Setting}:Document:{Role},Blood Vessel Tumors,0
7217,Removed,Acute Undifferentiated Leukemia,0
7218,Often - answer to question,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7219,Two,Benign tumor of eyelid,0
7220,Fluid Leak,Colorectal Neuroendocrine Tumor G2,0
7221,Science of Etiology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7222,Alveolar,BRCA2 Syndrome,0
7223,Taste Perception,Testicular cancer metastatic,0
7224,Risk,Testicular cancer metastatic,0
7225,Tobacco,Engraftment syndrome,0
7226,Tryptophanase,Benign Apocrine Neoplasm,0
7227,To,Benign neoplasm of thorax,0
7228,Painless,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7229,Tryptophanase,Ovarian germ cell choriocarcinoma stage IV,0
7230,Have Weight Loss,FIGO Stage IVA Ovarian Cancer,0
7231,epithelial,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7232,Occurrence,Stage III Adult Immunoblastic Lymphoma,0
7233,Much,Undifferentiated Endocervical Sarcoma,0
7234,Science of genetics,Maxillary Sinus Adenoid Cystic Carcinoma,0
7235,Lymphocyte component of blood,Adrenal Rest Tumor,0
7236,Etiology aspects,Stage III Cutaneous Melanoma AJCC v6,0
7237,Disease,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7238,Biological Response Modifiers,Colorectal High Grade B-Cell Lymphoma,0
7239,Bacteria,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7240,Vertebral column,Pancreatic Intraepithelial Neoplasia-3,0
7241,Childhood Soft Tissue Sarcoma,Pancreatic carcinoma,0
7242,Section (object),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7243,Classical Hodgkin's Lymphoma,FIGO Stage II Ovarian Cancer,0
7244,morphological,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7245,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Bladder adenocarcinoma stage IV,0
7246,Keratoconjunctivitis Sicca,Kaposi's sarcoma of skin,0
7247,Excessive,Leiomyoma of Gallbladder,0
7248,Manifested by,Atypical Lobular Breast Hyperplasia,0
7249,Cure (remedy),Stage III Cutaneous Melanoma AJCC v6,0
7250,Tumor type,Recurrent Testicular Lymphoma,0
7251,include - SetOperator,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7252,Hereditary,Small intestine carcinoma,0
7253,Increase in size since previous mammogram,Stage IV Colorectal Cancer AJCC v8,0
7254,potential,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7255,<90,Papillary squamous cell carcinoma,0
7256,W stress,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7257,NCI CTEP SDC Gestational Trophoblastic Disease Sub-Category Terminology,Recurrent Uveal Melanoma,0
7258,Completely Able,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7259,Identifiable Class,Metastatic Ductal Breast Carcinoma,0
7260,Thyroid Gland Follicular Adenoma,Hereditary Diffuse Gastric Adenocarcinoma,0
7261,Genus Homo,Digestive System Hodgkin Lymphoma,0
7262,Face (spatial concept),Unfavorable Non-Hodgkin Lymphoma,0
7263,Retinoic Acid Response Element,Small Intestinal Villous Adenoma,0
7264,Form:Finding:Point in time:{Setting}:Document:{Role},Non-Metastatic Gestational Trophoblastic Tumor,0
7265,Acute Myeloid Leukemia Pathway,squamous cell carcinoma of the thyroid gland,0
7266,Count of entities,Recurrent Testicular Lymphoma,0
7267,High,Methotrexate-Associated Hodgkin Lymphoma,0
7268,Death (finding),Colorectal High Grade B-Cell Lymphoma,0
7269,combination - answer to question,Mixed astrocytoma-ependymoma,0
7270,Sweating,Glomeruloid hemangioma,0
7271,Uveal melanoma,Lung squamous cell carcinoma stage I,0
7272,Histologic,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7273,Decision,Human Papillomavirus-Related Carcinoma,0
7274,consideration,Papillary squamous cell carcinoma,0
7275,Site,Adult Hepatocellular Carcinoma,0
7276,Descending,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7277,Malignant neoplasm of breast,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7278,Basis - conceptual entity,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7279,Neuroendocrine Tumors,Cerebral Primitive Neuroectodermal Tumor,0
7280,Form:Finding:Point in time:{Setting}:Document:{Role},FIGO Stage IVA Ovarian Cancer,0
7281,Molecular Mass,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
7282,Occurrence Indicator,Malignant neoplasm of thalamus,0
7283,Occur (action),Nasal cavity carcinoma,0
7284,Body structure,Metaplastic carcinoma of breast,0
7285,Refrigeration,Benign Anal Granular Cell Tumor,0
7286,Frequently,Gallbladder Adenocarcinoma,0
7287,Seventh,Recurrent Testicular Lymphoma,0
7288,Sore sensation,Metastatic Lung Neuroendocrine Neoplasm,0
7289,Term Birth,Carcinoma,0
7290,Recurrence (disease attribute),Acute Undifferentiated Leukemia,0
7291,NMYC Gene Amplification dysfunction,Acute Undifferentiated Leukemia,0
7292,Usual,Type II Endometrial Adenocarcinoma,0
7293,Usual Severity Weight Loss,BRCA2 Syndrome,0
7294,gastrointestinal,Diffuse malignant mesothelioma,0
7295,Massive,Metastatic Kidney Carcinoma,0
7296,Males,Vaginal Adenoma,0
7297,Asians,Vaginal Adenoma,0
7298,Axis vertebra,Melanomatosis,0
7299,Rituxan,Breast Ductal Adenoma,0
7300,Plasma Product,embryonal rhabdomyosarcoma of prostate,0
7301,Often - answer to question,Engraftment syndrome,0
7302,Pale color saturation,Benign Anal Granular Cell Tumor,0
7303,nonmetastatic,Vaginal Adenoma,0
7304,Hereditary,Bladder squamous cell carcinoma stage I,0
7305,Family,Liver Cavernous Hemangioma,0
7306,Seventh,Spongiotic dermatitis,0
7307,Early,clear cell adenocarcinoma of gallbladder,0
7308,Most,Digestive System Hodgkin Lymphoma,0
7309,Childhood Hodgkin Lymphoma,Extracranial Neuroblastoma,0
7310,Occurrence,Metastatic Carcinoma in the Lung,0
7311,Chemicals,Localized Ewing Sarcoma,0
7312,radiotherapeutic,Squamous cell carcinoma of lip,0
7313,Rest,Intestinal Neuroendocrine Carcinoma,0
7314,seen,Vaginal Adenoma,0
7315,Women's Health,embryonal rhabdomyosarcoma of prostate,0
7316,Treatment intent,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7317,Cystic,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7318,Infrequent,Human Papillomavirus-Related Carcinoma,0
7319,High Risk Acute Leukemia,Melanomatosis,0
7320,Classification,Chronic Myelomonocytic Leukemia-2,0
7321,>90,Childhood Anaplastic Large Cell Lymphoma,0
7322,Mutation Abnormality,Liver Cavernous Hemangioma,0
7323,Broken skin,Intestinal Neuroendocrine Carcinoma,0
7324,potential,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7325,Failure (biologic function),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7326,Malignant Neoplasms,Childhood Fibrillary Astrocytoma,0
7327,Relationship by association,clear cell adenocarcinoma of gallbladder,0
7328,Case unit dose,Splenic Manifestation of Hairy Cell Leukemia,0
7329,Surgery specialty,Intestinal Neuroendocrine Carcinoma,0
7330,Well Differentiated Oligodendroglioma,Vaginal Adenoma,0
7331,Related personal status,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7332,Divide,Childhood Lymphoma,0
7333,Adenocarcinoma of pancreas,Trabecular adenocarcinoma,0
7334,All of the Time,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7335,Pediculus humanus capitis (eukaryote),Clinical Stage I Cutaneous Melanoma AJCC v8,0
7336,International Classification of Disease for Oncology,Unfavorable Non-Hodgkin Lymphoma,0
7337,Relocation of home or business,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7338,Adverse Event Associated with Vascular,Adult Alveolar Soft Part Sarcoma,0
7339,Case unit dose,Papillary squamous cell carcinoma,0
7340,Sharing (Social Behavior),Xeroderma pigmentosum,0
7341,Cancer Genus,Stage II Carcinoma of Penis,0
7342,Tissue Specimen Code,gliosarcoma,0
7343,Carcinoma,Spongiotic dermatitis,0
7344,Squamous Epithelial Cells,Pancreatic carcinoma,0
7345,Primary malignant neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7346,Neuroglia,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7347,risk factors - observation list,Malignant melanoma of eyelid,0
7348,Sample Range,Benign Carotid Body Paraganglioma,0
7349,Chemotherapy Regimen,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7350,Body part,Maxillary Sinus Adenoid Cystic Carcinoma,0
7351,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
7352,Carcinoma in Situ,Childhood Thyroid Gland Follicular Carcinoma,0
7353,International Classification of Diseases,Stage III Cutaneous Melanoma AJCC v6,0
7354,Bone marrow myeloid dysplasia,Colorectal cancer,0
7355,Transplantation of liver,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7356,Form:Finding:Point in time:{Setting}:Document:{Role},Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7357,Face,Refractory Barrett Esophagus,0
7358,Offspring,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7359,include - SetOperator,Localized Ewing Sarcoma,0
7360,Symptoms,Stage IB Pancreatic Cancer AJCC v8,0
7361,various other nasal preparations in ATC,Lipoma of small intestine,0
7362,Cell Count,embryonal rhabdomyosarcoma of prostate,0
7363,Skeletal bone,Metastatic Lung Small Cell Carcinoma,0
7364,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7365,MOSTLY,Human Papillomavirus-Related Carcinoma,0
7366,North America,adenoid cystic carcinoma of lung,0
7367,800,Squamous cell carcinoma of lip,0
7368,Appearance Distress Question,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7369,Degree or extent,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7370,Adenocarcinoma,Breast Ductal Adenoma,0
7371,Usually,Advanced Lung Carcinoma,0
7372,Five,Anterior Urethral Malignant Neoplasm,0
7373,Adult human body,High Grade Glandular Intraepithelial Neoplasia,0
7374,Term (lexical),squamous cell carcinoma of the thyroid gland,0
7375,Occurrence Indicator,Digestive System Hodgkin Lymphoma,0
7376,Anatomic Site,Diffuse malignant mesothelioma,0
7377,Borg Category-Ratio 10 Perceived Exertion Score 5,Metastatic Neoplasm to the Gallbladder,0
7378,Third floor,Chronic Myelomonocytic Leukemia-2,0
7379,Five-year Survival Rate,Maxillary Sinus Adenocarcinoma,0
7380,Cicatrix,Diffuse malignant mesothelioma,0
7381,Type - attribute,Malignant melanoma of eyelid,0
7382,<50,Stage III Cutaneous Melanoma AJCC v6,0
7383,Definitely Related to Intervention,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7384,Different,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7385,Spectrum,Ichthyoses,0
7386,Cause of Death,Mucinous adenocarcinoma gastric,0
7387,Togo,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7388,Back structure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7389,40%,Breast Ductal Adenoma,0
7390,Common Specifications in HL7 V3 Publishing,Heavy Chain Deposition Disease,0
7391,Urticaria,Metastatic Lung Neuroendocrine Neoplasm,0
7392,Average,Intestinal Metaplasia of Bladder Urothelium,0
7393,Dysphagia,Parathyroid Gland Adenocarcinoma,0
7394,High Grade Ovarian Serous Adenocarcinoma,Maxillary Sinus Adenocarcinoma,0
7395,Stage,Stage IV Childhood Non-Hodgkin Lymphoma,0
7396,Suspected qualifier,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7397,Increase,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7398,Known,Cartilaginous exostosis,0
7399,Prophylactic treatment,Intestinal Metaplasia of Bladder Urothelium,0
7400,Type - attribute,Maxillary Sinus Adenoid Cystic Carcinoma,0
7401,Ultrasonography,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7402,Non-invasive,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7403,Value Above Reference Range,Trabecular adenocarcinoma,0
7404,Complete,Xeroderma pigmentosum,0
7405,Present,Human Papillomavirus-Related Carcinoma,0
7406,Localized,Deep Leiomyoma,0
7407,Including (qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7408,Very high,Stage IV Childhood Non-Hodgkin Lymphoma,0
7409,Involvement with,Vaginal Adenoid Cystic Carcinoma,0
7410,Usually,Leiomyoma of Gallbladder,0
7411,Operative Surgical Procedures,Digestive System Hodgkin Lymphoma,0
7412,Therapeutic procedure,Endometrial Small Cell Carcinoma,0
7413,Pelvic pain female,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7414,Dangerousness,Childhood Anaplastic Large Cell Lymphoma,0
7415,Enneking Low Surgical Grade,Spongiotic dermatitis,0
7416,Acute leukemia,Precursor B-lymphoblastic lymphoma stage II,0
7417,cancer risk,Mixed parotid tumor,0
7418,Geographic Locations,Blood Vessel Tumors,0
7419,Chemotherapy Regimen,Brain Tumor,0
7420,Name,Refractory Barrett Esophagus,0
7421,Out (direction),Breast Ductal Adenoma,0
7422,neck gland,Human Papillomavirus-Related Carcinoma,0
7423,Lymphatic System,Lipoma of small intestine,0
7424,Distant,Acute lymphadenitis,0
7425,Consortium or Network,Placental aromatase deficiency,0
7426,Aggressive malignancies,Stage II Hepatocellular Carcinoma AJCC v8,0
7427,Concept History,Malignant neoplasm of olfactory nerve,0
7428,System - kit,Refractory Ependymoma,0
7429,include - SetOperator,Type II Endometrial Adenocarcinoma,0
7430,Anabolism,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
7431,Major <insect>,ROSE Cluster 3,0
7432,Taxonomic,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7433,Occurrence,Benign squamous cell tumor,0
7434,National Cancer Institute,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7435,AS virus,FIGO Stage IVA Ovarian Cancer,0
7436,Pruritus,Kaposi's sarcoma of extrahepatic bile duct,0
7437,200,Stage II Hepatocellular Carcinoma AJCC v8,0
7438,Survival Rate,Squamous cell carcinoma of lip,0
7439,Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7440,Ultrasonics (sound),Childhood Lymphoma,0
7441,Disease,Spermatocytic seminoma,0
7442,Decision,de novo Myelodysplastic Syndrome,0
7443,Increase,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7444,Ductal Breast Carcinoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7445,Therapeutic procedure,Cervical Fibroepithelial Polyp,0
7446,Approximate,papillary carcinoma of penis,0
7447,Dry,Thyroid Hurthle Cell Carcinoma,0
7448,Include (action),Stage II Hepatocellular Carcinoma AJCC v8,0
7449,Basis - conceptual entity,Childhood Anaplastic Large Cell Lymphoma,0
7450,Occurrence,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7451,Thymus <angiosperm>,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7452,Histology aspects,Gastric Diffuse Large B-Cell Lymphoma,0
7453,3+ Score,Malignant melanoma of eyelid,0
7454,Spreading (qualifier value),Mucosal Melanoma,0
7455,Recommendation,Cherubism,0
7456,Due to,Non-Metastatic Gestational Trophoblastic Tumor,0
7457,Blood Cells,Colorectal Neuroendocrine Tumor G2,0
7458,Benign Smooth Muscle Neoplasm,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7459,Increase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7460,Completely - dosing instruction fragment,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
7461,cell transformation,Endometrial Small Cell Carcinoma,0
7462,Case (situation),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7463,Body tissue,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7464,Trial Screening,Kaposi's sarcoma of extrahepatic bile duct,0
7465,Feel Pain,Locally Advanced Epithelioid Hemangioendothelioma,0
7466,month,Locally Advanced Epithelioid Hemangioendothelioma,0
7467,Needs,non-Hodgkin's lymphoma of spleen,0
7468,Genus Homo,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7469,Obesity,Adrenal Rest Tumor,0
7470,Vomiting,Papillary squamous cell carcinoma,0
7471,Fever,Cervical Fibroepithelial Polyp,0
7472,seconds,Stage IB Lung Cancer AJCC v7,0
7473,<90,Adult Acute Eosinophilic Leukemia,0
7474,Mechanism Component of Device,Peripheral primitive neuroectodermal tumor of soft tissue,0
7475,Before,Hereditary corneal dystrophy,0
7476,Common Specifications in HL7 V3 Publishing,Colorectal cancer,0
7477,Lymphadenitis,Mucinous adenocarcinoma gastric,0
7478,Stem cell transplant,Recurrent Uveal Melanoma,0
7479,Taken,Squamous cell carcinoma of lip,0
7480,Adult human body,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7481,Arising in,Intraepithelial Melanocytic Hyperplasia,0
7482,Malignant Neoplasms,Refractory Barrett Esophagus,0
7483,Short,Recurrent Rhabdomyosarcoma,0
7484,Togo,Hodgkin lymphoma,0
7485,Benign,Astrocytoma of brain,0
7486,Endocrine Cells,Blood Vessel Tumors,0
7487,Relationships,Clonal Hematopoiesis of Indeterminate Potential,0
7488,Certain (qualifier value),Advanced Uterine Corpus Carcinosarcoma,0
7489,Science of Etiology,Carcinoma of urinary bladder,0
7490,Ninth,Hodgkin Disease,0
7491,structure,Hodgkin Disease,0
7492,IPSS Risk Category High,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7493,Reaching,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
7494,Males,Unresectable Rhabdomyosarcoma,0
7495,Grouping,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7496,Exposure to,Lipoma of small intestine,0
7497,Often - answer to question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7498,Usual Severity Weight Loss,adenoid cystic carcinoma of lung,0
7499,Disseminated Malignant Neoplasm,Childhood Central Nervous System Ganglioneuroblastoma,0
7500,combination of objects,Malignant Testicular Sertoli Cell Tumor,0
7501,Menstruation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7502,Screening,Human Papillomavirus-Related Carcinoma,0
7503,Immunoproliferative Disorders,squamous cell carcinoma of the thyroid gland,0
7504,Reported,Small intestine carcinoma,0
7505,Irritation (finding),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
7506,Unintentional,Chest Wall Fibromatosis,0
7507,Lung,Kaposi's sarcoma of skin,0
7508,NCI CTEP SDC Myelodysplastic Syndrome Sub-Category Terminology,Small Intestinal Villous Adenoma,0
7509,Inguinal part of abdomen,Intraepithelial Melanocytic Hyperplasia,0
7510,Science of Etiology,Breast Apocrine Adenoma,0
7511,X-linked inheritance,Pilocytic astrocytoma of cerebellum,0
7512,Always (frequency),Localized Ewing Sarcoma,0
7513,Formation,Papillary squamous cell carcinoma,0
7514,Separated from cohabitee,Vaginal Adenoma,0
7515,Preventive intent,Microcystic meningioma,0
7516,Metastatic Neoplasm,Anterior Urethral Malignant Neoplasm,0
7517,QPCT wt Allele,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7518,Idle,ROSE Cluster 3,0
7519,Combined Modality Therapy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7520,Shortness of Breath Visual Analogue Scale,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7521,Occurrence,Type II Endometrial Adenocarcinoma,0
7522,Primary malignant neoplasm,Hodgkin Disease,0
7523,Central Nervous System Neoplasms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7524,treatment - ActInformationManagementReason,Heavy Chain Deposition Disease,0
7525,Alkalies,Maxillary Sinus Adenocarcinoma,0
7526,Lymphatic vessel,Gallbladder Adenocarcinoma,0
7527,United States,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7528,Chemicals,Small cell neuroendocrine carcinoma of bladder,0
7529,Vomiting,Colorectal cancer,0
7530,Early,Digestive System Hodgkin Lymphoma,0
7531,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7532,Chest Wall Pain,Lung squamous cell carcinoma stage I,0
7533,Absence (morphologic abnormality),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7534,Palmitic Acid,Xeroderma pigmentosum,0
7535,Smear - instruction imperative,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7536,Five,Tumorlet,0
7537,Persistent,Bladder adenocarcinoma stage IV,0
7538,Blood group A (finding),Ichthyoses,0
7539,Good,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
7540,Reported Term,Undifferentiated Endocervical Sarcoma,0
7541,Complication,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7542,How Often Shortness of Breath,Stage IB Pancreatic Cancer AJCC v8,0
7543,Usual Severity Diarrhea,mucinous adenocarcinoma of gallbladder,0
7544,Melanoma Pathway,Adult Acute Eosinophilic Leukemia,0
7545,Cerebrum,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7546,Prognosis:Find:Pt:^Patient:Nom,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7547,Cessation of life,Undifferentiated Endocervical Sarcoma,0
7548,Human body structure,Unicystic ameloblastoma,0
7549,Kind of quantity - Taste,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7550,Negation,Bladder adenocarcinoma stage IV,0
7551,Screening,Refractory Ependymoma,0
7552,pathogenic aspects,embryonal rhabdomyosarcoma of prostate,0
7553,Genus Labia,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7554,Anorexia,Xeroderma pigmentosum,0
7555,Name,Mixed astrocytoma-ependymoma,0
7556,year,Leptomeningeal sarcoma,0
7557,gliosarcoma,Vaginal Adenoma,0
7558,Primary malignant neoplasm,Type II Endometrial Adenocarcinoma,0
7559,Often - answer to question,Glomeruloid hemangioma,0
7560,Beginning,Cancer of Urinary Tract,0
7561,Most of the time,Intraepithelial Melanocytic Hyperplasia,0
7562,Net (qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7563,Body part,BRCA2 Syndrome,0
7564,Biopsy,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7565,Ninein,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7566,Greater than one,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7567,Family history,Trichilemmocarcinoma,0
7568,Hematopoietic Neoplasms,Engraftment syndrome,0
7569,Pelvic pain female,mucinous adenocarcinoma of gallbladder,0
7570,Tryptophanase,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7571,Cancer Genus,Familial Hemophagocytic Lymphocytosis,0
7572,First (number),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7573,Body tissue,Malignant neoplasm of thalamus,0
7574,Successful,Noninfiltrating Intraductal Carcinoma,0
7575,Intellectual scale,Melanomatosis,0
7576,Nictitating Membrane,High Grade Glandular Intraepithelial Neoplasia,0
7577,risk factors - observation list,Adult Alveolar Soft Part Sarcoma,0
7578,Large,Acantholytic squamous cell carcinoma,0
7579,Arising in,Acinar cell carcinoma of pancreas,0
7580,Pediculus humanus capitis (eukaryote),mucinous adenocarcinoma of gallbladder,0
7581,More,Unicystic ameloblastoma,0
7582,Very High Level,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
7583,suffix,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
7584,Offspring,BRCA2 Syndrome,0
7585,Experimental Result,Bladder squamous cell carcinoma stage I,0
7586,Gravidity,Adult Hepatocellular Carcinoma,0
7587,Now (temporal qualifier),Unfavorable Non-Hodgkin Lymphoma,0
7588,Intermediate,Papillary squamous cell carcinoma,0
7589,Effectiveness,ROSE Cluster 3,0
7590,X-Ray Computed Tomography,Bladder adenocarcinoma stage IV,0
7591,Surgical aspects,Benign squamous cell tumor,0
7592,Ultrasonic Shockwave,Recurrent Testicular Lymphoma,0
7593,Tumor cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7594,Hereditary Diseases,sarcoma of spinal cord,0
7595,Northern Europe,Intracortical osteosarcoma,0
7596,As Much as Desired,Tongue Alveolar Soft Part Sarcoma,0
7597,Onset of (contextual qualifier),Maxillary Sinus Adenocarcinoma,0
7598,Progress,Thyroid Hurthle Cell Carcinoma,0
7599,Cancer Genus,Werner Syndrome,0
7600,History of previous events,Vaginal Adenoid Cystic Carcinoma,0
7601,Repaired,Intracortical osteosarcoma,0
7602,Usually,Xeroderma pigmentosum,0
7603,Cause of death.underlying,Adult Anaplastic Oligodendroglioma,0
7604,Mature,Stage III Adult Immunoblastic Lymphoma,0
7605,lobe,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7606,Night time,Stage II Hepatocellular Carcinoma AJCC v8,0
7607,Person Name,Hodgkin Disease,0
7608,Treatment Plan,Leiomyoma of Gallbladder,0
7609,Sun Exposure,Adult Hepatocellular Carcinoma,0
7610,Traumatic injury,Clonal Hematopoiesis of Indeterminate Potential,0
7611,What subject filter - Result,Stage II Hepatocellular Carcinoma AJCC v8,0
7612,Common (qualifier value),Metastatic Ductal Breast Carcinoma,0
7613,Body part,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7614,Hyperplasia,Metaplastic carcinoma of breast,0
7615,Followed by,Undifferentiated Endocervical Sarcoma,0
7616,United States,Localized Ewing Sarcoma,0
7617,Type A,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7618,Disease,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7619,Certainties,Squamous cell carcinoma of lip,0
7620,Anaplastic Oligodendroglioma,Adult Anaplastic Oligodendroglioma,0
7621,Pruritus,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7622,Diagnostic Imaging,Stage 0 Penile Cancer AJCC v8,0
7623,PSA Level Less than Five,Cervical Fibroepithelial Polyp,0
7624,Possible,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7625,Negation,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
7626,Group A (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
7627,Pregnancy,Acute Undifferentiated Leukemia,0
7628,Process,Cervical Fibroepithelial Polyp,0
7629,Smear - instruction imperative,Adult Acute Eosinophilic Leukemia,0
7630,Negation,Mucinous adenocarcinoma gastric,0
7631,Deglutition,Endometrial Small Cell Carcinoma,0
7632,Account number:Identifier:Point in time:^Patient:Nominal,Unicystic ameloblastoma,0
7633,Spindle,Cerebral Primitive Neuroectodermal Tumor,0
7634,Contain (action),Benign Anal Granular Cell Tumor,0
7635,Platelet Glycoprotein 4,Neonatal leukemia,0
7636,X-Ray Computed Tomography,Lipoma of small intestine,0
7637,Early,Thyroid Hurthle Cell Carcinoma,0
7638,New,Epithelioid Sarcoma NCI Grade 3,0
7639,Within,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7640,Dual,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
7641,Lung,Mucinous cystadenofibroma,0
7642,Confirmed by,Kaposi's sarcoma of extrahepatic bile duct,0
7643,Body tissue,Malignant neoplasm of olfactory nerve,0
7644,survival aspects,Bladder squamous cell carcinoma stage I,0
7645,Type A,Malignant neoplasm of gallbladder,0
7646,IPSS Risk Category High,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7647,Africa,Fibroadenoma of breast,0
7648,Wound number:ID:Pt:^Patient:Nom,Hemangioma,0
7649,Fasting,Maxillary Sinus Adenocarcinoma,0
7650,Group A (blood group),Ovarian Dermoid Cyst with Secondary Carcinoma,0
7651,In Blood,Recurrent Primary Lymphoma of Bone,0
7652,Canada,Vaginal Adenoid Cystic Carcinoma,0
7653,Anus,Cerebral Primitive Neuroectodermal Tumor,0
7654,Feel Tired question,Pancreatic Intraepithelial Neoplasia-3,0
7655,BRCA2 protein,Medulloblastoma,0
7656,Fasting,Digestive System Hodgkin Lymphoma,0
7657,Elderly (population group),Mucinous adenocarcinoma gastric,0
7658,Blood Cells,Fibroadenoma of breast,0
7659,World,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7660,Diarrhea,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7661,Usual Severity Shortness of Breath,Unicystic ameloblastoma,0
7662,Diagnosis Study,Locally Advanced Epithelioid Hemangioendothelioma,0
7663,combination - answer to question,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7664,Extension,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7665,See,Astrocytoma of brain,0
7666,Either,Ichthyosis,0
7667,Diagnosis Study,Malignant Testicular Sertoli Cell Tumor,0
7668,Body structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7669,Linear,Platinum-Resistant Lung Small Cell Carcinoma,0
7670,Application (Document),Pancreatic carcinoma,0
7671,Able to Concentrate Question,Recurrent Uveal Melanoma,0
7672,Secondary Neoplasm,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
7673,Presentation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7674,Manufactured sign,Airway Hemangioma,0
7675,Hodgkin Disease,Undifferentiated Endocervical Sarcoma,0
7676,Surface of skin,Kaposi's sarcoma of skin,0
7677,Anatomic Site,Testicular cancer metastatic,0
7678,Derivative,Colorectal Neuroendocrine Tumor G2,0
7679,Associated with,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7680,Person Name,Vaginal Adenoid Cystic Carcinoma,0
7681,Free (available (qualifier)),Thymoma malignant recurrent,0
7682,Serum calcium measurement,Cystadenocarcinoma,0
7683,Tryptophanase,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7684,Lymphoid Tissue,Benign squamous cell tumor,0
7685,Ephrin Type-B Receptor 1,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7686,Sarcoidosis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7687,Occurrence Indicator,Fibroadenoma of breast,0
7688,Congenital Abnormality,Locally Advanced Epithelioid Hemangioendothelioma,0
7689,Nipples,Metaplastic carcinoma of breast,0
7690,Time,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7691,Infrequent,embryonal rhabdomyosarcoma of prostate,0
7692,Range,Hemangioma,0
7693,Malignant Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7694,Malignant neoplasm of stomach,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7695,Qualitative form,Ovarian Carcinoid Tumor,0
7696,Base,Heavy Chain Deposition Disease,0
7697,Treatment Epoch,Vaginal Adenoma,0
7698,Common Specifications in HL7 V3 Publishing,Vaginal Adenoma,0
7699,white blood cell type,Mucinous adenocarcinoma gastric,0
7700,Definitive,Endometrial Small Cell Carcinoma,0
7701,Negation,Metastatic Malignant Neoplasm in the Sellar Region,0
7702,Contain (action),Malignant melanoma of eyelid,0
7703,Subject - topic,Refractory Ependymoma,0
7704,Blood,Endometrial Small Cell Carcinoma,0
7705,Cover - action,Extra-Adrenal Paraganglioma,0
7706,International Classification of Disease for Oncology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7707,Patient need for (contextual qualifier),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7708,Precancerous Conditions,Locally Advanced Carcinoma,0
7709,World Health Organization,Benign neoplasm of eye,0
7710,AKR1A1 wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7711,low,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7712,Involvement with,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
7713,Lung,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7714,East,Familial Hemophagocytic Lymphocytosis,0
7715,Three,Primary Cutaneous Plasmablastic Lymphoma,0
7716,Pharmacotherapy,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7717,Pancreas,non-Hodgkin's lymphoma of spleen,0
7718,Feature,Angiosarcoma of liver,0
7719,Manufactured form,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7720,Occur (action),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7721,Cardiac Lead Procedure,Intraepithelial Melanocytic Hyperplasia,0
7722,Lipoma,Malignant neoplasm of subglottis,0
7723,Pain NOS,Childhood Central Nervous System Ganglioneuroblastoma,0
7724,Document completion status - Documented,Multiple Endocrine Neoplasia,0
7725,Malignant neoplasm of lung,Localized Ewing Sarcoma,0
7726,PSA Level Less than Two,Gallbladder Adenocarcinoma,0
7727,Occurrence Indicator,adenosquamous carcinoma of breast,0
7728,Cell Differentiation process,Hemangioma,0
7729,oncology field,Blepharal carcinoma,0
7730,1+ Score,Giant cell angiofibroma,0
7731,Subtype (attribute),Astrocytoma of brain,0
7732,Molecular Mass,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
7733,Odontogenic Tumors,Metastatic Ductal Breast Carcinoma,0
7734,Viruses ingredient,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7735,Administration procedure,Pancreatic Endocrine Carcinoma,0
7736,Location of Oral Residue Following Swallowing,FIGO Stage II Ovarian Cancer,0
7737,Bilateral complete salpingectomy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
7738,Experimental Result,Splenic Manifestation of Hairy Cell Leukemia,0
7739,Others - Allergy,Kaposi's sarcoma of skin,0
7740,Sequela of disorder,Papillary cystic tumor,0
7741,chapter,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7742,Gonadal structure,Human Papillomavirus-Related Carcinoma,0
7743,Accounting (activity),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7744,High risk of,Squamous cell carcinoma of lip,0
7745,Further,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
7746,various allergen extracts,Angiosarcoma of liver,0
7747,Involvement with,Locally Advanced Squamous Cell Carcinoma,0
7748,Tryptophanase,Childhood Central Nervous System Immature Teratoma,0
7749,Extension,Heavy Chain Deposition Disease,0
7750,Percent Activity,Peripheral primitive neuroectodermal tumor of soft tissue,0
7751,FAT1 wt Allele,embryonal rhabdomyosarcoma of prostate,0
7752,Overall Publication Type,Nasal cavity carcinoma,0
7753,Form of uterus,Chondrosarcoma,0
7754,Adult Subependymal Giant Cell Astrocytoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
7755,Population Group,Pilocytic astrocytoma of cerebellum,0
7756,Unknown,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7757,biopsy characteristics,Medulloblastoma,0
7758,Common (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7759,Reduction (chemical),Refractory Ependymoma,0
7760,various other agents for local oral treatment in ATC,Plexosarcoma,0
7761,Group A (blood group),Malignant Neoplasm with Regional Lymph Node Involvement,0
7762,Code,Melanomatosis,0
7763,throat cancer,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7764,Discover,Refractory WHO Grade III Glioma,0
7765,Leg,Placental aromatase deficiency,0
7766,potential,Trichilemmocarcinoma,0
7767,Correct (qualifier),Thymic Clear Cell Carcinoma,0
7768,Spreading (qualifier value),Cervical Squamous Intraepithelial Neoplasia,0
7769,Exostoses,Malignant neoplasm of olfactory nerve,0
7770,Percent of Abnormal Cells,Bladder squamous cell carcinoma stage I,0
7771,Usual,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7772,Treatment intent,Endometrial Small Cell Carcinoma,0
7773,Breast Carcinoma,Bladder Neuroendocrine Neoplasm,0
7774,rhinoplasty,Splenic Manifestation of Hairy Cell Leukemia,0
7775,Body Fluid Discharge,Cerebral Primitive Neuroectodermal Tumor,0
7776,Tired,Intestinal Neuroendocrine Carcinoma,0
7777,Diagnosis,Localized Ewing Sarcoma,0
7778,veterans alcoholism screening test (VAST),Peripheral primitive neuroectodermal tumor of soft tissue,0
7779,Decreasing,Xeroderma pigmentosum,0
7780,Fluid behavior,Testicular cancer metastatic,0
7781,Metastatic malignant neoplasm to brain,Endometrial Small Cell Carcinoma,0
7782,95,Testicular cancer metastatic,0
7783,Diagnostic Imaging,Acute Undifferentiated Leukemia,0
7784,Germ cell tumor,Acantholytic squamous cell carcinoma,0
7785,Premalignant,Medulloblastoma,0
7786,Interstitial Route of Drug Administration,Hyperplasia of pituitary gland,0
7787,Histologic type,FIGO Stage IVA Ovarian Cancer,0
7788,Surrounding (qualifier value),Malignant Neoplasm with Regional Lymph Node Involvement,0
7789,Lip and Oral Cavity Carcinoma,Locally Advanced Carcinoma,0
7790,factor A,Clonal Hematopoiesis of Indeterminate Potential,0
7791,Combined,Stage III Cutaneous Melanoma AJCC v6,0
7792,Africa,Rhabdomyosarcoma with ganglionic differentiation,0
7793,Very,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7794,Cancer Genus,Recurrent Testicular Lymphoma,0
7795,Asbestos,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
7796,Disease Steps Questionnaire,Mixed astrocytoma-ependymoma,0
7797,radiotherapeutic,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7798,Cell Count,Xeroderma pigmentosum,0
7799,Line Specimen,Unresectable Rhabdomyosarcoma,0
7800,motor movement,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7801,Woman,Trabecular adenocarcinoma,0
7802,potential,Benign Ovarian Thecoma,0
7803,Type - attribute,Stage I Adult Non-Hodgkin Lymphoma,0
7804,Parameterized Data Type - Set,Human Papillomavirus-Related Carcinoma,0
7805,Surface,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7806,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7807,Referring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
7808,Mass,Malignant Neoplasm of Lung - Multiple Primary Sites,0
7809,Feel Tired question,Acantholytic squamous cell carcinoma,0
7810,Scrofula,Benign Apocrine Neoplasm,0
7811,Uterus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7812,Involvement with,Hemangioma,0
7813,Liver,Diffuse malignant mesothelioma,0
7814,Medical Imaging,Lipoma of small intestine,0
7815,Uterine Cancer,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
7816,Mass of body structure,Heavy Chain Deposition Disease,0
7817,Extracellular Matrix,adenosquamous carcinoma of breast,0
7818,Large,Refractory Barrett Esophagus,0
7819,Have Itch,Vaginal Adenoid Cystic Carcinoma,0
7820,Common Cold,mucinous adenocarcinoma of gallbladder,0
7821,Endometrial scraping,Digestive System Hodgkin Lymphoma,0
7822,Management procedure,Metastatic Lung Neuroendocrine Neoplasm,0
7823,Poverty,Mixed parotid tumor,0
7824,Cutaneous (intended site),Non-Metastatic Gestational Trophoblastic Tumor,0
7825,Point Name,Refractory Ependymoma,0
7826,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Recurrent Rhabdomyosarcoma,0
7827,Cells,Refractory Barrett Esophagus,0
7828,Fever,Fourth Ventricle and Brain Stem Ependymal Tumor,0
7829,Low Mitosis-Karyorrhexis Index,Childhood Anaplastic Large Cell Lymphoma,0
7830,Well Differentiated,Adult Acute Eosinophilic Leukemia,0
7831,Management procedure,Localized Ewing Sarcoma,0
7832,Metastasis,Cervical Adenomyoma,0
7833,Child,Adult Acute Eosinophilic Leukemia,0
7834,Overall Publication Type,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7835,Surrounding (qualifier value),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
7836,Intravascular line,Recurrent Testicular Lymphoma,0
7837,allowing,Peripheral primitive neuroectodermal tumor of soft tissue,0
7838,Asp snake,Testicular cancer metastatic,0
7839,Options,Non-Metastatic Gestational Trophoblastic Tumor,0
7840,Symptoms,Occult Lung Adenosquamous Carcinoma,0
7841,Skin tanning,Stage I Colon Neuroendocrine Tumor AJCC v8,0
7842,Tobacco,Collecting Duct Carcinoma of the Kidney,0
7843,Pathogenic organism,Low Grade Squamous Intraepithelial Neoplasia,0
7844,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7845,Frequently,Pancreatic Intraepithelial Neoplasia-3,0
7846,Plasma Cell Neoplasm,Carcinoma,0
7847,Clumped,FIGO Stage II Ovarian Cancer,0
7848,Primary,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7849,Include (action),gliosarcoma,0
7850,Slight (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7851,Symptoms aspect,embryonal rhabdomyosarcoma of prostate,0
7852,Abnormal Cell Count,Cartilaginous exostosis,0
7853,Biomaterial Treatment,Brain Tumor,0
7854,Overall,Small cell neuroendocrine carcinoma of bladder,0
7855,Human body structure,Intraepithelial Melanocytic Hyperplasia,0
7856,2+,Acute Undifferentiated Leukemia,0
7857,majority,Congenital hamartoma,0
7858,Containing (qualifier),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
7859,Regimen - CHV concept,High Grade Glandular Intraepithelial Neoplasia,0
7860,Beginning,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7861,Sharing (Social Behavior),Cervical Adenomyoma,0
7862,Often - answer to question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7863,Group A (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
7864,A Codes,Endometrial Small Cell Carcinoma,0
7865,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Advanced Uterine Corpus Carcinosarcoma,0
7866,Biochemical Pathway,Cystadenocarcinoma,0
7867,Frequently,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7868,newly,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7869,Symptoms aspect,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7870,Divide,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7871,Synonym (core metadata concept),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
7872,Reported Term,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
7873,Most,Childhood Central Nervous System Ganglioneuroblastoma,0
7874,Neoplasms,Carcinomatosis of peritoneal cavity,0
7875,Cell (compartment),Squamous cell carcinoma of lip,0
7876,Administration type,Bladder squamous cell carcinoma stage I,0
7877,Treatment Epoch,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
7878,Malignant lymphangioma,Stage 0 Penile Cancer AJCC v8,0
7879,Speech,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
7880,Metastatic to,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
7881,Headache,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7882,Vision:-:Point in time:^Patient:-,Childhood Central Nervous System Ganglioneuroblastoma,0
7883,Human body,Nasal cavity carcinoma,0
7884,newly,Placental aromatase deficiency,0
7885,Cancer Genus,Neonatal leukemia,0
7886,Body structure,Refractory Ependymoma,0
7887,Often - answer to question,Adrenal Rest Tumor,0
7888,Form:Finding:Point in time:{Setting}:Document:{Role},Benign tumor of eyelid,0
7889,Form:Finding:Point in time:{Setting}:Document:{Role},Cystadenocarcinoma,0
7890,Expiration,Tongue Alveolar Soft Part Sarcoma,0
7891,Malignant neoplasm of liver,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
7892,Excessive,Kaposi's sarcoma of extrahepatic bile duct,0
7893,Providing presence (regime/therapy),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7894,True primary (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7895,Extension,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7896,lymph nodes,Recurrent Uveal Melanoma,0
7897,CYREN gene,ROSE Cluster 3,0
7898,Diabetes,Type II Endometrial Adenocarcinoma,0
7899,ovarian,Benign tumor of eyelid,0
7900,ethnic european,Xeroderma pigmentosum,0
7901,Fascia,Malignant melanoma of eyelid,0
7902,Units Of Measure - bel,Periosteal Osteosarcoma,0
7903,Decision,Intestinal Metaplasia of Bladder Urothelium,0
7904,Human body,Choroid Necrotic Melanoma,0
7905,20%,Precursor B-lymphoblastic lymphoma stage II,0
7906,Manufactured form,Cerebral Primitive Neuroectodermal Tumor,0
7907,Anatomical compartments,Benign squamous cell tumor,0
7908,year,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
7909,Epithelium of vagina,Neonatal leukemia,0
7910,Rare,Maxillary Sinus Adenoid Cystic Carcinoma,0
7911,Back structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7912,Primary malignant neoplasm,Benign Apocrine Neoplasm,0
7913,various antiseptic throat preparations,Transitional cell carcinoma,0
7914,Count Dosing Unit,Malignant neoplasm of subglottis,0
7915,Diagnosis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7916,Array Feature,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7917,suggestion,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
7918,Approximate,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7919,Structure of right thigh,Adult Alveolar Soft Part Sarcoma,0
7920,Gonadal structure,Mucinous adenocarcinoma,0
7921,Childhood Extracranial Germ Cell Tumor,Ovarian Dermoid Cyst with Secondary Carcinoma,0
7922,One,Cerebral Primitive Neuroectodermal Tumor,0
7923,Not abnormal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7924,Code,Kaposi's sarcoma of skin,0
7925,Chemotherapy,Locally Advanced Carcinoma,0
7926,diagnosis aspect,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7927,Does swallow,adenosquamous carcinoma of breast,0
7928,Prevention Study,benign mature teratoma of pancreas,0
7929,Data Table,Testicular cancer metastatic,0
7930,Average,Metaplastic carcinoma of breast,0
7931,Transurethral Resection,Brain Tumor,0
7932,set (group),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
7933,Amount type - Percentage,Human Papillomavirus-Related Carcinoma,0
7934,treatment - ActInformationManagementReason,Stage II Hepatocellular Carcinoma AJCC v8,0
7935,Known,Familial Adenomatous Polyposis Associated Medulloblastoma,0
7936,New,ROSE Cluster 3,0
7937,Thyroid Hormones,Fibroadenoma of breast,0
7938,Malignancy,Malignant Testicular Sertoli Cell Tumor,0
7939,Ductal Breast Carcinoma,non-Hodgkin's lymphoma of spleen,0
7940,Most,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7941,Providing (action),Benign Anal Granular Cell Tumor,0
7942,Approximate,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
7943,International Classification of Diseases for Oncology,Recurrent Uveal Melanoma,0
7944,Times,adenoid cystic carcinoma of lung,0
7945,Geographic Locations,Adult Acute Eosinophilic Leukemia,0
7946,Immunoglobulins,FIGO Stage II Ovarian Cancer,0
7947,Lymphocyte Activation,Stage III Cutaneous Melanoma AJCC v6,0
7948,Folded structure,ROSE Cluster 3,0
7949,Biomaterial Treatment,Occult Lung Adenosquamous Carcinoma,0
7950,Show,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
7951,Usual Severity Pain,Unfavorable Non-Hodgkin Lymphoma,0
7952,Approximate,Benign Apocrine Neoplasm,0
7953,Clinical Study Case,Childhood Lymphoma,0
7954,Usual,Malignant melanoma of eyelid,0
7955,Adrenal Glands,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
7956,Formation,Uterine Cancer,0
7957,Symptoms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
7958,growth aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
7959,Smear - instruction imperative,Methotrexate-Associated Hodgkin Lymphoma,0
7960,Wound Healing,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
7961,Common (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
7962,Lung,Pancreatic Intraepithelial Neoplasia-3,0
7963,CD44 wt Allele,Neonatal leukemia,0
7964,Appearance,Periosteal Osteosarcoma,0
7965,Symptoms aspect,High Grade Glandular Intraepithelial Neoplasia,0
7966,Greater than one,Benign Carotid Body Paraganglioma,0
7967,Related personal status,Childhood Fibrillary Astrocytoma,0
7968,Neoplasms,Undifferentiated Endocervical Sarcoma,0
7969,Most,Contact dermatitis due to alkali,0
7970,Country number,Malignant melanoma of eyelid,0
7971,*Type - Kind of quantity,Vaginal Adenoma,0
7972,Abundance,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
7973,consider,Clonal Hematopoiesis of Indeterminate Potential,0
7974,Structure of lateral palpebral ligament,Liver Lymphangioma,0
7975,Often - answer to question,Carcinomatosis of peritoneal cavity,0
7976,Symptoms,Papillary squamous cell carcinoma,0
7977,Result,Thymoma malignant recurrent,0
7978,Biological Response Modifiers,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
7979,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Engraftment syndrome,0
7980,Rare,Granular Cell Leiomyosarcoma,0
7981,Chemotherapy Regimen,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
7982,Lymphocyte component of blood,Spindle Cell Melanoma,0
7983,Manufactured form,Unresectable Rhabdomyosarcoma,0
7984,Neoplasms,Occult Lung Adenosquamous Carcinoma,0
7985,Rating (action),Engraftment syndrome,0
7986,Slightly Able,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
7987,Mobility Ability,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7988,capsule (pharmacologic),Botryoid-Type Embryonal Rhabdomyosarcoma,0
7989,<90,Malignant neoplasm of choroid,0
7990,Beginning,Anterior Urethral Malignant Neoplasm,0
7991,Life Threatening or Disabling Adverse Event,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
7992,Fever symptoms (finding),Liver Lymphangioma,0
7993,Myeloid Cells,Colorectal Neuroendocrine Tumor G2,0
7994,60%,Breast Ductal Adenoma,0
7995,Apply (instruction),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
7996,Swallowing G-code,malignant lymphoma of pancreatic lymph nodes,0
7997,Time (foundation metadata concept),Childhood Central Nervous System Ganglioneuroblastoma,0
7998,Eye foreign bodies,Small intestine carcinoma,0
7999,Diabetes,Benign Carotid Body Paraganglioma,0
8000,Experimental Result,Type II Endometrial Adenocarcinoma,0
8001,Exposure to,Splenic Manifestation of Hairy Cell Leukemia,0
8002,Clinical Effectiveness,Refractory Bladder Carcinoma,0
8003,N+ (tumor staging),Multiple Skull Base Meningiomas,0
8004,Fresh (qualifier value),Childhood Choriocarcinoma,0
8005,Mean Percent of Normal,Unfavorable Non-Hodgkin Lymphoma,0
8006,Photon Correlation Spectroscopy,Female Breast Carcinoma,0
8007,Waste Products,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8008,Cell division,Xeroderma pigmentosum,0
8009,Pediatrics,Leptomeningeal sarcoma,0
8010,Experimental Result,Kaposi's sarcoma of skin,0
8011,Epithelial cell count (procedure),Botryoid-Type Embryonal Rhabdomyosarcoma,0
8012,Pharmacotherapy,Endometrial Small Cell Carcinoma,0
8013,Superkingdom (taxonomic category),Malignant neoplasm of thalamus,0
8014,Set scale,Thymic Clear Cell Carcinoma,0
8015,Smear - instruction imperative,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8016,Suspected diagnosis,Kaposi's sarcoma of extrahepatic bile duct,0
8017,Larynx,Vaginal Adenoid Cystic Carcinoma,0
8018,% volume (qualifier value),Benign squamous cell tumor,0
8019,Usual Severity Constipation,FIGO Stage II Ovarian Cancer,0
8020,Personal appearance,Cerebral hemangioma,0
8021,Encode (action),Thymic Clear Cell Carcinoma,0
8022,Followed by,Stage IV Penile Cancer AJCC v7,0
8023,Entity Determiner - specific,Blepharal carcinoma,0
8024,morphological,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8025,year,Pancreatic carcinoma,0
8026,Woman,Metaplastic carcinoma of breast,0
8027,Etiology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8028,Tract,Endometrial Small Cell Carcinoma,0
8029,Long Variable,Stage IV Colorectal Cancer AJCC v8,0
8030,survive,Neoplasms,0
8031,Compress (Compression Algorithm),Non-Hodgkin Lymphoma During Pregnancy,0
8032,Metastasis,Bladder Neuroendocrine Neoplasm,0
8033,Tryptophanase,Localized Askin Tumor,0
8034,20%,Localized Askin Tumor,0
8035,To,Basal Cell Ameloblastoma,0
8036,Carcinoma in Situ,Malignant neoplasm of olfactory nerve,0
8037,Person Name,Malignant neoplasm of thalamus,0
8038,Kaposi Sarcoma,Female Breast Carcinoma,0
8039,Hearing Loss,Kaposi's sarcoma of extrahepatic bile duct,0
8040,metastatic qualifier,Secondary malignant neoplasm of lymph node,0
8041,Air Filters,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8042,Structure of left half of body,Parathyroid Gland Adenocarcinoma,0
8043,Disease,Liver Lymphangioma,0
8044,Usual,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8045,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8046,Patient observation,Stage IV Childhood Non-Hodgkin Lymphoma,0
8047,Cell Device,Benign Apocrine Neoplasm,0
8048,Resolution,Female Breast Carcinoma,0
8049,High Mitosis-Karyorrhexis Index,Vaginal Adenoma,0
8050,Last,Xeroderma pigmentosum,0
8051,Hodgkin Disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8052,Shortness of Breath Visual Analogue Scale,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8053,Group A (qualifier value),Recurrent Primary Lymphoma of Bone,0
8054,Skin Specimen,Blepharal carcinoma,0
8055,<90,Acute Undifferentiated Leukemia,0
8056,Primary malignant neoplasm,Trichilemmocarcinoma,0
8057,radiotherapeutic,Xeroderma pigmentosum,0
8058,Pleomorphism,Primary Cutaneous Plasmablastic Lymphoma,0
8059,Tired,Cerebral Primitive Neuroectodermal Tumor,0
8060,Fasting,Pancreatic Intraepithelial Neoplasia-3,0
8061,Smell Perception,Malignant Neoplasm with Regional Lymph Node Involvement,0
8062,Negative Surgical Margin,Hodgkin lymphoma,0
8063,T-Lymphocyte,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8064,>90,Cancer of Urinary Tract,0
8065,Milliampere second,Epithelioid Sarcoma NCI Grade 3,0
8066,Medical Tent,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8067,Poor coordination,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8068,Progress,Intraepithelial Melanocytic Hyperplasia,0
8069,Attenuation,Refractory Ependymoma,0
8070,Version,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8071,Oral region,Female Breast Carcinoma,0
8072,Human papilloma virus infection,Locally Advanced Soft Tissue Sarcoma,0
8073,SERPINA3 wt Allele,Ichthyosis,0
8074,Widening,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8075,Back Pain,Ovarian germ cell choriocarcinoma stage IV,0
8076,Include (action),Splenic Manifestation of Hairy Cell Leukemia,0
8077,Abnormal,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
8078,What subject filter - Result,Acantholytic squamous cell carcinoma,0
8079,Cell (compartment),Extra-Adrenal Paraganglioma,0
8080,Pediatric,Stage III Cutaneous Melanoma AJCC v6,0
8081,Night sweats,Metaplastic carcinoma of breast,0
8082,Stem cell transplant,FIGO Stage II Ovarian Cancer,0
8083,Spread by direct extension,Malignant neoplasm of olfactory nerve,0
8084,Histopathologic Grade,Blood Vessel Tumors,0
8085,Gingiva,Malignant neoplasm of subglottis,0
8086,Medical Imaging,Nasal cavity carcinoma,0
8087,Diagnosis,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
8088,How Often Weight Loss,Childhood Central Nervous System Immature Teratoma,0
8089,Dictionaries as Topic,Benign Apocrine Neoplasm,0
8090,Dermatologic disorders,Bladder squamous cell carcinoma stage I,0
8091,Squamous cell carcinoma - category,Kaposi's sarcoma of skin,0
8092,Ultraviolet Rays,Acute Undifferentiated Leukemia,0
8093,Body part,Refractory Bladder Carcinoma,0
8094,Pharmacologic Substance,Adrenal Rest Tumor,0
8095,Skin Specimen,Type II Endometrial Adenocarcinoma,0
8096,Ovarian Carcinoma,Acute lymphadenitis,0
8097,Rattus norvegicus,papillary carcinoma of penis,0
8098,Extrinsic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8099,Including (qualifier),Childhood Central Nervous System Ganglioneuroblastoma,0
8100,Location of Pharyngeal Residue Following Swallowing,Adult Hepatocellular Carcinoma,0
8101,Soft Tissue Neoplasms,Adult Alveolar Soft Part Sarcoma,0
8102,Five-year Survival Rate,Recurrent Uveal Melanoma,0
8103,Pharmacotherapy,Intraepithelial Melanocytic Hyperplasia,0
8104,Most Recent,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8105,Two,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8106,Name (property) (qualifier value),Grade 3a Malignant Neoplasm,0
8107,Pancreatic Neoplasm,Stage IV Childhood Non-Hodgkin Lymphoma,0
8108,50%,Liver Lymphangioma,0
8109,Acute Megakaryocytic Leukemias,gliosarcoma,0
8110,Qualitative form,Human Papillomavirus-Related Carcinoma,0
8111,United States Military Commissioned Officer O4,Benign squamous cell tumor,0
8112,artesunate,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
8113,Brain,Bladder adenocarcinoma stage IV,0
8114,Fever,Mixed astrocytoma-ependymoma,0
8115,Fatigue,Collecting Duct Carcinoma of the Kidney,0
8116,Human body,Tubal Hyperplasia,0
8117,Family Felidae,sarcoma of spinal cord,0
8118,To,Liver Lymphangioma,0
8119,geographic population,Metaplastic carcinoma of breast,0
8120,General surgery specialty,Recurrent Uveal Melanoma,0
8121,Frequency of Pain Question,FIGO Stage IVA Ovarian Cancer,0
8122,Genome,Necrotizing Funisitis,0
8123,Crystal - natural material,FIGO Stage IVA Ovarian Cancer,0
8124,Old,Mucinous adenocarcinoma gastric,0
8125,Malignant neoplasm of skin,FIGO Stage II Ovarian Cancer,0
8126,In Situ Follicular Neoplasia,Multiple Skull Base Meningiomas,0
8127,1000000,Locally Advanced Soft Tissue Sarcoma,0
8128,Oral cavity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8129,Biopsy,Clonal Hematopoiesis of Indeterminate Potential,0
8130,Cessation of life,clear cell adenocarcinoma of gallbladder,0
8131,Screening,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8132,Regular,Multiple Skull Base Meningiomas,0
8133,Usual Severity Itching,Locally Advanced Squamous Cell Carcinoma,0
8134,Stomach structure,Pancreatic Intraepithelial Neoplasia-3,0
8135,heirarchal root,Chest Wall Fibromatosis,0
8136,Diffuse Large B-Cell Lymphoma,Localized Ewing Sarcoma,0
8137,Used by,Blepharal carcinoma,0
8138,Accepted,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8139,ultrasound device,Gallbladder Adenocarcinoma,0
8140,ATG5 wt Allele,BRCA2 Syndrome,0
8141,HLA Class II Histocompatibility Antigen Gamma Chain,Thyroid Hurthle Cell Carcinoma,0
8142,Percent (qualifier value),Unresectable Rhabdomyosarcoma,0
8143,Running (physical activity),Melanomatosis,0
8144,Endocervical epithelium,Refractory Ependymoma,0
8145,Treating,Trabecular adenocarcinoma,0
8146,Frequently,Airway Hemangioma,0
8147,Similarity,Benign neoplasm of thorax,0
8148,Cell Count,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8149,Materials,Mucinous adenocarcinoma gastric,0
8150,Edema,Benign tumor of eyelid,0
8151,Embryonic Germ Cells,Medulloblastoma,0
8152,Carcinoma of supraglottis,Cancer of Urinary Tract,0
8153,Skin Specimen,Bladder squamous cell carcinoma stage I,0
8154,combination - answer to question,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8155,Decision,Cherubism,0
8156,Country number,Advanced Lung Carcinoma,0
8157,Observation - diagnostic procedure,Stage III Cutaneous Melanoma AJCC v6,0
8158,Completely Able,Thyroid carcinoma,0
8159,Information,Benign Apocrine Neoplasm,0
8160,leukemia,Extracranial Neuroblastoma,0
8161,Transformation,Mucinous adenocarcinoma gastric,0
8162,Cell Count,Diffuse malignant mesothelioma,0
8163,Mutation,Small Intestinal Villous Adenoma,0
8164,Lymphatic,Bladder Neuroendocrine Neoplasm,0
8165,Vomiting,Thymic Clear Cell Carcinoma,0
8166,To,Contact dermatitis due to alkali,0
8167,Headache,Medulloblastoma,0
8168,Procedures involving the use of pharmaceuticals,Blepharal carcinoma,0
8169,Cure (remedy),Kaposi's sarcoma of extrahepatic bile duct,0
8170,Population Mean,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8171,Further,Fourth Ventricle and Brain Stem Ependymal Tumor,0
8172,Classification,Ovarian germ cell choriocarcinoma stage IV,0
8173,Upper abdominal pain,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8174,Primary malignant neoplasm,Anterior Urethral Malignant Neoplasm,0
8175,Yellow complexion,Thymoma malignant recurrent,0
8176,mucus layer,squamous cell carcinoma of the thyroid gland,0
8177,Name,Cancer of Urinary Tract,0
8178,Throat,Trabecular adenocarcinoma,0
8179,Out (direction),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
8180,Wounds - qualifier,Childhood Fibrillary Astrocytoma,0
8181,Beginning,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8182,Rare Lesion,Splenic Manifestation of Hairy Cell Leukemia,0
8183,professional occupation status,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8184,Human body structure,Recurrent Uveal Melanoma,0
8185,Common (qualifier value),Basal Cell Ameloblastoma,0
8186,Biomaterial Treatment,Testicular cancer metastatic,0
8187,Shortened,Stage IV Colorectal Cancer AJCC v8,0
8188,treatment options,Choroid Necrotic Melanoma,0
8189,IPSS Risk Category High,Mixed astrocytoma-ependymoma,0
8190,High,Benign Apocrine Neoplasm,0
8191,Pure Spanish horse breed (organism),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8192,rituximab,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8193,Update,Melanomatosis,0
8194,Lead,Bladder adenocarcinoma stage IV,0
8195,Histopathology,Recurrent Uveal Melanoma,0
8196,The Sun,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8197,Dependent - ability,Gallbladder adenoma,0
8198,Follow - dosing instruction imperative,Uterine Cancer,0
8199,World,Breast Apocrine Adenoma,0
8200,Divide,mucinous adenocarcinoma of gallbladder,0
8201,Therapeutic procedure,Small cell neuroendocrine carcinoma of bladder,0
8202,Carrying,Stage III Adult Immunoblastic Lymphoma,0
8203,Lymphatic System,Platinum-Resistant Lung Small Cell Carcinoma,0
8204,prevention aspects,Sarcomatoid Renal Cell Carcinoma,0
8205,Stem of plant,Unicystic ameloblastoma,0
8206,Malignant Neoplasms,Metastatic Lung Small Cell Carcinoma,0
8207,Numerous,Small cell neuroendocrine carcinoma of bladder,0
8208,Valid,FIGO Stage IVA Ovarian Cancer,0
8209,Skin,Recurrent Testicular Lymphoma,0
8210,Worse,Cerebral Primitive Neuroectodermal Tumor,0
8211,Uterus,Metastatic Ductal Breast Carcinoma,0
8212,Medical,Stage I Adult Non-Hodgkin Lymphoma,0
8213,More,Peripheral primitive neuroectodermal tumor of soft tissue,0
8214,Metastatic Neoplasm,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
8215,User Group,Recurrent Testicular Lymphoma,0
8216,Have Been Vomiting,Melanomatosis,0
8217,Spreading (qualifier value),Breast Ductal Adenoma,0
8218,Fever,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8219,Human patch material,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8220,Pathologic,Pilocytic astrocytoma of cerebellum,0
8221,Adult Myelodysplastic Syndrome,FIGO Stage II Ovarian Cancer,0
8222,Known,Intestinal Neuroendocrine Carcinoma,0
8223,Worse,Intraepithelial Melanocytic Hyperplasia,0
8224,Negation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8225,Medical service,FIGO Stage II Ovarian Cancer,0
8226,Interested,Precursor B-lymphoblastic lymphoma stage II,0
8227,Initially,Splenic Manifestation of Hairy Cell Leukemia,0
8228,Beginning,Testicular cancer metastatic,0
8229,Reported Term,Stage III Cutaneous Melanoma AJCC v6,0
8230,Call (Instruction),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
8231,Attachments (document),Fibroadenoma of breast,0
8232,Arising,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8233,Both ovaries,Tonsillar Carcinoma,0
8234,Dependent for bathing,Stage III Cutaneous Melanoma AJCC v6,0
8235,PSA Level Less than Two,Childhood Thyroid Gland Follicular Carcinoma,0
8236,Tissue Specimen Code,Carcinomatosis of peritoneal cavity,0
8237,68,Uterine Cancer,0
8238,Atlases,Spongiotic dermatitis,0
8239,Adenocarcinoma of pancreas,FIGO Stage IVA Ovarian Cancer,0
8240,AKR1A1 wt Allele,Multiple Skull Base Meningiomas,0
8241,Gene Deletion Abnormality,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8242,Macrophage Activation Syndrome,Liver Lymphangioma,0
8243,CD5L wt Allele,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8244,Evidence,Localized Askin Tumor,0
8245,Cystadenoma,Fourth Ventricle and Brain Stem Ependymal Tumor,0
8246,Deoxyribonucleic Acid Measurement,Recurrent Primary Lymphoma of Bone,0
8247,Schwann Cells,Intraepithelial Melanocytic Hyperplasia,0
8248,therapeutic aspects,Mixed astrocytoma-ependymoma,0
8249,Catch - Finding of sensory dimension of pain,Basal Cell Ameloblastoma,0
8250,pharmacotherapeutic,Acute Undifferentiated Leukemia,0
8251,Case unit dose,Adult Hepatocellular Carcinoma,0
8252,3+ Score,Anaplastic large cell lymphoma,0
8253,OTULIN gene,Maxillary Sinus Adenocarcinoma,0
8254,Include (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
8255,Sixty,Parathyroid Gland Adenocarcinoma,0
8256,Plasma,Childhood Central Nervous System Ganglioneuroblastoma,0
8257,Sweating,Benign neoplasm of thorax,0
8258,More Often than Once a Day,Stage IV Childhood Non-Hodgkin Lymphoma,0
8259,Malignant mesothelioma,Trabecular adenocarcinoma,0
8260,Nervous system structure,Maxillary Sinus Adenocarcinoma,0
8261,Childhood Brain Neoplasm,Spindle Cell Melanoma,0
8262,Malignant neoplasm of kidney,Cartilaginous exostosis,0
8263,To,Multiple Skull Base Meningiomas,0
8264,Mass,Secondary malignant neoplasm of lymph node,0
8265,To,Cystadenocarcinoma,0
8266,What subject filter - Result,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8267,Chest wall structure,Malignant Testicular Sertoli Cell Tumor,0
8268,Include (action),Localized Ewing Sarcoma,0
8269,Neoplasm Metastasis,Cancer of Urinary Tract,0
8270,Condition:Find:Pt:^Patient:Nom,Refractory Barrett Esophagus,0
8271,MOSTLY,benign mature teratoma of pancreas,0
8272,Body site,Stage IV Penile Cancer AJCC v7,0
8273,Kidney Tubules,Adenocarcinoma,0
8274,survival aspects,Blepharal carcinoma,0
8275,Therapeutic procedure,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
8276,Seven,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8277,Mature,Acute Undifferentiated Leukemia,0
8278,Myeloproliferative disease,Bladder squamous cell carcinoma stage I,0
8279,Positive Number,Cerebral Primitive Neuroectodermal Tumor,0
8280,Generation (action),Chest Wall Fibromatosis,0
8281,Stromal Cells,Mixed astrocytoma-ependymoma,0
8282,Smear - instruction imperative,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8283,Poor appetite question,Pancreatic Intraepithelial Neoplasia-3,0
8284,Section - Geographic Area,Germinoma,0
8285,Damage,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8286,Small cell carcinoma of lung,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8287,Third,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8288,Adult human body,Astrocytoma of brain,0
8289,Population Group,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8290,PFDN5 gene,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
8291,Common Specifications in HL7 V3 Publishing,Refractory Glioma,0
8292,Lymphocyte Count measurement,Cervical Squamous Intraepithelial Neoplasia,0
8293,Fraction of,Neonatal leukemia,0
8294,other medicated shampoos in ATC,Nasal cavity carcinoma,0
8295,pharmacotherapeutic,Mucinous adenocarcinoma gastric,0
8296,Cell Count,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8297,Better,Benign tumor of eyelid,0
8298,Complete excision,Benign Anal Granular Cell Tumor,0
8299,Cessation of life,Peripheral primitive neuroectodermal tumor of soft tissue,0
8300,risk factors - observation list,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8301,Involvement with,Metastatic Neoplasm to the Gallbladder,0
8302,Small cell carcinoma of lung,Unresectable Rhabdomyosarcoma,0
8303,Complete excision,Unicystic ameloblastoma,0
8304,Infant,Acantholytic squamous cell carcinoma,0
8305,Ameloblastoma,Mastocytosis,0
8306,Complicated,Stage IV Penile Cancer AJCC v7,0
8307,Table Cell Horizontal Align - left,Uterine Cancer,0
8308,Include (action),Stage III Cutaneous Melanoma AJCC v6,0
8309,Rare,Engraftment syndrome,0
8310,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
8311,Excision,Thymic Atypical Carcinoid Tumor,0
8312,Polypeptide Hormones,Werner Syndrome,0
8313,Chronic myeloproliferative disorder,Thymoma malignant recurrent,0
8314,Often - answer to question,mucinous adenocarcinoma of gallbladder,0
8315,Bladder Continence Question,Acute Undifferentiated Leukemia,0
8316,diagnosis aspect,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8317,Adult Diffuse Large B-Cell Lymphoma,mucinous adenocarcinoma of gallbladder,0
8318,How Much Distress Sweats,Digestive System Hodgkin Lymphoma,0
8319,Occurrence Indicator,Stage IB Lung Cancer AJCC v7,0
8320,Group A (blood group),ROSE Cluster 3,0
8321,Variety (taxon),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8322,Decision,sarcoma of spinal cord,0
8323,Squamous cell carcinoma,Human Papillomavirus-Related Carcinoma,0
8324,Determined by,BRCA2 Syndrome,0
8325,Neoplasms,Unresectable Rhabdomyosarcoma,0
8326,Type A,Liver Lymphangioma,0
8327,mesenchymal,Human Papillomavirus-Related Carcinoma,0
8328,Tissue Type Code - Basal cell carcinoma,Carcinomatosis of peritoneal cavity,0
8329,diagnosis aspect,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8330,Procedure findings:Finding:Point in time:^Patient:Narrative,Maxillary Sinus Adenocarcinoma,0
8331,Skin Erosion,Clonal Hematopoiesis of Indeterminate Potential,0
8332,Tryptophanase,Recurrent Testicular Lymphoma,0
8333,More,Undifferentiated Endocervical Sarcoma,0
8334,Volume 2,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8335,Manufactured form,Primary Cutaneous Plasmablastic Lymphoma,0
8336,Term Birth,Non-Metastatic Gestational Trophoblastic Tumor,0
8337,Specimen Source Codes - Lesion,Adult Brain Stem Mixed Glioma,0
8338,Seizures,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8339,Referring,Stage III Cutaneous Melanoma AJCC v6,0
8340,Pruritus,Maxillary Sinus Adenoid Cystic Carcinoma,0
8341,High,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
8342,100%,Mixed parotid tumor,0
8343,With shape,Bladder Neuroendocrine Neoplasm,0
8344,Pediculus (eukaryote),Metastatic Malignant Neoplasm in the Sellar Region,0
8345,Pylorus,Vaginal Adenoma,0
8346,Pure Spanish horse breed (organism),ICHTHYOSIS,0
8347,Superkingdom (taxonomic category),Recurrent Testicular Lymphoma,0
8348,Additional,adenoid cystic carcinoma of lung,0
8349,Operative Surgical Procedures,Diffuse malignant mesothelioma,0
8350,Used by,Liver Cavernous Hemangioma,0
8351,Present,Splenic Manifestation of Hairy Cell Leukemia,0
8352,Show,Uterine Cancer,0
8353,Yellow complexion,Undifferentiated Endocervical Sarcoma,0
8354,Smooth Muscle Tumor,FIGO Stage II Ovarian Cancer,0
8355,Consistency,BRCA2 Syndrome,0
8356,Surrounding (qualifier value),Cancer of Urinary Tract,0
8357,Dog family,Locally Advanced Epithelioid Hemangioendothelioma,0
8358,Skin Specimen,Recurrent Testicular Lymphoma,0
8359,FAT1 wt Allele,FIGO Stage II Ovarian Cancer,0
8360,Body cavities,Stage III Cutaneous Melanoma AJCC v6,0
8361,Value Above Reference Range,Congenital hamartoma,0
8362,Continuance of life,Adult Hepatocellular Carcinoma,0
8363,Call (Instruction),Digestive System Hodgkin Lymphoma,0
8364,therapeutic aspects,Stage III Cutaneous Melanoma AJCC v6,0
8365,Blood Circulation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8366,Determined by,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8367,Smear - instruction imperative,Astrocytoma of brain,0
8368,Did not receive therapy or drug for,Cancer of Urinary Tract,0
8369,Solid Dose Form,High Grade Glandular Intraepithelial Neoplasia,0
8370,Pharmacotherapy,Squamous cell carcinoma of lip,0
8371,In Blood,Benign neoplasm of thorax,0
8372,Body structure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8373,Group A (qualifier value),Locally Advanced Epithelioid Hemangioendothelioma,0
8374,Statistical Significance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8375,mucus layer,Colorectal Mucin Poor Hyperplastic Polyp,0
8376,Leukemic Cells Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8377,Adult Non-Hodgkin Lymphoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
8378,Skin,Non-Metastatic Gestational Trophoblastic Tumor,0
8379,Bone Marrow,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8380,Color change,Kaposi's sarcoma of extrahepatic bile duct,0
8381,Division (surgical procedure),Engraftment syndrome,0
8382,Further,Childhood Anaplastic Large Cell Lymphoma,0
8383,Curettage procedure,Noninfiltrating Intraductal Carcinoma,0
8384,Retinoic Acid Response Element,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
8385,Personal appearance,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8386,Most,malignant lymphoma of pancreatic lymph nodes,0
8387,Colorectal Carcinoma,Pilocytic astrocytoma of cerebellum,0
8388,Exist,Uterine Cancer,0
8389,Firstly,Kaposi's sarcoma of skin,0
8390,Outer cortex of kidney,Vaginal Adenoma,0
8391,Presence (property),FIGO Stage IVA Ovarian Cancer,0
8392,pharmacotherapeutic,Heavy Chain Deposition Disease,0
8393,LMOD1 gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8394,Occurrence,Malignant melanoma of eyelid,0
8395,Supportive assistance,Familial Hemophagocytic Lymphocytosis,0
8396,Cell (compartment),Trabecular adenocarcinoma,0
8397,brain cell,Unfavorable Non-Hodgkin Lymphoma,0
8398,Intraductal papillary mucinous neoplasm,Locally Advanced Soft Tissue Sarcoma,0
8399,Neonatal Deformity,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8400,Malignant Neoplasms,Microcystic meningioma,0
8401,Occur (action),Acantholytic squamous cell carcinoma,0
8402,Often - answer to question,Localized Askin Tumor,0
8403,Body Site Modifier - Lower,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8404,Cessation of life,Cervical Fibroepithelial Polyp,0
8405,Homo sapiens,Liver Cavernous Hemangioma,0
8406,Initial Usage,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8407,Very rare,Adult Hepatocellular Carcinoma,0
8408,Carcinoma,Brain Tumor,0
8409,Associated with,Anaplastic large cell lymphoma,0
8410,95,Non-Metastatic Gestational Trophoblastic Tumor,0
8411,Has difficulty doing (qualifier value),Chronic Myelomonocytic Leukemia-2,0
8412,Metastatic Neoplasm,Recurrent Testicular Lymphoma,0
8413,Worse,Spongiotic dermatitis,0
8414,Definitely Related to Intervention,GIANT PIGMENTED HAIRY NEVUS,0
8415,Unit,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8416,Signs and Symptoms,Bladder adenocarcinoma stage IV,0
8417,Malignant Central Nervous System Neoplasm,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8418,Multiple Partners,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8419,Cancer Genus,Digestive System Hodgkin Lymphoma,0
8420,MYELODYSPLASTIC SYNDROME,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8421,seen,Mucinous adenocarcinoma gastric,0
8422,Bothered by Night Sweats,Methotrexate-Associated Hodgkin Lymphoma,0
8423,Sarcoma,Childhood Fibrillary Astrocytoma,0
8424,Chest Wall Pain,Grade 3a Malignant Neoplasm,0
8425,Biogenic Amines,Cancer of Urinary Tract,0
8426,Perfusion route,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8427,Specimen Source Codes - tumor,Refractory WHO Grade III Glioma,0
8428,Subject Risk,Digestive System Hodgkin Lymphoma,0
8429,Extravasation,Xeroderma pigmentosum,0
8430,Togo,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8431,Good,Mucinous neoplasm,0
8432,Neoplasms,Benign Apocrine Neoplasm,0
8433,Therapeutic radiology procedure,Heavy Chain Deposition Disease,0
8434,Offspring,non-Hodgkin's lymphoma of spleen,0
8435,Screening Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8436,Group A (blood group),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8437,Occurrence,Childhood Anaplastic Large Cell Lymphoma,0
8438,Histamine Antagonists,FIGO Stage II Ovarian Cancer,0
8439,Initially,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8440,seconds,Stage II Carcinoma of Penis,0
8441,Ciliary Body,Refractory Bladder Carcinoma,0
8442,Adult human body,Adult Alveolar Soft Part Sarcoma,0
8443,Connective Tissue,FIGO Stage II Ovarian Cancer,0
8444,factor A,Unicystic ameloblastoma,0
8445,Pressure (finding),Congenital hamartoma,0
8446,Uveal melanoma,Unresectable Rhabdomyosarcoma,0
8447,Mobility aid,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8448,Essential,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
8449,Qualitative form,Secondary malignant neoplasm of lymph node,0
8450,bony process,clear cell adenocarcinoma of gallbladder,0
8451,Disk Dosing Unit,Trabecular adenocarcinoma,0
8452,Occurrence,Locally Advanced Epithelioid Hemangioendothelioma,0
8453,Coding,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8454,Virus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8455,Tissue Specimen Code,Benign squamous cell tumor,0
8456,Qualitative form,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8457,Areas <moth>,ICHTHYOSIS,0
8458,Formation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
8459,90%,Occult Lung Adenosquamous Carcinoma,0
8460,include - SetOperator,Intraepithelial Melanocytic Hyperplasia,0
8461,Cartilage,Medulloblastoma,0
8462,Make - Instruction Imperative,Adult Alveolar Soft Part Sarcoma,0
8463,Acute leukemia,embryonal rhabdomyosarcoma of prostate,0
8464,Pharmacotherapy,Intraepithelial Melanocytic Hyperplasia,0
8465,Alcohols,Metastatic Malignant Neoplasm in the Sellar Region,0
8466,Result,Thymic Atypical Carcinoid Tumor,0
8467,Condition,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8468,treatment - ActInformationManagementReason,Papillary cystic tumor,0
8469,Asia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8470,*Type - Kind of quantity,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8471,Domain (area of knowledge),Female Breast Carcinoma,0
8472,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
8473,Presentation,Cerebral hemangioma,0
8474,per year,Benign Apocrine Neoplasm,0
8475,Chemotherapy,Metaplastic carcinoma of breast,0
8476,Microscopy,Stage III Cutaneous Melanoma AJCC v6,0
8477,Tumor type,Small intestine carcinoma,0
8478,Local,Carcinoma of urinary bladder,0
8479,Malignant Neoplasms,Stage IV Colorectal Cancer AJCC v8,0
8480,Definition,Malignant Neoplasm with Regional Lymph Node Involvement,0
8481,Spur - plant part,FIGO Stage II Ovarian Cancer,0
8482,Neoplasms,embryonal rhabdomyosarcoma of prostate,0
8483,Response process,Ichthyoses,0
8484,900,Benign Anal Granular Cell Tumor,0
8485,CEL gene,High Grade Glandular Intraepithelial Neoplasia,0
8486,To,Undifferentiated Endocervical Sarcoma,0
8487,Formations,Kaposi's sarcoma of extrahepatic bile duct,0
8488,Easy,Diffuse malignant mesothelioma,0
8489,Tube - unit dose,FIGO Stage II Ovarian Cancer,0
8490,400,Chronic Myelomonocytic Leukemia-2,0
8491,Lower (action),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8492,Appearance of eyelid,Clonal Hematopoiesis of Indeterminate Potential,0
8493,Well Differentiated,Splenic Manifestation of Hairy Cell Leukemia,0
8494,Bluish red color,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8495,Pilomyxoid astrocytoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8496,Soft Tissue Route of Drug Administration,Human Papillomavirus-Related Carcinoma,0
8497,Precursor Cell Lymphoblastic Leukemia Lymphoma,Uterine Cancer,0
8498,Epithelium,Intestinal Metaplasia of Bladder Urothelium,0
8499,Ingestible alcohol,Kaposi's sarcoma of extrahepatic bile duct,0
8500,100%,Thyroid Hurthle Cell Carcinoma,0
8501,Cytoplasm,Pleomorphic adenoma of parotid gland,0
8502,Screening procedure,Adult Alveolar Soft Part Sarcoma,0
8503,Growth,Non-Metastatic Gestational Trophoblastic Tumor,0
8504,Togo,Adult Anaplastic Oligodendroglioma,0
8505,Lacrimal canaliculus structure,Benign Apocrine Neoplasm,0
8506,CEL gene,Nasal cavity carcinoma,0
8507,Adult Lymphoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8508,40%,Bladder adenocarcinoma stage IV,0
8509,Analysis,Carcinoma of urinary bladder,0
8510,*Type - Kind of quantity,Refractory Barrett Esophagus,0
8511,Stem of Organ,Metaplastic carcinoma of breast,0
8512,Relationships,Hereditary Diffuse Gastric Adenocarcinoma,0
8513,Blood group antibody I,Precursor B-lymphoblastic lymphoma stage II,0
8514,Most,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8515,Organ,Benign Anal Granular Cell Tumor,0
8516,Firstly,Cancer of Urinary Tract,0
8517,Name,Xeroderma pigmentosum,0
8518,risk factors,Precursor B-lymphoblastic lymphoma stage II,0
8519,Continuance of life,Malignant neoplasm of subglottis,0
8520,Case (situation),Recurrent Uveal Melanoma,0
8521,*Type - Kind of quantity,Familial Adenomatous Polyposis Associated Medulloblastoma,0
8522,shared attribute,BRCA2 Syndrome,0
8523,Epithelium,Childhood Fibrillary Astrocytoma,0
8524,Neoplasms,Childhood Cerebellar Neoplasm,0
8525,KIAA1549L gene,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8526,Taxonomic,Gallbladder adenoma,0
8527,Coding,Cherubism,0
8528,diagnosis aspect,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8529,Measurement,Recurrent Rhabdomyosarcoma,0
8530,World Health Organization,Pancreatic Endocrine Carcinoma,0
8531,Tissue specific,Localized Ewing Sarcoma,0
8532,Testing,Kaposi's sarcoma of extrahepatic bile duct,0
8533,Evidence,Stage IB Pancreatic Cancer AJCC v8,0
8534,Tumor cells,Benign squamous cell tumor,0
8535,Primary malignant neoplasm,Acantholytic squamous cell carcinoma,0
8536,Treated with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8537,combination - answer to question,Ampulla of Vater Tubular Adenoma,0
8538,Involvement with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8539,Hormone replacement therapy,Maxillary Sinus Adenoid Cystic Carcinoma,0
8540,Fever symptoms (finding),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
8541,Scientific Control,ROSE Cluster 3,0
8542,Increase,Gallbladder Adenocarcinoma,0
8543,Experimental Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8544,Devices,Localized Ewing Sarcoma,0
8545,Immune,Carcinoma of submandibular gland,0
8546,Abnormal Reference Range,Malignant Testicular Sertoli Cell Tumor,0
8547,appendiceal,Childhood Anaplastic Large Cell Lymphoma,0
8548,Dropping,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8549,survive,Cancer of Urinary Tract,0
8550,ASIP protein,Benign tumor of eyelid,0
8551,Surgical reduction,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8552,Manufactured form,Unicystic ameloblastoma,0
8553,Ectoderm,Periosteal Osteosarcoma,0
8554,Microplate Well,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8555,Premalignant Cell,Cerebral Primitive Neuroectodermal Tumor,0
8556,Togo,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
8557,Case unit dose,Malignant neoplasm of subglottis,0
8558,Digital Content Category,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8559,Serum,Recurrent Primary Lymphoma of Bone,0
8560,Component object,Tonsillar Carcinoma,0
8561,health and disease,Gallbladder adenoma,0
8562,Frequently,Endometrial Small Cell Carcinoma,0
8563,Sore to touch,Malignant neoplasm of gallbladder,0
8564,Urinary Bladder,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
8565,Chemotherapy,Squamous cell carcinoma of lip,0
8566,Liquid Tumor,Neonatal leukemia,0
8567,Only - dosing instruction fragment,Adult Alveolar Soft Part Sarcoma,0
8568,described,Adult Hepatocellular Carcinoma,0
8569,Characterization,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8570,Frequently,Ovarian germ cell choriocarcinoma stage IV,0
8571,Value Above Reference Range,Kaposi's sarcoma of extrahepatic bile duct,0
8572,respiratory gaseous exchange in organisms,Cancer of Urinary Tract,0
8573,Front of neck,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8574,Papillary,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8575,Squamous cell carcinoma,Airway Hemangioma,0
8576,Cerebrospinal Fluid,Tubal Hyperplasia,0
8577,combination - answer to question,Pancreatic Intraepithelial Neoplasia-3,0
8578,Pelvis+,Acantholytic squamous cell carcinoma,0
8579,Used by,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8580,year,Endometrial Small Cell Carcinoma,0
8581,Myasthenia Gravis,Occult Lung Adenosquamous Carcinoma,0
8582,depend,Locally Advanced Epithelioid Hemangioendothelioma,0
8583,Reduction (chemical),Chronic Myelomonocytic Leukemia-2,0
8584,New,Engraftment syndrome,0
8585,Case unit dose,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8586,History,Metastatic Lung Neuroendocrine Neoplasm,0
8587,Decreased,ROSE Cluster 3,0
8588,Frequently,Human Papillomavirus-Related Carcinoma,0
8589,Known,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8590,Togo,Secondary malignant neoplasm of lymph node,0
8591,What subject filter - Result,Vaginal Adenoma,0
8592,Malignant neoplasm of ovary,Malignant neoplasm of olfactory nerve,0
8593,Most,Intestinal Neuroendocrine Carcinoma,0
8594,Adult human body,Human Papillomavirus-Related Carcinoma,0
8595,Reaching,Mucinous adenocarcinoma,0
8596,Sinus - general anatomical term,Locally Advanced Soft Tissue Sarcoma,0
8597,Group A (qualifier value),Adult Acute Eosinophilic Leukemia,0
8598,Original Regulatory Submission,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8599,shared attribute,Bladder adenocarcinoma stage IV,0
8600,Initial (abbreviation),FIGO Stage II Ovarian Cancer,0
8601,Weight decreased,Familial Hemophagocytic Lymphocytosis,0
8602,Subject Risk,Recurrent Rhabdomyosarcoma,0
8603,Infection,Pancreatic Endocrine Carcinoma,0
8604,Swollen Lymph Node,Malignant Testicular Sertoli Cell Tumor,0
8605,Chromosomal translocation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8606,Decision,Mixed astrocytoma-ependymoma,0
8607,Carcinoma,Astrocytoma of brain,0
8608,Multiple malignancy,Cervical Squamous Intraepithelial Neoplasia,0
8609,Swollen Lymph Node,Stage 0 Lip Carcinoma,0
8610,Recommendation,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8611,Epithelial Cells,Vaginal Adenoma,0
8612,Further,Mucinous adenocarcinoma gastric,0
8613,Improved - answer to question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8614,Arising,Splenic Manifestation of Hairy Cell Leukemia,0
8615,Blood Vessel,FIGO Stage II Ovarian Cancer,0
8616,Referral placed,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
8617,Kit Dosing Unit,Unicystic ameloblastoma,0
8618,Case unit dose,Malignant melanoma of eyelid,0
8619,Referring,Xeroderma pigmentosum,0
8620,Meaning,mucinous adenocarcinoma of gallbladder,0
8621,Childhood Neuroblastoma,embryonal rhabdomyosarcoma of prostate,0
8622,Cytogenetics,Liver Lymphangioma,0
8623,Teens,Hemangioma,0
8624,Painful intercourse female,Plexosarcoma,0
8625,Biomaterial Treatment,Melanomatosis,0
8626,Dependent for Toilet Use,Trichilemmocarcinoma,0
8627,Formation,Granular Cell Leiomyosarcoma,0
8628,Treating,Localized Askin Tumor,0
8629,Biological Response Modifiers,Benign Anal Granular Cell Tumor,0
8630,Type - attribute,Cancer of Urinary Tract,0
8631,Primary,Mucinous cystadenofibroma,0
8632,THM gene,Cancer of Urinary Tract,0
8633,Carcinoma,Metastatic Ductal Breast Carcinoma,0
8634,In Blood,Unfavorable Non-Hodgkin Lymphoma,0
8635,various other agents for local oral treatment in ATC,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8636,Cancer of Lip,Kaposi's sarcoma of extrahepatic bile duct,0
8637,Europe,Neoplasms,0
8638,Combined,Type II Endometrial Adenocarcinoma,0
8639,Primary malignant neoplasm,FIGO Stage IVA Ovarian Cancer,0
8640,Experimental Result,Peripheral primitive neuroectodermal tumor of soft tissue,0
8641,biopsy characteristics,Diffuse malignant mesothelioma,0
8642,Providing presence (regime/therapy),Recurrent Rhabdomyosarcoma,0
8643,Basis - conceptual entity,Funisitis (disorder),0
8644,Extrinsic,Adult Alveolar Soft Part Sarcoma,0
8645,Prostate,Carcinoma ex pleomorphic adenoma of parotid gland,0
8646,ASPM wt Allele,Bladder adenocarcinoma stage IV,0
8647,Tests (qualifier value),Refractory Ependymoma,0
8648,Medical Drop,FIGO Stage IVA Ovarian Cancer,0
8649,Most,Stage I Colon Neuroendocrine Tumor AJCC v8,0
8650,Beginning,Noninfiltrating Intraductal Carcinoma,0
8651,brain cell,Stage IB Pancreatic Cancer AJCC v8,0
8652,Code,Nasal cavity carcinoma,0
8653,therapeutic aspects,Endometrial Small Cell Carcinoma,0
8654,Histology aspects,Spongiotic dermatitis,0
8655,health and disease,Cancer of Urinary Tract,0
8656,Occurrence,Acute lymphadenitis,0
8657,Adult Non-Hodgkin Lymphoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8658,Common (qualifier value),adenosquamous carcinoma of breast,0
8659,Pigment cell,Malignant neoplasm of thalamus,0
8660,Negation,Undifferentiated Endocervical Sarcoma,0
8661,Childhood Soft Tissue Sarcoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8662,Leads (device),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8663,Ischemia,Thymic Clear Cell Carcinoma,0
8664,Epithelium,Periosteal Osteosarcoma,0
8665,Left,Benign Anal Granular Cell Tumor,0
8666,United States Military Commissioned Officer O4,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8667,Related personal status,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8668,Person Name,Secondary malignant neoplasm of lymph node,0
8669,*Type - Kind of quantity,Childhood Fibrillary Astrocytoma,0
8670,removal technique,Vaginal Adenoma,0
8671,Part,Mucinous adenocarcinoma gastric,0
8672,Epithelial Cells,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8673,Usual,Airway Hemangioma,0
8674,per year,Tongue Alveolar Soft Part Sarcoma,0
8675,Ability,Neonatal leukemia,0
8676,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,Gastric Diffuse Large B-Cell Lymphoma,0
8677,Partial,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8678,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8679,combination - answer to question,Locally Advanced Squamous Cell Carcinoma,0
8680,Difficult (qualifier value),Colorectal Neuroendocrine Tumor G2,0
8681,*Type - Kind of quantity,Adult Hepatocellular Carcinoma,0
8682,Cell Device,Benign squamous cell tumor,0
8683,Historical aspects qualifier,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8684,Certain (qualifier value),Metastatic Lung Small Cell Carcinoma,0
8685,Term (temporal),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8686,Sharing (Social Behavior),adenoid cystic carcinoma of lung,0
8687,Sarcoma - category (morphologic abnormality),Cherubism,0
8688,Reduction (chemical),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8689,Australia,Choroid Epithelioid Cell Melanoma,0
8690,Endometrial scraping,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8691,Does communicate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8692,Immunotherapy,Diffuse malignant mesothelioma,0
8693,Two,Squamous cell carcinoma of lip,0
8694,Abnormally high,Kaposi's sarcoma of extrahepatic bile duct,0
8695,Singular,Bladder Neuroendocrine Neoplasm,0
8696,Incidental,Spongiotic dermatitis,0
8697,entry - cluster,Transitional cell carcinoma,0
8698,65+,Metastatic Lung Neuroendocrine Neoplasm,0
8699,Embryonic tissue,Locally Advanced Soft Tissue Sarcoma,0
8700,Human body structure,Human Papillomavirus-Related Carcinoma,0
8701,Usually,Leiomyoma of Gallbladder,0
8702,Nervous system structure,Occult Lung Adenosquamous Carcinoma,0
8703,Uterus,Anaplastic large cell lymphoma,0
8704,put - instruction imperative,Localized Malignant Neoplasm,0
8705,Spreading (qualifier value),Xeroderma pigmentosum,0
8706,Transplanted organ,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
8707,Present,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8708,Comparison,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8709,Frequently,Extracranial Neuroblastoma,0
8710,Treating,Adenoma,0
8711,Present,Mucinous adenocarcinoma gastric,0
8712,Table Frame - above,Benign squamous cell tumor,0
8713,Screening procedure,mucinous adenocarcinoma of gallbladder,0
8714,Financial Account,Intraepithelial Melanocytic Hyperplasia,0
8715,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
8716,Beginning,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8717,Numerous,Hereditary Diffuse Gastric Adenocarcinoma,0
8718,Swelling,Low Grade Squamous Intraepithelial Neoplasia,0
8719,How Often Itching,Noninfiltrating Intraductal Carcinoma,0
8720,Fragment,Localized Malignant Neoplasm,0
8721,Benign,Stage III Cutaneous Melanoma AJCC v6,0
8722,Financial Account,Engraftment syndrome,0
8723,Presentation,Anterior Urethral Malignant Neoplasm,0
8724,therapeutic aspects,Stage II Carcinoma of Penis,0
8725,Possibly Related to Intervention,Adult Alveolar Soft Part Sarcoma,0
8726,Type - attribute,papillary carcinoma of penis,0
8727,Speaking (activity),Kaposi's sarcoma of skin,0
8728,Kind of quantity - Consistency,Anaplastic large cell lymphoma,0
8729,Area,Bladder adenocarcinoma stage IV,0
8730,Visible,Microcystic meningioma,0
8731,Psammomatous Meningioma,Extracranial Neuroblastoma,0
8732,Adult,Basal Cell Ameloblastoma,0
8733,Slightly (qualifier value),FIGO Stage IVA Ovarian Cancer,0
8734,Vaginal mass,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8735,Biomaterial Treatment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8736,Shortened,Hereditary corneal dystrophy,0
8737,Death (finding),Malignant melanoma of eyelid,0
8738,Diagnosis Study,Botryoid-Type Embryonal Rhabdomyosarcoma,0
8739,Present,Liver Lymphangioma,0
8740,Common (qualifier value),Chest Wall Fibromatosis,0
8741,Humor therapy,Advanced Uterine Corpus Carcinosarcoma,0
8742,<3 (qualifier value),Microcystic meningioma,0
8743,MUTYH-Associate Polyposis,Grade 3a Malignant Neoplasm,0
8744,Presentation,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8745,Injury wounds,Kaposi's sarcoma of extrahepatic bile duct,0
8746,Chronic Lymphocytic Leukemia,Tumorlet,0
8747,Intestines,Cervical Squamous Intraepithelial Neoplasia,0
8748,Spinal meningocele,Metastatic Malignant Neoplasm in the Sellar Region,0
8749,Fasting,Non-Hodgkin Lymphoma During Pregnancy,0
8750,Frequently,Localized Askin Tumor,0
8751,Congenital MeSH qualifier,Benign neoplasm of thorax,0
8752,Version (morphologic abnormality),Recurrent Uveal Melanoma,0
8753,Subgroup,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8754,Negation,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
8755,Primary operation,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
8756,Eye,Small cell neuroendocrine carcinoma of bladder,0
8757,Cause of death:Find:Pt:^Patient:Nom,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
8758,Five-year Survival Rate,Basal Cell Ameloblastoma,0
8759,External lower lip,Acute Undifferentiated Leukemia,0
8760,Trial Screening,Female Breast Carcinoma,0
8761,Back structure,de novo Myelodysplastic Syndrome,0
8762,Term (temporal),Thyroid Hurthle Cell Carcinoma,0
8763,Often - answer to question,Contact dermatitis due to alkali,0
8764,unknown vaccine or immune globulin,Liver Lymphangioma,0
8765,Mass,Melanomatosis,0
8766,Related personal status,Colorectal cancer,0
8767,Location of Pharyngeal Residue Following Swallowing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
8768,Metastatic Neoplasm,Collecting Duct Carcinoma of the Kidney,0
8769,How Often Felt Normal question,Diffuse malignant mesothelioma,0
8770,International Classification of Diseases for Oncology,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8771,Pathology report,Intestinal Metaplasia of Bladder Urothelium,0
8772,Caucasians,Intraepithelial Melanocytic Hyperplasia,0
8773,Chronic acquired lymphedema,Stage III Cutaneous Melanoma AJCC v6,0
8774,Carcinoma,Cancer of Urinary Tract,0
8775,Means,Medulloblastoma,0
8776,Occurrence,Granular Cell Leiomyosarcoma,0
8777,Ability,Kaposi's sarcoma of skin,0
8778,Reporting,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
8779,Specimen Source Codes - Tears,Type II Endometrial Adenocarcinoma,0
8780,Visual Impairment,embryonal rhabdomyosarcoma of prostate,0
8781,Frequency of Pain Question,Cerebral Primitive Neuroectodermal Tumor,0
8782,shared attribute,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
8783,Hormonal,Adult Acute Eosinophilic Leukemia,0
8784,Pain NOS,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8785,Cells,Childhood Fibrillary Astrocytoma,0
8786,Linear,Stage III Cutaneous Melanoma AJCC v6,0
8787,Time (foundation metadata concept),Benign squamous cell tumor,0
8788,65+,Acute Undifferentiated Leukemia,0
8789,Branch of,Familial Hemophagocytic Lymphocytosis,0
8790,Medical Imaging,Giant cell angiofibroma,0
8791,Superkingdom (taxonomic category),Maxillary Sinus Adenocarcinoma,0
8792,Plain chest X-ray,ROSE Cluster 3,0
8793,Agreement,ROSE Cluster 3,0
8794,Infection,Colorectal Neuroendocrine Tumor G2,0
8795,Body structure,Ovarian Carcinoid Tumor,0
8796,Human papilloma virus infection,Chest Wall Fibromatosis,0
8797,Present,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8798,Lung,Diffuse malignant mesothelioma,0
8799,Malignant Female Reproductive System Neoplasm,Pancreatic Intraepithelial Neoplasia-3,0
8800,Percent of Bacteria,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
8801,Death (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8802,Mucous Membrane,Breast Ductal Adenoma,0
8803,Study Control,Metastatic Malignant Neoplasm in the Sellar Region,0
8804,Dyspareunia (female),Thymic Atypical Carcinoid Tumor,0
8805,diagnosis aspect,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8806,Severe (severity modifier),Stage III Adult Immunoblastic Lymphoma,0
8807,Cervix carcinoma,Carcinoma of urinary bladder,0
8808,Patient Reported Outcome Stem,Mixed astrocytoma-ependymoma,0
8809,Present,Granular Cell Leiomyosarcoma,0
8810,Tissue membrane,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
8811,System - kit,Pilocytic astrocytoma of cerebellum,0
8812,Negation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8813,Along edge (qualifier value),Undifferentiated Endocervical Sarcoma,0
8814,Aspects of disease screening,Recurrent Uveal Melanoma,0
8815,Deoxyribonucleic Acid Measurement,Angiosarcoma of liver,0
8816,Middle Aged,Familial Hemophagocytic Lymphocytosis,0
8817,Adult Non-Hodgkin Lymphoma,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
8818,Cancer Genus,Benign Apocrine Neoplasm,0
8819,Common (qualifier value),Childhood Choriocarcinoma,0
8820,True primary (qualifier value),Extra-abdominal fibromatosis,0
8821,Diffuse Large B-Cell Lymphoma,Vaginal Adenoma,0
8822,Tissue damage,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
8823,Rose extract,Intraepithelial Melanocytic Hyperplasia,0
8824,Component (part),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8825,Endocrine,Refractory Barrett Esophagus,0
8826,Greater,Malignant neoplasm of choroid,0
8827,Corneal dystrophy,embryonal rhabdomyosarcoma of prostate,0
8828,Usual,Stage III Cutaneous Melanoma AJCC v6,0
8829,300,Adult Acute Eosinophilic Leukemia,0
8830,pharmacotherapeutic,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8831,Liquid Tumor,embryonal rhabdomyosarcoma of prostate,0
8832,radiotherapeutic,malignant lymphoma of pancreatic lymph nodes,0
8833,Diabetes,Fibroadenoma of breast,0
8834,lymph nodes,Human Papillomavirus-Related Carcinoma,0
8835,Nasal septum structure,Neonatal leukemia,0
8836,Possible,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8837,Glioblastoma Multiforme Pathway,Metaplastic carcinoma of breast,0
8838,Approximate,Cancer of Urinary Tract,0
8839,Infant,Stage 0 Penile Cancer AJCC v8,0
8840,Sarcoma,Plexosarcoma,0
8841,Science of Etiology,Recurrent Uveal Melanoma,0
8842,Tent - Recreation Equipment,Type II Endometrial Adenocarcinoma,0
8843,lymph nodes,Mixed astrocytoma-ependymoma,0
8844,Blood in stool,Stage 0 Penile Cancer AJCC v8,0
8845,Classification of information,Localized Askin Tumor,0
8846,Chemotherapy Regimen,Giant cell angiofibroma,0
8847,Disease,Endometrial Small Cell Carcinoma,0
8848,CYP19A1 protein,Testicular cancer metastatic,0
8849,Fever symptoms (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8850,QPCT wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
8851,Buildup,Liver Lymphangioma,0
8852,Present,Clinical Stage I Cutaneous Melanoma AJCC v8,0
8853,Central Nervous System Neoplasms,Type II Endometrial Adenocarcinoma,0
8854,Graph Edge,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
8855,Appearance,Diffuse malignant mesothelioma,0
8856,Dryness of eye,Metastatic Neoplasm to the Gallbladder,0
8857,Experimental Result,Cystadenocarcinoma,0
8858,blood forming organ,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
8859,include - SetOperator,Endometrial Small Cell Carcinoma,0
8860,Nucleated Thrombocyte Count,Intraepithelial Melanocytic Hyperplasia,0
8861,Five,Cervical Fibroepithelial Polyp,0
8862,Congenital qualifier,Angiosarcoma of liver,0
8863,Malignant Neoplasms,Acinar cell carcinoma of pancreas,0
8864,Olfactory,Funisitis (disorder),0
8865,include - SetOperator,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8866,Post Device,Fibroadenoma of breast,0
8867,Pediatric Neoplasm,Refractory Ependymoma,0
8868,Status post,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
8869,Cancer Genus,Mixed parotid tumor,0
8870,Old,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8871,Call (Instruction),Mucinous adenocarcinoma gastric,0
8872,Usually,Mucinous adenocarcinoma gastric,0
8873,Togo,Childhood Central Nervous System Ganglioneuroblastoma,0
8874,Incidence,Recurrent Testicular Lymphoma,0
8875,Tumor size,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
8876,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Refractory Ependymoma,0
8877,Response to treatment,Childhood Anaplastic Large Cell Lymphoma,0
8878,unknown vaccine or immune globulin,Blepharal carcinoma,0
8879,Valid,Squamous cell carcinoma of lip,0
8880,Basis - conceptual entity,Methotrexate-Associated Hodgkin Lymphoma,0
8881,Intellectual scale,Recurrent Testicular Lymphoma,0
8882,Condoms,Refractory Barrett Esophagus,0
8883,Name,Metastatic Lung Small Cell Carcinoma,0
8884,Adipose tissue,Diffuse malignant mesothelioma,0
8885,Abnormal Reference Range,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8886,Femur length,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
8887,Physical findings,Pilocytic astrocytoma of cerebellum,0
8888,contextual factors,Localized Askin Tumor,0
8889,Usual,squamous cell carcinoma of the thyroid gland,0
8890,Oral region,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8891,Feature,Thymic Atypical Carcinoid Tumor,0
8892,Receptors,Undifferentiated Endocervical Sarcoma,0
8893,Vagina Carcinoma,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
8894,Ultraviolet Light Sterilization,Intraepithelial Melanocytic Hyperplasia,0
8895,risk factors,FIGO Stage IVA Ovarian Cancer,0
8896,Including (qualifier),sarcoma of spinal cord,0
8897,Purpose,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
8898,3+ Answer to Question,FIGO Stage IVA Ovarian Cancer,0
8899,Severe (severity modifier),Uterine Cancer,0
8900,Malignant neoplasm of ovary,Atypical Lobular Breast Hyperplasia,0
8901,Colon structure (body structure),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
8902,year,Refractory Ependymoma,0
8903,Organ,Angiosarcoma of liver,0
8904,Case unit dose,Colorectal cancer,0
8905,Including (qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
8906,Fever symptoms (finding),Acute Undifferentiated Leukemia,0
8907,Platelet Glycoprotein 4,Malignant Neoplasm of Lung - Multiple Primary Sites,0
8908,Often - answer to question,Stage IB Lung Cancer AJCC v7,0
8909,Work,Intestinal Metaplasia of Bladder Urothelium,0
8910,PREVENT (product),Bladder adenocarcinoma stage IV,0
8911,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
8912,Spreading (qualifier value),Breast Ductal Adenoma,0
8913,Thin skin,Periosteal Osteosarcoma,0
8914,analysis aspect,Maxillary Sinus Adenocarcinoma,0
8915,Estrogens,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
8916,Male Reproductive System Part,Undifferentiated Endocervical Sarcoma,0
8917,Histologic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8918,ESR1 gene,Acinar cell carcinoma of pancreas,0
8919,Subtype (attribute),Stage IV Colorectal Cancer AJCC v8,0
8920,Mammal liver preparation,Pancreatic Intraepithelial Neoplasia-3,0
8921,ERBB2 protein,Carcinomatosis of peritoneal cavity,0
8922,cancer risk,Lipoma of small intestine,0
8923,chance,Human Papillomavirus-Related Carcinoma,0
8924,Array Feature,Xeroderma pigmentosum,0
8925,Smear - instruction imperative,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
8926,NCI CTEP SDC Salivary Gland Cancer Sub-Category Terminology,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8927,Togo,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8928,Structure of zygote,Splenic Manifestation of Hairy Cell Leukemia,0
8929,Reduced,BRCA2 Syndrome,0
8930,English [International Organization for Standardization 639-1 code en] language reference set,Type II Endometrial Adenocarcinoma,0
8931,Did not receive therapy or drug for,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8932,Etiology aspects,Chronic Myelomonocytic Leukemia-2,0
8933,Concept History,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
8934,Worsening pattern,clear cell adenocarcinoma of gallbladder,0
8935,Publications,Thymic Clear Cell Carcinoma,0
8936,Malignant tumor of colon,Malignant neoplasm of choroid,0
8937,Mammary Gland Parenchyma,Pancreatic Intraepithelial Neoplasia-3,0
8938,No Application Type,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8939,Malignant Neoplasms,Chronic Myelomonocytic Leukemia-2,0
8940,Death NOS,Neonatal leukemia,0
8941,per second,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
8942,Tryptophanase,Cerebral hemangioma,0
8943,Type - attribute,Cervical Fibroepithelial Polyp,0
8944,Type A,Benign Anal Granular Cell Tumor,0
8945,Thin (qualifier value),Heavy Chain Deposition Disease,0
8946,fish - non-drug agent,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
8947,status - In progress,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
8948,DNA Damage,Low Grade Squamous Intraepithelial Neoplasia,0
8949,General surgery specialty,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
8950,Component object,Tonsillar Carcinoma,0
8951,Invasive Lesion,Intraepithelial Melanocytic Hyperplasia,0
8952,Benign Neoplasm,GIANT PIGMENTED HAIRY NEVUS,0
8953,Less Than,Refractory Bladder Carcinoma,0
8954,Internal,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
8955,Skin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8956,Togo,Recurrent Testicular Lymphoma,0
8957,Medical,Lipoma of small intestine,0
8958,Blood Vessel,Papillary squamous cell carcinoma,0
8959,Age,Heavy Chain Deposition Disease,0
8960,Aggressive behavior,Leiomyoma of Gallbladder,0
8961,CDISC SEND Body System Terminology,Gallbladder Adenocarcinoma,0
8962,<3 (qualifier value),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
8963,Case unit dose,Unfavorable Non-Hodgkin Lymphoma,0
8964,Wound Healing,Thyroid Hurthle Cell Carcinoma,0
8965,favor,Methotrexate-Associated Hodgkin Lymphoma,0
8966,Aggressive course,Digestive System Hodgkin Lymphoma,0
8967,>90,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
8968,Human body structure,Leptomeningeal sarcoma,0
8969,Categories,Atypical Mesothelial Hyperplasia,0
8970,Greater than one,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
8971,Lymphoid Tissue,Small cell neuroendocrine carcinoma of bladder,0
8972,Out (direction),Maxillary Sinus Adenoid Cystic Carcinoma,0
8973,Age,Brain Ependymoma,0
8974,Symptoms,Xeroderma pigmentosum,0
8975,risk factors - observation list,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
8976,Treating,Bladder Neuroendocrine Neoplasm,0
8977,Surgery specialty,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
8978,Skin,Locally Advanced Carcinoma,0
8979,Very Much,Basal Cell Ameloblastoma,0
8980,Classification,Thyroid Hurthle Cell Carcinoma,0
8981,Retinoic Acid Response Element,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
8982,Adenocarcinoma,Airway Hemangioma,0
8983,How Often Weight Loss,Cervical Fibroepithelial Polyp,0
8984,Pleomorphism (morphologic abnormality),Rhabdomyosarcoma with ganglionic differentiation,0
8985,primary tumor,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
8986,Extrinsic,Intraepithelial Melanocytic Hyperplasia,0
8987,shared attribute,Peripheral primitive neuroectodermal tumor of soft tissue,0
8988,Retinoic Acid Response Element,Type II Endometrial Adenocarcinoma,0
8989,veterans alcoholism screening test (VAST),Parathyroid Gland Adenocarcinoma,0
8990,Specimen Source Codes - Tube,Heavy Chain Deposition Disease,0
8991,Result,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
8992,Adult Classical Hodgkin Lymphoma,BRCA2 Syndrome,0
8993,Pleural Effusion,Carcinoma of urinary bladder,0
8994,65,Female Breast Carcinoma,0
8995,Test Result,Maxillary Sinus Adenoid Cystic Carcinoma,0
8996,Proliferation,Airway Hemangioma,0
8997,Therapeutic radiology procedure,Endometrial Small Cell Carcinoma,0
8998,suggestion,Stage IV Penile Cancer AJCC v7,0
8999,Stem of plant,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9000,Usually,Atypical Mesothelial Hyperplasia,0
9001,Genes,Kaposi's sarcoma of skin,0
9002,Population Group,papillary carcinoma of penis,0
9003,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Cervical Fibroepithelial Polyp,0
9004,Human body structure,benign mature teratoma of pancreas,0
9005,lymph nodes,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9006,Set of organs,Testicular cancer metastatic,0
9007,% Ercs,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
9008,Obese build,Pancreatic Intraepithelial Neoplasia-3,0
9009,Epithelial cell count (procedure),Maxillary Sinus Adenoid Cystic Carcinoma,0
9010,Lymphatic System,Mixed astrocytoma-ependymoma,0
9011,Encounter due to family history of colonic polyps,Tongue Alveolar Soft Part Sarcoma,0
9012,Lymphoma,Small cell neuroendocrine carcinoma of bladder,0
9013,Complete,Thymic Clear Cell Carcinoma,0
9014,Metastatic Neoplasm,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9015,Person Observer,Tonsillar Carcinoma,0
9016,white blood cell type,Bladder squamous cell carcinoma stage I,0
9017,Lymphadenopathy,Liver Lymphangioma,0
9018,Occur (action),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9019,Screening procedure,Splenic Manifestation of Hairy Cell Leukemia,0
9020,Status post,Xeroderma pigmentosum,0
9021,Carcinoma in Situ,FIGO Stage II Ovarian Cancer,0
9022,Diagnosis,Epithelioid Sarcoma NCI Grade 3,0
9023,Time,Primary Cutaneous Plasmablastic Lymphoma,0
9024,Embryonic Development,Metastatic Lung Small Cell Carcinoma,0
9025,Skin Specimen,Chondrosarcoma,0
9026,Environmental Pollutants,Precursor B-lymphoblastic lymphoma stage II,0
9027,Common (qualifier value),Liver Cavernous Hemangioma,0
9028,Manufactured form,Benign squamous cell tumor,0
9029,Tumor Mass,Leptomeningeal sarcoma,0
9030,Time,Blepharal carcinoma,0
9031,Therapeutic radiology procedure,Airway Hemangioma,0
9032,Fibroadenoma of breast,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9033,Cardiac Lead Procedure,Trichilemmocarcinoma,0
9034,Enlarged,Plexosarcoma,0
9035,Cutaneous leiomyoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9036,Short,FIGO Stage IVA Ovarian Cancer,0
9037,Occurrence,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9038,Liquid Tumor,Kaposi's sarcoma of extrahepatic bile duct,0
9039,Togo,Chronic Myelomonocytic Leukemia-2,0
9040,Stop (Instruction Imperative),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9041,potential,Adrenal Rest Tumor,0
9042,Cure (remedy),Cerebral Primitive Neuroectodermal Tumor,0
9043,Body tissue,Colorectal Neuroendocrine Tumor G2,0
9044,Cancer Genus,Precursor B-lymphoblastic lymphoma stage II,0
9045,South,BRCA2 Syndrome,0
9046,Germ cell tumor,Digestive System Hodgkin Lymphoma,0
9047,+2,Anterior Urethral Malignant Neoplasm,0
9048,Autosome,Cartilaginous exostosis,0
9049,Supportive assistance,adenosquamous carcinoma of breast,0
9050,Pelvic cavity structure,Unfavorable Non-Hodgkin Lymphoma,0
9051,Containing (qualifier),Placental aromatase deficiency,0
9052,Oral region,Squamous cell carcinoma of lip,0
9053,Case (situation),Microcystic meningioma,0
9054,One,Intraepithelial Melanocytic Hyperplasia,0
9055,Dilate procedure,Acute Undifferentiated Leukemia,0
9056,Hyperplastic Polyp,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9057,Trachea,Xeroderma pigmentosum,0
9058,Light Microscopy,Childhood Cerebellar Neoplasm,0
9059,Type - attribute,Benign Anal Granular Cell Tumor,0
9060,QPCT wt Allele,Benign tumor of eyelid,0
9061,Blue color,Placental aromatase deficiency,0
9062,Out (direction),Basal Cell Ameloblastoma,0
9063,Vision:-:Point in time:^Patient:-,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9064,Poor function,Recurrent Testicular Lymphoma,0
9065,Water Specimen,Carcinoma of urinary bladder,0
9066,+2,Refractory Ependymoma,0
9067,How Much Distress Itching,Maxillary Sinus Adenocarcinoma,0
9068,Malignant neoplasm of brain,Thymic Clear Cell Carcinoma,0
9069,Diet Code Specification Type - Preference,Kaposi's sarcoma of skin,0
9070,therapeutic aspects,Fibroadenoma of breast,0
9071,year,Benign squamous cell tumor,0
9072,Intracranial,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9073,Thecoma,Human Papillomavirus-Related Carcinoma,0
9074,Screening Study,Thymic Clear Cell Carcinoma,0
9075,Symptoms aspect,Familial Hemophagocytic Lymphocytosis,0
9076,primary tumor,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9077,Entity Determiner - specific,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9078,Cystic dermoid choristoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9079,Prostate,Cerebral Primitive Neuroectodermal Tumor,0
9080,Extent of disease,Stage IV Penile Cancer AJCC v7,0
9081,Cancer Genus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9082,shared attribute,Spermatocytic seminoma,0
9083,Etiology aspects,embryonal rhabdomyosarcoma of prostate,0
9084,Form:Finding:Point in time:{Setting}:Document:{Role},Mucinous adenocarcinoma gastric,0
9085,Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9086,Population Group,Liver Cavernous Hemangioma,0
9087,Presentation,Diffuse malignant mesothelioma,0
9088,Detected (finding),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
9089,Necrotic changes (finding),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9090,Disintegration (morphologic abnormality),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9091,Choroid Plexus Papilloma,Malignant Testicular Sertoli Cell Tumor,0
9092,Pancreas,Carcinoma,0
9093,Numerous,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
9094,Significant,Adult Acute Eosinophilic Leukemia,0
9095,posterior fossa,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9096,Part Dosing Unit,Pancreatic carcinoma,0
9097,Diagnosis Study,Xeroderma pigmentosum,0
9098,Term (lexical),Melanomatosis,0
9099,Increase,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9100,Physical findings,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
9101,Donor person,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9102,New Zealand,Recurrent Testicular Lymphoma,0
9103,Version,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9104,Abnormal cell,Clonal Hematopoiesis of Indeterminate Potential,0
9105,Tumor cells,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9106,Vaccinated (qualifier),Multiple Endocrine Neoplasia,0
9107,Biopsy,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9108,Proliferation,Mucinous adenocarcinoma,0
9109,Never (frequency),Recurrent Testicular Lymphoma,0
9110,Known,mucinous adenocarcinoma of gallbladder,0
9111,Primary,gliosarcoma,0
9112,Used by,Digestive System Hodgkin Lymphoma,0
9113,Aggressive behavior,ROSE Cluster 3,0
9114,adaptive,Deep Leiomyoma,0
9115,Very,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9116,Area,Acantholytic squamous cell carcinoma,0
9117,Astrocytoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
9118,User Group,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9119,Diagnosis Study,Congenital hamartoma,0
9120,Application Context,Pancreatic Intraepithelial Neoplasia-3,0
9121,Manufactured sign,Anterior Urethral Malignant Neoplasm,0
9122,70%,Microcystic meningioma,0
9123,Moved to,Basal Cell Ameloblastoma,0
9124,99,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9125,Childhood Rhabdomyosarcoma,Brain Tumor,0
9126,Nitrofurantoin,Intestinal Metaplasia of Bladder Urothelium,0
9127,Down Syndrome,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9128,Version (morphologic abnormality),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9129,Epithelium,Advanced Uterine Corpus Carcinosarcoma,0
9130,Persons,Kaposi's sarcoma of extrahepatic bile duct,0
9131,Certain (qualifier value),Adult Acute Eosinophilic Leukemia,0
9132,Central Nervous System Neoplasms,Collecting Duct Carcinoma of the Kidney,0
9133,Common (qualifier value),Benign Apocrine Neoplasm,0
9134,Biogenic Amines,Carcinomatosis of peritoneal cavity,0
9135,Pharyngeal structure,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9136,Including (qualifier),Recurrent Testicular Lymphoma,0
9137,Breast,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9138,Present,Type II Endometrial Adenocarcinoma,0
9139,Ankle joint structure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9140,Then,Gallbladder Adenocarcinoma,0
9141,Rare Diseases,non-Hodgkin's lymphoma of spleen,0
9142,Code,Mucosal Melanoma,0
9143,Cessation of life,Hemangioma,0
9144,Dietary Lead,ROSE Cluster 3,0
9145,Long Term Survivorship,Testicular cancer metastatic,0
9146,Broken skin,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9147,Professional guide,Astrocytoma of brain,0
9148,Weight decreased,Unfavorable Non-Hodgkin Lymphoma,0
9149,Term Birth,Mucinous adenocarcinoma gastric,0
9150,Pressure- physical agent,Benign neoplasm of thorax,0
9151,Symptoms aspect,Uterine Cancer,0
9152,Qualitative form,Bladder squamous cell carcinoma stage I,0
9153,Cells,Ovarian Carcinoid Tumor,0
9154,Polyp of large intestine,Stage IB Lung Cancer AJCC v7,0
9155,Body part,Metastatic Ductal Breast Carcinoma,0
9156,Case (situation),Cancer of Urinary Tract,0
9157,75,Breast Apocrine Adenoma,0
9158,New,Recurrent Primary Lymphoma of Bone,0
9159,Medical Device Emits Smoke,Mixed astrocytoma-ependymoma,0
9160,Common Specifications in HL7 V3 Publishing,adenoid cystic carcinoma of lung,0
9161,Assisting (procedure),Recurrent Testicular Lymphoma,0
9162,Vagina,Lipoma of small intestine,0
9163,PSA Level Less than Five,Thymic Clear Cell Carcinoma,0
9164,Drain device,Nasal cavity carcinoma,0
9165,Tired,Type II Endometrial Adenocarcinoma,0
9166,Presentation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9167,Anterior portion of neck,mucinous adenocarcinoma of gallbladder,0
9168,Antibodies,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9169,contagion,FIGO Stage IVA Ovarian Cancer,0
9170,alone - group size,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
9171,Rapid,Anterior Urethral Malignant Neoplasm,0
9172,foreign,Localized Ewing Sarcoma,0
9173,Frequently,papillary carcinoma of penis,0
9174,Add - instruction imperative,Localized Ewing Sarcoma,0
9175,National origin,Stage 0 Penile Cancer AJCC v8,0
9176,% live,Periosteal Osteosarcoma,0
9177,Anaplastic astrocytoma,Liver Cavernous Hemangioma,0
9178,Collection (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
9179,Human body,Stage 0 Lip Carcinoma,0
9180,Percent (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9181,Worsening pattern,Intraepithelial Melanocytic Hyperplasia,0
9182,Recommendation,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9183,Show,Childhood Lung Non-Small Cell Carcinoma,0
9184,dependent,Lung Mucinous Cystadenoma,0
9185,Diffuse Large B-Cell Lymphoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9186,Orbital region,Methotrexate-Associated Hodgkin Lymphoma,0
9187,Life threatening - Event Consequence,Refractory Ependymoma,0
9188,Specimen Source Codes - tumor,Grade 1 Clear Cell Renal Cell Carcinoma,0
9189,Macrophage Activation Syndrome,Ichthyosis,0
9190,color additive,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
9191,Peritoneum,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
9192,Colloids,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9193,Hormonal,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9194,Determined by,Locally Advanced Soft Tissue Sarcoma,0
9195,Genetic,Cervical Fibroepithelial Polyp,0
9196,Red color,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9197,Gastroesophageal reflux disease,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9198,Etiology aspects,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9199,Symptoms aspect,Non-Metastatic Gestational Trophoblastic Tumor,0
9200,Scientific Publication,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9201,Genetic,Thyroid Hurthle Cell Carcinoma,0
9202,Surface,Cerebral Primitive Neuroectodermal Tumor,0
9203,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
9204,Secondary to,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9205,Adult Lymphoma,Cerebral Primitive Neuroectodermal Tumor,0
9206,Administered Component Designation,Refractory Ependymoma,0
9207,Ultraviolet Rays,Cartilaginous exostosis,0
9208,precancerous lesions,Acantholytic squamous cell carcinoma,0
9209,Participation Type - origin,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9210,various other intestinal adsorbents in ATC,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9211,Time (foundation metadata concept),Extracranial Neuroblastoma,0
9212,Abnormality of the face,Small intestine carcinoma,0
9213,Dental Base,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9214,Anatomic Node,Medulloblastoma,0
9215,Aspects of signs,Nasal cavity carcinoma,0
9216,Immune System Processes,Refractory Bladder Carcinoma,0
9217,Neoplasm Metastasis,Childhood Anaplastic Large Cell Lymphoma,0
9218,contextual factors,Malignant neoplasm of gallbladder,0
9219,analysis aspect,Pancreatic carcinoma,0
9220,Qualitative form,Refractory Bladder Carcinoma,0
9221,CDISC SDTM Disease Outcome Terminology,embryonal rhabdomyosarcoma of prostate,0
9222,Organ,Platinum-Resistant Lung Small Cell Carcinoma,0
9223,Silent,Fourth Ventricle and Brain Stem Ependymal Tumor,0
9224,shared attribute,Intraepithelial Melanocytic Hyperplasia,0
9225,Estrogen [EPC],Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9226,Segmental Mastectomy,Cherubism,0
9227,Rare,Multiple Skull Base Meningiomas,0
9228,Deterioration of status,Locally Advanced Soft Tissue Sarcoma,0
9229,Sacrifice,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9230,List,Tongue Alveolar Soft Part Sarcoma,0
9231,Weight Loss,Benign Anal Granular Cell Tumor,0
9232,Result,Airway Hemangioma,0
9233,Current (present time),Childhood Central Nervous System Ganglioneuroblastoma,0
9234,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Neonatal leukemia,0
9235,High Risk Acute Leukemia,Precursor B-lymphoblastic lymphoma stage II,0
9236,Name (property) (qualifier value),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9237,Mean Percent of Normal,Adult Alveolar Soft Part Sarcoma,0
9238,Leading,Locally Advanced Soft Tissue Sarcoma,0
9239,How Often Itching,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9240,fludarabine,Squamous cell carcinoma of lip,0
9241,3+ Score,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9242,Original Regulatory Submission,Breast Ductal Adenoma,0
9243,Dental Cavity Lining,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
9244,Have Weight Loss,Liver Lymphangioma,0
9245,Condition,Airway Hemangioma,0
9246,Shapes,Ectomesenchymal Chondromyxoid Tumor,0
9247,Histologic,Clonal Hematopoiesis of Indeterminate Potential,0
9248,Both kidneys,Digestive System Hodgkin Lymphoma,0
9249,Related personal status,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9250,Physical findings,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9251,*Type - Kind of quantity,Uterine Cancer,0
9252,Carcinoma of lung,Small cell neuroendocrine carcinoma of bladder,0
9253,Left,Stage IB Pancreatic Cancer AJCC v8,0
9254,Unknown,Hereditary Diffuse Gastric Adenocarcinoma,0
9255,Occurrence,Refractory Barrett Esophagus,0
9256,Menopause present (finding),Nasal cavity carcinoma,0
9257,Cell Differentiation process,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9258,Occurrence,Malignant neoplasm of gallbladder,0
9259,Immune system,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9260,Well Differentiated,Gallbladder adenoma,0
9261,per day,Hemangioma,0
9262,Symptoms aspect,Female Breast Carcinoma,0
9263,cancer classification,Refractory Bladder Carcinoma,0
9264,Spreading (qualifier value),Periosteal Osteosarcoma,0
9265,teratologic,Refractory Ependymoma,0
9266,Decreased,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
9267,2+ Score,Non-Metastatic Gestational Trophoblastic Tumor,0
9268,Taxonomic,Locally Advanced Epithelioid Hemangioendothelioma,0
9269,Microvolt,Stage IB Pancreatic Cancer AJCC v8,0
9270,Approximate,non-Hodgkin's lymphoma of spleen,0
9271,Organ,Digestive System Hodgkin Lymphoma,0
9272,Base - General Qualifier,Benign Ovarian Thecoma,0
9273,Tryptophanase,Thymic Clear Cell Carcinoma,0
9274,Malignant Neoplasms,Pancreatic Endocrine Carcinoma,0
9275,Qualitative form,Benign Anal Granular Cell Tumor,0
9276,Inflammation,Grade 1 Clear Cell Renal Cell Carcinoma,0
9277,Fever,Anterior Urethral Malignant Neoplasm,0
9278,Primary malignant neoplasm,Acute Undifferentiated Leukemia,0
9279,Pediculus (eukaryote),Sarcomatoid Renal Cell Carcinoma,0
9280,Part of,Granular Cell Leiomyosarcoma,0
9281,Intraoral approach,Tongue Alveolar Soft Part Sarcoma,0
9282,Malignant Neoplasms,Benign neoplasm of thorax,0
9283,Anatomic Site,Chondrosarcoma,0
9284,Plumbum metallicum,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9285,Enlargement procedure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9286,Source,Acute Undifferentiated Leukemia,0
9287,Bladder Cancer Pathway,Secondary malignant neoplasm of lymph node,0
9288,Tissue damage,FIGO Stage II Ovarian Cancer,0
9289,How Often Sweats,Metastatic Lung Neuroendocrine Neoplasm,0
9290,Endocrine Cells,Splenic Manifestation of Hairy Cell Leukemia,0
9291,Present,Mucinous cystadenofibroma,0
9292,Biogenic Amines,Hyperplasia of pituitary gland,0
9293,Etiology aspects,Heavy Chain Deposition Disease,0
9294,Epstein-Barr Virus Early RNA,Locally Advanced Soft Tissue Sarcoma,0
9295,Vestibular fold,Anterior Urethral Malignant Neoplasm,0
9296,Bone Marrow Examination,Angiosarcoma of liver,0
9297,Study Site,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
9298,Excision,Undifferentiated Neuroblastoma,0
9299,Swallowing painful,Recurrent Rhabdomyosarcoma,0
9300,Increased,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9301,Human body structure,Hereditary Diffuse Gastric Adenocarcinoma,0
9302,newly,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9303,Mutation,Endometrial Small Cell Carcinoma,0
9304,Money or percentage indicator - Percentage,Chest Wall Fibromatosis,0
9305,Significant,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9306,Relationships,Adrenal Rest Tumor,0
9307,Reported,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
9308,Specimen Source Codes - tumor,Acute Undifferentiated Leukemia,0
9309,Feelings,Human Papillomavirus-Related Carcinoma,0
9310,generic name,Pancreatic carcinoma,0
9311,Part of,FIGO Stage II Ovarian Cancer,0
9312,Syndrome,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9313,Togo,Childhood Thyroid Gland Follicular Carcinoma,0
9314,Accident due to exposure to weather conditions,Testicular cancer metastatic,0
9315,General surgery specialty,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9316,Neuropathy,embryonal rhabdomyosarcoma of prostate,0
9317,Leg,Locally Advanced Carcinoma,0
9318,Cancer Other,Cancer of Urinary Tract,0
9319,Along edge (qualifier value),Female Breast Carcinoma,0
9320,Laryngeal papillomatosis,Refractory Bladder Carcinoma,0
9321,American College of Cardiology/American Heart Association Lesion Complexity Score C,Mucinous cystadenofibroma,0
9322,Tissue Specimen Code,Angiosarcoma of liver,0
9323,Abnormal host response,Mucinous adenocarcinoma gastric,0
9324,Often - answer to question,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9325,Lymphocyte,embryonal rhabdomyosarcoma of prostate,0
9326,Foreskin of penis,Locally Advanced Soft Tissue Sarcoma,0
9327,Thyroid carcinoma,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
9328,Equilibrium,Intestinal Metaplasia of Bladder Urothelium,0
9329,Approach,Locally Advanced Carcinoma,0
9330,Percent of Abnormal Cells,Airway Hemangioma,0
9331,Classical Hodgkin's Lymphoma,Cervical Squamous Intraepithelial Neoplasia,0
9332,Usual Severity Weight Loss,Malignant neoplasm of gallbladder,0
9333,Intestines,Spongiotic dermatitis,0
9334,Secretory Vesicles,Basal Cell Ameloblastoma,0
9335,Carcinoma of bladder,Bladder squamous cell carcinoma stage I,0
9336,2+,Benign Anal Granular Cell Tumor,0
9337,Recommendation,Undifferentiated Neuroblastoma,0
9338,Value Above Reference Range,Brain Tumor,0
9339,radiotherapeutic,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
9340,Count of entities,Childhood Anaplastic Large Cell Lymphoma,0
9341,include - SetOperator,Pleomorphic adenoma of parotid gland,0
9342,Adult Classical Hodgkin Lymphoma,Adult Acute Eosinophilic Leukemia,0
9343,Subject Risk,Stage III Cutaneous Melanoma AJCC v6,0
9344,Old,Refractory Ependymoma,0
9345,Ability,Hemangioma,0
9346,Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
9347,Occurrence Indicator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9348,Telephone Extension Number,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9349,Melanins,Refractory Ependymoma,0
9350,Secondary Neoplasm,Spongiotic dermatitis,0
9351,Referring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9352,Initially,Neoplasms,0
9353,Most,Extracranial Neuroblastoma,0
9354,Often - answer to question,Malignant Testicular Sertoli Cell Tumor,0
9355,Following,Lipoma of small intestine,0
9356,Sodium Chloride,Serous cystadenocarcinoma ovary,0
9357,Common Specifications in HL7 V3 Publishing,Undifferentiated Endocervical Sarcoma,0
9358,Molecular Mass,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9359,Progress,Mucinous cystadenofibroma,0
9360,Death (finding),Peripheral primitive neuroectodermal tumor of soft tissue,0
9361,Container status - Identified,Benign squamous cell tumor,0
9362,Skin,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
9363,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Neonatal leukemia,0
9364,Publishing,Hodgkin lymphoma,0
9365,Biopsy,Childhood Central Nervous System Ganglioneuroblastoma,0
9366,New Zealand Rabbits,FIGO Stage IVA Ovarian Cancer,0
9367,Bothered by Night Sweats,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9368,Both ovaries,Spongiotic dermatitis,0
9369,Mucins,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9370,Order (action),Non-Hodgkin Lymphoma During Pregnancy,0
9371,Left sided,Acantholytic squamous cell carcinoma,0
9372,Type A,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
9373,Activity (animal life circumstance),Unfavorable Non-Hodgkin Lymphoma,0
9374,CD69 protein,Choroid Necrotic Melanoma,0
9375,Tract,Localized Askin Tumor,0
9376,Symptoms,Recurrent Testicular Lymphoma,0
9377,depend,Refractory Ependymoma,0
9378,Logical Condition,Mucinous neoplasm,0
9379,Cell (compartment),Localized Ewing Sarcoma,0
9380,melanotic,Hyperplasia of pituitary gland,0
9381,Lymphatic,Peripheral primitive neuroectodermal tumor of soft tissue,0
9382,described,malignant lymphoma of pancreatic lymph nodes,0
9383,Affecting,Ectomesenchymal Chondromyxoid Tumor,0
9384,treatment options,Microcystic meningioma,0
9385,Segmental Mastectomy,Thyroid Hurthle Cell Carcinoma,0
9386,Operative Surgical Procedures,Intestinal Metaplasia of Bladder Urothelium,0
9387,Skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
9388,Including (qualifier),Squamous cell carcinoma of lip,0
9389,Container status - Identified,Pancreatic Intraepithelial Neoplasia-3,0
9390,Hematological Disease,Undifferentiated Endocervical Sarcoma,0
9391,Precipitating Factors,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9392,Entire great blood vessel (organ),Recurrent Uveal Melanoma,0
9393,Requirement,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9394,*Susceptibility,Endometrial Small Cell Carcinoma,0
9395,Most,Nasal cavity carcinoma,0
9396,Most,Stage IV Penile Cancer AJCC v7,0
9397,2+ Score,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9398,Characteristics,Intraepithelial Melanocytic Hyperplasia,0
9399,Communicable Diseases,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9400,Type A,Pancreatic Intraepithelial Neoplasia-3,0
9401,Abdomen distended,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
9402,shared attribute,Hyperplasia of pituitary gland,0
9403,The Sun,Thymic Clear Cell Carcinoma,0
9404,Mitosis,BRCA2 Syndrome,0
9405,Decision,Mucinous adenocarcinoma gastric,0
9406,Name,Pancreatic Intraepithelial Neoplasia-3,0
9407,Time (foundation metadata concept),Metastatic Malignant Neoplasm in the Sellar Region,0
9408,Mathematical Factor,Giant cell angiofibroma,0
9409,Malignant neoplasm of kidney,Vaginal Adenoid Cystic Carcinoma,0
9410,Have Weight Loss,Bladder squamous cell carcinoma stage I,0
9411,Malignant neoplasm of breast,Precursor B-lymphoblastic lymphoma stage II,0
9412,Including (qualifier),Familial Adenomatous Polyposis Associated Medulloblastoma,0
9413,Neuroendocrine Tumors,Stage III Cutaneous Melanoma AJCC v6,0
9414,Case unit dose,Cartilaginous exostosis,0
9415,Adult Non-Hodgkin Lymphoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9416,Characteristics,Endometrial Small Cell Carcinoma,0
9417,Prognosis:Find:Pt:^Patient:Nom,Recurrent Uveal Melanoma,0
9418,Europe,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9419,Always (frequency),papillary carcinoma of penis,0
9420,parotid gland swelling,Stage III Adult Immunoblastic Lymphoma,0
9421,Measured Tumor Identification,Localized Malignant Neoplasm,0
9422,Therapeutic radiology procedure,Malignant melanoma of eyelid,0
9423,Pain management,Benign Carotid Body Paraganglioma,0
9424,Either,Localized Ewing Sarcoma,0
9425,Linear,Metaplastic carcinoma of breast,0
9426,Divide,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9427,Neoplasm Metastasis,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9428,Feelings,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
9429,various other intestinal adsorbents in ATC,Kaposi's sarcoma of skin,0
9430,1+ Score,Peripheral primitive neuroectodermal tumor of soft tissue,0
9431,Disease,Chondrosarcoma,0
9432,Reported Term,Carcinoma ex pleomorphic adenoma of parotid gland,0
9433,Occur (action),Carcinoma of urinary bladder,0
9434,Relationships,Squamous cell carcinoma of lip,0
9435,include - SetOperator,Human Papillomavirus-Related Carcinoma,0
9436,Togo,Type II Endometrial Adenocarcinoma,0
9437,Before,Benign Apocrine Neoplasm,0
9438,Mesothelial hyperplasia,Testicular cancer metastatic,0
9439,Covered (qualifier value),Pleomorphic adenoma of parotid gland,0
9440,Persons,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9441,Similarity,Thymic Atypical Carcinoid Tumor,0
9442,Case (situation),Ovarian Dermoid Cyst with Secondary Carcinoma,0
9443,Twice - dosing instruction fragment,FIGO Stage IVA Ovarian Cancer,0
9444,Call (Instruction),Botryoid-Type Embryonal Rhabdomyosarcoma,0
9445,Loss of Appetite question,Advanced Uterine Corpus Carcinosarcoma,0
9446,Squamous cell carcinoma,Granular Cell Leiomyosarcoma,0
9447,Metastatic Neoplasm,Fibroadenoma of breast,0
9448,Subtype (attribute),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9449,What subject filter - Result,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9450,Time,Splenic Manifestation of Hairy Cell Leukemia,0
9451,Skin,Hyperplasia of pituitary gland,0
9452,Affecting,Unicystic ameloblastoma,0
9453,Cure (remedy),Malignant melanoma of eyelid,0
9454,Hematopoietic cell,Intraepithelial Melanocytic Hyperplasia,0
9455,Affecting,Primary Cutaneous Plasmablastic Lymphoma,0
9456,Does stand alone,Squamous cell carcinoma of lip,0
9457,Diffuse Large B-Cell Lymphoma,Localized Ewing Sarcoma,0
9458,Neoplasm Metastasis,Localized Askin Tumor,0
9459,Papillary thyroid carcinoma,gliosarcoma,0
9460,regional,ROSE Cluster 3,0
9461,Preventive intent,Blepharal carcinoma,0
9462,Lower (action),Endometrial Small Cell Carcinoma,0
9463,Term (temporal),Unfavorable Non-Hodgkin Lymphoma,0
9464,ano-rectal,ROSE Cluster 3,0
9465,Classification of information,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9466,Head and neck structure,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
9467,Intestinal cell,Spongiotic dermatitis,0
9468,Liquid substance,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9469,Togo,Localized Ewing Sarcoma,0
9470,*Type - Kind of quantity,Refractory Bladder Carcinoma,0
9471,Cerebellar Hypoplasia,Low Grade Squamous Intraepithelial Neoplasia,0
9472,Part Dosing Unit,High Grade Glandular Intraepithelial Neoplasia,0
9473,Congenital MeSH qualifier,Acantholytic squamous cell carcinoma,0
9474,Eighth,Angiosarcoma of liver,0
9475,One,Malignant melanoma of eyelid,0
9476,Morning,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
9477,Left sided,Benign Anal Granular Cell Tumor,0
9478,Array Feature,Hemangioma,0
9479,Term (temporal),Secondary malignant neoplasm of lymph node,0
9480,various antiinfectives and antiseptics for local oral treatment,Parathyroid Gland Adenocarcinoma,0
9481,Primary malignant neoplasm,Bladder adenocarcinoma stage IV,0
9482,Removing (action),Malignant melanoma of eyelid,0
9483,Common wart,Bladder adenocarcinoma stage IV,0
9484,Submandibular,Squamous cell carcinoma of lip,0
9485,Usually,Benign Ovarian Thecoma,0
9486,Ischemia Procedure,Mucinous adenocarcinoma gastric,0
9487,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Peripheral primitive neuroectodermal tumor of soft tissue,0
9488,1000000,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9489,Long,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9490,Cause of death:Find:Pt:^Patient:Nom,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9491,Low Mitosis-Karyorrhexis Index,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9492,Squamous cell carcinoma,Malignant neoplasm of olfactory nerve,0
9493,N+ (tumor staging),Angiosarcoma of liver,0
9494,CYREN gene,Kaposi's sarcoma of extrahepatic bile duct,0
9495,Therapeutic procedure,Uterine Cancer,0
9496,combination - answer to question,Mixed astrocytoma-ependymoma,0
9497,Frequently,Stage IV Penile Cancer AJCC v7,0
9498,Population Group,Localized Malignant Neoplasm,0
9499,Fever,Thymic Atypical Carcinoid Tumor,0
9500,Used by,Nasal cavity carcinoma,0
9501,Malignant Neoplasms,Astrocytoma of brain,0
9502,Assortment,Thymic Atypical Carcinoid Tumor,0
9503,Benign,Stage 0 Lip Carcinoma,0
9504,pharmacotherapeutic,Adenocarcinoma,0
9505,Intraepithelial Neoplasia,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9506,Nevus,Benign neoplasm of eye,0
9507,low,Xeroderma pigmentosum,0
9508,Part of,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
9509,CD69 wt Allele,Medulloblastoma,0
9510,various other nasal preparations in ATC,Carcinoma,0
9511,Common Specifications in HL7 V3 Publishing,Chest Wall Fibromatosis,0
9512,/40,Gallbladder adenoma,0
9513,Tryptophanase,Maxillary Sinus Adenoid Cystic Carcinoma,0
9514,Ultrasonography,papillary carcinoma of penis,0
9515,Line Unit of Length,Small cell neuroendocrine carcinoma of bladder,0
9516,Levator palpebrae superioris structure,Intraepithelial Melanocytic Hyperplasia,0
9517,Specimen Source Codes - Lesion,Intraepithelial Melanocytic Hyperplasia,0
9518,Breast Cancer Type 1 Susceptibility Protein Measurement,Liver Lymphangioma,0
9519,Interaction,Pancreatic Intraepithelial Neoplasia-3,0
9520,Groups,Atypical Lobular Breast Hyperplasia,0
9521,Increase,Blepharal carcinoma,0
9522,Term (lexical),Type II Endometrial Adenocarcinoma,0
9523,United States,Uterine Cancer,0
9524,bony process,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9525,Due to,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9526,diagnosis aspect,Fibroadenoma of breast,0
9527,Urine looks dark,Kaposi's sarcoma of extrahepatic bile duct,0
9528,color additive,Benign squamous cell tumor,0
9529,Nerve,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9530,Therapeutic procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9531,1+,Intraepithelial Melanocytic Hyperplasia,0
9532,analysis aspect,Localized Malignant Neoplasm,0
9533,Common Specifications in HL7 V3 Publishing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9534,Value Above Reference Range,Low Grade Squamous Intraepithelial Neoplasia,0
9535,Indexes,Digestive System Hodgkin Lymphoma,0
9536,<90,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9537,other medicated shampoos in ATC,Acantholytic squamous cell carcinoma,0
9538,Tobacco,Stage III Adult Immunoblastic Lymphoma,0
9539,Diagnosis Study,Mucinous adenocarcinoma gastric,0
9540,Characteristics,Collecting Duct Carcinoma of the Kidney,0
9541,Overall,Localized Askin Tumor,0
9542,Over (spatial),Clonal Hematopoiesis of Indeterminate Potential,0
9543,Rapid disease progression,Stage IB Pancreatic Cancer AJCC v8,0
9544,Cell Count,Blepharal carcinoma,0
9545,Secretory Vesicles,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9546,Subject Risk,Malignant Testicular Sertoli Cell Tumor,0
9547,Poor - grade value,Bladder squamous cell carcinoma stage I,0
9548,Containing (qualifier),Intestinal Metaplasia of Bladder Urothelium,0
9549,Brain Neoplasms,Gallbladder Adenocarcinoma,0
9550,Sequence Arm,Malignant neoplasm of gallbladder,0
9551,Symptoms,Localized Askin Tumor,0
9552,Diagnosis Study,Stage IB Pancreatic Cancer AJCC v8,0
9553,Adult Glioblastoma,Anaplastic large cell lymphoma,0
9554,Metastatic malignant neoplasm to brain,Anterior Urethral Malignant Neoplasm,0
9555,Morphology,Cancer of Urinary Tract,0
9556,More,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
9557,Connective Tissue,FIGO Stage IVA Ovarian Cancer,0
9558,English [International Organization for Standardization 639-1 code en] language reference set,Intraepithelial Melanocytic Hyperplasia,0
9559,Common Specifications in HL7 V3 Publishing,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9560,Adult,Colorectal High Grade B-Cell Lymphoma,0
9561,Often - answer to question,Peripheral primitive neuroectodermal tumor of soft tissue,0
9562,Kidney,Congenital hamartoma,0
9563,Combined,Carcinomatosis of peritoneal cavity,0
9564,Malignant Epithelial Cell,Chest Wall Fibromatosis,0
9565,Treating,Female Breast Carcinoma,0
9566,Common (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9567,Approximate,Benign tumor of eyelid,0
9568,Pressure (finding),Kaposi's sarcoma of extrahepatic bile duct,0
9569,SMG1 wt Allele,non-Hodgkin's lymphoma of spleen,0
9570,Fever,clear cell adenocarcinoma of gallbladder,0
9571,Decrease,Choroid Necrotic Melanoma,0
9572,Occurrence Indicator,Atypical Lobular Breast Hyperplasia,0
9573,Supportive assistance,Mucinous adenocarcinoma gastric,0
9574,Stem of plant,Angiosarcoma of liver,0
9575,Extrinsic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9576,Mixed (qualifier value),Anaplastic large cell lymphoma,0
9577,mouth swelling,Type II Endometrial Adenocarcinoma,0
9578,Body structure,Vaginal Adenoid Cystic Carcinoma,0
9579,Negation,Recurrent Testicular Lymphoma,0
9580,1+ Score,Lung squamous cell carcinoma stage I,0
9581,shared attribute,Peripheral primitive neuroectodermal tumor of soft tissue,0
9582,CDISC SEND Tumor Findings Results Terminology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9583,Detected (finding),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
9584,Diagnosis,Cervical Fibroepithelial Polyp,0
9585,Usual,Childhood Central Nervous System Ganglioneuroblastoma,0
9586,Specimen Source Codes - tumor,benign mature teratoma of pancreas,0
9587,How Much Distress Weight Loss,Tongue Alveolar Soft Part Sarcoma,0
9588,Feature,Engraftment syndrome,0
9589,Rare,Splenic Manifestation of Hairy Cell Leukemia,0
9590,Chewing,ICHTHYOSIS,0
9591,Pharmacotherapy,Liver Cavernous Hemangioma,0
9592,Range of Motion,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9593,Fasting Status Indicator,Lung squamous cell carcinoma stage I,0
9594,50%,Thymic Atypical Carcinoid Tumor,0
9595,Smear - instruction imperative,Stage IB Lung Cancer AJCC v7,0
9596,GORAB gene,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9597,Sunscreening Agents,papillary carcinoma of penis,0
9598,Malignant Neoplasms,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9599,pharmacotherapeutic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9600,Sequence Data Type,Localized Askin Tumor,0
9601,Certain (qualifier value),Lipoma of small intestine,0
9602,Primary malignant neoplasm,Engraftment syndrome,0
9603,Human body structure,Benign Anal Granular Cell Tumor,0
9604,Individual,Adult Acute Eosinophilic Leukemia,0
9605,Benign,Stage I Adult Non-Hodgkin Lymphoma,0
9606,Prior Chemotherapy,Basal Cell Ameloblastoma,0
9607,per period (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9608,900,Periosteal Osteosarcoma,0
9609,African American,Unicystic ameloblastoma,0
9610,CEL gene,Methotrexate-Associated Hodgkin Lymphoma,0
9611,shared attribute,Pancreatic Intraepithelial Neoplasia-3,0
9612,Childhood Lymphoma,Stage IB Lung Cancer AJCC v7,0
9613,Togo,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
9614,Diagnosis,Intestinal Neuroendocrine Carcinoma,0
9615,+5,Blood Vessel Tumors,0
9616,Precision - second,Xeroderma pigmentosum,0
9617,Twice (Numerical Qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9618,Malignant Neoplasms,Squamous cell carcinoma of lip,0
9619,Gum of mandible,Malignant neoplasm of thalamus,0
9620,Blood,Mucinous cystadenofibroma,0
9621,Common Specifications in HL7 V3 Publishing,Fibroadenoma of breast,0
9622,Cancer Remission,Cervical Squamous Intraepithelial Neoplasia,0
9623,Lumpectomy of breast,FIGO Stage IVA Ovarian Cancer,0
9624,Infrequent,Unicystic ameloblastoma,0
9625,Cells,Multiple Skull Base Meningiomas,0
9626,Value Above Reference Range,Stage I Adult Non-Hodgkin Lymphoma,0
9627,Blood Products Laboratory Testing,Benign Carotid Body Paraganglioma,0
9628,Case (situation),Basal Cell Ameloblastoma,0
9629,Forecast of outcome,Malignant melanoma of eyelid,0
9630,Ovarian Carcinoma,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
9631,Vague,Kaposi's sarcoma of extrahepatic bile duct,0
9632,day,Recurrent Testicular Lymphoma,0
9633,Occur (action),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9634,Scar Tissue,Primary Cutaneous Plasmablastic Lymphoma,0
9635,Frequently,Metastatic Ductal Breast Carcinoma,0
9636,risk factors,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9637,Formation,Non-Metastatic Gestational Trophoblastic Tumor,0
9638,Biomaterial Treatment,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9639,Egg of order Phthiraptera,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9640,Universal restriction modifier (core metadata concept),High Grade Glandular Intraepithelial Neoplasia,0
9641,Magnetic Resonance Imaging Study File,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9642,Code,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9643,Unlikely Related to Intervention,Small cell neuroendocrine carcinoma of bladder,0
9644,Pain,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9645,Cessation of life,Pancreatic Intraepithelial Neoplasia-3,0
9646,Offspring,embryonal rhabdomyosarcoma of prostate,0
9647,Primary malignant neoplasm,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9648,Form:Finding:Point in time:{Setting}:Document:{Role},Diffuse malignant mesothelioma,0
9649,Liver Flavor,Trabecular adenocarcinoma,0
9650,Singular,Carcinoma,0
9651,include - SetOperator,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
9652,Sneezing,ROSE Cluster 3,0
9653,removal technique,Recurrent Testicular Lymphoma,0
9654,Treatment Epoch,Type II Endometrial Adenocarcinoma,0
9655,Back Pain,Small cell neuroendocrine carcinoma of bladder,0
9656,Childhood Hodgkin Lymphoma,Primary Cutaneous Plasmablastic Lymphoma,0
9657,Risk,Precursor B-lymphoblastic lymphoma stage II,0
9658,Body tissue,Hemangioma,0
9659,Age of onset of symptoms:Time:Pt:^Patient:Qn,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9660,Common (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
9661,Term (lexical),Acute Undifferentiated Leukemia,0
9662,Ovary,Splenic Manifestation of Hairy Cell Leukemia,0
9663,Tryptophanase,Multiple Skull Base Meningiomas,0
9664,Specimen Source Codes - Lesion,Vaginal Adenoid Cystic Carcinoma,0
9665,Plasma Product,Intestinal Neuroendocrine Carcinoma,0
9666,Participation Type - origin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9667,Treating,Nasal cavity carcinoma,0
9668,Suspected diagnosis,Low Grade Squamous Intraepithelial Neoplasia,0
9669,Curettage procedure,Blepharal carcinoma,0
9670,heirarchal root,Maxillary Sinus Adenoid Cystic Carcinoma,0
9671,radiotherapeutic,Papillary squamous cell carcinoma,0
9672,Analysis,clear cell adenocarcinoma of gallbladder,0
9673,Increased,Liver Lymphangioma,0
9674,Formation,Adult Alveolar Soft Part Sarcoma,0
9675,Specimen Source Codes - Lesion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9676,shared attribute,Childhood Central Nervous System Ganglioneuroblastoma,0
9677,lymph nodes,Contact dermatitis due to alkali,0
9678,Tumor site:Anat:Pt:Specimen:Nom,Undifferentiated Endocervical Sarcoma,0
9679,Type - attribute,Diffuse malignant mesothelioma,0
9680,Lymphatic Abnormalities,BRCA2 Syndrome,0
9681,Table Cell Horizontal Align - left,BRCA2 Syndrome,0
9682,survival aspects,Nasal cavity carcinoma,0
9683,Contusions,Medulloblastoma,0
9684,90%,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
9685,Bone Marrow Examination,Adrenal Rest Tumor,0
9686,SLC6A2 wt Allele,Contact dermatitis due to alkali,0
9687,Case (situation),FIGO Stage IVA Ovarian Cancer,0
9688,One,Adult Fibrolamellar Carcinoma,0
9689,Use of,Acute Undifferentiated Leukemia,0
9690,Report (document),Trabecular adenocarcinoma,0
9691,Individual,Refractory Bladder Carcinoma,0
9692,Qualitative form,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9693,Urinary Bladder,Endometrial Small Cell Carcinoma,0
9694,Occur (action),Adult Hepatocellular Carcinoma,0
9695,Biopsy,Unicystic ameloblastoma,0
9696,NCI CTEP SDC Melanoma Sub-Category Terminology,Chondrosarcoma,0
9697,penis,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
9698,Platelets Product,FIGO Stage II Ovarian Cancer,0
9699,Carcinoid Tumor,Astrocytoma of brain,0
9700,Squamocolumnar junction of cervix,Refractory Barrett Esophagus,0
9701,Usual,Chondrosarcoma,0
9702,Muscle (organ),Primary Cutaneous Plasmablastic Lymphoma,0
9703,Adult Diffuse Large B-Cell Lymphoma,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9704,Late,Methotrexate-Associated Hodgkin Lymphoma,0
9705,Primary malignant neoplasm,Childhood Lymphoma,0
9706,Application Dosing Unit,Pancreatic carcinoma,0
9707,Reduced,Pancreatic carcinoma,0
9708,Chemotherapy,Grade 1 Clear Cell Renal Cell Carcinoma,0
9709,More,Benign Anal Granular Cell Tumor,0
9710,Skin fold,Clonal Hematopoiesis of Indeterminate Potential,0
9711,Greatly,Stage III Adult Immunoblastic Lymphoma,0
9712,Scaling,Sarcomatoid Renal Cell Carcinoma,0
9713,System (unit of presentation),Diffuse malignant mesothelioma,0
9714,Laboratory mice,Hodgkin Disease,0
9715,strategy,Xeroderma pigmentosum,0
9716,newly,Non-Metastatic Gestational Trophoblastic Tumor,0
9717,pharmacotherapeutic,Benign Anal Granular Cell Tumor,0
9718,Disease,Uterine Cancer,0
9719,Premalignant Cell,Bladder adenocarcinoma stage IV,0
9720,Examination of skin,Chronic Myelomonocytic Leukemia-2,0
9721,Biologic Development,Spindle Cell Melanoma,0
9722,Pediculus humanus capitis (eukaryote),Type II Endometrial Adenocarcinoma,0
9723,Connection,Stage IV Penile Cancer AJCC v7,0
9724,Age-Years,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9725,Mathematical Operator,Endometrial Small Cell Carcinoma,0
9726,Opening,Gallbladder Adenocarcinoma,0
9727,Myoepithelial,Anterior Urethral Malignant Neoplasm,0
9728,Needs,mucinous adenocarcinoma of gallbladder,0
9729,Recognition of Outliers by Sampling Ends,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9730,Participation Type - origin,Bladder squamous cell carcinoma stage I,0
9731,Malignant Neoplasms,Type II Endometrial Adenocarcinoma,0
9732,International Classification of Disease for Oncology,Malignant melanoma of eyelid,0
9733,Screening,Breast Ductal Adenoma,0
9734,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
9735,intent,Lung Inflammatory Myofibroblastic Tumor,0
9736,Spreading (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
9737,artesunate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9738,Ephrin Type-B Receptor 1,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
9739,Improved,Stage IV Penile Cancer AJCC v7,0
9740,Bone marrow: lymphocytes (finding),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9741,Cells,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9742,Pancreatic ductal cell,Stage IV Colorectal Cancer AJCC v8,0
9743,Coding,Advanced Uterine Corpus Carcinosarcoma,0
9744,Malignant neoplasm of thyroid,Stage IB Lung Cancer AJCC v7,0
9745,ultrasound device,Type II Endometrial Adenocarcinoma,0
9746,Often - answer to question,Melanomatosis,0
9747,Adult,Hodgkin lymphoma,0
9748,Usually,Low Grade Squamous Intraepithelial Neoplasia,0
9749,stage,Female Breast Carcinoma,0
9750,Code,Benign Carotid Body Paraganglioma,0
9751,65+,Bladder Neuroendocrine Neoplasm,0
9752,65,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9753,Staining method,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9754,Etiology aspects,Locally Advanced Carcinoma,0
9755,Only - dosing instruction fragment,Stage IV Childhood Non-Hodgkin Lymphoma,0
9756,eTMF Content Model Code,embryonal rhabdomyosarcoma of prostate,0
9757,Measles,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
9758,To,Carcinoma of urinary bladder,0
9759,contextual factors,Ichthyosis,0
9760,Cancer Genus,Tongue Alveolar Soft Part Sarcoma,0
9761,Less Than,Human Papillomavirus-Related Carcinoma,0
9762,Pediatric,Low Grade Squamous Intraepithelial Neoplasia,0
9763,Abnormal,Spongiotic dermatitis,0
9764,Continuous,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9765,Descent,Brain Tumor,0
9766,Therapeutic radiology procedure,Benign neoplasm of thorax,0
9767,Pancreatitis,Mucinous adenocarcinoma,0
9768,Feature,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9769,Tissue Specimen Code,BRCA2 Syndrome,0
9770,Cells,Recurrent Uveal Melanoma,0
9771,Multiply - dosing instruction fragment,Adult Alveolar Soft Part Sarcoma,0
9772,oncology field,Intestinal Metaplasia of Bladder Urothelium,0
9773,Active,Digestive System Hodgkin Lymphoma,0
9774,year,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9775,Definitely Related to Intervention,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9776,Pediatrics,Childhood Fibrillary Astrocytoma,0
9777,Report (document),Pancreatic Endocrine Carcinoma,0
9778,Case (situation),Fibroadenoma of breast,0
9779,Imaging Techniques,Serous cystadenocarcinoma ovary,0
9780,Qualitative form,Mixed astrocytoma-ependymoma,0
9781,Disease,Lung Mucinous Cystadenoma,0
9782,Overall Survival,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9783,1960s,Malignant neoplasm of subglottis,0
9784,Persons,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9785,Oral cavity,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
9786,Mass of body structure,High Grade Glandular Intraepithelial Neoplasia,0
9787,Seizures,Pancreatic Intraepithelial Neoplasia-3,0
9788,Detection,Mucinous adenocarcinoma gastric,0
9789,Body structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
9790,Togo,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
9791,Interventional procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
9792,Highest,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9793,Tryptophanase,Cervical Fibroepithelial Polyp,0
9794,Decision,Unicystic ameloblastoma,0
9795,Hip structure,Mucosal Melanoma,0
9796,eTMF Content Model Code,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9797,Thoracic spinal cord structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9798,Togo,Thymic Clear Cell Carcinoma,0
9799,Superkingdom (taxonomic category),Acantholytic squamous cell carcinoma,0
9800,Adenocarcinoma,Engraftment syndrome,0
9801,Combined,Nasal cavity carcinoma,0
9802,Blast count procedure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9803,Advanced phase,Undifferentiated Endocervical Sarcoma,0
9804,Group A (qualifier value),Squamous cell carcinoma of lip,0
9805,Detected (finding),Leptomeningeal sarcoma,0
9806,Hemangiosarcoma,Human Papillomavirus-Related Carcinoma,0
9807,Neuroblastoma,Funisitis (disorder),0
9808,Body part,Chondrosarcoma,0
9809,Renal carcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
9810,Cancer Other,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
9811,Nevus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9812,New,Liver Lymphangioma,0
9813,Cancer Genus,Mucosal Melanoma,0
9814,excessive growth,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
9815,Due to,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
9816,Glycation End Products,FIGO Stage IVA Ovarian Cancer,0
9817,defects aspect,ROSE Cluster 3,0
9818,Including (qualifier),Trabecular adenocarcinoma,0
9819,Degree or extent,Nasal cavity carcinoma,0
9820,+2,Giant cell angiofibroma,0
9821,Obese build,Chronic Myelomonocytic Leukemia-2,0
9822,Electromagnetic Radiation,Small cell neuroendocrine carcinoma of bladder,0
9823,Evaluation procedure,Unicystic ameloblastoma,0
9824,Usually,clear cell adenocarcinoma of gallbladder,0
9825,Leads (device),Mucinous cystadenofibroma,0
9826,Consistency,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9827,Somalia,Pancreatic Intraepithelial Neoplasia-3,0
9828,Most,Carcinoma of urinary bladder,0
9829,Treating,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
9830,Lead,Locally Advanced Carcinoma,0
9831,Tumor type,Refractory Bladder Carcinoma,0
9832,Diffuse Large B-Cell Lymphoma,Thyroid Hurthle Cell Carcinoma,0
9833,Metastasis,Malignant Neoplasm with Regional Lymph Node Involvement,0
9834,Intestines,Refractory Bladder Carcinoma,0
9835,depend,Stage II Carcinoma of Penis,0
9836,Frequently,Diffuse malignant mesothelioma,0
9837,Human body,Hereditary Diffuse Gastric Adenocarcinoma,0
9838,Classification,Rhabdomyosarcoma with ganglionic differentiation,0
9839,epithelial,Tonsillar Carcinoma,0
9840,Adenocarcinoma,Childhood Fibrillary Astrocytoma,0
9841,Childbirth,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9842,status - In progress,Liver Cavernous Hemangioma,0
9843,Nervous system structure,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
9844,Body structure,Cancer of Urinary Tract,0
9845,Feelings,Recurrent Primary Lymphoma of Bone,0
9846,In Blood,Intestinal Metaplasia of Bladder Urothelium,0
9847,Country,Transitional cell carcinoma,0
9848,PSA Level Less than Two,Familial Adenomatous Polyposis Associated Medulloblastoma,0
9849,respiratory,Grade 3a Malignant Neoplasm,0
9850,First (number),Noninfiltrating Intraductal Carcinoma,0
9851,Platelets Product,FIGO Stage IVA Ovarian Cancer,0
9852,Representation (action),Acute lymphadenitis,0
9853,Statistical Prevalence,Malignant melanoma of eyelid,0
9854,Progress,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
9855,Geographic Locations,Childhood Extragonadal Malignant Germ Cell Tumor,0
9856,Compleat Liquid Nutrition,Undifferentiated Endocervical Sarcoma,0
9857,Trachea,Primary Cutaneous Plasmablastic Lymphoma,0
9858,Mediastinum,Angiosarcoma of liver,0
9859,Onset of (contextual qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
9860,Make - Instruction Imperative,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
9861,Etiology aspects,Methotrexate-Associated Hodgkin Lymphoma,0
9862,Abnormally high,Benign Anal Granular Cell Tumor,0
9863,Condition,embryonal rhabdomyosarcoma of prostate,0
9864,Arsenic measurement,Testicular cancer metastatic,0
9865,Certainties,Adrenal Rest Tumor,0
9866,Make - Instruction Imperative,Refractory WHO Grade III Glioma,0
9867,Progress,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
9868,Intellectual scale,Granular Cell Leiomyosarcoma,0
9869,palmidrol,Lung squamous cell carcinoma stage I,0
9870,Illness: Cannot describe symptoms,Adult Alveolar Soft Part Sarcoma,0
9871,survive,Digestive System Hodgkin Lymphoma,0
9872,Lymphatic,Benign tumor of eyelid,0
9873,Brain Neoplasms,Unfavorable Non-Hodgkin Lymphoma,0
9874,Treating,Methotrexate-Associated Hodgkin Lymphoma,0
9875,Clinical Trial [Publication Type],Benign tumor of eyelid,0
9876,Treating,Cancer of Urinary Tract,0
9877,Benign neurologic neoplasms,Vaginal Adenoma,0
9878,Qualitative form,clear cell adenocarcinoma of gallbladder,0
9879,Swelling,Unicystic ameloblastoma,0
9880,DNA Microarray Chip,squamous cell carcinoma of the thyroid gland,0
9881,Worse,embryonal rhabdomyosarcoma of prostate,0
9882,survival aspects,Thymic Clear Cell Carcinoma,0
9883,Weight Loss,Extracranial Neuroblastoma,0
9884,To,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9885,Breast Feeding,Precursor B-lymphoblastic lymphoma stage II,0
9886,Medications,Stage I Colon Neuroendocrine Tumor AJCC v8,0
9887,To,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9888,Symptoms,Peripheral primitive neuroectodermal tumor of soft tissue,0
9889,Digital Content Category,Mucinous adenocarcinoma gastric,0
9890,Immunoproliferative Disorders,Xeroderma pigmentosum,0
9891,Aspects of signs,Clonal Hematopoiesis of Indeterminate Potential,0
9892,Sweating,Xeroderma pigmentosum,0
9893,Laboratory Procedures,carcinoma of middle ear,0
9894,Occurrence Indicator,Leiomyoma of Gallbladder,0
9895,Have Pain,Anterior Urethral Malignant Neoplasm,0
9896,Electrolytes,Medulloblastoma,0
9897,Homo sapiens,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9898,Attachment (action),sarcoma of spinal cord,0
9899,Side,papillary carcinoma of penis,0
9900,Body Site Modifier - Lower,Intestinal Metaplasia of Bladder Urothelium,0
9901,Raised,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
9902,Additional,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9903,<3 (qualifier value),benign mature teratoma of pancreas,0
9904,Laboratory Procedures,Type II Endometrial Adenocarcinoma,0
9905,Occurrence Indicator,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9906,Older child,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9907,Skin cell,Cerebral Primitive Neuroectodermal Tumor,0
9908,Primary malignant neoplasm,Kaposi's sarcoma of skin,0
9909,Qualitative form,Ovarian germ cell choriocarcinoma stage IV,0
9910,Teaching principal,Cancer of Urinary Tract,0
9911,Exostosis,Stage III Cutaneous Melanoma AJCC v6,0
9912,Chemotherapy,Mucosal Melanoma,0
9913,International Statistical Classification of Diseases and Related Health Problems,Localized Ewing Sarcoma,0
9914,Injury due to exposure to external cause,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9915,Common Specifications in HL7 V3 Publishing,Carcinoma of urinary bladder,0
9916,majority,Maxillary Sinus Adenoid Cystic Carcinoma,0
9917,VIPR1 wt Allele,Kaposi's sarcoma of extrahepatic bile duct,0
9918,described,Multiple Skull Base Meningiomas,0
9919,Overall Publication Type,Clinical Stage I Cutaneous Melanoma AJCC v8,0
9920,Code,Ichthyoses,0
9921,Last,Intestinal Metaplasia of Bladder Urothelium,0
9922,*Type - Kind of quantity,Tongue Alveolar Soft Part Sarcoma,0
9923,Recurrent infections,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9924,Anatomic Site,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
9925,Manufactured form,Malignant Neoplasm of Lung - Multiple Primary Sites,0
9926,Rating (action),Testicular cancer metastatic,0
9927,Usually Need Help from Another Person for Eating,Primary Cutaneous Plasmablastic Lymphoma,0
9928,Time,Cancer of Urinary Tract,0
9929,Multiple malignancy,Metaplastic carcinoma of breast,0
9930,Togo,Stage II Hepatocellular Carcinoma AJCC v8,0
9931,Seeding,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9932,MDFAttributeType - Fraction,Benign Anal Granular Cell Tumor,0
9933,Negation,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9934,Major,Diffuse malignant mesothelioma,0
9935,Net (qualifier),clear cell adenocarcinoma of gallbladder,0
9936,Arsenic measurement,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
9937,Relationships,Digestive System Hodgkin Lymphoma,0
9938,Occurrence Indicator,Adult Hepatocellular Carcinoma,0
9939,therapeutic aspects,Childhood Lymphoma,0
9940,Chemicals,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
9941,Common Specifications in HL7 V3 Publishing,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9942,Including (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9943,Direct (qualifier),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
9944,Rare,Adenocarcinoma of duodenum,0
9945,analysis aspect,Kaposi's sarcoma of skin,0
9946,Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
9947,More,Cervical Squamous Intraepithelial Neoplasia,0
9948,combination - answer to question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
9949,Source (property) (qualifier value),Multiple Skull Base Meningiomas,0
9950,Carcinoid Tumor,Stage II Carcinoma of Penis,0
9951,South,Childhood Central Nervous System Ganglioneuroblastoma,0
9952,Well,Mucinous adenocarcinoma gastric,0
9953,Cystadenocarcinoma,Brain Tumor,0
9954,Obesity,Metastatic Malignant Neoplasm in the Sellar Region,0
9955,Five,Thyroid Hurthle Cell Carcinoma,0
9956,Usually,Angiosarcoma of liver,0
9957,Macrophage Activation Syndrome,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9958,Usual Severity Shortness of Breath,Maxillary Sinus Adenocarcinoma,0
9959,Occur (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
9960,Regular,Thymic Clear Cell Carcinoma,0
9961,Usually,non-Hodgkin's lymphoma of spleen,0
9962,gene therapy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9963,Curative - procedure intent,Unresectable Rhabdomyosarcoma,0
9964,Occurrence Indicator,Acute Undifferentiated Leukemia,0
9965,Lower (action),Low Grade Squamous Intraepithelial Neoplasia,0
9966,Poor - qualifier,Malignant Testicular Sertoli Cell Tumor,0
9967,Experimental Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
9968,Referring,Diffuse malignant mesothelioma,0
9969,Description,Carcinoma of urinary bladder,0
9970,Fever symptoms (finding),Childhood Central Nervous System Ganglioneuroblastoma,0
9971,Term Birth,adenoid cystic carcinoma of lung,0
9972,Smear - instruction imperative,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
9973,Greater than one,mucinous adenocarcinoma of gallbladder,0
9974,Surgical aspects,Botryoid-Type Embryonal Rhabdomyosarcoma,0
9975,AMACR wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
9976,Disease Grade 2,Cervical Fibroepithelial Polyp,0
9977,Edema,Mixed astrocytoma-ependymoma,0
9978,Lymphadenopathy,Peripheral primitive neuroectodermal tumor of soft tissue,0
9979,1950s,Pancreatic Intraepithelial Neoplasia-3,0
9980,Human Papillomavirus Positive,Melanomatosis,0
9981,Togo,Refractory Barrett Esophagus,0
9982,Wash (cleansing action),Blepharal carcinoma,0
9983,Tubal Ligation,Primary Cutaneous Plasmablastic Lymphoma,0
9984,Condition:Find:Pt:^Patient:Nom,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
9985,incidence of cases,Cerebral hemangioma,0
9986,Smudge Cell Count,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
9987,Due to,Astrocytoma of brain,0
9988,curettage specimen,Recurrent Uveal Melanoma,0
9989,10%,Vaginal Adenoma,0
9990,Classification,Type II Endometrial Adenocarcinoma,0
9991,per year,Vaginal Adenoid Cystic Carcinoma,0
9992,Mucinous Adenocarcinoma,Intraepithelial Melanocytic Hyperplasia,0
9993,Case unit dose,Recurrent Uveal Melanoma,0
9994,Subtype (attribute),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
9995,Occurrence Indicator,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
9996,Arising in,Vaginal Adenoid Cystic Carcinoma,0
9997,Including (qualifier),Basal Cell Ameloblastoma,0
9998,Face,Pancreatic carcinoma,0
9999,Females,Mucinous adenocarcinoma,0
10000,Continuance of life,Diffuse malignant mesothelioma,0
10001,Occurrence Indicator,Refractory Ependymoma,0
10002,SLC6A2 protein,Nasal cavity carcinoma,0
10003,Symptoms,mucinous adenocarcinoma of gallbladder,0
10004,Bayer Corneal Epitheliopathy Grade 3,Maxillary Sinus Adenocarcinoma,0
10005,Rare Diseases,Noninfiltrating Intraductal Carcinoma,0
10006,Specimen Source Codes - Tears,Childhood Central Nervous System Ganglioneuroblastoma,0
10007,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10008,Frequently,Refractory Glioma,0
10009,Teens,Human Papillomavirus-Related Carcinoma,0
10010,Red blood cells,Liver Cavernous Hemangioma,0
10011,65,Gallbladder Adenocarcinoma,0
10012,Keratoconjunctivitis Sicca,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10013,Hormonal Contraception,Chest Wall Fibromatosis,0
10014,United States,Stage IB Lung Cancer AJCC v7,0
10015,Red Blood Cell Count measurement,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10016,Tumor Mass,Metastatic Carcinoma in the Lung,0
10017,Cancer invasiveness,Non-Metastatic Gestational Trophoblastic Tumor,0
10018,Megakaryocytes,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10019,Stem of Organ,Cancer of Urinary Tract,0
10020,Administration occupational activities,Stage IV Colorectal Cancer AJCC v8,0
10021,Nicotiana tabacum,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10022,1000000,sarcoma of spinal cord,0
10023,chapter,Werner Syndrome,0
10024,Process (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
10025,Treating,Carcinoma of urinary bladder,0
10026,Trauma,Stage 0 Penile Cancer AJCC v8,0
10027,More,Engraftment syndrome,0
10028,Sarcoma,Primary Cutaneous Plasmablastic Lymphoma,0
10029,Malignant - descriptor,Type II Endometrial Adenocarcinoma,0
10030,Practice Experience,Fibroadenoma of breast,0
10031,Surgery specialty,Cystadenocarcinoma,0
10032,Occur (action),Breast Ductal Adenoma,0
10033,Pleurodesis,Undifferentiated Endocervical Sarcoma,0
10034,Histologic type,Thyroid Hurthle Cell Carcinoma,0
10035,High Mitosis-Karyorrhexis Index,Stage IB Pancreatic Cancer AJCC v8,0
10036,Original Regulatory Submission,Xeroderma pigmentosum,0
10037,Act Class - review,Stage IB Lung Cancer AJCC v7,0
10038,Anatomic structures,Blood Vessel Tumors,0
10039,Parotid Gland,Brain Tumor,0
10040,Lead,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10041,Biomaterial Treatment,Chronic Myelomonocytic Leukemia-2,0
10042,Increased,Type II Endometrial Adenocarcinoma,0
10043,Qualitative form,Hereditary Diffuse Gastric Adenocarcinoma,0
10044,How Much Nausea During This Period,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10045,Average of Value Derivation Technique,Pancreatic Intraepithelial Neoplasia-3,0
10046,Usual,Carcinoma of urinary bladder,0
10047,Exposure to,Small Intestinal Villous Adenoma,0
10048,Manufactured form,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10049,shared attribute,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10050,Formation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10051,Alteration,Tonsillar Carcinoma,0
10052,West Haven Hepatic Encephalopathy Grade 3,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
10053,Carcinoma,Deep Leiomyoma,0
10054,Tumor grade G3,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10055,Removing (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10056,Common Specifications in HL7 V3 Publishing,Refractory Ependymoma,0
10057,Occur (action),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10058,65,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10059,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10060,Malignant Vaginal Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
10061,European race,Vaginal Adenoid Cystic Carcinoma,0
10062,CD69 protein,Hereditary Diffuse Gastric Adenocarcinoma,0
10063,Contain (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10064,site-specific telomere resolvase activity,Peripheral primitive neuroectodermal tumor of soft tissue,0
10065,Benign,Fibroadenoma of breast,0
10066,Usual,Breast Ductal Adenoma,0
10067,Approach,Splenic Manifestation of Hairy Cell Leukemia,0
10068,chance,Ovarian germ cell choriocarcinoma stage IV,0
10069,Basin,Recurrent Testicular Lymphoma,0
10070,metaplastic cell transformation,Extracranial Neuroblastoma,0
10071,SHORT STATURE,Larynx carcinoma recurrent,0
10072,Body part,Nasal cavity carcinoma,0
10073,Problems - What subject filter,Parathyroid Gland Adenocarcinoma,0
10074,Publishing,Clonal Hematopoiesis of Indeterminate Potential,0
10075,Etiology aspects,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
10076,Smaller,Stage IB Pancreatic Cancer AJCC v8,0
10077,Biomaterial Treatment,Metastatic Carcinoma in the Lung,0
10078,Characteristics,adenoid cystic carcinoma of lung,0
10079,General surgery specialty,Lung Inflammatory Myofibroblastic Tumor,0
10080,Benign Vascular Neoplasm,clear cell adenocarcinoma of gallbladder,0
10081,Image Feature,Medulloblastoma,0
10082,Age of Onset,Pancreatic carcinoma,0
10083,Nine,Type II Endometrial Adenocarcinoma,0
10084,Subacute,Maxillary Sinus Adenocarcinoma,0
10085,Sequence Data Type,Uterine Cancer,0
10086,Both ovaries,Localized Askin Tumor,0
10087,Human body,Refractory Ependymoma,0
10088,Given name,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10089,How Much Distress Weight Loss,Nasal cavity carcinoma,0
10090,Yellow color,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10091,Occurrence,Type II Endometrial Adenocarcinoma,0
10092,European race,Metastatic Ductal Breast Carcinoma,0
10093,Negation,embryonal rhabdomyosarcoma of prostate,0
10094,More,Stage III Cutaneous Melanoma AJCC v6,0
10095,Including (qualifier),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10096,70%,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10097,Classification,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10098,Orbital region,Acantholytic squamous cell carcinoma,0
10099,Sex Cord-Stromal Tumor,Refractory Bladder Carcinoma,0
10100,Vomiting,Refractory Barrett Esophagus,0
10101,Specimen Source Codes - Respiratory,FIGO Stage II Ovarian Cancer,0
10102,Rest,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
10103,Plasma Cells,Engraftment syndrome,0
10104,Carcinomatosis,Multiple Skull Base Meningiomas,0
10105,Process,Mastocytosis,0
10106,Mathematical Factor,Locally Advanced Soft Tissue Sarcoma,0
10107,growth aspects,Heavy Chain Deposition Disease,0
10108,Due to,Stage IB Pancreatic Cancer AJCC v8,0
10109,Formation,Benign Carotid Body Paraganglioma,0
10110,Monocyte count result,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10111,Breast collecting duct,Cancer of Urinary Tract,0
10112,Mechanism Component of Device,Breast Ductal Adenoma,0
10113,C-KIT Gene,Diffuse malignant mesothelioma,0
10114,Quantity,Intraepithelial Melanocytic Hyperplasia,0
10115,Never (frequency),Clonal Hematopoiesis of Indeterminate Potential,0
10116,Death (finding),Adenocarcinoma of the prostate metastatic,0
10117,Neoplastic disease,Keratoderma,0
10118,Country number:Find:Pt:^Patient:Nom,Childhood Thyroid Gland Follicular Carcinoma,0
10119,Include (action),Serous cystadenocarcinoma ovary,0
10120,Anemia,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10121,Base - General Qualifier,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10122,Known,Uterine Cancer,0
10123,Disease Screening,Hodgkin Disease,0
10124,Testiculo-,Unicystic ameloblastoma,0
10125,To,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10126,Asia,Localized Askin Tumor,0
10127,Cancer Genus,Malignant neoplasm of choroid,0
10128,lymph nodes,Diffuse malignant mesothelioma,0
10129,Africa,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10130,Five,Atypical Mesothelial Hyperplasia,0
10131,Mass of pancreas,Kaposi's sarcoma of extrahepatic bile duct,0
10132,Pediatric Neoplasm,embryonal rhabdomyosarcoma of prostate,0
10133,seen,Chronic Myelomonocytic Leukemia-2,0
10134,Surface,Acute Undifferentiated Leukemia,0
10135,Chest wall structure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10136,Vascular,Gallbladder Adenocarcinoma,0
10137,Symptoms aspect,Nasal cavity carcinoma,0
10138,Study Control,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
10139,In Blood,Digestive System Hodgkin Lymphoma,0
10140,African American,Recurrent Primary Lymphoma of Bone,0
10141,More,Spongiotic dermatitis,0
10142,Tissue of central nervous system,Benign Ovarian Thecoma,0
10143,Chemotherapy,Benign tumor of eyelid,0
10144,Togo,Female Breast Carcinoma,0
10145,Labrador retriever,Malignant neoplasm of thalamus,0
10146,status - In progress,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10147,Abnormal cell,Larynx carcinoma recurrent,0
10148,Severe (severity modifier),Human Papillomavirus-Related Carcinoma,0
10149,per second,Type II Endometrial Adenocarcinoma,0
10150,Decrease,Cerebral Primitive Neuroectodermal Tumor,0
10151,Diagnostic Imaging,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10152,Slow Growing,Carcinoma of urinary bladder,0
10153,Substance amount,Pancreatic carcinoma,0
10154,Smear - instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10155,Type A,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10156,Classes - encounter,Congenital hamartoma,0
10157,Measles virus genotype D1,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10158,Spreading (qualifier value),Lipoma of small intestine,0
10159,Pharmacotherapy,Vaginal Adenoid Cystic Carcinoma,0
10160,Preventive intent,Anterior Urethral Malignant Neoplasm,0
10161,Medulloblastoma,Benign squamous cell tumor,0
10162,Age,Recurrent Uveal Melanoma,0
10163,Bothered by Nausea,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10164,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Blepharal carcinoma,0
10165,Thin skin,Cerebral hemangioma,0
10166,Junctional,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10167,Relationships,Unresectable Rhabdomyosarcoma,0
10168,Including (qualifier),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10169,Secretory Vesicles,Basal Cell Ameloblastoma,0
10170,Lymphoma,Precursor B-lymphoblastic lymphoma stage II,0
10171,depend,Stage IV Penile Cancer AJCC v7,0
10172,Squamous cell carcinoma - category,Primary Cutaneous Plasmablastic Lymphoma,0
10173,Therapeutic procedure,Stage III Cutaneous Melanoma AJCC v6,0
10174,Decreased Immunologic Activity [PE],FIGO Stage II Ovarian Cancer,0
10175,Persons,embryonal rhabdomyosarcoma of prostate,0
10176,Treating,Metaplastic carcinoma of breast,0
10177,Smear - instruction imperative,Spermatocytic seminoma,0
10178,Linear,mucinous adenocarcinoma of gallbladder,0
10179,Painless,Refractory Ependymoma,0
10180,Detection,Liver Lymphangioma,0
10181,Benign,Malignant Testicular Sertoli Cell Tumor,0
10182,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10183,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10184,Thought,Extracranial Neuroblastoma,0
10185,Increasing,Kaposi's sarcoma of extrahepatic bile duct,0
10186,Telencephalon,Stage I Colon Neuroendocrine Tumor AJCC v8,0
10187,Biopsy,BRCA2 Syndrome,0
10188,Lower Extremity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10189,Others - Allergy,Uterine Cancer,0
10190,Goblet Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10191,Compresses (device),Neonatal leukemia,0
10192,Frequently,Benign neoplasm of eye,0
10193,What subject filter - Result,Stage IB Pancreatic Cancer AJCC v8,0
10194,Blink Reflexes,Digestive System Hodgkin Lymphoma,0
10195,Image Feature,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10196,Easy,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10197,Entity Determiner - specific,Engraftment syndrome,0
10198,Melanocytic nevus,Ichthyosis,0
10199,Acute lymphocytic leukemia,Small cell neuroendocrine carcinoma of bladder,0
10200,Symptoms,Testicular cancer metastatic,0
10201,Occurrence,FIGO Stage IVA Ovarian Cancer,0
10202,Occurrence Indicator,Acute Undifferentiated Leukemia,0
10203,International Statistical Classification of Diseases and Related Health Problems,Kaposi's sarcoma of extrahepatic bile duct,0
10204,Universal HL7CMETAttribution,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10205,<2 years,sarcoma of spinal cord,0
10206,Close,Carcinoma,0
10207,Borg Category-Ratio 10 Perceived Exertion Score 5,Gallbladder Adenocarcinoma,0
10208,Three,Pancreatic Intraepithelial Neoplasia-3,0
10209,Referring,Low Grade Squamous Intraepithelial Neoplasia,0
10210,Followed by,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10211,Advanced phase,Stage III Cutaneous Melanoma AJCC v6,0
10212,Colon <insect>,Clonal Hematopoiesis of Indeterminate Potential,0
10213,Urinary Bladder,Undifferentiated Endocervical Sarcoma,0
10214,Estimated,Stage 0 Penile Cancer AJCC v8,0
10215,Clinical Study Case,Benign Anal Granular Cell Tumor,0
10216,Drop Metastasis,Airway Hemangioma,0
10217,LINC01194 gene,Extra-abdominal fibromatosis,0
10218,Plumbum metallicum,Small cell neuroendocrine carcinoma of bladder,0
10219,National Academy of Sciences (U.S.),Kaposi's sarcoma of skin,0
10220,various antiinfectives and antiseptics for local oral treatment,Platinum-Resistant Lung Small Cell Carcinoma,0
10221,Well Differentiated,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10222,Frequently,Ichthyosis,0
10223,Adenocarcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10224,Area,Malignant Testicular Sertoli Cell Tumor,0
10225,Similarity,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10226,Others - Allergy,ROSE Cluster 3,0
10227,Bothered by Night Sweats,High Grade Glandular Intraepithelial Neoplasia,0
10228,Skin Pigmentation,ROSE Cluster 3,0
10229,Clonality,Pancreatic Intraepithelial Neoplasia-3,0
10230,Deterioration of status,Spongiotic dermatitis,0
10231,Contain (action),Non-Hodgkin Lymphoma During Pregnancy,0
10232,Surgery specialty,Type II Endometrial Adenocarcinoma,0
10233,Manufactured sign,Uterine Cancer,0
10234,To,Recurrent Uveal Melanoma,0
10235,PSA Level Less than Five,Nasal cavity carcinoma,0
10236,Abdomen,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10237,Eczema,Plexosarcoma,0
10238,Value Above Reference Range,Chondrosarcoma,0
10239,diagnosis aspect,Maxillary Sinus Adenocarcinoma,0
10240,Including (qualifier),Carcinoma of urinary bladder,0
10241,Characterization,Adult Alveolar Soft Part Sarcoma,0
10242,Risk,Diffuse malignant mesothelioma,0
10243,Homo sapiens,ICHTHYOSIS,0
10244,Walled,Splenic Manifestation of Hairy Cell Leukemia,0
10245,Larynx,Blood Vessel Tumors,0
10246,Surrounding (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
10247,Overall Survival,Unresectable Rhabdomyosarcoma,0
10248,Blood capillaries,Lung Mucinous Cystadenoma,0
10249,Racial group,Cartilaginous exostosis,0
10250,Negation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10251,Colorectal Cancer Pathway,Stage II Hepatocellular Carcinoma AJCC v8,0
10252,Tumor type,Astrocytoma of brain,0
10253,To,Metastatic Neoplasm to the Gallbladder,0
10254,35,Childhood Central Nervous System Ganglioneuroblastoma,0
10255,Contrast Media,Malignant Testicular Sertoli Cell Tumor,0
10256,Domain (area of knowledge),Digestive System Hodgkin Lymphoma,0
10257,Links List,Heavy Chain Deposition Disease,0
10258,Slow Growing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10259,70%,Spongiotic dermatitis,0
10260,Subtype (attribute),Benign Anal Granular Cell Tumor,0
10261,Oral region,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
10262,Qualitative form,Locally Advanced Squamous Cell Carcinoma,0
10263,Ancestry-Informative Marker,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10264,List,Breast Apocrine Adenoma,0
10265,Third,Anterior Urethral Malignant Neoplasm,0
10266,Spread by direct extension,Chondrosarcoma,0
10267,Common Specifications in HL7 V3 Publishing,Squamous cell carcinoma of lip,0
10268,Neuroectodermal Tumor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10269,Replaced by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10270,50%,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10271,Serum blood tests,Urethral Carcinoma,0
10272,Application Context,Malignant neoplasm of subglottis,0
10273,Carcinoma,Refractory Glioma,0
10274,Array Feature,Colorectal Neuroendocrine Tumor G2,0
10275,High Mitosis-Karyorrhexis Index,BRCA2 Syndrome,0
10276,Swallowing:-:Point in time:^Patient:-,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10277,Primary,Basal Cell Ameloblastoma,0
10278,Initially,Fibroadenoma of breast,0
10279,Tumor Mass,FIGO Stage II Ovarian Cancer,0
10280,Overall Publication Type,Benign tumor of eyelid,0
10281,Disease Outcome,Childhood Anaplastic Large Cell Lymphoma,0
10282,Source,Childhood Lung Non-Small Cell Carcinoma,0
10283,Urinary Diversion,Childhood Central Nervous System Ganglioneuroblastoma,0
10284,/40,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
10285,Spreading (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10286,American College of Cardiology/American Heart Association Lesion Complexity Score C,Intestinal Metaplasia of Bladder Urothelium,0
10287,90%,Uterine Cancer,0
10288,Increased risk,Kaposi's sarcoma of skin,0
10289,Taken,Recurrent Uveal Melanoma,0
10290,Diagnosis,embryonal rhabdomyosarcoma of prostate,0
10291,Carcinoid Tumor,Endometrial Small Cell Carcinoma,0
10292,Genus Homo,Basal Cell Ameloblastoma,0
10293,Treatment Epoch,Colorectal High Grade B-Cell Lymphoma,0
10294,Diabetes,Primary Cutaneous Plasmablastic Lymphoma,0
10295,depend,Nasal cavity carcinoma,0
10296,Cover (physical object),Angiosarcoma of liver,0
10297,Ninein,Uterine Cancer,0
10298,Bacterial Infections,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10299,At risk of infection,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10300,depend,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10301,How Much Distress Itching,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10302,Primary malignant neoplasm of endometrium,Placental aromatase deficiency,0
10303,structure,Adenocarcinoma of duodenum,0
10304,Rate,Granular Cell Leiomyosarcoma,0
10305,Phase,Pancreatic Endocrine Carcinoma,0
10306,Vaginal intraepithelial neoplasia,Diffuse malignant mesothelioma,0
10307,Part of,Endometrial Small Cell Carcinoma,0
10308,Presentation,FIGO Stage IVA Ovarian Cancer,0
10309,Administration procedure,Localized Ewing Sarcoma,0
10310,Frequently,Refractory Bladder Carcinoma,0
10311,prior radiation therapy,Granular Cell Leiomyosarcoma,0
10312,Packaging Case,Acinar cell carcinoma of pancreas,0
10313,Cosmetics,Adenocarcinoma of the prostate metastatic,0
10314,human epidermal growth factor,High Grade Glandular Intraepithelial Neoplasia,0
10315,International Classification of Diseases for Oncology,Stage IV Penile Cancer AJCC v7,0
10316,Numbers,Acute Undifferentiated Leukemia,0
10317,Hematopoietic Neoplasms,Tonsillar Carcinoma,0
10318,Top (position),Ovarian Carcinoid Tumor,0
10319,Body part,Undifferentiated Endocervical Sarcoma,0
10320,Asia,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10321,Include (action),Intraepithelial Melanocytic Hyperplasia,0
10322,Childbirth,Endometrial Small Cell Carcinoma,0
10323,growth aspects,Malignant Testicular Sertoli Cell Tumor,0
10324,Carcinoma of lung,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10325,Pleural effusion disorder,Platinum-Resistant Lung Small Cell Carcinoma,0
10326,Esophagus,Acantholytic squamous cell carcinoma,0
10327,Pigment cell,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10328,Fasting Status Indicator,Cerebral Primitive Neuroectodermal Tumor,0
10329,Both ovaries,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10330,2+,Airway Hemangioma,0
10331,Measurement,Angiosarcoma of liver,0
10332,Angioimmunoblastic Lymphadenopathy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10333,Fracture,Mucinous adenocarcinoma gastric,0
10334,Analysis,embryonal rhabdomyosarcoma of prostate,0
10335,1+,Benign neoplasm of eye,0
10336,combination of objects,Neonatal leukemia,0
10337,Togo,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10338,Major,Mucinous adenocarcinoma gastric,0
10339,Dorsal,Cerebral Primitive Neuroectodermal Tumor,0
10340,Source,Localized Askin Tumor,0
10341,Trial Screening,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10342,Cultured Cell Line,Stage IB Pancreatic Cancer AJCC v8,0
10343,Highest,Engraftment syndrome,0
10344,*Activity (kind of quantity),Placental aromatase deficiency,0
10345,Use of,Localized Askin Tumor,0
10346,Early,Cancer of Urinary Tract,0
10347,Body of penis,Mucinous adenocarcinoma gastric,0
10348,Qualitative form,Adult Hepatocellular Carcinoma,0
10349,Varies,Periosteal Osteosarcoma,0
10350,Syndrome,Engraftment syndrome,0
10351,include - SetOperator,Gallbladder Adenocarcinoma,0
10352,European Medicines Agency,Breast Ductal Adenoma,0
10353,Covers (device),Metaplastic carcinoma of breast,0
10354,photoreactivating enzyme activity,Cerebral Primitive Neuroectodermal Tumor,0
10355,Increased,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10356,Child,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10357,Have Weight Loss,Stage IB Lung Cancer AJCC v7,0
10358,Death Related to Adverse Event,Stage II Carcinoma of Penis,0
10359,Manufactured form,Tonsillar Carcinoma,0
10360,Body part,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
10361,Male Gender,Acantholytic squamous cell carcinoma,0
10362,Thyroid Gland Follicular Adenoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10363,Overall Survival,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10364,Internal,Unicystic ameloblastoma,0
10365,sex,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10366,Cell secretion,Stage IB Pancreatic Cancer AJCC v8,0
10367,Ovulation,Metastatic Ductal Breast Carcinoma,0
10368,Turner Syndrome,Testicular cancer metastatic,0
10369,Feel Pain,Benign tumor of eyelid,0
10370,Sunglasses (physical object),papillary carcinoma of penis,0
10371,Common (qualifier value),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
10372,Vaginal,Small cell neuroendocrine carcinoma of bladder,0
10373,Occur (action),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
10374,Cancer Genus,Ichthyosis,0
10375,Abnormal result,Cerebral Primitive Neuroectodermal Tumor,0
10376,Small cell carcinoma of lung,Carcinoma,0
10377,Often - answer to question,Malignant neoplasm of subglottis,0
10378,Frequency,Medulloblastoma,0
10379,Cause of death.underlying,Neoplasms,0
10380,Body Fluids,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10381,Mesenchymal Stem Cells,Vaginal Adenoid Cystic Carcinoma,0
10382,<90,Stage IV Penile Cancer AJCC v7,0
10383,Type - attribute,Kaposi's sarcoma of skin,0
10384,Anemia,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10385,Ivory Coast,Xeroderma pigmentosum,0
10386,Central African Republic,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10387,Only - dosing instruction fragment,Acantholytic squamous cell carcinoma,0
10388,Hair follicle structure,Ichthyosis,0
10389,Malignant tumor of cervix,Metaplastic carcinoma of breast,0
10390,removal technique,Stage 0 Lip Carcinoma,0
10391,Often - answer to question,Spermatocytic seminoma,0
10392,Numbers,Malignant neoplasm of choroid,0
10393,Body tissue,Mucinous adenocarcinoma gastric,0
10394,Distant,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10395,Occurrence,Mucosal Melanoma,0
10396,Null cell,Prostate Lymphoma,0
10397,Occurrence,Brain Tumor,0
10398,Grade,Adrenal Rest Tumor,0
10399,Version,Locally Advanced Epithelioid Hemangioendothelioma,0
10400,Affecting,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10401,What subject filter - Result,Undifferentiated Neuroblastoma,0
10402,Diagnosis,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
10403,Manufactured form,Trabecular adenocarcinoma,0
10404,Pallor of skin,Stage III Cutaneous Melanoma AJCC v6,0
10405,Magnetic Resonance Imaging,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
10406,Skin Specimen,Cancer of Urinary Tract,0
10407,Major,Tonsillar Carcinoma,0
10408,Chemotherapy,Small cell neuroendocrine carcinoma of bladder,0
10409,Cell Differentiation process,Airway Hemangioma,0
10410,What subject filter - Result,Stage III Cutaneous Melanoma AJCC v6,0
10411,Usual Severity Vomiting,Trabecular adenocarcinoma,0
10412,regional,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10413,WHO Central Nervous System Grade I,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10414,Acute monocytic leukemia,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10415,majority,Cerebral Primitive Neuroectodermal Tumor,0
10416,N not otherwise specified Antibody,FIGO Stage II Ovarian Cancer,0
10417,Aspects of disease screening,Breast Ductal Adenoma,0
10418,Usual Severity Weight Loss,Brain Ependymoma,0
10419,Ultrasonics (sound),Mucinous adenocarcinoma gastric,0
10420,Approximate,Childhood Extragonadal Malignant Germ Cell Tumor,0
10421,Computed Tomography Study File,Mucinous adenocarcinoma gastric,0
10422,BRAF gene,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10423,In Blood,Necrotizing Funisitis,0
10424,Removed,Carcinomatosis of peritoneal cavity,0
10425,treatment - ActInformationManagementReason,Intestinal Metaplasia of Bladder Urothelium,0
10426,Tired,Benign squamous cell tumor,0
10427,Extreme Response,Pancreatic Intraepithelial Neoplasia-3,0
10428,Body structure,non-Hodgkin's lymphoma of spleen,0
10429,Skin tanning,Breast Ductal Adenoma,0
10430,Geographic Locations,clear cell adenocarcinoma of gallbladder,0
10431,Prior Chemotherapy,Endometrial Small Cell Carcinoma,0
10432,Bladder Neoplasm,Pilocytic astrocytoma of cerebellum,0
10433,X-linked inheritance,Stage IV Colorectal Cancer AJCC v8,0
10434,Include (action),Adenocarcinoma,0
10435,Group A (blood group),Epithelioid Sarcoma NCI Grade 3,0
10436,BRCA2 gene,papillary carcinoma of penis,0
10437,Subgroup A Nepoviruses,Unicystic ameloblastoma,0
10438,Tryptophanase,Digestive System Hodgkin Lymphoma,0
10439,Index,benign mature teratoma of pancreas,0
10440,10 days,Cerebral Primitive Neuroectodermal Tumor,0
10441,Agent,Recurrent Testicular Lymphoma,0
10442,risk factors - observation list,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10443,Relate - vinyl resin,Localized Ewing Sarcoma,0
10444,Middle Age,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10445,Fibrosis,Melanomatosis,0
10446,Equus caballus,Refractory WHO Grade III Glioma,0
10447,Occurrence Indicator,Stage IV Colorectal Cancer AJCC v8,0
10448,Often - answer to question,Stage IB Pancreatic Cancer AJCC v8,0
10449,Part Dosing Unit,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10450,23,Peripheral primitive neuroectodermal tumor of soft tissue,0
10451,Value Above Reference Range,Astrocytoma of brain,0
10452,Form:Finding:Point in time:{Setting}:Document:{Role},Childhood Central Nervous System Ganglioneuroblastoma,0
10453,Frequently,Thymic Clear Cell Carcinoma,0
10454,Diagnosis,Advanced Lung Carcinoma,0
10455,Adult,Acute Undifferentiated Leukemia,0
10456,Known,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
10457,How Much Distress Vomiting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10458,Embryonic Development,Hereditary Diffuse Gastric Adenocarcinoma,0
10459,Sharing (Social Behavior),Neoplasms,0
10460,Abnormal Reference Range,Pancreatic Endocrine Carcinoma,0
10461,Primary,Angiosarcoma of liver,0
10462,Body part,FIGO Stage II Ovarian Cancer,0
10463,High probability,Primary Cutaneous Plasmablastic Lymphoma,0
10464,Collection (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
10465,Diagnostic Neoplasm Staging,Locally Advanced Squamous Cell Carcinoma,0
10466,common types,Neoplasms,0
10467,Diagnosis Study,Clinical Stage I Cutaneous Melanoma AJCC v8,0
10468,Gastrointestinal Neoplasms,Pancreatic Endocrine Carcinoma,0
10469,Numbers,Adult Hepatocellular Carcinoma,0
10470,seen,Blood Vessel Tumors,0
10471,Arytenoid Cartilage,Melanomatosis,0
10472,Associated with,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10473,Progress,Metastatic Kidney Carcinoma,0
10474,Cyperus papyrus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10475,Night time,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
10476,Oral region,Human Papillomavirus-Related Carcinoma,0
10477,Does jump,Undifferentiated Neuroblastoma,0
10478,Contain (action),Recurrent Uveal Melanoma,0
10479,Tissue Specimen Code,Female Breast Carcinoma,0
10480,Blood,Benign neoplasm of eye,0
10481,Historical aspects qualifier,mucinous adenocarcinoma of gallbladder,0
10482,Malignant Neoplasms,Stage IB Lung Cancer AJCC v7,0
10483,Benign,Cartilaginous exostosis,0
10484,Occurrence,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10485,Present,Cervical Squamous Intraepithelial Neoplasia,0
10486,Patient Discharge,Type II Endometrial Adenocarcinoma,0
10487,Aspects of disease screening,Platinum-Resistant Lung Small Cell Carcinoma,0
10488,Removed,Papillary cystic tumor,0
10489,Personal Contact,Cancer of Urinary Tract,0
10490,Requirement,Undifferentiated Neuroblastoma,0
10491,Affecting,FIGO Stage II Ovarian Cancer,0
10492,aggressive cancer,Benign tumor of eyelid,0
10493,Increased risk,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10494,survival aspects,Maxillary Sinus Adenoid Cystic Carcinoma,0
10495,Fever symptoms (finding),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10496,Numbers,Childhood Central Nervous System Ganglioneuroblastoma,0
10497,Location,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10498,Mathematical Factor,Cervical Fibroepithelial Polyp,0
10499,status - In progress,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10500,Statistical Prevalence,Peripheral primitive neuroectodermal tumor of soft tissue,0
10501,Males,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
10502,Visual,Childhood Thyroid Gland Follicular Carcinoma,0
10503,Methods,Astrocytoma of brain,0
10504,Occurrence,Pilocytic astrocytoma of cerebellum,0
10505,Bowen's Disease,Xeroderma pigmentosum,0
10506,Low Level,FIGO Stage II Ovarian Cancer,0
10507,One,Metaplastic carcinoma of breast,0
10508,Thoracic Duct,Adenocarcinoma,0
10509,Largest,Type II Endometrial Adenocarcinoma,0
10510,NCI CTEP SDC Melanoma Sub-Category Terminology,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10511,Metastatic Neoplasm,Cerebral Primitive Neuroectodermal Tumor,0
10512,curative treatment,Human Papillomavirus-Related Carcinoma,0
10513,Sensory organ,Malignant melanoma of eyelid,0
10514,Diagnosis Study,Liver Lymphangioma,0
10515,Oral,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10516,Mantle Zone,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10517,Leads (device),Clinical Stage I Cutaneous Melanoma AJCC v8,0
10518,IgY,Cerebral hemangioma,0
10519,Vagina Carcinoma,Carcinomatosis of peritoneal cavity,0
10520,Patient need for (contextual qualifier),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10521,Northern Europe,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10522,Swollen Lymph Node,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10523,Target,Thymic Clear Cell Carcinoma,0
10524,Specific qualifier value,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10525,Egg of order Phthiraptera,Cancer of Urinary Tract,0
10526,Body tissue,Locally Advanced Carcinoma,0
10527,N not otherwise specified Antibody,FIGO Stage II Ovarian Cancer,0
10528,Discharge,Carcinoma ex pleomorphic adenoma of parotid gland,0
10529,Disease,Fibroadenoma of breast,0
10530,Limited (extensiveness),Hereditary Diffuse Gastric Adenocarcinoma,0
10531,Ulcer,Blepharal carcinoma,0
10532,Tobacco smoking behavior,Adult Alveolar Soft Part Sarcoma,0
10533,Present,Testicular cancer metastatic,0
10534,Specific qualifier value,Tonsillar Carcinoma,0
10535,Prominent,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10536,Itchiness,adenosquamous carcinoma of breast,0
10537,Malignant Neoplasms,Xeroderma pigmentosum,0
10538,Primary operation,Childhood Fibrillary Astrocytoma,0
10539,Poor - qualifier,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
10540,Proteins,Malignant melanoma of eyelid,0
10541,Blood group antibody I,Metaplastic carcinoma of breast,0
10542,Referring,Adult Acute Eosinophilic Leukemia,0
10543,Mathematical Operator,Thyroid Hurthle Cell Carcinoma,0
10544,Tryptophanase,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10545,Administrative Division,Thymic Clear Cell Carcinoma,0
10546,United States Military Commissioned Officer O4,Breast Ductal Adenoma,0
10547,Type A,Stage IB Pancreatic Cancer AJCC v8,0
10548,Extremely Agree,Urethral Carcinoma,0
10549,Africa,Gallbladder adenoma,0
10550,Bone structure of cranium,Engraftment syndrome,0
10551,Spreading (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
10552,Copy (object),Liver Lymphangioma,0
10553,Linear,Undifferentiated Neuroblastoma,0
10554,Location of Pharyngeal Residue Following Swallowing,Bladder squamous cell carcinoma stage I,0
10555,Screening Study,Intraepithelial Melanocytic Hyperplasia,0
10556,New,squamous cell carcinoma of the thyroid gland,0
10557,Very rare,Maxillary Sinus Adenocarcinoma,0
10558,Benign,Childhood Fibrillary Astrocytoma,0
10559,Large blood vessel structure,Pancreatic carcinoma,0
10560,Death (finding),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10561,Biologic Development,Childhood Lymphoma,0
10562,Buildup,Melanomatosis,0
10563,90%,Carcinoma ex pleomorphic adenoma of parotid gland,0
10564,Age at diagnosis,papillary carcinoma of penis,0
10565,Sarcoma,Intraepithelial Melanocytic Hyperplasia,0
10566,per year,Benign tumor of eyelid,0
10567,Neoplasm Metastasis,Malignant Testicular Sertoli Cell Tumor,0
10568,Catalogs,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10569,Precipitating Factors,Blood Vessel Tumors,0
10570,Metabolic Syndrome X,Pancreatic carcinoma,0
10571,Two,Cervical Fibroepithelial Polyp,0
10572,Type A,Bladder squamous cell carcinoma stage I,0
10573,Period (temporal qualifier),Peripheral primitive neuroectodermal tumor of soft tissue,0
10574,Lesion of breast,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
10575,Togo,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10576,Reduced,Recurrent Testicular Lymphoma,0
10577,High Risk Acute Leukemia,Localized Askin Tumor,0
10578,More,Vaginal Adenoma,0
10579,Synonym,Kaposi's sarcoma of extrahepatic bile duct,0
10580,Bathing,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10581,High Grade Ovarian Serous Adenocarcinoma,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10582,Histology Procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10583,Cartilaginous exostosis,Stage III Cutaneous Melanoma AJCC v6,0
10584,Targeted Therapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10585,Alternative,Adenocarcinoma of duodenum,0
10586,Beginning,Carcinoma of submandibular gland,0
10587,Base - General Qualifier,Nasal cavity carcinoma,0
10588,Pharmaceutical Preparations,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10589,Possible diagnosis,Cartilaginous exostosis,0
10590,Thickened,Bladder squamous cell carcinoma stage I,0
10591,Affecting,Testicular cancer metastatic,0
10592,Biomaterial Treatment,Cervical Squamous Intraepithelial Neoplasia,0
10593,Life Threatening or Disabling Adverse Event,Intestinal Metaplasia of Bladder Urothelium,0
10594,include - SetOperator,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10595,Taxonomic,Adrenal Rest Tumor,0
10596,Frequently,Splenic Manifestation of Hairy Cell Leukemia,0
10597,Infection,Angiosarcoma of liver,0
10598,Qualitative form,Vaginal Adenoma,0
10599,Surrounding (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10600,Pharyngeal structure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10601,Reverse,Malignant neoplasm of choroid,0
10602,Mechanism (attribute),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10603,Y protein,Childhood Lung Non-Small Cell Carcinoma,0
10604,Known,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10605,year,Stage I Adult Non-Hodgkin Lymphoma,0
10606,Low Mitosis-Karyorrhexis Index,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10607,Lacking,Low Grade Squamous Intraepithelial Neoplasia,0
10608,Negation,Vaginal Adenoma,0
10609,Contents,Liver Lymphangioma,0
10610,Histamine Release,Brain Tumor,0
10611,Lower urinary tract infectious disease,Rhabdomyosarcoma with ganglionic differentiation,0
10612,Series,Carcinoma of urinary bladder,0
10613,Secondary Neoplasm,Acute lymphadenitis,0
10614,Esophagus,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10615,How Often Weight Loss,Refractory Barrett Esophagus,0
10616,Gland,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10617,Lymphoid Tissue,Refractory Ependymoma,0
10618,Dependent for bathing,Mucinous adenocarcinoma,0
10619,Clinical Study Case,Splenic Manifestation of Hairy Cell Leukemia,0
10620,Unmarried,Localized Ewing Sarcoma,0
10621,Teratoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10622,Oxygen,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
10623,Treating,Anterior Urethral Malignant Neoplasm,0
10624,Specimen Type - Macrophages,Malignant Neoplasm of Lung - Multiple Primary Sites,0
10625,Prominent,Peripheral primitive neuroectodermal tumor of soft tissue,0
10626,Progress,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10627,Thymus Gland,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10628,Etiology aspects,Carcinomatosis of peritoneal cavity,0
10629,Hair follicle structure,Uterine Cancer,0
10630,Characteristics,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10631,Surgical service,Hyperplasia of pituitary gland,0
10632,Ultrasonography,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10633,ITGBL1 gene,Cervical Squamous Intraepithelial Neoplasia,0
10634,VARIOUS DRUG CLASSES IN ATC,Recurrent Testicular Lymphoma,0
10635,Known,Spongiotic dermatitis,0
10636,Tumor type,Heavy Chain Deposition Disease,0
10637,Pediculus (eukaryote),Childhood Fibrillary Astrocytoma,0
10638,Feature,Gallbladder Adenocarcinoma,0
10639,To,Metaplastic carcinoma of breast,0
10640,Cells,Ectomesenchymal Chondromyxoid Tumor,0
10641,Categories,Locally Advanced Squamous Cell Carcinoma,0
10642,Probably,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10643,Hematoxylin and eosin stain method,Pancreatic carcinoma,0
10644,Cancer Genus,Engraftment syndrome,0
10645,Known,Undifferentiated Neuroblastoma,0
10646,Basal Cell Carcinoma Pathway,Pilocytic astrocytoma of cerebellum,0
10647,Acid reflux SYMPTOMS,Periosteal Osteosarcoma,0
10648,Two,Astrocytoma of brain,0
10649,Primary,Cancer of Urinary Tract,0
10650,84,Cervical Squamous Intraepithelial Neoplasia,0
10651,Skeletal bone,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
10652,Rule (guideline),Hereditary Diffuse Gastric Adenocarcinoma,0
10653,Volume 2,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
10654,Well Differentiated,Angiosarcoma of liver,0
10655,Symptoms aspect,Undifferentiated Endocervical Sarcoma,0
10656,1+ Score,Benign Anal Granular Cell Tumor,0
10657,To,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10658,Myelodysplastic-Myeloproliferative Diseases,Undifferentiated Endocervical Sarcoma,0
10659,Burkina Faso,Basal Cell Ameloblastoma,0
10660,Body part,Bladder squamous cell carcinoma stage I,0
10661,Anabolism,Plexosarcoma,0
10662,Rare,Refractory Ependymoma,0
10663,Cancer Genus,Intestinal Metaplasia of Bladder Urothelium,0
10664,Smear - instruction imperative,Cartilaginous exostosis,0
10665,Much,Benign Carotid Body Paraganglioma,0
10666,Common (qualifier value),Thymic Clear Cell Carcinoma,0
10667,Large,Bladder squamous cell carcinoma stage I,0
10668,include - SetOperator,adenosquamous carcinoma of breast,0
10669,Pruritus,adenoid cystic carcinoma of lung,0
10670,Drain number:ID:Pt:^Patient:Nom,Neonatal leukemia,0
10671,Africa,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10672,Term Birth,Locally Advanced Squamous Cell Carcinoma,0
10673,Use of,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10674,Young Adult,Small cell neuroendocrine carcinoma of bladder,0
10675,Different,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10676,Common Specifications in HL7 V3 Publishing,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
10677,Approximate,Thymoma malignant recurrent,0
10678,100%,Intraepithelial Melanocytic Hyperplasia,0
10679,Malignant Neoplasms,Benign Anal Granular Cell Tumor,0
10680,shared attribute,Benign Apocrine Neoplasm,0
10681,Endocrine finding,Parathyroid Gland Adenocarcinoma,0
10682,Immune System Finding,Fibroadenoma of breast,0
10683,World,Epithelioid Sarcoma NCI Grade 3,0
10684,Lymphocyte,Chronic Myelomonocytic Leukemia-2,0
10685,CDISC SDTM Procedure Terminology,Cervical Fibroepithelial Polyp,0
10686,Containing (qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10687,Body part,Lipoma of small intestine,0
10688,Caucasians,Engraftment syndrome,0
10689,Term (lexical),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10690,Most,Locally Advanced Squamous Cell Carcinoma,0
10691,More,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10692,year,Pancreatic carcinoma,0
10693,Epithelial Cells,Stage IB Lung Cancer AJCC v7,0
10694,Genus Homo,Grade 3a Malignant Neoplasm,0
10695,What subject filter - Result,Metastatic Malignant Neoplasm in the Sellar Region,0
10696,Cervical lymph node group,Neonatal leukemia,0
10697,removal technique,Adult Anaplastic Oligodendroglioma,0
10698,Reduced,Advanced Uterine Corpus Carcinosarcoma,0
10699,Therapy Object (animal model),Kaposi's sarcoma of skin,0
10700,Malignant Childhood Neoplasm,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10701,Function Axis,Childhood Cerebellar Neoplasm,0
10702,Take,Cerebral Primitive Neuroectodermal Tumor,0
10703,Usual,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10704,Frequency of Pain Question,Kaposi's sarcoma of skin,0
10705,Olfactory organ,Metaplastic carcinoma of breast,0
10706,Analysis of substances,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10707,Involvement with,Blepharal carcinoma,0
10708,Enlargement procedure,Metastatic Carcinoma in the Lung,0
10709,Pelvic cavity structure,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10710,Areas <moth>,Acantholytic squamous cell carcinoma,0
10711,Electromagnetic Radiation,Microcystic meningioma,0
10712,Diagnosis Study,Colorectal cancer,0
10713,Therapeutic radiology procedure,Ovarian Carcinoid Tumor,0
10714,Breast Feeding,Nasal cavity carcinoma,0
10715,Skin Erosion,Engraftment syndrome,0
10716,Milliampere second,Unicystic ameloblastoma,0
10717,Females,Mucinous adenocarcinoma gastric,0
10718,Provide (product),Cerebral hemangioma,0
10719,Neoplastic Glandular Cell,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10720,Urinary tract infection,Tonsillar Carcinoma,0
10721,Experimental Result,Thymic Clear Cell Carcinoma,0
10722,Human Cells,Recurrent Primary Lymphoma of Bone,0
10723,Type A,FIGO Stage IVA Ovarian Cancer,0
10724,depend,Bladder adenocarcinoma stage IV,0
10725,various antiinfectives and antiseptics for local oral treatment,Female Breast Carcinoma,0
10726,Levels (qualifier value),Localized Malignant Neoplasm,0
10727,Associated topography,Kaposi's sarcoma of extrahepatic bile duct,0
10728,Mass of body region,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10729,unknown vaccine or immune globulin,Astrocytoma of brain,0
10730,Experimental Result,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10731,combination - answer to question,Uterine Cancer,0
10732,Fever,mucinous adenocarcinoma of gallbladder,0
10733,development aspects,Adult Acute Eosinophilic Leukemia,0
10734,Epithelial ovarian cancer,Primary Cutaneous Plasmablastic Lymphoma,0
10735,Genetic Heterogeneity,Acantholytic squamous cell carcinoma,0
10736,Case unit dose,Cancer of Urinary Tract,0
10737,Death (finding),Occult Lung Adenosquamous Carcinoma,0
10738,Basis - conceptual entity,Melanomatosis,0
10739,Pediatrics,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
10740,Usual,Adult Acute Eosinophilic Leukemia,0
10741,More,Pancreatic Intraepithelial Neoplasia-3,0
10742,Singular,Diffuse malignant mesothelioma,0
10743,Vision,Stage III Adult Immunoblastic Lymphoma,0
10744,Brain,Endometrial Small Cell Carcinoma,0
10745,Literature,Recurrent Uveal Melanoma,0
10746,Common Specifications in HL7 V3 Publishing,Heavy Chain Deposition Disease,0
10747,Include (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
10748,Estimated,Angiosarcoma of liver,0
10749,One,FIGO Stage II Ovarian Cancer,0
10750,Most,Benign neoplasm of thorax,0
10751,Risk,Choroid Necrotic Melanoma,0
10752,Symptom severity level,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10753,Adolescent (age group),Maxillary Sinus Adenocarcinoma,0
10754,Known,Intracortical osteosarcoma,0
10755,Organ,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10756,depend,Recurrent Uveal Melanoma,0
10757,Spongiosis,Testicular cancer metastatic,0
10758,High risk of,Acute Undifferentiated Leukemia,0
10759,Benign Vascular Neoplasm,Angiosarcoma of liver,0
10760,Affecting,Xeroderma pigmentosum,0
10761,Disease,Splenic Manifestation of Hairy Cell Leukemia,0
10762,High Grade Ovarian Serous Adenocarcinoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
10763,Symptoms,Angiosarcoma of liver,0
10764,Base - General Qualifier,Werner Syndrome,0
10765,Thyroid carcinoma,Malignant neoplasm of gallbladder,0
10766,Tired,Metastatic Malignant Neoplasm in the Sellar Region,0
10767,Including (qualifier),Ovarian Dermoid Cyst with Secondary Carcinoma,0
10768,Infrequent,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
10769,Intestinal Obstruction,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
10770,Over (spatial),Mucinous adenocarcinoma gastric,0
10771,Moon,Stage III Adult Immunoblastic Lymphoma,0
10772,Cessation of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10773,Cancer Genus,Benign tumor of eyelid,0
10774,Symptoms aspect,Spindle Cell Melanoma,0
10775,Genes,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10776,Neoplasms,Squamous cell carcinoma of lip,0
10777,Architecture,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
10778,35,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10779,Disease,Periosteal Osteosarcoma,0
10780,Case (situation),Precursor B-lymphoblastic lymphoma stage II,0
10781,Lower lip structure,Endometrial Small Cell Carcinoma,0
10782,Smear - instruction imperative,Acantholytic squamous cell carcinoma,0
10783,Body tissue,Hyperplasia of pituitary gland,0
10784,Intestines,Ichthyosis,0
10785,Extent of disease,Adult Acute Eosinophilic Leukemia,0
10786,How Much Nausea During This Period,Fourth Ventricle and Brain Stem Ependymal Tumor,0
10787,Common Specifications in HL7 V3 Publishing,Bladder adenocarcinoma stage IV,0
10788,Treating,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10789,parent,Digestive System Hodgkin Lymphoma,0
10790,1+,Chest Wall Fibromatosis,0
10791,/40,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10792,Negative Surgical Margin,Fibroadenoma of breast,0
10793,What subject filter - Result,Malignant Testicular Sertoli Cell Tumor,0
10794,Long,Malignant melanoma of eyelid,0
10795,leukemia,Localized Malignant Neoplasm,0
10796,Spreading (qualifier value),malignant lymphoma of pancreatic lymph nodes,0
10797,Type A,Malignant neoplasm of subglottis,0
10798,alone - group size,Engraftment syndrome,0
10799,High,Fibroadenoma of breast,0
10800,Less Than,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10801,photoreactivating enzyme activity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10802,Form of uterus,Neoplasms,0
10803,Virilization,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10804,Malignant Neoplasms,Benign Anal Granular Cell Tumor,0
10805,Protein Turn,Female Breast Carcinoma,0
10806,Tumor cells,FIGO Stage II Ovarian Cancer,0
10807,Sore sensation,Metaplastic carcinoma of breast,0
10808,Reflux within Device Medical Device Problem,Liver Lymphangioma,0
10809,Persons,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10810,Epitopes,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10811,Reported Term,Bladder Neuroendocrine Neoplasm,0
10812,per year,Blepharal carcinoma,0
10813,Offspring,embryonal rhabdomyosarcoma of prostate,0
10814,Package Type Not Applicable,Liver Lymphangioma,0
10815,High risk of,Giant cell angiofibroma,0
10816,Malignant Neoplasms,Uterine Cancer,0
10817,Exposure to radiation,Recurrent Uveal Melanoma,0
10818,Vestigium,Metastatic Lung Neuroendocrine Neoplasm,0
10819,lymph nodes,Stage III Cutaneous Melanoma AJCC v6,0
10820,Measuring ruler,Refractory Barrett Esophagus,0
10821,unknown vaccine or immune globulin,Recurrent Uveal Melanoma,0
10822,Hereditary,Serous cystadenocarcinoma ovary,0
10823,Near,Splenic Manifestation of Hairy Cell Leukemia,0
10824,Tumor Mass,Serous cystadenocarcinoma ovary,0
10825,PREVENT (product),Methotrexate-Associated Hodgkin Lymphoma,0
10826,therapeutic aspects,Diffuse malignant mesothelioma,0
10827,Person Name,Neonatal leukemia,0
10828,Transection (procedure),ROSE Cluster 3,0
10829,Result,Extra-abdominal fibromatosis,0
10830,Lower - spatial qualifier,non-Hodgkin's lymphoma of spleen,0
10831,90 - 100%,Brain Ependymoma,0
10832,therapeutic aspects,Pancreatic carcinoma,0
10833,Administration occupational activities,Hodgkin Disease,0
10834,Original,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
10835,Response (statement),Adult Hepatocellular Carcinoma,0
10836,Rate,Granular Cell Leiomyosarcoma,0
10837,Primary malignant neoplasm,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
10838,How Often Felt Normal question,Blood Vessel Tumors,0
10839,Fasting Status Indicator,Carcinoma ex pleomorphic adenoma of parotid gland,0
10840,Tumor site:Anat:Pt:Specimen:Nom,Hyperplasia of pituitary gland,0
10841,Circulatory Process,Unresectable Rhabdomyosarcoma,0
10842,Childhood Renal Cell Carcinoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
10843,Enteral Route of Drug Administration,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
10844,Back Pain,Endometrial Small Cell Carcinoma,0
10845,Natural History,Anaplastic large cell lymphoma,0
10846,Allergen (brand of diphenylpyraline),Cervical Squamous Intraepithelial Neoplasia,0
10847,Benign Neoplasm,Precursor B-lymphoblastic lymphoma stage II,0
10848,Ultraviolet Rays,sarcoma of spinal cord,0
10849,Erythropoiesis,Medulloblastoma,0
10850,Linear,Acute Undifferentiated Leukemia,0
10851,Gastric Adenocarcinoma,Airway Hemangioma,0
10852,Study,Adult Anaplastic Oligodendroglioma,0
10853,Scientific Control,Familial Adenomatous Polyposis Associated Medulloblastoma,0
10854,Unit of radiation dose,Intraepithelial Melanocytic Hyperplasia,0
10855,Greater,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
10856,treatment - ActInformationManagementReason,Familial Hemophagocytic Lymphocytosis,0
10857,prior radiation therapy,Medulloblastoma,0
10858,combination of objects,Intraepithelial Melanocytic Hyperplasia,0
10859,Recombinant Interleukins,Endometrial Small Cell Carcinoma,0
10860,therapeutic aspects,Recurrent Uveal Melanoma,0
10861,Count,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10862,Age,Blepharal carcinoma,0
10863,Etiology,Ovarian Dermoid Cyst with Secondary Carcinoma,0
10864,Deterioration of status,Squamous cell carcinoma of lip,0
10865,National Academy of Sciences (U.S.),Vaginal Adenoid Cystic Carcinoma,0
10866,Living Alone,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
10867,Others - Allergy,Stage 0 Lip Carcinoma,0
10868,North America,Acantholytic squamous cell carcinoma,0
10869,Cell Count,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10870,Classification,Digestive System Hodgkin Lymphoma,0
10871,Pressure- physical agent,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
10872,Change -- procedure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
10873,Persons,FIGO Stage IVA Ovarian Cancer,0
10874,Embryonal Neoplasm,Malignant neoplasm of olfactory nerve,0
10875,Upper arm,Nasal cavity carcinoma,0
10876,Cells,Cervical Squamous Intraepithelial Neoplasia,0
10877,Devices,Type II Endometrial Adenocarcinoma,0
10878,To,Chest Wall Fibromatosis,0
10879,Common (qualifier value),Pancreatic carcinoma,0
10880,Common (qualifier value),Benign Apocrine Neoplasm,0
10881,/40,Splenic Manifestation of Hairy Cell Leukemia,0
10882,Oral cavity,Benign squamous cell tumor,0
10883,Tumor Mass,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10884,Observation of color of skin,FIGO Stage IVA Ovarian Cancer,0
10885,Negation,Colorectal Neuroendocrine Tumor G2,0
10886,Make - Instruction Imperative,Stage II Carcinoma of Penis,0
10887,Multiplicative Product,Refractory Barrett Esophagus,0
10888,Infiltration,Localized Askin Tumor,0
10889,Occurrence,Testicular cancer metastatic,0
10890,Debris,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10891,Advanced phase,Noninfiltrating Intraductal Carcinoma,0
10892,Count of entities,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
10893,Occurrence,FIGO Stage IVA Ovarian Cancer,0
10894,30%,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10895,Call (Instruction),Carcinoma of urinary bladder,0
10896,Mechanism Component of Device,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
10897,CDISC SEND Body System Terminology,Cerebral Primitive Neuroectodermal Tumor,0
10898,Symptoms aspect,Intraepithelial Melanocytic Hyperplasia,0
10899,Patient Reported Outcome Stem,Xeroderma pigmentosum,0
10900,early disease,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10901,Secondary Neoplasm,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
10902,Administration procedure,Vaginal Adenoma,0
10903,Body tissue,Nasal cavity carcinoma,0
10904,Administration procedure,Stage III Adult Immunoblastic Lymphoma,0
10905,Speech Disorders,Liver Lymphangioma,0
10906,Data call receiving device,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
10907,Togo,Cervical Adenomyoma,0
10908,Present,Ichthyosis,0
10909,ethnic european,Neonatal leukemia,0
10910,Heart,Unfavorable Non-Hodgkin Lymphoma,0
10911,Occurrence,ICHTHYOSIS,0
10912,Occur (action),Lipoma of small intestine,0
10913,Less Than,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10914,shared attribute,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10915,First (number),Type II Endometrial Adenocarcinoma,0
10916,Histology:Find:Pt:Cancer.XXX:Nar,Mixed astrocytoma-ependymoma,0
10917,Surrounding (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10918,State,Maxillary Sinus Adenoid Cystic Carcinoma,0
10919,Neoplasm Metastasis,Hemangioma,0
10920,Genus Homo,Hodgkin lymphoma,0
10921,Chest pain:Finding:Point in time:^Patient:Ordinal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
10922,More,Leiomyoma of Gallbladder,0
10923,Tryptophanase,Malignant Testicular Sertoli Cell Tumor,0
10924,Facial edema,Fibroadenoma of breast,0
10925,biopsy characteristics,Giant cell angiofibroma,0
10926,Body tissue,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
10927,Slightly Agree,Bladder adenocarcinoma stage IV,0
10928,Include (action),Childhood Anaplastic Large Cell Lymphoma,0
10929,pathologic fistula,Tongue Alveolar Soft Part Sarcoma,0
10930,Most,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
10931,Glioblastoma Multiforme Pathway,Uterine Cancer,0
10932,Case (situation),Airway Hemangioma,0
10933,Well,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
10934,Intravascular line,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
10935,Further,Basal Cell Ameloblastoma,0
10936,Malignant - descriptor,Female Breast Carcinoma,0
10937,Speech,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
10938,Imaging Techniques,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
10939,Act Relationship Subset - previous,Stage II Carcinoma of Penis,0
10940,photograph,Heavy Chain Deposition Disease,0
10941,Head and neck structure,Extra-abdominal fibromatosis,0
10942,fibroblast proliferation,Bladder squamous cell carcinoma stage I,0
10943,immune system development,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
10944,Include (action),Secondary malignant neoplasm of lymph node,0
10945,MAPK1IP1L gene,Adult Acute Eosinophilic Leukemia,0
10946,Before,Serous cystadenocarcinoma ovary,0
10947,child survival,Stage III Adult Immunoblastic Lymphoma,0
10948,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Thymic Clear Cell Carcinoma,0
10949,Simpson Grade 3,Stage III Adult Immunoblastic Lymphoma,0
10950,Egg of order Phthiraptera,Mixed astrocytoma-ependymoma,0
10951,Pancreas,Mucinous neoplasm,0
10952,Body structure,Recurrent Testicular Lymphoma,0
10953,Iodides,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
10954,Geographic Locations,Small cell neuroendocrine carcinoma of bladder,0
10955,Appearance,Giant cell angiofibroma,0
10956,Urine for culture,Stage II Carcinoma of Penis,0
10957,Due to,Clonal Hematopoiesis of Indeterminate Potential,0
10958,treatment - ActInformationManagementReason,Mastocytosis,0
10959,Aplasia Cutis Congenita,Cerebral hemangioma,0
10960,Symptoms,Digestive System Hodgkin Lymphoma,0
10961,Laminar,Acute Undifferentiated Leukemia,0
10962,history (of) disease family,Astrocytoma of brain,0
10963,Present,Adenocarcinoma,0
10964,Head and neck structure,Stage III Cutaneous Melanoma AJCC v6,0
10965,Cancer Genus,Splenic Manifestation of Hairy Cell Leukemia,0
10966,Channel,Medulloblastoma,0
10967,Infective cystitis,Malignant neoplasm of subglottis,0
10968,Ovary,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10969,Mature,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
10970,Fertility,Carcinomatosis of peritoneal cavity,0
10971,Oligomeric Procyanidin Complex,Pancreatic carcinoma,0
10972,Slightly (qualifier value),Periosteal Osteosarcoma,0
10973,Tired,Human Papillomavirus-Related Carcinoma,0
10974,Two,Thymic Clear Cell Carcinoma,0
10975,Lymphocyte,Metastatic Carcinoma in the Lung,0
10976,Medical problem:Finding:Point in time:^Patient:Nominal,Microcystic meningioma,0
10977,Bone Marrow Cells,Methotrexate-Associated Hodgkin Lymphoma,0
10978,Overall,Blepharal carcinoma,0
10979,Endometrium,Clonal Hematopoiesis of Indeterminate Potential,0
10980,Persistent embryonic structure,Breast Ductal Adenoma,0
10981,Spreading (qualifier value),Gallbladder Adenocarcinoma,0
10982,Kidney,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
10983,Caucasoid Race,Human Papillomavirus-Related Carcinoma,0
10984,Top (position),Thyroid Hurthle Cell Carcinoma,0
10985,Young,Brain Tumor,0
10986,World,Funisitis (disorder),0
10987,Data Transformation,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
10988,Term (temporal),Liver Cavernous Hemangioma,0
10989,Thyroid Gland Follicular Cell,ROSE Cluster 3,0
10990,Tanning of leather,Botryoid-Type Embryonal Rhabdomyosarcoma,0
10991,Communicable Diseases,Non-Hodgkin Lymphoma During Pregnancy,0
10992,Glioma,Localized Askin Tumor,0
10993,PSA Level Less than Five,Contact dermatitis due to alkali,0
10994,Metastatic Neoplasm,Refractory Bladder Carcinoma,0
10995,Abundance,Localized Malignant Neoplasm,0
10996,Immunotherapy,mucinous adenocarcinoma of gallbladder,0
10997,Linear,Acute Undifferentiated Leukemia,0
10998,newly,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
10999,Symptoms,Hemangioma,0
11000,Appearance,Mucinous adenocarcinoma,0
11001,Body structure,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11002,Occurrence Indicator,Adult Fibrolamellar Carcinoma,0
11003,System - kit,Recurrent Primary Lymphoma of Bone,0
11004,High Mitosis-Karyorrhexis Index,Melanomatosis,0
11005,Malignant neoplasm of endometrium,Childhood Extragonadal Malignant Germ Cell Tumor,0
11006,Life threatening illness,Stage 0 Penile Cancer AJCC v8,0
11007,Pelvis+,Gallbladder Adenocarcinoma,0
11008,Rating (action),Mixed astrocytoma-ependymoma,0
11009,10%,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11010,Representation (action),Thyroid Hurthle Cell Carcinoma,0
11011,Form:Finding:Point in time:{Setting}:Document:{Role},Thymic Clear Cell Carcinoma,0
11012,Give - dosing instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11013,Males,Methotrexate-Associated Hodgkin Lymphoma,0
11014,Easy,Pilocytic astrocytoma of cerebellum,0
11015,Point Name,Chronic Myelomonocytic Leukemia-2,0
11016,Weight Loss,Gallbladder Adenocarcinoma,0
11017,therapeutic aspects,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
11018,Childbirth,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11019,More Often than Once a Day,Recurrent Uveal Melanoma,0
11020,Edit Action,Airway Hemangioma,0
11021,Infiltration (procedure),Unresectable Rhabdomyosarcoma,0
11022,Confirmed by,Blepharal carcinoma,0
11023,Leukocytes,Carcinoma of submandibular gland,0
11024,Coloring Excipient,Melanomatosis,0
11025,Persistent embryonic structure,Metastatic Carcinoma in the Lung,0
11026,Average,Benign Anal Granular Cell Tumor,0
11027,Twice - dosing instruction fragment,Extracranial Neuroblastoma,0
11028,Case (situation),gliosarcoma,0
11029,Income,Pancreatic carcinoma,0
11030,International Classification of Diseases for Oncology,Anterior Urethral Malignant Neoplasm,0
11031,biomedical tube device,Hyperplasia of pituitary gland,0
11032,Carcinoid Tumor,Ovarian Carcinoid Tumor,0
11033,IPSS Risk Category High,Adult Acute Eosinophilic Leukemia,0
11034,Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11035,unknown vaccine or immune globulin,Epithelioid Sarcoma NCI Grade 3,0
11036,Medications,High Grade Glandular Intraepithelial Neoplasia,0
11037,Spreading (qualifier value),Female Breast Carcinoma,0
11038,Age,Epithelioid Sarcoma NCI Grade 3,0
11039,Pigment cell,Acantholytic squamous cell carcinoma,0
11040,Cell Count,Cancer of Urinary Tract,0
11041,3+ Score,Pancreatic Endocrine Carcinoma,0
11042,Shapes,Tonsillar Carcinoma,0
11043,Abnormal result,Secondary malignant neoplasm of lymph node,0
11044,World,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11045,Occurrence Indicator,Squamous cell carcinoma of lip,0
11046,Major <insect>,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
11047,Cherubism,adenosquamous carcinoma of breast,0
11048,Specimen Source Codes - tumor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11049,More,Childhood Extragonadal Malignant Germ Cell Tumor,0
11050,CDISC SEND Tumor Findings Results Terminology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11051,Persons,Blepharal carcinoma,0
11052,Did not receive therapy or drug for,FIGO Stage IVA Ovarian Cancer,0
11053,History of previous events,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11054,Aim (idea),Carcinoma ex pleomorphic adenoma of parotid gland,0
11055,Acrospiroma,Grade 3a Malignant Neoplasm,0
11056,Treatment Epoch,Hereditary corneal dystrophy,0
11057,Vagina Carcinoma,Refractory Ependymoma,0
11058,Cessation of life,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11059,potential,Pancreatic carcinoma,0
11060,CDISC Relationship Class,Giant cell angiofibroma,0
11061,Abnormal Reference Range,Intraepithelial Melanocytic Hyperplasia,0
11062,Changing,Female Breast Carcinoma,0
11063,Mass of body region,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11064,Route,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11065,Neuroglia,Papillary squamous cell carcinoma,0
11066,Tryptophanase,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11067,Usual,Thyroid Hurthle Cell Carcinoma,0
11068,Intercellular edema,Extracranial Neuroblastoma,0
11069,Back Pain,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11070,Providing (action),Recurrent Primary Lymphoma of Bone,0
11071,Areas <moth>,Parathyroid Gland Adenocarcinoma,0
11072,Fatigue,squamous cell carcinoma of the thyroid gland,0
11073,Malignant Vaginal Neoplasm,Secondary malignant neoplasm of lymph node,0
11074,Hematologic Tests,Kaposi's sarcoma of skin,0
11075,Classification,Breast Ductal Adenoma,0
11076,site-specific telomere resolvase activity,Malignant Testicular Sertoli Cell Tumor,0
11077,Usually,Colorectal High Grade B-Cell Lymphoma,0
11078,Treating,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11079,100%,Spongiotic dermatitis,0
11080,Numbers,Carcinoma of submandibular gland,0
11081,Study,Cancer of Urinary Tract,0
11082,dendritic spine neck,Clonal Hematopoiesis of Indeterminate Potential,0
11083,Pharmaceutical Preparations,mucinous adenocarcinoma of gallbladder,0
11084,pharmacotherapeutic,Benign Anal Granular Cell Tumor,0
11085,Study Site,FIGO Stage II Ovarian Cancer,0
11086,Form of bone,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11087,Etiology aspects,Stage II Hepatocellular Carcinoma AJCC v8,0
11088,Vagina,FIGO Stage IVA Ovarian Cancer,0
11089,Does carry,Astrocytoma of brain,0
11090,Data (eukaryote),Sarcomatoid Renal Cell Carcinoma,0
11091,Call (Instruction),Type II Endometrial Adenocarcinoma,0
11092,Itchiness,Gallbladder Adenocarcinoma,0
11093,Similarity,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11094,Infiltration,Anterior Urethral Malignant Neoplasm,0
11095,Sequence Data Type,gliosarcoma,0
11096,Spreading (qualifier value),Neoplasms,0
11097,Patient observation,Heavy Chain Deposition Disease,0
11098,Nasal cartilage structure,Benign squamous cell tumor,0
11099,status - In progress,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11100,Treating,Human Papillomavirus-Related Carcinoma,0
11101,Frequently,Carcinomatosis of peritoneal cavity,0
11102,Glioblastoma,Hyperplasia of pituitary gland,0
11103,adnexal mass,Choroid Necrotic Melanoma,0
11104,Frequently,Cervical Squamous Intraepithelial Neoplasia,0
11105,Release - action (qualifier value),FIGO Stage IVA Ovarian Cancer,0
11106,Hematological Disease,FIGO Stage IVA Ovarian Cancer,0
11107,Prevalence aspects,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11108,Spleen,Human Papillomavirus-Related Carcinoma,0
11109,1+,gliosarcoma,0
11110,Macrophage Activation Syndrome,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
11111,Treated with,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11112,Closed,Stage III Cutaneous Melanoma AJCC v6,0
11113,shared attribute,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11114,Cell (compartment),Ichthyoses,0
11115,Bleeding tendency,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11116,Anterior portion of neck,Carcinoma of urinary bladder,0
11117,Type - attribute,Breast Ductal Adenoma,0
11118,National origin,Female Breast Carcinoma,0
11119,Thought,Adenocarcinoma,0
11120,First sign,Recurrent Testicular Lymphoma,0
11121,Initial Usage,Squamous cell carcinoma of lip,0
11122,Anorexia,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11123,Neuroglia,Recurrent Uveal Melanoma,0
11124,Tears - SpecimenType,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11125,Human body structure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11126,Xeroderma Pigmentosum,Childhood Central Nervous System Ganglioneuroblastoma,0
11127,Cure (remedy),Mucinous adenocarcinoma gastric,0
11128,Sequence Arm,Extra-abdominal fibromatosis,0
11129,Ovulation,Diffuse malignant mesothelioma,0
11130,One,Recurrent Rhabdomyosarcoma,0
11131,*Type - Kind of quantity,Basal Cell Ameloblastoma,0
11132,Thick,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11133,Abnormal cell,Localized Malignant Neoplasm,0
11134,+2,Maxillary Sinus Adenoid Cystic Carcinoma,0
11135,Chemotherapy,Locally Advanced Carcinoma,0
11136,Type A,Malignant Testicular Sertoli Cell Tumor,0
11137,Carcinoma of lung,Engraftment syndrome,0
11138,Test Result,FIGO Stage II Ovarian Cancer,0
11139,<3 (qualifier value),Cherubism,0
11140,Patients,Human Papillomavirus-Related Carcinoma,0
11141,Leaking,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11142,Feel Tired question,Secondary malignant neoplasm of lymph node,0
11143,Malignant Vaginal Neoplasm,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11144,Increased,Bladder adenocarcinoma stage IV,0
11145,Usually,Localized Askin Tumor,0
11146,Accessory,Carcinomatosis of peritoneal cavity,0
11147,PREVENT (product),FIGO Stage IVA Ovarian Cancer,0
11148,Intermediate Soft Tissue Tumor,Medulloblastoma,0
11149,VIPR1 wt Allele,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11150,Tissue of urinary bladder,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11151,Europe,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11152,Physical shape,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11153,Physical findings,Refractory Barrett Esophagus,0
11154,Function (attribute),Stage IV Childhood Non-Hodgkin Lymphoma,0
11155,Symptoms,Melanomatosis,0
11156,Adult Lymphoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11157,Entity Determiner - specific,Malignant melanoma of eyelid,0
11158,Male Phenotype,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
11159,Age,Thyroid Hurthle Cell Carcinoma,0
11160,Characterization,Atypical Lobular Breast Hyperplasia,0
11161,Myelodysplastic Syndrome,Peripheral primitive neuroectodermal tumor of soft tissue,0
11162,Morphology,Anterior Urethral Malignant Neoplasm,0
11163,Thinking,Benign Anal Granular Cell Tumor,0
11164,Central Nervous System,Chronic Myelomonocytic Leukemia-2,0
11165,Type A,Hemangioma,0
11166,Endometrial biopsy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11167,Antibiotics,Malignant neoplasm of olfactory nerve,0
11168,Malignant Neoplasms,Thyroid Hurthle Cell Carcinoma,0
11169,Three,Extracranial Neuroblastoma,0
11170,98,Atypical Lobular Breast Hyperplasia,0
11171,40%,Thymic Atypical Carcinoid Tumor,0
11172,Analysis of substances,Gastric Diffuse Large B-Cell Lymphoma,0
11173,Therapy Object (animal model),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11174,2+ Score,Giant cell angiofibroma,0
11175,Hormonal Contraception,Cartilaginous exostosis,0
11176,>90,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11177,Urinary Bladder,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
11178,Treatment Effectiveness,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11179,Negative,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11180,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
11181,Anorectal Malformations,Occult Lung Adenosquamous Carcinoma,0
11182,International Classification of Diseases for Oncology,Refractory Glioma,0
11183,treatment - ActInformationManagementReason,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11184,Commercial Lot,Recurrent Uveal Melanoma,0
11185,Throat,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11186,ultrasound device,Recurrent Uveal Melanoma,0
11187,Skin Specimen,Gallbladder Adenocarcinoma,0
11188,Carcinoma,Peripheral primitive neuroectodermal tumor of soft tissue,0
11189,Occurrence Indicator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11190,Glioblastoma Multiforme,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11191,Set scale,Malignant neoplasm of subglottis,0
11192,Frequently,papillary carcinoma of penis,0
11193,Common Specifications in HL7 V3 Publishing,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
11194,lymph nodes,Acute Undifferentiated Leukemia,0
11195,Net (qualifier),Basal Cell Ameloblastoma,0
11196,Disease,Human Papillomavirus-Related Carcinoma,0
11197,To,Intracortical osteosarcoma,0
11198,To,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11199,Zone,Recurrent Diffuse Intrinsic Pontine Glioma,0
11200,Squamous cell carcinoma,Benign Carotid Body Paraganglioma,0
11201,Treatment intent,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11202,Type A,Colorectal High Grade B-Cell Lymphoma,0
11203,Squamous cell carcinoma - category,Carcinoma,0
11204,55,Diffuse malignant mesothelioma,0
11205,Specific qualifier value,Engraftment syndrome,0
11206,Case unit dose,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
11207,Specimen,Extra-Adrenal Paraganglioma,0
11208,Life Threatening,Mastocytosis,0
11209,Common Specifications in HL7 V3 Publishing,Choroid Epithelioid Cell Melanoma,0
11210,Smear - instruction imperative,Recurrent Rhabdomyosarcoma,0
11211,Formation,Localized Askin Tumor,0
11212,ultrasound device,sarcoma of spinal cord,0
11213,Case (situation),Benign squamous cell tumor,0
11214,Has difficulty doing (qualifier value),Refractory Barrett Esophagus,0
11215,Primary,Adenocarcinoma,0
11216,Tissue of urinary bladder,Recurrent Primary Lymphoma of Bone,0
11217,Medical,Heavy Chain Deposition Disease,0
11218,Array Feature,FIGO Stage II Ovarian Cancer,0
11219,Right lymphatic duct,Cartilaginous exostosis,0
11220,Total thymectomy,Bladder Neuroendocrine Neoplasm,0
11221,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
11222,Human body structure,Methotrexate-Associated Hodgkin Lymphoma,0
11223,Screening procedure,Endometrial Small Cell Carcinoma,0
11224,Fatigue,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11225,research subject screening,Cancer of Urinary Tract,0
11226,Hyperlink,Cartilaginous exostosis,0
11227,Negation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11228,Biomaterial Treatment,Thymic Clear Cell Carcinoma,0
11229,Within,adenosquamous carcinoma of breast,0
11230,Modify status - jump,Hereditary Diffuse Gastric Adenocarcinoma,0
11231,Upper genitourinary tract structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11232,United States,Adult Alveolar Soft Part Sarcoma,0
11233,Appearance,Parathyroid Gland Adenocarcinoma,0
11234,Tumor Mass,Xeroderma pigmentosum,0
11235,Primary malignant neoplasm,Pancreatic Endocrine Carcinoma,0
11236,Mathematical Operator,Refractory Barrett Esophagus,0
11237,Decision,Squamous cell carcinoma of lip,0
11238,Name (property) (qualifier value),Xeroderma pigmentosum,0
11239,Primary malignant neoplasm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11240,Object Class,Localized Askin Tumor,0
11241,pharmacotherapeutic,Diffuse malignant mesothelioma,0
11242,To,Intracortical osteosarcoma,0
11243,Vagina Carcinoma,Stage 0 Penile Cancer AJCC v8,0
11244,Estrogen Receptors,Refractory Barrett Esophagus,0
11245,Aim (idea),Diffuse malignant mesothelioma,0
11246,0%,Malignant neoplasm of subglottis,0
11247,Occur (action),Ovarian Carcinoid Tumor,0
11248,Including (qualifier),Anterior Urethral Malignant Neoplasm,0
11249,Act Relationship Subset - previous,Splenic Manifestation of Hairy Cell Leukemia,0
11250,Seminoma,Spindle Cell Melanoma,0
11251,Base - General Qualifier,carcinoma of middle ear,0
11252,Tryptophanase,Refractory Barrett Esophagus,0
11253,Bodily secretions,Stage IB Pancreatic Cancer AJCC v8,0
11254,Changed status,Localized Ewing Sarcoma,0
11255,Clinical Study Case,Tubal Hyperplasia,0
11256,Before values,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11257,Specimen Source Codes - Mucosa,Low Grade Squamous Intraepithelial Neoplasia,0
11258,Breast Feeding,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11259,N not otherwise specified Antibody,Xeroderma pigmentosum,0
11260,Feelings,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11261,Weight decreased,Childhood Central Nervous System Ganglioneuroblastoma,0
11262,Negation,Malignant melanoma of eyelid,0
11263,Personal appearance,Ovarian Carcinoid Tumor,0
11264,radiotherapeutic,Tongue Alveolar Soft Part Sarcoma,0
11265,Malignant Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
11266,PODXL wt Allele,Intraepithelial Melanocytic Hyperplasia,0
11267,Aim (idea),Childhood Central Nervous System Immature Teratoma,0
11268,Togo,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11269,monoclonal,Benign Apocrine Neoplasm,0
11270,Large,benign mature teratoma of pancreas,0
11271,Sharing (Social Behavior),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
11272,Sweat,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11273,Overlap,Neoplasms,0
11274,Decision,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11275,Togo,Childhood Lung Non-Small Cell Carcinoma,0
11276,Before,Localized Ewing Sarcoma,0
11277,Two,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11278,Often - answer to question,Precursor B-lymphoblastic lymphoma stage II,0
11279,Body part,Cancer of Urinary Tract,0
11280,Case unit dose,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
11281,pump (device),adenosquamous carcinoma of breast,0
11282,Weight,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11283,Five,Localized Askin Tumor,0
11284,Capillary vessel,gliosarcoma,0
11285,Central neuroblastoma,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
11286,Laryngeal prominence,Stage I Adult Non-Hodgkin Lymphoma,0
11287,Endocrine Cells,Human Papillomavirus-Related Carcinoma,0
11288,High Level,Choroid Necrotic Melanoma,0
11289,Type - attribute,Plexosarcoma,0
11290,Common (qualifier value),Undifferentiated Endocervical Sarcoma,0
11291,1800s,Stage III Cutaneous Melanoma AJCC v6,0
11292,Malignant Neoplasms,Acute Undifferentiated Leukemia,0
11293,Genome - anatomical entity,non-Hodgkin's lymphoma of spleen,0
11294,Primary operation,clear cell adenocarcinoma of gallbladder,0
11295,Cell Device,Cherubism,0
11296,T prime,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
11297,Lymphatic duct,Gallbladder adenoma,0
11298,1000000,Human Papillomavirus-Related Carcinoma,0
11299,Determined by,Brain Ependymoma,0
11300,Carcinoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11301,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,Giant cell angiofibroma,0
11302,Screening Study,Kaposi's sarcoma of extrahepatic bile duct,0
11303,Meaning,Metastatic Lung Neuroendocrine Neoplasm,0
11304,Death (finding),Unfavorable Non-Hodgkin Lymphoma,0
11305,Colon Carcinoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11306,Improved - answer to question,Breast Ductal Adenoma,0
11307,Death NOS,Undifferentiated Endocervical Sarcoma,0
11308,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,embryonal rhabdomyosarcoma of prostate,0
11309,protein expression,Anterior Urethral Malignant Neoplasm,0
11310,Body structure,Low Grade Squamous Intraepithelial Neoplasia,0
11311,Multiplication,Astrocytoma of brain,0
11312,Increase in size since previous mammogram,Clonal Hematopoiesis of Indeterminate Potential,0
11313,Syndrome,Stage I Adult Non-Hodgkin Lymphoma,0
11314,Form:Finding:Point in time:{Setting}:Document:{Role},Choroid Necrotic Melanoma,0
11315,Western Europe,Type II Endometrial Adenocarcinoma,0
11316,Form:Finding:Point in time:{Setting}:Document:{Role},Basal Cell Ameloblastoma,0
11317,Pharmacotherapy,Non-Metastatic Gestational Trophoblastic Tumor,0
11318,Injury wounds,Xeroderma pigmentosum,0
11319,cell type,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11320,Carcinoid Tumor,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11321,Centroblast,Maxillary Sinus Adenocarcinoma,0
11322,US State,Clonal Hematopoiesis of Indeterminate Potential,0
11323,Workplace,Microcystic meningioma,0
11324,Greeks,Mucinous adenocarcinoma gastric,0
11325,Symptoms aspect,Tongue Alveolar Soft Part Sarcoma,0
11326,Human body structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11327,Symptoms aspect,Platinum-Resistant Lung Small Cell Carcinoma,0
11328,penis,Childhood Fibrillary Astrocytoma,0
11329,Left,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
11330,Exposure to radiation,Refractory Bladder Carcinoma,0
11331,Linear,Cervical Adenomyoma,0
11332,Administration procedure,Stage IB Pancreatic Cancer AJCC v8,0
11333,Central Nervous System Neoplasms,Multiple Endocrine Neoplasia,0
11334,Usual,Stage III Cutaneous Melanoma AJCC v6,0
11335,Immunotherapy,Digestive System Hodgkin Lymphoma,0
11336,History of present illness,Localized Askin Tumor,0
11337,Mutation,Childhood Fibrillary Astrocytoma,0
11338,Several,Carcinomatosis of peritoneal cavity,0
11339,Manufactured form,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11340,Communicable Diseases,Spindle Cell Melanoma,0
11341,Distant,Pancreatic Endocrine Carcinoma,0
11342,+2,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
11343,Control function,Endometrial Small Cell Carcinoma,0
11344,High risk,Periosteal Osteosarcoma,0
11345,Respiratory distress,Anterior Urethral Malignant Neoplasm,0
11346,Nature,Occult Lung Adenosquamous Carcinoma,0
11347,epithelial,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
11348,Retinoic Acid Response Element,Digestive System Hodgkin Lymphoma,0
11349,Manufactured form,adenosquamous carcinoma of breast,0
11350,Sunscreening Agents,Clonal Hematopoiesis of Indeterminate Potential,0
11351,Genetic screening method,Benign squamous cell tumor,0
11352,Recurrent infections,Unresectable Rhabdomyosarcoma,0
11353,Brain,Squamous cell carcinoma of lip,0
11354,1000000,FIGO Stage IVA Ovarian Cancer,0
11355,Tumor cells,Microcystic meningioma,0
11356,Neoplasms,malignant lymphoma of pancreatic lymph nodes,0
11357,Etiology aspects,Colorectal High Grade B-Cell Lymphoma,0
11358,solid substance,Liver Lymphangioma,0
11359,Cartilage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11360,Leading,Grade 1 Clear Cell Renal Cell Carcinoma,0
11361,Morphology,Cervical Adenomyoma,0
11362,Fever,Hodgkin lymphoma,0
11363,Participation Type - origin,Endometrial Small Cell Carcinoma,0
11364,Classification of information,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11365,Good,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11366,Gastric Acid,Tongue Alveolar Soft Part Sarcoma,0
11367,Involvement with,Thyroid Hurthle Cell Carcinoma,0
11368,Order (document),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11369,Smooth muscle (tissue),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11370,Manufactured form,Hereditary Diffuse Gastric Adenocarcinoma,0
11371,regional,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
11372,Include (action),FIGO Stage IVA Ovarian Cancer,0
11373,Lymphoma,Adenocarcinoma,0
11374,Internal,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11375,Base - General Qualifier,Locally Advanced Carcinoma,0
11376,Formation,Carcinomatosis of peritoneal cavity,0
11377,Approximate,Acantholytic squamous cell carcinoma,0
11378,1+ Score,Brain Tumor,0
11379,Specimen Type - Serum,Angiosarcoma of liver,0
11380,Neoplasms,Extra-Adrenal Paraganglioma,0
11381,Malignant Neoplasms,Benign neoplasm of eye,0
11382,Lower - spatial qualifier,Refractory Barrett Esophagus,0
11383,control aspects,Xeroderma pigmentosum,0
11384,European race,Bladder squamous cell carcinoma stage I,0
11385,Primary malignant neoplasm,Type II Endometrial Adenocarcinoma,0
11386,Adult Classical Hodgkin Lymphoma,Breast Ductal Adenoma,0
11387,Science of Statistics,Adult Alveolar Soft Part Sarcoma,0
11388,Occurrence Indicator,Gallbladder Adenocarcinoma,0
11389,Usual,Recurrent Testicular Lymphoma,0
11390,Malignant Neoplasms,Type II Endometrial Adenocarcinoma,0
11391,Retarded,Parathyroid Gland Adenocarcinoma,0
11392,To,Adrenal Rest Tumor,0
11393,Result,Angiosarcoma of liver,0
11394,Links List,Acute Undifferentiated Leukemia,0
11395,Including (qualifier),Advanced Lung Carcinoma,0
11396,Human body,Hemangioma,0
11397,Abdomen+,benign mature teratoma of pancreas,0
11398,hiv-infection/aids,Leiomyoma of Gallbladder,0
11399,Primary malignant neoplasm,Gallbladder Adenocarcinoma,0
11400,Sequence Data Type,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11401,Stromal Cells,Unresectable Rhabdomyosarcoma,0
11402,Present,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11403,Manufactured form,Extracranial Neuroblastoma,0
11404,Radiation Ionizing Radiotherapy,Giant cell angiofibroma,0
11405,Microvolt,Unfavorable Non-Hodgkin Lymphoma,0
11406,Tobacco smoking behavior,High Grade Glandular Intraepithelial Neoplasia,0
11407,Metastatic Disease Clinical Trial Setting,Keratoderma,0
11408,stage,FIGO Stage II Ovarian Cancer,0
11409,Colloid,Stage III Cutaneous Melanoma AJCC v6,0
11410,Movement,Childhood Anaplastic Large Cell Lymphoma,0
11411,Severe (severity modifier),Choroid Necrotic Melanoma,0
11412,Tryptophanase,Atypical Mesothelial Hyperplasia,0
11413,PREVENT (product),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11414,Digital Content Category,FIGO Stage IVA Ovarian Cancer,0
11415,Operative Surgical Procedures,Mucinous adenocarcinoma gastric,0
11416,How Much Distress Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
11417,soluble,Hodgkin Disease,0
11418,Metastatic Neoplasm,benign mature teratoma of pancreas,0
11419,Make - Instruction Imperative,Mucinous adenocarcinoma,0
11420,Admission Level of Care Code - Improved,Trichilemmocarcinoma,0
11421,Carcinoma in Situ,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11422,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Transitional cell carcinoma,0
11423,Transformation,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11424,Cessation of life,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11425,Body site,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11426,Due to,Epithelioid Sarcoma NCI Grade 3,0
11427,suggestion,Occult Lung Adenosquamous Carcinoma,0
11428,Precision - second,Recurrent Testicular Lymphoma,0
11429,Current (present time),Unresectable Rhabdomyosarcoma,0
11430,Specific qualifier value,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11431,First (number),Kaposi's sarcoma of skin,0
11432,Overall Publication Type,Adult Alveolar Soft Part Sarcoma,0
11433,Childhood Hodgkin Lymphoma,Leiomyoma of Gallbladder,0
11434,Science of Etiology,Atypical Lobular Breast Hyperplasia,0
11435,suggestion,Mucinous adenocarcinoma gastric,0
11436,Diagnosis,Liver Cavernous Hemangioma,0
11437,Li-Fraumeni Syndrome,Ectomesenchymal Chondromyxoid Tumor,0
11438,Internal,Kaposi's sarcoma of skin,0
11439,Relative,Low Grade Squamous Intraepithelial Neoplasia,0
11440,Name Given at Birth,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11441,Antidepressive Agents,Deep Leiomyoma,0
11442,Fever,clear cell adenocarcinoma of gallbladder,0
11443,Myeloproliferative disease,Splenic Manifestation of Hairy Cell Leukemia,0
11444,Polypeptide Hormones,Blood Vessel Tumors,0
11445,To,Endometrial Small Cell Carcinoma,0
11446,Membrane,Adult Alveolar Soft Part Sarcoma,0
11447,Tissue Growth,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11448,SPG21 gene,Benign Ovarian Thecoma,0
11449,Tumor cells,Testicular cancer metastatic,0
11450,Unusual,Grade 3a Malignant Neoplasm,0
11451,Body tissue,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11452,Progress,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11453,radiotherapeutic,Placental aromatase deficiency,0
11454,Qualitative form,Benign neoplasm of eye,0
11455,Very Much,non-Hodgkin's lymphoma of spleen,0
11456,Epiglottis structure,Stage I Colon Neuroendocrine Tumor AJCC v8,0
11457,Involvement with,Plexosarcoma,0
11458,Median Statistical Measurement,Choroid Epithelioid Cell Melanoma,0
11459,Male population group,Endometrial Small Cell Carcinoma,0
11460,Young Adult,Metastatic Lung Neuroendocrine Neoplasm,0
11461,Allergens,High Grade Glandular Intraepithelial Neoplasia,0
11462,Cervical lymph node group,Bladder adenocarcinoma stage IV,0
11463,Biological Response Modifier Therapy,Benign squamous cell tumor,0
11464,Variable (uniformity),Periosteal Osteosarcoma,0
11465,biopsy characteristics,Localized Malignant Neoplasm,0
11466,Genus Homo,Recurrent Testicular Lymphoma,0
11467,Negative - answer,Undifferentiated Endocervical Sarcoma,0
11468,NCI CTEP SDC Uterine Cancer Sub-Category Terminology,Xeroderma pigmentosum,0
11469,point - UnitsOfMeasure,FIGO Stage IVA Ovarian Cancer,0
11470,Serum albumin level decreased below normal (finding),Stage II Fallopian Tube Cancer,0
11471,survival aspects,Acantholytic squamous cell carcinoma,0
11472,Mature Lymphocyte,Nasal cavity carcinoma,0
11473,Infrequent,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11474,Swelling,Extracranial Neuroblastoma,0
11475,Surface,Kaposi's sarcoma of skin,0
11476,Occurrence Indicator,Undifferentiated Neuroblastoma,0
11477,Cancer Genus,Mixed astrocytoma-ependymoma,0
11478,Call (Instruction),Pancreatic carcinoma,0
11479,foreign,FIGO Stage IVA Ovarian Cancer,0
11480,Mesothelium,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11481,Fatigue,Recurrent Testicular Lymphoma,0
11482,acute,Hereditary corneal dystrophy,0
11483,Location,Chronic Myelomonocytic Leukemia-2,0
11484,shared attribute,Recurrent Uveal Melanoma,0
11485,Treating,embryonal rhabdomyosarcoma of prostate,0
11486,Biopsy,Benign squamous cell tumor,0
11487,Abdominal bloating,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11488,Chemotherapy Regimen,Malignant melanoma of eyelid,0
11489,Upper urinary tract structure,Intestinal Metaplasia of Bladder Urothelium,0
11490,Death Related to Adverse Event,Benign Anal Granular Cell Tumor,0
11491,True primary (qualifier value),Breast Apocrine Adenoma,0
11492,Previously Treated Childhood Rhabdomyosarcoma,Localized Askin Tumor,0
11493,Stillbirth,Cartilaginous exostosis,0
11494,site-specific telomere resolvase activity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11495,peripheral blood,Medulloblastoma,0
11496,Blood flow,Xeroderma pigmentosum,0
11497,Personal appearance,Stage IB Lung Cancer AJCC v7,0
11498,Greasy hair,Chest Wall Fibromatosis,0
11499,Spreading (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11500,Location of Oral Residue Following Swallowing,Childhood Thyroid Gland Follicular Carcinoma,0
11501,form name,Mucinous adenocarcinoma gastric,0
11502,Diagnosis,Mucinous adenocarcinoma,0
11503,Spreading (qualifier value),Mixed parotid tumor,0
11504,>90,Intestinal Metaplasia of Bladder Urothelium,0
11505,Negation,Localized Ewing Sarcoma,0
11506,High risk of,Xeroderma pigmentosum,0
11507,Nervous system structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11508,respiratory gaseous exchange in organisms,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11509,Administration procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
11510,Often - answer to question,Testicular cancer metastatic,0
11511,Percent normal,Breast Ductal Adenoma,0
11512,Interferes with,Squamous cell carcinoma of lip,0
11513,Infant,Carcinoma ex pleomorphic adenoma of parotid gland,0
11514,Ultrasonography,Benign squamous cell tumor,0
11515,Physical findings,Malignant neoplasm of subglottis,0
11516,Changing,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11517,Lesion,Mucinous adenocarcinoma gastric,0
11518,Social group,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11519,Smear - instruction imperative,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11520,Childhood Germ Cell Tumor,Adult Anaplastic Oligodendroglioma,0
11521,Lymphatic obstruction,Papillary squamous cell carcinoma,0
11522,Qualitative form,Small Intestinal Villous Adenoma,0
11523,analysis aspect,Kaposi's sarcoma of skin,0
11524,removal technique,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
11525,Gastrointestinal tract structure,embryonal rhabdomyosarcoma of prostate,0
11526,Several,Transitional cell carcinoma,0
11527,Include (action),Diffuse malignant mesothelioma,0
11528,Contrast,sarcoma of spinal cord,0
11529,Bacteria present,Refractory Barrett Esophagus,0
11530,Bladder Cancer Pathway,Childhood Central Nervous System Ganglioneuroblastoma,0
11531,To,Stage IV Penile Cancer AJCC v7,0
11532,Occur (action),Pancreatic Intraepithelial Neoplasia-3,0
11533,Two,Clinical Stage I Cutaneous Melanoma AJCC v8,0
11534,Relationships,Cancer of Urinary Tract,0
11535,contact person,Collecting Duct Carcinoma of the Kidney,0
11536,Block Specimens,Mucinous cystadenofibroma,0
11537,Living Alone,adenosquamous carcinoma of breast,0
11538,Offspring,ROSE Cluster 3,0
11539,year,Atypical Lobular Breast Hyperplasia,0
11540,artesunate,Locally Advanced Carcinoma,0
11541,Four,Anterior Urethral Malignant Neoplasm,0
11542,Biomedicine,Lipoma of small intestine,0
11543,Frequency of Pain Question,Childhood Central Nervous System Ganglioneuroblastoma,0
11544,Child,FIGO Stage II Ovarian Cancer,0
11545,Risk,Engraftment syndrome,0
11546,>90,Recurrent Testicular Lymphoma,0
11547,Intestines,Plexosarcoma,0
11548,Heterogeneity,Clonal Hematopoiesis of Indeterminate Potential,0
11549,Abdomen+,Childhood Thyroid Gland Follicular Carcinoma,0
11550,soft tissue,Cherubism,0
11551,Mixed Salivary Gland Tumor,Thyroid Hurthle Cell Carcinoma,0
11552,Did not receive therapy or drug for,Collecting Duct Carcinoma of the Kidney,0
11553,Male,Stage III Cutaneous Melanoma AJCC v6,0
11554,Complete Pharyngeal Contraction,Adult Anaplastic Oligodendroglioma,0
11555,lymph nodes,Metastatic Malignant Neoplasm in the Sellar Region,0
11556,Often - answer to question,Breast Ductal Adenoma,0
11557,Adenocarcinoma,Refractory Ependymoma,0
11558,Blood group antibody I,Xeroderma pigmentosum,0
11559,Term (lexical),Peripheral primitive neuroectodermal tumor of soft tissue,0
11560,Esophageal pH Monitoring,Intraepithelial Melanocytic Hyperplasia,0
11561,Infrequent,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
11562,Therapeutic procedure,Medulloblastoma,0
11563,Removed,Tonsillar Carcinoma,0
11564,Aggressive behavior,Adenocarcinoma,0
11565,Immune System Processes,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11566,Sound - physical agent,gliosarcoma,0
11567,Lumen,Atypical Mesothelial Hyperplasia,0
11568,Condition:Find:Pt:^Patient:Nom,Mucinous adenocarcinoma gastric,0
11569,Skin Specimen,Type II Endometrial Adenocarcinoma,0
11570,Either,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11571,Rate,embryonal rhabdomyosarcoma of prostate,0
11572,Genes,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
11573,Assisted (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11574,Mathematical Factor,Primary Cutaneous Plasmablastic Lymphoma,0
11575,Object Class,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11576,Non-Small Cell Lung Carcinoma,Splenic Manifestation of Hairy Cell Leukemia,0
11577,Volume Measurement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11578,combination of objects,Carcinoma of urinary bladder,0
11579,Diagnosis,Kaposi's sarcoma of extrahepatic bile duct,0
11580,Square Mile,Hyperplasia of pituitary gland,0
11581,Less Than,Benign tumor of eyelid,0
11582,Chemotherapy,Congenital hamartoma,0
11583,Transurethral Resection,ROSE Cluster 3,0
11584,Pharmaceutical Preparations,Thymic Atypical Carcinoid Tumor,0
11585,Value Above Reference Range,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11586,Case (situation),Squamous cell carcinoma of lip,0
11587,Metaplasia,Stage III Adult Immunoblastic Lymphoma,0
11588,Malignant neoplasm of mouth,Cancer of Urinary Tract,0
11589,Architecture,Adult Alveolar Soft Part Sarcoma,0
11590,Occurrence,Squamous cell carcinoma of lip,0
11591,Reaching,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11592,Treatment Epoch,Kaposi's sarcoma of skin,0
11593,Togo,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
11594,Cell Device,Metastatic Neoplasm to the Gallbladder,0
11595,Lung,Tonsillar Carcinoma,0
11596,How Much Distress Nausea,Small intestine carcinoma,0
11597,Caucasians,embryonal rhabdomyosarcoma of prostate,0
11598,Anatomic Site,Intestinal Metaplasia of Bladder Urothelium,0
11599,Back structure,embryonal rhabdomyosarcoma of prostate,0
11600,Volume,Childhood Fibrillary Astrocytoma,0
11601,diagnosis aspect,FIGO Stage II Ovarian Cancer,0
11602,Smear - instruction imperative,Benign squamous cell tumor,0
11603,Neuron spine,Benign Anal Granular Cell Tumor,0
11604,Qualitative form,Diffuse malignant mesothelioma,0
11605,Malignant Squamous Cell Neoplasm,Werner Syndrome,0
11606,Tip,FIGO Stage IVA Ovarian Cancer,0
11607,Base - General Qualifier,Recurrent Testicular Lymphoma,0
11608,leukemia,Gallbladder Adenocarcinoma,0
11609,Occurrence,Undifferentiated Endocervical Sarcoma,0
11610,Sharp Edges,High Grade Glandular Intraepithelial Neoplasia,0
11611,Tissue damage,Contact dermatitis due to alkali,0
11612,Prophylactic behavior,Medulloblastoma,0
11613,Pancreatic carcinoma,Leiomyoma of Gallbladder,0
11614,Occur (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11615,month,Xeroderma pigmentosum,0
11616,Form:Finding:Point in time:{Setting}:Document:{Role},Undifferentiated Endocervical Sarcoma,0
11617,Qualitative mobility,Malignant neoplasm of thalamus,0
11618,Male population group,Plexosarcoma,0
11619,Mechanism (attribute),Thymic Clear Cell Carcinoma,0
11620,Human body structure,squamous cell carcinoma of the thyroid gland,0
11621,Young,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11622,Gender,Kaposi's sarcoma of skin,0
11623,pharmacotherapeutic,Transitional cell carcinoma,0
11624,melanoma,Stage 0 Penile Cancer AJCC v8,0
11625,Unknown (origin) (qualifier value),Cartilaginous exostosis,0
11626,Erythrocytes,Cerebral Primitive Neuroectodermal Tumor,0
11627,Colon <insect>,Bladder squamous cell carcinoma stage I,0
11628,Body tissue,Refractory Barrett Esophagus,0
11629,shared attribute,Benign Apocrine Neoplasm,0
11630,*Type - Kind of quantity,Malignant Testicular Sertoli Cell Tumor,0
11631,Common (qualifier value),Recurrent Diffuse Intrinsic Pontine Glioma,0
11632,Average,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
11633,Act Relationship Type - occurrence,Peripheral primitive neuroectodermal tumor of soft tissue,0
11634,Occurrence Indicator,Childhood Fibrillary Astrocytoma,0
11635,Surgical aspects,Activated B-cell type diffuse large B-cell lymphoma,0
11636,Complete,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
11637,Portion of urine,Undifferentiated Neuroblastoma,0
11638,Negation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11639,Body Fluids,Astrocytoma of brain,0
11640,Colorectal Cancer,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11641,Common (qualifier value),Grade 1 Clear Cell Renal Cell Carcinoma,0
11642,Chemotherapy Regimen,Engraftment syndrome,0
11643,Plumbum metallicum,Stage I Colon Neuroendocrine Tumor AJCC v8,0
11644,Neoplasm Metastasis,Recurrent Testicular Lymphoma,0
11645,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Melanomatosis,0
11646,Brain,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11647,Forecast of outcome,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11648,Chemotherapy Regimen,Cervical Fibroepithelial Polyp,0
11649,metaplastic cell transformation,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11650,Abnormal Cell Count,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
11651,Wall of blood vessel,Pancreatic Intraepithelial Neoplasia-3,0
11652,Antibiotic throat preparations,Intraepithelial Melanocytic Hyperplasia,0
11653,risk factors - observation list,Placental aromatase deficiency,0
11654,Often - answer to question,Vaginal Adenoid Cystic Carcinoma,0
11655,Lifetime,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
11656,Lymphadenopathy,Squamous cell carcinoma of lip,0
11657,Affecting,Kaposi's sarcoma of skin,0
11658,Paraplegia,Ovarian Carcinoid Tumor,0
11659,United Kingdom,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11660,Crystallography,Gastric Diffuse Large B-Cell Lymphoma,0
11661,Cutaneous Melanoma,Xeroderma pigmentosum,0
11662,65,Extra-abdominal fibromatosis,0
11663,Infective cystitis,Metastatic Malignant Neoplasm in the Sellar Region,0
11664,Malignant - descriptor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11665,Cell Count,Chronic Myelomonocytic Leukemia-2,0
11666,Usual,Diffuse malignant mesothelioma,0
11667,Case (situation),Extra-abdominal fibromatosis,0
11668,shared attribute,Gallbladder Adenocarcinoma,0
11669,Widening,Malignant melanoma of eyelid,0
11670,Lung,Adenocarcinoma,0
11671,Sensation quality,Peripheral primitive neuroectodermal tumor of soft tissue,0
11672,Deterioration of status,Testicular cancer metastatic,0
11673,Disease,Benign Anal Granular Cell Tumor,0
11674,Occur (action),Spongiotic dermatitis,0
11675,Lymphatic vessel,Pancreatic carcinoma,0
11676,Reported Term,Carcinoma of urinary bladder,0
11677,Including (qualifier),ICHTHYOSIS,0
11678,include - SetOperator,Stage III Cutaneous Melanoma AJCC v6,0
11679,Logical Condition,Malignant neoplasm of gallbladder,0
11680,Subject is Randomized,Undifferentiated Endocervical Sarcoma,0
11681,Positive,gliosarcoma,0
11682,Domain (area of knowledge),Blood Vessel Tumors,0
11683,Diagnostic Imaging,Vaginal Adenoma,0
11684,Structure of posterior fossa of cranial cavity,Intestinal Metaplasia of Bladder Urothelium,0
11685,Primary malignant neoplasm,Familial Adenomatous Polyposis Associated Medulloblastoma,0
11686,include - SetOperator,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11687,Loss,Adult Brain Stem Mixed Glioma,0
11688,Infantile hemangioma,Transitional cell carcinoma,0
11689,Good,Acantholytic squamous cell carcinoma,0
11690,Various patch test substance,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11691,Formation,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11692,Means,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11693,Statistical Prevalence,Thyroid Hurthle Cell Carcinoma,0
11694,low,papillary carcinoma of penis,0
11695,Scientific Publication,Congenital hamartoma,0
11696,cell growth,Undifferentiated Endocervical Sarcoma,0
11697,Include (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11698,Tissue damage,mucinous adenocarcinoma of gallbladder,0
11699,Common Specifications in HL7 V3 Publishing,Malignant neoplasm of gallbladder,0
11700,Malignant Neoplasms,Nasal cavity carcinoma,0
11701,Degree or extent,FIGO Stage II Ovarian Cancer,0
11702,Involvement with,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11703,Tissue Specimen Code,Epithelioid Sarcoma NCI Grade 3,0
11704,Study Control,Recurrent Testicular Lymphoma,0
11705,Form:Finding:Point in time:{Setting}:Document:{Role},Neonatal leukemia,0
11706,Cavitation,Metastatic Malignant Neoplasm in the Sellar Region,0
11707,Type A,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11708,diagnosis aspect,Pancreatic carcinoma,0
11709,Itchiness,FIGO Stage II Ovarian Cancer,0
11710,Only - dosing instruction fragment,Chronic Myelomonocytic Leukemia-2,0
11711,Randomization,Endometrial Small Cell Carcinoma,0
11712,disease markers,Adenocarcinoma of duodenum,0
11713,Arsenic measurement,Bladder adenocarcinoma stage IV,0
11714,Common (qualifier value),Kaposi's sarcoma of skin,0
11715,Publishing,Colorectal High Grade B-Cell Lymphoma,0
11716,General surgery specialty,Recurrent Testicular Lymphoma,0
11717,Multiplication,Mucosal Melanoma,0
11718,Coins,Anterior Urethral Malignant Neoplasm,0
11719,Reported Term,Cancer of Urinary Tract,0
11720,Both ovaries,FIGO Stage II Ovarian Cancer,0
11721,Lymphoid Cell Count,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
11722,Occur (action),Hodgkin Disease,0
11723,Smear - instruction imperative,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11724,medication - HL7 publishing domain,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11725,Cream,Cartilaginous exostosis,0
11726,Hematologist,Ectomesenchymal Chondromyxoid Tumor,0
11727,Adult human body,Adult Alveolar Soft Part Sarcoma,0
11728,Tissue sampling,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11729,encoding mental process,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
11730,% index,Adult Hepatocellular Carcinoma,0
11731,Extravasation,Recurrent Uveal Melanoma,0
11732,Sustained,Benign Anal Granular Cell Tumor,0
11733,Adult Grade III Meningioma,Bladder squamous cell carcinoma stage I,0
11734,Location,FIGO Stage IVA Ovarian Cancer,0
11735,Cavern,Childhood Anaplastic Large Cell Lymphoma,0
11736,Patient need for (contextual qualifier),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
11737,treatment - ActInformationManagementReason,Chest Wall Fibromatosis,0
11738,Immune,Locally Advanced Squamous Cell Carcinoma,0
11739,Count of entities,Endometrial Small Cell Carcinoma,0
11740,Chemotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11741,Referral placed,Melanomatosis,0
11742,majority,Neoplasms,0
11743,Fatty Liver Disease,FIGO Stage IVA Ovarian Cancer,0
11744,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11745,Third revision,Primary Cutaneous Plasmablastic Lymphoma,0
11746,Eye,Basal Cell Ameloblastoma,0
11747,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Childhood Central Nervous System Ganglioneuroblastoma,0
11748,Young,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11749,Woman,Recurrent Testicular Lymphoma,0
11750,Lighter device,Stage III Adult Immunoblastic Lymphoma,0
11751,Frequently,Locally Advanced Soft Tissue Sarcoma,0
11752,Diagnostic Neoplasm Staging,Acute Undifferentiated Leukemia,0
11753,Cellular infiltrate,Malignant melanoma of eyelid,0
11754,Hormonal,Kaposi's sarcoma of extrahepatic bile duct,0
11755,Irregular,FIGO Stage IVA Ovarian Cancer,0
11756,Relocation of home or business,Microcystic meningioma,0
11757,Problems - What subject filter,Refractory Bladder Carcinoma,0
11758,Uvea,Carcinoma ex pleomorphic adenoma of parotid gland,0
11759,Menopause present (finding),Malignant Neoplasm of Lung - Multiple Primary Sites,0
11760,diagnosis aspect,Mucinous adenocarcinoma gastric,0
11761,Acids,Digestive System Hodgkin Lymphoma,0
11762,Only - dosing instruction fragment,adenosquamous carcinoma of breast,0
11763,Reduction procedure,Stage IV Penile Cancer AJCC v7,0
11764,Sometimes,Stage III Cutaneous Melanoma AJCC v6,0
11765,High Grade Ovarian Serous Adenocarcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11766,Sexually Transmitted Diseases,Recurrent Uveal Melanoma,0
11767,Homo sapiens,Malignant neoplasm of thalamus,0
11768,Removing (action),Methotrexate-Associated Hodgkin Lymphoma,0
11769,Childhood Osteosarcoma,Uterine Cancer,0
11770,Vertebral column,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11771,Pruritus,embryonal rhabdomyosarcoma of prostate,0
11772,Sufficiently defined concept definition status (core metadata concept),Small cell neuroendocrine carcinoma of bladder,0
11773,Experimental Result,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
11774,Characteristics,Intraepithelial Melanocytic Hyperplasia,0
11775,Common Specifications in HL7 V3 Publishing,Unfavorable Non-Hodgkin Lymphoma,0
11776,Show,Melanomatosis,0
11777,Formation,Anterior Urethral Malignant Neoplasm,0
11778,respiratory,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
11779,research subject screening,Ovarian Dermoid Cyst with Secondary Carcinoma,0
11780,Name,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
11781,Most,Xeroderma pigmentosum,0
11782,Breast,Pancreatic Intraepithelial Neoplasia-3,0
11783,Aspects of disease screening,Metastatic Neoplasm to the Gallbladder,0
11784,85,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11785,How Often Itching,Diffuse malignant mesothelioma,0
11786,Grade,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11787,Levels (qualifier value),Papillary squamous cell carcinoma,0
11788,Skin,Tonsillar Carcinoma,0
11789,Hodgkin Disease,Childhood Central Nervous System Ganglioneuroblastoma,0
11790,Human body structure,Adenocarcinoma of duodenum,0
11791,Measurement,FIGO Stage IVA Ovarian Cancer,0
11792,Recommendation,Metastatic Neoplasm to the Gallbladder,0
11793,Cells,Intraepithelial Melanocytic Hyperplasia,0
11794,Morphology,Ovarian germ cell choriocarcinoma stage IV,0
11795,Spherical shape,Stage III Cutaneous Melanoma AJCC v6,0
11796,Characterization,Endometrial Small Cell Carcinoma,0
11797,Anterior,Intraepithelial Melanocytic Hyperplasia,0
11798,site-specific telomere resolvase activity,Bladder adenocarcinoma stage IV,0
11799,Palpebral margin,Small cell neuroendocrine carcinoma of bladder,0
11800,Pain of lymph node,Trabecular adenocarcinoma,0
11801,Fatigue,Platinum-Resistant Lung Small Cell Carcinoma,0
11802,Individual,Pleomorphic adenoma of parotid gland,0
11803,Empty (qualifier),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11804,Estimated,Werner Syndrome,0
11805,Medical Device Emits Smoke,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11806,Malignant Neoplasms,Childhood Central Nervous System Ganglioneuroblastoma,0
11807,Occurrence,Mucinous neoplasm,0
11808,Swollen Lymph Node,gliosarcoma,0
11809,Enzyme Unit,Grade 1 Clear Cell Renal Cell Carcinoma,0
11810,Recommendation,Blepharal carcinoma,0
11811,Tube - unit dose,Undifferentiated Endocervical Sarcoma,0
11812,Primary Malignant Liver Neoplasm,Refractory Barrett Esophagus,0
11813,In Blood,Splenic Manifestation of Hairy Cell Leukemia,0
11814,Carcinoma,Intraepithelial Melanocytic Hyperplasia,0
11815,1+ Score,Intraepithelial Melanocytic Hyperplasia,0
11816,anatomical layer,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11817,Approximate,Epithelioid Sarcoma NCI Grade 3,0
11818,Sinus - general anatomical term,FIGO Stage IVA Ovarian Cancer,0
11819,Sweat,Cherubism,0
11820,VARIOUS DRUG CLASSES IN ATC,BRCA2 Syndrome,0
11821,90%,Metaplastic carcinoma of breast,0
11822,Night time,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
11823,Hereditary,Localized Malignant Neoplasm,0
11824,Australia,Benign Ovarian Thecoma,0
11825,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
11826,Known,Locally Advanced Soft Tissue Sarcoma,0
11827,Hemorrhage,Malignant Neoplasm with Regional Lymph Node Involvement,0
11828,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11829,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Recurrent Uveal Melanoma,0
11830,Body tissue,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
11831,Continuous,Kaposi's sarcoma of extrahepatic bile duct,0
11832,Subtype (attribute),Benign Anal Granular Cell Tumor,0
11833,Cervix carcinoma,Human Papillomavirus-Related Carcinoma,0
11834,Patient Reported Outcome Stem,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11835,Human Age Group,clear cell adenocarcinoma of gallbladder,0
11836,United States,Stage IB Pancreatic Cancer AJCC v8,0
11837,Old,Endometrial Small Cell Carcinoma,0
11838,Mechanism Component of Device,Mucinous adenocarcinoma gastric,0
11839,Name,Trichilemmocarcinoma,0
11840,Lymphocyte,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11841,Cartilage,Engraftment syndrome,0
11842,per year,Stage 0 Penile Cancer AJCC v8,0
11843,Numbers,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11844,Childhood Lymphoma,Nasal cavity carcinoma,0
11845,Within,Deep Leiomyoma,0
11846,Certain (qualifier value),Stage I Colon Neuroendocrine Tumor AJCC v8,0
11847,Include (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
11848,Certainties,Intraepithelial Melanocytic Hyperplasia,0
11849,Cardiovascular system,Metastatic Neoplasm to the Gallbladder,0
11850,Angioma,Spongiotic dermatitis,0
11851,Nose,Locally Advanced Soft Tissue Sarcoma,0
11852,Symptoms,Squamous cell carcinoma of lip,0
11853,Lymphoma,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
11854,cure of disease,BRCA2 Syndrome,0
11855,Disease Management,Choroid Epithelioid Cell Melanoma,0
11856,Occurrence Indicator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
11857,Removed,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11858,General Health:Find:Pt:^Patient:Ord,Tongue Alveolar Soft Part Sarcoma,0
11859,Classification,Stage 0 Penile Cancer AJCC v8,0
11860,Death (finding),adenoid cystic carcinoma of lung,0
11861,treatment - ActInformationManagementReason,Gastric Diffuse Large B-Cell Lymphoma,0
11862,Skin Specimen,Secondary malignant neoplasm of lymph node,0
11863,Able to Concentrate Question,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
11864,PSA Level Less than Two,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11865,Person Name,Recurrent Uveal Melanoma,0
11866,status - In progress,Stage IB Lung Cancer AJCC v7,0
11867,Heel Spur,Intestinal Metaplasia of Bladder Urothelium,0
11868,NBL1 wt Allele,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11869,Glandular,Pilocytic astrocytoma of cerebellum,0
11870,Retinoic Acid Response Element,High Grade Glandular Intraepithelial Neoplasia,0
11871,Life,Endometrial Small Cell Carcinoma,0
11872,Tryptophanase,Ovarian Carcinoid Tumor,0
11873,Comparison,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11874,shared attribute,embryonal rhabdomyosarcoma of prostate,0
11875,Cause of Death,Benign Anal Granular Cell Tumor,0
11876,Tumor Mass,Plexosarcoma,0
11877,Negation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11878,Have Sweats,Melanomatosis,0
11879,eTMF Content Model Code,Localized Malignant Neoplasm,0
11880,Radiation Oncology specialty,carcinoma of middle ear,0
11881,Smear - instruction imperative,Testicular cancer metastatic,0
11882,Prognosis:Find:Pt:^Patient:Nom,Papillary squamous cell carcinoma,0
11883,Presentation,Cherubism,0
11884,ACTG2 wt Allele,Testicular cancer metastatic,0
11885,Devices,Lipoma of small intestine,0
11886,High Risk Acute Leukemia,Pancreatic carcinoma,0
11887,Family member,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
11888,CYP19A1 gene,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11889,Most,Choroid Necrotic Melanoma,0
11890,Body tissue,Malignant neoplasm of thalamus,0
11891,Diagnosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11892,Small cell carcinoma of lung,Unresectable Rhabdomyosarcoma,0
11893,Main,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
11894,Microplate Well,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11895,Persons,Hodgkin lymphoma,0
11896,As Much as Desired,Adenocarcinoma of the prostate metastatic,0
11897,Social group,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11898,Numbers,Kaposi's sarcoma of extrahepatic bile duct,0
11899,SLC6A2 wt Allele,Childhood Central Nervous System Ganglioneuroblastoma,0
11900,Common (qualifier value),Undifferentiated Endocervical Sarcoma,0
11901,>5,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11902,Near,Childhood Lung Non-Small Cell Carcinoma,0
11903,Mixed Cell Morphology,Gallbladder Adenocarcinoma,0
11904,Cells,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11905,United States,FIGO Stage II Ovarian Cancer,0
11906,Occurrence Indicator,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
11907,Occur (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11908,Skin Aging,Digestive System Hodgkin Lymphoma,0
11909,Lymph,Localized Ewing Sarcoma,0
11910,Flowers,Pilocytic astrocytoma of cerebellum,0
11911,Fourth ventricle structure,Kaposi's sarcoma of skin,0
11912,Diagnosis Study,Adult Acute Eosinophilic Leukemia,0
11913,Infiltrative Growth Pattern,FIGO Stage IVA Ovarian Cancer,0
11914,Phenotype,Colorectal High Grade B-Cell Lymphoma,0
11915,Body tissue,Low Grade Squamous Intraepithelial Neoplasia,0
11916,Neoadjuvant Therapy Clinical Trial Setting,Neonatal leukemia,0
11917,Beginning,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
11918,Dependent for bathing,Ovarian germ cell choriocarcinoma stage IV,0
11919,Multiple Myeloma,Maxillary Sinus Adenoid Cystic Carcinoma,0
11920,Greater,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11921,Large,Recurrent Uveal Melanoma,0
11922,Highest,Medulloblastoma,0
11923,Rare,embryonal rhabdomyosarcoma of prostate,0
11924,Biopsy,ROSE Cluster 3,0
11925,Extremely Agree,Botryoid-Type Embryonal Rhabdomyosarcoma,0
11926,Ethanol,Locally Advanced Epithelioid Hemangioendothelioma,0
11927,include - SetOperator,Maxillary Sinus Adenocarcinoma,0
11928,Infrequent,Choroid Epithelioid Cell Melanoma,0
11929,Human papillomavirus types,Intraepithelial Melanocytic Hyperplasia,0
11930,general population,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11931,Primary malignant neoplasm,Undifferentiated Endocervical Sarcoma,0
11932,Multiple adenomatous polyps,Pancreatic carcinoma,0
11933,Vaccines,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
11934,Carcinoma,Carcinoma,0
11935,Rare,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
11936,Others - Allergy,Female Breast Carcinoma,0
11937,Tryptophanase,Basal Cell Ameloblastoma,0
11938,Known,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
11939,Skin,Vaginal Adenoma,0
11940,Adult,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
11941,Percent normal,Clonal Hematopoiesis of Indeterminate Potential,0
11942,School Grade,Childhood Central Nervous System Ganglioneuroblastoma,0
11943,Near,Mixed astrocytoma-ependymoma,0
11944,Medicine,Stage III Adult Immunoblastic Lymphoma,0
11945,North America,Recurrent Uveal Melanoma,0
11946,Neoplasms,Vaginal Adenoma,0
11947,leukemia,Unicystic ameloblastoma,0
11948,Primary malignant neoplasm,Unicystic ameloblastoma,0
11949,Specific qualifier value,Acinar cell carcinoma of pancreas,0
11950,Occur (action),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
11951,metaplastic cell transformation,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
11952,Epidermal cells,Undifferentiated Neuroblastoma,0
11953,Upper arm,Giant cell angiofibroma,0
11954,Pale feces (finding),Advanced Lung Carcinoma,0
11955,Exposure to,Female Breast Carcinoma,0
11956,Unknown,Childhood Fibrillary Astrocytoma,0
11957,Adult,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
11958,Monoclonal antibodies,Undifferentiated Endocervical Sarcoma,0
11959,Endothelium,Lipoma of small intestine,0
11960,Removing (action),Noninfiltrating Intraductal Carcinoma,0
11961,Death Related to Adverse Event,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
11962,What subject filter - Result,Non-Metastatic Gestational Trophoblastic Tumor,0
11963,Europe,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
11964,Obesity,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
11965,WHO Central Nervous System Grade I,Adult Anaplastic Oligodendroglioma,0
11966,Back,Vaginal Adenoid Cystic Carcinoma,0
11967,3+ Answer to Question,Melanomatosis,0
11968,Array,Splenic Manifestation of Hairy Cell Leukemia,0
11969,Vibroacoustic Stimulation,Squamous cell carcinoma of lip,0
11970,Concept History,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11971,Numbers,Congenital hamartoma,0
11972,Interventional procedure,Vaginal Adenoid Cystic Carcinoma,0
11973,Abdomen distended,benign mature teratoma of pancreas,0
11974,High risk,Pancreatic Intraepithelial Neoplasia-3,0
11975,active (HL7 RoleLink),Congenital hamartoma,0
11976,Person Name,Adult Acute Eosinophilic Leukemia,0
11977,Cancer Other,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11978,Low Mitosis-Karyorrhexis Index,FIGO Stage II Ovarian Cancer,0
11979,per second,Recurrent Uveal Melanoma,0
11980,Canada,Digestive System Hodgkin Lymphoma,0
11981,Telencephalon,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
11982,Cancer Genus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
11983,Aspects of signs,Malignant melanoma of eyelid,0
11984,Free of (attribute),Intraepithelial Melanocytic Hyperplasia,0
11985,NCI CTEP SDC Astrocytoma,Precursor B-lymphoblastic lymphoma stage II,0
11986,Bladder Continence Question,Extracranial Neuroblastoma,0
11987,high - ActExposureLevelCode,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
11988,Stage,Mucinous cystadenofibroma,0
11989,Levels (qualifier value),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
11990,Increase,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
11991,Polycythemia,Digestive System Hodgkin Lymphoma,0
11992,physiological aspects,Localized Ewing Sarcoma,0
11993,Qualitative form,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
11994,Cell Device,Childhood Choriocarcinoma,0
11995,Immune,Refractory Barrett Esophagus,0
11996,Form:Finding:Point in time:{Setting}:Document:{Role},Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
11997,Face (spatial concept),mucinous adenocarcinoma of gallbladder,0
11998,Benign,Stage II Carcinoma of Penis,0
11999,combination of objects,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12000,Formation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12001,Risk,Locally Advanced Squamous Cell Carcinoma,0
12002,Extension,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12003,Dairy Cream,Heavy Chain Deposition Disease,0
12004,4+ Answer to question,Bladder squamous cell carcinoma stage I,0
12005,Vaginal (intended site),Hemangioma,0
12006,Physical Medical Procedure,Secondary malignant neoplasm of lymph node,0
12007,Biopsy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12008,Factor,ICHTHYOSIS,0
12009,Network Device,Female Breast Carcinoma,0
12010,How Often Itching,Neoplasms,0
12011,Apply (administration method),Tonsillar Carcinoma,0
12012,Palmitic Acid,Multiple Endocrine Neoplasia,0
12013,Greater than one,Neonatal leukemia,0
12014,Related personal status,Type II Endometrial Adenocarcinoma,0
12015,Further,Childhood Anaplastic Large Cell Lymphoma,0
12016,Changing,Intestinal Metaplasia of Bladder Urothelium,0
12017,seconds,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12018,Mediator brand of benfluorex hydrochloride,Recurrent Testicular Lymphoma,0
12019,Screening Study,Endometrial Small Cell Carcinoma,0
12020,Pediatric Neoplasm,Cervical Squamous Intraepithelial Neoplasia,0
12021,High Level,mucinous adenocarcinoma of gallbladder,0
12022,diagnosis aspect,Pancreatic Intraepithelial Neoplasia-3,0
12023,Treatment Epoch,Lung squamous cell carcinoma stage I,0
12024,Plasmacytoma - category,Recurrent Uveal Melanoma,0
12025,Numbers,Splenic Manifestation of Hairy Cell Leukemia,0
12026,Including (qualifier),Childhood Lymphoma,0
12027,Science of Morphology,Mucinous neoplasm,0
12028,Uveal melanoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12029,Tobacco smoking behavior,Plexosarcoma,0
12030,Adult human body,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12031,Sexual Partners,Thymoma malignant recurrent,0
12032,Ovary,Recurrent Uveal Melanoma,0
12033,Small,Childhood Lymphoma,0
12034,Therapeutic radiology procedure,Undifferentiated Endocervical Sarcoma,0
12035,Therapeutic radiology procedure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12036,Infection,Angiosarcoma of liver,0
12037,liter,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12038,described,Transitional cell carcinoma,0
12039,Possible,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12040,Progress,Intraepithelial Melanocytic Hyperplasia,0
12041,Less often,Pleomorphic adenoma of parotid gland,0
12042,Cancer Genus,Ovarian germ cell choriocarcinoma stage IV,0
12043,Pathogenic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12044,Symptoms,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12045,Visual Impairment,Kaposi's sarcoma of skin,0
12046,Thymectomy,Human Papillomavirus-Related Carcinoma,0
12047,mononuclear cells,Localized Ewing Sarcoma,0
12048,defective,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12049,Problems - What subject filter,Testicular cancer metastatic,0
12050,Therapeutic radiology procedure,malignant lymphoma of pancreatic lymph nodes,0
12051,Known,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12052,Diagnosis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12053,Array,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12054,Immune system,Blepharal carcinoma,0
12055,Location,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12056,Surgery specialty,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12057,Negation,Serous cystadenocarcinoma ovary,0
12058,Sex Cord-Stromal Tumor,Recurrent Uveal Melanoma,0
12059,Abnormal Reference Range,Acantholytic squamous cell carcinoma,0
12060,Anabolism,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12061,Enlarged,Digestive System Hodgkin Lymphoma,0
12062,What subject filter - Result,Non-Metastatic Gestational Trophoblastic Tumor,0
12063,Doubling Time,Acantholytic squamous cell carcinoma,0
12064,40%,Childhood Anaplastic Large Cell Lymphoma,0
12065,Common (qualifier value),Angiosarcoma of liver,0
12066,Hormonal,Placental aromatase deficiency,0
12067,Occurrence Indicator,Stage III Cutaneous Melanoma AJCC v6,0
12068,Approximate,Engraftment syndrome,0
12069,Approximate,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12070,therapeutic aspects,Intraepithelial Melanocytic Hyperplasia,0
12071,site-specific telomere resolvase activity,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12072,Anaplastic astrocytoma,Astrocytoma of brain,0
12073,<3 (qualifier value),Gallbladder adenoma,0
12074,Categories,Maxillary Sinus Adenocarcinoma,0
12075,Affect (mental function),Adenocarcinoma,0
12076,Protons,Malignant melanoma of eyelid,0
12077,Congenital anomaly of liver,Benign neoplasm of thorax,0
12078,Shortness of Breath Visual Analogue Scale,Childhood Extragonadal Malignant Germ Cell Tumor,0
12079,3+ Answer to Question,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12080,skin color,Clonal Hematopoiesis of Indeterminate Potential,0
12081,Pickle,Recurrent Testicular Lymphoma,0
12082,Head,Chronic Myelomonocytic Leukemia-2,0
12083,Togo,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12084,Sequence Data Type,Grade 3a Malignant Neoplasm,0
12085,Visceral,Nasal cavity carcinoma,0
12086,Formation,Adenocarcinoma of duodenum,0
12087,Operative Surgical Procedures,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12088,Lymphoma,Adenocarcinoma,0
12089,month,Colorectal cancer,0
12090,Analysis of substances,Stage IV Colorectal Cancer AJCC v8,0
12091,Statistical Significance,Cerebral Primitive Neuroectodermal Tumor,0
12092,Antibiotics,Grade 3a Malignant Neoplasm,0
12093,Genus Chalazion,Mucinous adenocarcinoma gastric,0
12094,Reciprocal translocation,Intestinal Neuroendocrine Carcinoma,0
12095,PCYT1A wt Allele,Endometrial Small Cell Carcinoma,0
12096,To,Localized Askin Tumor,0
12097,Medulla,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12098,mast cell,Adult Alveolar Soft Part Sarcoma,0
12099,Pancreas,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12100,Statistical Significance,Mucinous adenocarcinoma,0
12101,Milk - dietary,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12102,Usually,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12103,risk factors - observation list,Testicular cancer metastatic,0
12104,Methods aspects,Primary Cutaneous Plasmablastic Lymphoma,0
12105,Adverse Event by CTCAE Category,Carcinoma of submandibular gland,0
12106,peripheral blood,Choroid Necrotic Melanoma,0
12107,Giant Cells,Ovarian germ cell choriocarcinoma stage IV,0
12108,Females,Anterior Urethral Malignant Neoplasm,0
12109,radiotherapeutic,Multiple Skull Base Meningiomas,0
12110,Sublingual Gland,Pancreatic Intraepithelial Neoplasia-3,0
12111,Cellular infiltrate,Recurrent Primary Lymphoma of Bone,0
12112,Mobility aid,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12113,Lighter device,Childhood Fibrillary Astrocytoma,0
12114,Does play,Benign Carotid Body Paraganglioma,0
12115,Surgical reduction,Methotrexate-Associated Hodgkin Lymphoma,0
12116,Increased,Non-Metastatic Gestational Trophoblastic Tumor,0
12117,shared attribute,Refractory Ependymoma,0
12118,Behavior:-:Point in time:^Patient:-,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12119,Symptoms,Chondrosarcoma,0
12120,Females,Hereditary Diffuse Gastric Adenocarcinoma,0
12121,80%,Recurrent Primary Lymphoma of Bone,0
12122,biopsy characteristics,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12123,Disease,Adult Acute Eosinophilic Leukemia,0
12124,Biomaterial Treatment,Cervical Fibroepithelial Polyp,0
12125,Abnormal,Fourth Ventricle and Brain Stem Ependymal Tumor,0
12126,common procedures,Unicystic ameloblastoma,0
12127,Beginning,Rhabdomyosarcoma with ganglionic differentiation,0
12128,radiotherapeutic,Stage III Cutaneous Melanoma AJCC v6,0
12129,Symptoms aspect,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12130,Formation,Pancreatic carcinoma,0
12131,Smear - instruction imperative,Hereditary Diffuse Gastric Adenocarcinoma,0
12132,Two,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12133,Status post,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12134,common types,malignant lymphoma of pancreatic lymph nodes,0
12135,Supratentorial Embryonal Tumor,Germinoma,0
12136,Type A,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12137,Tumor Mass,Heavy Chain Deposition Disease,0
12138,List,Intraepithelial Melanocytic Hyperplasia,0
12139,Cervical lymph node group,Cervical Fibroepithelial Polyp,0
12140,Experimental Result,Tumorlet,0
12141,Frequently,Pancreatic carcinoma,0
12142,Surgical aspects,Neonatal leukemia,0
12143,Family history of leukemia,Kaposi's sarcoma of skin,0
12144,>90,Vaginal Adenoid Cystic Carcinoma,0
12145,Painless,Hemangioma,0
12146,Space - property,Leptomeningeal sarcoma,0
12147,Phrase,Rhabdomyosarcoma with ganglionic differentiation,0
12148,Operation excision,Localized Askin Tumor,0
12149,Basal Cell Cancer,Refractory Bladder Carcinoma,0
12150,How Much Distress Diarrhea,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12151,Unknown GENC,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12152,Cells,Intraepithelial Melanocytic Hyperplasia,0
12153,Part,Giant cell angiofibroma,0
12154,Duodenum,FIGO Stage IVA Ovarian Cancer,0
12155,Out (direction),Childhood Central Nervous System Ganglioneuroblastoma,0
12156,Include (action),Brain Ependymoma,0
12157,metaplastic cell transformation,Low Grade Squamous Intraepithelial Neoplasia,0
12158,Post,Carcinoma,0
12159,Ulceration,Small Intestinal Villous Adenoma,0
12160,Diagnosis,High Grade Glandular Intraepithelial Neoplasia,0
12161,Firstly,Digestive System Hodgkin Lymphoma,0
12162,Always (frequency),adenosquamous carcinoma of breast,0
12163,Type 1,Metaplastic carcinoma of breast,0
12164,Dysuria,Refractory Bladder Carcinoma,0
12165,Fever,Malignant neoplasm of thalamus,0
12166,Neoplasms,Childhood Lung Non-Small Cell Carcinoma,0
12167,Gene Cluster Text Format,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12168,Linear,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12169,Volume (publication),Neoplasms,0
12170,Therapeutic procedure,Angiosarcoma of liver,0
12171,4+ Answer to question,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12172,Occur (action),Multiple Endocrine Neoplasia,0
12173,Surgery specialty,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12174,Mucous body substance,Female Breast Carcinoma,0
12175,Malignant neoplasm of brain,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12176,Glandular stomach,Methotrexate-Associated Hodgkin Lymphoma,0
12177,Structure of subclavian vein,Melanomatosis,0
12178,Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12179,Neoplasms,Malignant neoplasm of gallbladder,0
12180,Parameterized Data Type - Set,Metaplastic carcinoma of breast,0
12181,Superkingdom (taxonomic category),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
12182,white blood cell type,embryonal rhabdomyosarcoma of prostate,0
12183,Immunotherapy,Adult Anaplastic Oligodendroglioma,0
12184,FAT1 wt Allele,Hereditary Diffuse Gastric Adenocarcinoma,0
12185,Five,Congenital hamartoma,0
12186,Feel Nausea,Anterior Urethral Malignant Neoplasm,0
12187,Vermilion border of lip,Malignant Testicular Sertoli Cell Tumor,0
12188,Have Been Vomiting,Xeroderma pigmentosum,0
12189,Neutral Charge,Stage III Cutaneous Melanoma AJCC v6,0
12190,Broken skin,embryonal rhabdomyosarcoma of prostate,0
12191,Formed,Locally Advanced Epithelioid Hemangioendothelioma,0
12192,Cell septum,Type II Endometrial Adenocarcinoma,0
12193,Negation,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
12194,Gram per Deciliter,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12195,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Parathyroid Gland Adenocarcinoma,0
12196,Intact,FIGO Stage II Ovarian Cancer,0
12197,Prognosis:Find:Pt:^Patient:Nom,Bladder adenocarcinoma stage IV,0
12198,Support,Ichthyosis,0
12199,Very High Level,Bladder squamous cell carcinoma stage I,0
12200,Spreading (qualifier value),benign mature teratoma of pancreas,0
12201,Fatal,Advanced Lung Carcinoma,0
12202,Therapeutic radiology procedure,Collecting Duct Carcinoma of the Kidney,0
12203,Surrounding (qualifier value),Nasal cavity carcinoma,0
12204,Muscle Contraction,Metastatic Ductal Breast Carcinoma,0
12205,Biomaterial Treatment,Leptomeningeal sarcoma,0
12206,Occurrence Indicator,Congenital hamartoma,0
12207,MOSTLY,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12208,Involvement with,Carcinomatosis of peritoneal cavity,0
12209,Oropharyngeal,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12210,Surgical aspects,Metastatic Neoplasm to the Gallbladder,0
12211,Body tissue,Intraepithelial Melanocytic Hyperplasia,0
12212,Result,Cervical Adenomyoma,0
12213,Africa,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12214,Point Name,Brain Ependymoma,0
12215,Wound Healing,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12216,Central Nervous System,Female Breast Carcinoma,0
12217,Sounds device,Bladder Neuroendocrine Neoplasm,0
12218,Medical service,Maxillary Sinus Adenoid Cystic Carcinoma,0
12219,Science of Statistics,Melanomatosis,0
12220,Low Level,Astrocytoma of brain,0
12221,Forecast of outcome,Extra-abdominal fibromatosis,0
12222,Childhood diseases,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12223,Concern,sarcoma of spinal cord,0
12224,Enlarged,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12225,Benign,Precursor B-lymphoblastic lymphoma stage II,0
12226,Occur (action),Diffuse malignant mesothelioma,0
12227,Early disease stage,Spermatocytic seminoma,0
12228,Body structure,Fibroadenoma of breast,0
12229,Weight Loss,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12230,Symptoms,Melanomatosis,0
12231,Related personal status,Melanomatosis,0
12232,Most,Extracranial Neuroblastoma,0
12233,risk factors,Recurrent Testicular Lymphoma,0
12234,Embryonic tissue,Non-Metastatic Gestational Trophoblastic Tumor,0
12235,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12236,Symptoms aspect,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12237,Common (qualifier value),Acantholytic squamous cell carcinoma,0
12238,Formation,Cherubism,0
12239,Brain Neoplasms,Acantholytic squamous cell carcinoma,0
12240,Pharmacotherapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12241,Group Object,Recurrent Rhabdomyosarcoma,0
12242,Involvement with,High Grade Glandular Intraepithelial Neoplasia,0
12243,PGR gene,Stage IB Pancreatic Cancer AJCC v8,0
12244,Weight measurement scales,Atypical Lobular Breast Hyperplasia,0
12245,Device Spring,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12246,Ependyma,FIGO Stage IVA Ovarian Cancer,0
12247,Breast tissue sample,Congenital hamartoma,0
12248,Nursing interventions,Stage IB Pancreatic Cancer AJCC v8,0
12249,error,Localized Askin Tumor,0
12250,Class,Carcinomatosis of peritoneal cavity,0
12251,*Type - Kind of quantity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12252,Woman,Mucinous adenocarcinoma gastric,0
12253,Occur (action),Malignant melanoma of eyelid,0
12254,Eye,Cancer of Urinary Tract,0
12255,Residential flat,Recurrent Uveal Melanoma,0
12256,Genes,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12257,Cancer stage iv,Astrocytoma of brain,0
12258,Tryptophanase,Lung squamous cell carcinoma stage I,0
12259,high - ActExposureLevelCode,Acantholytic squamous cell carcinoma,0
12260,Fibrosis,Refractory Bladder Carcinoma,0
12261,Financial Account,Platinum-Resistant Lung Small Cell Carcinoma,0
12262,Often - answer to question,Undifferentiated Endocervical Sarcoma,0
12263,High,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12264,Voice,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12265,Aggressive behavior,Recurrent Testicular Lymphoma,0
12266,Poor - grade value,Kaposi's sarcoma of extrahepatic bile duct,0
12267,Lung,Childhood Fibrillary Astrocytoma,0
12268,Pain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12269,Known,Adult Hepatocellular Carcinoma,0
12270,Mother (person),Cervical Fibroepithelial Polyp,0
12271,Operative Surgical Procedures,Platinum-Resistant Lung Small Cell Carcinoma,0
12272,Woman,Bladder adenocarcinoma stage IV,0
12273,Mammal liver preparation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12274,Pancreatic carcinoma,Neoplasms,0
12275,Common (qualifier value),Anterior Urethral Malignant Neoplasm,0
12276,Ultraviolet Rays,Low Grade Squamous Intraepithelial Neoplasia,0
12277,Ability,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12278,Body part,Acantholytic squamous cell carcinoma,0
12279,Malignant Neoplasms,Liver Cavernous Hemangioma,0
12280,Known,Melanomatosis,0
12281,various other intestinal adsorbents in ATC,Benign tumor of eyelid,0
12282,Early,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12283,Therapeutic procedure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12284,eTMF Content Model Code,Plexosarcoma,0
12285,Gastric Content,Tongue Alveolar Soft Part Sarcoma,0
12286,Secondary Neoplasm,Squamous cell carcinoma of lip,0
12287,Neoplasms,Kaposi's sarcoma of extrahepatic bile duct,0
12288,Completely - dosing instruction fragment,Childhood Central Nervous System Ganglioneuroblastoma,0
12289,Detached,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12290,Consultation,Engraftment syndrome,0
12291,Function Axis,Recurrent Uveal Melanoma,0
12292,HLA Class II Histocompatibility Antigen Gamma Chain,Benign Anal Granular Cell Tumor,0
12293,Call (Instruction),Hyperplasia of pituitary gland,0
12294,Benign melanocytic nevus,Stage III Cutaneous Melanoma AJCC v6,0
12295,Lesion,Mixed parotid tumor,0
12296,factor A,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
12297,Occur (action),Adenocarcinoma of duodenum,0
12298,Possibly Related to Intervention,malignant lymphoma of pancreatic lymph nodes,0
12299,Body tissue,Bladder squamous cell carcinoma stage I,0
12300,Persons,Necrotizing Funisitis,0
12301,Laboratory Procedures,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12302,Certain (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
12303,N not otherwise specified Antibody,Mastocytosis,0
12304,Contain (action),Benign Apocrine Neoplasm,0
12305,Identified,Mucinous adenocarcinoma gastric,0
12306,Architecture,Locally Advanced Squamous Cell Carcinoma,0
12307,Cancer Genus,Acute lymphadenitis,0
12308,Condition,Cervical Fibroepithelial Polyp,0
12309,Ultrasonography,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12310,Mass in breast,Thyroid Hurthle Cell Carcinoma,0
12311,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
12312,Back Pain,Gallbladder adenoma,0
12313,Endodermal,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12314,M NOS ANTIBODY,Kaposi's sarcoma of extrahepatic bile duct,0
12315,Location of Pharyngeal Residue Following Swallowing,Periosteal Osteosarcoma,0
12316,Parotid Neoplasms,Testicular cancer metastatic,0
12317,Ovary,Malignant melanoma of eyelid,0
12318,Cure (remedy),Childhood Choriocarcinoma,0
12319,Type - attribute,Thymoma malignant recurrent,0
12320,Either,Cancer of Urinary Tract,0
12321,Function Axis,Clonal Hematopoiesis of Indeterminate Potential,0
12322,United States,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12323,shared attribute,ROSE Cluster 3,0
12324,Colorectal Cancer,Giant cell angiofibroma,0
12325,diagnosis aspect,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12326,Urothelial Carcinoma,Tongue Alveolar Soft Part Sarcoma,0
12327,Approximate,Astrocytoma of brain,0
12328,Disease Screening,Choroid Necrotic Melanoma,0
12329,Area,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
12330,Supernumerary,clear cell adenocarcinoma of gallbladder,0
12331,Overlap,Ampulla of Vater Tubular Adenoma,0
12332,Tumor Mass,Hemangioma,0
12333,Type A,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12334,Version,Colorectal High Grade B-Cell Lymphoma,0
12335,Etiology,Intraepithelial Melanocytic Hyperplasia,0
12336,Rare,Cartilaginous exostosis,0
12337,Insecticides,Liver Lymphangioma,0
12338,pharmacotherapeutic,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
12339,Removed,Tonsillar Carcinoma,0
12340,Major,Ovarian germ cell choriocarcinoma stage IV,0
12341,Primary malignant neoplasm,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
12342,Liver,Melanomatosis,0
12343,Symptoms,Stage III Adult Immunoblastic Lymphoma,0
12344,Europe,Vaginal Adenoid Cystic Carcinoma,0
12345,Methods aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12346,React,Occult Lung Adenosquamous Carcinoma,0
12347,Distal (qualifier value),Occult Lung Adenosquamous Carcinoma,0
12348,Rare,Undifferentiated Endocervical Sarcoma,0
12349,Bone Pain,Heavy Chain Deposition Disease,0
12350,International Classification of Disease,Mucinous adenocarcinoma gastric,0
12351,View,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12352,MOSTLY,Mucinous adenocarcinoma gastric,0
12353,Occurrence Indicator,Vaginal Adenoid Cystic Carcinoma,0
12354,Painless,Intestinal Neuroendocrine Carcinoma,0
12355,Have Nausea,malignant lymphoma of pancreatic lymph nodes,0
12356,Growth,Benign Apocrine Neoplasm,0
12357,As Much as Desired,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12358,Abdomen+,Recurrent Testicular Lymphoma,0
12359,Cure (remedy),Botryoid-Type Embryonal Rhabdomyosarcoma,0
12360,Relocation of home or business,Refractory Bladder Carcinoma,0
12361,Fresh Specimen,Cartilaginous exostosis,0
12362,Point,Unresectable Rhabdomyosarcoma,0
12363,More,High Grade Glandular Intraepithelial Neoplasia,0
12364,Part of,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
12365,Lacrimal sac,Kaposi's sarcoma of extrahepatic bile duct,0
12366,Cover - action,Adult Alveolar Soft Part Sarcoma,0
12367,Have Weight Loss,Cancer of Urinary Tract,0
12368,Numbers,squamous cell carcinoma of the thyroid gland,0
12369,Several,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12370,Paraplegia,Hemangioma,0
12371,Age-Years,Breast Ductal Adenoma,0
12372,To,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
12373,Genitourinary system,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12374,Experimental Result,Metastatic Lung Small Cell Carcinoma,0
12375,Study Protocol,Blepharal carcinoma,0
12376,Classification,Granular Cell Leiomyosarcoma,0
12377,Form:Finding:Point in time:{Setting}:Document:{Role},Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12378,Supraglottis (body part),BRCA2 Syndrome,0
12379,Requirement,Engraftment syndrome,0
12380,Irregular,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12381,Precision - second,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12382,Carcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12383,Persons,Unfavorable Non-Hodgkin Lymphoma,0
12384,Bladder Cancer Pathway,Xeroderma pigmentosum,0
12385,Worsening pattern,Human Papillomavirus-Related Carcinoma,0
12386,Symptoms aspect,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12387,Variant,Blepharal carcinoma,0
12388,Various patch test substance,Adult Acute Eosinophilic Leukemia,0
12389,Oral region,Grade 3a Malignant Neoplasm,0
12390,Hodgkin Disease,BRCA2 Syndrome,0
12391,American College of Cardiology/American Heart Association Lesion Complexity Score C,Methotrexate-Associated Hodgkin Lymphoma,0
12392,*Type - Kind of quantity,BRCA2 Syndrome,0
12393,Irregular,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12394,Twice - dosing instruction fragment,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12395,Name (property) (qualifier value),Engraftment syndrome,0
12396,cancer therapy,Diffuse malignant mesothelioma,0
12397,Retinoic Acid Response Element,Recurrent Primary Lymphoma of Bone,0
12398,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12399,Primary malignant neoplasm,Adult Hepatocellular Carcinoma,0
12400,Participation Type - origin,Localized Askin Tumor,0
12401,Diagnosis Study,Tongue Alveolar Soft Part Sarcoma,0
12402,One,Methotrexate-Associated Hodgkin Lymphoma,0
12403,First (number),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12404,Persons,Bladder adenocarcinoma stage IV,0
12405,Before,Locally Advanced Epithelioid Hemangioendothelioma,0
12406,Females,Intraepithelial Melanocytic Hyperplasia,0
12407,Device system,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12408,Contain (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
12409,50%,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12410,Probable diagnosis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12411,Malignant Neoplasms,FIGO Stage IVA Ovarian Cancer,0
12412,Small cell carcinoma of lung,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12413,To,Occult Lung Adenosquamous Carcinoma,0
12414,Spreading (qualifier value),Choroid Epithelioid Cell Melanoma,0
12415,Togo,Lung squamous cell carcinoma stage I,0
12416,Smear - instruction imperative,Acute lymphadenitis,0
12417,shared attribute,Benign neoplasm of eye,0
12418,Area,FIGO Stage IVA Ovarian Cancer,0
12419,Persons,Acantholytic squamous cell carcinoma,0
12420,Mathematical Factor,Uterine Cancer,0
12421,combination of objects,Medulloblastoma,0
12422,Meninges,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12423,Grade III Meningioma,Periosteal Osteosarcoma,0
12424,Recommendation,Testicular cancer metastatic,0
12425,diagnosis aspect,Testicular cancer metastatic,0
12426,Diagnosis,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12427,Universal restriction modifier (core metadata concept),ICHTHYOSIS,0
12428,Affect (mental function),Thyroid Hurthle Cell Carcinoma,0
12429,Mixed Tumor,Malignant neoplasm of thalamus,0
12430,Large,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12431,Salivary Gland Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
12432,Esophagus,Acute Undifferentiated Leukemia,0
12433,Condition,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12434,Extrinsic,Adenocarcinoma of duodenum,0
12435,Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12436,Cell (compartment),FIGO Stage IVA Ovarian Cancer,0
12437,Common (qualifier value),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12438,Cervical lymph node group,Spermatocytic seminoma,0
12439,Hour Times Percent,Malignant neoplasm of olfactory nerve,0
12440,3+ Score,Mucinous adenocarcinoma gastric,0
12441,Smoking,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12442,Semilunar fold of fauces,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12443,Reduced,Hemangioma,0
12444,Malignant Neoplasms,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
12445,Lymphocyte component of blood,Stage 0 Penile Cancer AJCC v8,0
12446,Cartilage,Placental aromatase deficiency,0
12447,Approximate,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12448,appendage,Refractory Barrett Esophagus,0
12449,Cavern,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12450,SPINK5 gene,Hyperplasia of pituitary gland,0
12451,Neoplasms,Noninfiltrating Intraductal Carcinoma,0
12452,Cicatrix,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12453,Evaluation procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12454,Correlation,Bladder squamous cell carcinoma stage I,0
12455,Childhood,Adenocarcinoma,0
12456,Poor function,Stage III Cutaneous Melanoma AJCC v6,0
12457,Primary malignant neoplasm,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
12458,Concept History,Tonsillar Carcinoma,0
12459,Salivary Gland Neoplasms,Benign Anal Granular Cell Tumor,0
12460,Hematologic Tests,Stage II Carcinoma of Penis,0
12461,Free of (attribute),Digestive System Hodgkin Lymphoma,0
12462,Measures,Malignant neoplasm of choroid,0
12463,Platelets Product,Adult Alveolar Soft Part Sarcoma,0
12464,Related personal status,Giant cell angiofibroma,0
12465,status - In progress,Recurrent Testicular Lymphoma,0
12466,Fibrous connective tissue,Ovarian germ cell choriocarcinoma stage IV,0
12467,Common (qualifier value),Refractory Barrett Esophagus,0
12468,Risk,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12469,Body tissue,Benign neoplasm of eye,0
12470,General surgery specialty,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12471,Manufactured form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12472,Manufactured form,Extra-Adrenal Paraganglioma,0
12473,Cancer/Testis Antigen,Stage IV Penile Cancer AJCC v7,0
12474,Abnormal Reference Range,Advanced Uterine Corpus Carcinosarcoma,0
12475,Form:Finding:Point in time:{Setting}:Document:{Role},Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12476,History,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12477,flower allergenic extracts,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12478,Radiation,Tonsillar Carcinoma,0
12479,Sample Mean,BRCA2 Syndrome,0
12480,Acquired (qualifier value),Acute Undifferentiated Leukemia,0
12481,Term (temporal),Childhood Extragonadal Malignant Germ Cell Tumor,0
12482,Related personal status,Angiosarcoma of liver,0
12483,Bodily secretions,Thyroid Hurthle Cell Carcinoma,0
12484,Call (Instruction),Malignant Testicular Sertoli Cell Tumor,0
12485,Direct (qualifier),Hemangioma,0
12486,shared attribute,Intracortical osteosarcoma,0
12487,follow-up,Acute Undifferentiated Leukemia,0
12488,Example,Childhood Lymphoma,0
12489,3+ Score,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12490,Decision,Carcinoma of urinary bladder,0
12491,In Blood,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12492,Procedure (set of actions),Splenic Manifestation of Hairy Cell Leukemia,0
12493,Bayer Corneal Epitheliopathy Grade 3,Digestive System Hodgkin Lymphoma,0
12494,Mathematical Operator,sarcoma of spinal cord,0
12495,Characterization,Childhood Thyroid Gland Follicular Carcinoma,0
12496,Therapeutic radiology procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12497,Occurrence,Ovarian Carcinoid Tumor,0
12498,Primary malignant neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
12499,Greater Than,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12500,Fresh Water,FIGO Stage II Ovarian Cancer,0
12501,lymph nodes,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12502,Ultrasonic Shockwave,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12503,Table Cell Horizontal Align - left,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12504,Colon Carcinoma,Benign Anal Granular Cell Tumor,0
12505,Genus Anemia,High Grade Glandular Intraepithelial Neoplasia,0
12506,Usually,Hemangioma,0
12507,Primary malignant neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12508,Referring,Cancer of Urinary Tract,0
12509,Microplate Well,Human Papillomavirus-Related Carcinoma,0
12510,To,Squamous cell carcinoma of lip,0
12511,Type - attribute,Malignant neoplasm of gallbladder,0
12512,Associated with,Locally Advanced Squamous Cell Carcinoma,0
12513,Elderly (population group),Mixed astrocytoma-ependymoma,0
12514,Etiology aspects,Intraepithelial Melanocytic Hyperplasia,0
12515,Administration procedure,benign mature teratoma of pancreas,0
12516,Most,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12517,Usually Need Help from Another Person for Reach,Carcinoma of urinary bladder,0
12518,body system,Acute Undifferentiated Leukemia,0
12519,Fatigue,FIGO Stage II Ovarian Cancer,0
12520,Differentiation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12521,Aggressive course,Malignant melanoma of eyelid,0
12522,treatment - ActInformationManagementReason,Grade 3a Malignant Neoplasm,0
12523,Post,Anterior Urethral Malignant Neoplasm,0
12524,Symptoms aspect,Choroid Epithelioid Cell Melanoma,0
12525,Development,Acantholytic squamous cell carcinoma,0
12526,List,Benign squamous cell tumor,0
12527,Central African Republic,Mucinous adenocarcinoma gastric,0
12528,Providing (action),Small cell neuroendocrine carcinoma of bladder,0
12529,Low Grade,Malignant Testicular Sertoli Cell Tumor,0
12530,Appearance Distress Question,Giant cell angiofibroma,0
12531,per year,Kaposi's sarcoma of skin,0
12532,Triggered by,Precursor B-lymphoblastic lymphoma stage II,0
12533,Including (qualifier),Hemangioma,0
12534,brain cell,Splenic Manifestation of Hairy Cell Leukemia,0
12535,Metastatic malignant neoplasm to brain,Acantholytic squamous cell carcinoma,0
12536,Cultured Cell Line,Hodgkin Disease,0
12537,Uredinales,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12538,shared attribute,Mucinous cystadenofibroma,0
12539,melanoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
12540,System (unit of presentation),Engraftment syndrome,0
12541,Infrequent,Type II Endometrial Adenocarcinoma,0
12542,seen,Stage IB Pancreatic Cancer AJCC v8,0
12543,Renal pelvis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12544,Confirmation,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
12545,Persistent,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12546,Related personal status,Primary Cutaneous Plasmablastic Lymphoma,0
12547,Abdomen,Testicular cancer metastatic,0
12548,North America,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
12549,Cell (compartment),Unfavorable Non-Hodgkin Lymphoma,0
12550,Eye,Undifferentiated Endocervical Sarcoma,0
12551,insensitivity,Uterine Cancer,0
12552,Term (lexical),Acute lymphadenitis,0
12553,Treatment Epoch,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
12554,Oral contraception,Noninfiltrating Intraductal Carcinoma,0
12555,Set scale,Basal Cell Ameloblastoma,0
12556,Complete Pharyngeal Contraction,Uterine Cancer,0
12557,Abnormal,Mucinous adenocarcinoma,0
12558,To,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12559,Disease Screening,Spongiotic dermatitis,0
12560,Dependent for Toilet Use,Childhood Anaplastic Large Cell Lymphoma,0
12561,Living Alone,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12562,Secretory Vesicles,Localized Askin Tumor,0
12563,Part of,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12564,Negation,Thyroid Hurthle Cell Carcinoma,0
12565,PREVENT (product),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
12566,55,Bladder squamous cell carcinoma stage I,0
12567,Linear,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12568,Carcinoma,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
12569,Night time,embryonal rhabdomyosarcoma of prostate,0
12570,Bothered by Vomiting,Metastatic Lung Neuroendocrine Neoplasm,0
12571,Ectodermal,Vaginal Adenoid Cystic Carcinoma,0
12572,Occurrence,Bladder adenocarcinoma stage IV,0
12573,Blood,Maxillary Sinus Adenocarcinoma,0
12574,Basis - conceptual entity,Mixed astrocytoma-ependymoma,0
12575,Lung,Pancreatic carcinoma,0
12576,Classification,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12577,New,Recurrent Primary Lymphoma of Bone,0
12578,Adult Anaplastic Astrocytoma,Adenocarcinoma,0
12579,United States,Malignant neoplasm of olfactory nerve,0
12580,cancer location,Urethral Carcinoma,0
12581,3+ Score,Leiomyoma of Gallbladder,0
12582,Descending,Clonal Hematopoiesis of Indeterminate Potential,0
12583,Disease,Bladder adenocarcinoma stage IV,0
12584,intended - ParticipationSignature,Peripheral primitive neuroectodermal tumor of soft tissue,0
12585,per year,Bladder Neuroendocrine Neoplasm,0
12586,HEMOCHROMATOSIS,Kaposi's sarcoma of extrahepatic bile duct,0
12587,Known,Refractory Bladder Carcinoma,0
12588,Metastatic Neoplasm,Stage III Adult Immunoblastic Lymphoma,0
12589,prior radiation therapy,Nasal cavity carcinoma,0
12590,Affecting,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12591,Multiple Partners,Maxillary Sinus Adenoid Cystic Carcinoma,0
12592,Response process,adenoid cystic carcinoma of lung,0
12593,More,FIGO Stage II Ovarian Cancer,0
12594,Include (action),Malignant melanoma of eyelid,0
12595,Pharmacotherapy,Transitional cell carcinoma,0
12596,Optical filter,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12597,Local disease,FIGO Stage II Ovarian Cancer,0
12598,Lesion,Refractory Barrett Esophagus,0
12599,Choose (action),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12600,2+,Chondrosarcoma,0
12601,Skin,Blood Vessel Tumors,0
12602,Endocrine Cells,Childhood Central Nervous System Ganglioneuroblastoma,0
12603,Administration procedure,Chronic Myelomonocytic Leukemia-2,0
12604,Electromagnetic Radiation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12605,Liver,Localized Ewing Sarcoma,0
12606,Common (qualifier value),ROSE Cluster 3,0
12607,Preventive monitoring,Brain Tumor,0
12608,low exposure,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
12609,Pancreas,Xeroderma pigmentosum,0
12610,Persons,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12611,Nursing interventions,embryonal rhabdomyosarcoma of prostate,0
12612,Account number:Identifier:Point in time:^Patient:Nominal,Diffuse malignant mesothelioma,0
12613,CD44 wt Allele,Engraftment syndrome,0
12614,shared attribute,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12615,Include (action),Recurrent Primary Lymphoma of Bone,0
12616,Decision,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12617,Synonym,Stage III Cutaneous Melanoma AJCC v6,0
12618,Removal of bladder,Breast Apocrine Adenoma,0
12619,Symptoms,Endometrial Small Cell Carcinoma,0
12620,Lymphatic vessel,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12621,radiotherapeutic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12622,FAT1 wt Allele,Maxillary Sinus Adenoid Cystic Carcinoma,0
12623,Pleomorphic carcinoma,Cerebral Primitive Neuroectodermal Tumor,0
12624,Adult Non-Hodgkin Lymphoma,Metaplastic carcinoma of breast,0
12625,therapeutic aspects,Congenital hamartoma,0
12626,Liquid substance,Stage III Cutaneous Melanoma AJCC v6,0
12627,1000000,clear cell adenocarcinoma of gallbladder,0
12628,Numerous,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12629,Myeloproliferation,Benign Anal Granular Cell Tumor,0
12630,Pruritus,Blepharal carcinoma,0
12631,AS virus,High Grade Glandular Intraepithelial Neoplasia,0
12632,Dietary Lead,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
12633,Present,Extra-Adrenal Paraganglioma,0
12634,History of present illness,Childhood Fibrillary Astrocytoma,0
12635,Diagnosis Study,Anaplastic large cell lymphoma,0
12636,Hormone Therapy,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12637,Therapeutic procedure,Engraftment syndrome,0
12638,Adult,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12639,Endometrial Carcinoma,Recurrent Rhabdomyosarcoma,0
12640,X-Ray Computed Tomography,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12641,Contact Dermatitis,Acantholytic squamous cell carcinoma,0
12642,white blood cell type,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12643,Changed status,Malignant Neoplasm with Regional Lymph Node Involvement,0
12644,70%,Deep Leiomyoma,0
12645,Thick,Carcinoma of urinary bladder,0
12646,Sometimes,Cerebral Primitive Neuroectodermal Tumor,0
12647,Occur (action),Parathyroid Gland Adenocarcinoma,0
12648,Fever,Thymic Clear Cell Carcinoma,0
12649,Night time,Lung squamous cell carcinoma stage I,0
12650,Spinal Cord,Engraftment syndrome,0
12651,European race,Cerebral Primitive Neuroectodermal Tumor,0
12652,Prevalence aspects,Liver Lymphangioma,0
12653,metastatic qualifier,Bladder adenocarcinoma stage IV,0
12654,Formation,Recurrent Rhabdomyosarcoma,0
12655,Lower (action),Blepharal carcinoma,0
12656,Malignant Neoplasms,Intestinal Neuroendocrine Carcinoma,0
12657,Open,Endometrial Small Cell Carcinoma,0
12658,Increased,Localized Malignant Neoplasm,0
12659,Classification of information,Recurrent Testicular Lymphoma,0
12660,Medical service,Intraepithelial Melanocytic Hyperplasia,0
12661,Old,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12662,Membrane Device,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12663,Basis - conceptual entity,Uterine Cancer,0
12664,Diameter (qualifier value),mucinous adenocarcinoma of gallbladder,0
12665,Communicable Diseases,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12666,20%,Locally Advanced Soft Tissue Sarcoma,0
12667,Physician:Identifier:Point in time:^Patient:Nominal,Neoplasms,0
12668,Reduction (chemical),Unfavorable Non-Hodgkin Lymphoma,0
12669,Coding,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12670,Childhood Diffuse Large B-Cell Lymphoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12671,Antibiotics,Vaginal Adenoid Cystic Carcinoma,0
12672,associated disease,Benign squamous cell tumor,0
12673,Abdomen distended,Malignant neoplasm of subglottis,0
12674,Estimated,Congenital hamartoma,0
12675,Include (action),Stage III Cutaneous Melanoma AJCC v6,0
12676,fludarabine,Kaposi's sarcoma of skin,0
12677,Glioblastoma Multiforme Pathway,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
12678,Pediatric Neoplasm,Acantholytic squamous cell carcinoma,0
12679,Pharmacotherapy,Undifferentiated Endocervical Sarcoma,0
12680,Special,Stage I Adult Non-Hodgkin Lymphoma,0
12681,MOSTLY,Prostate Lymphoma,0
12682,Part,Carcinoma ex pleomorphic adenoma of parotid gland,0
12683,Feelings,Localized Ewing Sarcoma,0
12684,high - ActExposureLevelCode,Platinum-Resistant Lung Small Cell Carcinoma,0
12685,Development,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12686,Mammary Gland Parenchyma,Metastatic Malignant Neoplasm in the Sellar Region,0
12687,include - SetOperator,Xeroderma pigmentosum,0
12688,Part of,Stage IV Childhood Non-Hodgkin Lymphoma,0
12689,Status post,Tubal Hyperplasia,0
12690,Identified,Metastatic Malignant Neoplasm in the Sellar Region,0
12691,How Often Weight Loss,Malignant melanoma of eyelid,0
12692,Operative Surgical Procedures,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12693,CD69 wt Allele,Transitional cell carcinoma,0
12694,Known,Diffuse malignant mesothelioma,0
12695,Enlarged,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12696,Treatment Effectiveness,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12697,70%,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12698,Specimen Source Codes - tumor,Medulloblastoma,0
12699,Fasting Status Indicator,Localized Askin Tumor,0
12700,Analysis of substances,benign mature teratoma of pancreas,0
12701,Qualitative form,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12702,Second Suffix,Stage 0 Lip Carcinoma,0
12703,various other nasal preparations in ATC,Hodgkin Disease,0
12704,Data call receiving device,Noninfiltrating Intraductal Carcinoma,0
12705,Hemopoietic tissue,Localized Askin Tumor,0
12706,IPSS Risk Category High,Diffuse malignant mesothelioma,0
12707,Pleura,Tonsillar Carcinoma,0
12708,Neoplasms,Mucinous adenocarcinoma gastric,0
12709,described,Benign Anal Granular Cell Tumor,0
12710,Clinical Study Follow-up,Cartilaginous exostosis,0
12711,European race,Non-Metastatic Gestational Trophoblastic Tumor,0
12712,Count of entities,Liver Lymphangioma,0
12713,Squamous cell carcinoma - category,non-Hodgkin's lymphoma of spleen,0
12714,Main,Acantholytic squamous cell carcinoma,0
12715,eTMF Content Model Code,Benign Carotid Body Paraganglioma,0
12716,Infrequent,Tubal Hyperplasia,0
12717,Others - Allergy,Uterine Cancer,0
12718,National origin,Childhood Central Nervous System Immature Teratoma,0
12719,Result,Mixed astrocytoma-ependymoma,0
12720,Multiplication,Refractory Ependymoma,0
12721,Necrosis,Periosteal Osteosarcoma,0
12722,Measures,Malignant Testicular Sertoli Cell Tumor,0
12723,Genetic Heterogeneity,Intestinal Metaplasia of Bladder Urothelium,0
12724,include - SetOperator,Papillary squamous cell carcinoma,0
12725,RMS,Heavy Chain Deposition Disease,0
12726,Neoplasms,Stage II Carcinoma of Penis,0
12727,Science of Etiology,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12728,Basal Cell Cancer,Tonsillar Carcinoma,0
12729,Continuance of life,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12730,Biologist (general),Metaplastic carcinoma of breast,0
12731,Manufactured form,Benign Anal Granular Cell Tumor,0
12732,Type - attribute,Benign Anal Granular Cell Tumor,0
12733,Biopsy,Chest Wall Fibromatosis,0
12734,Pediculus humanus capitis (eukaryote),Intestinal Neuroendocrine Carcinoma,0
12735,Tissue Specimen Code,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12736,Serving,Breast Ductal Adenoma,0
12737,metaplastic cell transformation,Liver Lymphangioma,0
12738,include - SetOperator,Benign neoplasm of thorax,0
12739,Usually,Precursor B-lymphoblastic lymphoma stage II,0
12740,Affecting,Basal Cell Ameloblastoma,0
12741,Neoplasm Metastasis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12742,Molecular Mass,Localized Malignant Neoplasm,0
12743,Cough,Breast Apocrine Adenoma,0
12744,Immunotherapy,Tongue Alveolar Soft Part Sarcoma,0
12745,Characteristics,Endometrial Small Cell Carcinoma,0
12746,Benign condition,Intraepithelial Melanocytic Hyperplasia,0
12747,Tissue Specimen Code,Advanced Lung Carcinoma,0
12748,Metastatic Neoplasm,Low Grade Squamous Intraepithelial Neoplasia,0
12749,Screening Study,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12750,History of previous events,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12751,Status post,Adenocarcinoma of the prostate metastatic,0
12752,Out (direction),Medulloblastoma,0
12753,Severe (severity modifier),Thymic Atypical Carcinoid Tumor,0
12754,Liver Cirrhosis,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12755,Chemotherapy Regimen,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12756,Tumor cells,Mucinous neoplasm,0
12757,Device system,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12758,International Classification of Diseases,Heavy Chain Deposition Disease,0
12759,Meaning,Bladder squamous cell carcinoma stage I,0
12760,Nerve injury,Childhood Central Nervous System Ganglioneuroblastoma,0
12761,Medical service,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12762,Physiology,Xeroderma pigmentosum,0
12763,10%,Xeroderma pigmentosum,0
12764,Term (temporal),Ichthyoses,0
12765,Bone structure of cranium,Small cell neuroendocrine carcinoma of bladder,0
12766,Blood group A (finding),Parathyroid Gland Adenocarcinoma,0
12767,Completely Able,Mucinous adenocarcinoma gastric,0
12768,Neuroendocrine Tumors,Locally Advanced Epithelioid Hemangioendothelioma,0
12769,shared attribute,Breast Ductal Adenoma,0
12770,Intervention regimes,Werner Syndrome,0
12771,Antibodies,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12772,Unknown,Clonal Hematopoiesis of Indeterminate Potential,0
12773,Lung,Pancreatic carcinoma,0
12774,Exception - Property or Attribute,clear cell adenocarcinoma of gallbladder,0
12775,Testis,Vaginal Adenoma,0
12776,Science of Etiology,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12777,Pediculus humanus capitis (eukaryote),Cancer of Urinary Tract,0
12778,Neoplasms,FIGO Stage II Ovarian Cancer,0
12779,Heart,Adenocarcinoma,0
12780,commercial,Low Grade Squamous Intraepithelial Neoplasia,0
12781,Malignant Cell Count,Adult Acute Eosinophilic Leukemia,0
12782,Experimental Result,Acantholytic squamous cell carcinoma,0
12783,biopsy characteristics,mucinous adenocarcinoma of gallbladder,0
12784,Disease,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12785,Human Cells,Carcinoma,0
12786,Including (qualifier),Chest Wall Fibromatosis,0
12787,Skin,Stage I Adult Non-Hodgkin Lymphoma,0
12788,Contribution,Refractory WHO Grade III Glioma,0
12789,Pain NOS,Engraftment syndrome,0
12790,Containing (qualifier),benign mature teratoma of pancreas,0
12791,Manufactured form,Diffuse malignant mesothelioma,0
12792,Group Object,Secondary malignant neoplasm of lymph node,0
12793,Pure Spanish horse breed (organism),Recurrent Testicular Lymphoma,0
12794,Object Class,Human Papillomavirus-Related Carcinoma,0
12795,Present,Childhood Central Nervous System Ganglioneuroblastoma,0
12796,Reflecting,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
12797,0%,Type II Endometrial Adenocarcinoma,0
12798,Qualitative form,Bladder adenocarcinoma stage IV,0
12799,Show,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12800,Females,Benign neoplasm of thorax,0
12801,Grade IV Childhood Astrocytic Neoplasm,Diffuse malignant mesothelioma,0
12802,Sublingual Gland,Kaposi's sarcoma of skin,0
12803,Primary malignant neoplasm,Carcinomatosis of peritoneal cavity,0
12804,Malignant neoplasm of ovary,Cervical Squamous Intraepithelial Neoplasia,0
12805,Due to,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
12806,Decision,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12807,Diagnosis Study,Benign neoplasm of thorax,0
12808,Precision - characteristic,Grade 3a Malignant Neoplasm,0
12809,mucosa-associated lymphoid tissue,Extra-Adrenal Paraganglioma,0
12810,Parotid inflammation,BRCA2 Syndrome,0
12811,Sometimes,Endometrial Small Cell Carcinoma,0
12812,Social group,Grade 3a Malignant Neoplasm,0
12813,Abnormal,Cherubism,0
12814,Epithelial Cells,Acute Undifferentiated Leukemia,0
12815,Entity Determiner - specific,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
12816,Endocrine,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
12817,Due to,Localized Ewing Sarcoma,0
12818,Case (situation),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12819,Fused structure,Familial Hemophagocytic Lymphocytosis,0
12820,Fibrous papule of nose,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12821,Abnormal,Splenic Manifestation of Hairy Cell Leukemia,0
12822,Neoplasms,FIGO Stage IVA Ovarian Cancer,0
12823,Experimental Result,Benign Apocrine Neoplasm,0
12824,eTMF Content Model Code,Adenocarcinoma of the prostate metastatic,0
12825,Immunotherapy,Maxillary Sinus Adenoid Cystic Carcinoma,0
12826,Slow,Recurrent Testicular Lymphoma,0
12827,Records,Malignant neoplasm of gallbladder,0
12828,Choriocarcinoma,Hereditary Diffuse Gastric Adenocarcinoma,0
12829,Metastasis,Trabecular adenocarcinoma,0
12830,Universal,Tonsillar Carcinoma,0
12831,Human Cells,Mucosal Melanoma,0
12832,Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12833,Specimen Source Codes - tumor,High Grade Glandular Intraepithelial Neoplasia,0
12834,History,Thymic Atypical Carcinoid Tumor,0
12835,Usual,Trabecular adenocarcinoma,0
12836,Usual Severity Pain,Trabecular adenocarcinoma,0
12837,Worsening pattern,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12838,Two,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12839,Embryonic tissue,Papillary cystic tumor,0
12840,pharmacotherapeutic,Mucinous adenocarcinoma,0
12841,Physical Examination,Malignant neoplasm of subglottis,0
12842,A Codes,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
12843,Operative Surgical Procedures,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12844,Dominant,Stage II Hepatocellular Carcinoma AJCC v8,0
12845,Vaginal Hemorrhage,Undifferentiated Endocervical Sarcoma,0
12846,Subtype (attribute),Refractory Barrett Esophagus,0
12847,Type - attribute,FIGO Stage IVA Ovarian Cancer,0
12848,Involvement with,GIANT PIGMENTED HAIRY NEVUS,0
12849,Benign melanocytic nevus,Mucinous adenocarcinoma gastric,0
12850,Plant nodule,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
12851,Stage Grouping,Recurrent Testicular Lymphoma,0
12852,Class,Leptomeningeal sarcoma,0
12853,biomedical tube device,Small cell neuroendocrine carcinoma of bladder,0
12854,Science of Anatomy,Congenital hamartoma,0
12855,Effectiveness,squamous cell carcinoma of the thyroid gland,0
12856,chance,Thymic Atypical Carcinoid Tumor,0
12857,New,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12858,Orbital region,Malignant neoplasm of olfactory nerve,0
12859,Approximate,Recurrent Uveal Melanoma,0
12860,Aggressive course,Hemangioma,0
12861,unknown vaccine or immune globulin,Airway Hemangioma,0
12862,Shortness of breath:-:Point in time:^Patient:-,Squamous cell carcinoma of lip,0
12863,English Language,Malignant neoplasm of subglottis,0
12864,Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12865,Disease,Colorectal High Grade B-Cell Lymphoma,0
12866,IGHV@ gene cluster,Thymic Clear Cell Carcinoma,0
12867,Concern,Papillary squamous cell carcinoma,0
12868,Bone Marrow,clear cell adenocarcinoma of gallbladder,0
12869,Oral mucous membrane structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12870,Beginning,Stage IB Pancreatic Cancer AJCC v8,0
12871,ICD-9,Mucinous neoplasm,0
12872,Rumex,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12873,Volume Measurement,Atypical Mesothelial Hyperplasia,0
12874,Precision - second,Malignant melanoma of eyelid,0
12875,Skin Specimen,Epithelioid Sarcoma NCI Grade 3,0
12876,Including (qualifier),Cervical Adenomyoma,0
12877,Together,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12878,Logical Condition,gliosarcoma,0
12879,Hormones,Rhabdomyosarcoma with ganglionic differentiation,0
12880,General surgery specialty,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12881,Occurrence Indicator,Squamous cell carcinoma of lip,0
12882,Have Weight Loss,Nasal cavity carcinoma,0
12883,Rubella,Stage IB Pancreatic Cancer AJCC v8,0
12884,Retained,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12885,Approximate,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12886,GUCY2C protein,Human Papillomavirus-Related Carcinoma,0
12887,Methods,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12888,Age at menopause:Time:Point in time:^Patient:Quantitative,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12889,Paracel Islands,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12890,Delta (difference),Metastatic Lung Neuroendocrine Neoplasm,0
12891,Science of Etiology,Malignant Testicular Sertoli Cell Tumor,0
12892,Then,Stage III Cutaneous Melanoma AJCC v6,0
12893,Screening,FIGO Stage II Ovarian Cancer,0
12894,Usually,Malignant Neoplasm of Lung - Multiple Primary Sites,0
12895,Further,Childhood Central Nervous System Ganglioneuroblastoma,0
12896,Activity (animal life circumstance),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12897,Beginning,Type II Endometrial Adenocarcinoma,0
12898,Numbers,Vaginal Adenoma,0
12899,Run action,Sarcomatoid Renal Cell Carcinoma,0
12900,Eighth,Mucinous adenocarcinoma gastric,0
12901,High Grade Lymphoma (neoplasm),Acute lymphadenitis,0
12902,Personal appearance,Carcinoma ex pleomorphic adenoma of parotid gland,0
12903,Ability,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12904,Mast/Stem Cell Growth Factor Receptor Kit,Malignant melanoma of eyelid,0
12905,High,Benign Anal Granular Cell Tumor,0
12906,Skeletal system,Atypical Lobular Breast Hyperplasia,0
12907,Magnetic Resonance Imaging Study File,Recurrent Uveal Melanoma,0
12908,Penis carcinoma,clear cell adenocarcinoma of gallbladder,0
12909,Show,Childhood Extragonadal Malignant Germ Cell Tumor,0
12910,Abnormal cellular component of blood,Bladder squamous cell carcinoma stage I,0
12911,Derived value,Mucinous adenocarcinoma gastric,0
12912,Two,Childhood Central Nervous System Ganglioneuroblastoma,0
12913,Adult Lymphoma,Vaginal Adenoma,0
12914,error,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12915,Involvement with,Digestive System Hodgkin Lymphoma,0
12916,Age-Years,Human Papillomavirus-Related Carcinoma,0
12917,Body part,Benign Anal Granular Cell Tumor,0
12918,Contain (action),Localized Malignant Neoplasm,0
12919,United States,Breast Ductal Adenoma,0
12920,Magnetic Resonance Imaging Study File,Leiomyoma of Gallbladder,0
12921,3+ Score,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12922,0%,Carcinoma of submandibular gland,0
12923,Age,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12924,In Blood,clear cell adenocarcinoma of gallbladder,0
12925,Cause of death:Find:Pt:^Patient:Nom,Recurrent Primary Lymphoma of Bone,0
12926,Symptoms,Vaginal Adenoma,0
12927,Angiosarcoma of liver,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12928,Ovarian Carcinoma,Anterior Urethral Malignant Neoplasm,0
12929,Neoplasm Metastasis,Tonsillar Carcinoma,0
12930,seen,Keratoderma,0
12931,More Often than Once a Day,Acute lymphadenitis,0
12932,Palatine Tonsil,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12933,Fever symptoms (finding),Ectomesenchymal Chondromyxoid Tumor,0
12934,Therapeutic procedure,Recurrent Uveal Melanoma,0
12935,Treatment Epoch,Clonal Hematopoiesis of Indeterminate Potential,0
12936,Publications,Unicystic ameloblastoma,0
12937,Glandular stomach,Neoplasms,0
12938,include - SetOperator,Mucinous adenocarcinoma gastric,0
12939,Accounting (activity),Chest Wall Fibromatosis,0
12940,Disease,Localized Malignant Neoplasm,0
12941,Fever,FIGO Stage IVA Ovarian Cancer,0
12942,Case unit dose,Stage 0 Lip Carcinoma,0
12943,Genetic Heterogeneity,Undifferentiated Endocervical Sarcoma,0
12944,To,adenoid cystic carcinoma of lung,0
12945,Benign Neoplasm,Mucinous adenocarcinoma gastric,0
12946,Adoptive Immunotherapy,Localized Ewing Sarcoma,0
12947,Cluster,Spermatocytic seminoma,0
12948,Left sided,Granular Cell Leiomyosarcoma,0
12949,External lower lip,Mixed parotid tumor,0
12950,Cell Device,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12951,Exposure to,Mastocytosis,0
12952,Proportion,Engraftment syndrome,0
12953,Call (Instruction),Malignant Neoplasm of Lung - Multiple Primary Sites,0
12954,survival aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12955,Homo sapiens,Low Grade Squamous Intraepithelial Neoplasia,0
12956,New,Atypical Lobular Breast Hyperplasia,0
12957,The Sun,Acantholytic squamous cell carcinoma,0
12958,Numbers,FIGO Stage II Ovarian Cancer,0
12959,diagnostic image,Recurrent Diffuse Intrinsic Pontine Glioma,0
12960,Entity Determiner - specific,Plexosarcoma,0
12961,P-Glycoprotein,embryonal rhabdomyosarcoma of prostate,0
12962,Fever symptoms (finding),Recurrent Testicular Lymphoma,0
12963,Germ cell tumor,Squamous cell carcinoma of lip,0
12964,Classification of information,Hereditary Diffuse Gastric Adenocarcinoma,0
12965,Known,FIGO Stage IVA Ovarian Cancer,0
12966,include - SetOperator,Metaplastic carcinoma of breast,0
12967,Vaginal (intended site),adenosquamous carcinoma of breast,0
12968,Present,clear cell adenocarcinoma of gallbladder,0
12969,Research Activities,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12970,Papanicolaou Test,Malignant melanoma of eyelid,0
12971,Abdomen+,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12972,Diagnosis Study,Malignant neoplasm of choroid,0
12973,90%,Benign squamous cell tumor,0
12974,Topical Cream,Tonsillar Carcinoma,0
12975,Usual Severity Cough,Childhood Anaplastic Large Cell Lymphoma,0
12976,Pain Distress Question,Childhood Anaplastic Large Cell Lymphoma,0
12977,section sample,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12978,Subject Risk,Digestive System Hodgkin Lymphoma,0
12979,Neurofibromatosis 2,BRCA2 Syndrome,0
12980,low confidentiality,Choroid Necrotic Melanoma,0
12981,Qualitative form,Childhood Anaplastic Large Cell Lymphoma,0
12982,Primary malignant neoplasm,Type II Endometrial Adenocarcinoma,0
12983,Injection Route of Drug Administration,Bladder Neuroendocrine Neoplasm,0
12984,Spreading (qualifier value),Malignant neoplasm of thalamus,0
12985,High risk,Mucinous adenocarcinoma gastric,0
12986,Blood Vessel,Metastatic Ductal Breast Carcinoma,0
12987,Most,Malignant neoplasm of choroid,0
12988,Lymphoid leukemia,Tonsillar Carcinoma,0
12989,Malignant Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
12990,Chemotherapy Regimen,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12991,Follow-up status,benign mature teratoma of pancreas,0
12992,Biopsy,Engraftment syndrome,0
12993,Person Name,Ovarian Dermoid Cyst with Secondary Carcinoma,0
12994,Location of Pharyngeal Residue Following Swallowing,Mucinous adenocarcinoma gastric,0
12995,Spread by direct extension,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12996,Togo,Intraepithelial Melanocytic Hyperplasia,0
12997,Ten,Squamous cell carcinoma of lip,0
12998,Hyperestrogenism,Testicular cancer metastatic,0
12999,Tryptophanase,Ichthyoses,0
13000,Characterization,Mucinous cystadenofibroma,0
13001,65,Anterior Urethral Malignant Neoplasm,0
13002,inflammatory,Epithelioid Sarcoma NCI Grade 3,0
13003,Occurrence Indicator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13004,Survival Rate,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13005,COL18A1 wt Allele,Extra-Adrenal Paraganglioma,0
13006,Neck,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
13007,Smear - instruction imperative,FIGO Stage IVA Ovarian Cancer,0
13008,Genital system,Pancreatic carcinoma,0
13009,Syndrome,Fibroadenoma of breast,0
13010,Reported Term,Refractory Barrett Esophagus,0
13011,Base of the Brain,Stage I Colon Neuroendocrine Tumor AJCC v8,0
13012,+5,Bladder adenocarcinoma stage IV,0
13013,Lymphocyte component of blood,Hodgkin lymphoma,0
13014,shared attribute,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13015,English Language,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13016,low exposure,Atypical Lobular Breast Hyperplasia,0
13017,Characterization,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13018,Atypical Ductal Breast Hyperplasia,Blepharal carcinoma,0
13019,color additive,Multiple Endocrine Neoplasia,0
13020,Squamous cell carcinoma of skin,Recurrent Testicular Lymphoma,0
13021,Numerous,Mastocytosis,0
13022,Screening Study,Neoplasms,0
13023,Low Level,Kaposi's sarcoma of skin,0
13024,T-Cell Marker,Childhood Fibrillary Astrocytoma,0
13025,Hollow shape,Gallbladder Adenocarcinoma,0
13026,Increase in size since previous mammogram,Collecting Duct Carcinoma of the Kidney,0
13027,Forecast of outcome,Benign Carotid Body Paraganglioma,0
13028,Lymphocyte,Carcinoma of urinary bladder,0
13029,Result,Benign Anal Granular Cell Tumor,0
13030,Including (qualifier),Atypical Mesothelial Hyperplasia,0
13031,Elderly (population group),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13032,error,Undifferentiated Endocervical Sarcoma,0
13033,risk factors - observation list,Intestinal Metaplasia of Bladder Urothelium,0
13034,Disease Screening,Chest Wall Fibromatosis,0
13035,90%,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13036,Central,Benign squamous cell tumor,0
13037,Sweat,Recurrent Primary Lymphoma of Bone,0
13038,Collections (publication),Kaposi's sarcoma of extrahepatic bile duct,0
13039,Most,Adult Acute Eosinophilic Leukemia,0
13040,Drain number:ID:Pt:^Patient:Nom,Acute Undifferentiated Leukemia,0
13041,10%,Metastatic Carcinoma in the Lung,0
13042,Possible diagnosis,Stage IB Lung Cancer AJCC v7,0
13043,Microplate Well,Peripheral primitive neuroectodermal tumor of soft tissue,0
13044,Gene Mutation,Airway Hemangioma,0
13045,protein expression,Nasal cavity carcinoma,0
13046,Common Specifications in HL7 V3 Publishing,Unresectable Rhabdomyosarcoma,0
13047,Primary malignant neoplasm,Mucinous adenocarcinoma gastric,0
13048,<90,Acantholytic squamous cell carcinoma,0
13049,Occurrence Indicator,Pancreatic Endocrine Carcinoma,0
13050,Involvement with,Recurrent Primary Lymphoma of Bone,0
13051,True primary (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13052,pharmacotherapeutic,Undifferentiated Endocervical Sarcoma,0
13053,Breaking down,Keratoderma,0
13054,All,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13055,Primary malignant neoplasm,Gallbladder Adenocarcinoma,0
13056,Colorectal Cancer Pathway,Benign tumor of eyelid,0
13057,Smear - instruction imperative,Carcinoma,0
13058,Return to (contextual qualifier) (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13059,Body tissue,Childhood Lymphoma,0
13060,Coloring Excipient,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13061,Device system,Thymic Clear Cell Carcinoma,0
13062,low exposure,malignant lymphoma of pancreatic lymph nodes,0
13063,Decision,Intestinal Metaplasia of Bladder Urothelium,0
13064,Drug Kit,Cartilaginous exostosis,0
13065,Providing presence (regime/therapy),Metastatic Lung Neuroendocrine Neoplasm,0
13066,Universities,Placental aromatase deficiency,0
13067,Smear - instruction imperative,Cervical Fibroepithelial Polyp,0
13068,Equidae,Pancreatic Intraepithelial Neoplasia-3,0
13069,Publishing,Precursor B-lymphoblastic lymphoma stage II,0
13070,Special,Human Papillomavirus-Related Carcinoma,0
13071,Hematology (discipline),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13072,Benign Smooth Muscle Neoplasm,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13073,Reduced,Colorectal High Grade B-Cell Lymphoma,0
13074,Unique,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13075,Filter - medical device,Splenic Manifestation of Hairy Cell Leukemia,0
13076,Divide,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13077,Application Context,adenoid cystic carcinoma of lung,0
13078,Therapeutic procedure,Acute Undifferentiated Leukemia,0
13079,Caucasoid Race,Refractory Ependymoma,0
13080,Disease,Adult Anaplastic Oligodendroglioma,0
13081,Group A (blood group),Cartilaginous exostosis,0
13082,Name (property) (qualifier value),adenoid cystic carcinoma of lung,0
13083,Logical Condition,Metastatic Lung Neuroendocrine Neoplasm,0
13084,Different,Recurrent Uveal Melanoma,0
13085,Include (action),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13086,Sore Throat,Stage III Adult Immunoblastic Lymphoma,0
13087,epithelial,Bladder adenocarcinoma stage IV,0
13088,active (HL7 RoleLink),Squamous cell carcinoma of lip,0
13089,Ulcer,Unicystic ameloblastoma,0
13090,Initial (abbreviation),FIGO Stage II Ovarian Cancer,0
13091,Surrounding (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
13092,Lymphocyte component of blood,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13093,Aspects of disease screening,Cerebral Primitive Neuroectodermal Tumor,0
13094,Include (action),Blood Vessel Tumors,0
13095,cell type,mucinous adenocarcinoma of gallbladder,0
13096,Common Specifications in HL7 V3 Publishing,Undifferentiated Neuroblastoma,0
13097,Leading,Mixed parotid tumor,0
13098,Adult Anaplastic Astrocytoma,Fourth Ventricle and Brain Stem Ependymal Tumor,0
13099,Symptoms,FIGO Stage II Ovarian Cancer,0
13100,Abnormal Cell Count,Pancreatic Intraepithelial Neoplasia-3,0
13101,Numerous,Non-Metastatic Gestational Trophoblastic Tumor,0
13102,BEP regimen,Locally Advanced Epithelioid Hemangioendothelioma,0
13103,Sexual function,gliosarcoma,0
13104,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13105,Only - dosing instruction fragment,Malignant Testicular Sertoli Cell Tumor,0
13106,Cessation of life,Recurrent Testicular Lymphoma,0
13107,Metastatic Neoplasm,BRCA2 Syndrome,0
13108,Primary malignant neoplasm,Airway Hemangioma,0
13109,Gut,Pilocytic astrocytoma of cerebellum,0
13110,epidemiologic,Pleomorphic adenoma of parotid gland,0
13111,Representation (action),Localized Askin Tumor,0
13112,Pallor,Malignant melanoma of eyelid,0
13113,Specimen Source Codes - tumor,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13114,Nucleotide Excision Repair Pathway,Cerebral Primitive Neuroectodermal Tumor,0
13115,combination - answer to question,Refractory Ependymoma,0
13116,Glioblastoma,clear cell adenocarcinoma of gallbladder,0
13117,2+ Score,Benign Anal Granular Cell Tumor,0
13118,Most,Mixed astrocytoma-ependymoma,0
13119,Contain (action),Kaposi's sarcoma of skin,0
13120,Tobacco smoking behavior,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
13121,Neoplasms,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13122,Pain of lymph node,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13123,Class (taxonomic),Tonsillar Carcinoma,0
13124,Tryptophanase,Airway Hemangioma,0
13125,United States Military Commissioned Officer O4,Recurrent Uveal Melanoma,0
13126,Treatment intent,Benign Apocrine Neoplasm,0
13127,various antiinfectives and antiseptics for local oral treatment,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13128,Myeloid Progenitor Cells,Refractory Barrett Esophagus,0
13129,Factor,Heavy Chain Deposition Disease,0
13130,Tissue specific,Human Papillomavirus-Related Carcinoma,0
13131,Tryptophanase,Liver Cavernous Hemangioma,0
13132,High Level,Malignant melanoma of eyelid,0
13133,Symptoms,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13134,Hematologic Tests,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13135,Type - attribute,Kaposi's sarcoma of extrahepatic bile duct,0
13136,Targeted Therapy,Pancreatic Endocrine Carcinoma,0
13137,Papule,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13138,Manufactured form,Stage III Cutaneous Melanoma AJCC v6,0
13139,List,Cerebral Primitive Neuroectodermal Tumor,0
13140,Twice - dosing instruction fragment,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13141,per year,Female Breast Carcinoma,0
13142,Historical aspects qualifier,Thymic Atypical Carcinoid Tumor,0
13143,Rhabdomyosarcoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13144,radiotherapeutic,Recurrent Uveal Melanoma,0
13145,chronic,Human Papillomavirus-Related Carcinoma,0
13146,Food,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13147,Occur (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13148,>90,Stage IV Childhood Non-Hodgkin Lymphoma,0
13149,Primary malignant neoplasm,Xeroderma pigmentosum,0
13150,Contain (action),Stage II Carcinoma of Penis,0
13151,respiratory,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13152,Cover (physical object),Congenital hamartoma,0
13153,Cyclophosphamide,adenosquamous carcinoma of breast,0
13154,Small cell carcinoma of lung,Childhood Choriocarcinoma,0
13155,Infertility,Pancreatic Endocrine Carcinoma,0
13156,Family history,Chest Wall Fibromatosis,0
13157,Sore Throat,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13158,error,Multiple Endocrine Neoplasia,0
13159,Specimen Source Codes - Respiratory,Undifferentiated Endocervical Sarcoma,0
13160,Transurethral Resection,Mucinous adenocarcinoma gastric,0
13161,Squamous cell carcinoma,Unicystic ameloblastoma,0
13162,Occurrence Indicator,Kaposi's sarcoma of skin,0
13163,Feelings,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
13164,Tumor type,Atypical Lobular Breast Hyperplasia,0
13165,Tonsil,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13166,List,ROSE Cluster 3,0
13167,Treating,Choroid Epithelioid Cell Melanoma,0
13168,1+ Score,Melanomatosis,0
13169,Pacemakers,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13170,Thymoma,Astrocytoma of brain,0
13171,Requirement,Thymic Atypical Carcinoid Tumor,0
13172,Major <insect>,Adenocarcinoma of the prostate metastatic,0
13173,Secondary Neoplasm,Xeroderma pigmentosum,0
13174,Nevus,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13175,Class (taxonomic),Carcinoma of urinary bladder,0
13176,Diagnosis Study,ROSE Cluster 3,0
13177,Locally,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13178,Combined Modality Therapy,Benign squamous cell tumor,0
13179,High Mitosis-Karyorrhexis Index,Plexosarcoma,0
13180,Cell Differentiation process,Benign Anal Granular Cell Tumor,0
13181,Including (qualifier),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13182,Cessation of life,Basal Cell Ameloblastoma,0
13183,Empty (qualifier),Hodgkin lymphoma,0
13184,Specific qualifier value,Squamous cell carcinoma of lip,0
13185,Confirmed by,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13186,Desmoplastic fibroma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13187,Europe,papillary carcinoma of penis,0
13188,Offspring,Malignant Testicular Sertoli Cell Tumor,0
13189,Call (Instruction),Childhood Central Nervous System Ganglioneuroblastoma,0
13190,Hematopoietic Neoplasms,Squamous cell carcinoma of lip,0
13191,body system,Adenocarcinoma,0
13192,100%,embryonal rhabdomyosarcoma of prostate,0
13193,Primary,Stage IB Lung Cancer AJCC v7,0
13194,Brain Neoplasms,Recurrent Uveal Melanoma,0
13195,Neck,Recurrent Primary Lymphoma of Bone,0
13196,Lymphocyte component of blood,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
13197,Biological Response Modifiers,Refractory Bladder Carcinoma,0
13198,Medical pathologist,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13199,Assisted (qualifier value),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13200,Nephrons,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13201,Image Feature,Endometrial Small Cell Carcinoma,0
13202,Aspects of signs,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13203,Benign tumor of salivary gland,Localized Malignant Neoplasm,0
13204,Milliampere second,Benign Apocrine Neoplasm,0
13205,Aflatoxins,Angiosarcoma of liver,0
13206,shared attribute,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13207,Gypsum,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13208,Shortened,Breast Apocrine Adenoma,0
13209,Normal hemostatic function,Squamous cell carcinoma of lip,0
13210,Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13211,Unintentional,Digestive System Hodgkin Lymphoma,0
13212,Back structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13213,include - SetOperator,Stage IV Penile Cancer AJCC v7,0
13214,Multiply - dosing instruction fragment,Recurrent Testicular Lymphoma,0
13215,Derivative,Astrocytoma of brain,0
13216,Gait normal,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13217,Most,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13218,Pharmacotherapy,Gallbladder Adenocarcinoma,0
13219,Reduction procedure,Small intestine carcinoma,0
13220,Unusual,Mastocytosis,0
13221,60%,Vaginal Adenoma,0
13222,Common bile duct structure,Digestive System Hodgkin Lymphoma,0
13223,Papillomaviridae,Undifferentiated Endocervical Sarcoma,0
13224,Biological Response Modifiers,Recurrent Uveal Melanoma,0
13225,Usage,Benign Anal Granular Cell Tumor,0
13226,Hematologic Tests,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13227,clinical syndromes,adenosquamous carcinoma of breast,0
13228,Diffuse Large B-Cell Lymphoma,Basal Cell Ameloblastoma,0
13229,Improved,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
13230,Severe Extremity Pain,Mucinous adenocarcinoma gastric,0
13231,Adult Anaplastic Astrocytoma,Colorectal High Grade B-Cell Lymphoma,0
13232,How Much Distress Weight Loss,Platinum-Resistant Lung Small Cell Carcinoma,0
13233,Adult Myelodysplastic Syndrome,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13234,Including (qualifier),Malignant neoplasm of olfactory nerve,0
13235,Cutaneous Melanoma,Adult Acute Eosinophilic Leukemia,0
13236,Literature,Localized Ewing Sarcoma,0
13237,Body structure,Childhood Central Nervous System Ganglioneuroblastoma,0
13238,Pharmacotherapy,Ovarian Carcinoid Tumor,0
13239,Entity Determiner - specific,Werner Syndrome,0
13240,How Much Distress Pain,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13241,Usual,Gallbladder Adenocarcinoma,0
13242,Adult Germ Cell Tumor,mucinous adenocarcinoma of gallbladder,0
13243,Have Weight Loss,Atypical Lobular Breast Hyperplasia,0
13244,3+ Answer to Question,Maxillary Sinus Adenocarcinoma,0
13245,STOMACH: EXCISIONS,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13246,Slightly Agree,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13247,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
13248,Increase,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13249,Occur (action),Stage IB Lung Cancer AJCC v7,0
13250,Time (foundation metadata concept),Pilocytic astrocytoma of cerebellum,0
13251,geographic population,Mucinous adenocarcinoma gastric,0
13252,Case (situation),Giant cell angiofibroma,0
13253,Approximate,Childhood Central Nervous System Ganglioneuroblastoma,0
13254,Cell Device,Papillary cystic tumor,0
13255,Metastasis,Low Grade Squamous Intraepithelial Neoplasia,0
13256,Ulcer,Human Papillomavirus-Related Carcinoma,0
13257,Five-year Survival Rate,Vaginal Adenoid Cystic Carcinoma,0
13258,Different,Acantholytic squamous cell carcinoma,0
13259,Anatomic Structure,Refractory Barrett Esophagus,0
13260,CDISC SEND Tumor Findings Results Terminology,FIGO Stage II Ovarian Cancer,0
13261,Interferes with,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13262,International Classification of Diseases for Oncology,Adult Acute Eosinophilic Leukemia,0
13263,Bone pain,Melanomatosis,0
13264,60%,Malignant neoplasm of thalamus,0
13265,City of Boston,Mucinous adenocarcinoma gastric,0
13266,Removed,Nasal cavity carcinoma,0
13267,Location of Pharyngeal Residue Following Swallowing,Localized Ewing Sarcoma,0
13268,Malignant Neoplasms,Refractory Ependymoma,0
13269,Psychotherapy,Stage I Adult Non-Hodgkin Lymphoma,0
13270,Occurrence Indicator,Malignant melanoma of eyelid,0
13271,Common Specifications in HL7 V3 Publishing,Benign Anal Granular Cell Tumor,0
13272,Often - answer to question,FIGO Stage II Ovarian Cancer,0
13273,High risk of,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13274,Substance,Maxillary Sinus Adenocarcinoma,0
13275,Swollen Lymph Node,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13276,CD44 wt Allele,Adult Hepatocellular Carcinoma,0
13277,Category Type,mucinous adenocarcinoma of gallbladder,0
13278,Reported Term,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13279,Malignant - descriptor,Childhood Thyroid Gland Follicular Carcinoma,0
13280,Carcinoma,Childhood Central Nervous System Ganglioneuroblastoma,0
13281,include - SetOperator,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13282,Complete excision,Cervical Fibroepithelial Polyp,0
13283,Urinary system,Localized Askin Tumor,0
13284,Creation,Prostate Lymphoma,0
13285,Skin Pigmentation,Stage I Colon Neuroendocrine Tumor AJCC v8,0
13286,Nicotiana tabacum,Refractory Ependymoma,0
13287,UV Radiation Exposure,Endometrial Small Cell Carcinoma,0
13288,Most,Blepharal carcinoma,0
13289,inflammatory,adenoid cystic carcinoma of lung,0
13290,Asia,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13291,Half,Bladder squamous cell carcinoma stage I,0
13292,Etiology aspects,Tumorlet,0
13293,Europe,Breast Ductal Adenoma,0
13294,*Type - Kind of quantity,Cerebral Primitive Neuroectodermal Tumor,0
13295,ovarian,Thymoma malignant recurrent,0
13296,Associated with,Adenocarcinoma of duodenum,0
13297,Behavior:-:Point in time:^Patient:-,Carcinoma of urinary bladder,0
13298,Singular,Vaginal Adenoma,0
13299,shared attribute,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13300,Groups,Stage IV Colorectal Cancer AJCC v8,0
13301,Onset of illness,Giant cell angiofibroma,0
13302,Possible,Tubal Hyperplasia,0
13303,Death (finding),FIGO Stage IVA Ovarian Cancer,0
13304,Cell Count,BRCA2 Syndrome,0
13305,Treatment Epoch,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13306,>90,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13307,Section (object),Tonsillar Carcinoma,0
13308,Bothered by Night Sweats,Thymic Clear Cell Carcinoma,0
13309,Contact with,Spermatocytic seminoma,0
13310,Two,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13311,Since,Lipoma of small intestine,0
13312,Recent,Extra-Adrenal Paraganglioma,0
13313,described,Pancreatic Intraepithelial Neoplasia-3,0
13314,Touch sensation,Stage II Carcinoma of Penis,0
13315,Tumor cells,Undifferentiated Endocervical Sarcoma,0
13316,Binding (Molecular Function),Medulloblastoma,0
13317,Symptoms,Tubal Hyperplasia,0
13318,Fibroid Tumor,ICHTHYOSIS,0
13319,Outer cortex of kidney,Recurrent Primary Lymphoma of Bone,0
13320,Grade IV Childhood Astrocytic Neoplasm,Carcinoma of urinary bladder,0
13321,Measurement,Pancreatic Intraepithelial Neoplasia-3,0
13322,Most,Neoplasms,0
13323,Obesity,Female Breast Carcinoma,0
13324,Various patch test substance,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13325,Feature,Digestive System Hodgkin Lymphoma,0
13326,potential,Melanomatosis,0
13327,Approximate,Cerebral hemangioma,0
13328,algorithm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13329,Anal part of perineum,Stage 0 Penile Cancer AJCC v8,0
13330,Have Sweats,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13331,Presence (property),Clinical Stage I Cutaneous Melanoma AJCC v8,0
13332,Headache,Extra-abdominal fibromatosis,0
13333,Publications,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13334,Adult human body,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13335,1000000,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
13336,Present,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13337,Usual,Cancer of Urinary Tract,0
13338,British Virgin Islands,Vaginal Adenoma,0
13339,100%,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13340,Occur (action),Female Breast Carcinoma,0
13341,Tissue of urinary bladder,Acantholytic squamous cell carcinoma,0
13342,Frequently,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13343,child survival,Benign Anal Granular Cell Tumor,0
13344,Trial Screening,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13345,Young Adult,Carcinoma of urinary bladder,0
13346,product,Recurrent Testicular Lymphoma,0
13347,Malignant Neoplasms,Peripheral primitive neuroectodermal tumor of soft tissue,0
13348,Workers,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13349,Areas <moth>,Grade 1 Clear Cell Renal Cell Carcinoma,0
13350,Neoplasms,Cherubism,0
13351,What subject filter - Result,Collecting Duct Carcinoma of the Kidney,0
13352,Primary malignant neoplasm of fallopian tube,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13353,Usual,Colorectal cancer,0
13354,Singular,Squamous cell carcinoma of lip,0
13355,Old,Kaposi's sarcoma of skin,0
13356,Symptoms aspect,Malignant neoplasm of thalamus,0
13357,Cold Sensation,Carcinoma,0
13358,Nervous system structure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13359,Genus Anemia,Metastatic Malignant Neoplasm in the Sellar Region,0
13360,Specimen Source Codes - tumor,FIGO Stage IVA Ovarian Cancer,0
13361,/hour,Cervical Adenomyoma,0
13362,Lymphoma,Heavy Chain Deposition Disease,0
13363,Layer of dermis,Intraepithelial Melanocytic Hyperplasia,0
13364,Device Plate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13365,Primary,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13366,Females,Extra-Adrenal Paraganglioma,0
13367,Presentation,FIGO Stage IVA Ovarian Cancer,0
13368,ethnic european,Pancreatic Intraepithelial Neoplasia-3,0
13369,Set (Psychology),Childhood Choriocarcinoma,0
13370,Egg of order Phthiraptera,Recurrent Uveal Melanoma,0
13371,Test - temporal region,Papillary cystic tumor,0
13372,Make - Instruction Imperative,Pancreatic Intraepithelial Neoplasia-3,0
13373,SPINK5 gene,ALK positive large B-cell lymphoma,0
13374,Disease,squamous cell carcinoma of the thyroid gland,0
13375,subapical complex location,Adenocarcinoma,0
13376,International Classification of Diseases,Stage III Adult Immunoblastic Lymphoma,0
13377,control substance,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13378,Tissue membrane,Pleomorphic adenoma of parotid gland,0
13379,3+ Answer to Question,Precursor B-lymphoblastic lymphoma stage II,0
13380,diagnosis aspect,Stage III Cutaneous Melanoma AJCC v6,0
13381,Call (Instruction),Metastatic Carcinoma in the Lung,0
13382,Contusions,Malignant neoplasm of thalamus,0
13383,Variety (taxon),Stage IV Colorectal Cancer AJCC v8,0
13384,Less Than,Stage 0 Lip Carcinoma,0
13385,Useful,Carcinoma of urinary bladder,0
13386,Adult human body,Nasal cavity carcinoma,0
13387,Occur (action),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13388,United States,Metaplastic carcinoma of breast,0
13389,classical example,Kaposi's sarcoma of extrahepatic bile duct,0
13390,Blood Vessel,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13391,Science of Etiology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13392,Original,Intraepithelial Melanocytic Hyperplasia,0
13393,Biospecimen,Kaposi's sarcoma of extrahepatic bile duct,0
13394,Bothered by Night Sweats,Colorectal High Grade B-Cell Lymphoma,0
13395,Vulvovaginal Region,Refractory Barrett Esophagus,0
13396,Monitoring Device,Benign Anal Granular Cell Tumor,0
13397,Malignant neoplasm of soft tissue,Cerebral hemangioma,0
13398,Cervical lymph node group,Cancer of Urinary Tract,0
13399,Usual Severity Itching,embryonal rhabdomyosarcoma of prostate,0
13400,Nausea,Acantholytic squamous cell carcinoma,0
13401,2+,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13402,Diagnosis Study,Pancreatic Intraepithelial Neoplasia-3,0
13403,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13404,Difficult (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13405,Nasal sinus,Mastocytosis,0
13406,Mesenchymal Stem Cells,Precursor B-lymphoblastic lymphoma stage II,0
13407,Certainties,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13408,Symptoms aspect,Kaposi's sarcoma of extrahepatic bile duct,0
13409,Oral region,Tonsillar Carcinoma,0
13410,Vital High Nitrogen Enteral Nutrition,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13411,United States,Bladder adenocarcinoma stage IV,0
13412,Endotracheal aspiration,Breast Ductal Adenoma,0
13413,Physical findings,Squamous cell carcinoma of lip,0
13414,Complete Pharyngeal Contraction,Uterine Cancer,0
13415,Goes <invertebrate>,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13416,Hepatitis C,Pancreatic Intraepithelial Neoplasia-3,0
13417,status - In progress,Human Papillomavirus-Related Carcinoma,0
13418,Used by,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13419,Harbor,Acantholytic squamous cell carcinoma,0
13420,Inflammatory lesion,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13421,Person Name,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13422,Number of birth,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13423,To,Basal Cell Ameloblastoma,0
13424,Five,Chest Wall Fibromatosis,0
13425,Epithelium,Kaposi's sarcoma of extrahepatic bile duct,0
13426,Disc Shape,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13427,Psychological inhibition,Recurrent Primary Lymphoma of Bone,0
13428,Set of regional lymph nodes,Stage IV Childhood Non-Hodgkin Lymphoma,0
13429,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13430,Tubal Ligation,Cerebral hemangioma,0
13431,Developing Countries,Cancer of Urinary Tract,0
13432,Adult,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13433,Lobule,Stage III Cutaneous Melanoma AJCC v6,0
13434,Non-small cell carcinoma,clear cell adenocarcinoma of gallbladder,0
13435,Concept Relationship,Papillary cystic tumor,0
13436,Include (action),Adult Alveolar Soft Part Sarcoma,0
13437,Science of Etiology,Refractory Bladder Carcinoma,0
13438,Contain (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13439,Additional,Breast Ductal Adenoma,0
13440,System,Secondary malignant neoplasm of lymph node,0
13441,Cells,Vaginal Adenoid Cystic Carcinoma,0
13442,Prognosis:Find:Pt:^Patient:Nom,ROSE Cluster 3,0
13443,Circumscribe (action),Intestinal Metaplasia of Bladder Urothelium,0
13444,Unmarried person,Carcinomatosis of peritoneal cavity,0
13445,Death (finding),Diffuse malignant mesothelioma,0
13446,Fluid Leak,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13447,Lymphadenopathy,Liver Cavernous Hemangioma,0
13448,Science of Etiology,Chest Wall Fibromatosis,0
13449,Elements,Non-Hodgkin Lymphoma During Pregnancy,0
13450,10%,Human Papillomavirus-Related Carcinoma,0
13451,Primary malignant neoplasm,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
13452,Bladder Cancer Pathway,Adult Brain Stem Mixed Glioma,0
13453,Skin,Engraftment syndrome,0
13454,Tumor cells,Metastatic Ductal Breast Carcinoma,0
13455,Arising,Extra-abdominal fibromatosis,0
13456,Diagnosis,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13457,floor (object),Acute Undifferentiated Leukemia,0
13458,Bloating,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13459,Adult Anaplastic Large Cell Lymphoma,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
13460,Anatomic Site,Pancreatic Intraepithelial Neoplasia-3,0
13461,Result,Cerebral Primitive Neuroectodermal Tumor,0
13462,Singular,Medulloblastoma,0
13463,Classification,Hereditary Diffuse Gastric Adenocarcinoma,0
13464,Intravascular line,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13465,Tryptophanase,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
13466,Increase in size since previous mammogram,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13467,Growth abnormality,Recurrent Testicular Lymphoma,0
13468,Often - answer to question,Hair nevus,0
13469,65,Metastatic Malignant Neoplasm in the Sellar Region,0
13470,Cervical dysplasia,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13471,Non-Secretory Plasma Cell Myeloma,Locally Advanced Soft Tissue Sarcoma,0
13472,Firstly,Thyroid carcinoma,0
13473,Recombinant Human Chorionic Gonadotropin,Engraftment syndrome,0
13474,Thymectomy,Neoplasms,0
13475,Salivary Glands,Endometrial Small Cell Carcinoma,0
13476,Sometimes,Mixed parotid tumor,0
13477,newly,FIGO Stage II Ovarian Cancer,0
13478,Pancreatic Hormones,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13479,Form:Finding:Point in time:{Setting}:Document:{Role},FIGO Stage II Ovarian Cancer,0
13480,Blood Platelets,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13481,Result,Malignant Neoplasm with Regional Lymph Node Involvement,0
13482,Known,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13483,shared attribute,papillary carcinoma of penis,0
13484,Europe,Human Papillomavirus-Related Carcinoma,0
13485,Genetic Risk,Benign Carotid Body Paraganglioma,0
13486,SLC6A2 wt Allele,Intraepithelial Melanocytic Hyperplasia,0
13487,Person 1,Adult Acute Eosinophilic Leukemia,0
13488,SLC6A2 wt Allele,Unresectable Rhabdomyosarcoma,0
13489,Special,Intracortical osteosarcoma,0
13490,Including (qualifier),Clinical Stage I Cutaneous Melanoma AJCC v8,0
13491,Drainage procedure,Lipoma of small intestine,0
13492,Base - General Qualifier,Papillary cystic tumor,0
13493,SPINK5 gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13494,Malignant Neoplasms,Benign Anal Granular Cell Tumor,0
13495,Usual,FIGO Stage IVA Ovarian Cancer,0
13496,Edema,Acute lymphadenitis,0
13497,Cancer Remission,Squamous cell carcinoma of lip,0
13498,Rare,Nasal cavity carcinoma,0
13499,suggestion,Colorectal High Grade B-Cell Lymphoma,0
13500,Limited (extensiveness),Astrocytoma of brain,0
13501,/40,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13502,Anatomic Site,Metastatic Lung Neuroendocrine Neoplasm,0
13503,per period (qualifier value),Unresectable Rhabdomyosarcoma,0
13504,Sharing (Social Behavior),Refractory Barrett Esophagus,0
13505,Cultured Cell Line,Leptomeningeal sarcoma,0
13506,Certain (qualifier value),embryonal rhabdomyosarcoma of prostate,0
13507,Identified,Thyroid Hurthle Cell Carcinoma,0
13508,Plant seeds,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
13509,Malignant Neoplasms,Prostate Lymphoma,0
13510,New,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13511,Identified,Trichilemmocarcinoma,0
13512,Mutation,Metastatic Malignant Neoplasm in the Sellar Region,0
13513,Childhood Non-Hodgkin Lymphoma,Secondary malignant neoplasm of lymph node,0
13514,nonmetastatic,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13515,95,Small Intestinal Villous Adenoma,0
13516,various other agents for local oral treatment in ATC,Gallbladder Adenocarcinoma,0
13517,site-specific telomere resolvase activity,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
13518,MOSTLY,embryonal rhabdomyosarcoma of prostate,0
13519,Group A (blood group),Hyperplasia of pituitary gland,0
13520,Tissue Specimen Code,gliosarcoma,0
13521,/40,Localized Ewing Sarcoma,0
13522,Obesity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13523,Have Weight Loss,Spermatocytic seminoma,0
13524,Magnetic Resonance Imaging,Recurrent Uveal Melanoma,0
13525,Case unit dose,Metastatic Lung Neuroendocrine Neoplasm,0
13526,risk factors - observation list,Melanomatosis,0
13527,Followed by,Cystadenocarcinoma,0
13528,Infection of kidney,Chondrosarcoma,0
13529,Abnormal Cell Count,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13530,Loss of Appetite question,Mucinous adenocarcinoma gastric,0
13531,Description,Recurrent Uveal Melanoma,0
13532,3+ Answer to Question,Malignant melanoma of eyelid,0
13533,point - UnitsOfMeasure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13534,Fever,Maxillary Sinus Adenoid Cystic Carcinoma,0
13535,Call (Instruction),Thymoma malignant recurrent,0
13536,Rate,Giant cell angiofibroma,0
13537,Fever,Werner Syndrome,0
13538,Sun Exposure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13539,Act Status - obsolete,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13540,One,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13541,Bothered by Night Sweats,Chronic Myelomonocytic Leukemia-2,0
13542,Body Site Modifier - Lower,Recurrent Uveal Melanoma,0
13543,Ultraviolet Light Sterilization,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13544,combination - answer to question,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13545,AKT1S1 wt Allele,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13546,Psyche structure,Female Breast Carcinoma,0
13547,seen,Mucinous adenocarcinoma gastric,0
13548,Age of Onset,Cystadenocarcinoma,0
13549,Histocompatibility Testing,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13550,Time (foundation metadata concept),Lipoma of small intestine,0
13551,Collections (publication),Malignant neoplasm of gallbladder,0
13552,Air Conditioning,Familial Hemophagocytic Lymphocytosis,0
13553,Frequently,Thymic Clear Cell Carcinoma,0
13554,Central Nervous System Embryonal Tumor,mucinous adenocarcinoma of gallbladder,0
13555,Neuroendocrine Tumors,FIGO Stage IVA Ovarian Cancer,0
13556,Sclerotherapy,Small intestine carcinoma,0
13557,Young,Childhood Fibrillary Astrocytoma,0
13558,Prognosis:Find:Pt:^Patient:Nom,Rhabdomyosarcoma with ganglionic differentiation,0
13559,Replacement,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
13560,Heart,Low Grade Squamous Intraepithelial Neoplasia,0
13561,Disruptive,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13562,Geographic Locations,Adenocarcinoma,0
13563,Similarity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13564,Probable diagnosis,Nasal cavity carcinoma,0
13565,Secondary Neoplasm,Serous cystadenocarcinoma ovary,0
13566,Inferior,Cervical Adenomyoma,0
13567,Malignant neoplasm of breast,Chronic Myelomonocytic Leukemia-2,0
13568,Formations,Liver Lymphangioma,0
13569,Secondary Neoplasm,Kaposi's sarcoma of skin,0
13570,*Type - Kind of quantity,Mucinous adenocarcinoma gastric,0
13571,Devices,Stage 0 Penile Cancer AJCC v8,0
13572,Never (frequency),clear cell adenocarcinoma of gallbladder,0
13573,Bacteria present,Acute Undifferentiated Leukemia,0
13574,Human body structure,Adult Hepatocellular Carcinoma,0
13575,Specimen Source Codes - tumor,Childhood Central Nervous System Ganglioneuroblastoma,0
13576,Name,Astrocytoma of brain,0
13577,Call (Instruction),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13578,Child,Recurrent Uveal Melanoma,0
13579,To,Cartilaginous exostosis,0
13580,Pylorus,Ichthyosis,0
13581,Infrequent,Acute Undifferentiated Leukemia,0
13582,Mutation,Benign squamous cell tumor,0
13583,1+,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
13584,Most,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13585,Qualitative form,Adult Acute Eosinophilic Leukemia,0
13586,Sweat,Childhood Lymphoma,0
13587,Social group,Cerebral Primitive Neuroectodermal Tumor,0
13588,More,Peripheral primitive neuroectodermal tumor of soft tissue,0
13589,Firstly,Refractory Barrett Esophagus,0
13590,Name,Brain Ependymoma,0
13591,Including (qualifier),Cerebral Primitive Neuroectodermal Tumor,0
13592,Direct (qualifier),Xeroderma pigmentosum,0
13593,Tumor cells,Nasal cavity carcinoma,0
13594,Sometimes,Lipoma of small intestine,0
13595,Biopsy,Pancreatic Endocrine Carcinoma,0
13596,Therapeutic procedure,Vaginal Adenoid Cystic Carcinoma,0
13597,Library Protocol,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13598,To,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13599,Cell Device,Vaginal Adenoma,0
13600,Occur (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
13601,Overall,clear cell adenocarcinoma of gallbladder,0
13602,Feel Tired question,Precursor B-lymphoblastic lymphoma stage II,0
13603,Numbness,Chronic Myelomonocytic Leukemia-2,0
13604,Supportive assistance,Recurrent Testicular Lymphoma,0
13605,Pancreas,High Grade Glandular Intraepithelial Neoplasia,0
13606,Beginning,Childhood Central Nervous System Ganglioneuroblastoma,0
13607,Cover - action,Thymic Atypical Carcinoid Tumor,0
13608,Adult human body,Carcinomatosis of peritoneal cavity,0
13609,Active,Locally Advanced Carcinoma,0
13610,Adrenal Medulla,Malignant neoplasm of choroid,0
13611,Function (attribute),Splenic Manifestation of Hairy Cell Leukemia,0
13612,High Grade Ovarian Serous Adenocarcinoma,Breast Apocrine Adenoma,0
13613,Constipation,Refractory Ependymoma,0
13614,Insect Bites,Endometrial Small Cell Carcinoma,0
13615,Specimen Source Codes - tumor,Localized Askin Tumor,0
13616,Immune System Processes,Mucosal Melanoma,0
13617,Lymphocyte,Colorectal High Grade B-Cell Lymphoma,0
13618,Beginning,Bladder squamous cell carcinoma stage I,0
13619,Monoclonal Antibodies,Stage IV Childhood Non-Hodgkin Lymphoma,0
13620,Increased,Splenic Manifestation of Hairy Cell Leukemia,0
13621,Blood,embryonal rhabdomyosarcoma of prostate,0
13622,Complication,Thymic Clear Cell Carcinoma,0
13623,Blue - answer to question,Ovarian germ cell choriocarcinoma stage IV,0
13624,Thymus Neoplasms,Malignant neoplasm of choroid,0
13625,generic name,Recurrent Uveal Melanoma,0
13626,Including (qualifier),Microcystic meningioma,0
13627,Cancer Remission,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13628,Wild,Multiple Endocrine Neoplasia,0
13629,Type A,Kaposi's sarcoma of skin,0
13630,unknown vaccine or immune globulin,carcinoma of middle ear,0
13631,Medications,Cancer of Urinary Tract,0
13632,Lymphocyte component of blood,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13633,Various patch test substance,Collecting Duct Carcinoma of the Kidney,0
13634,Descent,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13635,High risk,Epithelioid Sarcoma NCI Grade 3,0
13636,Tissue damage,Cervical Fibroepithelial Polyp,0
13637,Concern,Peripheral primitive neuroectodermal tumor of soft tissue,0
13638,Treatment Epoch,Intraepithelial Melanocytic Hyperplasia,0
13639,Primary operation,Extra-abdominal fibromatosis,0
13640,Case unit dose,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13641,Skeletal,Thyroid carcinoma,0
13642,Source of radiation (attribute),Gallbladder adenoma,0
13643,Entity Name Part Qualifier - birth,adenosquamous carcinoma of breast,0
13644,Lower Urinary Tract Symptoms,Neoplasms,0
13645,Primary,Hodgkin Disease,0
13646,described,Precursor B-lymphoblastic lymphoma stage II,0
13647,Type A,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13648,Occurrence Indicator,Liver Cavernous Hemangioma,0
13649,Malignant - descriptor,Intestinal Metaplasia of Bladder Urothelium,0
13650,Possible diagnosis,Angiosarcoma of liver,0
13651,Rapid,Mucinous adenocarcinoma gastric,0
13652,Similarity,Localized Ewing Sarcoma,0
13653,Body tissue,Neoplasms,0
13654,Adipose tissue,Low Grade Squamous Intraepithelial Neoplasia,0
13655,Geographic Locations,Childhood Lymphoma,0
13656,Togo,Carcinoma,0
13657,Feature,Digestive System Hodgkin Lymphoma,0
13658,Changed status,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13659,Before,Benign neoplasm of thorax,0
13660,Progesterone Receptor Measurement,Cerebral Primitive Neuroectodermal Tumor,0
13661,Cells,Stage III Cutaneous Melanoma AJCC v6,0
13662,Pharmacotherapy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13663,Similarity,Chest Wall Fibromatosis,0
13664,Experimental Result,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13665,Term (temporal),Cartilaginous exostosis,0
13666,Increasing,Blepharal carcinoma,0
13667,Maintenance,Thyroid Hurthle Cell Carcinoma,0
13668,Category Type,Contact dermatitis due to alkali,0
13669,False Discovery Rate,Childhood Lung Non-Small Cell Carcinoma,0
13670,Fasting Status Indicator,Tonsillar Carcinoma,0
13671,Both kidneys,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13672,Smear - instruction imperative,Brain Ependymoma,0
13673,Family member,Benign Anal Granular Cell Tumor,0
13674,SLC6A2 wt Allele,Thyroid Hurthle Cell Carcinoma,0
13675,Sharing (Social Behavior),Malignant neoplasm of gallbladder,0
13676,Reported Term,Kaposi's sarcoma of extrahepatic bile duct,0
13677,CEL gene,mucinous adenocarcinoma of gallbladder,0
13678,Primary malignant neoplasm,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13679,Smear - instruction imperative,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
13680,Transformation,Periosteal Osteosarcoma,0
13681,NIN gene,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13682,Disease,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13683,Infection,Cancer of Urinary Tract,0
13684,shared attribute,Chronic Myelomonocytic Leukemia-2,0
13685,Experimental Result,Stage I Colon Neuroendocrine Tumor AJCC v8,0
13686,Abnormal result,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13687,Bone Marrow,Acute Undifferentiated Leukemia,0
13688,Togo,Liver Lymphangioma,0
13689,survive,Female Breast Carcinoma,0
13690,Abnormal Reference Range,Noninfiltrating Intraductal Carcinoma,0
13691,Beginning,Thyroid Hurthle Cell Carcinoma,0
13692,Treatment Epoch,Stage IB Lung Cancer AJCC v7,0
13693,cell transformation,Ampulla of Vater Tubular Adenoma,0
13694,International Classification of Disease for Oncology,Extra-Adrenal Paraganglioma,0
13695,IPSS Risk Category High,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13696,Primary,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13697,Fatal,Benign Apocrine Neoplasm,0
13698,Include (action),Microcystic meningioma,0
13699,Biomaterial Treatment,Diffuse malignant mesothelioma,0
13700,Bruising,Stage IV Penile Cancer AJCC v7,0
13701,American College of Cardiology/American Heart Association Lesion Complexity Score C,Intestinal Metaplasia of Bladder Urothelium,0
13702,Living Alone,Malignant neoplasm of gallbladder,0
13703,Turner Syndrome,Bladder squamous cell carcinoma stage I,0
13704,Merkel cell carcinoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13705,Reciprocal translocation,FIGO Stage IVA Ovarian Cancer,0
13706,Type A,Intraepithelial Melanocytic Hyperplasia,0
13707,Rate,Cartilaginous exostosis,0
13708,Sometimes,Stage I Colon Neuroendocrine Tumor AJCC v8,0
13709,Weight decreased,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13710,Code,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
13711,Approximate,Blepharal carcinoma,0
13712,Mass of neck,Unicystic ameloblastoma,0
13713,English [International Organization for Standardization 639-1 code en] language reference set,Clonal Hematopoiesis of Indeterminate Potential,0
13714,Manual pelvic examination (procedure),Xeroderma pigmentosum,0
13715,Hepatoblastoma,Childhood Fibrillary Astrocytoma,0
13716,Germinoma,ROSE Cluster 3,0
13717,Primary malignant neoplasm,Astrocytoma of brain,0
13718,Coughing,Stage III Cutaneous Melanoma AJCC v6,0
13719,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Adult Alveolar Soft Part Sarcoma,0
13720,International Statistical Classification of Diseases and Related Health Problems,Unresectable Rhabdomyosarcoma,0
13721,Function (attribute),Angiosarcoma of liver,0
13722,Connect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13723,Thick,Mucinous adenocarcinoma gastric,0
13724,Usual,Rhabdomyosarcoma with ganglionic differentiation,0
13725,Rate,Recurrent Primary Lymphoma of Bone,0
13726,Increased,Intracortical osteosarcoma,0
13727,Mutation Abnormality,Nasal cavity carcinoma,0
13728,Very,Mucinous cystadenofibroma,0
13729,Genital region,Intestinal Metaplasia of Bladder Urothelium,0
13730,depend,Cervical Adenomyoma,0
13731,Third revision,Blepharal carcinoma,0
13732,Term (temporal),Tonsillar Carcinoma,0
13733,Pluripotent,Human Papillomavirus-Related Carcinoma,0
13734,Wall of lymphatic vessel,FIGO Stage II Ovarian Cancer,0
13735,Malignant neoplasm of thyroid,Childhood Anaplastic Large Cell Lymphoma,0
13736,Urinary tract,Undifferentiated Neuroblastoma,0
13737,Orbital region,Human Papillomavirus-Related Carcinoma,0
13738,Common Specifications in HL7 V3 Publishing,Cerebral hemangioma,0
13739,Childhood Diffuse Large B-Cell Lymphoma,Human Papillomavirus-Related Carcinoma,0
13740,Childhood Leukemia,Recurrent Primary Lymphoma of Bone,0
13741,Persons,Carcinoma ex pleomorphic adenoma of parotid gland,0
13742,Present,Cerebral Primitive Neuroectodermal Tumor,0
13743,Specific qualifier value,Low Grade Squamous Intraepithelial Neoplasia,0
13744,Neuroendocrine Tumors,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13745,See,Melanomatosis,0
13746,Recommendation,non-Hodgkin's lymphoma of spleen,0
13747,Thymic Tissue,benign mature teratoma of pancreas,0
13748,Precision - temporal,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13749,Fever,Microcystic meningioma,0
13750,MYELODYSPLASTIC SYNDROME,Adult Alveolar Soft Part Sarcoma,0
13751,shared attribute,Hereditary Diffuse Gastric Adenocarcinoma,0
13752,Therapeutic procedure,Mucosal Melanoma,0
13753,Neoplastic disease,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13754,Image Feature,Kaposi's sarcoma of extrahepatic bile duct,0
13755,General surgery specialty,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13756,diagnosis aspect,Locally Advanced Soft Tissue Sarcoma,0
13757,Difficult (qualifier value),Carcinomatosis of peritoneal cavity,0
13758,Removed,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13759,Males,Childhood Extragonadal Malignant Germ Cell Tumor,0
13760,Manufactured sign,Ovarian germ cell choriocarcinoma stage IV,0
13761,Cellular infiltrate,Clonal Hematopoiesis of Indeterminate Potential,0
13762,Formed,Metastatic Carcinoma in the Lung,0
13763,Age at menopause,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
13764,Adult,Blepharal carcinoma,0
13765,Cervix Uteri,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
13766,Breaking down,Intestinal Metaplasia of Bladder Urothelium,0
13767,Basis - conceptual entity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13768,Males,Undifferentiated Neuroblastoma,0
13769,Universal restriction modifier (core metadata concept),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13770,System - kit,Intraepithelial Melanocytic Hyperplasia,0
13771,Qualitative form,Diffuse malignant mesothelioma,0
13772,Liver Flavor,Malignant neoplasm of choroid,0
13773,Financial Account,Stage IB Pancreatic Cancer AJCC v8,0
13774,Communicable Diseases,Pancreatic carcinoma,0
13775,Bladder Neoplasm,Thymic Clear Cell Carcinoma,0
13776,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13777,Therapeutic radiology procedure,Digestive System Hodgkin Lymphoma,0
13778,Benign Neoplasm,Metastatic Carcinoma in the Lung,0
13779,Pressure (property),Stage IB Pancreatic Cancer AJCC v8,0
13780,Lineage,Benign neoplasm of eye,0
13781,Therapeutic procedure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13782,Vagina,Cerebral Primitive Neuroectodermal Tumor,0
13783,Most,Keratoderma,0
13784,Benign melanocytic nevus,Childhood Fibrillary Astrocytoma,0
13785,Menstruation,Chronic Myelomonocytic Leukemia-2,0
13786,Cells,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13787,Appearance Distress Question,Recurrent Testicular Lymphoma,0
13788,Experimental Result,Locally Advanced Carcinoma,0
13789,More,Adult Hepatocellular Carcinoma,0
13790,Muscle Tissue,Nasal cavity carcinoma,0
13791,Placenta Specimen,Pancreatic Intraepithelial Neoplasia-3,0
13792,Twice (Numerical Qualifier),Thymic Clear Cell Carcinoma,0
13793,Therapeutic procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13794,Surface,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13795,Neoplasm Metastasis,Cervical Squamous Intraepithelial Neoplasia,0
13796,Congenital defects,Melanomatosis,0
13797,Tumor Mass,Cerebral hemangioma,0
13798,Mental concentration,Melanomatosis,0
13799,Malignant neoplasm of lung,Intestinal Metaplasia of Bladder Urothelium,0
13800,Therapeutic procedure,Stage IB Pancreatic Cancer AJCC v8,0
13801,Genitourinary organs,Malignant neoplasm of olfactory nerve,0
13802,Device system,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13803,Malignant Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13804,Case unit dose,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13805,Childhood Hodgkin Lymphoma,ROSE Cluster 3,0
13806,Funisitis (disorder),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13807,Fordyce's disease,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13808,Carrying,Undifferentiated Neuroblastoma,0
13809,Collection (action),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13810,Head and Neck Carcinoma,Childhood Fibrillary Astrocytoma,0
13811,Diagnosis Study,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13812,Sectioning technique,Malignant neoplasm of gallbladder,0
13813,Occur (action),Thymoma malignant recurrent,0
13814,Used by,Thymic Clear Cell Carcinoma,0
13815,Resolution,Uterine Cancer,0
13816,Life Expectancy Greater than Twenty Years,Xeroderma pigmentosum,0
13817,Followed by,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13818,Type A,Grade 1 Clear Cell Renal Cell Carcinoma,0
13819,Human body structure,Thyroid Hurthle Cell Carcinoma,0
13820,Atla (fungus),Lipoma of small intestine,0
13821,Formation,Intestinal Metaplasia of Bladder Urothelium,0
13822,Telephone Extension Number,adenosquamous carcinoma of breast,0
13823,CDISC SDTM Disease Outcome Terminology,Refractory Barrett Esophagus,0
13824,year,Squamous cell carcinoma of lip,0
13825,Adolescent (age group),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13826,Cultured Cell Line,FIGO Stage II Ovarian Cancer,0
13827,SLC6A2 wt Allele,embryonal rhabdomyosarcoma of prostate,0
13828,Breast Cancer Type 1 Susceptibility Protein Measurement,Benign Anal Granular Cell Tumor,0
13829,1960s,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13830,Chew (administration method),Vaginal Adenoid Cystic Carcinoma,0
13831,Unmarried,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13832,<50,Cartilaginous exostosis,0
13833,Administration procedure,Chondrosarcoma,0
13834,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13835,Africa,Lung squamous cell carcinoma stage I,0
13836,Old,Metastatic Carcinoma in the Lung,0
13837,Approximate,Granular Cell Leiomyosarcoma,0
13838,include - SetOperator,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13839,Percent (qualifier value),FIGO Stage IVA Ovarian Cancer,0
13840,Include (action),Benign Anal Granular Cell Tumor,0
13841,Telencephalon,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13842,Protein antibody,Acute lymphadenitis,0
13843,Disease Screening,Intestinal Neuroendocrine Carcinoma,0
13844,Increase,Bladder adenocarcinoma stage IV,0
13845,Treating,Benign tumor of eyelid,0
13846,Beginning,Ovarian Carcinoid Tumor,0
13847,CD44 wt Allele,Periosteal Osteosarcoma,0
13848,Moving,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13849,Molecule,Localized Ewing Sarcoma,0
13850,diabetic,Childhood Choriocarcinoma,0
13851,Intestines,Thymic Clear Cell Carcinoma,0
13852,Increase,Stage 0 Penile Cancer AJCC v8,0
13853,Manufactured form,Intraepithelial Melanocytic Hyperplasia,0
13854,Referring,Heavy Chain Deposition Disease,0
13855,Following,Carcinomatosis of peritoneal cavity,0
13856,Chemotherapy Regimen,Angiosarcoma of liver,0
13857,Base - General Qualifier,Vaginal Adenoma,0
13858,Multiple malignancy,Digestive System Hodgkin Lymphoma,0
13859,Subtype (attribute),Stage II Carcinoma of Penis,0
13860,Africa,Benign Anal Granular Cell Tumor,0
13861,operate <remove>,Breast Ductal Adenoma,0
13862,penis,Pilocytic astrocytoma of cerebellum,0
13863,More,High Grade Glandular Intraepithelial Neoplasia,0
13864,MDFAttributeType - Fraction,Testicular cancer metastatic,0
13865,Better,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13866,Dangerousness,Angiosarcoma of liver,0
13867,melanoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13868,Due to,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13869,Type - attribute,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13870,Malignant tumor of cervix,FIGO Stage IVA Ovarian Cancer,0
13871,Tryptophanase,Larynx carcinoma recurrent,0
13872,Cancer Genus,Xeroderma pigmentosum,0
13873,row - Table,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13874,Age,Cancer of Urinary Tract,0
13875,Primary malignant neoplasm,Metastatic Lung Neuroendocrine Neoplasm,0
13876,NCI CTEP SDC Mastocytosis Sub-Category Terminology,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13877,Congenital condition,Stage II Hepatocellular Carcinoma AJCC v8,0
13878,Sarcoma of soft tissue,Kaposi's sarcoma of extrahepatic bile duct,0
13879,Pharmacotherapy,Benign tumor of eyelid,0
13880,Mesenchymal Stem Cells,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13881,Malignant neoplasm of endometrium,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
13882,Dietary Lead,Transitional cell carcinoma,0
13883,Support,Cervical Fibroepithelial Polyp,0
13884,Early,Recurrent Primary Lymphoma of Bone,0
13885,More,Xeroderma pigmentosum,0
13886,Loss of appetite (finding),Funisitis (disorder),0
13887,World,Metastatic Malignant Neoplasm in the Sellar Region,0
13888,Fluid behavior,Atypical Lobular Breast Hyperplasia,0
13889,Sequence Data Type,Type II Endometrial Adenocarcinoma,0
13890,Type A,Engraftment syndrome,0
13891,Polycythemia,Locally Advanced Soft Tissue Sarcoma,0
13892,Height / growth measure,Lipoma of small intestine,0
13893,Tongue,Platinum-Resistant Lung Small Cell Carcinoma,0
13894,3+ Score,Adult Anaplastic Oligodendroglioma,0
13895,Childhood Medulloblastoma,Vaginal Adenoid Cystic Carcinoma,0
13896,Occur (action),Hair nevus,0
13897,One,Bladder squamous cell carcinoma stage I,0
13898,Early stage,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13899,Intestines,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13900,South East Asian,Benign Apocrine Neoplasm,0
13901,Absence (morphologic abnormality),Acinar cell carcinoma of pancreas,0
13902,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Mucosal Melanoma,0
13903,Percent (qualifier value),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13904,Type - attribute,Localized Ewing Sarcoma,0
13905,Type - attribute,Kaposi's sarcoma of extrahepatic bile duct,0
13906,risk factors - observation list,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13907,Platelets,Female Breast Carcinoma,0
13908,Neoplasms,Female Breast Carcinoma,0
13909,Body tissue,Mucinous adenocarcinoma gastric,0
13910,cancer therapy,Recurrent Testicular Lymphoma,0
13911,include - SetOperator,Unicystic ameloblastoma,0
13912,Rare Diseases,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13913,Linear,Splenic Manifestation of Hairy Cell Leukemia,0
13914,First (number),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13915,Choroid plexus of cerebral hemisphere,Intestinal Metaplasia of Bladder Urothelium,0
13916,Definition,Epithelioid Sarcoma NCI Grade 3,0
13917,Offspring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13918,Widening,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13919,Cell Device,Localized Askin Tumor,0
13920,Anatomic Site,Locally Advanced Squamous Cell Carcinoma,0
13921,Etiology aspects,squamous cell carcinoma of the thyroid gland,0
13922,Ability,Childhood Fibrillary Astrocytoma,0
13923,Death (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13924,Cancer Registry,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13925,peripheral blood,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13926,Include (action),Metastatic Neoplasm to the Gallbladder,0
13927,Cancer Genus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13928,Sweating,Clonal Hematopoiesis of Indeterminate Potential,0
13929,800,Chondrosarcoma,0
13930,Statistical Prevalence,Pleomorphic adenoma of parotid gland,0
13931,Common (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
13932,True primary (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13933,Government,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13934,Call (Instruction),Diffuse malignant mesothelioma,0
13935,Vaginal (intended site),Non-Metastatic Gestational Trophoblastic Tumor,0
13936,Paraplegia,Recurrent Primary Lymphoma of Bone,0
13937,Usually,Trabecular adenocarcinoma,0
13938,Head - Component of Device,Malignant neoplasm of subglottis,0
13939,Autoimmune Diseases,Mucinous adenocarcinoma gastric,0
13940,active (HL7 RoleLink),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13941,Known,Stage IB Lung Cancer AJCC v7,0
13942,Multiple Partners,Anterior Urethral Malignant Neoplasm,0
13943,low exposure,Metastatic Ductal Breast Carcinoma,0
13944,geographic population,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13945,Adenocarcinoma,Liver Cavernous Hemangioma,0
13946,Estimated,BRCA2 Syndrome,0
13947,Spreading (qualifier value),BRCA2 Syndrome,0
13948,Deferred,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13949,Average,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13950,Life Expectancy Less than Ten Years,Female Breast Carcinoma,0
13951,Early,Sarcomatoid Renal Cell Carcinoma,0
13952,Participation Type - origin,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13953,Greater than one,Acantholytic squamous cell carcinoma,0
13954,Mastocytosis,Female Breast Carcinoma,0
13955,Percent of Abnormal Cells,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13956,Occur (action),Splenic Manifestation of Hairy Cell Leukemia,0
13957,Pancreas,Recurrent Testicular Lymphoma,0
13958,Involvement with,Neonatal leukemia,0
13959,examination of cervix,Childhood Fibrillary Astrocytoma,0
13960,Peripheral,benign mature teratoma of pancreas,0
13961,Update,Refractory Bladder Carcinoma,0
13962,Tumor tissue sample,Uterine Cancer,0
13963,Omphalitis,Nasal cavity carcinoma,0
13964,Beginning,Stage III Cutaneous Melanoma AJCC v6,0
13965,Taxonomic,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13966,therapeutic aspects,Intestinal Neuroendocrine Carcinoma,0
13967,Lateral column (anatomical descriptor),Locally Advanced Epithelioid Hemangioendothelioma,0
13968,Smear - instruction imperative,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13969,Effective,Neonatal leukemia,0
13970,Aspiration of food,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13971,Time,Acantholytic squamous cell carcinoma,0
13972,Microorganism,Non-Metastatic Gestational Trophoblastic Tumor,0
13973,Measures,FIGO Stage IVA Ovarian Cancer,0
13974,Atypical Teratoid Rhabdoid Tumor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13975,Array Feature,Familial Hemophagocytic Lymphocytosis,0
13976,Five,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
13977,One,Maxillary Sinus Adenocarcinoma,0
13978,Deterioration of status,Primary Cutaneous Plasmablastic Lymphoma,0
13979,Cover (physical object),Primary Cutaneous Plasmablastic Lymphoma,0
13980,Early,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13981,Area,Epithelioid Sarcoma NCI Grade 3,0
13982,Spur (body structure),Mucinous cystadenofibroma,0
13983,Enhance (action),Grade 3a Malignant Neoplasm,0
13984,Used by,Brain Tumor,0
13985,In Blood,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13986,radiotherapeutic,embryonal rhabdomyosarcoma of prostate,0
13987,Growth abnormality,Cervical Squamous Intraepithelial Neoplasia,0
13988,risk factors - observation list,Multiple Skull Base Meningiomas,0
13989,Exact (qualifier),Ovarian germ cell choriocarcinoma stage IV,0
13990,Histocompatibility Testing,Xeroderma pigmentosum,0
13991,shared attribute,Vaginal Adenoma,0
13992,Platelet Glycoprotein 4,Stage II Fallopian Tube Cancer,0
13993,include - SetOperator,Secondary malignant neoplasm of lymph node,0
13994,High,gliosarcoma,0
13995,Negation,embryonal rhabdomyosarcoma of prostate,0
13996,Anatomic Site,Cancer of Urinary Tract,0
13997,Prognosis:Find:Pt:^Patient:Nom,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13998,<90,Peripheral primitive neuroectodermal tumor of soft tissue,0
13999,Lymphocyte,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14000,Screening,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14001,Including (qualifier),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14002,NCI CTEP SDC Myeloma Sub-Category Terminology,Benign Apocrine Neoplasm,0
14003,Cell Shape,Small Intestinal Villous Adenoma,0
14004,Pain,sarcoma of spinal cord,0
14005,Have Shortness of Breath question,Type II Endometrial Adenocarcinoma,0
14006,uti symptoms,Small cell neuroendocrine carcinoma of bladder,0
14007,Term (lexical),Breast Ductal Adenoma,0
14008,eTMF Content Model Code,Pleomorphic adenoma of parotid gland,0
14009,Malignant Central Nervous System Neoplasm,Cherubism,0
14010,Blocking,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14011,pharmacotherapeutic,Keratoderma,0
14012,Specimen Source Codes - tumor,Pleomorphic adenoma of parotid gland,0
14013,Process,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14014,Money or percentage indicator - Percentage,Cancer of Urinary Tract,0
14015,Sunlight,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14016,Carcinoma,Trabecular adenocarcinoma,0
14017,research subject screening,Malignant melanoma of eyelid,0
14018,Child,Recurrent Primary Lymphoma of Bone,0
14019,Rare,Papillary squamous cell carcinoma,0
14020,Ultrasonics (sound),Female Breast Carcinoma,0
14021,Togo,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14022,majority,Metastatic Carcinoma in the Lung,0
14023,Environment,Spermatocytic seminoma,0
14024,Neoadjuvant Therapy Clinical Trial Setting,Recurrent Testicular Lymphoma,0
14025,Antineoplastic Chemotherapy Protocols,Bladder squamous cell carcinoma stage I,0
14026,Make - Instruction Imperative,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14027,Type - attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
14028,Anatomic Site,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
14029,Long hair,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14030,Study Variable,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14031,Small,Plexosarcoma,0
14032,Hematologist,Fibroadenoma of breast,0
14033,Symptoms,Digestive System Hodgkin Lymphoma,0
14034,School Grade,Stage I Colon Neuroendocrine Tumor AJCC v8,0
14035,Unknown GENC,Stage IV Childhood Non-Hodgkin Lymphoma,0
14036,Tumor cells,Stage II Carcinoma of Penis,0
14037,Affecting,Trabecular adenocarcinoma,0
14038,Continuous,BRCA2 Syndrome,0
14039,Approximate,Unfavorable Non-Hodgkin Lymphoma,0
14040,Including (qualifier),Lipoma of small intestine,0
14041,therapeutic aspects,Acantholytic squamous cell carcinoma,0
14042,Internal,FIGO Stage II Ovarian Cancer,0
14043,Definitely Related to Intervention,embryonal rhabdomyosarcoma of prostate,0
14044,Normal hair follicles,Intraepithelial Melanocytic Hyperplasia,0
14045,Period (temporal qualifier),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
14046,Cancer Genus,Squamous cell carcinoma of lip,0
14047,Progesterone Receptor,Childhood Central Nervous System Ganglioneuroblastoma,0
14048,Biologic Development,Trabecular adenocarcinoma,0
14049,Abnormally high,Stage III Cutaneous Melanoma AJCC v6,0
14050,Retinoic Acid Response Element,Stage III Cutaneous Melanoma AJCC v6,0
14051,Patient Caretaker,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14052,Qualitative form,Prostate Lymphoma,0
14053,Ovulation,Congenital hamartoma,0
14054,Tryptophanase,Stage IV Penile Cancer AJCC v7,0
14055,Areas <moth>,Type II Endometrial Adenocarcinoma,0
14056,peripheral blood,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
14057,Lacking,Medulloblastoma,0
14058,Involvement with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14059,World Health Organization,Activated B-cell type diffuse large B-cell lymphoma,0
14060,Often - answer to question,Acantholytic squamous cell carcinoma,0
14061,Formation,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
14062,consider,Unfavorable Non-Hodgkin Lymphoma,0
14063,Phase,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
14064,More,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14065,Stage Grouping,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
14066,Cessation of life,Recurrent Testicular Lymphoma,0
14067,Mass of body structure,Cherubism,0
14068,Remetinostat,Nasal cavity carcinoma,0
14069,Malignant Testicular Germ Cell Tumor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14070,Structure of posterior spinal artery,Localized Askin Tumor,0
14071,Causing,Undifferentiated Neuroblastoma,0
14072,Large,Giant cell angiofibroma,0
14073,Administration procedure,Blood Vessel Tumors,0
14074,Often - answer to question,Stage III Adult Immunoblastic Lymphoma,0
14075,Smear - instruction imperative,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14076,Cancer Genus,Anterior Urethral Malignant Neoplasm,0
14077,Related personal status,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14078,Respiratory System,Stage I Adult Non-Hodgkin Lymphoma,0
14079,Nasolacrimal duct structure,Colorectal Neuroendocrine Tumor G2,0
14080,Structure of lymphatic trunk,Testicular cancer metastatic,0
14081,Thin (qualifier value),Benign Anal Granular Cell Tumor,0
14082,Microbial anatomical capsule structure,Non-Hodgkin Lymphoma During Pregnancy,0
14083,Often - answer to question,Liver Lymphangioma,0
14084,Occur (action),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14085,Representation (action),Pancreatic Intraepithelial Neoplasia-3,0
14086,Brain,Undifferentiated Endocervical Sarcoma,0
14087,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Mixed astrocytoma-ependymoma,0
14088,Body tissue,mucinous adenocarcinoma of gallbladder,0
14089,Approximate,Placental aromatase deficiency,0
14090,Varies,Recurrent Primary Lymphoma of Bone,0
14091,Form:Finding:Point in time:{Setting}:Document:{Role},Cartilaginous exostosis,0
14092,Acquisition (action),Malignant Neoplasm of Lung - Multiple Primary Sites,0
14093,Chemotherapy,Childhood Anaplastic Large Cell Lymphoma,0
14094,Life Expectancy Greater than Twenty Years,Granular Cell Leiomyosarcoma,0
14095,Condition:Find:Pt:^Patient:Nom,Heavy Chain Deposition Disease,0
14096,Adult Medulloblastoma,Occult Lung Adenosquamous Carcinoma,0
14097,Compleat Liquid Nutrition,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14098,Childhood,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14099,risk factors - observation list,Benign tumor of eyelid,0
14100,Term (temporal),Locally Advanced Carcinoma,0
14101,What subject filter - Result,Mixed parotid tumor,0
14102,cell growth,embryonal rhabdomyosarcoma of prostate,0
14103,Precancerous Conditions,Pancreatic carcinoma,0
14104,Aggressive course,Splenic Manifestation of Hairy Cell Leukemia,0
14105,Parotid Neoplasms,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
14106,/mL,Cervical Fibroepithelial Polyp,0
14107,described,Undifferentiated Neuroblastoma,0
14108,bony process,Cervical Adenomyoma,0
14109,Cystoscopy,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14110,Blood Platelets,Unresectable Rhabdomyosarcoma,0
14111,radiotherapeutic,Adenocarcinoma of the prostate metastatic,0
14112,Present,Cancer of Urinary Tract,0
14113,CDISC SEND Tumor Findings Results Terminology,Medulloblastoma,0
14114,Hematuria,Acinar cell carcinoma of pancreas,0
14115,60%,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14116,Neoplasms,FIGO Stage IVA Ovarian Cancer,0
14117,Anal sac glands,Ovarian germ cell choriocarcinoma stage IV,0
14118,Negation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14119,Particle,Metastatic Kidney Carcinoma,0
14120,Separate,Locally Advanced Epithelioid Hemangioendothelioma,0
14121,Low Grade,Plexosarcoma,0
14122,Numbers,Benign Ovarian Thecoma,0
14123,Function Axis,Methotrexate-Associated Hodgkin Lymphoma,0
14124,Therapeutic procedure,Stage I Adult Non-Hodgkin Lymphoma,0
14125,Occurrence,Methotrexate-Associated Hodgkin Lymphoma,0
14126,SPINK5 gene,Benign neoplasm of thorax,0
14127,Histopathologic Grade differentiation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14128,Muscle Tissue,Adult Alveolar Soft Part Sarcoma,0
14129,Cancer Genus,Carcinoma ex pleomorphic adenoma of parotid gland,0
14130,Patient Monitoring,Kaposi's sarcoma of extrahepatic bile duct,0
14131,3+ Score,Undifferentiated Endocervical Sarcoma,0
14132,Fatigue,Spongiotic dermatitis,0
14133,macrophage,Benign Anal Granular Cell Tumor,0
14134,To,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14135,Case unit dose,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14136,Feature,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14137,Throat,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14138,Not Otherwise Specified,Undifferentiated Endocervical Sarcoma,0
14139,Five-year Survival Rate,Familial Hemophagocytic Lymphocytosis,0
14140,To,Intestinal Metaplasia of Bladder Urothelium,0
14141,To,Diffuse malignant mesothelioma,0
14142,Concept model range (foundation metadata concept),Lipoma of small intestine,0
14143,PREVENT (product),Botryoid-Type Embryonal Rhabdomyosarcoma,0
14144,Pelvis,Recurrent Testicular Lymphoma,0
14145,Development,Endometrial Small Cell Carcinoma,0
14146,Response to treatment,Cancer of Urinary Tract,0
14147,Tired,Acantholytic squamous cell carcinoma,0
14148,shared attribute,BRCA2 Syndrome,0
14149,Serious,Unicystic ameloblastoma,0
14150,40%,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
14151,Leg,Transitional cell carcinoma,0
14152,Greater than one,Breast Ductal Adenoma,0
14153,Aggressive behavior,Advanced Uterine Corpus Carcinosarcoma,0
14154,Domain specific term,Pancreatic Endocrine Carcinoma,0
14155,Poor - grade value,Refractory Ependymoma,0
14156,Term (temporal),Pancreatic Intraepithelial Neoplasia-3,0
14157,set (group),Non-Metastatic Gestational Trophoblastic Tumor,0
14158,Characterization,Cartilaginous exostosis,0
14159,Specimen,Diffuse malignant mesothelioma,0
14160,Logical Condition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14161,Occur (action),Undifferentiated Endocervical Sarcoma,0
14162,Tumor cells,Squamous cell carcinoma of lip,0
14163,Lower (action),Ichthyoses,0
14164,membrane attack complex location,Spindle Cell Melanoma,0
14165,Genetic Marker Expression,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14166,In Situ Lesion,Stage 0 Gastric Cancer AJCC v6 and v7,1
14167,Mesenchymal Component Present,Nephrogenic adenofibroma,1
14168,Epithelial Component Present,Localized Extrahepatic Bile Duct Carcinoma,1
14169,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage IV,1
14170,Anaplasia,Thymic Sarcomatoid Carcinoma,1
14171,Necrotic changes (finding),Prostate Stromal Sarcoma,1
14172,Malignant Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma,1
14173,Indolent Clinical Course,Hemangioma of bone,1
14174,Well Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
14175,Epithelial Component Present,Seminal Vesicle Adenocarcinoma,1
14176,Epithelial Component Present,Pre-Malignant Skin Epithelial Lesion,1
14177,Epithelial Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,1
14178,Malignant Cellular Infiltrate,Small Intestinal Mixed Adenoneuroendocrine Carcinoma,1
14179,Carcinomatous Component Present,Distal Bile Duct Cancer by AJCC v7 Stage,1
14180,Carcinomatous Component Present,Refractory Bile Duct Carcinoma,1
14181,Carcinomatous Component Present,Gastroesophageal Junction Neuroendocrine Carcinoma,1
14182,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
14183,Benign Cellular Infiltrate,Benign Epithelioma,1
14184,Epithelial Component Present,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
14185,Epithelial Component Present,Carcinoma of sublingual gland,1
14186,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
14187,Malignant Cellular Infiltrate,Cervical Adenosquamous Carcinoma,1
14188,Malignant Cellular Infiltrate,Stage I Uterine Corpus Adenosarcoma AJCC v8,1
14189,Benign Cellular Infiltrate,Benign neoplasm of mesothelial tissue of peritoneum,1
14190,Myxoid Stroma Formation,"Fibro-odontoma, Ameloblastic",1
14191,Mitotic Activity,Glioblastoma,1
14192,Epithelial Component Present,"Cystadenoma, Mucinous",1
14193,Epithelial Component Present,Colorectal Adenoma with Moderate Dysplasia,1
14194,Locally Aggressive Lesion,"Dermatofibrosarcoma Protuberans, Myxoid",1
14195,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor G1,1
14196,Radial Growth Phase,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
14197,Rapidly Enlarging Mass,Anal Rhabdomyosarcoma,1
14198,Metastatic Lesion,Good Prognosis Metastatic Gestational Trophoblastic Tumor,1
14199,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
14200,Malignant Cellular Infiltrate,Childhood Ovarian Yolk Sac Tumor,1
14201,Oligodendroglial Component Present,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
14202,Carcinomatous Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
14203,Malignant Cellular Infiltrate,Localized Gallbladder Carcinoma,1
14204,Lytic lesion,Osteoclastic Giant Cell-Rich Tumor of Bone,1
14205,Papillary Pattern,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
14206,Epithelial Component Present,Carcinoma of supraglottis,1
14207,Epithelial Component Present,Foveolar-Type Adenoma,1
14208,Malignant Cellular Infiltrate,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma,1
14209,Aflatoxins Toxicity,Aflatoxins-Related Hepatocellular Carcinoma,1
14210,Malignant Cellular Infiltrate,Splenic diffuse red pulp small B-cell lymphoma,1
14211,Neuroendocrine Differentiation,Refractory Extensive Stage Lung Small Cell Carcinoma,1
14212,Epithelial Component Present,Cervical Papillary Squamous Cell Carcinoma,1
14213,Nodular Pattern,Ann Arbor Stage III Grade 2 Follicular Lymphoma,1
14214,Low Grade Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1,1
14215,Carcinomatous Component Present,Hepatitis B Virus-Related Hepatocellular Carcinoma,1
14216,Malignant Cellular Infiltrate,Childhood Yolk Sac Tumor,1
14217,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
14218,Malignant Cellular Infiltrate,Testicular embryonal carcinoma,1
14219,Metastatic Lesion,Advanced Synovial Sarcoma,1
14220,Malignant Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor,1
14221,Epithelial Component Present,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
14222,Single Cell Necrosis,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
14223,Mild cytologic atypia,Glottis Verrucous Carcinoma,1
14224,Diffuse Pattern,"Mesothelioma, biphasic, malignant",1
14225,Tubular Pattern,Syringoma,1
14226,Monomorphic Cellular Infiltrate,Adult Brain Ependymoma,1
14227,Malignant Cellular Infiltrate,Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma,1
14228,Benign Cellular Infiltrate,Cranial Nodular Fasciitis,1
14229,Osseous Component Present,Osteochondromyxoma,1
14230,Benign Cellular Infiltrate,Benign neoplasm of spleen,1
14231,Necrotic changes (finding),Anal Canal Small Cell Neuroendocrine Carcinoma,1
14232,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Nasopharynx,1
14233,Stromal Invasion,Endometrioid carcinoma ovary,1
14234,Epithelial Component Present,Oral Cavity Carcinoma,1
14235,Low Mitotic Activity,Malignant Pancreatic Insulinoma,1
14236,Epithelial Component Present,Nasopharyngeal Papillary Adenocarcinoma,1
14237,Malignant Cellular Infiltrate,Colorectal Mixed Adenoneuroendocrine Carcinoma,1
14238,Carcinomatous Component Present,Verrucous carcinoma of penis,1
14239,Mesenchymal Component Present,Benign Prostate Phyllodes Tumor,1
14240,Malignant Cellular Infiltrate,Childhood Central Nervous System Germinoma,1
14241,Poorly Differentiated Lesion,Skin Sarcomatoid Basal Cell Carcinoma,1
14242,Metastatic Lesion,Advanced Unresectable Gastric Adenocarcinoma,1
14243,Epithelial Component Present,Conventional (Clear Cell) Renal Cell Carcinoma,1
14244,Tissue Differentiation Uncertain,Mediastinal Synovial Sarcoma,1
14245,High Mitotic Activity,Anaplastic Oligoastrocytoma,1
14246,Malignant Cellular Infiltrate,Stage III Vaginal Cancer AJCC v6 and v7,1
14247,Childhood Lesion,Recurrent Childhood Non-Hodgkin Lymphoma,1
14248,Papillary Pattern,papillary squamous cell carcinoma of larynx,1
14249,Vascular Channel Formation,Colorectal Angiosarcoma,1
14250,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma recurrent,1
14251,Malignant Cellular Infiltrate,Malignant Mixed Mesodermal (Mullerian) Tumor,1
14252,Epithelial Component Present,Recurrent Parotid Gland Acinic Cell Carcinoma,1
14253,Exophytic Polypoid Lesion,Colorectal Traditional Serrated Adenoma,1
14254,Malignant Cellular Infiltrate,Recurrent Rhabdomyosarcoma,1
14255,Epithelial Component Present,Stage IIB Vaginal Cancer AJCC v8,1
14256,Epithelial Component Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,1
14257,Malignant Cellular Infiltrate,Unresectable Urethral Urothelial Carcinoma,1
14258,Cutaneous Involvement,Sebaceous adenoma,1
14259,Monoclonal Eosinophils Present,Chronic eosinophilic leukemia,1
14260,Perineural spread,Adenoid cystic breast carcinoma,1
14261,Calcitonin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
14262,Immature Myeloid Cells Increased in Bone Marrow,Alkylating Agent-Related Acute Myeloid Leukemia,1
14263,Malignant Cellular Infiltrate,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
14264,Epithelial Component Present,Stage I Intrahepatic Bile Duct Cancer AJCC v8,1
14265,Malignant Cellular Infiltrate,Resectable Malignant Mesothelioma,1
14266,EBV-Positive Neoplastic Cells Present,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,1
14267,Epithelial Component Present,Vulvar adenocarcinoma,1
14268,Blasts of Mixed Phenotype Present,acute biphenotypic leukemia in relapse,1
14269,atypia morphology,Complex Endometrial Hyperplasia with Atypia,1
14270,Somatostatin Positive Neoplastic Cells Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
14271,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma,1
14272,Tissue of Mullerian Origin Present,Ovarian Clear Cell Cystadenofibroma,1
14273,Pseudoglandular Pattern,teratocarcinoma of mediastinum,1
14274,Intracellular Accumulation of Lipids,Anaplastic Pleomorphic Xanthoastrocytoma,1
14275,Rapidly Enlarging Mass,rhabdomyosarcoma of prostate,1
14276,Monoclonal Cellular Population Present,Smoldering Systemic Mastocytosis,1
14277,Pushing Tumor Margin,verrucous carcinoma of vagina,1
14278,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,1
14279,Malignant Cellular Infiltrate,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage,1
14280,Perineural spread,adenoid cystic carcinoma of accessory sinus,1
14281,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
14282,Malignant Cellular Infiltrate,Hodgkin Lymphoma During Pregnancy,1
14283,Epithelial Component Present,Functioning Endocrine Neoplasm,1
14284,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1A,1
14285,Infiltrative Growth Pattern,Adult Giant Cell Glioblastoma,1
14286,Malignant Cellular Infiltrate,Vulvar Merkel Cell Carcinoma,1
14287,Malignant Cellular Infiltrate,Fusion-Negative Alveolar Rhabdomyosarcoma,1
14288,Malignant Cellular Infiltrate,Vaginal adenocarcinoma,1
14289,Malignant Cellular Infiltrate,Malignant lymphomatous polyposis,1
14290,Localized Lesion,Solitary Osseous Plasmacytoma,1
14291,Benign Cellular Infiltrate,Atypical neurofibroma,1
14292,Increased Cellularity Present,Recurrent Childhood Anaplastic Oligodendroglioma,1
14293,Fibrotic Stroma Formation,Cystadenofibroma,1
14294,Mixed Cellular Population,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
14295,Cutaneous Involvement,Senile angioma,1
14296,Refractory Disease,Peripheral T-cell lymphoma unspecified refractory,1
14297,Malignant Cellular Infiltrate,Prognostic Stage IV Breast Cancer AJCC v8,1
14298,Epithelial Component Present,Stage 0 Vulvar Carcinoma,1
14299,Cutaneous Involvement,Apocrine Sweat Gland Hamartoma,1
14300,Benign Cellular Infiltrate,Childhood Testicular Mature Teratoma,1
14301,Bone Marrow Dysplasia Present,Refractory High Risk Myelodysplastic Syndrome,1
14302,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
14303,Dysplasia,Pancreatic intraepithelial neoplasia,1
14304,Myxoid Stroma Formation,Odontogenic myxoma,1
14305,Primary Lesion,Childhood Gliosarcoma,1
14306,Carcinomatous Component Present,Malignant Mixed Mesodermal (Mullerian) Tumor,1
14307,Epithelial Component Present,"Adenocarcinoma of lung, stage IV",1
14308,Carcinomatous Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14309,Epithelial Component Present,Advanced Digestive System Neuroendocrine Neoplasm,1
14310,Secondary Lesion,"Neoplasms, Unknown Primary",1
14311,Malignant Cellular Infiltrate,Recurrent Combined Thymic Epithelial Neoplasm,1
14312,Carcinomatous Component Present,AIDS-Related Anal Carcinoma,1
14313,Carcinomatous Component Present,Vaginal cancer recurrent,1
14314,Epithelial Component Present,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
14315,Invasive Lesion,minimally invasive follicular carcinoma of the thyroid gland,1
14316,Fibrotic Stroma Formation,Resectable Intrahepatic Cholangiocarcinoma,1
14317,Infiltrating Tumor Margins Present,Stage IB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
14318,Epithelial Component Present,Gallbladder papillary adenocarcinoma,1
14319,Neuroendocrine Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
14320,Well-Circumscribed Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,1
14321,Malignant Cellular Infiltrate,ALK positive large B-cell lymphoma,1
14322,Invasive Lesion,Growth Hormone-Producing Pituitary Gland Carcinoma,1
14323,Adnexal Differentiation,Ceruminous Neoplasm,1
14324,Carcinomatous Component Present,Refractory Head and Neck Carcinoma,1
14325,Adnexal Differentiation,Perifollicular fibroma,1
14326,Cystic Change,Pancreatic Acinar Cell Cystadenoma,1
14327,Solitary mass,"Bronchiolo-alveolar carcinoma, non-mucinous",1
14328,Malignant Cellular Infiltrate,Lentigo maligna recurrent,1
14329,Biphasic Pattern,Malignant Vulvar Phyllodes Tumor,1
14330,Dysplasia,Adenoma of ampulla of Vater,1
14331,Childhood Lesion,Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage,1
14332,Metastatic Lesion,Secondary malignant neoplasm of ovary,1
14333,No Evidence of Metastatic Disease,Non-Metastatic Childhood Soft Tissue Sarcoma,1
14334,Cartilaginous Differentiation,Secondary Chondrosarcoma,1
14335,Carcinomatous Component Present,Stage IA Esophageal Cancer AJCC v7,1
14336,Malignant Cellular Infiltrate,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
14337,Carcinomatous Component Present,undifferentiated carcinoma of gallbladder,1
14338,Myxoid Stroma Formation,Undifferentiated (Embryonal) Sarcoma,1
14339,Neuroendocrine Differentiation,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
14340,Epithelial Component Present,large cell neuroendocrine carcinoma of appendix,1
14341,Epithelial Component Present,Stage III Lung Cancer AJCC v7,1
14342,Malignant Cellular Infiltrate,Stage III Pancreatic Cancer AJCC v6 and v7,1
14343,Malignant Cellular Infiltrate,Extragonadal Seminoma,1
14344,Malignant Cellular Infiltrate,Metastatic Renal Pelvis Urothelial Carcinoma,1
14345,Carcinomatous Component Present,Lung Basaloid Squamous Cell Carcinoma,1
14346,Necrotic changes (finding),Malignant Uterine Corpus PEComa,1
14347,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage IV,1
14348,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
14349,Cutaneous Involvement,Eccrine mixed tumor of skin,1
14350,Epithelial Component Present,"Adenocarcinoma, Oxyphilic",1
14351,Epithelial Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
14352,Malignant Cellular Infiltrate,Squamous cell carcinoma of vulva,1
14353,Macrofollicular Structures Present,Juvenile Type Testicular Granulosa Cell Tumor,1
14354,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
14355,Carcinomatous Component Present,Stage 0 Gastric Cancer AJCC v6 and v7,1
14356,Biphasic Pattern,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
14357,Exophytic Papillary Lesion,keratoacanthoma,1
14358,Malignant Cellular Infiltrate,Stage IV Oral Cavity Cancer AJCC v6 and v7,1
14359,Delicate Arborizing Vascular Channel Formation,Myxoid liposarcoma metastatic,1
14360,Intermediate Grade Lesion,Periosteal Osteosarcoma,1
14361,Malignant Cellular Infiltrate,Ependymoblastoma,1
14362,Epithelial Component Present,"Transitional cell carcinoma, spindle cell",1
14363,Malignant Cellular Infiltrate,Stage III Testicular Seminoma AJCC v6 and v7,1
14364,Epithelial Component Present,Borderline Ovarian Mucinous Adenofibroma,1
14365,Carcinomatous Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8,1
14366,Intraosseous Lesion,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
14367,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
14368,Metaplasia,Pleomorphic adenoma of lacrimal gland,1
14369,Carcinomatous Component Present,Recurrent Carcinoma of Unknown Primary,1
14370,Thin-Walled Branching Vascular Pattern,Pericardial Solitary Fibrous Tumor,1
14371,Epithelial Component Present,Type 1 Papillary Renal Cell Carcinoma,1
14372,Progressive Clinical Course,Rapidly progressive glomerulonephritis,1
14373,Therapy-Related Toxicity,Transplant-Related Renal Cell Carcinoma,1
14374,Malignant Cellular Infiltrate,Hutchinson's Melanotic Freckle,1
14375,Enterochromaffin Type Granules Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
14376,Primary Lesion,Supratentorial Ependymal Tumor,1
14377,Fibrotic Stroma Formation,serous adenocarcinofibroma of ovary,1
14378,Childhood Lesion,Childhood Fibrosarcoma,1
14379,Childhood Lesion,Childhood Testicular Immature Teratoma,1
14380,Immunologic Deficiency Syndromes,Transplant-Related Carcinoma,1
14381,Malignant Cellular Infiltrate,Unfavorable Hodgkin Lymphoma,1
14382,Hereditary Lesion,Hereditary Prostate Carcinoma,1
14383,Malignant Cellular Infiltrate,Stage IIB Ovarian Cancer AJCC v8,1
14384,Epithelial Component Present,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14385,Malignant Cellular Infiltrate,Vaginal Adenoid Cystic Carcinoma,1
14386,Acinar Cell Differentiation,Recurrent Pancreatic Acinar Cell Carcinoma,1
14387,Regional Disease,Locally Advanced Thymic Carcinoma,1
14388,Mesenchymal Component Present,Vulvar Ectopic Fibroadenoma,1
14389,Cystic Change,Rete Ovarii Cystadenoma,1
14390,atypia morphology,Atypical adenoma,1
14391,Childhood Lesion,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
14392,Carcinomatous Component Present,Refractory Carcinoma,1
14393,Deep Lesion,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
14394,Epithelial Component Present,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,1
14395,Immunologic Deficiency Syndromes,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
14396,Hyperkeratosis,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
14397,Carcinomatous Component Present,Adenocarcinoma of rectum,1
14398,Epithelial Component Present,Refractory Endometrial Endometrioid Adenocarcinoma,1
14399,Epithelial Component Present,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
14400,Epithelial Component Present,Metastatic Salivary Gland Carcinoma,1
14401,Radiation Sickness,Radiation damage to artery,1
14402,Malignant Cellular Infiltrate,undifferentiated carcinoma of pancreas,1
14403,Carcinomatous Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
14404,Adulthood Lesion,Adult Central Nervous System Teratoma,1
14405,Lesion with Diameter of 4mm or More,Vulvar Dysplastic Melanocytic Nevus,1
14406,Recurrent disease,Recurrent Endometrial Clear Cell Adenocarcinoma,1
14407,Malignant Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v8,1
14408,Malignant Cellular Infiltrate,Stage IA Fallopian Tube Cancer AJCC v8,1
14409,Adulthood Lesion,Adult Central Nervous System Embryonal Carcinoma,1
14410,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,1
14411,Malignant Cellular Infiltrate,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
14412,Malignant Cellular Infiltrate,Minimally Invasive Mucinous Lung Adenocarcinoma,1
14413,Childhood Lesion,Childhood Ovarian Yolk Sac Tumor,1
14414,Malignant Cellular Infiltrate,Pancreatic Small Cell Neuroendocrine Carcinoma,1
14415,Fibrosis,Primary mediastinal large B-cell lymphoma recurrent,1
14416,Cribriform Pattern,Rectal Cribriform Comedo-Type Adenocarcinoma,1
14417,Malignant Cellular Infiltrate,Childhood Extraskeletal Osteosarcoma,1
14418,Low Mitotic Activity,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
14419,Epithelial Component Present,Colorectal Adenosquamous Carcinoma,1
14420,Malignant Cellular Infiltrate,Grade 3 Teratoma,1
14421,Secondary Lesion,Locally Advanced Digestive System Carcinoma,1
14422,Biphasic Pattern,Carcinosarcoma of ovary,1
14423,Cutaneous Involvement,Dartoic myoma,1
14424,Malignant Cellular Infiltrate,Stage III Colon Cancer,1
14425,Malignant Cellular Infiltrate,small cell carcinoma of salivary gland,1
14426,Epithelial Component Present,Metastatic Lung Small Cell Carcinoma,1
14427,Poorly Differentiated Lesion,Thymic Sarcomatoid Carcinoma,1
14428,Epithelial Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
14429,Malignant Cellular Infiltrate,Secondary malignant neoplasm of retina,1
14430,Metastatic Lesion,Metastatic Malignant Solid Neoplasm,1
14431,Splenomegaly,Refractory Hairy Cell Leukemia,1
14432,High Mitotic Activity,Large cell neuroendocrine carcinoma,1
14433,Carcinomatous Component Present,Renal Cell Carcinoma with Constitutional Chromosome 3 Translocations,1
14434,Mixed Cellular Population,Adult Kidney Wilms Tumor,1
14435,Lymphadenopathy,Ann Arbor Stage I Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
14436,Diffuse Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
14437,Malignant Cellular Infiltrate,Malignant neoplasm of labium minus,1
14438,Malignant Cellular Infiltrate,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
14439,Chronic lymphocytic inflammation,"Thymoma, type B2, malignant",1
14440,Exophytic Polypoid Lesion,Gastric Juvenile Polyp,1
14441,Adnexal Differentiation,"Adenoma, Sweat Gland",1
14442,Malignant Cellular Infiltrate,Leiomyosarcoma of Vessels,1
14443,Carcinomatous Component Present,Accessory Urethral Gland Carcinoma,1
14444,Chromogranin A Positive Neoplastic Cells Present,Ascending Colon Neuroendocrine Tumor G1,1
14445,Immunologic Deficiency Syndromes,Burkitt lymphoma associated with AIDS,1
14446,Low Grade Lesion,malignant epithelioid hemangioendothelioma of liver,1
14447,Cystic Change,Borderline cystadenoma,1
14448,Epithelial Component Present,"Cystadenoma, Mucinous",1
14449,Leukoerythroblastic Reaction,Post polycythaemia vera myelofibrosis,1
14450,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
14451,atypia morphology,Liver Dysplastic Nodule,1
14452,Malignant Cellular Infiltrate,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
14453,Cutaneous Involvement,Vulvar Clear Cell Hidradenocarcinoma,1
14454,Childhood Lesion,Childhood Cerebellar Anaplastic Astrocytoma,1
14455,Carcinomatous Component Present,Vaginal Large Cell Neuroendocrine Carcinoma,1
14456,Hot Nodule,Thyroid Gland Hyperfunctioning Adenoma,1
14457,Follicular Cell Differentiation,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
14458,Carcinomatous Component Present,Stage IV Prostate Carcinoma,1
14459,Favorable Clinical Outcome,Retroperitoneal Ganglioneuroma,1
14460,Storiform Growth Pattern,Unresectable Undifferentiated Pleomorphic Sarcoma,1
14461,Pathologic TNM Finding,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14462,Low Mitotic Activity,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
14463,Epithelial Component Present,Stage IIB Penile Cancer AJCC v8,1
14464,Malignant Cellular Infiltrate,Stage III Paranasal Sinus Cancer AJCC v6 and v7,1
14465,Mixed Cellular Population,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
14466,Carcinomatous Component Present,Early Invasive Cervical Squamous Cell Carcinoma,1
14467,Vascular Channel Formation,Blood Vessel Tumors,1
14468,Osteoid formation,Fibroblastic osteosarcoma,1
14469,Malignant Component Present,Testicular Teratoma with Somatic-Type Malignancy,1
14470,Carcinomatous Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
14471,Carcinomatous Component Present,Large cell lung cancer stage III,1
14472,Malignant Cellular Infiltrate,Follicular Lymphoma by Ann Arbor Stage,1
14473,Neuroendocrine Differentiation,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
14474,Epithelial Component Present,Adamantinoma,1
14475,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
14476,Widely Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
14477,Toxic effect,Solar Radiation-Related Cutaneous Melanoma,1
14478,Widely Invasive Lesion,Widely Invasive Thymoma,1
14479,Malignant Cellular Infiltrate,Childhood Anaplastic Large Cell Lymphoma,1
14480,Cutaneous Involvement,Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
14481,Carcinomatous Component Present,Breast Columnar Cell Mucinous Carcinoma,1
14482,Benign Cellular Infiltrate,Metanephric adenoma,1
14483,Immunologic Deficiency Syndromes,AIDS-Related Plasmablastic Lymphoma,1
14484,Epithelial Component Present,Multicentric Thyroid Gland Papillary Carcinoma,1
14485,Well-Circumscribed Lesion,Giant cell angiofibroma,1
14486,Diffuse Pattern,Diffuse large B-cell lymphoma of central nervous system,1
14487,Epithelial Component Present,Adenoid cystic carcinoma of trachea,1
14488,Cutaneous Involvement,Benign Eccrine Neoplasm,1
14489,Malignant Cellular Infiltrate,Stage I Lip Basal Cell Carcinoma,1
14490,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor,1
14491,Monoclonal Cellular Population Present,Aggressive Systemic Mastocytosis,1
14492,Malignant Cellular Infiltrate,Fallopian Tube Papillary Adenocarcinoma,1
14493,Malignant Cellular Infiltrate,Endocervical Carcinoma,1
14494,Severe cytologic atypia,large cell neuroendocrine carcinoma of gallbladder,1
14495,Malignant Cellular Infiltrate,Stage III Testicular Cancer AJCC v6 and v7,1
14496,Secondary Lesion,"Squamous cell carcinoma, metastatic",1
14497,Nuclear Atypia,Childhood Cerebellar Anaplastic Astrocytoma,1
14498,Histiocytosis haematophagic,Secondary haemophagocytic lymphohistiocytosis,1
14499,Bone Marrow Lymphoplasmacytic Infiltrate,Familial Waldenstrom's Macroglobulinaemia,1
14500,Primary Lesion,BCLC Stage D Adult Hepatocellular Carcinoma,1
14501,Epithelial Component Present,Foveolar-Type Adenoma,1
14502,Thick-Walled Hyalinized Vessels Present,Jugular Foramen Schwannoma,1
14503,Carcinomatous Component Present,Unresectable Transitional Cell Carcinoma,1
14504,Carcinomatous Component Present,Malignant myoepithelioma,1
14505,Carcinomatous Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
14506,Epithelial Component Present,Parathyroid Adenoma,1
14507,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v6 and v7,1
14508,Childhood Lesion,Childhood Atypical Teratoid/Rhabdoid Tumor,1
14509,Carcinomatous Component Present,Metastatic Lip and Oral Cavity Carcinoma,1
14510,Well-Circumscribed Lesion,Serous cystadenoma of ovary,1
14511,Malignant Cellular Infiltrate,Cardiac Malignant Fibrous Histiocytoma,1
14512,Carcinomatous Component Present,Stage IVB Liver Cancer,1
14513,Epithelial Component Present,Carcinoid tumor of the duodenum,1
14514,Secondary Lesion,Metastatic malignant neoplasm to nasopharynx,1
14515,Benign Cellular Infiltrate,Cellular fibroma,1
14516,Epithelial Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
14517,Hemosiderin pigmentation,"Histiocytoma, Angiomatoid Fibrous",1
14518,Carcinomatous Component Present,Prolactin-Producing Pituitary Gland Carcinoma,1
14519,Epithelial Component Present,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
14520,Well-Circumscribed Lesion,Unclassified Hepatocellular Adenoma,1
14521,Well-Circumscribed Lesion,Deep histiocytoma,1
14522,Malignant Cellular Infiltrate,Stage III Cervical Cancer AJCC v6 and v7,1
14523,Malignant Cellular Infiltrate,Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
14524,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 1 Follicular Lymphoma,1
14525,Malignant Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma,1
14526,Malignant Cellular Infiltrate,Stage IIIC Uveal Melanoma AJCC v7,1
14527,Malignant Cellular Infiltrate,Stage III Esophageal Cancer AJCC v7,1
14528,Epithelial Component Present,Stage II Lung Cancer AJCC v7,1
14529,Malignant Cellular Infiltrate,Recurrent Acute Myelomonocytic Leukemia,1
14530,Nodular Pattern,Skin Nodular Basal Cell Carcinoma,1
14531,Cutaneous Involvement,Eccrine Poroma,1
14532,Therapy-Related Toxicity,Radiation-Related Sarcoma,1
14533,High Grade Lesion,Synovial sarcoma metastatic,1
14534,Carcinomatous Component Present,Refractory Uterine Corpus Carcinoma,1
14535,Epithelial Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
14536,Well-Circumscribed Lesion,Anal polyp,1
14537,Epithelial Component Present,Stage I Anal Cancer AJCC v8,1
14538,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v6 and v7,1
14539,Well Differentiated Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
14540,Epithelial Component Present,Recurrent Lobular Breast Carcinoma,1
14541,Monoclonal Langerhans Cells Present,Refractory Langerhans Cell Histiocytosis,1
14542,Stromal Invasion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
14543,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
14544,Malignant Cellular Infiltrate,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
14545,Carcinomatous Component Present,Rectal Cancer by AJCC v6 Stage,1
14546,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of peritoneum,1
14547,Metastatic Lesion,Locally Advanced Unresectable Cervical Carcinoma,1
14548,Epithelial Component Present,Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14549,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Carcinoma,1
14550,Epithelial Component Present,Recurrent Ovarian Transitional Cell Carcinoma,1
14551,Carcinomatous Component Present,squamous cell carcinoma of the thyroid gland,1
14552,Epithelial Component Present,Stage IV Nasopharyngeal Carcinoma AJCC v7,1
14553,Adulthood Lesion,Adult Anaplastic Oligodendroglioma,1
14554,Locally Aggressive Lesion,Kaposiform Hemangioendothelioma,1
14555,Malignant Cellular Infiltrate,Hepatic cancer stage IVA,1
14556,Secondary Lesion,Metastatic Colorectal Carcinoma,1
14557,CD56-Positive Neoplastic Cells Present,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
14558,Malignant Cellular Infiltrate,Fibrosarcoma,1
14559,Epithelial Component Present,Ampulla of Vater Tubular Adenoma,1
14560,Nuclear Atypia,Anaplastic Hemispheric Astrocytoma,1
14561,Carcinomatous Component Present,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
14562,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma metastatic,1
14563,Malignant Cellular Infiltrate,Malignant neoplasm of thymus,1
14564,Metaplasia,Bladder squamous cell carcinoma stage 0,1
14565,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v7,1
14566,Carcinomatous Component Present,Metastatic Lung Carcinoma,1
14567,Hereditary Lesion,Hereditary Prostate Carcinoma,1
14568,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood,1
14569,Intracytoplasmic Eosinophilic Inclusion,Recurrent Rhabdoid Tumor,1
14570,Carcinomatous Component Present,Stage 0 Colorectal Cancer AJCC v8,1
14571,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
14572,Malignant Cellular Infiltrate,Precursor cell lymphoblastic lymphoma,1
14573,Malignant Cellular Infiltrate,Stage IIIB Cutaneous Melanoma AJCC v7,1
14574,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",1
14575,Clinical TNM Finding,Clinical Stage III Retinoblastoma AJCC v8,1
14576,Carcinomatous Component Present,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
14577,Epithelial Component Present,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
14578,Refractory Disease,Refractory Lung Carcinoma,1
14579,Malignant Cellular Infiltrate,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7,1
14580,Dense Intercellular Reticulin Network Present,Temporal Lobe Pleomorphic Xanthoastrocytoma,1
14581,Poorly Differentiated Lesion,"Lung Large Cell Carcinoma, Clear Cell Variant",1
14582,Recurrent disease,Verrucous carcinoma of the oral cavity recurrent,1
14583,Carcinomatous Component Present,Childhood Laryngeal Carcinoma,1
14584,Metastatic Lesion,Metastatic Thyroid Gland Follicular Carcinoma,1
14585,Benign Cellular Infiltrate,Adenoma of lung,1
14586,Bone Marrow Dysplasia Present,Therapy-related myelodysplastic syndrome,1
14587,Epithelial Component Present,Merkel cell carcinoma,1
14588,Edematous Stroma Formation,Aggressive angiomyxoma,1
14589,Malignant Cellular Infiltrate,Kidney Extraskeletal Osteosarcoma,1
14590,Epithelial Component Present,Masaoka-Koga Stage I,1
14591,Epithelial Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage,1
14592,Epithelial Component Present,Ovarian Insular Carcinoid Tumor,1
14593,Epithelial Component Present,Syringoma,1
14594,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
14595,Malignant Cellular Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
14596,Severe dysplasia,Pleomorphic lobular carcinoma in situ of breast,1
14597,Mixed Cellular Population,"Uterine Carcinosarcoma, Heterologous Type",1
14598,Childhood Lesion,Childhood Choriocarcinoma,1
14599,Carcinomatous Component Present,"Squamous cell carcinoma, microinvasive",1
14600,Malignant Cellular Infiltrate,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,1
14601,Epithelial Component Present,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
14602,Carcinomatous Component Present,Carcinoma Arising from Craniopharyngioma,1
14603,Epithelial Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
14604,Carcinomatous Component Present,Refractory Female Reproductive System Carcinoma,1
14605,Malignant Cellular Infiltrate,Adult Unfavorable Prognosis Hodgkin Lymphoma,1
14606,Vascular Channel Formation,Kaposi's sarcoma of esophagus,1
14607,Childhood Lesion,"Childhood Ganglioneuroblastoma, Intermixed",1
14608,Epithelial Component Present,Maxillary Sinus Squamous Cell Carcinoma,1
14609,Malignant Cellular Infiltrate,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
14610,Epithelial Component Present,Recurrent Pancreatic Ductal Adenocarcinoma,1
14611,Malignant Cellular Infiltrate,Malignant neoplasm of ampulla of Vater,1
14612,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
14613,Malignant Cellular Infiltrate,Lung squamous cell carcinoma stage II,1
14614,Tissue of Mullerian Origin Present,Uterine Corpus Adenofibroma,1
14615,Cutaneous Involvement,Lichen Planus,1
14616,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v7,1
14617,Epithelial Component Present,Anal carcinoma,1
14618,Well Differentiated Neuroendocrine Lesion,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
14619,Malignant Cellular Infiltrate,Stage IA Lung Adenocarcinoma AJCC v7,1
14620,Epithelial Component Present,Esophageal High Grade Intraepithelial Neoplasia,1
14621,Cutaneous Involvement,Locally Advanced Skin Squamous Cell Carcinoma,1
14622,Secondary Lesion,Recurrent Metastatic Digestive System Carcinoma,1
14623,Well-Circumscribed Lesion,Preauricular skin tag,1
14624,Low Grade Neuroendocrine Lesion,Localized Digestive System Neuroendocrine Tumor G1,1
14625,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
14626,Diffuse Lesion,Pericardial Carcinomatosis,1
14627,Intraductal Lesion,Intraductal papilloma of breast,1
14628,Carcinomatous Component Present,Pathologic Stage II Gastric Cancer AJCC v8,1
14629,Epithelial Component Present,villous adenoma of stomach,1
14630,Malignant Cellular Infiltrate,Periosteal Osteosarcoma,1
14631,Carcinomatous Component Present,Squamous cell carcinoma of tonsil,1
14632,Recurrent disease,Recurrent Primary Peritoneal Serous Adenocarcinoma,1
14633,Malignant Cellular Infiltrate,Submucosal Invasive Colon Adenocarcinoma,1
14634,Local disease,Adrenal Cortex Adenomatoid Tumor,1
14635,Local disease,Chondroid lipoma,1
14636,Malignant Cellular Infiltrate,Adult Malignant Peripheral Nerve Sheath Tumor,1
14637,Recurrent disease,Recurrent Adult Hepatocellular Carcinoma,1
14638,Unclassifiable Lesion,"Refractory NK-Cell Lymphoma, Unclassifiable",1
14639,Adulthood Lesion,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8,1
14640,Carcinomatous Component Present,Clear cell adenocarcinoma of ovary,1
14641,Recurrent disease,Recurrent Gastroesophageal Junction Adenocarcinoma,1
14642,Vascular Channel Formation,Pyogenic granuloma of oral mucosa,1
14643,Epithelial Component Present,Pancreatic Ductal Adenocarcinoma,1
14644,Malignant Cellular Infiltrate,Childhood Malignant Small Intestinal Neoplasm,1
14645,Malignant Cellular Infiltrate,Stage I Colorectal Cancer AJCC v6 and v7,1
14646,Local disease,Lipoma of skin,1
14647,Epithelial Component Present,Locally Advanced Unresectable Cervical Carcinoma,1
14648,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor G2,1
14649,Benign Cellular Infiltrate,Hemangioma acquired,1
14650,Mixed Cellular Population,Anaplastic Kidney Wilms Tumor,1
14651,Metastatic Lesion,Secondary malignant neoplasm of sternum,1
14652,Malignant Cellular Infiltrate,Olfactory Neuroblastoma,1
14653,Edema,Inflammatory carcinoma of breast stage IV,1
14654,Skin nodule,Pilomatrixoma,1
14655,Syncytial Pattern,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
14656,Recurrent disease,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
14657,Favorable Clinical Outcome,Testicular Follicular Lymphoma,1
14658,Epithelial Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
14659,Fibrosarcomatous Component Present,Metastatic Dermatofibrosarcoma Protuberans,1
14660,Epithelial Component Present,adenocarcinoma of breast with spindle cell metaplasia,1
14661,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v7 Stage,1
14662,Malignant Cellular Infiltrate,Peripheral Intrahepatic Cholangiocarcinoma,1
14663,Carcinomatous Component Present,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8",1
14664,Carcinomatous Component Present,Primary Peritoneal Low Grade Serous Adenocarcinoma,1
14665,Infiltrative Growth Pattern,"Fibromatosis, Aggressive",1
14666,Vascular Channel Formation,Hemangioma,1
14667,Malignant Cellular Infiltrate,Lugano Classification Stage II Hodgkin Lymphoma AJCC v8,1
14668,Hyaline Cartilage Differentiation,Secondary Peripheral Chondrosarcoma,1
14669,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Skin,1
14670,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
14671,Malignant Cellular Infiltrate,Extraskeletal Osteosarcoma,1
14672,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v8,1
14673,Refractory Disease,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
14674,Epithelial Component Present,Bartholin Gland Squamous Cell Carcinoma,1
14675,Exophytic Polypoid Lesion,Gallbladder adenoma,1
14676,Malignant Cellular Infiltrate,Major Salivary Gland Cancer by AJCC v7 Stage,1
14677,Cystic Change,Thyroid Gland Mucoepidermoid Carcinoma,1
14678,Multinodular Mass,Thyroid Angiosarcoma,1
14679,Calcitonin serum level increased,Sporadic Thyroid Gland Micromedullary Carcinoma,1
14680,Antoni A Pattern,Benign Intraocular Schwannoma,1
14681,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v7,1
14682,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia with Atypia,1
14683,Plasma cell inflammation,Inflammatory pseudotumor of liver,1
14684,Emperipolesis,Sinus histiocytosis,1
14685,Vascular Channel Formation,Lymphadenopathic Kaposi Sarcoma,1
14686,Pseudoalveolar Pattern,Alveolar soft part sarcoma recurrent,1
14687,Carcinomatous Component Present,Stage III Vulvar Cancer AJCC v8,1
14688,Malignant Cellular Infiltrate,Recurrent Malignant Central Nervous System Neoplasm,1
14689,Delicate Arborizing Vascular Channel Formation,Recurrent Myxoid Liposarcoma,1
14690,Mixed Cellular Population,Pleomorphic adenoma of lacrimal gland,1
14691,Primary Lesion,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
14692,Non-Malignant Cellular Infiltrate,Cervical lymphadenitis,1
14693,Carcinomatous Component Present,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
14694,Childhood Lesion,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
14695,Local disease,Fallopian Tube Adenomatoid Tumor,1
14696,Unresectable Mass,Locally Advanced Unresectable Gastric Adenocarcinoma,1
14697,Epithelial Component Present,Malignant neoplasm of stomach stage III,1
14698,Secondary Lesion,Metastatic angiosarcoma,1
14699,Malignant Cellular Infiltrate,Recurrent Transformed Chronic Lymphocytic Leukemia,1
14700,Epithelial Component Present,Metastatic Prostate Carcinoma,1
14701,Carcinomatous Component Present,Eyelid Sebaceous Gland Carcinoma,1
14702,Clinical TNM Finding,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,1
14703,Malignant Cellular Infiltrate,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
14704,Malignant Cellular Infiltrate,DS Stage III Plasma Cell Myeloma,1
14705,Microcystic Change,Ovarian Microcystic Stromal Tumor,1
14706,Epithelial Component Present,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,1
14707,Malignant Cellular Infiltrate,Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder,1
14708,Malignant Cellular Infiltrate,Recurrent Central Nervous System Non-Hodgkin Lymphoma,1
14709,Epithelial Component Present,Nasopharyngeal Differentiated Carcinoma,1
14710,Childhood Lesion,Childhood Central Nervous System Mature Teratoma,1
14711,Tissue Differentiation Uncertain,Acral Fibromyxoma,1
14712,Hyperkeratosis,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
14713,Tissue Differentiation Uncertain,Benign Lung PEComa,1
14714,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
14715,Epithelial Component Present,Intermediate Grade Lung Neuroendocrine Neoplasm,1
14716,Carcinomatous Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
14717,Carcinomatous Component Present,Verrucous carcinoma,1
14718,Tissue of Mullerian Origin Present,Adenosarcoma of cervix uteri,1
14719,Carcinomatous Component Present,Stage IIB Gastric Cancer AJCC v7,1
14720,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
14721,Rapidly Enlarging Mass,"Myositis, Proliferative",1
14722,'Starry-sky' pattern,Gastric Burkitt Lymphoma,1
14723,Recurrent disease,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
14724,Eosinophil count raised (finding),Adult Acute Eosinophilic Leukemia,1
14725,Immunosuppression-Related Post-Transplant Toxicity,Neoplastic Post-Transplant Lymphoproliferative Disorder,1
14726,Cutaneous Involvement,Ductal Eccrine Carcinoma with Squamous Metaplasia,1
14727,Malignant Cellular Infiltrate,Colon Leiomyosarcoma,1
14728,Tissue of Mullerian Origin Present,Carcinosarcoma of cervix uteri,1
14729,Sarcomatous or Carcinomatous Component Present,Testicular Teratoma with Somatic-Type Malignancy,1
14730,Multifocal Lesion,Atypical Adenomatous Lung Hyperplasia,1
14731,Childhood Lesion,Childhood Unfavorable Prognosis Hodgkin Lymphoma,1
14732,Malignant Cellular Infiltrate,Primary myoepithelial carcinoma of lung,1
14733,Malignant Cellular Infiltrate,Alcohol-Related Laryngeal Carcinoma,1
14734,Epithelial Component Present,Colon Adenoma with Severe Dysplasia,1
14735,Adulthood Lesion,Stage IIIC Adult Liver Cancer AJCC v7,1
14736,Alternative Fascicle (Bundle) Pattern,Prostate Leiomyoma,1
14737,Adulthood Lesion,Adult Burkitt Leukemia,1
14738,Malignant Cellular Infiltrate,Stage III Bladder Cancer AJCC v8,1
14739,Recurrent disease,Lung adenocarcinoma recurrent,1
14740,Local disease,Adrenal Cortex Adenomatoid Tumor,1
14741,Epithelial Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
14742,Eccrine Differentiation,Benign Eccrine Neoplasm,1
14743,Papillary Pattern,Squamous cell papilloma of eyelid,1
14744,Epithelial Component Present,Parotid monomorphic adenoma,1
14745,Carcinomatous Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
14746,Metastatic Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
14747,Monomorphic Cellular Infiltrate,Head and Neck Basaloid Carcinoma,1
14748,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx,1
14749,Well Differentiated Lesion,Laryngeal verrucous carcinoma recurrent,1
14750,Antoni A Pattern,Microcystic/Reticular Schwannoma,1
14751,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent Myelodysplastic Syndrome,1
14752,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma,1
14753,Cellular Changes Resembling Foveolar Epithelium Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
14754,Refractory Disease,Adult T-cell lymphoma/leukemia refractory,1
14755,Carcinomatous Component Present,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
14756,Malignant Cellular Infiltrate,olfactory neuroblastoma of nasal cavity,1
14757,Epithelial Component Present,malignant myoepithelioma of breast,1
14758,Myxoid Stroma Formation,Chondroid chordoma,1
14759,Malignant Cellular Infiltrate,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type",1
14760,Malignant Cellular Infiltrate,Contralateral Breast Carcinoma,1
14761,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma,1
14762,Epithelial Component Present,Cervical Endometrioid Adenocarcinoma,1
14763,Malignant Cellular Infiltrate,Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
14764,Malignant Cellular Infiltrate,Stage IV Vulvar Cancer AJCC v6,1
14765,High Mitotic Activity,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
14766,Malignant Cellular Infiltrate,Childhood Yolk Sac Tumor,1
14767,Transformed Phase of Disease,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,1
14768,Malignant Cellular Infiltrate,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
14769,Refractory Disease,Refractory Aggressive Non-Hodgkin Lymphoma,1
14770,In Situ Lesion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
14771,Deep Lesion,"Fibromatosis, Abdominal",1
14772,Gastrin Positive Neoplastic Cells Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
14773,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,1
14774,Malignant Cellular Infiltrate,Adenocarcinoma of Accessory Sinus,1
14775,CD30-Positive Neoplastic Cells Present,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,1
14776,Carcinomatous Component Present,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
14777,Malignant Cellular Infiltrate,Malignant Chest Wall Bone Neoplasm,1
14778,Malignant Cellular Infiltrate,Stage IB Retroperitoneal Sarcoma AJCC v8,1
14779,Secondary Lesion,Synovial sarcoma metastatic,1
14780,Papillary Pattern,papillary squamous cell carcinoma of larynx,1
14781,Epithelial Component Present,Recurrent Liver Carcinoma,1
14782,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
14783,Epithelial Component Present,Nasopharyngeal cancer recurrent,1
14784,Mitotic Activity,Adult Anaplastic Astrocytoma,1
14785,Hereditary Lesion,"Corneal Dystrophy, Juvenile Epithelial of Meesmann",1
14786,Malignant Cellular Infiltrate,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14787,Epithelial Component Present,Stage III Pancreatic Cancer AJCC v6 and v7,1
14788,Malignant Cellular Infiltrate,Poorly Differentiated Fibrosarcoma,1
14789,Epithelial Component Present,Maxillary Sinus Squamous Cell Carcinoma,1
14790,Malignant Cellular Infiltrate,Childhood Grade III Meningioma,1
14791,Hereditary Lesion,"Pancreatic carcinoma, familial",1
14792,Malignant Cellular Infiltrate,Mantle cell lymphoma stage III,1
14793,Carcinomatous Component Present,Metastatic Oral Cavity Carcinoma,1
14794,High Grade Lesion,Embryonal Rhabdomyosarcoma,1
14795,Neuroendocrine Differentiation,Gastrinoma,1
14796,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
14797,Malignant Cellular Infiltrate,Stage IIIB Small Intestinal Adenocarcinoma AJCC v8,1
14798,Vascular Channel Formation,Gallbladder Kaposi's Sarcoma,1
14799,Epithelial Component Present,Sessile Serrated Adenoma/Polyp,1
14800,Vascular Channel Formation,Benign neoplasm of lymph vessels,1
14801,Exophytic Polypoid Lesion,Cyst of Skene's duct,1
14802,Emperipolesis,Sinus histiocytosis,1
14803,Acinar Cell Differentiation,Acinar cell tumor,1
14804,Nodular Pattern,Vulvar Nodular Hidradenoma,1
14805,Vascular Channel Formation with Muscular Walls,Glomangiomyoma,1
14806,Malignant Cellular Infiltrate,Esophageal adenocarcinoma recurrent,1
14807,Epithelial Component Present,Masaoka-Koga Stage IVa,1
14808,Anaplasia,Classical Glioblastoma,1
14809,Carcinomatous Component Present,Recurrent Liver Carcinoma,1
14810,Fibrotic Stroma Formation,Broad Ligament Serous Cystadenofibroma,1
14811,Favorable Clinical Outcome,Type B Lymphomatoid Papulosis,1
14812,Tissue of Mullerian Origin Present,"Mixed Tumor, Mullerian",1
14813,Poorly Differentiated Lesion,Large cell lung cancer stage I,1
14814,Generalized Hydropic Villous Change,Complete hydatidiform mole,1
14815,Epithelial Component Present,Invasive Carcinoma,1
14816,Epithelial Component Present,Pancreatic neuroendocrine tumor metastatic,1
14817,Well-Circumscribed Lesion,Intramuscular Myxoma,1
14818,Epithelial Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
14819,Recurrent disease,Liposarcoma recurrent,1
14820,Insular Pattern,Pancreatic Somatostatinoma,1
14821,Necrotic changes (finding),Combined Lung Small Cell and Squamous Cell Carcinoma,1
14822,Cystic Change,Papillary serous cystadenocarcinoma,1
14823,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
14824,Cutaneous Involvement,Signet Ring Melanoma,1
14825,Antoni A Pattern,Conventional Schwannoma,1
14826,Metastatic Lesion,Metastatic Uveal Melanoma,1
14827,Epithelial Component Present,Major Salivary Gland Mucoepidermoid Carcinoma,1
14828,Adulthood Lesion,Adult Pure Erythroid Leukemia,1
14829,Keratin pearl formation,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,1
14830,Epithelial Component Present,Lung Carcinoma Metastatic in the Bone,1
14831,atypia morphology,Borderline serous tumor of ovary,1
14832,Perineural spread,Laryngeal Adenoid Cystic Carcinoma,1
14833,Malignant Cellular Infiltrate,Disseminated Malignant Neoplasm,1
14834,Hydropic degeneration,Uterine Corpus Dissecting Leiomyoma,1
14835,Adnexal Differentiation,Benign Eccrine Neoplasm,1
14836,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Carcinoma,1
14837,Epithelial Component Present,carcinosarcoma of lung,1
14838,Epithelial Component Present,Recurrent Parotid Gland Undifferentiated Carcinoma,1
14839,Benign Cellular Infiltrate,Ovarian serous cystadenofibroma,1
14840,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
14841,Epithelial Component Present,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
14842,Carcinomatous Component Present,Stage I Carcinoma of Bladder,1
14843,Carcinomatous Component Present,Resectable Pancreatic Ductal Adenocarcinoma,1
14844,Malignant Cellular Infiltrate,Refractory Primary Effusion Lymphoma,1
14845,Pregnancy Complications,Funisitis (disorder),1
14846,atypia morphology,Recurrent Grade II Lymphomatoid Granulomatosis,1
14847,Epithelial Component Present,Desmoplastic trichilemmoma,1
14848,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Adenosarcoma AJCC v8,1
14849,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v6 Stage,1
14850,High Grade Lesion,Breast Rhabdomyosarcoma,1
14851,Resectable Mass,Resectable Intrahepatic Cholangiocarcinoma,1
14852,Low Mitotic Activity,Malignant Pancreatic Insulinoma,1
14853,Carcinomatous Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
14854,Pathologic TNM Finding,Pathologic Stage 0 Gastric Cancer AJCC v8,1
14855,Cutaneous Involvement,Exacerbation of acne,1
14856,Ineffective hematopoiesis,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1
14857,Aberrant Thyroid Tissue Present,Struma Ovarii,1
14858,Intraosseous Lesion,Basal Cell Ameloblastoma,1
14859,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
14860,Papillary Pattern,Infiltrating papillary adenocarcinoma,1
14861,Epithelial Component Present,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,1
14862,Metastatic Lesion,Secondary malignant neoplasm of pancreas,1
14863,Alcohol Toxicity,Alcohol-Related Esophageal Squamous Cell Carcinoma,1
14864,Metastatic/Recurrent Disease,Malignant Soft Tissue Tumor of Uncertain Differentiation,1
14865,Cutaneous Involvement,Herpes zoster dermatitis of eyelid,1
14866,Cutaneous Involvement,Acquired keratoderma,1
14867,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Spindle Cell Variant",1
14868,Nodular Pattern,Grade 2 Cutaneous Follicular Lymphoma,1
14869,Carcinomatous Component Present,Advanced Neuroendocrine Carcinoma,1
14870,Slow Growing Mass,Kadish Stage A Olfactory Neuroblastoma,1
14871,Cutaneous Involvement,Hidradenoma Papilliferum,1
14872,Epithelial Component Present,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
14873,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II,1
14874,Epithelial Component Present,Lung Adenocarcinoma In Situ,1
14875,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Recurrent Myelodysplastic Syndrome,1
14876,Mixed Cellular Population,Anaplastic Oligoastrocytoma,1
14877,Malignant Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7,1
14878,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,1
14879,Epithelial Component Present,Stage IIIA Vulvar Cancer AJCC v8,1
14880,Immunosuppression-Related Post-Transplant Toxicity,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,1
14881,High Mitotic Activity,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
14882,Neuronal Differentiation,Central Neurocytoma,1
14883,Malignant Cellular Infiltrate,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
14884,Malignant Cellular Infiltrate,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
14885,Capillary Sized Vascular Channel Formation,Breast Capillary Hemangioma,1
14886,Severe dysplasia,"Glandular intraepithelial neoplasia, grade III",1
14887,Capillary Sized Vascular Channel Formation,Infantile hemangioma of liver,1
14888,Thin-Walled Branching Vascular Pattern,Malignant Solitary Fibrous Tumor,1
14889,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v7,1
14890,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma stage II,1
14891,Adnexal Differentiation,Vulvar Sebaceous Carcinoma,1
14892,Diffuse Pattern,Recurrent Childhood Gliosarcoma,1
14893,Hyperchromatism,"Perineurioma, malignant",1
14894,Carcinomatous Component Present,Stage I Prostate Carcinoma,1
14895,Malignant Cellular Infiltrate,Malignant neoplasm of thorax,1
14896,Carcinomatous Component Present,Endometrioid adenocarcinoma recurrent,1
14897,Mesenchymal Component Present,Pleomorphic adenoma of parotid gland,1
14898,Epithelial Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
14899,Melanocytes Near the Tips and Sides of Elongated Rete Ridges Present,Vulvar Dysplastic Melanocytic Nevus,1
14900,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage II,1
14901,Benign Cellular Infiltrate,Benign neoplasm of choroid,1
14902,Papillary Pattern,Ethmoid Sinus Schneiderian Papilloma,1
14903,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
14904,Epithelial Component Present,Stage IV Eyelid Carcinoma AJCC v7,1
14905,Dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
14906,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v8 Stage,1
14907,Malignant Cellular Infiltrate,Childhood Malignant Solid Neoplasm,1
14908,Epithelial Component Present,Recurrent Adrenal Gland Pheochromocytoma,1
14909,Apocrine Differentiation,External Auditory Canal Ceruminous Adenoma,1
14910,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Micromedullary Carcinoma,1
14911,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v8,1
14912,Well-Circumscribed Lesion,Adrenal Cortex Oncocytic Adenoma,1
14913,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v8,1
14914,Epithelial Component Present,Refractory Fallopian Tube Carcinoma,1
14915,Carcinomatous Component Present,Serous Tubal Intraepithelial Carcinoma,1
14916,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage II,1
14917,Epithelial Component Present,Stage IIA Ampulla of Vater Cancer AJCC v7,1
14918,Secondary Lesion,Adenocarcinoma of the prostate metastatic,1
14919,Malignant Cellular Infiltrate,Stage III Adult Non-Hodgkin Lymphoma,1
14920,Recurrent disease,Recurrent Childhood Astrocytic Tumor,1
14921,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
14922,Epithelial Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
14923,Monoclonal Cellular Population Present,Thyroid Gland Spindle Cell Follicular Adenoma,1
14924,Synchronous Lesion,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
14925,Carcinomatous Component Present,Squamous cell carcinoma of palate,1
14926,Epithelial Component Present,Stage IV Pancreatic Cancer AJCC v8,1
14927,Mucoid Stroma Formation,Microcystic meningioma,1
14928,Calcinosis,Psammomatous Meningioma,1
14929,Malignant Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
14930,Epithelial Component Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
14931,Slow Growing Mass,Pilocytic Astrocytoma,1
14932,Single Cell Necrosis,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
14933,Cutaneous Involvement,Hidrocystoma,1
14934,Epithelial Component Present,BCLC Stage A Hepatocellular Carcinoma,1
14935,Malignant Cellular Infiltrate,Refractory Malignant Head and Neck Neoplasm,1
14936,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v7,1
14937,Alternative Fascicle (Bundle) Pattern,Uterine Fibroids,1
14938,Malignant Cellular Infiltrate,Skin Nodular Solid Basal Cell Carcinoma,1
14939,Immunologic Deficiency Syndromes,"Leukoplakia, Hairy",1
14940,Epithelial Component Present,External Ear Actinic Keratosis,1
14941,Secondary Lesion,Secondary Neoplasm,1
14942,Slit-Like Stromal Retraction Present,Superficial basal cell carcinoma,1
14943,Primary Lesion,Adult Brain Glioblastoma,1
14944,Infiltrative Growth Pattern,Cerebellar Glioblastoma,1
14945,Indolent Clinical Course,Perineural Hemangioma,1
14946,Malignant Cellular Infiltrate,Ciliary Body Epithelioid Cell Melanoma,1
14947,Carcinomatous Component Present,Renal Pelvis Cancer by AJCC v8 Stage,1
14948,Recurrent disease,Bladder cancer recurrent,1
14949,Papillary Pattern,"Transitional cell papilloma, inverted",1
14950,Severe dysplasia,Carcinoma in situ of penis,1
14951,Absence of Invasion,High Grade Ductal Breast Carcinoma In Situ,1
14952,Regional Disease,Locally Advanced Urothelial Carcinoma,1
14953,"Undifferentiated ""Fetal-Type"" Tissues Present",Grade 1 Teratoma,1
14954,Tubular Structures Present,Malignant Sertoli Cell Tumor,1
14955,Glandular Differentiation,Adenocarcinoid tumor,1
14956,Epithelial Component Present,Grade 1 Rectal Adenocarcinoma,1
14957,Necrotic changes (finding),Childhood Brain Stem Gliosarcoma,1
14958,Solitary mass,Chordoma of clivus,1
14959,High Mitotic Activity,Anal Canal Small Cell Neuroendocrine Carcinoma,1
14960,Carcinomatous Component Present,Vulvar Warty Carcinoma,1
14961,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,1
14962,Malignant Cellular Infiltrate,Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7,1
14963,Epithelial Component Present,Infiltrating Urothelial Carcinoma,1
14964,Carcinomatous Component Present,Pulmonary Blastoma,1
14965,Carcinomatous Component Present,Carcinoma of anal margin,1
14966,Adnexal Differentiation,Adenoid cystic eccrine carcinoma,1
14967,Carcinomatous Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,1
14968,Carcinomatous Component Present,Thymic Adenocarcinoma,1
14969,Malignant Cellular Infiltrate,Stage IIB Soft Tissue Sarcoma AJCC v7,1
14970,Cartilaginous Component Present,Chondroid Hamartoma,1
14971,Epithelial Component Present,benign myoepithelioma of salivary gland,1
14972,Malignant Cellular Infiltrate,Refractory Cytopenia of Childhood,1
14973,1p/19q Codeletion Status Unknown,oligodendroglioma,1
14974,Carcinomatous Component Present,Parotid Gland Adenocarcinoma,1
14975,Perivascular Arrangement of Tumor Cells,"Perivascular epithelioid tumor, benign",1
14976,Childhood Lesion,Childhood Bladder Carcinoma,1
14977,Malignant Cellular Infiltrate,Skin squamous cell carcinoma metastatic,1
14978,Malignant Cellular Infiltrate,Locally Recurrent Malignant Neoplasm,1
14979,Malignant Cellular Infiltrate,Ovarian Embryonal Carcinoma,1
14980,Epithelial Component Present,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
14981,Adulthood Lesion,Adult Acute Myeloid Leukemia without Maturation,1
14982,Malignant Cellular Infiltrate,Luminal B Prostate Carcinoma,1
14983,High Grade Lesion,MGMT-Unmethylated Glioblastoma,1
14984,Epithelial Component Present,Stage IVB Colorectal Cancer AJCC v8,1
14985,Benign Cellular Infiltrate,Cavernous lymphangioma,1
14986,Malignant Cellular Infiltrate,Stage III Adult Immunoblastic Lymphoma,1
14987,Acanthosis,verrucous carcinoma of vulva,1
14988,Epithelial Component Present,Childhood Breast Carcinoma,1
14989,High Grade Lesion,Anaplastic Diencephalic Astrocytoma,1
14990,Epithelial Component Present,Cervical Microglandular Polyp,1
14991,Storiform Growth Pattern,Childhood Undifferentiated Pleomorphic Sarcoma,1
14992,Epithelial Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
14993,Malignant Cellular Infiltrate,Parotid Gland Kaposi Sarcoma,1
14994,Carcinomatous Component Present,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
14995,Epithelial Component Present,Primary Carcinoma,1
14996,Epithelial Component Present,Stage I Prostate Carcinoma,1
14997,Malignant Cellular Infiltrate,Advanced Urothelial Carcinoma,1
14998,Secondary Lesion,Secondary malignant neoplasm of hypopharynx,1
14999,Skin Papule,Desmoplastic trichoepithelioma,1
15000,Epithelial Component Present,Multiple adenomatous polyps,1
15001,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic Lymphadenopathy,1
15002,Resectable Mass,Cholangiocarcinoma resectable,1
15003,Carcinomatous Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,1
15004,Epithelial Component Present,Small cell carcinoma of the cervix,1
15005,Epithelial Component Present,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
15006,Apocrine Differentiation,Benign Apocrine Neoplasm,1
15007,Diffuse Pattern,Primary mediastinal large B-cell lymphoma refractory,1
15008,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage IV,1
15009,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v8,1
15010,Storiform Growth Pattern,Childhood Undifferentiated Pleomorphic Sarcoma,1
15011,Epithelial Component Present,Plurihormonal Pituitary Gland Adenoma,1
15012,Epithelial Component Present,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
15013,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
15014,Carcinomatous Component Present,Invasive Breast Carcinoma by Histologic Grade,1
15015,Adnexal Differentiation,Papillary Eccrine Carcinoma,1
15016,Indolent Clinical Course,Hemangioma of gingiva,1
15017,Dysplasia,Vaginal intraepithelial neoplasia grade 2,1
15018,Malignant Cellular Infiltrate,Pleomorphic Variant Mantle Cell Lymphoma,1
15019,Hemorrhagic,Pulmonary Artery Angiosarcoma,1
15020,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
15021,Cavernous Vascular Space Formation,Cavernous Angioleiomyoma,1
15022,"Undifferentiated ""Fetal-Type"" Tissues Present",Mediastinal Immature Teratoma,1
15023,Malignant Cellular Infiltrate,Stage I Uterine Corpus Adenosarcoma AJCC v8,1
15024,Cutaneous Involvement,Benign neoplasm of sebaceous gland,1
15025,Fibrosis,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
15026,Absence of Invasion,Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7,1
15027,Malignant Cellular Infiltrate,Malignant neoplasm of lower third of esophagus,1
15028,Low Cellularity Present,Recurrent Childhood Protoplasmic Astrocytoma,1
15029,Refractory Disease,Refractory Digestive System Neuroendocrine Carcinoma,1
15030,Epithelial Component Present,Pericanalicular fibroadenoma,1
15031,Low Mitotic Activity,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
15032,High Grade Lesion,Vulvar Alveolar Rhabdomyosarcoma,1
15033,Alternative Fascicle (Bundle) Pattern,Degeneration of uterine fibroid,1
15034,Lymphoplasmacytic Infiltrate,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
15035,Cutaneous Involvement,Contact dermatitis due to arnica,1
15036,Cutaneous Involvement,Papillary Eccrine Carcinoma,1
15037,Malignant Cellular Infiltrate,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
15038,Malignant Cellular Infiltrate,Localized Extrahepatic Bile Duct Carcinoma,1
15039,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
15040,Malignant Cellular Infiltrate,Desmoplastic Medulloblastoma,1
15041,Adulthood Lesion,Adult Pilocytic Astrocytoma,1
15042,Malignant Component Present,Ovarian Dermoid Cyst with Angiosarcoma,1
15043,Refractory Disease,Waldenstrom's macroglobulinemia refractory,1
15044,High Grade Lesion,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
15045,Locally Aggressive Lesion,Pelvic Fibromatosis,1
15046,Metastatic Lesion,Secondary malignant neoplasm of orbit,1
15047,Storiform Growth Pattern,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
15048,Calcitonin Positive Neoplastic Cells Present,Sporadic Thyroid Gland Micromedullary Carcinoma,1
15049,Malignant Cellular Infiltrate,EBV-Related Carcinoma,1
15050,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant",1
15051,Epithelial Component Present,Ureter Cancer by AJCC v8 Stage,1
15052,Epithelial Component Present,Stage IV Ovarian Carcinoma,1
15053,Epithelial Component Present,Ameloblastic Carcinoma,1
15054,Well Differentiated Neuroendocrine Lesion,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
15055,Well-Circumscribed Lesion,Childhood Kidney Wilms Tumor,1
15056,Bone Marrow Dysplasia Present,Adult Myelodysplastic Syndrome,1
15057,Borderline Lesion,Angiocentric immunoproliferative lesion grade 2,1
15058,Neuroendocrine Differentiation,Vaginal Large Cell Neuroendocrine Carcinoma,1
15059,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
15060,Malignant Cellular Infiltrate,Pilomatrix carcinoma of skin,1
15061,Carcinomatous Component Present,Bladder Enteric Type Adenocarcinoma,1
15062,Malignant Cellular Infiltrate,Ear carcinoma,1
15063,Cutaneous Involvement,Subungual glomus tumor,1
15064,Epithelial Component Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
15065,CD56-Positive Neoplastic Cells Present,Refractory Aggressive NK-Cell Leukemia,1
15066,Regional Disease,Locally Advanced Chordoma,1
15067,Increased Cellularity Present,Undifferentiated Neuroblastoma,1
15068,Indolent Clinical Course,Cerebral Hemisphere Lipoma,1
15069,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
15070,Epithelial Component Present,"Thymoma, type A",1
15071,Epithelial Component Present,Carcinoma of submandibular gland,1
15072,Secondary Lesion,Advanced Urothelial Carcinoma,1
15073,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,1
15074,Carcinomatous Component Present,Alcohol-Related Laryngeal Carcinoma,1
15075,Primary Lesion,Angiosarcoma non-metastatic,1
15076,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v7,1
15077,Metaplasia of Malignant Cells Present,Metaplastic carcinoma of breast,1
15078,Malignant Cellular Infiltrate,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
15079,Carcinomatous Component Present,Ovarian Transitional Cell Carcinoma,1
15080,Malignant Cellular Infiltrate,Mediastinal Germ Cell Tumor with Somatic-Type Malignancy,1
15081,Fibrotic Stroma Formation,Broad Ligament Serous Cystadenofibroma,1
15082,Epithelial Component Present,Stage I Colorectal Cancer AJCC v8,1
15083,Malignant Cellular Infiltrate,Recurrent Carcinoma,1
15084,Secondary Lesion,Locally Advanced Squamous Cell Carcinoma,1
15085,Epithelial Component Present,Sarcomatoid Hepatocellular Carcinoma,1
15086,Tissue Differentiation Uncertain,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
15087,Clinical TNM Finding,Clinical Stage II Gastric Cancer AJCC v8,1
15088,Increased Cellularity Present,Anaplastic Diencephalic Astrocytoma,1
15089,Locally Aggressive Lesion,Cardiac Inflammatory Myofibroblastic Tumor,1
15090,Carcinomatous Component Present,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
15091,Argentaffin Positive Neoplastic Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
15092,Epithelial Component Present,Benign oncocytoma of salivary gland,1
15093,Nuclear pleomorphism,Childhood Pleomorphic Rhabdomyosarcoma,1
15094,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma,1
15095,Malignant Cellular Infiltrate,Recurrent Malignant Neoplasm,1
15096,Nuclear Molding,Stage IIA Lung Small Cell Carcinoma AJCC v7,1
15097,Malignant Cellular Infiltrate,Anal Lymphoma,1
15098,Epithelial Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
15099,Carcinomatous Component Present,Stage I Anal Cancer AJCC v8,1
15100,Absence of Invasion,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
15101,Benign Cellular Infiltrate,Benign melanocytic nevus,1
15102,Local disease,Kidney Lipoma,1
15103,Malignant Cellular Infiltrate,Familial medullary thyroid carcinoma,1
15104,Malignant Cellular Infiltrate,Gastric Cardia Adenocarcinoma,1
15105,Malignant Cellular Infiltrate,Stage IA Ovarian Germ Cell Tumor AJCC v6 and v7,1
15106,Epithelial Component Present,Stage IVA Colon Cancer AJCC v8,1
15107,Malignant Cellular Infiltrate,Kaposi's sarcoma of esophagus,1
15108,Metastatic Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
15109,Malignant Cellular Infiltrate,Childhood Acute Monoblastic and Monocytic Leukemia,1
15110,Carcinomatous Component Present,Rectal Adenosquamous Carcinoma,1
15111,Malignant Cellular Infiltrate,"Synovial sarcoma, biphasic",1
15112,Epithelial Component Present,Minor Salivary Gland Acinic Cell Carcinoma,1
15113,Cutaneous Involvement,Benign Dermal Neoplasm,1
15114,Epithelial Component Present,Lung Pleomorphic Carcinoma,1
15115,Epithelial Component Present,Malignant Ovarian Clear Cell Tumor,1
15116,Slow Growing Mass,Adult Pineocytoma,1
15117,Malignant Cellular Infiltrate,small cell carcinoma of extrahepatic bile duct,1
15118,Neuroendocrine Differentiation,Regional Digestive System Neuroendocrine Tumor G1,1
15119,Papillary Pattern,Bladder Urothelial Papilloma,1
15120,Epithelial Component Present,Metastatic Sarcomatoid Renal Cell Carcinoma,1
15121,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Stage,1
15122,Nuclear Atypia,Adult Brain Glioblastoma,1
15123,Carcinomatous Component Present,Stage IIIB Appendix Carcinoma AJCC v8,1
15124,Epithelial Component Present,Fallopian Tube Papilloma,1
15125,Unresectable Mass,Unresectable Urethral Urothelial Carcinoma,1
15126,Well Differentiated Neuroendocrine Lesion,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
15127,Rimming of Adipose Tissue Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
15128,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity stage I,1
15129,High Mitotic Activity,large cell neuroendocrine carcinoma of anal canal,1
15130,Diffuse Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
15131,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic-Phase",1
15132,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
15133,Follicular Cell Differentiation,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
15134,Dysplasia,Small Intestinal Intraepithelial Neoplasia,1
15135,Unresectable Mass,Pancreatic carcinoma non-resectable,1
15136,Epithelial Component Present,Recurrent Lung Carcinoma Cell Type Unspecified,1
15137,Childhood Lesion,Refractory Hepatoblastoma,1
15138,Radiation Sickness,Post-Radiotherapy Breast Angiosarcoma,1
15139,Acanthosis,Buccal Mucosa Verrucous Carcinoma,1
15140,Well-Circumscribed Lesion,Deep histiocytoma,1
15141,Moderately Differentiated Lesion,Moderately Differentiated Prostate Adenocarcinoma,1
15142,Childhood Lesion,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
15143,Cutaneous Involvement,Seborrheic keratosis,1
15144,Mixed Cellular Population,Carcinosarcoma of ovary,1
15145,Cutaneous Involvement,Stage II Merkel Cell Carcinoma AJCC v7,1
15146,Generalized Dysplasia,Filiform Serrated Adenoma,1
15147,Epithelial Component Present,Vaginal Cancer by AJCC v6 Stage,1
15148,Severe dysplasia,Skin Squamous Cell Carcinoma In Situ,1
15149,Well Differentiated Neuroendocrine Lesion,Ileal Neuroendocrine Tumor by AJCC v8 Stage,1
15150,Splenomegaly,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,1
15151,Refractory Disease,Refractory Lung Carcinoma,1
15152,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
15153,Epithelial Component Present,Apocrine cystadenoma,1
15154,Carcinomatous Component Present,Locally Advanced Head and Neck Carcinoma,1
15155,Epithelial Component Present,Stage II Fallopian Tube Cancer AJCC v8,1
15156,Focal dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
15157,Malignant Cellular Infiltrate,Stage 0 Uterine Corpus Cancer,1
15158,Carcinomatous Component Present,Stage IIA Breast Carcinoma,1
15159,Malignant Cellular Infiltrate,Stage III Nasopharyngeal Carcinoma AJCC v7,1
15160,Hyperplastic Tissue Present,Atypical hyperplasia of breast,1
15161,Pathologic TNM Finding,Pathologic Stage IA Cutaneous Melanoma AJCC v8,1
15162,Desmoplastic Stroma Formation,Pilomatrix carcinoma of skin,1
15163,Carcinomatous Component Present,Pancreatic adenocarcinoma recurrent,1
15164,Malignant Cellular Infiltrate,Advanced Cervical Carcinoma,1
15165,Atypical Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrioid adenoma, borderline malignancy",1
15166,Carcinomatous Component Present,Cervix carcinoma,1
15167,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Adenofibroma,1
15168,Carcinomatous Component Present,Stage II Esophageal Squamous Cell Carcinoma AJCC v7,1
15169,Benign Cellular Infiltrate,Parotid monomorphic adenoma,1
15170,Absence of Stromal Invasion,Borderline Ovarian Mucinous Adenofibroma,1
15171,Pseudoglandular Pattern,Testicular Mixed Embryonal Carcinoma and Teratoma with Seminoma,1
15172,Carcinomatous Component Present,Low Grade Adenosquamous Breast Carcinoma,1
15173,Multinodular Mass,Aortic Angiosarcoma,1
15174,Malignant Cellular Infiltrate,Stage IV Ovarian Cancer AJCC v8,1
15175,Mitotic Activity,teratocarcinoma of mediastinum,1
15176,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid adenocarcinoma recurrent,1
15177,Malignant Cellular Infiltrate,adenoid cystic carcinoma of floor of mouth,1
15178,Fibrotic Stroma Formation,carcinoma of pancreas with osteoclast-like giant cells,1
15179,Benign Cellular Infiltrate,Airway Hemangioma,1
15180,Benign Cellular Infiltrate,Benign neoplasm of esophagus,1
15181,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor,1
15182,Rimming of Adipose Tissue Cells Present,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
15183,Radiation Sickness,Radiation-induced myelopathy,1
15184,Serotonin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
15185,Malignant Cellular Infiltrate,Small intestine carcinoma recurrent,1
15186,Slow Growing Painless Mass,Lipofibromatosis,1
15187,Benign Cellular Infiltrate,Childhood Ovarian Mature Teratoma,1
15188,Carcinomatous Component Present,Recurrent BRCA-Mutated Ovarian Carcinoma,1
15189,Epithelial Component Present,Stage IVC Major Salivary Gland Cancer AJCC v8,1
15190,Carcinomatous Component Present,Small intestine carcinoma stage II,1
15191,Indolent Clinical Course,Glomeruloid hemangioma,1
15192,Metastatic Lesion,Secondary malignant neoplasm of vertebral column,1
15193,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
15194,Mixture of Germ Cell Neoplastic Components Present,Mediastinal Mixed Non-Seminomatous Germ Cell Tumor,1
15195,Intracytoplasmic Eosinophilic Inclusion,Refractory Rhabdoid Tumor,1
15196,Recurrent disease,Recurrent Adult Hepatocellular Carcinoma,1
15197,Mixed Cellular Population,Malignant Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
15198,Immature Myeloid Cells Increased in Bone Marrow,Alkylating Agent-Related Acute Myeloid Leukemia,1
15199,High Grade Lesion,Unresectable Synovial Sarcoma,1
15200,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v7,1
15201,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation,1
15202,Malignant Cellular Infiltrate,Stage I Carcinoma of Bladder,1
15203,Nodular Pattern,Ovarian Myxoid Liposarcoma,1
15204,atypia morphology,Borderline Fallopian Tube Neoplasm,1
15205,Infiltrative Growth Pattern,Morpheic basal cell carcinoma,1
15206,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Acute monoblastic leukemia,1
15207,Papillary Pattern,Lung Mixed Squamous Cell and Glandular Papilloma,1
15208,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
15209,Carcinomatous Component Present,Adenocarcinoma of lung stage IIIA,1
15210,Papillary Pattern,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,1
15211,Malignant Cellular Infiltrate,Lung Cancer by AJCC v8 Stage,1
15212,Epithelial Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
15213,Malignant Cellular Infiltrate,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
15214,Epithelial Component Present,Locally Advanced Head and Neck Carcinoma,1
15215,Malignant Cellular Infiltrate,Hard Palate Mucoepidermoid Carcinoma,1
15216,Carcinomatous Component Present,Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7,1
15217,Anaplasia,Stage II Anaplastic Large Cell Lymphoma,1
15218,Metastatic/Recurrent Disease,Adult Desmoplastic Small Round Cell Tumor,1
15219,In Situ Lesion,Lung Squamous Cell Carcinoma In Situ,1
15220,Malignant Cellular Infiltrate,Small cell carcinoma of the cervix,1
15221,Monomorphic Cellular Infiltrate,"Adenoma, Basal Cell",1
15222,Dysplasia,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
15223,Neuroendocrine Differentiation,Stage I Lung Small Cell Carcinoma AJCC v7,1
15224,Encapsulated Mass,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
15225,Carcinomatous Component Present,Skin Squamous Cell Carcinoma In Situ,1
15226,Severe dysplasia,Intraepithelial Squamous Cell Carcinoma,1
15227,Malignant Cellular Infiltrate,Rectal Micropapillary Adenocarcinoma,1
15228,Epithelial Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
15229,Metastatic Lesion,Metastatic Signet Ring Cell Breast Carcinoma,1
15230,Syncytial Pattern,Nasopharyngeal lymphoepithelioma recurrent,1
15231,Solitary mass,Epithelioid hemangioendothelioma,1
15232,atypia morphology,Recurrent Grade II Lymphomatoid Granulomatosis,1
15233,Dysplasia,Precancerous Polyp,1
15234,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma,1
15235,Epithelial Component Present,Paget Disease,1
15236,Alternative Fascicle (Bundle) Pattern,Cervical Leiomyoma,1
15237,Neuronal Differentiation,Pituitary Gland Mixed Gangliocytoma-Adenoma,1
15238,Childhood Lesion,Recurrent Childhood Central Nervous System Embryonal Neoplasm,1
15239,Benign Cellular Infiltrate,Benign Ovarian Clear Cell Tumor,1
15240,Cystic Change,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
15241,Childhood Lesion,Pediatric Extraocular Retinoblastoma,1
15242,Cystic Change,Recurrent Ovarian Cystadenocarcinoma,1
15243,Cystic Change,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
15244,Severe dysplasia,Intraepithelial Squamous Cell Carcinoma,1
15245,Epithelial Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
15246,Low Mitotic Activity,Stage II Ileal Neuroendocrine Tumor AJCC v8,1
15247,Malignant Cellular Infiltrate,Stage I Anal Cancer AJCC v8,1
15248,Epithelial Component Present,Endolymphatic sac tumor,1
15249,Vascular Channel Formation,Ovarian Angiosarcoma,1
15250,Cigarette Smoking Toxicity,Cigarette Smoking-Related Carcinoma,1
15251,Carcinomatous Component Present,Poorly Differentiated Thyroid Carcinoma,1
15252,Carcinomatous Component Present,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
15253,Metastatic Lesion,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
15254,Adnexal Differentiation,Benign Pilar-Associated Mesenchyme Neoplasm,1
15255,Recurrent disease,Recurrent Fallopian Tube Carcinoma,1
15256,Dysplasia,Intraepithelial Neoplasia,1
15257,Pregnancy Complications,Fallopian Tube Gestational Choriocarcinoma,1
15258,VIP Positive Neoplastic Cells Present,Pancreatic Vipoma,1
15259,Secondary Lesion,Metastatic Neoplasm to the Bladder,1
15260,Well-Circumscribed Lesion,Juvenile polyp,1
15261,Epithelial Component Present,Papillary Eccrine Carcinoma,1
15262,Malignant Cellular Infiltrate,Hypocellular Myelodysplastic Syndrome,1
15263,Chromogranin A Positive Neoplastic Cells Present,Descending Colon Neuroendocrine Tumor G1,1
15264,Mixed Cellular Population,Ovarian Seromucinous Adenofibroma,1
15265,Malignant Cellular Infiltrate,Adult Medulloblastoma,1
15266,Recurrent disease,Chondrosarcoma recurrent,1
15267,Malignant Cellular Infiltrate,Hard Palate Squamous Cell Carcinoma,1
15268,Osseous Component Present,Subungual exostoses,1
15269,Epithelial Component Present,Adenocarcinoma of the prostate stage I,1
15270,Tissue Differentiation Uncertain,Pleural Biphasic Synovial Sarcoma,1
15271,Epithelial Component Present,Stage III Laryngeal Cancer AJCC v8,1
15272,Carcinomatous Component Present,Metastatic Cervical Adenocarcinoma,1
15273,Necrotic changes (finding),Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
15274,Epithelial Component Present,Cervix carcinoma,1
15275,Angiodestructive Pattern,Recurrent Grade II Lymphomatoid Granulomatosis,1
15276,Malignant Cellular Infiltrate,Childhood Embryonal Rhabdomyosarcoma,1
15277,Epithelial Component Present,Stage IIIA Breast Carcinoma,1
15278,Chronic Inflammatory Infiltrate,Childhood Grade III Lymphomatoid Granulomatosis,1
15279,Malignant Cellular Infiltrate,Metastatic Ductal Breast Carcinoma,1
15280,Exophytic Polypoid Lesion,Colorectal Cowden-Associated Polyp,1
15281,Progressive Clinical Course,Progressive Hairy Cell Leukemia Initial Treatment,1
15282,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma stage III,1
15283,Vascular Channel Formation,Angiosarcoma of liver,1
15284,Cystic Change,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
15285,High Mitotic Activity,Stage IB Merkel Cell Carcinoma AJCC v7,1
15286,Local disease,PNET of bone localized,1
15287,Epithelial Component Present,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7,1
15288,Papillary Pattern,Vestibular Papilloma,1
15289,Malignant Cellular Infiltrate,Angiosarcoma of the Skin of the Arm after Radical Mastectomy followed by Lymphedema,1
15290,Malignant Cellular Infiltrate,Postsurgical Stage III Hepatoblastoma,1
15291,Papillary Pattern,Papilloma of buccal mucosa,1
15292,Increased Cellularity Present,Neuroblastoma of brain,1
15293,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
15294,Malignant Cellular Infiltrate,Carcinoma bone,1
15295,Rapidly Enlarging Mass,Recurrent Childhood Rhabdomyosarcoma,1
15296,Epithelial Component Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
15297,More than 10 Mitoses per 10HPF,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
15298,Carcinomatous Component Present,Refractory Uterine Corpus Carcinoma,1
15299,Vascular Channel Formation,Superior Vena Cava Angiosarcoma,1
15300,Papillary Pattern,Papillary ependymoma,1
15301,Dysplasia,adenoma of intrahepatic bile duct,1
15302,Malignant Cellular Infiltrate,Gallbladder Carcinoma,1
15303,Black Discoloration,Thyroid Gland Black Follicular Adenoma,1
15304,Benign Cellular Infiltrate,Benign Hair Follicle Neoplasm,1
15305,In Situ Lesion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
15306,Necrotic changes (finding),large cell neuroendocrine carcinoma of lung,1
15307,Epithelial Component Present,Stage II Prostate Carcinoma,1
15308,Malignant Cellular Infiltrate,Stage IIIB Pleural Malignant Mesothelioma AJCC v8,1
15309,Hereditary Lesion,Li-Fraumeni Syndrome,1
15310,Severe cytologic atypia,large cell neuroendocrine carcinoma of anal canal,1
15311,Exophytic Polypoid Lesion,Gastrointestinal polyps,1
15312,Malignant Cellular Infiltrate,Stage II Adult Immunoblastic Lymphoma,1
15313,Carcinomatous Component Present,Small intestine carcinoma stage II,1
15314,Carcinomatous Component Present,Lung Pleomorphic Carcinoma,1
15315,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
15316,Vascular Channel Formation,Myxoma,1
15317,Cystic Lesion,Unresectable Craniopharyngioma,1
15318,Epithelial Component Present,Platinum-Resistant Urothelial Carcinoma,1
15319,Tissue Differentiation Uncertain,Vulvar Alveolar Soft Part Sarcoma,1
15320,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
15321,Malignant Cellular Infiltrate,Vaginal Melanoma,1
15322,Malignant Cellular Infiltrate,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,1
15323,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
15324,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm,1
15325,Primary Lesion,Telangiectatic osteosarcoma,1
15326,High Mitotic Activity,Stage 0 Merkel Cell Carcinoma AJCC v7,1
15327,Epithelial Component Present,Sphenoid Sinus Inverted Papilloma,1
15328,Perivascular fibrosis,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",1
15329,Hereditary Lesion,"Colorectal cancer, hereditary nonpolyposis, type 1",1
15330,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
15331,Malignant Cellular Infiltrate,Transitional cell carcinoma in situ,1
15332,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
15333,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,1
15334,Epithelial Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,1
15335,Peribronchial Proliferation of Neoplastic Cells Present,tumor miofibroblstico peribronquial congnito,1
15336,Epithelial Component Present,Extra-Adrenal Retroperitoneal Paraganglioma,1
15337,Borderline Lesion,Borderline Ovarian Serous Cystadenofibroma,1
15338,Malignant Germinomatous Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
15339,Carcinomatous Component Present,Squamous cell carcinoma of rectum,1
15340,Cutaneous Involvement,Malignant melanoma in junctional nevus,1
15341,High Grade Lesion,Combined Lung Large Cell Neuroendocrine Carcinoma,1
15342,Primary Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
15343,Hereditary Lesion,Congenital Bone Marrow Failure Syndromes,1
15344,Nodular Pattern,Grade 2 Cutaneous Follicular Lymphoma,1
15345,Follicular Structures Present,Thyroid Gland Mucinous Follicular Adenoma,1
15346,Mucinous degeneration,Recurrent Childhood Protoplasmic Astrocytoma,1
15347,Carcinomatous Component Present,Colon Intramucosal Adenocarcinoma,1
15348,Neuroendocrine Differentiation,Stage IV Merkel Cell Carcinoma AJCC v7,1
15349,Myxoid Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
15350,Diffuse Pattern,Refractory Intravascular Large B-Cell Lymphoma,1
15351,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,1
15352,Epithelial Component Present,Bladder adenocarcinoma stage 0,1
15353,Mesenchymal Component Present,Lung Adenofibroma,1
15354,Carcinomatous Component Present,Carcinosarcoma,1
15355,Malignant Cellular Infiltrate,Stage III Superficial Spreading Melanoma AJCC v7,1
15356,Malignant Cellular Infiltrate,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation,1
15357,Hereditary Lesion,Familial Atypical Mole Melanoma Syndrome,1
15358,Epithelial Component Present,Bladder transitional cell carcinoma stage IV,1
15359,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
15360,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
15361,Epithelial Component Present,Stage IIB Primary Peritoneal Cancer AJCC v8,1
15362,Nodular Pattern,Skin Nodular Solid Basal Cell Carcinoma,1
15363,Well-Circumscribed Lesion,Vulvar Superficial Myofibroblastoma,1
15364,Monoclonal Eosinophils Present,Chronic eosinophilic leukemia,1
15365,Malignant Cellular Infiltrate,Cardiac Myeloid Sarcoma,1
15366,Exophytic Polypoid Lesion,Colon adenoma,1
15367,Epithelial Component Present,Exocervical Carcinoma,1
15368,Epithelial Component Present,Thymic Squamous Cell Carcinoma,1
15369,Carcinomatous Component Present,Endometrial Mixed Cell Adenocarcinoma,1
15370,Secondary Lesion,Locally Advanced Digestive System Carcinoma,1
15371,Myxoid Stroma Formation,Myxoma,1
15372,Fibrotic Stroma Formation,Colloid Carcinoma of the Pancreas,1
15373,High Grade Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
15374,Borderline Lesion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
15375,Glandular Pattern,Somatostatinoma,1
15376,Malignant Cellular Infiltrate,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
15377,Fibrosis,Primary mediastinal large B-cell lymphoma recurrent,1
15378,Well-Circumscribed Lesion,Vulvar Fibroepithelial Stromal Polyp,1
15379,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
15380,Epithelial Component Present,Metastatic Triple-Negative Breast Carcinoma,1
15381,Cutaneous Involvement,Scleromyxedema,1
15382,Vascular Channel Formation,Angiosarcoma of the breast,1
15383,Carcinomatous Component Present,Resectable Carcinoma,1
15384,Malignant Cellular Infiltrate,Stage IVA Osteosarcoma AJCC v7,1
15385,Nuclear Expression of STAT6 Protein,Pleural Solitary Fibrous Tumor,1
15386,Polymorphic Cellular Infiltrate,Recurrent Langerhans Cell Histiocytosis,1
15387,Malignant Cellular Infiltrate,Adenocarcinoma of nasal cavity,1
15388,Cutaneous Involvement,Neurodermatitis,1
15389,Metastatic/Recurrent Disease,"Ossifying fibromyxoid tumor, malignant",1
15390,Malignant Cellular Infiltrate,Breast Cancer by AJCC v8 Prognostic Stage,1
15391,Epithelial Component Present,Stage IV Lip Basal Cell Carcinoma,1
15392,Adnexal Differentiation,Malignant Eccrine Neoplasm,1
15393,Carcinomatous Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
15394,Multifocal Lesion,Multifocal superficial basal cell carcinoma,1
15395,Ependymal Differentiation,Angiocentric glioma,1
15396,Epithelial Component Present,Appendix Villous Adenoma,1
15397,Tubular Pattern,Appendix Tubular Adenoma,1
15398,Immunologic Deficiency Syndromes,AIDS-Related Anal Carcinoma,1
15399,Epithelial Component Present,Villous adenocarcinoma,1
15400,Epithelial Component Present,Rectosigmoid Signet Ring Cell Carcinoma,1
15401,Peripheral Nuclear Palisading,basaloid squamous cell carcinoma of floor of mouth,1
15402,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
15403,Epithelial Component Present,Stage IB Esophageal Cancer AJCC v7,1
15404,Hereditary Lesion,Familial Colorectal Cancer Type X,1
15405,Increased Cellularity Present,"Perineurioma, malignant",1
15406,Epithelial Component Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
15407,Malignant Cellular Infiltrate,Multicentric Thyroid Gland Papillary Carcinoma,1
15408,Carcinomatous Component Present,Eccrine ductal carcinoma,1
15409,Metastatic Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,1
15410,Epithelial Component Present,small cell carcinoma of extrahepatic bile duct,1
15411,No Identifiable Line of Differentiation,Undifferentiated spindle cell sarcoma,1
15412,Carcinomatous Component Present,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
15413,Malignant Cellular Infiltrate,Locally Advanced Basal Cell Carcinoma,1
15414,Carcinomatous Component Present,Squamous cell carcinoma of prostate,1
15415,Carcinomatous Component Present,Prognostic Stage IA Breast Cancer AJCC v8,1
15416,Resectable Mass,Resectable Renal Cell Carcinoma,1
15417,Secondary Lesion,Locally Advanced Malignant Solid Neoplasm,1
15418,Carcinomatous Component Present,Stage I Carcinoma of Penis,1
15419,Epithelial Component Present,Stage IIA Small Intestinal Adenocarcinoma AJCC v8,1
15420,Cystic Change,Mucinous cystadenocarcinoma of ovary,1
15421,Secondary Lesion,Metastatic Neoplasm to the Placenta,1
15422,Carcinomatous Component Present,Oropharyngeal lymphepithelioma,1
15423,Epithelial Component Present,Stage IIIB Colon Cancer AJCC v7,1
15424,Chronic Inflammatory Infiltrate,Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma,1
15425,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q13;q21),1
15426,Refractory Disease,Refractory Malignant Male Reproductive System Neoplasm,1
15427,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous and osseous metaplasia,1
15428,Carcinomatous Component Present,Adenocarcinoma of rectum,1
15429,Recurrent disease,Recurrent Childhood Glioblastoma,1
15430,Non-Malignant Cellular Infiltrate,Suppurative lymphadenopathy,1
15431,Childhood Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
15432,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
15433,Splenomegaly,Blast Phase,1
15434,Epithelial Component Present,Alcohol-Related Hepatocellular Carcinoma,1
15435,High Mitotic Activity,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
15436,Carcinomatous Component Present,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
15437,Childhood Lesion,Childhood Brain Neoplasm,1
15438,Carcinomatous Component Present,Stage II Esophageal Squamous Cell Carcinoma AJCC v7,1
15439,Myeloblasts Under 5 Percent of Peripheral Blood White Cells,Refractory anemia with excess blasts I,1
15440,High Mitotic Activity,Colorectal Large Cell Neuroendocrine Carcinoma,1
15441,Poorly Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Carcinoma,1
15442,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
15443,Carcinomatous Component Present,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
15444,Perineural spread,adenoid cystic carcinoma of esophagus,1
15445,Poorly Differentiated Neuroendocrine Lesion,Small cell carcinoma of esophagus,1
15446,Epithelial Component Present,Childhood Lung Non-Small Cell Carcinoma,1
15447,Malignant Cellular Infiltrate,Recurrent Head and Neck Carcinoma,1
15448,Mucoid Stroma Formation,Mucinous adenocarcinoma of appendix,1
15449,Epithelial Component Present,Lung Typical Carcinoid Tumor,1
15450,Epithelial Component Present,Cervical Mullerian Papilloma,1
15451,Malignant Cellular Infiltrate,Soft Palate Squamous Cell Carcinoma,1
15452,Epithelial Component Present,Esophageal Squamous Intraepithelial Neoplasia,1
15453,Lymphoplasmacytic Infiltrate,Stage IVC Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
15454,Epithelial Component Present,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
15455,Metastatic/Recurrent Disease,Childhood Synovial Sarcoma,1
15456,Epithelial Component Present,Stage III Renal Cell Cancer AJCC v7,1
15457,Malignant Cellular Infiltrate,Primary Peritoneal Cancer by AJCC v7 Stage,1
15458,Indolent Clinical Course,Thyroid Gland Benign Vascular Neoplasm,1
15459,Cutaneous Involvement,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,1
15460,Pathologic TNM Finding,Pathologic Stage 0 Gastric Cancer AJCC v8,1
15461,Immunosuppression-Related Post-Transplant Toxicity,Infectious mononucleosis-like post-transplant lymphoproliferative disorder,1
15462,Benign Cellular Infiltrate,Peripheral Breast Papilloma,1
15463,Pregnancy Complications,Exaggerated placental site,1
15464,Papillary Pattern,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
15465,High Grade Lesion,Recurrent Childhood Giant Cell Glioblastoma,1
15466,Nuclear Grooves,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
15467,Epithelial Component Present,Stage IV Vaginal Cancer AJCC v8,1
15468,Carcinomatous Component Present,Carcinoma in situ of skin,1
15469,Endophytic Tumor Growth,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
15470,Malignant Cellular Infiltrate,Fallopian Tube Adenosarcoma,1
15471,Epithelial Component Present,Stage IIIA Ampulla of Vater Cancer AJCC v8,1
15472,Malignant Cellular Infiltrate,Ciliary Body Spindle Cell Type B Melanoma,1
15473,Epithelial Component Present,Adenosquamous cell lung cancer stage IV,1
15474,Dysplasia,Bladder squamous cell carcinoma stage 0,1
15475,Benign Cellular Infiltrate,Hemangioma of subcutaneous tissue,1
15476,Malignant Cellular Infiltrate,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
15477,Mesenchymal Differentiation,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
15478,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Leiomyosarcoma AJCC v8,1
15479,Malignant Cellular Infiltrate,Burkitt's lymphoma of small intestine,1
15480,Malignant Cellular Infiltrate,Distal-Type Epithelioid Sarcoma,1
15481,Malignant Cellular Infiltrate,Penile Urethral Malignant Neoplasm,1
15482,Carcinomatous Component Present,Breast Carcinoma by Gene Expression Profile,1
15483,Benign Cellular Infiltrate,Oral Cavity Adenoma,1
15484,Thin-Walled Branching Vascular Pattern,Peritoneal Solitary Fibrous Tumor,1
15485,Calcitonin serum level increased,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
15486,Epithelial Component Present,Ovarian Cancer by AJCC v8 Stage,1
15487,Intermediate Grade Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
15488,Splenomegaly,Splenic Manifestation of Chronic Lymphocytic Leukemia,1
15489,Increased Cellularity Present,Adult Anaplastic Oligodendroglioma,1
15490,Epithelial Component Present,Rectal Sessile Serrated Adenoma/Polyp,1
15491,Well Differentiated Neuroendocrine Lesion,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
15492,Carcinomatous Component Present,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
15493,Malignant Cellular Infiltrate,Hereditary Melanoma,1
15494,Locally Aggressive Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
15495,Malignant Cellular Infiltrate,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
15496,Infiltrative Growth Pattern,Childhood Cerebral Anaplastic Astrocytoma,1
15497,Malignant Cellular Infiltrate,Cardiac Leiomyosarcoma,1
15498,Carcinomatous Component Present,Primary Carcinoma Unspecified Site,1
15499,Malignant Cellular Infiltrate,Stage IIIB Small Intestinal Cancer AJCC v7,1
15500,Hyaline Cartilage Differentiation,Enchondroma,1
15501,Biphasic Pattern,Cystadenofibroma,1
15502,Malignant Cellular Infiltrate,Localized Gastroesophageal Junction Adenocarcinoma,1
15503,Childhood Lesion,Juvenile astrocytoma,1
15504,Malignant Cellular Infiltrate,Malignant tumor of rectosigmoid junction,1
15505,Adulthood Lesion,Stage III Adult Immunoblastic Lymphoma,1
15506,Gastric-Type Epithelial Differentiation,Pyloric Gland Adenoma,1
15507,Epithelial Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
15508,Cutaneous Involvement,Benign Breast Eccrine Spiradenoma,1
15509,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
15510,Malignant Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v8,1
15511,Epithelial Component Present,Vulvar Large Cell Neuroendocrine Carcinoma,1
15512,Epithelial Component Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
15513,Antoni A Pattern,Jugular Foramen Schwannoma,1
15514,Benign Cellular Infiltrate,Ovarian Fetiform Teratoma,1
15515,Carcinomatous Component Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
15516,Diffuse Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
15517,Serrated Glandular Architecture,Colorectal Filiform Serrated Adenoma,1
15518,Malignant Cellular Infiltrate,Colon Burkitt Lymphoma,1
15519,Malignant Cellular Infiltrate,Stage I Childhood Lymphoblastic Lymphoma,1
15520,Regional Disease,Locally Advanced Soft Tissue Sarcoma,1
15521,Epithelial Component Present,Malignant Vulvar Phyllodes Tumor,1
15522,Locally Aggressive Lesion,Intermediate Soft Tissue Tumor of Uncertain Differentiation,1
15523,Malignant Cellular Infiltrate,Malignant neoplasm of uvula,1
15524,Neuroendocrine Differentiation,Small cell carcinoma of the cervix,1
15525,Epithelial Component Present,Metastatic thymic carcinoma,1
15526,Diffuse Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",1
15527,Epithelial Component Present,Metastatic Urethral Urothelial Carcinoma,1
15528,Unclassifiable Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",1
15529,Biphasic Pattern,Vaginal Adenosarcoma,1
15530,Metastatic/Recurrent Disease,Alveolar Soft Part Sarcoma,1
15531,Confluent Sheets of Neoplastic B-Lymphocytes Present,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
15532,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage I,1
15533,Adulthood Lesion,Adult Pineoblastoma,1
15534,Malignant Cellular Infiltrate,Stage I Skin Cancer,1
15535,Hemorrhagic Neuroblastic Nodules Present,"Ganglioneuroblastoma, Nodular",1
15536,Malignant Cellular Infiltrate,Metastatic Lung Carcinoma,1
15537,Papillary Pattern,Papillary adenocarcinoma,1
15538,Well Differentiated Lesion,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
15539,Glandular Pattern,"Somatostatinoma, malignant",1
15540,Inconspicuous Syncytiotrophoblastic Cell Component,Testicular Monophasic Choriocarcinoma,1
15541,Malignant Cellular Infiltrate,Adult Acute Myelomonocytic Leukemia,1
15542,Blasts of Mixed Phenotype Present,Mixed phenotype acute leukemia B/myeloid,1
15543,Carcinomatous Component Present,Stage IVC Appendix Carcinoma AJCC v7,1
15544,Epithelial Component Present,Lung Lymphoepithelioma-Like Carcinoma,1
15545,Malignant Cellular Infiltrate,Stage IIIB Cervical Cancer AJCC v6 and v7,1
15546,Low Mitotic Activity,Gastric Neuroendocrine Tumor G2,1
15547,Epithelial Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
15548,Decreased platelet count,Myeloid Neoplasms with Germline ETV6 Mutation,1
15549,Acanthosis,Laryngeal verrucous carcinoma stage IV,1
15550,Malignant Cellular Infiltrate,Undifferentiated Epithelioid Sarcoma,1
15551,Malignant Cellular Infiltrate,Adult Brain Glioblastoma,1
15552,Malignant Cellular Infiltrate,Stage C Chronic Lymphocytic Leukemia,1
15553,Locally Aggressive Lesion,"Fibromatosis, Aggressive",1
15554,Local disease,Cardiac Lipoma,1
15555,Indolent Clinical Course,Endometrial stromal nodule,1
15556,Exophytic Papillary Lesion,Verrucous carcinoma of oral cavity,1
15557,Bone Marrow Dysplasia Present,Refractory cytopenia with multilineage dysplasia,1
15558,Borderline Lesion,Peritoneal cystic mesothelioma,1
15559,Malignant Cellular Infiltrate,Refractory Aggressive Non-Hodgkin Lymphoma,1
15560,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
15561,Non-Invasive Lesion,Stage 0a Bladder Cancer AJCC v8,1
15562,Epithelial Component Present,Recurrent Malignant Ovarian Brenner Tumor,1
15563,Rapidly Enlarging Mass,Nodular fasciitis,1
15564,Carcinomatous Component Present,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,1
15565,Malignant Cellular Infiltrate,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
15566,Bone Marrow Dysplasia Present,Refractory anemias,1
15567,Infiltrative Growth Pattern,Anaplastic Brain Stem Astrocytoma,1
15568,Cutaneous Involvement,Skin squamous cell carcinoma recurrent,1
15569,Malignant Cellular Infiltrate,Vulvar Neuroendocrine Carcinoma,1
15570,Malignant Cellular Infiltrate,Fallopian Tube Adenocarcinoma,1
15571,Epithelial Component Present,Hepatocellular Adenoma,1
15572,Carcinomatous Component Present,Ampulla of Vater Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
15573,Malignant Cellular Infiltrate,Sacral Chordoma,1
15574,Pseudoencapsulated Mass,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
15575,Epithelial Component Present,Stage II Major Salivary Gland Cancer AJCC v7,1
15576,Malignant Cellular Infiltrate,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma,1
15577,Secondary Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
15578,Carcinomatous Component Present,Stage II Carcinoma of Penis,1
15579,Malignant Cellular Infiltrate,Neuroendocrine carcinoma of appendix,1
15580,Absence of Invasion,High Grade Ductal Breast Carcinoma In Situ,1
15581,Dysplasia,Villous adenoma of colon,1
15582,Immunosuppression-Related Post-Transplant Toxicity,Acute cellular allograft nephropathy,1
15583,Malignant Cellular Infiltrate,Clinical Stage 0 Gastric Cancer AJCC v8,1
15584,Epithelial Component Present,Stage III Adrenal Cortex Carcinoma AJCC v7,1
15585,Malignant Cellular Infiltrate,Advanced Favorable Hodgkin Lymphoma,1
15586,Immunologic Deficiency Syndromes,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
15587,Metastatic Lesion,Metastatic Thyroid Gland Follicular Carcinoma,1
15588,Metastatic Lesion,Advanced Neuroendocrine Neoplasm,1
15589,Absence of Stromal Invasion,Borderline Ovarian Endometrioid Adenofibroma,1
15590,Tumor Vascular Invasion,Malignant Testicular Leydig Cell Tumor,1
15591,Malignant Cellular Infiltrate,Metaplastic carcinoma,1
15592,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma AJCC v7,1
15593,Malignant Cellular Infiltrate,Clivus Chondroid Chordoma,1
15594,Perivascular Arrangement of Tumor Cells,Glomangioma of skin,1
15595,Carcinomatous Component Present,Advanced Cervical Carcinoma,1
15596,Epithelial Component Present,Esophageal Neuroendocrine Tumor,1
15597,Refractory Disease,Refractory Classic Hodgkin Lymphoma,1
15598,Adulthood Lesion,Adult Malignant Peripheral Nerve Sheath Tumor,1
15599,Epithelial Component Present,High Grade Esophageal Squamous Intraepithelial Neoplasia,1
15600,Benign Cellular Infiltrate,Colorectal Benign Granular Cell Tumor,1
15601,Chronic Inflammatory Infiltrate,Inflammatory liposarcoma,1
15602,Benign Cellular Infiltrate,Benign neoplasm of large intestine,1
15603,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
15604,Cutaneous Involvement,Vulvar Dysplastic Melanocytic Nevus,1
15605,Metastatic Lesion,Secondary malignant neoplasm of ciliary body,1
15606,Malignant Cellular Infiltrate,Recurrent Malignant Bone Neoplasm,1
15607,Epithelial Component Present,Stage IB Lung Small Cell Carcinoma AJCC v7,1
15608,Malignant Cellular Infiltrate,adenoid cystic carcinoma of pharynx,1
15609,Malignant Cellular Infiltrate,Classic Variant of Chromophobe Renal Cell Carcinoma,1
15610,Severe dysplasia,Stage 0is Urethral Cancer AJCC v8,1
15611,Local disease,Localized Gallbladder Carcinoma,1
15612,Multifocal Lesion,"Histiocytosis, Langerhans-Cell",1
15613,Malignant Cellular Infiltrate,Stage IIB Soft Tissue Sarcoma AJCC v7,1
15614,Epithelial Component Present,Unresectable Intrahepatic Cholangiocarcinoma,1
15615,Argentaffin Positive Neoplastic Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
15616,Low Grade Lesion,Low-grade fibromyxoid sarcoma,1
15617,Recurrent disease,Oropharyngeal cancer recurrent,1
15618,Malignant Cellular Infiltrate,Stage IIB Lung Large Cell Carcinoma AJCC v7,1
15619,Malignant Cellular Infiltrate,Apocrine breast carcinoma,1
15620,Malignant Cellular Infiltrate,Malignant lymphoma of testis,1
15621,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v7,1
15622,Malignant Cellular Infiltrate,Adenocarcinoma in situ in villous adenoma,1
15623,Toxic effect,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
15624,Malignant Cellular Infiltrate,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
15625,Epithelial Component Present,Vulvar Neuroendocrine Carcinoma,1
15626,Indolent Clinical Course,Ameloblastic fibrodentinoma,1
15627,Myxoid Stroma Formation,Dedifferentiated chordoma,1
15628,Neuroendocrine Differentiation,Paraganglioma,1
15629,Well Differentiated Lesion,Well Differentiated Leiomyosarcoma,1
15630,Epithelial Component Present,Breast Carcinoma Metastatic in the Bone,1
15631,Recurrent disease,Thymoma malignant recurrent,1
15632,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
15633,Malignant Cellular Infiltrate,recurrent gastric cancer,1
15634,Malignant Cellular Infiltrate,Stage IVA Paranasal Sinus Cancer AJCC v7,1
15635,Myxoid Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
15636,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary,1
15637,Neuroectodermal Differentiation,ganglioneuroblastoma of mediastinum,1
15638,Neuroendocrine Differentiation,Breast Carcinoid Tumor,1
15639,Hyperplastic Tissue Present,Neoplastic C-Cell Hyperplasia,1
15640,Chronic Inflammatory Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
15641,Neuroendocrine Differentiation,Malignant neoplasm of carotid body,1
15642,Malignant Cellular Infiltrate,Dedifferentiated chondrosarcoma,1
15643,Malignant Cellular Infiltrate,Hepatic lymphoma,1
15644,Epithelial Component Present,Primary Peritoneal Cancer by AJCC v8 Stage,1
15645,Malignant Cellular Infiltrate,Chondroid chordoma,1
15646,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma refractory,1
15647,Neuroendocrine Differentiation,Kidney Neuroendocrine Neoplasm,1
15648,Chromogranin A Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell",1
15649,Low Grade Lesion,Classical Low Grade Fibromyxoid Sarcoma,1
15650,Malignant Cellular Infiltrate,malignant steroid cell tumor of ovary,1
15651,Cystic Change,Cystic basal cell carcinoma,1
15652,Cutaneous Involvement,Cutaneous Mantle Cell Lymphoma,1
15653,Acinar Cell Differentiation,Pancreatic Acinar Cell Cystadenoma,1
15654,Epithelial Component Present,Thyroid Gland Oncocytic Adenoma,1
15655,Malignant Cellular Infiltrate,Refractory T Lymphoblastic Lymphoma,1
15656,Neuroendocrine Differentiation,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
15657,Metastatic Lesion,Metastatic Bladder Urothelial Carcinoma,1
15658,Epithelial Component Present,Gallbladder Cancer by AJCC v6 Stage,1
15659,Chronic lymphocytic inflammation,Benign Breast Eccrine Spiradenoma,1
15660,Epithelial Component Present,Prostate Phyllodes Tumor,1
15661,Malignant Cellular Infiltrate,Malignant neoplasm of maxillary sinus,1
15662,Malignant Cellular Infiltrate,M5b Acute differentiated monocytic leukemia,1
15663,Indolent Clinical Course,Histiocytoid hemangioma,1
15664,Severe dysplasia,Stage 0 Colon Cancer AJCC v8,1
15665,Malignant Cellular Infiltrate,Advanced Head and Neck Squamous Cell Carcinoma,1
15666,Neuroendocrine Differentiation,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
15667,Primary Lesion,Adult Brain Stem Glioma,1
15668,Nerve palsy,Facial Nerve Palsy Related to Trauma,1
15669,Malignant Cellular Infiltrate,Retromolar Trigone Squamous Cell Carcinoma,1
15670,Malignant Cellular Infiltrate,Recurrent T Acute Lymphoblastic Leukemia,1
15671,Benign Cellular Infiltrate,Benign Female Reproductive System Neoplasm,1
15672,Carcinomatous Component Present,Laryngeal squamous cell carcinoma recurrent,1
15673,Benign Cellular Infiltrate,Palisaded encapsulated neuroma,1
15674,Multifocal Lesion,Multiple adenomatous polyps,1
15675,Recurrent disease,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
15676,Ineffective hematopoiesis,Myelodysplastic Syndrome with Gene Mutation,1
15677,Epithelial Component Present,Neuroendocrine neoplasm of lung,1
15678,Cutaneous Involvement,Skin tumor of smooth muscle origin,1
15679,Recurrent disease,Recurrent Thyroid Gland Papillary Carcinoma,1
15680,Epithelial Component Present,Gastric carcinoma stage IV,1
15681,Cutaneous Involvement,Spongiotic dermatitis,1
15682,Mitotic Activity,Recurrent Childhood Pilomyxoid Astrocytoma,1
15683,Borderline Lesion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
15684,Carcinomatous Component Present,Hilar Cholangiocarcinoma by AJCC v8 Stage,1
15685,More than 10 Mitoses per 10HPF,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
15686,Carcinomatous Component Present,Stage II Skin Cancer,1
15687,Malignant Cellular Infiltrate,Vulvar Large Cell Neuroendocrine Carcinoma,1
15688,Malignant Cellular Infiltrate,Stage IIIA2 Ovarian Cancer AJCC v8,1
15689,Recurrent Genetic Abnormalities Present,Hypergranular promyelocytic leukemia,1
15690,Epithelial Component Present,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",1
15691,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated, TP53-Mutant",1
15692,Borderline Lesion,IgM monoclonal gammopathy of uncertain significance,1
15693,Mixed Cellular Population,Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
15694,Well Differentiated Lesion,Supraglottic Verrucous Carcinoma,1
15695,Benign Cellular Infiltrate,Nasopharyngeal Angiofibroma,1
15696,Cutaneous Involvement,Skin squamous cell carcinoma metastatic,1
15697,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
15698,atypia morphology,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
15699,Adulthood Lesion,Hodgkin Lymphoma During Pregnancy,1
15700,Cutaneous Involvement,Bowenoid papulosis of penis,1
15701,Carcinomatous Component Present,Metastatic Lip Carcinoma,1
15702,Carcinomatous Component Present,Colon cancer recurrent,1
15703,Recurrent disease,Melanoma recurrent,1
15704,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
15705,Local disease,Fallopian Tube Adenomatoid Tumor,1
15706,Carcinomatous Component Present,Stage IA Ovarian Cancer,1
15707,Epithelial Component Present,Stage IIIA2 Ovarian Cancer AJCC v8,1
15708,Recurrent disease,Cholangiocarcinoma recurrent,1
15709,Painless Mass,chondroma of lung,1
15710,Malignant Cellular Infiltrate,Carcinoma breast stage I,1
15711,Epithelial Component Present,Prostate Carcinoma Metastatic in the Soft Tissue,1
15712,Bone marrow reticulin fibrosis,Refractory Hairy Cell Leukemia,1
15713,Cartilaginous Differentiation,Chondrosarcoma,1
15714,Diffuse Pattern,mixed gliomas,1
15715,Carcinomatous Component Present,Undifferentiated carcinoma of nasopharynx,1
15716,Benign Cellular Infiltrate,Benign Bone Schwannoma,1
15717,Refractory Disease,Refractory Peripheral Primitive Neuroectodermal Tumor,1
15718,Malignant Cellular Infiltrate,Primary Cutaneous Plasmablastic Lymphoma,1
15719,Extensive Stage Lesion,Advanced Favorable Non-Hodgkin Lymphoma,1
15720,Carcinomatous Component Present,Invasive Ductal Breast Carcinoma with Predominant Intraductal Component,1
15721,Anaplasia,Adult Anaplastic (Malignant) Meningioma,1
15722,Diffuse Pattern,Glioblastoma multiforme of spinal cord,1
15723,Epithelial Component Present,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
15724,Malignant Cellular Infiltrate,EBV-Positive T-Cell Lymphoproliferative Disorder of Childhood,1
15725,Tissue Differentiation Uncertain,Adult Epithelioid Sarcoma,1
15726,Carcinomatous Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
15727,Epithelial Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
15728,Malignant Cellular Infiltrate,Childhood Acute Megakaryoblastic Leukemia,1
15729,Epithelial Component Present,Vulvar Syringoma,1
15730,Epithelial Component Present,Multiple endocrine neoplasia Type 2,1
15731,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
15732,Mixture of Germ Cell Neoplastic Components Present,Childhood Testicular Mixed Embryonal Carcinoma and Teratoma,1
15733,Calcitonin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
15734,Malignant Cellular Infiltrate,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
15735,Tissue of Mullerian Origin Present,Mucinous cystadenofibroma,1
15736,Monoclonal Cellular Population Present,"Leukemia, Mast-Cell",1
15737,'Starry-sky' pattern,EBV-Related Burkitt Lymphoma,1
15738,Metastatic/Recurrent Disease,Extrarenal rhabdoid tumor,1
15739,Ineffective hematopoiesis,Acute myeloid leukemia with multilineage dysplasia,1
15740,Carcinomatous Component Present,Small intestine carcinoma stage II,1
15741,Duct-Like Structures Present,Epithelial-myoepithelial carcinoma,1
15742,Epithelial Component Present,Cervix carcinoma recurrent,1
15743,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v8,1
15744,Well-Circumscribed Lesion,Adenoma of ampulla of Vater,1
15745,In Situ Lesion,In situ follicular neoplasia,1
15746,Carcinomatous Component Present,Stage II Renal Cell Cancer AJCC v8,1
15747,Fibrotic Stroma Formation,Borderline Ovarian Serous Cystadenofibroma,1
15748,Cutaneous Involvement,Unresectable Cutaneous Melanoma,1
15749,Monomorphic Cellular Infiltrate,Childhood Oligodendroglioma,1
15750,Epithelial Component Present,carcinoma of pancreas with osteoclast-like giant cells,1
15751,Hyaline Cartilage Differentiation,Grade II Chondrosarcoma,1
15752,Stromal Invasion,Stage I Ovarian Cancer AJCC v6 and v7,1
15753,Refractory Disease,Refractory Pancreatic Carcinoma,1
15754,Carcinomatous Component Present,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
15755,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v8,1
15756,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Tumor,1
15757,Locally Aggressive Lesion,Metastatic Dermatofibrosarcoma Protuberans,1
15758,Epithelial Component Present,Stage 0 Colon Cancer AJCC v6 and v7,1
15759,Carcinomatous Component Present,Locally Advanced Cervical Adenocarcinoma,1
15760,Peripheral Nuclear Palisading,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
15761,Vascular Channel Formation,"Neoplasms, Vascular Tissue",1
15762,Malignant Cellular Infiltrate,Inflammatory liposarcoma,1
15763,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
15764,Indolent Clinical Course,Benign bone neoplasm,1
15765,Perineural spread,Metastatic Adenoid Cystic Carcinoma,1
15766,Epithelial Component Present,Stage IV Thymus Epithelial Neoplasm AJCC v8,1
15767,Necrotic changes (finding),Anal Canal Small Cell Neuroendocrine Carcinoma,1
15768,Infiltrating Tumor Margins Present,Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
15769,Well-Circumscribed Lesion,Colorectal Tubular Adenoma,1
15770,Indolent Clinical Course,Hemangioma of intra-abdominal structure,1
15771,Chromogranin A Positive Neoplastic Cells Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",1
15772,Epithelial Component Present,Borderline Ovarian Mucinous Adenofibroma,1
15773,Cutaneous Involvement,apocrine adenocarcinoma of vulva,1
15774,Alternative Fascicle (Bundle) Pattern,Intravenous leiomyomatosis,1
15775,Pregnancy Complications,Recurrent Gestational Trophoblastic Tumor,1
15776,Epithelial Component Present,Refractory Endometrial Endometrioid Adenocarcinoma,1
15777,Cord-Like Pattern,Clear cell sarcoma of kidney,1
15778,Follicular Cell Differentiation,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
15779,Extensive Stage Lesion,Advanced Neuroendocrine Neoplasm,1
15780,Malignant Cellular Infiltrate,Multifocal breast carcinoma,1
15781,Cutaneous Involvement,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
15782,Epithelial Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
15783,Metastatic Lesion,Pleural mesothelioma malignant advanced,1
15784,Extensive Stage Lesion,Advanced Prostate Carcinoma,1
15785,Epithelial Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
15786,Malignant Cellular Infiltrate,Head and Neck Carcinoma,1
15787,Carcinomatous Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v8,1
15788,Adulthood Lesion,Adult Acute Myeloblastic Leukemia,1
15789,Malignant Cellular Infiltrate,Stage 0 Breast Cancer AJCC v6 and v7,1
15790,Cutaneous Involvement,Keratoderma,1
15791,Generalized illness,Leiomyomatosis peritonealis disseminata,1
15792,Nodular Pattern,Recurrent Grade 3 Follicular Lymphoma,1
15793,Epithelial Component Present,Transitional cell carcinoma urethra,1
15794,Carcinomatous Component Present,Stage IIA Eyelid Carcinoma AJCC v8,1
15795,Carcinomatous Component Present,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
15796,Epithelial Component Present,Lobular carcinoma in situ of breast,1
15797,Well Differentiated Neuroendocrine Lesion,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,1
15798,Epithelial Component Present,Vaginal Mullerian Papilloma,1
15799,Intraosseous Lesion,Primary solid type intraosseous squamous cell carcinoma,1
15800,Carcinomatous Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
15801,Primary Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
15802,Benign Cellular Infiltrate,Odontogenic myxofibroma,1
15803,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor G2,1
15804,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
15805,Carcinomatous Component Present,Squamous cell carcinoma of skin,1
15806,Carcinomatous Component Present,Stage IVA Laryngeal Cancer AJCC v8,1
15807,Malignant Cellular Infiltrate,Anaplastic Carcinoma of the Rectum,1
15808,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",1
15809,Serotonin Positive Neoplastic Cells Present,Carcinoid tumor of pancreas,1
15810,Carcinomatous Component Present,Stage I Lung Small Cell Carcinoma AJCC v7,1
15811,Epithelial Component Present,Papillary serous cystadenoma,1
15812,"Amorphus, Eosinophilic, and Acellular Deposit","Amyloidosis, Familial",1
15813,Intestinal metaplasia,Lung Enteric Adenocarcinoma,1
15814,Invasive Lesion,Grade 3 Invasive Breast Carcinoma,1
15815,Malignant Cellular Infiltrate,liposarcoma,1
15816,Malignant Cellular Infiltrate,Vaginal cancer recurrent,1
15817,Malignant Cellular Infiltrate,Mucosal Melanoma of the Head and Neck by AJCC v7 Stage,1
15818,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
15819,Carcinomatous Component Present,Papillary serous endometrial carcinoma,1
15820,Unresectable Mass,Unresectable Gastrointestinal Stromal Tumor,1
15821,Carcinomatous Component Present,Stage 0a Renal Pelvis Cancer AJCC v7,1
15822,Malignant Cellular Infiltrate,Stage IVB Ovarian Cancer AJCC v8,1
15823,Dermal Involvement,Eccrine porocarcinoma,1
15824,Cutaneous Involvement,"Keratoderma, Palmoplantar, Epidermolytic",1
15825,Vascular Channel Formation,Anastomosing Hemangioma,1
15826,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
15827,Epithelial Component Present,adenoma of intrahepatic bile duct,1
15828,Carcinomatous Component Present,Stage III Penile Cancer AJCC v6,1
15829,Encapsulated Mass,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
15830,Epithelial Component Present,Stage I Appendix Carcinoma AJCC v7,1
15831,Epithelial Component Present,Laryngeal Lymphoepithelial Carcinoma,1
15832,Hyalinized Stroma Formation,Childhood Epithelioid Hemangioendothelioma,1
15833,Malignant Cellular Infiltrate,Aggressive Systemic Mastocytosis,1
15834,Malignant Cellular Infiltrate,Conventional (Clear Cell) Renal Cell Carcinoma,1
15835,Severe dysplasia,Adenocarcinoma in situ in tubular adenoma,1
15836,High Mitotic Activity,Childhood Central Nervous System Embryonal Carcinoma,1
15837,Blasts Under 20 Percent of Peripheral Blood White Cells,"Leukemia, Myelomonocytic, Chronic",1
15838,Epithelial Component Present,Thyroid Gland Adenocarcinoma,1
15839,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma refractory,1
15840,Keratin pearl formation,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
15841,Epithelial Component Present,Benign Epithelioma,1
15842,Malignant Cellular Infiltrate,Placental Choriocarcinoma,1
15843,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage II,1
15844,Increased Cellularity Present,Childhood Neuroblastoma,1
15845,Malignant Cellular Infiltrate,Stage III Childhood Non-Hodgkin Lymphoma,1
15846,Unresectable Mass,Unresectable Skin Basal Cell Carcinoma,1
15847,Cutaneous Involvement,Stage III Lip Basal Cell Carcinoma,1
15848,Adulthood Lesion,Localized Resectable Adult Liver Carcinoma,1
15849,Malignant Cellular Infiltrate,Advanced Microsatellite Stable Colorectal Carcinoma,1
15850,Malignant Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v6 and v7,1
15851,Malignant Cellular Infiltrate,Clear cell squamous cell carcinoma of skin,1
15852,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of ileum,1
15853,Malignant Cellular Infiltrate,Acute Myelomonocytic Leukemia without Abnormal Eosinophils,1
15854,Mitotic Activity,Recurrent Giant Cell Glioblastoma,1
15855,Malignant Cellular Infiltrate,Recurrent Thyroid Gland Anaplastic Carcinoma,1
15856,Malignant Cellular Infiltrate,Adult Undifferentiated Pleomorphic Sarcoma,1
15857,Severe dysplasia,Stage 0is Renal Pelvis Cancer AJCC v7,1
15858,Malignant Cellular Infiltrate,M5b Acute differentiated monocytic leukemia,1
15859,Adnexal Differentiation,Ceruminous Neoplasm,1
15860,Well-Circumscribed Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
15861,Slow Growing Mass,Metastatic Chordoma,1
15862,Superficial Lesion,Superficial fibromatosis,1
15863,Malignant Cellular Infiltrate,Stage III Lung Cancer AJCC v8,1
15864,Papillary Pattern,Recurrent respiratory papillomatosis,1
15865,Epithelial Component Present,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
15866,Primary Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
15867,Carcinomatous Component Present,Nasal cavity carcinoma,1
15868,Sarcomatous Component Present,Malignant Phyllodes Tumor of Prostate,1
15869,Epithelial Component Present,Colon Cancer by AJCC v7 Stage,1
15870,CD56-Positive Neoplastic Cells Present,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
15871,Carcinomatous Component Present,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
15872,Malignant Cellular Infiltrate,Adult Desmoplastic Small Round Cell Tumor,1
15873,Pain,Juxtacortical chondrosarcoma,1
15874,High Mitotic Activity,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
15875,High Grade Lesion,Adult Giant Cell Glioblastoma,1
15876,Benign Cellular Infiltrate,Perineural Hemangioma,1
15877,Secondary Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,1
15878,Adulthood Lesion,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8,1
15879,Antoni B Pattern,Acoustic Neuroma,1
15880,Well-Circumscribed Lesion,Adult Extracardiac Rhabdomyoma,1
15881,Carcinomatous Component Present,External Ear Carcinoma,1
15882,Emperipolesis,Giant cell carcinoma of lung,1
15883,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
15884,Capillary Sized Vascular Channel Formation,Breast Epithelioid Hemangioma,1
15885,Infiltrative Growth Pattern,Childhood Glioblastoma,1
15886,Cutaneous Involvement,Toxic Epidermal Necrolysis,1
15887,Malignant Cellular Infiltrate,Advanced Carcinoma,1
15888,Neuroendocrine Differentiation,Thymic Atypical Carcinoid Tumor,1
15889,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia-2,1
15890,Indolent Clinical Course,Benign Mediastinal Soft Tissue Neoplasm,1
15891,Malignant Cellular Infiltrate,Secondary malignant neoplasm of parathyroid gland,1
15892,Hyperplastic Tissue Present,Complex Endometrial Hyperplasia,1
15893,Epithelial Component Present,Small Intestinal Neuroendocrine Tumor,1
15894,Cystic Change,mucoepidermoid carcinoma of floor of mouth,1
15895,Human Papillomavirus Negative,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
15896,Biphasic Pattern,Metaplastic thymoma,1
15897,Aggressive Clinical Course,Mediastinal/Thymic NUT Carcinoma,1
15898,Metastatic Lesion,Lung Carcinoma Metastatic in the Bone,1
15899,Malignant Cellular Infiltrate,Endometrial Carcinoma,1
15900,Hemorrhagic,Cutaneous Radiation-Related Angiosarcoma,1
15901,Malignant Cellular Infiltrate,Childhood Ganglioneuroblastoma,1
15902,Malignant Cellular Infiltrate,Intracranial Myeloid Sarcoma,1
15903,IDH Gene Family Mutation Status Unknown,Diffuse Astrocytoma,1
15904,Epithelial Component Present,verrucous carcinoma of vagina,1
15905,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
15906,Malignant Cellular Infiltrate,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
15907,Acanthosis,Urethral Verrucous Carcinoma,1
15908,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
15909,Exophytic Papillary Lesion,Vaginal Papillary Carcinoma,1
15910,Carcinomatous Component Present,Stage II Gastric Carcinoma,1
15911,Hyaline Cartilage Differentiation,Grade II Chondrosarcoma,1
15912,Pregnancy Complications,Eclampsia,1
15913,Papillary Pattern,Well-differentiated papillary mesothelioma,1
15914,Mesenchymal Component Present,Giant fibroadenoma of breast,1
15915,Epithelial Component Present,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
15916,Endobronchial Lesion,Lung Glandular Papilloma,1
15917,Malignant Cellular Infiltrate,Squamous cell carcinoma of tongue,1
15918,Absence of Stromal Invasion,Borderline epithelial tumor of ovary,1
15919,Transformed Phase of Disease,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,1
15920,Benign Cellular Infiltrate,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
15921,Carcinomatous Component Present,Cervical Esophagus Adenocarcinoma,1
15922,Carcinomatous Component Present,Stage IIA Distal Bile Duct Cancer AJCC v8,1
15923,Epithelial Component Present,Vaginal adenocarcinoma,1
15924,Well-Circumscribed Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
15925,Well-Circumscribed Lesion,Adenomatous Polyps,1
15926,Malignant Cellular Infiltrate,Bladder squamous cell carcinoma stage III,1
15927,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Carcinoma,1
15928,Epithelial Component Present,Stage I Distal Bile Duct Cancer AJCC v8,1
15929,Immunologic Deficiency Syndromes,Methotrexate-Associated Burkitt Lymphoma,1
15930,High Mitotic Activity,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
15931,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Pineal Region Choriocarcinoma,1
15932,Epithelial Component Present,"Pheochromocytoma, malignant",1
15933,Tubular Pattern,Tubulovillous adenoma,1
15934,Lobulated Growth Pattern,Cutaneous myxoma,1
15935,Metastatic Lesion,Secondary malignant neoplasm of neck,1
15936,Malignant Cellular Infiltrate,Stage IA Fallopian Tube Cancer AJCC v8,1
15937,Carcinomatous Component Present,Combined Lung Large Cell Neuroendocrine Carcinoma,1
15938,Malignant Cellular Infiltrate,adenosquamous carcinoma of salivary gland,1
15939,Malignant Cellular Infiltrate,Stage IIB Appendix Carcinoma AJCC v7,1
15940,Papillary Pattern,Papillary tumor of the pineal region,1
15941,Epithelial Component Present,Vulvar Inverted Follicular Keratosis,1
15942,Cartilaginous Differentiation,Juxtacortical chondroma,1
15943,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G2,1
15944,Epithelial Component Present,malignant myoepithelioma of breast,1
15945,Malignant Cellular Infiltrate,Squamous cell carcinoma of tongue,1
15946,High Mitotic Activity,Recurrent Childhood Anaplastic Oligoastrocytoma,1
15947,Cutaneous Involvement,Recurrent Skin Angiosarcoma,1
15948,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma,1
15949,Malignant Cellular Infiltrate,Metastatic Urethral Carcinoma,1
15950,Metastatic Lesion,Locally Advanced Prostate Adenocarcinoma,1
15951,Malignant Cellular Infiltrate,Childhood Myxoid Chondrosarcoma,1
15952,Cutaneous Involvement,Scleromyxedema,1
15953,Well Differentiated Neuroendocrine Lesion,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
15954,Resectable Mass,Resectable Malignant Mesothelioma,1
15955,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
15956,Mixed Cellular Population,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
15957,Epithelial Component Present,"Acanthoma, Clear Cell",1
15958,Carcinomatous Component Present,"Hepatocellular carcinoma, scirrhous",1
15959,Indolent Clinical Course,Cellular Myxoma,1
15960,Exophytic Papillary Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
15961,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Modified Rai Staging System,1
15962,Pseudoglandular Pattern,Embryonal Carcinoma,1
15963,Recurrent disease,Recurrent Non-Cutaneous Melanoma,1
15964,Carcinomatous Component Present,Mucoepidermoid carcinoma of parotid gland,1
15965,Exophytic Polypoid Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
15966,Carcinomatous Component Present,Stage IV Ureter Cancer AJCC v8,1
15967,Juvenile Lesion,Juvenile rheumatoid arthritis,1
15968,Macrocystic Change,"Lymphangioma, Cystic",1
15969,Malignant Cellular Infiltrate,Recurrent Prostate Acinar Adenocarcinoma,1
15970,Dysplasia,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
15971,Thin-Walled Branching Vascular Pattern,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
15972,Epithelial Component Present,Subglottic Squamous Cell Carcinoma,1
15973,Poorly Differentiated Neuroendocrine Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma,1
15974,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
15975,Chemotherapeutic Agent Toxicity,Alkylating Agent-Related Acute Myeloid Leukemia,1
15976,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v7,1
15977,Carcinomatous Component Present,Pathologic Stage IV Merkel Cell Carcinoma AJCC v8,1
15978,Infiltrative Growth Pattern,Peyronie Disease,1
15979,Malignant Cellular Infiltrate,Adult Lymphoma,1
15980,Malignant Cellular Infiltrate,Cervical Papillary Squamous Cell Carcinoma,1
15981,Carcinomatous Component Present,Stage II Intrahepatic Bile Duct Cancer AJCC v8,1
15982,Malignant Cellular Infiltrate,"Leukemia, Radiation-Induced",1
15983,Nodular lesions,"Childhood Ganglioneuroblastoma, Nodular",1
15984,Epithelial Component Present,Squamous cell carcinoma of buccal mucosa,1
15985,Neoplastic Promonocytes in Bone Marrow Markedly Increased,M5b Acute differentiated monocytic leukemia,1
15986,Malignant Cellular Infiltrate,Carcinoma Arising in Nasal Papillomatosis,1
15987,Epithelial Component Present,ACTH-producing pituitary tumor,1
15988,Benign Cellular Infiltrate,Benign neoplasm of subglottis,1
15989,Epithelial Component Present,intraductal micropapillary carcinoma of breast,1
15990,Carcinomatous Component Present,combined small cell carcinoma of lung,1
15991,Well-Circumscribed Lesion,Malignant Phyllodes Tumor of Prostate,1
15992,Refractory Disease,Refractory Hairy Cell Leukemia,1
15993,Metastatic Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
15994,Nodular Pattern,Recurrent Grade 3 Follicular Lymphoma,1
15995,Malignant Cellular Infiltrate,Stage IIIC Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
15996,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
15997,Hyperplastic Tissue Present,Follicular Lymph Node Hyperplasia,1
15998,Nodular and Diffuse Pattern,Large B-cell lymphoma with IRF4 rearrangement,1
15999,Biphasic Pattern,Malignant Cystosarcoma Phyllodes,1
16000,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v8,1
16001,Well-Circumscribed Lesion,Inflammatory Hepatocellular Adenoma,1
16002,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
16003,Carcinomatous Component Present,Colon Cribriform Comedo-Type Adenocarcinoma,1
16004,Carcinomatous Component Present,Stage IVB Laryngeal Cancer AJCC v8,1
16005,Malignant Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v7,1
16006,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Lung,1
16007,Primitive Mesenchymal Stroma Formation,Pulmonary Blastoma,1
16008,Diffuse Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,1
16009,Carcinomatous Component Present,Urethral Cancer by AJCC v7 Stage,1
16010,Plasma cell inflammation,Syringocystadenoma Papilliferum,1
16011,Cutaneous Involvement,Clinical Stage II Cutaneous Melanoma AJCC v8,1
16012,Monoclonal Langerhans Cells Present,Recurrent Langerhans Cell Histiocytosis,1
16013,Adulthood Lesion,Adult Choroid Plexus Neoplasm,1
16014,Indolent Clinical Course,Gastric Hemangioma,1
16015,Epithelial Component Present,Breast Carcinoma Metastatic in the Lung,1
16016,Childhood Lesion,Childhood T Acute Lymphoblastic Leukemia,1
16017,Encapsulated Mass,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
16018,High Mitotic Activity,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
16019,Well-Circumscribed Lesion,Sporadic Thyroid Gland Medullary Carcinoma,1
16020,In Situ Lesion,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
16021,Carcinomatous Component Present,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
16022,Carcinomatous Component Present,Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
16023,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
16024,Thyroglobulin Positive Neoplastic Cells Present,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
16025,Epithelial Component Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1
16026,Malignant Cellular Infiltrate,Adenocarcinoma in villous adenoma,1
16027,Storiform Growth Pattern,Deep histiocytoma,1
16028,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
16029,Malignant Cellular Infiltrate,Uterine Ligament Adenocarcinoma,1
16030,Cutaneous Involvement,Acantholytic acanthoma,1
16031,Epithelial Component Present,Stage II Pancreatic Cancer AJCC v8,1
16032,Well Differentiated Lesion,Grade I Chondrosarcoma,1
16033,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Wildtype",1
16034,Malignant Cellular Infiltrate,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
16035,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of lung,1
16036,Therapy-Related Toxicity,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders,1
16037,Epithelial Component Present,Laryngeal Lymphoepithelial Carcinoma,1
16038,Favorable Clinical Outcome,Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm,1
16039,Granulocytes Increased in Bone Marrow,Prefibrotic/Early Primary Myelofibrosis,1
16040,Local disease,Colon Lipoma,1
16041,Severe dysplasia,Intraepithelial Squamous Cell Carcinoma,1
16042,Carcinomatous Component Present,Malignant eccrine spiradenoma,1
16043,Skin nodule,Lipoid dermatoarthritis,1
16044,Malignant Cellular Infiltrate,Helicobacter Pylori-Related Carcinoma,1
16045,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
16046,Benign Cellular Infiltrate,Bladder Urothelial Papilloma,1
16047,Recurrent disease,Recurrent Neurofibromatosis Type 1,1
16048,Slow Growing Painless Mass,Nodular tenosynovitis,1
16049,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
16050,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7,1
16051,Cystic Change,Bile duct cystadenocarcinoma,1
16052,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage I,1
16053,Osseous Differentiation,Stage IB Osteosarcoma AJCC v7,1
16054,Epithelial Component Present,Recurrent Carcinoma,1
16055,Benign Cellular Infiltrate,Bladder Squamous Papilloma,1
16056,Epithelial Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
16057,Nested Pattern,Ovarian gonadoblastoma,1
16058,Secondary Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
16059,Malignant Cellular Infiltrate,Cervical Mesonephric Adenocarcinoma,1
16060,Vascular Channel Formation,Lymphangioma of skin,1
16061,Fibrotic Stroma Formation,Mucoepidermoid Carcinoma,1
16062,Multilocular Lesion,Cystic Partially Differentiated Nephroblastoma,1
16063,Indolent Clinical Course,Esophageal hemangioma,1
16064,Diffuse Lesion,Diffuse leptomeningeal glioneuronal neoplasm,1
16065,High Mitotic Activity,large cell neuroendocrine carcinoma of gallbladder,1
16066,Refractory Disease,Refractory Endometrial Clear Cell Adenocarcinoma,1
16067,Malignant Cellular Infiltrate,Intraocular retinoblastoma,1
16068,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
16069,Carcinomatous Component Present,Penile Cancer by AJCC v6 Stage,1
16070,Recurrent disease,Recurrent Ovarian Clear Cell Adenocarcinoma,1
16071,Nuclear Atypia,Grade III Childhood Astrocytoma,1
16072,Carcinomatous Component Present,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
16073,Carcinomatous Component Present,adenocarcinoma of oral cavity,1
16074,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
16075,Malignant Cellular Infiltrate,Stage IV Nasal Cavity Carcinoma AJCC v7,1
16076,High Mitotic Activity,Undifferentiated Stromal Sarcoma,1
16077,Childhood Lesion,Childhood Brain Glioblastoma,1
16078,Epithelial Component Present,Non-Functioning Pituitary Gland Microadenoma,1
16079,"Variably-Sized Cysts Filled With Clear, Serous, or Gelatinous Fluid",Cystadenocarcinoma of kidney,1
16080,Myomatous Stroma Formation,Cervical Adenomyoma,1
16081,Carcinomatous Component Present,Nasopharyngeal Nonkeratinizing Carcinoma,1
16082,Malignant Cellular Infiltrate,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
16083,Malignant Cellular Infiltrate,Refractory Malignant Endocrine Neoplasm,1
16084,Primary Lesion,Cerebellar and Brain Stem Ependymal Tumor,1
16085,Malignant Cellular Infiltrate,Stage II Ovarian Polyembryoma AJCC v6 and v7,1
16086,Necrotic changes (finding),Gastric Small Cell Carcinoma,1
16087,Anaplasia,Common Variant Anaplastic Large Cell Lymphoma,1
16088,Carcinomatous Component Present,Prognostic Stage IIA Breast Cancer AJCC v8,1
16089,Metastatic Lesion,Colon Carcinoma Metastatic in the Liver,1
16090,Pathologic TNM Finding,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
16091,Diffuse Pattern,Anaplastic Oligoastrocytoma,1
16092,Calcitonin serum level increased,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
16093,Metastatic/Recurrent Disease,"Ossifying fibromyxoid tumor, malignant",1
16094,Refractory Disease,Refractory Langerhans Cell Histiocytosis,1
16095,Diffuse Pattern,Lymphohistiocytoid Mesothelioma,1
16096,Cystic Change,Benign cystic nephroma,1
16097,Malignant Cellular Infiltrate,rhabdomyosarcoma of prostate,1
16098,Secondary Lesion,Distantly Metastatic Malignant Neoplasm,1
16099,Cutaneous Involvement,Papillary Eccrine Carcinoma,1
16100,Indolent Clinical Course,Lipoma,1
16101,Exophytic Polypoid Lesion,Colon Juvenile Polyp,1
16102,Malignant Cellular Infiltrate,Recurrent WHO Grade III Glioma,1
16103,Epithelial Component Present,Stage III Esophageal Cancer AJCC v7,1
16104,Epithelial Component Present,High Grade Penile Intraepithelial Neoplasia,1
16105,Slow Growing Mass,Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,1
16106,Carcinomatous Component Present,Stage 0 Ureter Cancer AJCC v7,1
16107,Diffuse Pattern,Refractory Intravascular Large B-Cell Lymphoma,1
16108,Malignant Cellular Infiltrate,Mixed Cellularity Classic Hodgkin Lymphoma by Ann Arbor Stage,1
16109,Well Differentiated Lesion,Grade 1 Rectal Adenocarcinoma,1
16110,Malignant Cellular Infiltrate,Meningothelial sarcoma,1
16111,Malignant Cellular Infiltrate,Stage II Renal Cell Cancer AJCC v8,1
16112,Malignant Cellular Infiltrate,Pancreatic Cancer by AJCC v6 and v7 Stage,1
16113,Epithelial Component Present,Stage III Ureter Cancer AJCC v7,1
16114,Malignant Cellular Infiltrate,Adenocarcinoma of pancreas,1
16115,Indolent Clinical Course,Dermal Fibroma,1
16116,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage II,1
16117,Malignant Cellular Infiltrate,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8,1
16118,Carcinomatous Component Present,Pancreatic Large Cell Neuroendocrine Carcinoma,1
16119,Malignant Cellular Infiltrate,Myelodysplastic-Myeloproliferative Diseases,1
16120,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,"Acute Myeloid Leukemia, M1",1
16121,Malignant Cellular Infiltrate,Stage IC Fallopian Tube Cancer AJCC v8,1
16122,Multifocal Lesion,Lipoblastomatosis,1
16123,Bone Marrow Dysplasia Present,Refractory cytopenia with unilineage dysplasia,1
16124,Cutaneous Involvement,"Carcinoma, Basosquamous",1
16125,Myxoid Stroma Formation,Vulvar Superficial Angiomyxoma,1
16126,Malignant Cellular Infiltrate,Gallbladder Leiomyosarcoma,1
16127,Epithelial Component Present,Hepatoid adenocarcinoma,1
16128,Malignant Cellular Infiltrate,"Lymphoma, T-Cell, Cutaneous",1
16129,Complex Glandular Pattern,Uterine Corpus Atypical Polypoid Adenomyoma,1
16130,Poorly Differentiated Lesion,Metastatic Kidney Medullary Carcinoma,1
16131,Diffuse Pattern,Adult Glioblastoma,1
16132,Malignant Cellular Infiltrate,Childhood Neuroblastoma,1
16133,Vascular Channel Formation,Senile angioma,1
16134,Malignant Cellular Infiltrate,Childhood Central Nervous System Embryonal Carcinoma,1
16135,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
16136,Lymphoplasmacytic Infiltrate,"Castleman Disease, Hyaline-Vascular Type",1
16137,Metastatic Lesion,Metastatic Neuroendocrine Neoplasm,1
16138,Acanthosis,Buccal Mucosa Verrucous Carcinoma,1
16139,Epithelial Component Present,Pancreatic Cancer by AJCC v8 Stage,1
16140,Epithelial Component Present,Adenoid cystic carcinoma of salivary gland,1
16141,Cystic Change,Borderline Ovarian Serous Cystadenofibroma,1
16142,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
16143,Aggressive Clinical Course,"Thymoma, type A, malignant",1
16144,Refractory Disease,Refractory Malignant Bone Neoplasm,1
16145,Cutaneous Involvement,Indeterminate dendritic cell tumor,1
16146,Well Differentiated Neuroendocrine Lesion,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
16147,Metastatic Lesion,Locally Advanced Lung Carcinoma,1
16148,Adulthood Lesion,Adult Burkitt Lymphoma,1
16149,Encapsulated Mass,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
16150,Cellular Stratification,Borderline Ovarian Mucinous Adenofibroma,1
16151,Adulthood Lesion,Lugano Classification Limited Stage Adult Lymphoma AJCC v8,1
16152,Clinical TNM Finding,Clinical Stage IVA Gastric Cancer AJCC v8,1
16153,Malignant Cellular Infiltrate,signet ring cell carcinoma of breast,1
16154,Mild cytologic atypia,Plantar Verrucous Skin Carcinoma,1
16155,Primary Lesion,Bone Surface (Peripheral) Osteosarcoma,1
16156,High Grade Lesion,Epithelioid Sarcoma NCI Grade 3,1
16157,Locally Aggressive Lesion,Recurrent Desmoid-Type Fibromatosis,1
16158,Carcinomatous Component Present,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
16159,Malignant Cellular Infiltrate,Stage I Soft Tissue Sarcoma AJCC v7,1
16160,Epithelial Component Present,Stage II Colorectal Cancer,1
16161,Epithelial Component Present,Laryngeal squamous cell carcinoma recurrent,1
16162,Epithelial Component Present,"Lung Large Cell Carcinoma, Clear Cell Variant",1
16163,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage II,1
16164,Benign Cellular Infiltrate,Hemangioma of gingiva,1
16165,Malignant Cellular Infiltrate,Metastatic Colon Carcinoma,1
16166,Malignant Cellular Infiltrate,Sellar Dedifferentiated Chordoma,1
16167,Benign Cellular Infiltrate,Adenoma of the nipple,1
16168,Malignant Germinomatous Cellular Infiltrate,Seminoma,1
16169,Recurrent disease,Recurrent Head and Neck Carcinoma,1
16170,Carcinomatous Component Present,Endometrial Large Cell Neuroendocrine Carcinoma,1
16171,Malignant Cellular Infiltrate,Childhood Acute Monoblastic Leukemia,1
16172,Intraluminal Tumor Growth,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,1
16173,Malignant Cellular Infiltrate,Transitional cell cancer of the renal pelvis and ureter localized,1
16174,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
16175,Non-Invasive Lesion,Ureter Urothelial Papilloma,1
16176,Adulthood Lesion,Glioblastoma multiforme of spinal cord,1
16177,Malignant Cellular Infiltrate,Gastric lymphoma,1
16178,Severe cytologic atypia,Digestive System Neuroendocrine Carcinoma,1
16179,Regional Disease,Regional Adrenal Gland Pheochromocytoma,1
16180,Bone Marrow Dysplasia Present,Refractory anemia with excess blasts II,1
16181,Malignant Cellular Infiltrate,Refractory Malignant Bone Neoplasm,1
16182,Carcinomatous Component Present,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
16183,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma,1
16184,Primary Lesion,Recurrent Childhood Anaplastic Oligodendroglioma,1
16185,Malignant Cellular Infiltrate,Early gastric cancer,1
16186,Malignant Cellular Infiltrate,Locally Advanced Malignant Neoplasm,1
16187,Nodular Pattern,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
16188,Slow Growing Painless Mass,Lipofibromatosis,1
16189,Malignant Cellular Infiltrate,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
16190,Non-Invasive Lesion,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
16191,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
16192,Localized Hydropic Villous Change,"Hydatidiform Mole, Partial",1
16193,Malignant Cellular Infiltrate,Melanoma recurrent,1
16194,Benign Cellular Infiltrate,Benign neoplasm of ureter,1
16195,Epithelial Component Present,Juvenile granulosa cell tumor,1
16196,Epithelial Component Present,Stage IV Urethral Cancer AJCC v8,1
16197,Diffuse Pattern,T-cell/histiocyte rich large B-cell lymphoma,1
16198,Exophytic Polypoid Lesion,Duodenal Adenoma,1
16199,Necrotic changes (finding),Multifocal Glioblastomas,1
16200,Cutaneous Involvement,Metastatic Dermatofibrosarcoma Protuberans,1
16201,Carcinomatous Component Present,Bladder transitional cell carcinoma stage II,1
16202,atypia morphology,Bowenoid papulosis of penis,1
16203,Malignant Cellular Infiltrate,Stage IA Distal Bile Duct Cancer AJCC v7,1
16204,Keratin pearl formation,Clear cell squamous cell carcinoma of skin,1
16205,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7,1
16206,Epithelial Component Present,Follicular thyroid carcinoma,1
16207,Malignant Cellular Infiltrate,Stage I Oral Cavity Cancer AJCC v6 and v7,1
16208,Epithelial Component Present,Borderline Resectable Pancreatic Adenocarcinoma,1
16209,Indolent Clinical Course,Endobronchial Leiomyoma,1
16210,Malignant Cellular Infiltrate,Lower Gingival Squamous Cell Carcinoma,1
16211,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v8,1
16212,Adulthood Lesion,Refractory Adult Spinal Cord Neoplasm,1
16213,Epithelial Component Present,Borderline Ovarian Transitional Cell Tumor,1
16214,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to nasopharynx,1
16215,Epithelial Component Present,Stage IV Thymus Epithelial Neoplasm AJCC v8,1
16216,Malignant Cellular Infiltrate,Sarcomatoid Carcinoma of the Penis,1
16217,Cutaneous Involvement,Epidermolytic acanthoma,1
16218,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor,1
16219,Severe dysplasia,Bowenoid papulosis of penis,1
16220,Childhood Lesion,Childhood Cerebral Astrocytoma,1
16221,Epithelial Component Present,Stage II Jejunal Neuroendocrine Tumor AJCC v8,1
16222,Well-Circumscribed Lesion,Ovarian Seromucinous Cystadenoma,1
16223,Malignant Cellular Infiltrate,Recurrent Malignant Male Reproductive System Neoplasm,1
16224,Epithelial Component Present,Bladder cancer stage IV,1
16225,Severe cytologic atypia,Proximal-Type Epithelioid Sarcoma,1
16226,High Mitotic Activity,Malignant Testicular Leydig Cell Tumor,1
16227,Borderline Lesion,Type E Lymphomatoid Papulosis,1
16228,Indolent Clinical Course,Adenomatoid tumor of epididymis,1
16229,Biphasic Pattern,Cervical Atypical Polypoid Adenomyoma,1
16230,Chromogranin A Positive Neoplastic Cells Present,Foregut Carcinoid Tumor,1
16231,Thin Bands of Collagen Present,Pericardial Solitary Fibrous Tumor,1
16232,Indolent Clinical Course,Pelvic lipomatosis,1
16233,Neuroectodermal Differentiation,Refractory Neuroblastoma,1
16234,Cartilaginous Differentiation,Chondrosarcoma,1
16235,Malignant Cellular Infiltrate,Pleural Malignant Mesothelioma by AJCC v7 Stage,1
16236,atypia morphology,Malignant Ovarian Luteinized Thecoma,1
16237,High Grade Lesion,Pleomorphic Rhabdomyosarcoma,1
16238,Anastomosing Cells Connected to the Basal Layer of the Epidermis Present,Superficial Epithelioma with Sebaceous Differentiation,1
16239,Epithelial Component Present,Glomus vagale tumor,1
16240,Carcinomatous Component Present,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
16241,Epithelial Component Present,Infiltrating papillary adenocarcinoma,1
16242,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage III,1
16243,Geographic Necrosis,Testicular Mixed Embryonal Carcinoma and Teratoma,1
16244,Intraosseous Lesion,Granular cell ameloblastoma,1
16245,Malignant Cellular Infiltrate,Vaginal Neuroendocrine Carcinoma,1
16246,Epithelial Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
16247,Malignant Cellular Infiltrate,Stage IVB Laryngeal Cancer AJCC v8,1
16248,Indolent Clinical Course,Benign neoplasm of tongue,1
16249,Epithelial Component Present,Recurrent Urethral Cancer,1
16250,Architectural Distortion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
16251,Anaplasia,Childhood Brain Anaplastic Astrocytoma,1
16252,Borderline Lesion,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
16253,Adulthood Lesion,Adult Yolk Sac Tumor,1
16254,High Grade Lesion,Childhood Spindle Cell Rhabdomyosarcoma,1
16255,Lipomatous Component Present,Thymolipoma,1
16256,High Grade Lesion,Adult Synovial Sarcoma,1
16257,Encapsulated Mass,Encapsulated Variant Thyroid Gland Papillary Carcinoma,1
16258,Carcinomatous Component Present,Stage IIB Prostate Cancer AJCC v7,1
16259,Epithelial Component Present,Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
16260,Secondary Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
16261,Epithelial Component Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
16262,Malignant Cellular Infiltrate,Vulvar Alveolar Rhabdomyosarcoma,1
16263,Epithelial Component Present,Bladder Mixed Adenocarcinoma,1
16264,Neuroendocrine Differentiation,Malignant Pancreatic Insulinoma,1
16265,Malignant Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant",1
16266,Malignant Cellular Infiltrate,Malignant Pineal Region Germ Cell Tumor,1
16267,Mild dysplasia,Appendix Low Grade Intraepithelial Neoplasia,1
16268,Recurrent disease,Urothelial carcinoma urethra recurrent,1
16269,Cribriform Pattern,Salivary duct carcinoma,1
16270,Poorly Differentiated Lesion,Large cell lung cancer stage I,1
16271,Malignant Cellular Infiltrate,Stage I Fallopian Tube Cancer,1
16272,Neuroendocrine Differentiation,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
16273,Carcinomatous Component Present,Childhood Paranasal Sinus Carcinoma,1
16274,Peripheral Nuclear Palisading,Thymic Basaloid Carcinoma,1
16275,Malignant Germinomatous Cellular Infiltrate,Stage IV Ovarian Dysgerminoma AJCC v6 and v7,1
16276,Childhood Lesion,Childhood Ganglioneuroblastoma,1
16277,Encapsulated Mass,Thyroid Gland Mucinous Follicular Adenoma,1
16278,Malignant Cellular Infiltrate,Prognostic Stage IIA Breast Cancer AJCC v8,1
16279,Malignant Cellular Infiltrate,"Carcinoma, Endometrioid",1
16280,Epithelial Component Present,Squamous Cell Carcinoma of Anal Margin,1
16281,Adulthood Lesion,Stage IA Adult Soft Tissue Sarcoma AJCC v7,1
16282,Epithelial Component Present,Intraductal Non-Comedo Breast Adenocarcinoma,1
16283,Benign Cellular Infiltrate,Adenoma of lung,1
16284,Immunologic Deficiency Syndromes,Transplant-Related Bladder Urothelial Carcinoma,1
16285,Carcinomatous Component Present,Hepatoma resectable,1
16286,Malignant Cellular Infiltrate,Myxosarcoma,1
16287,Multinodular Mass,Angiosarcoma non-metastatic,1
16288,Cervical lymphadenopathy,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
16289,Monoclonal Langerhans Cells Present,"Histiocytosis, Langerhans-Cell",1
16290,Carcinomatous Component Present,Squamous cell carcinoma of palate,1
16291,Slow Growing Mass,Cellular Ependymoma,1
16292,Positive Axillary Lymph Node,Occult Breast Carcinoma,1
16293,Malignant Cellular Infiltrate,Stage IV Hilar Cholangiocarcinoma AJCC v8,1
16294,Tubular Structures Present,Ovarian Sertoli Cell Tumor with Lipid Storage,1
16295,Carcinomatous Component Present,Refractory Digestive System Carcinoma,1
16296,Refractory Disease,Refractory Histiocytic and Dendritic Cell Neoplasm,1
16297,Malignant Cellular Infiltrate,Recurrent Rhabdoid Tumor,1
16298,Recurrent disease,Recurrent Gestational Trophoblastic Tumor,1
16299,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of appendix,1
16300,Epithelial Component Present,Cholangiolocellular Carcinoma,1
16301,Unresectable Mass,Locally Advanced Unresectable Renal Cell Carcinoma,1
16302,Carcinomatous Component Present,Gallbladder Carcinoma,1
16303,Carcinomatous Component Present,Human Papillomavirus-Related Squamous Cell Carcinoma,1
16304,Malignant Cellular Infiltrate,Ann Arbor Stage II Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
16305,Low Mitotic Activity,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
16306,Adulthood Lesion,Stage III Adult Soft Tissue Sarcoma AJCC v7,1
16307,Beaded Anastomosing Cords Present,canalicular adenoma of salivary gland,1
16308,Epithelial Component Present,High Grade Salivary Gland Carcinoma,1
16309,Anaplasia,Recurrent Giant Cell Glioblastoma,1
16310,Tubular Pattern,Colonic tubulovillous adenoma,1
16311,Carcinomatous Component Present,Stage II Hilar Cholangiocarcinoma AJCC v7,1
16312,Benign Cellular Infiltrate,Cervical Atypical Polypoid Adenomyoma,1
16313,Malignant Cellular Infiltrate,Hodgkin Lymphoma During Pregnancy,1
16314,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
16315,Melanin Pigment Present,Melanocytic nevus of skin,1
16316,Anaplasia,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
16317,Malignant Cellular Infiltrate,Unresectable Osteosarcoma,1
16318,Carcinomatous Component Present,Advanced Carcinoma,1
16319,Nuclear Atypia,Childhood Anaplastic Oligoastrocytoma,1
16320,Indolent Clinical Course,Oral Cavity Pleomorphic Adenoma,1
16321,Follicular Structures Present,Thyroid Gland Hyperfunctioning Adenoma,1
16322,Indolent Clinical Course,Benign Connective and Soft Tissue Neoplasm,1
16323,Malignant Cellular Infiltrate,Neck Carcinoma,1
16324,Carcinomatous Component Present,Renal Cell Cancer by AJCC v8 Stage,1
16325,Tissue Differentiation Uncertain,Atypical fibroxanthoma of skin,1
16326,Necrotic changes (finding),Vaginal Large Cell Neuroendocrine Carcinoma,1
16327,Unresectable Mass,Metastatic Unresectable Basal Cell Carcinoma,1
16328,Epithelial Component Present,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
16329,Mixed Cellular Population,Mixed germ cell-sex cord-stromal tumor,1
16330,Carcinomatous Component Present,Stage IIIC Ovarian Cancer AJCC v8,1
16331,Single Cell Necrosis,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
16332,Papillary Pattern,Fallopian Tube Papillary Adenocarcinoma,1
16333,Primary Lesion,Recurrent Adult Hepatocellular Carcinoma,1
16334,Epithelial Component Present,Type I Endometrial Adenocarcinoma,1
16335,Carcinomatous Component Present,Combined Lung Large Cell Neuroendocrine Carcinoma,1
16336,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
16337,Cord-Like Pattern,Adenoid basal carcinoma of cervix uteri,1
16338,Annular Tubules Present,Ovarian Sex Cord Tumor with Annular Tubules,1
16339,BRAF V600E Mutation Present,Progressive Hairy Cell Leukemia Initial Treatment,1
16340,Benign Cellular Infiltrate,Epididymal Papillary Cystadenoma,1
16341,Benign Cellular Infiltrate,Benign neoplasm of great vessels,1
16342,Collagenous Stroma Formation,Vulvar Superficial Myofibroblastoma,1
16343,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
16344,Epithelial Component Present,Pituitary carcinoma,1
16345,Malignant Cellular Infiltrate,Stage 0is Bladder Cancer AJCC v8,1
16346,Dysplasia,Tubular adenoma of colon,1
16347,Benign Cellular Infiltrate,Cortisol-Producing Adrenal Cortex Adenoma,1
16348,Nodular Pattern,Grade 3 Cutaneous Follicular Lymphoma,1
16349,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",1
16350,Thyroglobulin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
16351,Immunologic Deficiency Syndromes,Hyperacute allograft rejection,1
16352,Epithelial Component Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
16353,Secondary Lesion,Advanced Carcinoid Tumor,1
16354,Calcitonin serum level increased,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
16355,Birbeck Granules Present,Eosinophilic Granuloma,1
16356,Intracellular Accumulation of Lipids,Childhood Pleomorphic Xanthoastrocytoma,1
16357,Dysplasia,Lobular carcinoma in situ of breast,1
16358,Immunosuppression-Related Post-Transplant Toxicity,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
16359,Epithelial Component Present,Rectal Cancer by AJCC v6 Stage,1
16360,Metastatic Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,1
16361,Carcinomatous Component Present,Clinical Stage IVA Gastric Cancer AJCC v8,1
16362,Argentaffin Positive Neoplastic Cells Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
16363,Neuroendocrine Differentiation,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
16364,Epithelial Component Present,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
16365,Neuroendocrine Differentiation,Combined Lung Small Cell and Squamous Cell Carcinoma,1
16366,Thin-Walled Branching Vascular Pattern,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
16367,Myxoid Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
16368,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
16369,Malignant Cellular Infiltrate,"Myelodysplastic syndrome, no ICD-O subtype",1
16370,Transformed Phase of Disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
16371,Carcinomatous Component Present,Stage III Lung Cancer AJCC v6,1
16372,Malignant Cellular Infiltrate,Carcinoma in a polyp,1
16373,Hyperplastic Tissue Present,Usual ductal hyperplasia of breast,1
16374,Adulthood Lesion,Adult Acute Erythroid Leukemia,1
16375,Neuroendocrine Differentiation,Stage I Merkel Cell Carcinoma AJCC v7,1
16376,CD56-Positive Neoplastic Cells Present,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
16377,Metastatic Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
16378,Malignant Cellular Infiltrate,Gallbladder Rhabdomyosarcoma,1
16379,Epithelial Component Present,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
16380,Immunosuppression-Related Post-Transplant Toxicity,Acute humoral allograft nephropathy,1
16381,Epithelial Component Present,Ductal Breast Carcinoma,1
16382,Malignant Cellular Infiltrate,Secondary malignant neoplasm of small intestine,1
16383,Tissue Differentiation Uncertain,Clear-Cell Myomelanocytic Tumors,1
16384,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Adult Erythroleukemia,1
16385,Epithelial Component Present,Vaginal Mullerian Papilloma,1
16386,Necrotic changes (finding),Proneural Glioblastoma,1
16387,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
16388,S-100-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
16389,Malignant Cellular Infiltrate,Carcinoma of the Floor of the Mouth,1
16390,Carcinomatous Component Present,Squamous cell carcinoma of penis,1
16391,Adulthood Lesion,Stage II Adult Burkitt Lymphoma,1
16392,Carcinomatous Component Present,Squamous cell carcinoma of floor of mouth,1
16393,Refractory Disease,Extranodal marginal zone B-cell lymphoma (MALT type) refractory,1
16394,Secondary Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
16395,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Soft Tissue Amyloid Neoplasm,1
16396,Malignant Cellular Infiltrate,Intrahepatic Cholangiocarcinoma,1
16397,Carcinomatous Component Present,malignant neoplasm of large intestine stage IV,1
16398,Indolent Clinical Course,Cardiac hemangioma,1
16399,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,High Risk Myelodysplastic Syndrome,1
16400,Low Grade Lesion,Classical Low Grade Fibromyxoid Sarcoma,1
16401,Carcinomatous Component Present,Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
16402,Metastatic Lesion,Metastatic Ureter Carcinoma,1
16403,Absence of Malignant Features,Benign tumor of choroid plexus,1
16404,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
16405,Indolent Clinical Course,Lipoma of skin,1
16406,Malignant Cellular Infiltrate,Serous Tubal Intraepithelial Carcinoma,1
16407,Absence of Invasion,Stage 0 Gastric Cancer AJCC v6 and v7,1
16408,Multifocal Lesion,Multiple polyps,1
16409,Well-Circumscribed Lesion,Focal nodular hyperplasia of liver,1
16410,Collagen Bundles Formation,Lymphangioendothelioma,1
16411,Breast Microcalcification,Oligodendroglioma of spinal cord,1
16412,Malignant Cellular Infiltrate,Malignant Sebaceous Neoplasm,1
16413,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma metastatic,1
16414,Malignant Cellular Infiltrate,adenosquamous carcinoma of esophagus,1
16415,Unresectable Mass,Locally Advanced Unresectable Soft Tissue Sarcoma,1
16416,Benign Cellular Infiltrate,Lung Myolipoma,1
16417,Malignant Cellular Infiltrate,Cardiac Kaposi's Sarcoma,1
16418,Malignant Cellular Infiltrate,Colorectal Angiosarcoma,1
16419,Adulthood Lesion,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8,1
16420,Malignant Cellular Infiltrate,Stage IIIA Ovarian Cancer AJCC v8,1
16421,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v7,1
16422,Radial Growth Phase,Stage III Superficial Spreading Melanoma AJCC v7,1
16423,Cutaneous Involvement,Cutaneous Precursor Lymphoid Neoplasm,1
16424,Epithelial Component Present,Lung adenocarcinoma recurrent,1
16425,Locally Aggressive Lesion,Intermediate Fibrohistiocytic Neoplasm,1
16426,Recurrent disease,Recurrent Childhood Pleomorphic Xanthoastrocytoma,1
16427,Vascular Channel Formation,Cardiac hemangioma,1
16428,Invasive Lesion,Metastatic Dermatofibrosarcoma Protuberans,1
16429,Low Mitotic Activity,"Gastrinoma, malignant",1
16430,Refractory Disease,Refractory Malignant Skin Neoplasm,1
16431,Malignant Cellular Infiltrate,Locally Recurrent Malignant Neoplasm,1
16432,Solid Growth Pattern,Breast Columnar Cell Mucinous Carcinoma,1
16433,Anaplasia,Supratentorial Glioblastoma,1
16434,atypia morphology,Borderline Fallopian Tube Neoplasm,1
16435,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
16436,EBV-Positive Neoplastic Cells Present,Primary EBV-Positive Nodal T-Cell or NK-Cell Lymphoma,1
16437,Epithelial Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
16438,Well-Circumscribed Lesion,Cellular Myxoma,1
16439,Diffuse Pattern,"Malignant lymphoma centroblastic, diffuse",1
16440,Indolent Clinical Course,chondroma of lung,1
16441,Malignant Cellular Infiltrate,Childhood Lymphoma by AJCC v8 Stage,1
16442,Malignant Cellular Infiltrate,Proneural Glioblastoma,1
16443,Neuroendocrine Differentiation,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
16444,Neuroendocrine Differentiation,Stage I Duodenal Neuroendocrine Tumor AJCC v8,1
16445,Absence of Invasion,Carcinoma in situ of skin,1
16446,Carcinomatous Component Present,Grade 3 Rectal Adenocarcinoma,1
16447,Hyperplastic Tissue Present,Esophageal Basal Cell Hyperplasia,1
16448,Carcinomatous Component Present,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
16449,Epithelial Component Present,Eccrine Poroma,1
16450,Benign Cellular Infiltrate,Intraductal papilloma of breast,1
16451,Non-Hereditary Lesion,Poorly Cohesive Gastric Carcinoma,1
16452,Epithelial Component Present,Platinum-Resistant Ovarian Carcinoma,1
16453,Benign Cellular Infiltrate,Benign neuroendocrine tumor,1
16454,Secondary Lesion,Advanced Urothelial Carcinoma,1
16455,Malignant Cellular Infiltrate,Stage 0 Vaginal Cancer AJCC v7,1
16456,Cystic Change,"Serous cystadenoma, borderline malignancy",1
16457,Malignant Cellular Infiltrate,basaloid squamous cell carcinoma of vulva,1
16458,Neuroendocrine Differentiation,Esophageal Neuroendocrine Tumor G2,1
16459,Carcinomatous Component Present,"Carcinoma, Lobular",1
16460,Well Differentiated Neuroendocrine Lesion,Gastro-enteropancreatic neuroendocrine tumor,1
16461,Malignant Cellular Infiltrate,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
16462,Pregnancy Complications,"Trophoblastic tumor, epithelioid",1
16463,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
16464,Monoclonal Langerhans Cells Present,Recurrent Langerhans Cell Histiocytosis,1
16465,Malignant Cellular Infiltrate,Stage III Penile Cancer AJCC v6,1
16466,Epithelial Component Present,Unresectable Carcinoid Tumor,1
16467,Recurrent disease,Recurrent Parotid Gland Acinic Cell Carcinoma,1
16468,Follicular Cell Differentiation,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
16469,Biphasic Pattern,mesenchymal chondrosarcoma of bone,1
16470,Malignant Cellular Infiltrate,Grade 2 Cutaneous Follicular Lymphoma,1
16471,Unresectable Mass,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
16472,Primary Lesion,Recurrent Childhood Anaplastic Astrocytoma,1
16473,Malignant Cellular Infiltrate,Recurrent Ovarian Adenocarcinoma,1
16474,Malignant Cellular Infiltrate,Precursor B-cell lymphoblastic leukemia,1
16475,Metastatic/Recurrent Disease,Alveolar soft part sarcoma recurrent,1
16476,Malignant Cellular Infiltrate,Childhood Parathyroid Gland Carcinoma,1
16477,Aggressive Clinical Course,Childhood Burkitt Leukemia,1
16478,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) refractory,1
16479,Epithelial Component Present,Testicular Brenner Tumor,1
16480,Carcinomatous Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
16481,Malignant Cellular Infiltrate,"Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype",1
16482,Hyalinized Stroma Formation,Dedifferentiated Solitary Fibrous Tumor,1
16483,Mild cytologic atypia,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
16484,Hyalinized Stroma Formation,Epithelioid hemangioendothelioma,1
16485,Epithelial Component Present,Stage I Lung Cancer AJCC v8,1
16486,Cutaneous Involvement,Skin tumor of smooth muscle origin,1
16487,Malignant Cellular Infiltrate,Recurrent Endometrial Serous Adenocarcinoma,1
16488,Ineffective hematopoiesis,Myelodysplastic Syndrome with Isolated del(5q),1
16489,Unresectable Mass,Pancreatic carcinoma non-resectable,1
16490,Villous Pattern,Ampulla of Vater Tubulovillous Adenoma,1
16491,Carcinomatous Component Present,Stage IIIB Penile Cancer AJCC v8,1
16492,Malignant Cellular Infiltrate,Pulmonary Artery Choriocarcinoma,1
16493,Mitotic Activity,Recurrent Childhood Pilomyxoid Astrocytoma,1
16494,Juvenile Lesion,Juvenile osteochondrosis of tibial tubercle,1
16495,Wheezing,Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia,1
16496,Exophytic Polypoid Lesion,Adenomatous Polyposis Coli,1
16497,Non-Invasive Lesion,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
16498,Malignant Cellular Infiltrate,Intermediate Cell Type Ciliary Body Melanoma,1
16499,Malignant Cellular Infiltrate,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
16500,Benign Cellular Infiltrate,Benign Cutaneous Vascular Neoplasm,1
16501,Secondary Lesion,Cholangiocarcinoma metastatic,1
16502,atypia morphology,Borderline serous tumor of ovary,1
16503,Malignant Cellular Infiltrate,Sternal Lymphoma,1
16504,IDH Gene Family Mutation Status Unknown,Glioblastoma,1
16505,Carcinomatous Component Present,Stage IIIA Bladder Cancer AJCC v8,1
16506,Therapy-Related Toxicity,Transplant-Related Hepatocellular Carcinoma,1
16507,Malignant Cellular Infiltrate,Stage IV Rectal Carcinoma,1
16508,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage III,1
16509,Epithelial Component Present,Stage IV Vulvar Cancer AJCC v7,1
16510,Carcinomatous Component Present,Ampulla of Vater Cancer by AJCC v7 Stage,1
16511,Primary Lesion,Stage IVA Osteosarcoma AJCC v7,1
16512,Epithelial Component Present,Oropharyngeal lymphepithelioma,1
16513,Monoclonal Cellular Population Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
16514,Borderline Lesion,Borderline Ovarian Transitional Cell Tumor,1
16515,Epithelial Component Present,Recurrent Digestive System Neuroendocrine Carcinoma,1
16516,Follicular Structures Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
16517,High Mitotic Activity,small cell carcinoma of kidney,1
16518,Immunologic Deficiency Syndromes,Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder,1
16519,Malignant Cellular Infiltrate,Splenic B Lymphoblastic Lymphoma,1
16520,Epithelial Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
16521,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myelomonocytic leukemia,1
16522,Carcinomatous Component Present,Stage 0is Urethral Cancer AJCC v7,1
16523,Benign Cellular Infiltrate,Seborrheic keratosis,1
16524,Angiocentric Pattern,Grade III Lymphomatoid Granulomatosis,1
16525,Diffuse Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",1
16526,Blasts Under 20 Percent of Peripheral Blood White Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
16527,Epithelial Component Present,Adenocarcinoma of salivary gland,1
16528,Malignant Cellular Infiltrate,Stage III Uterine Corpus Adenosarcoma AJCC v8,1
16529,Malignant Cellular Infiltrate,Cervical Cancer by AJCC v8 Stage,1
16530,Epithelial Component Present,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type",1
16531,Infiltrative Growth Pattern,Glioblastoma with Primitive Neuronal Component,1
16532,Malignant Cellular Infiltrate,AIDS-Related Anal Non-Hodgkin Lymphoma,1
16533,Malignant Cellular Infiltrate,Grade 1 Rectal Adenocarcinoma,1
16534,Carcinomatous Component Present,Adenosquamous cell lung cancer,1
16535,Neuroendocrine Differentiation,Malignant neoplasm of carotid body,1
16536,Epithelial Component Present,Early Invasive Cervical Squamous Cell Carcinoma,1
16537,Epithelial Component Present,Juvenile type ovarian granulosa cell tumor,1
16538,Malignant Cellular Infiltrate,Stage I Indolent Adult Non-Hodgkin Lymphoma,1
16539,atypia morphology,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
16540,Malignant Cellular Infiltrate,Extrarenal rhabdoid tumor,1
16541,Recurrent Genetic Abnormalities Present,Acute promyelocytic leukemia - hypogranular variant,1
16542,Mixed Cellular Population,Mixed astrocytoma-ependymoma,1
16543,Dysplasia,Appendix Sessile Serrated Adenoma/Polyp,1
16544,Papillary Pattern,Urethral Inverted Papilloma,1
16545,Absence of Invasion,Pathologic Stage 0 Gastric Cancer AJCC v8,1
16546,Micropapillary Pattern,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
16547,Polymorphic Cellular Infiltrate,Eosinophilic Granuloma,1
16548,Cutaneous Involvement,Mycosis fungoides recurrent,1
16549,Increased Cellularity Present,Stage 1 Neuroblastoma,1
16550,Chronic Inflammatory Infiltrate,Recurrent Grade III Lymphomatoid Granulomatosis,1
16551,Carcinomatous Component Present,Adenocarcinoma,1
16552,Lymphoplasmacytic Infiltrate,Smoldering Waldenstrom Macroglobulinemia,1
16553,Fever,Multi-centric Castleman's Disease,1
16554,Malignant Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
16555,Recurrent disease,Recurrent Gastrointestinal Stromal Tumor,1
16556,Dysplasia,Cervical intraepithelial neoplasia grade 1,1
16557,Secondary Lesion,Locally Advanced Carcinoma,1
16558,Carcinomatous Component Present,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
16559,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,1
16560,Malignant Cellular Infiltrate,recurrent childhood acute myeloid leukemia,1
16561,Malignant Cellular Infiltrate,Mantle cell lymphoma stage III,1
16562,Epithelial Component Present,basal cell carcinoma of scrotum,1
16563,Epithelial Component Present,Lung adenocarcinoma recurrent,1
16564,Superficial Lesion,Peyronie Disease,1
16565,Malignant Cellular Infiltrate,Chronic eosinophilic leukemia,1
16566,Childhood Lesion,St. Jude Stage IV Childhood Non-Hodgkin Lymphoma AJCC v8,1
16567,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v8,1
16568,Carcinomatous Component Present,Stage IIIC Colorectal Cancer AJCC v7,1
16569,Epithelial Component Present,Skin carcinoma,1
16570,Malignant Cellular Infiltrate,Type 1 Papillary Renal Cell Carcinoma,1
16571,Dysplasia,Gallbladder Papillary Biliary Intraepithelial Neoplasia,1
16572,Childhood Lesion,Childhood Central Nervous System Neuroblastoma,1
16573,Focal dysplasia,Rectal Sessile Serrated Adenoma/Polyp,1
16574,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Teratoma,1
16575,Low Grade Neuroendocrine Lesion,Regional Digestive System Neuroendocrine Tumor G1,1
16576,Carcinomatous Component Present,Childhood Esophageal Carcinoma,1
16577,Epithelial Component Present,Cervical Endometrioid Adenocarcinoma,1
16578,Metaplasia,Bladder squamous cell carcinoma stage II,1
16579,Carcinomatous Component Present,Stage IIIB Gallbladder Cancer AJCC v7,1
16580,CD30-Positive Neoplastic Cells Present,Childhood Anaplastic Large Cell Lymphoma,1
16581,Malignant Cellular Infiltrate,Infratentorial Glioblastoma,1
16582,Carcinomatous Component Present,Stage IIIB Lung Cancer AJCC v8,1
16583,Absence of Stromal Invasion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
16584,Epithelial Component Present,Well Differentiated Prostate Adenocarcinoma,1
16585,Malignant Cellular Infiltrate,Favorable Hodgkin Lymphoma,1
16586,Childhood Lesion,Stage IV Childhood Non-Hodgkin Lymphoma,1
16587,Hyperkeratosis,"Lung Squamous Cell Carcinoma, Papillary Variant",1
16588,Carcinomatous Component Present,Skin Squamous Cell Carcinoma In Situ,1
16589,Epithelial Component Present,Stage IIA1 Cervical Cancer AJCC v7,1
16590,Malignant Cellular Infiltrate,PRETEXT Stage 2 Hepatoblastoma,1
16591,Carcinomatous Component Present,Stage IV Bladder Cancer AJCC v7,1
16592,Perivascular Arrangement of Tumor Cells,"Glomus tumor, malignant",1
16593,Mesenchymal Component Present,Hard Palate Pleomorphic Adenoma,1
16594,Malignant Cellular Infiltrate,Cervical Clear Cell Adenocarcinoma,1
16595,Malignant Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v7,1
16596,Diffuse Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
16597,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v7,1
16598,Cutaneous Involvement,Pilomatrixoma,1
16599,Indolent Clinical Course,Cavernous lymphangioma,1
16600,Microvascular Proliferation,Adult Pilocytic Astrocytoma,1
16601,Benign Cellular Infiltrate,Fallopian Tube Adenomatoid Tumor,1
16602,Nuclear Pseudoinclusion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
16603,Benign Cellular Infiltrate,Fallopian Tube Serous Adenofibroma,1
16604,Increased megakaryocytes (bone marrow),"Thrombocythemia, Essential",1
16605,Metastatic Lesion,Secondary malignant neoplasm of peritoneum,1
16606,Chromogranin A Positive Neoplastic Cells Present,Ascending Colon Neuroendocrine Tumor G1,1
16607,Epithelial Component Present,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
16608,Malignant Cellular Infiltrate,Radiation-Related Osteosarcoma,1
16609,Malignant Cellular Infiltrate,Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8,1
16610,Recurrent disease,Recurrent Malignant Neoplasm of Salivary Gland,1
16611,Malignant Cellular Infiltrate,Laryngeal Squamous Cell Carcinoma,1
16612,Calcitonin serum level increased,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
16613,Malignant Cellular Infiltrate,Malignant tumor of nasal sinuses,1
16614,Ground Glass Nuclear Inclusion,Papillary Thyroid Microcarcinoma,1
16615,Malignant Cellular Infiltrate,Stage IV Bone Cancer AJCC v8,1
16616,Local disease,Osteosarcoma localised,1
16617,Secondary Lesion,Metastatic Malignant Genitourinary System Neoplasm,1
16618,Malignant Cellular Infiltrate,"Carcinoid, Goblet Cell",1
16619,Epithelial Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
16620,Cutaneous Involvement,Invasive Apocrine Breast Carcinoma,1
16621,Carcinomatous Component Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
16622,Epithelial Component Present,squamous cell carcinoma of salivary gland,1
16623,Epithelial Component Present,Grade 3 Invasive Breast Carcinoma,1
16624,Borderline Lesion,Indolent T-cell lymphoproliferative disorder of gastrointestinal tract,1
16625,Benign Cellular Infiltrate,Central Nervous System Hemangioma,1
16626,Osteoid formation,Extraskeletal Osteosarcoma,1
16627,Malignant Cellular Infiltrate,Stage 0 Hilar Cholangiocarcinoma AJCC v7,1
16628,Carcinomatous Component Present,Stage IIIB Anal Canal Cancer AJCC v6 and v7,1
16629,Epithelial Component Present,Gallbladder Cribriform Carcinoma,1
16630,Malignant Cellular Infiltrate,Cecum Lymphoma,1
16631,Hyalinized Stroma Formation,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
16632,Carcinomatous Component Present,Ovarian Dermoid Cyst with Adenocarcinoma,1
16633,Fibrovascular Stroma Formation,Pterygium Of Conjunctiva And Cornea,1
16634,Malignant Cellular Infiltrate,Recurrent Appendix Mucinous Adenocarcinoma,1
16635,Carcinomatous Component Present,Stage IIC Merkel Cell Carcinoma AJCC v7,1
16636,CD1a-Positive Neoplastic Cells Present,"Langerhans Cell Histiocytosis, Polystotic",1
16637,Malignant Cellular Infiltrate,Thymic Adenosquamous Carcinoma,1
16638,Epithelial Component Present,Extrapulmonary Small Cell Carcinoma,1
16639,Malignant Cellular Infiltrate,FIGO Stage IIIB Ovarian Cancer,1
16640,Epithelial Component Present,Lung Carcinoma Metastatic in the Brain,1
16641,Cutaneous Involvement,Metastatic Dermatofibrosarcoma Protuberans,1
16642,Carcinomatous Component Present,Colorectal Large Cell Neuroendocrine Carcinoma,1
16643,Indolent Clinical Course,Colon Lipoma,1
16644,Well-Circumscribed Lesion,Soft tissue chondroma,1
16645,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v7,1
16646,Neuronal Differentiation,Neural Glioblastoma,1
16647,Epithelial Component Present,Perineal Ectopic Fibroadenoma,1
16648,Epithelial Component Present,Stage I Anal Canal Cancer AJCC v6 and v7,1
16649,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
16650,Epithelial Component Present,cloacogenic carcinoma of rectum,1
16651,Benign Cellular Infiltrate,Benign neoplasm of cecum,1
16652,Malignant Cellular Infiltrate,Stage IV Superficial Spreading Melanoma AJCC v6 and v7,1
16653,Well-Circumscribed Lesion,Childhood Kidney Wilms Tumor,1
16654,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Breast Carcinoma with Choriocarcinomatous Features,1
16655,Carcinomatous Component Present,FIGO Stage IC2 Ovarian Cancer,1
16656,Epithelial Component Present,Metastatic Carcinoma in the Liver,1
16657,Cutaneous Involvement,"Dermatitis, Allergic Contact",1
16658,Deep Lesion,Tendon Sheath Lipoma,1
16659,Epithelial Component Present,Stage IB Vulvar Carcinoma AJCC v6,1
16660,Epithelial Component Present,Vulvar Squamous Neoplasm,1
16661,Indolent Clinical Course,Pericardial Leiomyoma,1
16662,Malignant Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
16663,Epithelial Component Present,Endometrial Adenosquamous Carcinoma,1
16664,Cutaneous Involvement,Merkel cell carcinoma,1
16665,Benign Cellular Infiltrate,Benign neoplasm of brain stem,1
16666,Deep Lesion,Pelvic Fibromatosis,1
16667,Hyperkeratosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
16668,Malignant Cellular Infiltrate,Stage IV Osteosarcoma AJCC v7,1
16669,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
16670,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type C",1
16671,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
16672,Somatostatin Positive Neoplastic Cells Present,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
16673,Malignant Cellular Infiltrate,Stage IA Esophageal Cancer AJCC v7,1
16674,Malignant Cellular Infiltrate,Unresectable Gastric Adenocarcinoma,1
16675,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma,1
16676,Immunologic Deficiency Syndromes,Transplant-Related Renal Cell Carcinoma,1
16677,Metastatic Lesion,Skin squamous cell carcinoma metastatic,1
16678,Secondary Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,1
16679,Lesion with Diameter Greater than 10mm,Functioning Pituitary Gland Macroadenoma,1
16680,Carcinomatous Component Present,Stage 0is Renal Pelvis Cancer AJCC v7,1
16681,High Mitotic Activity,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
16682,Unresectable Mass,Small intestine carcinoma non-resectable,1
16683,Malignant Cellular Infiltrate,Stage I Prostate Cancer AJCC v8,1
16684,Carcinomatous Component Present,large cell neuroendocrine carcinoma of lung,1
16685,Malignant Cellular Infiltrate,Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
16686,Malignant Cellular Infiltrate,Occult Lung Squamous Cell Carcinoma,1
16687,Monoclonal Gammapathies,Familial Waldenstrom's Macroglobulinaemia,1
16688,Malignant Cellular Infiltrate,Pagetoid reticulosis,1
16689,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory cytopenia with multilineage dysplasia,1
16690,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Tumor G2,1
16691,Papillary Pattern,Respiratory papilloma,1
16692,Anastomosing Strands of Tumor Cells Present,Syringofibroadenoma,1
16693,Cutaneous Involvement,Sarcoma of skin,1
16694,Chronic lymphocytic inflammation,Lymphoepithelioma-Like Hepatocellular Carcinoma,1
16695,Epithelial Component Present,"Squamous Cell Carcinoma of the Penis, Usual Type",1
16696,Infiltrative Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma,1
16697,Extramedullary Hematopoiesis (disorder),Post polycythaemia vera myelofibrosis,1
16698,Metastatic Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
16699,Secondary Lesion,Locally Advanced Salivary Gland Carcinoma,1
16700,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation,1
16701,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage IV,1
16702,Recurrent disease,Peritoneal mesothelioma malignant recurrent,1
16703,Epithelial Component Present,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
16704,Malignant Cellular Infiltrate,Metastatic osteosarcoma,1
16705,Malignant Cellular Infiltrate,Stage IIB Rectal Cancer AJCC v7,1
16706,Benign Cellular Infiltrate,Exophytic Schneiderian Papilloma,1
16707,Encapsulated Mass,Macrofollicular adenoma,1
16708,Precise Histogenesis Unknown,Medullary Hemangioblastoma,1
16709,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides AJCC v7,1
16710,Epithelial Component Present,Prostate Basal Cell Carcinoma,1
16711,Syncytial Pattern,atypical medullary carcinoma of breast,1
16712,Follicular Differentiation,Pilomatrixoma,1
16713,Hormone Receptor Positive,Refractory Hormone Receptor Positive Breast Carcinoma,1
16714,Hemorrhagic,Angiosarcoma non-metastatic,1
16715,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Acute Myeloid Leukemia (AML-M2),1
16716,Malignant Cellular Infiltrate,Childhood Myelodysplastic Syndrome,1
16717,Severe dysplasia,Lung Squamous Cell Carcinoma In Situ,1
16718,Well-Circumscribed Lesion,Polyp of vagina,1
16719,Malignant Cellular Infiltrate,Large cell lung cancer recurrent,1
16720,Carcinomatous Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
16721,Malignant Cellular Infiltrate,Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8,1
16722,Epithelial Component Present,Stage III Merkel Cell Carcinoma AJCC v7,1
16723,Malignant Cellular Infiltrate,Liver Extraskeletal Osteosarcoma,1
16724,Cutaneous Involvement,Warty dyskeratoma,1
16725,Chromogranin A Positive Neoplastic Cells Present,Thymic Atypical Carcinoid Tumor,1
16726,Carcinomatous Component Present,Central Nervous System Carcinoma,1
16727,Carcinomatous Component Present,Adenocarcinoma of lung (disorder),1
16728,Carcinomatous Component Present,Serous cystadenocarcinoma of pancreas,1
16729,Solitary mass,Recurrent Chordoma,1
16730,Cytoplasmic Eosinophilic Globules Present,Undifferentiated (Embryonal) Sarcoma,1
16731,Malignant Cellular Infiltrate,Malignant neoplasm of middle ear,1
16732,Malignant Cellular Infiltrate,Seminoma,1
16733,Malignant Cellular Infiltrate,Stage IV Adult Soft Tissue Sarcoma AJCC v7,1
16734,Epithelial Component Present,Adamantinous Craniopharyngioma,1
16735,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders,1
16736,Epithelial Component Present,Recurrent respiratory papillomatosis,1
16737,Systemic disease,Smoldering Systemic Mastocytosis,1
16738,Childhood Lesion,Metastatic Childhood Soft Tissue Sarcoma,1
16739,Epithelial Component Present,"Adenocarcinoma, endocervical type",1
16740,Nuclear Pseudoinclusion,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
16741,Carcinomatous Component Present,Advanced Neuroendocrine Carcinoma,1
16742,Malignant Cellular Infiltrate,Leiomyosarcoma of stomach,1
16743,Encapsulated Mass,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
16744,Metastatic Lesion,Secondary malignant neoplasm of thymus,1
16745,Tubular Pattern,Appendix Tubulovillous Adenoma,1
16746,Carcinomatous Component Present,Stage IC Fallopian Tube Cancer AJCC v6 and v7,1
16747,Epithelial Component Present,Chromophobe Renal Cell Carcinoma,1
16748,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G1,1
16749,atypia morphology,Borderline Fallopian Tube Mucinous Tumor,1
16750,Malignant Cellular Infiltrate,Stage IB Uterine Corpus Adenosarcoma AJCC v8,1
16751,Hemorrhagic,Angiosarcoma of the breast,1
16752,Malignant Cellular Infiltrate,Stage III Ovarian Cancer AJCC v8,1
16753,Carcinomatous Component Present,Stage IIIB Adult Liver Cancer AJCC v7,1
16754,Metastatic Lesion,Advanced Prostate Carcinoma,1
16755,Poorly Differentiated Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma,1
16756,Pagetoid Proliferation,Stage III Superficial Spreading Melanoma AJCC v7,1
16757,Malignant Cellular Infiltrate,Peritoneal mesothelioma malignant recurrent,1
16758,Epithelial Component Present,Malignant Sertoli Cell Tumor,1
16759,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1,1
16760,Absence of Stromal Invasion,Borderline Fallopian Tube Neoplasm,1
16761,Epithelial Component Present,Early-Stage Breast Carcinoma,1
16762,Epithelial Component Present,Masaoka-Koga Stage IVa,1
16763,Dysplasia,Anogenital papillomaviral intraepithelial neoplasia,1
16764,Myxoid Stroma Formation,Adult Epithelioid Hemangioendothelioma,1
16765,Secondary Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
16766,Epithelial Component Present,Well Differentiated Pancreatic Endocrine Tumor,1
16767,Malignant Cellular Infiltrate,Parotid Gland Kaposi Sarcoma,1
16768,Hyperplastic Tissue Present,Atypical adenomatous hyperplasia,1
16769,Epithelial Component Present,Stage IB Lung Adenocarcinoma AJCC v7,1
16770,Neuroendocrine Differentiation,Gastric Gastrin-Producing Neuroendocrine Tumor,1
16771,Epithelial Component Present,Vagina Carcinoma,1
16772,Absence of Stromal Invasion,Borderline Fallopian Tube Mucinous Tumor,1
16773,Carcinomatous Component Present,Cervical Villoglandular Adenocarcinoma,1
16774,Epithelial Component Present,Small cell carcinoma of lung,1
16775,Drug Exposure,Chemotherapy-Related Leukemia,1
16776,Epithelial Component Present,"Thymoma, type B2, malignant",1
16777,Malignant Cellular Infiltrate,Disseminated Malignant Neoplasm,1
16778,Papillary Pattern,Maxillary Sinus Inverted Papilloma,1
16779,Malignant Cellular Infiltrate,leiomyosarcoma of vagina,1
16780,Indolent Clinical Course,Juvenile Xanthogranuloma,1
16781,Epithelial Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
16782,Epithelial Component Present,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
16783,Malignant Cellular Infiltrate,Recurrent Endometrial Cancer,1
16784,Carcinomatous Component Present,Recurrent Chromophobe Renal Cell Carcinoma,1
16785,Locally Aggressive Lesion,"Gastrointestinal stromal tumor, uncertain malignant potential",1
16786,Indolent Clinical Course,"Chondromatosis, Synovial",1
16787,Epithelial Component Present,Prostate Carcinoma Metastatic in the Bone,1
16788,Malignant Cellular Infiltrate,Verrucous carcinoma of the oral cavity recurrent,1
16789,Mesenchymal Component Present,"Neoplasms, Fibroepithelial",1
16790,Recurrent disease,Recurrent Parotid Gland Adenoid Cystic Carcinoma,1
16791,Absence of a Hormonal Syndrome,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
16792,Malignant Cellular Infiltrate,Stage IIIB Colon Cancer AJCC v7,1
16793,Carcinomatous Component Present,Infiltrating basal cell carcinoma,1
16794,Firm mass,"Perineurioma, malignant",1
16795,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
16796,Recurrent Genetic Abnormalities Present,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",1
16797,Malignant Cellular Infiltrate,"Malignant neoplasm of kidney, except pelvis",1
16798,Well-Circumscribed Lesion,Vaginal Rhabdomyoma,1
16799,Necrotic changes (finding),Giant Cell Glioblastoma,1
16800,Hypocellular Tissue,Cellular Myxoma,1
16801,Childhood Lesion,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
16802,Anaplasia,Frontal Lobe Anaplastic Astrocytoma,1
16803,Benign Cellular Infiltrate,Intramuscular lipoma,1
16804,"Fully Differentiated ""Adult-Type"" Tissues Present",Extragonadal primary malignant teratoma,1
16805,Recurrent disease,Recurrent Desmoid-Type Fibromatosis,1
16806,Epithelial Component Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
16807,Koilocytotic atypia,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
16808,Hereditary Lesion,Familial Acute Myeloid Leukemia with Mutated Cebpa,1
16809,Malignant Cellular Infiltrate,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
16810,Metastatic Lesion,Transitional cell carcinoma metastatic,1
16811,Carcinomatous Component Present,Gastrointestinal carcinoma in situ,1
16812,Papillary Pattern,Noninfiltrating intraductal papillary adenocarcinoma,1
16813,Metastatic Lesion,Undifferentiated Carcinoma of Unknown Primary,1
16814,Epithelial Component Present,Stage IVA Rectal Cancer AJCC v8,1
16815,Malignant Cellular Infiltrate,Acute myelomonocytic leukemia,1
16816,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
16817,Epithelial Component Present,Breast Carcinoma Metastatic in the Liver,1
16818,Epithelial Component Present,Hepatocellular Carcinoma by AJCC v8 Stage,1
16819,Malignant Cellular Infiltrate,Malignant fibrous histiocytoma metastatic,1
16820,Malignant Cellular Infiltrate,adenocarcinoma of oral cavity,1
16821,Neuroendocrine Differentiation,Cervical Large Cell Neuroendocrine Carcinoma,1
16822,Malignant Cellular Infiltrate,Parotid Gland Carcinosarcoma,1
16823,Tissue Differentiation Uncertain,"Phosphaturic mesenchymal tumor, benign",1
16824,Malignant Cellular Infiltrate,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
16825,Adulthood Lesion,Lugano Classification Stage IIE Adult Lymphoma AJCC v8,1
16826,Alternative Fascicle (Bundle) Pattern,Leiomyoma of lung,1
16827,Serotonin Positive Neoplastic Cells Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
16828,Indolent Clinical Course,Infantile hemangioma of liver,1
16829,Carcinomatous Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7,1
16830,Low Mitotic Activity,Pancreatic Vipoma,1
16831,Negative Peripheral Blood,Aleukemic Acute Lymphoblastic Leukemia,1
16832,Aggregates of Poorly Differentiated Neuroepithelial Cells Present,Desmoplastic infantile ganglioglioma,1
16833,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7,1
16834,Low Mitotic Activity,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
16835,Mixed Cellular Population,Oral Cavity Pleomorphic Adenoma,1
16836,Cystic Lesion,Intracerebral Cystic Meningioma,1
16837,Sebaceous Differentiation,Parotid Gland Sebaceous Lymphadenoma,1
16838,Metaplasia,Lung Enteric Adenocarcinoma,1
16839,Moderately Differentiated Lesion,Grade 2 Colorectal Adenocarcinoma,1
16840,Carcinomatous Component Present,"Carcinoma of urinary bladder, superficial",1
16841,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
16842,Malignant Cellular Infiltrate,BN2 Diffuse Large B-Cell Lymphoma,1
16843,Extensive Stage Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
16844,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
16845,Carcinomatous Component Present,Carcinoma,1
16846,Epithelial Component Present,Labia Minora Carcinoma,1
16847,Mesenchymal Component Present,Cellular Pleomorphic Adenoma,1
16848,Primary Lesion,Anaplastic Brain Stem Glioma,1
16849,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
16850,Carcinomatous Component Present,Stage III Cervical Cancer AJCC v6 and v7,1
16851,Epithelial Component Present,Accessory Urethral Gland Carcinoma,1
16852,Malignant Cellular Infiltrate,Pediatric follicular lymphoma,1
16853,Epithelial Component Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
16854,Carcinomatous Component Present,undifferentiated carcinoma of salivary gland,1
16855,Cutaneous Involvement,Lymphomatoid Papulosis,1
16856,Adulthood Lesion,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,1
16857,Radiation Sickness,Radiation-Induced Dermatitis,1
16858,Necrotic changes (finding),"Ovarian Small Cell Carcinoma, Pulmonary Type",1
16859,Malignant Cellular Infiltrate,Throat cancer,1
16860,Malignant Cellular Infiltrate,Adenocarcinoma of rete ovarii,1
16861,Benign Cellular Infiltrate,Sphenoid Sinus Schneiderian Papilloma,1
16862,Myxoid Stroma Formation,Sacral Chordoma,1
16863,Carcinomatous Component Present,Stage III Hypopharyngeal Carcinoma AJCC v6,1
16864,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
16865,Carcinomatous Component Present,Thymic Papillary Adenocarcinoma,1
16866,Epithelial Component Present,Locally Advanced Unresectable Renal Cell Carcinoma,1
16867,Carcinomatous Component Present,Hard Palate Adenoid Cystic Carcinoma,1
16868,More than 5 Mitoses per 50HPF,Stage I Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
16869,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v6,1
16870,Neuroendocrine Differentiation,Small cell carcinoma of the cervix,1
16871,Capillary Sized Vascular Channel Formation,Retinal hemangioblastoma,1
16872,Pathologic TNM Finding,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,1
16873,High Grade Lesion,Alveolar soft part sarcoma non-metastatic,1
16874,Intestinal metaplasia,Vaginal Adenoma,1
16875,Epithelial Component Present,Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
16876,Non Lipogenic Sarcomatous Stroma Present,Refractory Dedifferentiated Liposarcoma,1
16877,Cutaneous Involvement,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
16878,Fibrosis,Breast Blunt Duct Adenosis,1
16879,Childhood Lesion,Neonatal leukemia,1
16880,Juvenile Lesion,Juvenile polyp,1
16881,Carcinomatous Component Present,Locally Advanced Thymic Carcinoma,1
16882,Epithelial Component Present,Vaginal high grade squamous intraepithelial lesion,1
16883,Metastatic Lesion,Adenocarcinoma of the prostate stage IV,1
16884,Increased Cellularity Present,Peripheral neuroblastoma,1
16885,Cutaneous Involvement,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
16886,Locally Aggressive Lesion,Atypical Lipoma,1
16887,Carcinomatous Component Present,Stage III Major Salivary Gland Cancer AJCC v7,1
16888,Well-Circumscribed Lesion,"Phyllodes tumor, benign",1
16889,Breast Microcalcification,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
16890,Carcinomatous Component Present,Carcinoma of upper gum,1
16891,Epithelial Component Present,Malignant Breast Eccrine Spiradenoma,1
16892,Malignant Cellular Infiltrate,Pancoast Tumor,1
16893,Cutaneous Involvement,External Ear Actinic Keratosis,1
16894,Complete Spontaneous Regression,Lymphomatoid Papulosis,1
16895,Malignant Cellular Infiltrate,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
16896,Hereditary Lesion,fanconi anemia complementation group g,1
16897,Epithelial Component Present,Stage III Cervical Cancer AJCC v8,1
16898,Epithelial Component Present,Stage IA Merkel Cell Carcinoma AJCC v7,1
16899,Cystic Change,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
16900,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage,1
16901,Carcinomatous Component Present,Subglottic Verrucous Carcinoma,1
16902,Diffuse Lesion,Nonencapsulated sclerosing tumor,1
16903,Benign Cellular Infiltrate,Capillary hemangioma of retina,1
16904,Epithelial Component Present,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,1
16905,Epithelial Component Present,Stage IIB Ampulla of Vater Cancer AJCC v8,1
16906,Fibrous Septa Present,"Bone Cysts, Aneurysmal",1
16907,Neuroectodermal Differentiation,"Childhood Ganglioneuroblastoma, Nodular",1
16908,High Mitotic Activity,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
16909,Carcinomatous Component Present,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
16910,Low Mitotic Activity,Meckel Diverticulum Neuroendocrine Tumor G1,1
16911,Malignant Cellular Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
16912,Childhood Lesion,Childhood Grade I Meningioma,1
16913,Carcinomatous Component Present,Vulvar Cancer by AJCC v8 Stage,1
16914,Epithelial Component Present,Sex cord stromal tumor of testis,1
16915,Severe cytologic atypia,Primary hepatic neuroendocrine carcinoma,1
16916,Severe dysplasia,High Grade Ductal Breast Carcinoma In Situ,1
16917,Low Mitotic Activity,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
16918,Epithelial Component Present,BCLC Stage B Adult Hepatocellular Carcinoma,1
16919,Refractory Disease,Refractory WHO Grade II Glioma,1
16920,Malignant Cellular Infiltrate,Angiocentric lymphoma recurrent,1
16921,Indolent Clinical Course,Deep Lipoma,1
16922,Papillary Pattern,Maxillary Sinus Schneiderian Papilloma,1
16923,Epithelial Component Present,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,1
16924,Epithelial Component Present,Stage IV Prostate Carcinoma,1
16925,Oligodendroglial Component Present,Childhood Anaplastic Oligoastrocytoma,1
16926,Hyaline Cartilage Differentiation,Dedifferentiated chondrosarcoma,1
16927,Therapy-Related Toxicity,"Neoplasms, Therapy-Associated",1
16928,Chemotherapeutic Agent Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
16929,Vascular Channel Formation,Hemangioma of skin,1
16930,Cystic Change,Mucoepidermoid carcinoma of salivary gland,1
16931,Epithelial Component Present,Stage 0 Penile Cancer AJCC v6,1
16932,Poorly Differentiated Lesion,"Transitional cell carcinoma, spindle cell",1
16933,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
16934,Progressive Disease,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
16935,Cystic Change,"Cystadenoma, Serous",1
16936,Epithelial Component Present,Stage IIB Lung Cancer AJCC v7,1
16937,Malignant Cellular Infiltrate,Ovarian mixed epithelial carcinoma,1
16938,Malignant Cellular Infiltrate,Malignant tumor of exocrine pancreas,1
16939,Dysplasia,Vulval intraepithelial neoplasia,1
16940,Malignant Cellular Infiltrate,Stage III Choroidal and Ciliary Body Melanoma AJCC v8,1
16941,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
16942,Lobulated Growth Pattern,Soft tissue chondroma,1
16943,Childhood Lesion,Stage IV Childhood Anaplastic Large Cell Lymphoma,1
16944,Carcinomatous Component Present,Keratinizing Paranasal Sinus Squamous Cell Carcinoma,1
16945,Secondary Lesion,Secondary malignant neoplasm of hypopharynx,1
16946,Adulthood Lesion,Adult Intracranial Neoplasm,1
16947,Malignant Cellular Infiltrate,"Carcinoid, Goblet Cell",1
16948,Anaplasia,"Carcinoma, Spindle-Cell",1
16949,Malignant Cellular Infiltrate,Carcinosarcoma,1
16950,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q23;q21),1
16951,Malignant Cellular Infiltrate,Luminal A Breast Carcinoma,1
16952,Hyaline Cartilage Differentiation,Childhood Myxoid Chondrosarcoma,1
16953,Malignant Cellular Infiltrate,Adult Extraskeletal Myxoid Chondrosarcoma,1
16954,Epithelial Component Present,Retromolar Trigone Squamous Cell Carcinoma,1
16955,Poorly Differentiated Lesion,Rectal Sarcomatoid Carcinoma,1
16956,Nuclear pleomorphism,Pleomorphic Rhabdomyosarcoma,1
16957,Epithelial Component Present,Ovarian Stromal Tumor with Minor Sex Cord Elements,1
16958,Invasive Lesion,Paget Disease of the Breast with Invasive Ductal Carcinoma,1
16959,atypia morphology,Proliferating Brenner Tumor,1
16960,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
16961,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma During Pregnancy,1
16962,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Carcinoma,1
16963,Epithelial Component Present,Sphenoid Sinus Schneiderian Papilloma,1
16964,Carcinomatous Component Present,Squamous cell carcinoma of the oral cavity stage II,1
16965,Epithelial Component Present,Breast Cancer by AJCC v8 Prognostic Stage,1
16966,Malignant Cellular Infiltrate,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
16967,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
16968,Chronic lymphocytic inflammation,Gastric Inflammatory Myofibroblastic Tumor,1
16969,Epithelial Component Present,Maxillary Sinus Adenocarcinoma,1
16970,Epithelial Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
16971,Malignant Cellular Infiltrate,Stage IV Adult Hodgkin Lymphoma,1
16972,Benign Cellular Infiltrate,Rete Ovarii Cystadenoma,1
16973,Malignant Cellular Infiltrate,Extraskeletal osteosarcoma non-metastatic,1
16974,Malignant Cellular Infiltrate,Primary Myelofibrosis,1
16975,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
16976,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage III,1
16977,Lymphoplasmacytic Infiltrate,Suprasellar Germinoma,1
16978,Epithelial Component Present,Familial Adrenal Gland Pheochromocytoma,1
16979,Primary Lesion,Stage IVB Osteosarcoma AJCC v7,1
16980,Well Differentiated Lesion,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
16981,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
16982,Epithelial Component Present,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
16983,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage I,1
16984,Primary Lesion,Infratentorial Glioblastoma,1
16985,Primary Lesion,"lymphomatoid papulosis, type C",1
16986,Papillary Pattern,Serous surface papillary carcinoma,1
16987,Epithelial Component Present,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
16988,Keratin pearl formation,Lung Basaloid Squamous Cell Carcinoma,1
16989,Mass of body structure,Cardiac Myeloid Sarcoma,1
16990,Epithelial Component Present,Stage IV Colon Cancer AJCC v8,1
16991,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,MYELODYSPLASTIC SYNDROME,1
16992,Mixed Cellular Population,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
16993,Mitotic Activity,Childhood Yolk Sac Tumor,1
16994,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage,1
16995,Epithelial Component Present,Papillary carcinoma in situ,1
16996,Epithelial Component Present,adenocarcinoma of epididymis,1
16997,Well-Circumscribed Lesion,Lung Mucinous Cystadenoma,1
16998,Primary Lesion,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,1
16999,Solitary mass,Chest Wall Solitary Plasmacytoma,1
17000,Epithelial Component Present,Recurrent Rectal Cancer,1
17001,Carcinomatous Component Present,"Adenocarcinoma, endocervical type",1
17002,Adnexal Differentiation,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
17003,Epithelial Component Present,Stage I Appendix Neuroendocrine Tumor AJCC v8,1
17004,Metastatic Lesion,Lung Carcinoma Metastatic in the Brain,1
17005,Childhood Lesion,Childhood Malignant Ovarian Germ Cell Tumor,1
17006,Recurrent Genetic Abnormalities Present,"Acute myeloid leukemia, t(8;21) (q22;q22)",1
17007,Skin nodule,Proliferative dermal lesion in congenital nevus,1
17008,Alternative Fascicle (Bundle) Pattern,Gastric Leiomyoma,1
17009,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Microcystic Pattern",1
17010,Borderline Lesion,Angiocentric immunoproliferative lesion grade 2,1
17011,Diffuse Pattern,Lymphohistiocytoid Mesothelioma,1
17012,Koilocytotic atypia,Cervical Warty Carcinoma,1
17013,Pushing Tumor Margin,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
17014,Neuroendocrine Differentiation,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
17015,Low Mitotic Activity,Colon Neuroendocrine Tumor,1
17016,Benign Cellular Infiltrate,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
17017,Malignant Cellular Infiltrate,Mesothelioma malignant localized,1
17018,Malignant Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer,1
17019,Malignant Cellular Infiltrate,Metastatic Malignant Germ Cell Tumor,1
17020,Epithelial Component Present,Adenocarcinoma in tubular adenoma,1
17021,Epithelial Component Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
17022,Papillary Pattern,Nonencapsulated sclerosing tumor,1
17023,Carcinomatous Component Present,Adenocarcinoma of large intestine,1
17024,Malignant Cellular Infiltrate,Anal Extramucosal (Perianal) Adenocarcinoma,1
17025,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemias,1
17026,Indolent Clinical Course,Tendon Sheath Lipoma,1
17027,Absence of Invasion,Bowen's Disease,1
17028,Metastatic Lesion,Pancreatic adenocarcinoma metastatic,1
17029,Biphasic Pattern,Vaginal Adenosarcoma,1
17030,Mixed Cellular Population,Uterine Corpus Adenofibroma,1
17031,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Papillary Variant",1
17032,Epithelial Component Present,Endometrial Undifferentiated Carcinoma,1
17033,Epithelial Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
17034,Epithelial Component Present,Thoracic Esophagus Squamous Cell Carcinoma,1
17035,Thick-Walled Hyalinized Vessels Present,Degenerated Schwannoma,1
17036,Carcinomatous Component Present,Breast Carcinoma with Choriocarcinomatous Features,1
17037,Carcinomatous Component Present,Stage IVA Rectal Cancer AJCC v7,1
17038,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma,1
17039,Epithelial Component Present,Thecoma,1
17040,Malignant Cellular Infiltrate,Recurrent Grade 3 Follicular Lymphoma,1
17041,Malignant Cellular Infiltrate,Gallbladder Carcinoma,1
17042,Malignant Cellular Infiltrate,Transplant-Related Bladder Urothelial Carcinoma,1
17043,Epithelial Component Present,Maxillary Sinus Schneiderian Papilloma,1
17044,CD1a-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
17045,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
17046,Mixed Cellular Population,Intraductal carcinoma and lobular carcinoma in situ,1
17047,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
17048,Epithelial Component Present,Stage IA Breast Cancer AJCC v7,1
17049,Epithelial Component Present,Stage IIC Rectal Cancer AJCC v7,1
17050,Epithelial Component Present,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
17051,Epithelial Component Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1
17052,Carcinomatous Component Present,Resectable Pancreatic Acinar Cell Carcinoma,1
17053,Malignant Cellular Infiltrate,Undifferentiated carcinoma of ovary,1
17054,Epithelial Component Present,Stage I Renal Pelvis Cancer AJCC v8,1
17055,Adnexal Differentiation,Trichoadenoma,1
17056,Malignant Cellular Infiltrate,Sporadic Thyroid Gland Medullary Carcinoma,1
17057,Collagenous Stroma Formation,"Fibromatosis, Abdominal",1
17058,Carcinomatous Component Present,large cell neuroendocrine carcinoma of bladder,1
17059,Carcinomatous Component Present,Stage IIC Rectal Cancer AJCC v7,1
17060,Malignant Cellular Infiltrate,Primary mediastinal large B-cell lymphoma recurrent,1
17061,Cystic Change,Benign cystic nephroma,1
17062,Epithelial Component Present,Rectal Small Cell Neuroendocrine Carcinoma,1
17063,Epithelial Component Present,Thyroid Gland Paraganglioma,1
17064,Carcinomatous Component Present,Advanced Renal Cell Carcinoma,1
17065,Recurrent disease,Osteosarcoma recurrent,1
17066,Malignant Cellular Infiltrate,Undifferentiated (Embryonal) Sarcoma,1
17067,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
17068,Carcinomatous Component Present,Stage IIB Ovarian Cancer AJCC v8,1
17069,Therapy-Related Toxicity,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,1
17070,Metastatic Lesion,Metastatic Uveal Melanoma,1
17071,Epithelial Component Present,cloacogenic carcinoma of rectum,1
17072,Carcinomatous Component Present,Squamous cell carcinoma of penis,1
17073,Therapy-Related Toxicity,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
17074,Papillary Pattern,Verrucous carcinoma of oral cavity,1
17075,Adnexal Differentiation,Eccrine mixed tumor of skin,1
17076,Epithelial Component Present,Small Intestinal Neuroendocrine Neoplasm,1
17077,Carcinomatous Component Present,Diffuse Gastric Adenocarcinoma,1
17078,Carcinomatous Component Present,Stage 0is Ureter Cancer AJCC v7,1
17079,Neuroendocrine Differentiation,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
17080,Epithelial Component Present,epithelial-myoepithelial carcinoma of lung,1
17081,Malignant Cellular Infiltrate,Stage I Penile Cancer AJCC v8,1
17082,Malignant Cellular Infiltrate,Esophageal Mucosa-Associated Lymphoid Tissue Lymphoma,1
17083,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Seminoma,1
17084,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
17085,Carcinomatous Component Present,"Carcinoma, Cribriform",1
17086,Unresectable Mass,Localized Non-Resectable Adult Liver Carcinoma,1
17087,Sarcomatous Component Present,Uterine Corpus Carcinosarcoma,1
17088,Acanthosis,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
17089,Cutaneous Involvement,"Skin Diseases, Infectious",1
17090,Hyalinized Stroma Formation,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
17091,Malignant Cellular Infiltrate,Bladder Alveolar Soft Part Sarcoma,1
17092,Epithelial Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
17093,Malignant Cellular Infiltrate,Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7,1
17094,Epithelial Component Present,Stage III Lung Small Cell Carcinoma AJCC v7,1
17095,Calcitonin Positive Neoplastic Cells Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
17096,Antoni A Pattern,Benign Esophageal Schwannoma,1
17097,Epithelial Component Present,Squamous cell carcinoma of trachea,1
17098,Benign Cellular Infiltrate,Vaginal Squamous Papilloma,1
17099,Malignant Cellular Infiltrate,Adenocarcinoma of lacrimal gland,1
17100,Epithelial Component Present,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
17101,Epithelial Component Present,Thymic Small Cell Carcinoma,1
17102,Primary Lesion,AIDS-Related Primary Effusion Lymphoma,1
17103,Microcystic Change,Subependymal Glioma,1
17104,Cutaneous Involvement,Cutaneous schistosomiasis,1
17105,Acinar Cell Differentiation,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
17106,Nuclear Atypia,Adult Anaplastic Astrocytoma,1
17107,Malignant Cellular Infiltrate,Stage IB Ovarian Germ Cell Tumor AJCC v6 and v7,1
17108,Cutaneous Involvement,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E",1
17109,Neuroectodermal Differentiation,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
17110,Malignant Cellular Infiltrate,Refractory Glioblastoma,1
17111,Clinical TNM Finding,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
17112,Multinodular Mass,Mediastinal Angiosarcoma,1
17113,Antoni A Pattern,Plexiform Schwannoma,1
17114,Biphasic Pattern,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
17115,Epithelial Component Present,Unresectable Gallbladder Carcinoma,1
17116,Carcinomatous Component Present,Alcohol-Related Esophageal Squamous Cell Carcinoma,1
17117,Carcinomatous Component Present,Rectal Signet Ring Cell Adenocarcinoma,1
17118,Epithelial Component Present,Stage I Hypopharyngeal Carcinoma AJCC v6,1
17119,High Mitotic Activity,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
17120,Carcinomatous Component Present,pleomorphic carcinoma of breast,1
17121,Refractory Disease,Non-Hodgkin's lymphoma refractory,1
17122,Poorly Differentiated Neuroendocrine Lesion,Digestive System Neuroendocrine Carcinoma,1
17123,Malignant Cellular Infiltrate,Malignant tumor of renal pelvis,1
17124,Dysplasia,Stage 0 Vulvar Cancer,1
17125,Malignant Cellular Infiltrate,Recurrent Retinoblastoma,1
17126,Chronic Inflammatory Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
17127,Infiltrative Growth Pattern,Fibromatosis colli,1
17128,Malignant Cellular Infiltrate,Renal carcinoma,1
17129,Encapsulated Mass,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
17130,Epithelial Component Present,Unresectable Extrahepatic Bile Duct Carcinoma,1
17131,Epithelial Component Present,Metastatic Parathyroid Gland Carcinoma,1
17132,More than 10 Mitoses per 10HPF,Refractory Lung Small Cell Carcinoma,1
17133,Epithelial Component Present,Thymic Atypical Carcinoid Tumor,1
17134,Polymorphic Cellular Infiltrate,Recurrent Langerhans Cell Histiocytosis,1
17135,Malignant Cellular Infiltrate,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
17136,Refractory Disease,Refractory Adrenal Gland Pheochromocytoma,1
17137,Adulthood Lesion,Recurrent Adult Hepatocellular Carcinoma,1
17138,Secondary Lesion,Pleural Carcinomatosis,1
17139,Cutaneous Involvement,Local infection skin/subcut tissue NOS,1
17140,Malignant Cellular Infiltrate,Uterine Corpus Sarcoma,1
17141,Epithelial Component Present,Clear cell adenocarcinoma of ovary,1
17142,Neuronal Differentiation,Medulloblastoma with extensive nodularity,1
17143,Benign Cellular Infiltrate,Benign Extragonadal Germ Cell Tumor,1
17144,High Grade Lesion,High Grade Broad Ligament Serous Adenocarcinoma,1
17145,Cutaneous Involvement,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
17146,Childhood Lesion,Recurrent Childhood Anaplastic Oligodendroglioma,1
17147,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1B,1
17148,Epithelial Component Present,Stage I Thymoma AJCC v8,1
17149,Malignant Cellular Infiltrate,Stage III Testicular Cancer AJCC v8,1
17150,Malignant Cellular Infiltrate,Refractory Cytopenia of Childhood,1
17151,Severe dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
17152,Slow Growing Mass,Recurrent Childhood Subependymal Giant Cell Astrocytoma,1
17153,Well Differentiated Neuroendocrine Lesion,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
17154,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage III,1
17155,Epithelial Component Present,Advanced Cervical Carcinoma,1
17156,Epithelial Component Present,Carcinoma in situ of penis,1
17157,Neuroectodermal Differentiation,Undifferentiated Neuroblastoma,1
17158,Rapidly Enlarging Mass,Spindle Cell/Sclerosing Rhabdomyosarcoma,1
17159,Five or Less Mitoses per 50HPF,Benign Gastric Gastrointestinal Stromal Tumor,1
17160,Malignant Cellular Infiltrate,Gliomatosis Cerebri Type II,1
17161,Malignant Cellular Infiltrate,Stage III Pharynx Carcinoma,1
17162,Malignant Cellular Infiltrate,Unresectable Intrahepatic Cholangiocarcinoma,1
17163,Cutaneous Involvement,Pilomatrixoma,1
17164,Cartilaginous Component Present,Endobronchial Hamartoma,1
17165,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
17166,Papillary Pattern,Papilloma of eyelid,1
17167,Organoid Pattern,Vulvar Alveolar Soft Part Sarcoma,1
17168,Secondary Lesion,Secondary Acute Myeloid Leukemia,1
17169,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
17170,Epithelial Component Present,Paget's disease of vulva,1
17171,Malignant Cellular Infiltrate,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
17172,Benign Cellular Infiltrate,Soft tissue perineurioma,1
17173,Epithelial Component Present,Thyroid Gland Hyperfunctioning Adenoma,1
17174,Epithelial Component Present,small cell carcinoma of salivary gland,1
17175,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
17176,Malignant Cellular Infiltrate,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
17177,Malignant Cellular Infiltrate,Recurrent Primary Effusion Lymphoma,1
17178,Epithelial Component Present,Glucagonoma,1
17179,Mass of body structure,Cardiac Myeloid Sarcoma,1
17180,Secondary Lesion,Metastatic Unresectable Sarcoma,1
17181,Carcinomatous Component Present,Stage IVB Ovarian Cancer AJCC v8,1
17182,Malignant Cellular Infiltrate,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,1
17183,Epithelial Component Present,Stage IA Esophageal Adenocarcinoma AJCC v7,1
17184,Malignant Cellular Infiltrate,ROSE Cluster 3,1
17185,Encapsulated Mass,Childhood Thyroid Gland Follicular Carcinoma,1
17186,Diffuse Pattern,Well Differentiated Oligodendroglioma,1
17187,Fibrotic Stroma Formation,Mucoepidermoid Breast Carcinoma,1
17188,Benign Cellular Infiltrate,Benign Anterior Tongue Neoplasm,1
17189,Malignant Cellular Infiltrate,Adult T-Cell Lymphoma/Leukemia,1
17190,Necrotic changes (finding),large cell neuroendocrine carcinoma of gallbladder,1
17191,Pseudopapillary Pattern,Teratocarcinoma,1
17192,Metastatic Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
17193,Carcinomatous Component Present,Unresectable Lung Carcinoma,1
17194,Favorable Clinical Outcome,Type D Lymphomatoid Papulosis,1
17195,Nuclear Atypia,Secondary Supratentorial Anaplastic Astrocytoma,1
17196,Carcinomatous Component Present,Bartholin Gland Transitional Cell Carcinoma,1
17197,Epithelial Component Present,Old Burn Scar-Related Skin Squamous Cell Carcinoma,1
17198,Carcinomatous Component Present,Pancreatic Ductal Adenocarcinoma,1
17199,Malignant Cellular Infiltrate,Recurrent Intravascular Large B-Cell Lymphoma,1
17200,Polymorphic Cellular Infiltrate,Adult Langerhans Cell Histiocytosis,1
17201,Malignant Cellular Infiltrate,Polycythemia Vera,1
17202,Necrotic changes (finding),Pancreatic Large Cell Neuroendocrine Carcinoma,1
17203,Comedo Necrosis,Comedocarcinoma,1
17204,High Grade Lesion,Stage I Lung Small Cell Carcinoma AJCC v7,1
17205,Secondary Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
17206,High Mitotic Activity,Childhood Testicular Embryonal Carcinoma,1
17207,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
17208,Malignant Cellular Infiltrate,Acute lymphocytic leukemia,1
17209,Cutaneous Involvement,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
17210,Epithelial Component Present,carcinosarcoma of extrahepatic bile duct,1
17211,Epithelial Component Present,Squamous cell carcinoma of the paranasal sinus,1
17212,Malignant Cellular Infiltrate,Metastatic Lung Carcinoma,1
17213,Low Mitotic Activity,Intestinal Gangliocytic Paraganglioma,1
17214,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v7 Stage,1
17215,High Mitotic Activity,Unresectable Pancreatic Neuroendocrine Carcinoma,1
17216,Indolent Clinical Course,Esophageal Fibroma,1
17217,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v6 and v7,1
17218,Myxoid Stroma Formation,Recurrent Myxoid Liposarcoma,1
17219,Epithelial Component Present,Fibroepithelioma of Pinkus,1
17220,Childhood Lesion,Childhood Undifferentiated Pleomorphic Sarcoma,1
17221,Epithelial Component Present,Refractory Fallopian Tube Carcinoma,1
17222,Carcinomatous Component Present,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
17223,Diffuse Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
17224,Adulthood Lesion,Adult Anaplastic Ependymoma,1
17225,Refractory Disease,Chronic lymphocytic leukemia refractory,1
17226,Cribriform Pattern,"Carcinoma, Cribriform",1
17227,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v7,1
17228,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
17229,Hyperkeratosis,Vulvar Inverted Follicular Keratosis,1
17230,Carcinomatous Component Present,Stage I Nasal Cavity and Paranasal Sinus Cancer AJCC v6 and v7,1
17231,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
17232,Neuroendocrine Differentiation,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
17233,Well Differentiated Neuroendocrine Lesion,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
17234,Malignant Cellular Infiltrate,Malignant odontogenic tumor,1
17235,Epithelial Component Present,Lung Adenocarcinoma In Situ,1
17236,Malignant Cellular Infiltrate,Gastric Cardia Carcinoma,1
17237,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
17238,Cutaneous Involvement,Acquired keratoderma,1
17239,Malignant Cellular Infiltrate,Metastatic leiomyosarcoma,1
17240,Eccrine Differentiation,Eccrine porocarcinoma,1
17241,Carcinomatous Component Present,Carcinoma of hard palate,1
17242,Well-Circumscribed Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
17243,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7,1
17244,Malignant Cellular Infiltrate,Colon Medullary Carcinoma,1
17245,Carcinomatous Component Present,Urothelial cancer of renal pelvis,1
17246,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Prefibrotic/Early Primary Myelofibrosis,1
17247,Indolent Clinical Course,Cutaneous leiomyoma,1
17248,Well Differentiated Neuroendocrine Lesion,Gastro-enteropancreatic neuroendocrine tumor,1
17249,Carcinomatous Component Present,Stage 0 Vulvar Cancer,1
17250,Recurrent disease,Endometrioid adenocarcinoma recurrent,1
17251,Mesenchymal Component Present,Malignant Phyllodes Tumor of Prostate,1
17252,Hyperplastic Tissue Present,Prostatic Basal Cell Hyperplasia,1
17253,Malignant Cellular Infiltrate,"Leiomyosarcoma, Myxoid",1
17254,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v7,1
17255,Epithelial Component Present,Stage IA Pancreatic Cancer AJCC v6 and v7,1
17256,Mixed Cellular Population,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8,1
17257,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage I,1
17258,Carcinomatous Component Present,Uterine Ligament Clear Cell Adenocarcinoma,1
17259,Cutaneous Involvement,Acral Lentiginous Malignant Melanoma,1
17260,Adulthood Lesion,Stage II Adult Soft Tissue Sarcoma AJCC v7,1
17261,Carcinomatous Component Present,Laryngeal Cancer by AJCC v6 Stage,1
17262,Adnexal Differentiation,Malignant Outer Hair Sheath and Infundibulum Neoplasm,1
17263,Malignant Cellular Infiltrate,Stage IV Vaginal Cancer AJCC v6 and v7,1
17264,Necrotic changes (finding),Glioblastoma,1
17265,Epithelial Component Present,"Transitional cell papilloma, benign",1
17266,Benign Cellular Infiltrate,benign mature teratoma of pancreas,1
17267,Malignant Cellular Infiltrate,"Squamous Cell Breast Carcinoma, Large Cell Keratinizing Variant",1
17268,Carcinomatous Component Present,Refractory Pancreatic Neuroendocrine Carcinoma,1
17269,Cellular Pleomorphism,Giant Cell Fibrous Histiocytoma,1
17270,Childhood Lesion,Childhood Synovial Sarcoma,1
17271,Malignant Cellular Infiltrate,Anatomic Stage IA Breast Cancer AJCC v8,1
17272,Increased Cellularity Present,Cellular leiomyoma,1
17273,Epithelial Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
17274,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v7,1
17275,Epithelial Component Present,Recurrent Thyroid Gland Follicular Carcinoma,1
17276,Malignant Cellular Infiltrate,Secondary malignant neoplasm of nervous system,1
17277,Malignant Cellular Infiltrate,Salivary Gland Oncocytic Carcinoma,1
17278,Well-Circumscribed Lesion,Gastric adenoma,1
17279,Cystic Change,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
17280,Secondary Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,1
17281,Secondary Lesion,Metastatic Malignant Solid Neoplasm,1
17282,Epithelial Component Present,Squamous cell carcinoma of tongue,1
17283,Childhood Lesion,Recurrent Childhood Pilomyxoid Astrocytoma,1
17284,Malignant Cellular Infiltrate,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
17285,Mixed Cellular Population,Anaplastic Kidney Wilms Tumor,1
17286,Epithelial Component Present,Ovarian Serous Tumor,1
17287,Malignant Cellular Infiltrate,Undifferentiated Carcinoma of Unknown Primary,1
17288,Malignant Cellular Infiltrate,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,1
17289,Malignant Cellular Infiltrate,Stage III Vulvar Cancer AJCC v7,1
17290,Epithelial Component Present,Periampullary Adenocarcinoma,1
17291,Spindle Cell Osteo-Fibrous Component Present,Tibial adamantinoma,1
17292,Epithelial Component Present,Stage IVA Rectal Cancer AJCC v7,1
17293,Secondary Lesion,Advanced Carcinoma,1
17294,Adulthood Lesion,Glioblastoma multiforme of spinal cord,1
17295,IDH Gene Family Mutation Status Unknown,Anaplastic Oligoastrocytoma,1
17296,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Oxyphilic Endometrial Endometrioid Adenocarcinoma,1
17297,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis,1
17298,Extraosseous Lesion,Extraskeletal osteosarcoma recurrent,1
17299,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pharynx,1
17300,Benign Cellular Infiltrate,Benign Cerebellar Neoplasms,1
17301,Malignant Cellular Infiltrate,Placental Choriocarcinoma,1
17302,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1,1
17303,Epithelial Component Present,Breast adenocarcinoma,1
17304,Malignant Cellular Infiltrate,Cutaneous Liposarcoma,1
17305,Diffuse Pattern,Anaplastic Oligodendroglioma,1
17306,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Angiosarcoma,1
17307,Cystic Change,mucoepidermoid carcinoma of esophagus,1
17308,Epithelial Component Present,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
17309,Malignant Cellular Infiltrate,lymphangiosarcoma,1
17310,Adulthood Lesion,Stage III Adult Immunoblastic Lymphoma,1
17311,Epithelial Component Present,BRCA-Mutated Ovarian Carcinoma,1
17312,Malignant Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma,1
17313,Hemorrhagic,Pericardial Angiosarcoma,1
17314,Epithelial Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
17315,Necrotic changes (finding),Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
17316,Endophytic Tumor Growth,Inverted Papilloma,1
17317,Epithelial Component Present,Stage IV Lip Basal Cell Carcinoma,1
17318,Benign Cellular Infiltrate,Congenital hemangioma,1
17319,Infiltrative Growth Pattern,Central Nervous System Desmoid-Type Fibromatosis,1
17320,Benign Cellular Infiltrate,Jugular Foramen Schwannoma,1
17321,Malignant Cellular Infiltrate,Desmoplastic mesothelioma,1
17322,High Grade Lesion,Chondroblastic osteosarcoma,1
17323,Malignant Cellular Infiltrate,Ann Arbor Stage IIIA Hodgkin Lymphoma,1
17324,Nodular Pattern,Ann Arbor Stage III Grade 2 Follicular Lymphoma,1
17325,Pseudoencapsulated Mass,Melanotic malignant nerve sheath tumor,1
17326,Neuroendocrine Differentiation,Paraganglioma,1
17327,Malignant Cellular Infiltrate,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
17328,Malignant Cellular Infiltrate,Rhabdomyosarcoma,1
17329,Benign Cellular Infiltrate,Ovarian Cystadenoma,1
17330,'Starry-sky' pattern,Adult Burkitt Lymphoma,1
17331,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of gallbladder,1
17332,Carcinomatous Component Present,Adenocarcinoma of the prostate stage I,1
17333,Malignant Cellular Infiltrate,Papillary squamous cell carcinoma,1
17334,Peripheral Nuclear Palisading,Metastatic Lung Small Cell Carcinoma,1
17335,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Pulmonary Blastoma,1
17336,Childhood Lesion,Noncutaneous Childhood Anaplastic Large Cell Lymphoma by Ann Arbor Stage,1
17337,Carcinomatous Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
17338,Locally Aggressive Lesion,Intermediate Vascular Neoplasm,1
17339,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v7 Stage,1
17340,Lymphoplasmacytic Infiltrate,germinoma of brain,1
17341,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
17342,Malignant Cellular Infiltrate,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
17343,Osseous Differentiation,Childhood Conventional Osteosarcoma,1
17344,Malignant Cellular Infiltrate,Stage IVA Bone Sarcoma AJCC v7,1
17345,Mitotic Activity,Neural Glioblastoma,1
17346,Epithelial Component Present,Stage IIIA Gastric Carcinoma,1
17347,Well-Circumscribed Lesion,Palisaded Lymph Node Myofibroblastoma,1
17348,Alternative Fascicle (Bundle) Pattern,Bladder Leiomyoma,1
17349,Sheets of Interfollicular Plasma Cells Present,"Castleman Disease, Plasma Cell Type",1
17350,Locally Aggressive Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1
17351,Malignant Cellular Infiltrate,liposarcoma of breast,1
17352,Epithelial Component Present,Intraepithelial Neoplasia,1
17353,Malignant Cellular Infiltrate,Advanced Cutaneous Melanoma of the Extremity,1
17354,Pregnancy Complications,"Non-Neoplastic, Non-Molar Trophoblastic Disorder",1
17355,Epithelial Component Present,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
17356,Myxoid Stroma Formation,Dedifferentiated chordoma,1
17357,Rapidly Enlarging Mass,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
17358,Locally Aggressive Lesion,Classic Type Atypical Fibroxanthoma,1
17359,Well-Circumscribed Lesion,Stage I Kidney Wilms Tumor,1
17360,Carcinomatous Component Present,Laryngeal Cancer by AJCC v8 Stage,1
17361,Malignant Cellular Infiltrate,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,1
17362,Secondary Lesion,Metastatic Paraganglioma,1
17363,Neuroectodermal Differentiation,Kadish Stage B Olfactory Neuroblastoma,1
17364,Nodular Pattern,Recurrent Myxoid Liposarcoma,1
17365,Malignant Cellular Infiltrate,Bile duct clear cell adenocarcinoma,1
17366,Immunosuppression-Related Post-Transplant Toxicity,Bone Marrow Transplantation Nephropathy,1
17367,Papillary Pattern,Hereditary Papillary Renal Carcinoma,1
17368,Epithelial Component Present,Stage 0is Urethral Cancer AJCC v7,1
17369,Malignant Cellular Infiltrate,Chronic Myelomonocytic Leukemia-0,1
17370,Malignant Cellular Infiltrate,Marginal Zone Lymphoma by Ann Arbor Stage,1
17371,Malignant Cellular Infiltrate,Pleural Carcinomatosis,1
17372,Lytic lesion,Osteolytic Neoplasm,1
17373,Nuclear Expression of STAT6 Protein,benign fibroma of liver,1
17374,Recurrent disease,Recurrent High Risk Myelodysplastic Syndrome,1
17375,Epithelial Component Present,Stage IIB Cervical Cancer AJCC v6 and v7,1
17376,Benign Cellular Infiltrate,Lung Myolipoma,1
17377,Adulthood Lesion,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,1
17378,Carcinomatous Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
17379,Benign Cellular Infiltrate,Benign neoplasm of retina,1
17380,Immunosuppression-Related Post-Transplant Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
17381,Malignant Cellular Infiltrate,Recurrent Ovarian Serous Adenocarcinoma,1
17382,Epithelioid Component Present,Pleural Biphasic Synovial Sarcoma,1
17383,Pathologic TNM Finding,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
17384,Poorly Differentiated Lesion,Sarcomatoid Renal Cell Carcinoma,1
17385,Carcinomatous Component Present,Resectable Head and Neck Squamous Cell Carcinoma,1
17386,Epithelial Component Present,Cardiac Paraganglioma,1
17387,Ground Glass Nuclear Inclusion,Papillary thyroid carcinoma,1
17388,Malignant Cellular Infiltrate,Malignant neoplasm of bronchus,1
17389,Benign Cellular Infiltrate,Benign Peripheral Nerve Granular Cell Tumor,1
17390,Epithelial Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck,1
17391,Well-Circumscribed Lesion,Extracardiac Rhabdomyoma,1
17392,Benign Cellular Infiltrate,Vulvar Angiomyofibroblastoma,1
17393,Hyperplastic Epithelial Tissue Present,Columnar Cell Hyperplasia of the Breast,1
17394,Pathologic TNM Finding,Pathologic Stage IB Cutaneous Melanoma AJCC v8,1
17395,Epithelial Component Present,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
17396,Cystic Change,Mucinous cystadenocarcinoma of ovary,1
17397,In Situ Lesion,Stage 0 Colon Cancer AJCC v6 and v7,1
17398,Mitotic Activity,Chondroblastoma,1
17399,Cribriform Pattern,Recurrent Salivary Duct Carcinoma,1
17400,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,1
17401,Hereditary Lesion,Hereditary Female Breast Carcinoma,1
17402,Epithelial Component Present,Virus-Related Carcinoma,1
17403,Epithelial Component Present,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,1
17404,Secondary Lesion,Metastatic Ductal Breast Carcinoma,1
17405,Necrotic changes (finding),Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
17406,Nested Pattern,Clear Cell Sarcoma of Soft Tissue,1
17407,Malignant Cellular Infiltrate,Recurrent Aggressive NK-Cell Leukemia,1
17408,Fibrotic Stroma Formation,Pancreatic Foamy Gland Adenocarcinoma,1
17409,Childhood Lesion,"MYELOPROLIFERATIVE SYNDROME, TRANSIENT",1
17410,Malignant Cellular Infiltrate,Metastatic Lung Carcinoma,1
17411,Pre-existing condition,Myeloid Neoplasms with Germline Predisposition Associated with Telomerase Biology Disorders,1
17412,Cutaneous Involvement,Plexiform fibrohistiocytic tumor,1
17413,Neuroectodermal Differentiation,Peripheral Primitive Neuroectodermal Tumor of the Kidney,1
17414,Anaplasia,Secondary Supratentorial Anaplastic Astrocytoma,1
17415,Benign Cellular Infiltrate,Benign male reproductive tract neoplasm,1
17416,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
17417,Cutaneous Involvement,Acquired ichthyosis,1
17418,Well-Circumscribed Lesion,Juvenile polyp,1
17419,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical",1
17420,Malignant Cellular Infiltrate,"Undifferentiated Sarcoma, Not Otherwise Specified",1
17421,Malignant Cellular Infiltrate,Ann Arbor Stage II Supradiaphragmatic Hodgkin Lymphoma,1
17422,Mitotic Activity,"Testicular Yolk Sac Tumor, Microcystic Pattern",1
17423,Refractory Disease,Refractory Metastatic Digestive System Carcinoma,1
17424,Malignant Cellular Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
17425,Cutaneous Involvement,Precancerous Dermatitis,1
17426,Benign Cellular Infiltrate,Desmoplastic Nevus,1
17427,Refractory Disease,Refractory Aggressive Non-Hodgkin Lymphoma,1
17428,Malignant Cellular Infiltrate,Unresectable Synovial Sarcoma,1
17429,Carcinomatous Component Present,"Adenocarcinoma, Clear Cell",1
17430,Epithelial Component Present,Fallopian Tube Squamous Cell Carcinoma,1
17431,Dysplasia,Intraductal carcinoma and lobular carcinoma in situ,1
17432,Malignant Cellular Infiltrate,Stage IA Vaginal Cancer AJCC v8,1
17433,Indolent Clinical Course,Uterine Corpus Hydropic Leiomyoma,1
17434,Carcinomatous Component Present,Transplant-Related Bladder Urothelial Carcinoma,1
17435,Recurrent disease,Non-Hodgkin's lymphoma transformed recurrent,1
17436,Epithelial Component Present,"Adenoma, Sweat Gland",1
17437,Recurrent disease,Recurrent Malignant Ovarian Brenner Tumor,1
17438,Malignant Cellular Infiltrate,Stage IIIA Lung Cancer AJCC v8,1
17439,Malignant Cellular Infiltrate,Metastatic Colorectal Carcinoma,1
17440,Epithelial Component Present,Periampullary Adenocarcinoma,1
17441,Carcinomatous Component Present,verrucous carcinoma of vulva,1
17442,Non-Hereditary Lesion,Sporadic Burkitt's lymphoma,1
17443,Epithelial Component Present,Mixed Acinar-Ductal Carcinoma of the Pancreas,1
17444,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with Neuroblastoma,1
17445,Intermediate Filaments Present,Rhabdoid Tumor,1
17446,Recurrent disease,Recurrent Abdominal Neuroendocrine Neoplasm,1
17447,Metaplasia of Malignant Cells Present,Adenocarcinoma with apocrine metaplasia,1
17448,Malignant Cellular Infiltrate,Stage III Testicular Cancer AJCC v8,1
17449,Intramucosal Lesion,"Carcinoma of urinary bladder, superficial",1
17450,Invasive Lesion,adenosquamous carcinoma of breast,1
17451,Epithelial Component Present,"Cystadenoma, Papillary",1
17452,Mesenchymal Component Present,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
17453,Malignant Cellular Infiltrate,verrucous carcinoma of vagina,1
17454,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of lung,1
17455,Carcinomatous Component Present,Mucoepidermoid carcinoma of submandibular gland,1
17456,Abundance of Small Lymphocytes,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
17457,Carcinomatous Component Present,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
17458,Epithelial Component Present,Stage I Pancreatic Cancer AJCC v6 and v7,1
17459,Nodular Pattern,Ann Arbor Stage III Grade 2 Follicular Lymphoma,1
17460,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v7 Stage,1
17461,Epithelial Component Present,Recurrent Liver Carcinoma,1
17462,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Tumor,1
17463,Immunosuppression-Related Post-Transplant Toxicity,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
17464,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
17465,Microcystic Change,Microcystic adnexal carcinoma,1
17466,Malignant Cellular Infiltrate,Stage 0 Vulvar Cancer,1
17467,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
17468,Malignant Cellular Infiltrate,Cancer of Lip,1
17469,Malignant Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
17470,Eosinophilic inflammation,Inflammatory pseudotumor of liver,1
17471,Abundance of Small Lymphocytes,Refractory Lymphocyte-Rich Classic Hodgkin Lymphoma,1
17472,Pathologic TNM Finding,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
17473,Exophytic Papillary Lesion,Condyloma anal,1
17474,Carcinomatous Component Present,Stage III Nasal Cavity Cancer AJCC v6 and v7,1
17475,Carcinomatous Component Present,mucoepidermoid carcinoma of lacrimal gland,1
17476,Carcinomatous Component Present,Stage I Esophageal Cancer AJCC v7,1
17477,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Clinical Stage,1
17478,Unresectable Mass,Unresectable Digestive System Adenocarcinoma,1
17479,Benign Cellular Infiltrate,"Fibro-odontoma, Ameloblastic",1
17480,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma stage III,1
17481,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v7,1
17482,Epithelial Component Present,Vaginal Cancer by AJCC v6 Stage,1
17483,Chromogranin A Positive Neoplastic Cells Present,Breast Carcinoid Tumor,1
17484,Hyperplastic Tissue Present,Utricle-Associated Mucosal Gland Hyperplasia,1
17485,Pathologic TNM Finding,Pathologic Stage IIB Cutaneous Melanoma AJCC v8,1
17486,Exophytic Polypoid Lesion,Appendix Traditional Serrated Adenoma,1
17487,Carcinomatous Component Present,"Carcinoma, Spindle-Cell",1
17488,Malignant Component Present,Dermoid cyst with secondary tumor,1
17489,Carcinomatous Component Present,Vaginal Cancer by AJCC v6 Stage,1
17490,High Grade Lesion,Glioblastoma with Primitive Neuronal Component,1
17491,Carcinomatous Component Present,Upper Gingival Verrucous Carcinoma,1
17492,Epithelial Component Present,Apocrine adenoma,1
17493,Adulthood Lesion,Adult Choroid Plexus Neoplasm,1
17494,Childhood Lesion,Childhood Ganglioneuroblastoma,1
17495,Low Mitotic Activity,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,1
17496,Malignant Cellular Infiltrate,Clinical Stage IA Cutaneous Melanoma AJCC v8,1
17497,Dysplasia,Tubulovillous adenoma of rectum,1
17498,Poorly Differentiated Neuroendocrine Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,1
17499,Malignant Cellular Infiltrate,Locally Advanced Salivary Gland Carcinoma,1
17500,Increased NFkappaB Pathway Activation,Primary mediastinal large B-cell lymphoma refractory,1
17501,Indolent Clinical Course,Follicular Myxoma,1
17502,Childhood Lesion,Childhood Refractory Malignant Solid Neoplasm,1
17503,Malignant Cellular Infiltrate,Third Ventricle Germinoma,1
17504,Malignant Cellular Infiltrate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
17505,Carcinomatous Component Present,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,1
17506,Acanthosis,Lower Gingival Verrucous Carcinoma,1
17507,Malignant Cellular Infiltrate,verrucous carcinoma of vagina,1
17508,Mitotic Activity,Mesenchymal Glioblastoma,1
17509,Benign Cellular Infiltrate,Schwannoma of the Twelfth Cranial Nerve,1
17510,Epithelial Component Present,Colorectal Undifferentiated Carcinoma,1
17511,Epithelial Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
17512,Malignant Cellular Infiltrate,Orbital Melanoma,1
17513,Epithelial Component Present,Cervical carcinoma stage II AJCC v7,1
17514,Malignant Cellular Infiltrate,Hepatoblastoma,1
17515,Embryoid Bodies Present,polyembryoma of testis,1
17516,Osseous Differentiation,Osteogenic Neoplasm,1
17517,Epithelial Component Present,Vulvar Cancer by AJCC v8 Stage,1
17518,Carcinomatous Component Present,Stage IV Hepatocellular Carcinoma AJCC v7,1
17519,Solid Growth Pattern,Solid Alveolar Rhabdomyosarcoma,1
17520,Ground Glass Nuclear Inclusion,Papillary Thyroid Microcarcinoma,1
17521,Metaplasia,Urethral Nephrogenic Adenoma,1
17522,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,1
17523,Well Differentiated Neuroendocrine Lesion,Malignant Vipoma,1
17524,Carcinomatous Component Present,Major Salivary Gland Cancer by AJCC v7 Stage,1
17525,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,1
17526,Pseudopapillary Pattern,Papillary Meningioma,1
17527,Anaplasia,Anaplastic Sarcoma of the Kidney,1
17528,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
17529,Recurrent disease,Nodal marginal zone B-cell lymphoma recurrent,1
17530,Proliferation of Basaloid Cells Parallel to the Long Axis of the Epidermis Present,Multifocal superficial basal cell carcinoma,1
17531,Carcinomatous Component Present,Invasive Carcinoma,1
17532,Epithelial Component Present,carcinoma of lacrimal gland,1
17533,Metastatic Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,1
17534,Epithelial Component Present,Metastatic Thyroid Gland Carcinoma,1
17535,Childhood Lesion,Childhood Undifferentiated Pleomorphic Sarcoma,1
17536,Metastatic Lesion,Breast Carcinoma Metastatic in the Brain,1
17537,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage III,1
17538,Malignant Cellular Infiltrate,Recurrent Testicular Lymphoma,1
17539,Lymphoplasmacytic Infiltrate,Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma,1
17540,Cutaneous Involvement,Dysplastic Nevus,1
17541,Carcinomatous Component Present,AIDS-Related Cervical Carcinoma,1
17542,'Starry-sky' pattern,Stage IV Burkitt Lymphoma,1
17543,Metastatic Lesion,Castration-Sensitive Prostate Carcinoma,1
17544,High Mitotic Activity,Pancreatic Endocrine Carcinoma,1
17545,Epithelial Component Present,Stage IIIC Ovarian Cancer,1
17546,Malignant Cellular Infiltrate,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
17547,Epithelial Component Present,Stage IIIB Lung Large Cell Carcinoma AJCC v7,1
17548,Epithelial Component Present,Childhood Hepatocellular Carcinoma,1
17549,Malignant Cellular Infiltrate,Malignant neoplasm of thalamus,1
17550,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
17551,Epithelial Component Present,Stage II Ureter Cancer AJCC v8,1
17552,Epithelial Component Present,Pancreatic adenocarcinoma metastatic,1
17553,Epithelial Component Present,Intramucosal Adenocarcinoma,1
17554,Malignant Cellular Infiltrate,carcinosarcoma of extrahepatic bile duct,1
17555,Metastatic Lesion,Castration-Naive Prostate Carcinoma,1
17556,High Mitotic Activity,"Perineurioma, malignant",1
17557,Varicosity,Phlebitis,1
17558,Epithelial Component Present,Carcinoma of anal margin,1
17559,Monocytosis,Recurrent Chronic Myelomonocytic Leukemia,1
17560,Neuroectodermal Differentiation,neuroblastoma of spinal cord,1
17561,High Mitotic Activity,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
17562,Malignant Cellular Infiltrate,Adenocarcinoma in multiple adenomatous polyps,1
17563,Adulthood Lesion,recurrent adult acute myeloid leukemia,1
17564,Epithelial Component Present,Esophageal adenocarcinoma recurrent,1
17565,Neuroectodermal Differentiation,Resectable Neuroblastoma,1
17566,Malignant Cellular Infiltrate,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
17567,Fibrotic Stroma Formation,Pigmented villonodular synovitis,1
17568,Malignant Cellular Infiltrate,Lung Biphasic Synovial Sarcoma,1
17569,Epithelial Component Present,Metastatic Lip Carcinoma,1
17570,Local disease,Angiolipoma,1
17571,Decreased platelet count,Myeloid Neoplasms with Germline ETV6 Mutation,1
17572,Primary Lesion,High grade surface osteosarcoma,1
17573,Follicular Structures Present,Thyroid Gland Clear Cell Follicular Adenoma,1
17574,Cellular Stratification,"Borderline Ovarian Mucinous Tumor, Intestinal Type",1
17575,Carcinomatous Component Present,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
17576,White blood cell count increased (lab result),"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
17577,Oligodendroglial Component Present,Recurrent Childhood Oligoastrocytoma,1
17578,Indolent Clinical Course,Odontogenic myxoma,1
17579,Histiocytosis haematophagic,Hemophagocytic Syndrome,1
17580,Carcinomatous Component Present,Stage IA Eyelid Carcinoma AJCC v7,1
17581,Malignant Cellular Infiltrate,Grade 1 Malignant Neoplasm,1
17582,Malignant Cellular Infiltrate,Stage I Distal Bile Duct Cancer AJCC v8,1
17583,Thin Bands of Collagen Present,benign fibroma of liver,1
17584,Secondary Lesion,Pleural mesothelioma malignant advanced,1
17585,Epithelial Component Present,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
17586,Epithelial Component Present,Stage IVB Liver Cancer,1
17587,Primary Lesion,Recurrent Testicular Lymphoma,1
17588,Cutaneous Involvement,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,1
17589,Necrotic changes (finding),Glioblastoma by Gene Expression Profile,1
17590,Hyperkeratosis,Verrucous carcinoma,1
17591,Epithelial Component Present,Testicular Brenner Tumor,1
17592,Malignant Cellular Infiltrate,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
17593,More than 10 Mitoses per 10HPF,Combined Lung Small Cell and Squamous Cell Carcinoma,1
17594,Unresectable Mass,Unresectable Desmoid-Type Fibromatosis,1
17595,Malignant Cellular Infiltrate,Asbestos-Related Malignant Mesothelioma,1
17596,Indolent Clinical Course,Benign neoplasm of lymph vessels,1
17597,Malignant Cellular Infiltrate,Environment-Related Malignant Neoplasm,1
17598,Epithelial Component Present,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
17599,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of extrahepatic bile duct,1
17600,Unresectable Mass,Unresectable Carcinoma,1
17601,Neuroendocrine Differentiation,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,1
17602,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
17603,Metastatic/Recurrent Disease,Extra-osseous Ewing's sarcoma,1
17604,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma recurrent,1
17605,Carcinomatous Component Present,Stage I Rectosigmoid Cancer AJCC v6 and v7,1
17606,Primary Lesion,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
17607,Cutaneous Involvement,Syringoma,1
17608,Cutaneous Involvement,Sweat gland adenocarcinoma,1
17609,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Clinical Stage,1
17610,Mixed Cellular Population,clear cell adenocarcinofibroma of ovary,1
17611,Clinical TNM Finding,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
17612,Malignant Cellular Infiltrate,undifferentiated carcinoma of ureter,1
17613,Carcinomatous Component Present,Stage IVB Laryngeal Cancer AJCC v8,1
17614,Severe dysplasia,Stage 0 Colon Cancer AJCC v8,1
17615,Carcinomatous Component Present,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type",1
17616,Well-Circumscribed Lesion,Ampulla of Vater Villous Adenoma,1
17617,Organoid Pattern,Alveolar soft part sarcoma recurrent,1
17618,Epithelial Component Present,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
17619,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
17620,Malignant Cellular Infiltrate,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
17621,Borderline Lesion,Proliferating Brenner Tumor,1
17622,Benign Cellular Infiltrate,Central Nervous System Leiomyoma,1
17623,Myxoid Stroma Formation,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
17624,Syncytial Pattern,Medullary carcinoma of breast,1
17625,Epithelial Component Present,Stage I Hilar Cholangiocarcinoma AJCC v8,1
17626,Well-Circumscribed Lesion,Adult Pleomorphic Rhabdomyosarcoma,1
17627,Carcinomatous Component Present,Urothelial cancer of renal pelvis,1
17628,Non-Invasive Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
17629,Dense Intercellular Reticulin Network Present,Desmoplastic Medulloblastoma,1
17630,Epithelial Component Present,adenocarcinoma of breast with squamous metaplasia,1
17631,Pushing Tumor Margin,verrucous carcinoma of esophagus,1
17632,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage II,1
17633,Neuroendocrine Differentiation,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
17634,Slow Growing Mass,Myxopapillary ependymoma,1
17635,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 3,1
17636,Osteoid formation,Radiation-Related Osteosarcoma,1
17637,Local disease,Lipoma of external auditory meatus,1
17638,Stromal Invasion,FIGO Stage IIIA2 Ovarian Cancer,1
17639,Indolent Clinical Course,leiomyoma of trachea,1
17640,Pathologic TNM Finding,Pathologic Stage III Retinoblastoma AJCC v8,1
17641,Malignant Cellular Infiltrate,Stage IIIB Rectal Cancer AJCC v7,1
17642,Malignant Cellular Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
17643,Adulthood Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
17644,Carcinomatous Component Present,solid type ductal carcinoma in situ of breast,1
17645,Carcinomatous Component Present,Adenocarcinoma of the prostate metastatic,1
17646,Mixed Cellular Population,Mixed Oligodendroglioma-Astrocytoma,1
17647,Malignant Cellular Infiltrate,Stage IIB Ampulla of Vater Cancer AJCC v8,1
17648,Malignant Cellular Infiltrate,Metastatic Soft Tissue Sarcoma,1
17649,High Grade Lesion,Glioblastoma by Gene Expression Profile,1
17650,Storiform Growth Pattern,Deep histiocytoma,1
17651,Carcinomatous Component Present,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
17652,Malignant Cellular Infiltrate,Myxosarcoma,1
17653,Localized Lesion,Pleural Well Differentiated Papillary Mesothelioma,1
17654,Intraepithelial Neoplasia,Malignant melanoma in precancerous melanosis,1
17655,Carcinomatous Component Present,Posterior Tongue Mucoepidermoid Carcinoma,1
17656,Epithelial Component Present,Stage IIIC Esophageal Squamous Cell Carcinoma AJCC v7,1
17657,Subcutaneous nodule,Subcutaneous panniculitis-like T-cell lymphoma,1
17658,Malignant Cellular Infiltrate,Non-squamous non-small cell lung cancer,1
17659,Indolent Clinical Course,Desmoplastic fibroblastoma,1
17660,Fibrotic Stroma Formation,Brenner Tumor,1
17661,Borderline Lesion,Borderline Ovarian Endometrioid Adenofibroma,1
17662,Carcinomatous Component Present,Ampulla of Vater Mucinous Adenocarcinoma,1
17663,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1,1
17664,Refractory Disease,Refractory Central Nervous System Lymphoma,1
17665,Carcinomatous Component Present,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
17666,Hyaline Cartilage Differentiation,Juxtacortical chondroma,1
17667,Epithelial Component Present,Stage II Renal Cell Cancer AJCC v7,1
17668,Dual Population of Bone Marrow Blasts Present,Acute bilineal leukemia,1
17669,Benign Cellular Infiltrate,Benign tumor of lacrimal drainage structure,1
17670,Epithelial Component Present,Serous cystadenocarcinoma of pancreas,1
17671,Infiltrative Growth Pattern,"Fibromatosis, Aggressive",1
17672,Slow Growing Mass,Recurrent Ependymoma,1
17673,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
17674,Childhood Lesion,Recurrent Childhood Rhabdomyosarcoma,1
17675,Epithelial Component Present,mucinous adenocarcinoma of gallbladder,1
17676,Mixed Cellular Population,Uterine Corpus Carcinofibroma,1
17677,Epithelial Component Present,Oropharyngeal squamous papilloma,1
17678,High Grade Lesion,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
17679,Epithelial Component Present,Neuroendocrine neoplasm of appendix,1
17680,Cutaneous Involvement,Lentigo simplex,1
17681,Unifocal Lesion,Eosinophilic Granuloma,1
17682,Nuclear Grooves,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
17683,Epithelial Component Present,Intrahepatic Bile Duct Microcystic Adenoma,1
17684,Metastatic Lesion,Metastatic Lung Small Cell Carcinoma,1
17685,atypia morphology,"Papillary mucinous cystadenoma, borderline malignancy",1
17686,Acanthosis,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
17687,Well-Circumscribed Lesion,Small Intestinal Tubular Adenoma,1
17688,High Mitotic Activity,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
